| Active Ingredient | Originator | CAS Number | Structure |
| 01-76D3-1 | Kitasato Gakuen (Japan) | |  |
| 0601-GIP-3794 | Amylin Pharmaceuticals (US) | |  |
| 1-alpha-hydroxy-24-epi-vitamin D5 | Nisshin Flour Milling | 331437-90-2 |  |
| 1-alpha-Hydroxyvitamin D5 | University of Illinois | 187935-17-7 |  |
| (+)-1-Bisabolone | CSIR India | |  |
| 1-hydroxyoxaunomycin | Sanraku | 145165-10-2 |  |
| 1-NAP-Lobelane | University of Kentucky | |  |
| 1-O-DPPC | Liplasome pharma ; Danish university of pharmaceutical sciences ; University of Denmark | |  |
| 1-SP-4-84 | ChemGenex ; Michigan State University | |  |
| 1-SP-6-95 | ChemGenex ; Michigan State University | |  |
| 1,3-dichloropropene | | 542-75-6 |  |
| 1,6-DPDOHNH2 | | |  |
| [10]-Gingerol | | 23513-15-7 |  |
| [10]-Paradol | | |  |
| [10]-Shogaol | | 36752-54-2 |  |
| 103D5R | Emory University ; Scripps Research Institute | |  |
| 10G11-9H10 DVD-Ig | Abbott Laboratories (US) | | No Structure |
| 111In-ST-2210 | Sigma Tau | |  |
| [111In]-Capromab pendetide | Cytogen Corp. (US) | | No Structure |
| 1192U90 | Wellcome (GSK) | 155289-31-9 |  |
| [11C]-AZD-2184 | AstraZeneca AB | |  |
| [11C]-BF-227 | Tohoku University (Japan) | |  |
| [11C]-DASB | Centre for Addiction and Mental Health (Canada) | |  |
| [11C]-GSK-215083 | GlaxoSmithKline plc (GB) | |  |
| [11C]-GSK-931145 | GlaxoSmithKline plc (GB) | |  |
| [11C]-JNJ-16567083 | Janssen Pharmaceutica (Johnson & Johnson) | |  |
| [11C]-MDDP | | |  |
| [11C]-MK-4232 | Merck & Co Inc. | |  |
| [11C]-NS-12857 | NeuroSearch AS | |  |
| [11C]-P-943 | Pfizer Inc. | |  |
| [11C]-PBR-28 | National Institute of Mental Health (US) ; National Institutes of Health (US) | |  |
| [11C]-PipISB | National Institutes of Health (US) ; Karolinska Hospital (Sweden) ; Eli Lilly & Co. (US) | |  |
| [11C]-SB-207145 | GlaxoSmithKline plc (GB) | |  |
| [11C]-ZIET | Emory University | |  |
| 1229U91 | Wellcome (GSK) | |  |
| [123I]-ZIET | Emory University | |  |
| [123I]MNI-420 | Institute for Neurodegenerative Disorders (US) | |  |
| [125I]-AB-MECA | Department of Health and Human Services (US) | |  |
| [125I]-S-36057 | Servier | |  |
| [125I]BMS-356188 | BMS (Bristol-Myers Squibb) | |  |
| 131I-Chlorotoxin | TransMolecular | |  |
| 131I-Labetuzumab | Immunomedics Inc. | | No Structure |
| [131I]-Metuximab | Fourth Military Medical University (CN) | | No Structure |
| [131I]-MIP-1375 | Molecular Insight Pharmaceuticals Inc. | |  |
| 145U87 | Wellcome (GSK) | |  |
| 15-Methoxypinusolidic acid | Seoul National University | 462636-79-9 |  |
| 15d-PGJ(2) | Photogenesis | 89886-60-2 |  |
| 16-alpha-fluoroestradiol | University of Illinois | |  |
| 165RL90 | Acadia Pharmaceuticals | |  |
| 16alpha-gitoxin | Erfurt Medical Academy | |  |
| 173FBA73BL | Acadia Pharmaceuticals | |  |
| 17C91 | Wellcome Foundation (GSK) | |  |
| 18-F-Faza | Natural Pharmacia International | |  |
| 188Re-SOCTA-Trastuzumab | Institute of Nuclear Energy Research, ROCAEC (Taiwan ) | | No Structure |
| [188Re]-DXR-liposome | Institute of Nuclear Energy Research (Taiwan) ; National Health Research Institutes (Taiwan) | | No Structure |
| [188Re]P-2045 | Diatide, Inc. | 362588-08-7 |  |
| 18F-Dasatinib | Sloan-Kettering Institute for Cancer Research (US) | |  |
| [18F]-D-FMT | Hamamatsu Photonics KK | |  |
| [18F]-F-15599 | Pierre Fabre Medicament | |  |
| [18F]-FAC | University of California (US) | |  |
| [18F]-FACPC | Emory University (US) | |  |
| [18F]-FCPyPB | Merck & Co. Inc. (US) | |  |
| [18F]-FCWAY | | |  |
| [18F]-FE-PE2I | Karolinska Institutet (Sweden) ; Stockholm Brain Institute (Sweden) ; Inserm U619 (France) | |  |
| [18F]-FEDAA-1106 | Japan Science and Technology ; National Institute of Radiological Sciences | |  |
| [18F]-FMDAA-1106 | Japan Science and Technology ; National Institute of Radiological Sciences | |  |
| [18F]-FP2OP | Beijing Normal University (China) | |  |
| [18F]-FPEB | Merck & Co Inc. | |  |
| [18F]-FZ-202-1 | Emory University (US) | |  |
| [18F]-LW-54 | Cancer Targeted Technology LLC | |  |
| [18F]-MK-3328 | Merck & Co Inc. | |  |
| [18F]-MK-9470 | Merck & Co. Inc. (US) | |  |
| [18F]-N-Me-FAMP2 | Emory University | |  |
| [18F]-PBR-06 | National Institute of Mental Health (US) | |  |
| [18F]-PipISB | National Institutes of Health (US) ; Karolinska Hospital (Sweden) ; Eli Lilly & Co. (US) | |  |
| [18F]-TTA-A4 | Merck & Co Inc. (US) | |  |
| [18F]AZD-4694 | AstraZeneca AB (Sweden) | | No Structure |
| [18F]fpe-Caf2 | ABX Advanced Biochemical Compounds ; Technische Universitat Munchen (DE) | |  |
| [18F]fpr-suf[398373] | ABX Advanced Biochemical Compounds ; Technische Universitat Munchen (DE) | |  |
| [18F]HX-4 | Siemens Medical Solutions (US) | |  |
| [18F]SU-11248 | | |  |
| 19-O-Methylgeldanamycin | Chulalongkorn University (Thailand) ; Nagoya University (Japan) | |  |
| 198RL26 | Acadia Pharmaceuticals | |  |
| 1RFA-3M | Universidad de Oviedo (Spain) | |  |
| 1RFA-5M | Universidad de Oviedo (Spain) | |  |
| 2-APB | Institute of Physical and Chemical Resarch \n(JP) | |  |
| 2-BFI | Eli Lilly | 72583-92-7 |  |
| 2-Bn-Tet-AMPA | H. Lundbeck AS (Denmark) | |  |
| 2-Deoxy-D-glucose | University of Miami | 154-17-6 |  |
| 2-Ethoxybenzoic acid | Lundbeck | 134-11-2 |  |
| 2-Hydroxymyristic acid | BTG International | 2507-55-3 |  |
| 2-IBPO | Osaka University | 460720-66-5 |  |
| 2-Mercaptobenzothiazole | | 149-30-4 |  |
| 2-methoxyestradiol | Pharm-Eco Laboratories (Johnson Matthey Pharma Services) | 362-07-2 |  |
| 2-Methoxyestradiol disulfamate | Sterix (Ipsen) | 401600-86-0 |  |
| 2,5-dimethylcelecoxib | Ohio State University Research Foundation (US) | |  |
| 2,7-dibromocryptolepine | University of Bradford ; London School of Hygiene and Tropical Medicine | |  |
| 20k-PEG-bLf | NRL Pharma Inc. (Japan) | | No Structure |
| (21CysPEG5K)-Glucagon | Indiana University Research & Technology Corp. (US) | |  |
| [227Th]-Rituximab | Algeta ASA (Norway) | | No Structure |
| (+)-23,24-Dihydrodiscodermolide | Kosan Biosciences (BMS) | |  |
| 24,25 dihydroxycholecalciferol | Teva | |  |
| 240GG01 | Acadia Pharmaceuticals Inc. (US) | |  |
| 250B05 | Oncalis AG (Switzerland) | |  |
| 253-G8 | Philadelphia Health & Education Corporation (Drexel University College of Medicine) | |  |
| 26-Fluoroepothilone B | Scripps Research Institute | |  |
| 264W94 | Wellcome (GSK) | 178961-24-5 |  |
| 28-deacetylsendanin | Li Jinshan | 58812-37-6 |  |
| 2CX4.401 | Carlsberg | |  |
| 2H9-MC-vc-PAB-MMAE | Genentech | | No Structure |
| 2NTX-99 | Universita degli Studi di Milano | 479579-01-6 |  |
| (2R,4S)-Itraconazole | Janssen Pharmaceutica (Johnson & Johnson) | 84625-61-6 |  |
| 3-Allyfarnesol | Wayne State University | 247942-40-1 |  |
| 3-BAABE | Mount Sinai School of Medicine | 209345-05-1 |  |
| 3-Benzylidene Camphor | | 15087-24-8 |  |
| 3-Bromodiosmine | CNRS ; Universite Paris Sud XI | |  |
| 3-Bromomethcathinone | East Carolina University (US) | |  |
| 3-CI-AHPC | Burnham Institute | |  |
| 3-Hydroxymethyl-DCK | Panacos Pharmaceuticals | |  |
| 3-IAABE | Mount Sinai School of Medicine | 268749-50-4 |  |
| 3-IAABU | Mount Sinai School of Medicine | 218935-77-4 |  |
| 3-MATIDA | GlaxoSmithKline (GSK) | |  |
| 3-methoxy-pregnenolone | Mapreg | |  |
| 3,4-Dicaffeoylquinic acid | Ergo Forschung | 14534-61-3 |  |
| 3,7-Diepicasuarine | Molecular nature Ltd. | |  |
| 35AKU-21 | Acadia Pharmaceuticals | |  |
| 3858U92 | Glaxo Wellcome (GSK) | |  |
| 3874-H1 | Hoechst (Sanofi-Aventis) | 204858-12-8 |  |
| 3874-H3 | Hoechst (Sanofi-Aventis) | 204858-14-0 |  |
| 39-TDW-12C | Johns Hopkins University (US) ; Wayne State University (US) | |  |
| 39-TDW-47C | Johns Hopkins University (US) ; Wayne State University (US) | |  |
| 3DP-4815 | 3-Dimensional (Johnson & Johnson Pharmaceutical) | |  |
| 3F8 MAb | Sloan-Kettering Institute for Cancer Research (US) | | No Structure |
| [3H]-2-FA | AstraZeneca AB (Sweden) ; Targacept Inc. (US) | |  |
| [3H]-A-804598 | Abbott Laboratories (US) | |  |
| [3H]-OSIP-339391 | OSI Pharmaceuticals | |  |
| [3H]A-585539 | Abbott Laboratories (US) | |  |
| 3M-003 | Minnesota Mining & Manufacturing Compagny (3M Pharmaceuticals) | |  |
| 3M-011 | 3M Innovative Properties Co. (US) | |  |
| 3M-852A | 3M Innovative Properties Co. | |  |
| 4-[18F]-ADAM | University of Pennsylvania (US) | |  |
| 4-chlorokynurenine | Pharmacia ; University of Maryland | 164789-11-1 |  |
| 4-demethylepothilone B | Novartis | |  |
| 4-Demethylpenclomedine | (US HEALTH (US); SOUTHERN RES INST (US) | |  |
| 4-F-Benzoyl-TN-14003 | Takeda | |  |
| 4-F-GlcNAc | Brigham and Women's Hospital ; Health Research | 129785-44-0 |  |
| 4-HBTTNPB | Wisconsin Alumni Research Foundation (US) | |  |
| 4-Ipomeanol | Boston University | 32954-58-8 |  |
| 4-methyl-UAB-30 | | |  |
| (4-Methylbenzylidene)-Camphor | | 38102-62-4 ; 36861-47-9 ; 84055-65-2 |  |
| 4-OH-DHA | Cayman Chemical Co. (US) ; Maruha Nichiro Holdings Inc. (Japan) | 90906-40-4 |  |
| 4,6-DIENE-CER | Tulane University ; City University of New York | |  |
| 4'-Methoxydaidzein 7-oleate | China Pharmaceutical University (China) | |  |
| 4030W92 | Glaxo (GSK) | 189013-61-4 |  |
| 4162W94 | Maxygen (Codexis) | 339175-81-4 | No Structure |
| 44AANA47-RANTES | Applied Research Systems ARS Holding NV (Netherlands) | |  |
| 46-TDW-34C | Johns Hopkins University (US) ; Wayne State University (US) | |  |
| 4991W93 | Wellcome (GSK) | 171549-56-7 |  |
| 5-aminolevulinic acid | University of Illinois ; Queens University | 106-60-5 |  |
| 5-Br-nosc | Emory University | |  |
| 5-Bromotetrandrine | Kanghong USA Inc. | |  |
| 5-CITEP | Shionogi & Co | |  |
| 5-fluoropyrimidine | Bayer | 675-21-8 |  |
| 5-FP | SuperGen | 671-35-25 |  |
| 5-Methylurapidil | Byk Gulden (Nycomed) | 34661-85-3 |  |
| 5,14-20-HEDGE | Medical College of Wisconsin (US) | |  |
| 5'-noraristeromycin | Hoechst (Sanofi-Aventis) | 142635-42-5 |  |
| 5(S)-CTP | Dr. Reddy's Laboratories | |  |
| 572-Trii | | |  |
| 5A-APC | Socratech LLC ; University of Rochester (US) ; Scripps Research Institute (US) | | No Structure |
| 6-anilinouracil | Microbiotix | 7269-15-0 |  |
| 6-azacytidine | Pro-Neuron | 3131-60-0 |  |
| 6-Benzyladenine | Wisconsin Alumni Research Foundation | 1214-39-7 |  |
| 6-chloro-ddG | Sanyo | |  |
| 6-DBF-7 | University of Minnesota | |  |
| 6-MCDF | Texas A & M University | 115039-00-4 |  |
| 6-MPG | Tanabe | 153355-02-3 |  |
| [6]-Gingerol | | 23513-14-6 |  |
| [6]-Paradol | | 27113-22-0 |  |
| [6]-Shogaol | | 555-66-8 |  |
| 69-NLS-75 | Acadia | |  |
| 6alpha-Fluoro ursodeoxycholic acid | Giuliani | 132056-33-8 |  |
| 6D6-1 | INSERM (France) | |  |
| 7-alpha-methyl-19-nortestosterone | Population Council | 3764-87-2 |  |
| 7-methoxytacrine | Vojenska Lekarska Akademie | 5778-80-3 |  |
| 739W94 | Glaxo (GSK) | |  |
| 8-Amino-9-benzyl-guanine | Ciba-Geigy (Novartis) | 100890-94-6 |  |
| 8-Chloroadenosine | Evanston Northwestern Healthca (US) | 34408-14-5 |  |
| 8-Chlorotheophylline | | 85-18-7 |  |
| 8-PN | Schering AG ; Kairosmed GmbH (Germany) | 53846-50-7 |  |
| [8]-Gingerol | | 23513-08-8 |  |
| [8]-Paradol | | 27113-23-1 |  |
| [8]-Shogaol | | 36700-45-5 |  |
| 8S-GLP-1+5R | Sanwa | |  |
| 9-AC | Research Triangle Institute | 94124-43-1 |  |
| [90Y-DOTA]776.1 | Euro Celtique SA (Luxembourg) | | No Structure |
| 90Y-Edotreotide | Novartis | 189758-25-6 |  |
| 90Y-ST-2210 | Sigma Tau | |  |
| [90Y]-DOTAGA-Substance P | Kantonsspital Basel ; Universität Bern | |  |
| 99mTc-EC-0652 | Purdue Research Foundation (US) | |  |
| [99mTc]-MIP-1340 | Molecular InSight Pharmaceuticals Inc. | |  |
| [99mTc]-MIP-1407 | Molecular Insight Pharmaceuticals Inc. | |  |
| [99mTc]-PAMA-Cbl | Solidago AG (Switzerland) ; Universitaet Zuerich (Switzerland) ; Paul Scherrer Institut (Switzerland | |  |
| [99Tc]Demobesin 3 | National Center for Scientific Research ; Demokritos Institute of Radioisotopes-Radiodiagnostic Prod | |  |
| [99Tc]Demobesin 4 | National Center for Scientific Research ; Demokritos Institute of Radioisotopes-Radiodiagnostic Prod | |  |
| 9cUAB30 | UAB Research Foundation (University of Alabama at Birmingham) | 205252-59-1 |  |
| A-001 | Teijin Pharma | |  |
| A-003118157 | Aventis Pharma (Sanofi-Aventis) | |  |
| A-003394934A | Sanofi Aventis Deutschland GmbH | |  |
| A-003394937A | Sanofi Aventis Deutschland GmbH | |  |
| A-003401273A | Sanofi Aventis Deutschland GmbH | |  |
| A-003407940A | Sanofi Aventis Deutschland GmbH | |  |
| A-1010002 | Abbott Laboratories | | No Structure |
| A-101211 | Abbott | 186197-61-5 |  |
| A-104954 | Abbott | 169748-83-8 |  |
| A-105972 | Abbott | 343346-07-6 |  |
| A-1110U | Burroughs Wellcome (GSK) | 96860-23-0 |  |
| A-121798 | Abbott | 153950-29-9 |  |
| A-127722 | Abbott | 195704-72-4 |  |
| A-131701 | Abbott | 181490-18-6 |  |
| A-134974 | Abbott | 186141-75-3 |  |
| A-151892 | Abbott ; Icagen | |  |
| A-160621 | Abbott | |  |
| A-172013 | Abbott | |  |
| A-177430 | Abbott | 210484-07-4 |  |
| A-177775 | Abbott | 243852-01-9 |  |
| A-181978 | Abbott | 198557-55-0 |  |
| A-184656 | Abbott | 381221-99-4 |  |
| A-192411.29 | Abbott | 263846-33-9 |  |
| A-192558 | Abbott | 341969-96-8 |  |
| A-192621 | Abbott | 195529-54-5 |  |
| A-198401 | Abbott | |  |
| A-1998 | Zhongshan University | |  |
| A-204176 | Abbott | 258527-44-5 |  |
| A-204197 | Abbott | 373647-71-3 |  |
| A-205804 | Abbott | |  |
| A-207036 | Abbott | |  |
| A-217213 | Abbott | 205111-68-8 |  |
| A-249377 | Abbott | 251996-00-6 |  |
| A-2545 | Alkaloida Vegyeszeti Gyar | 93799-37-2 |  |
| A-259745 | Abbott | |  |
| A-276575 | Abbott ; Ligand Pharmaceuticals | |  |
| A-278637 | Abbott | 227609-65-6 |  |
| A-286501 | Abbott | 483341-15-7 |  |
| A-286982 | Abbott | |  |
| A-289099 | Abbott | |  |
| A-292438 | Abbott | 380180-69-8 |  |
| A-299620 | Abbott | |  |
| A-304121 | Abbott | 360551-71-9 |  |
| A-304470 | Abbott | |  |
| A-306552 | Abbott | |  |
| A-308830 | ABBOTT | 497164-64-4 |  |
| A-315675 | Abbott | 335679-69-1 |  |
| A-316023 | Abbott | 361546-46-5 |  |
| A-317491 | Abbott | 475205-49-3 |  |
| A-317567 | Abbott Laboratories | |  |
| A-317920 | Abbott | |  |
| A-318315 | Abbott | 312299-92-6 |  |
| A-318484 | Abbott Laboratories | |  |
| A-320436 | Abbott | |  |
| A-321842 | Abbott | |  |
| A-322278 | Abbott | 335695-06-2 |  |
| A-324920 | Abbott | |  |
| A-325100 | Abbott | |  |
| A-331440 | Abbott | 392338-13-5 |  |
| A-349821 | Abbott | |  |
| A-358 | Arrow Therapeutics | 335335-69-8 |  |
| A-364504 | Abbott | |  |
| A-37215 | BMS | |  |
| A-3922 | Nippon Soda Co. Ltd. (Japan) | |  |
| A-412997 | Abbott | |  |
| A-417022 | Abbott Laboratories | |  |
| A-420983 | Abbott | |  |
| A-422885.66 | Abbott ; BASF AG | |  |
| A-423579 | Abbott Laboratories | |  |
| A-425619 | Abbott | |  |
| A-431404 | Abbott | |  |
| A-448 | Arrow Therapeutics | |  |
| A-5021 | Ajinomoto | |  |
| A-5226A | The University of Tokyo (Japan) ; Perseus Proteomics Inc. (Japan) | | No Structure |
| A-550 | Idenix Pharmaceuticals Inc. (US) ; Centre National de la Recherche Scientifique (France) ; L’Univers | |  |
| A-582941 | Abbott | |  |
| A-6 | Angstrom Pharmaceuticals | |  |
| A-61603 | Abbott | |  |
| A-620223 | Basf AG (Abbott) | |  |
| A-62176 | Abbott | 111783-54-1 |  |
| A-62824 | Abbott | 111279-87-9 |  |
| A-65186 | Abbott Laboratories | 119295-94-2 |  |
| A-65281 | Abbott | 111279-49-3 |  |
| A-65282 | Abbott | 135906-72-8 |  |
| A-65317 | Abbott | 122224-84-4 |  |
| A-68828 | Abbott | 132309-52-5 |  |
| A-68930 | Abbott | 153448-83-0 |  |
| A-69024 | Schering Corp (Merck & Co) | 58939-37-0 |  |
| A-690344 | Abbott | |  |
| A-69328 | Abbott | 134108-11-5 |  |
| A-69334 | Abbott | 134060-33-6 |  |
| A-69412 | Abbott | 123606-23-5 |  |
| A-71378 | Pennwalt | 127902-33-4 |  |
| A-71623 | Abbott | 130408-77-4 |  |
| A-73209 | Abbott | 136451-98-4 |  |
| A-74704 | SmithKline Beecham (GSK) | 129467-45-4 |  |
| A-748835 | Abbott Laboratories Inc. (US) | |  |
| A-74932 | Abbott | 148201-60-9 |  |
| A-75169 | Abbott | 125067-40-5 |  |
| A-761 | Millennium Pharmaceuticals (Takeda) | |  |
| A-76154 | Abbott | 136989-30-5 |  |
| A-769662 | Abbott | |  |
| A-77 | Pfizer Inc. (US) | |  |
| A-77003 | Abbott | 134878-17-4 |  |
| A-770041 | Abbott | |  |
| A-77143 | Abbott | 143656-50-2 |  |
| A-77636 | Abbott | 145307-34-2 (HCl) |  |
| A-778193 | Abbott | |  |
| A-778728 | Abbott | |  |
| A-780150 | Abbott Laboratories | |  |
| A-784168 | Abbott Laboratories | |  |
| A-78773 | Abbott | 141579-67-1 |  |
| A-792611 | Abbott Laboratories | |  |
| A-796260 | Abbott | |  |
| A-800141 | Abbott | |  |
| A-802715 | Hoechst (Sanofi-Aventis) | 107767-58-8 |  |
| A-803467 | Abbott ; ICAgen | |  |
| A-80426 | Abbott | 152148-63-5 |  |
| A-804485 | Abbott | |  |
| A-80556 | Abbott | 121357-19-5 |  |
| A-80609 | Abbott | 139160-88-6 |  |
| A-81282 | Abbott | 141872-46-0 |  |
| A-836339 | Abbott Laboratories (US) | |  |
| A-837093 | Abbott Laboratories (US) | |  |
| A-84066 | Abbott | 139160-86-4 |  |
| A-841720 | Abbott | |  |
| A-843277 | Abbott GmbH & Co | |  |
| A-84441 | Abbott | 142136-44-5 |  |
| A-844606 | Abbott | |  |
| A-84643 | Abbott | 175483-66-6 |  |
| A-848837 | Abbott | |  |
| A-85653 | Abbott Laboratories | |  |
| A-859261 | Abbott Laboratories (US) | |  |
| A-86281 | Abbott | 148147-65-3 |  |
| A-866111 | Abbot Laboratories (US) | |  |
| A-867744 | Abbott Laboratories (US) | |  |
| A-890 | Arrow Therapeutics Ltd. | |  |
| A-906119 | Hoechst (Sanofi-Aventis) | 134072-58-5 |  |
| A-914880 | Abbott | |  |
| A-916165 | Abbott | |  |
| A-920076 | Abbott GmbH & Co. KG | |  |
| A-922500 | Abbott Laboratories (US) | 959122-11-3 |  |
| A-923573.7 | Abbott Laboratories | |  |
| A-940894 | Abbott Laboratories | |  |
| A-943931 | Abbott Laboratories (US) | |  |
| A-945381 | Abbott Laboratories (US) | |  |
| A-947864 | Abbott Laboratories (US) | |  |
| A-94964A | Sankyo | |  |
| A-966942 | Abbott Laboratories | |  |
| A-967079 | Abbott Laboratories | |  |
| A-988056 | Abbott Laboratories (US) | |  |
| A-99058-1 | Abbott | 185692-62-0 |  |
| A-995662 | Abbott Laboratories | |  |
| A-dmDT390-bisFv(UCHT1) | Government of the USA (US) ; Novartis AG (Switzerland) | | No Structure |
| A1P | University of Pennsylvania (US) ; University of Toronto (Canada) | |  |
| A3-APO | University of Leipzig ; University of Melbourne ; Wistar Institute | |  |
| AA-001 | Cancer Research Technology Ltd. (GB) | |  |
| AA-012 | Cancer Research Technology Ltd. (GB) ; Institute of Cancer Research Royal Cancer Hospital (GB) | |  |
| AA-018 | Cancer Rec Tech Ltd, GB ; Cancer Res Inst Royal, GB | |  |
| AA-019 | Cancer Research Technology Ltd. (GB) ; Institute of Cancer Research (GB) | |  |
| AA-067 | Cancer Rec Tech Ltd, GB ; Cancer Res Inst Royal, GB | |  |
| AA-41793 | H. Lundbeck AS | |  |
| AAB-002 | Elan Corp. plc (Ireland) | | No Structure |
| AAD-2004 | Neurotech Pharmaceuticals (South Korea) | |  |
| AAG-154353 | Duquesne University of the Holy Spirit (US) ; Wayne State University (US) | |  |
| AAL-993 | Novartis Pharma ; Schering AG | |  |
| AAP-10 | BASF (Abbott) | 159503-65-8 |  |
| AAV2-5-PR2.1-hGNAT2 | Suny Upstate Medical University (US) ; University of Florida (US) | | No Structure |
| AAV2-CBA-sFLT01 | Genzyme Corp. (US) | | No Structure |
| AAV9-S100-A1 | Thomas Jefferson University (US) | | No Structure |
| AB-1001(Granisetron) | Abeille Pharmaceuticals | |  |
| AB-129 | University of California | |  |
| AB-200434 | Ambit Biosciences | |  |
| AB-4 | University of Bialystok (PL) | |  |
| AB-5 | University of Texas (US) | |  |
| Abacavir | Wellcome (GSK) | 136470-78-5 ; 136777-48-5 (HCl) |  |
| Abafungin | Bayer | 129639-79-8 |  |
| Abagovomab | University of Bonn | 792921-10-9 | No Structure |
| Abamectin | Merck & Co. | 71751-41-2 |  |
| Abanoquil | Pfizer | 90402-40-7 |  |
| Abaperidone | Ferrer | 183849-43-6 |  |
| Abarelix | Advanced Research & Technology Inst. | 183552-38-7 |  |
| Abatacept | | 213252-14-3 | No Structure |
| ABBF | Bayer AG (Germany) | |  |
| Abciximab | Centocor ; Univ New York | 143653-53-6 | No Structure |
| ABD-295 | University of Aberdeen (UK) | |  |
| ABD-350 | University of Aberdeen (GB) | |  |
| ABD-56 | University of Aberdeen | |  |
| ABE | Indiana University School of Medicine | |  |
| Abecarnil | Schering AG | 111841-85-1 |  |
| Abediterol | Almirall Prodesfarma SA (Almirall SA) | 915133-65-2 |  |
| Abetimus | | 167362-48-3 |  |
| ABI-0043 | ActivBiotics | |  |
| ABI-008 (Docetaxel) | American BioScience Inc. (Abraxis BioScience Inc.) | 114977-28-5 ; 148408-66-5 (hydrate) |  |
| ABI-009 (Sirolimus) | American BioScience, Inc. (Abraxis BioScience Inc.) (US) | 53123-88-9 |  |
| ABI-010 (Tanespimycin) | American BioScience, Inc. (Abraxis BioScience Inc.) (US) | 75747-14-7 |  |
| ABI-011 (IDN-5404) | American BioScience Inc. (Abraxis BioScience Inc.) | |  |
| ABI-1131 | Kanegafuchi Chemical (Kaneka) | |  |
| ABI-1662 | University of Washington | |  |
| Abiraterone | British Technology Group (BTG) | 154229-19-3 |  |
| Abiraterone acetate | British Technology Group (BTG) | 154229-18-2 |  |
| ABJ-879 | Scripps Research Institute | |  |
| ABN-912 | Novartis | | No Structure |
| ABP-309 | Novartis | |  |
| ABS-212 | Argolyn Bioscience Inc. ; Medical University of South Carolina (US) | |  |
| ABS-EPI | Daiichi Sankyo Co. Ltd. (Japan) ; Essential Therapeutics Inc. (US) | |  |
| ABT-100 | Abbott Laboratories | |  |
| ABT-102 | Abbott Laboratories (US) | 808756-71-0 |  |
| ABT-107 | | | No Structure |
| ABT-116 | Abbott Laboratories | |  |
| ABT-127 | Abbott | |  |
| ABT-143 (Rosuvastatin & Fenofibric acid) | Abbott Laboratories (US) | 147098-20-2 (Rosuvastatin) ; 856676-23-8 (Fenofibric acid) |  |
| ABT-224 | Hokuriku (Abbott) | |  |
| ABT-232 | Nippon Shinyaku | 137431-04-0 (HCl) |  |
| ABT-239 | Abbott | |  |
| ABT-255 | Abbott | 186293-38-9 |  |
| ABT-279 | Abbott Laboratories | |  |
| ABT-299 | Abbott | 161395-35-3 |  |
| ABT-418 | Abbott | 147402-53-7 |  |
| ABT-450 | | | No Structure |
| ABT-491 | Abbott | 170499-15-7 |  |
| ABT-510 | Abbott | |  |
| ABT-518 | Abbott | 286845-00-9 |  |
| ABT-526 | Abbott | |  |
| ABT-546 | Abbott | |  |
| ABT-560 | | | No Structure |
| ABT-598 | | |  |
| ABT-702 | Abbott | 214697-26-4 |  |
| ABT-719 | Abbott | 162763-53-3 |  |
| ABT-724 | Abbott Laboratories | |  |
| ABT-737 | Abbott | 852808-04-9 |  |
| ABT-751 | Eisai | 141430-65-1 |  |
| ABT-866 | Abbott | 371790-02-2 |  |
| ABT-963 | Abbott | 266320-83-6 |  |
| ABX | Anacor Pharmaceuticals Inc. | |  |
| ABX-10241 | Abgenix (Amgen) | | No Structure |
| ABX-96 | Dr. Reddy's Research Foundation | |  |
| ABX-MA1 | Abgenix (Amgen) | 561063-60-3 | No Structure |
| AC-100 | Acologix | |  |
| AC-162325 | | | No Structure |
| AC-165024 | Acadia Pharmaceuticals | 319428-14-3 |  |
| AC-165043 | Acadia Pharmaceuticals | 319428-16-5 |  |
| AC-260584 | Acadia Pharmaceuticals Inc. | |  |
| AC-261066 | ACADIA Pharmaceuticals | |  |
| AC-262271 | ACADIA Pharmaceuticals Inc. | | No Structure |
| AC-262536 | Acadia Pharm Inc. (US) | |  |
| AC-264613 | Acadia Pharmaceuticals Inc. (US) | |  |
| AC-394 | Ajinomoto | 182236-82-4 |  |
| AC-55541 | Acadia Pharmaceuticals Inc. (US) | 916170-19-9 |  |
| AC-7 | Universidade Federal de Pernambuco UFPE (Brazil) | |  |
| AC-7954 | Acadia Pharmaceuticals | |  |
| AC-90179 | Acadia Pharmaceuticals | 359878-17-4 |  |
| Ac-GKAFRRL-12ADT | University of Johns Hopkins (US) | |  |
| Ac-PLP-BPI-NH2 | University of Kansas (US) | |  |
| Ac-PLP-BPI-NH2-2 | University of Kansas (US) | | No Structure |
| Ac-rER | Open University | |  |
| Acacetin | | 480-44-4 |  |
| Acadesine | University of California, (US) | 2627-69-2 |  |
| ACAM-2010 | | | No Structure |
| ACAM-529 | Dana Farber Cancer Institute (US) ; Harvard College (US) | | No Structure |
| Acamprosate | Meram (Lipha) | 77337-76-9 |  |
| Acarbose | Bayer | 56180-94-0 |  |
| ACC-001 | Elan ; Wyeth (Pfizer Inc.) | | No Structure |
| ACC-9369 | American Hospital Supply | 102203-23-6 |  |
| ACE-031 | Acceleron Pharma Inc. (US) | | No Structure |
| ACE-041 | Acceleron Pharma Inc. | | No Structure |
| ACE-435 | Acceleron Pharma Inc. | | No Structure |
| ACE-536 | Acceleron Pharma Inc. | | No Structure |
| ACE-661 | Acceleron Pharma Inc. | | No Structure |
| ACEA-1011 | Acea Pharma | 153504-72-4 |  |
| ACEA-1031 | Pfizer | 153504-82-6 |  |
| ACEA-1328 | Acea Pharma | 160954-05-2 |  |
| ACEA-1416 | Acea Pharma | 167415-33-0 |  |
| ACEA-762 | CoCensys | 181122-94-1 |  |
| Acebutolol | May & Baker (Aventis) | 37517-30-9 |  |
| Acecarbromal | Bayer | 77-66-7 |  |
| Aceclidine | Roche | 827-61-2 |  |
| Aceclofenac | Prodes (Almirall) | 89796-99-6 |  |
| Acedapson | | 77-46-3 |  |
| Acediasulfone | Cilag | 80-03-5 |  |
| Acedoben | Medea | 556-08-1 |  |
| Acefylline | E. Merck KGaA | 652-37-9 |  |
| Acefylline Piperazine | Delalande | 15302-00-8 |  |
| Aceglutamide | Kyowa Hakko | 2490-97-3 |  |
| Acemetacin | Troponwerke | 53164-05-9 |  |
| Acenocoumarol | Ciba-Geigy (Novartis) | 152-72-7 |  |
| Aceperone | Janssen Pharmaceutica (Johnson & Johnson) | 807-31-8 |  |
| Acephate | Chevron | 30560-19-1 |  |
| Acepromazine | Bayer | 61-00-7 |  |
| Aceprometazine | Bayer | 13461-01-3 |  |
| Acequinocyl | Dupont | 57960-19-7 |  |
| Acesulfame | Hoechst (Sanofi-Aventis) | 33665-90-6 |  |
| ACET | Eli Lilly & Co. (US) | |  |
| Acetamiprid | Nippon Soda | 135410-20-7 |  |
| Acetarsol | Hoechst (Sanofi-Aventis) | 97-44-9 |  |
| Acetazolamide | American Cyanamid (Wyeth) | 59-66-5 |  |
| Acetiamine | Pharmuka | 299-89-8 |  |
| Acetochlor | Monsanto | 34256-82-1 |  |
| Acetohexamide | Eli Lilly | 968-81-0 |  |
| Acetohydroxamic acid | | 546-88-3 |  |
| Acetophenazine | Schering Corp (Merck & Co) | 2751-68-0 |  |
| Acetoprole | Rhone-Poulenc | 209861-58-5 |  |
| Acetoxyvalerenic acid | | 81397-67-3 |  |
| Acetrizoic acid | Mallinckrodt | 85-36-9 |  |
| Acetyl-NMS | Panacea Biotec Ltd. (India) | |  |
| Acetylcholine | | 60-31-1 |  |
| Acetylcysteine | Mead Johnson (BMS) | 616-91-1 |  |
| Acetylfuratrizine | Toyama | 1787-26-0 |  |
| Acetylleucine | | 99-15-0 |  |
| Acetylmethionine | Distillers Products | 65-82-7 |  |
| Acetylmorphine-S-Nornicotine | University of Kentucky (US) | |  |
| Acetylsalicylic acid | Bayer | 50-78-2 |  |
| Acetylsulfafurazole | Roche | 80-74-0 |  |
| Acexamic acid | Rowa | 57-08-9 |  |
| AcGnG-NM | University of Alabama | |  |
| ACH-1095 | Achillion Pharmaceuticals Inc. | |  |
| ACH-126445 | Yale University; University of Georgia | |  |
| ACH-1625 | Achillion Pharmaceuticals Inc. | | No Structure |
| ACH-2684 | Achillion Pharmaceuticals Inc. | | No Structure |
| ACH-702 | Achillion Pharmaceuticals Inc. (US) | |  |
| ACH-806 | Achillion Pharmaceuticals Inc. | |  |
| ACHN-490 | Achaogen Inc. | |  |
| ACHP | Bayer | |  |
| Acibenzolar | Ciba-Geigy (Novartis) | 135158-54-2 |  |
| Aciclovir | Wellcome Foundation (GSK) | 59277-89-3 |  |
| Aciclovir elaidate | Norsk Hydro | 151090-37-8 |  |
| Acifluorfen | Rohm & Haas | 50594-66-6 |  |
| Acifran | American Home Products (Wyeth) | 72420-38-3 |  |
| Acipimox | Farmitalia Carlo Erba (Pharmacia) | 51037-30-0 |  |
| Acitazanolast | Wakamoto Pharma | 114607-46-4 |  |
| Acitemate | Chinoin | 101197-99-3 |  |
| Acitretin | Hoffmann La Roche (Roche) | 55079-83-9 |  |
| Acivicin | Upjohn (Pharmacia) | 42228-92-2 |  |
| Aclarubicin | MCRF (Microbial Chemistry Research Foundation) | 57576-44-0 |  |
| Aclatonium Napadisilate | Toyama | 55071-30-0 |  |
| Aclidinium bromide | Almirall | 320345-99-1 |  |
| Aclonifen | Celamerck | 74070-46-5 |  |
| Acodazole | Morton Norwich | 79152-85-5 |  |
| Acolbifene | Endorecherche | |  |
| Aconiazide | Bayer | 13410-86-1 |  |
| Acotiamide | Zeria | 773092-05-0 |  |
| Acreozast | Toyo Boseki | 123548-56-1 |  |
| Acriflavine Chloride | IG Farben | 8048-52-0 |  |
| Acrinathrin | Roussel-Uclaf (Bayer) | 101007-06-1 |  |
| Acrivastine | Wellcome Foundation (GSK) | 87848-99-5 |  |
| Acrolein | Shell Oil Co | 107-02-8 |  |
| ACS-67 | CTG Pharma srl (Italy) | |  |
| ACT-1 | MUSC Foundation for Research Development (US) | |  |
| ACT-132577 | Actelion Pharmaceuticals Ltd. | |  |
| ACT-3673 | ClanoTech AB (Sweden) | |  |
| ACT-NMS | Panacea Biotec Ltd. (India) | |  |
| Actarit | Nippon Shinyaku ; Mitsubishi Chemical | 18699-02-0 |  |
| Actein | | 18642-44-9 |  |
| Actilon | Coley Pharmaceutical (Pfizer) | | No Structure |
| Actinonin | Versicor (Vicuron) | 13434-13-4 |  |
| Actinoquinol | Alcon | 15301-40-3 |  |
| Actisomide | Searle (Pharmacia) | 96914-39-5 |  |
| Actofunicone | Kitasato Institute | |  |
| ACU-02 | Acucela | | No Structure |
| ACU-4429 | Acucela Inc. (US) | | No Structure |
| Acuracet (Oxycodone & Paracetamol) | Acura Pharmaceuticals Inc. | 76-42-6 (Oxycodone) ; 103-90-2 (Paracetamol) |  |
| Acurox (Oxycodone & Nicotinic acid) | Acura Pharmaceuticals Inc. | 76-42-6 (Oxycodone) ; 59-67-6 (Nicotinic acid) |  |
| ACVTPdG | Protera (Italy) | |  |
| Acyline | The Salk Institute For Biological Studies (US) | 170157-13-8 |  |
| AD-0261 | Green Cross (Mitsubishi Pharma) | 145600-69-7 |  |
| AD-143 | Sidney Farber Cancer Inst. | 80787-29-7 |  |
| AD-198 | Tennessee University | 98983-21-2 |  |
| AD-20 | Biotec | 111542-07-5 |  |
| AD-2754 | Yissum | |  |
| AD-312 | University of Tennessee | 128420-31-5 |  |
| AD-5 | Biotec | 92455-12-4 |  |
| AD-5075 | Merck & Co. | 103788-05-2 |  |
| AD-5467 | Takeda | 138333-32-1 |  |
| AD-8717 | Dainippon | 181821-99-8 |  |
| AD-923 (Fentanyl sublingual Spray) | Sirus Pharmaceuticals Ltd. (Sosei Co. Ltd.) | 437-38-7 |  |
| Ad5-PSA | University of Iowa (US) | | No Structure |
| Ad5-ZH | Got-a-Gene AB (Sweden) | | No Structure |
| Adalimumab | UCLA | 331731-18-1 | No Structure |
| ADAMB | Daiichi | 172965-22-9 |  |
| Adamexine | Ferrer | 54785-02-3 |  |
| Adapalene | Centre International de Recherches Dermatologiques, CIRD (Galderma, France) | 106685-40-9 |  |
| Adaphostin | US Health | |  |
| Adaprolol | Nicholas S. Bodor | 101479-70-3 |  |
| Adarotene | Sigma-Tau | |  |
| Adatanserin | American Home Products (Wyeth) | 127266-56-2 |  |
| ADC-02390946 | Adolor Corp. (US) | |  |
| ADCI | National Inst. of Health (NIH) | 124070-15-1 |  |
| ADD-17014 | University of Kentucky | 55643-87-3 |  |
| ADD-196022 | Howard University | 142458-16-0 |  |
| ADD-213063 | Sangyo Kaisha | 158276-70-1 |  |
| Adecatumumab | Micromet | 503605-66-1 | No Structure |
| Adefovir | Beecham (GSK) | 106941-25-7 |  |
| Adefovir dipivoxil | Rega Stichting (Belgium) ; Ceskoslovenska Akademie VED (Czech Republic)\n | 142340-99-6 |  |
| ADEK | University of Rochester ; University of Wisconsin-Madison | |  |
| Adekalant | AstraZeneca | 227940-00-3 |  |
| Adelmidrol | Lifegroup Spa (Italy) | 1675-66-7 |  |
| Adelmidrol (Veterinary) | Lifegroup Spa (Italy) | 1675-66-7 |  |
| Ademetionine | Boehringer Mannheim | 29908-03-0 |  |
| Adenine | Pharmascience | 73-24-5 |  |
| Adenosine | | 58-61-7 |  |
| ADEP-4 | Bayer | |  |
| Aderbasib | Incyte | 791828-58-5 |  |
| Adhesamine | Kyoto University (Japan) | |  |
| Adhexil (TM) | | | No Structure |
| Adinazolam | Ciba-Geigy (Novartis) | 37115-32-5 |  |
| Adiphenine | Ciba (Novartis) | 64-95-9 |  |
| Adipiodone | Schering AG (Bayer Schering Pharma) | 606-17-7 |  |
| Adipiplon | Neurogen Corp. | 840486-93-3 |  |
| ADL-5747 | Adolor | |  |
| ADL-5859 | Adolor Corporation | 850173-95-4 |  |
| ADL-5945 | Eli Lilly & Co. (US) | | No Structure |
| ADL-7445 | Adolor Corp. (US) | | No Structure |
| Adociaquinone B | University of Oklahoma | |  |
| Adomiparin | Momenta Pharmaceuticals | 9005-49-6 ; 9041-08-1 (sodium salt) | No Structure |
| Adoprazine | Solvay | 222551-17-9 |  |
| Adosterol | Daiichi Radioisotope Lab ; Mallinckrodt | 55623-03-5 |  |
| Adozelesin | Upjohn (Pharmacia) | 110314-48-2 |  |
| ADPM-01 | University College Dublin (Ireland) | |  |
| ADPM-06 | University College Dublin (Ireland) | |  |
| ADR-851 | Adria | 138559-56-5 |  |
| Adrafinil | Lafon (Cephalon) | 63547-13-7 |  |
| Adrenalone | Hoechst (Sanofi-Aventis) | 99-45-6 |  |
| Adrogolide | Abbott | 166591-11-3 (HCl) |  |
| ADS-108297 | Corcept Therapeutics Inc. (US) | |  |
| ADS-J1 | New York Blood Center | |  |
| Advax | Aaron Diamond AIDS Research Center (US) | | No Structure |
| ADX-10059 | Addex Pharmaceuticals (Switzerland) | | No Structure |
| ADX-10061 | Novo Nordisk | 128022-68-4 |  |
| ADX-415 | | | No Structure |
| ADX-47273 | Addex Pharmaceuticals | |  |
| ADX-63365 | Addex Pharmaceuticals | | No Structure |
| ADX-68692 | Addex Pharmaceuticals | | No Structure |
| ADX-71149 | Addex Pharmaceuticals | | No Structure |
| ADX-71943 | Addex Pharmaceuticals | | No Structure |
| Adxanthromycin | Daiichi | 223740-97-4 |  |
| AE-37 | Generex Biotechnology Corp. (Canada) | |  |
| AE-3763 | Dainippon Pharmaceutical | 291778-77-3 |  |
| AE-66034 | H. Lundbeck AS | |  |
| AEAC | Albert Einstein College of Medicine (US) | |  |
| AECHL-1 | University of Baroda (India) ; University of Pune Campus (India) | |  |
| AEE-788 | Novartis | |  |
| AEG-3482 | Aegera Therapeutics | |  |
| AEG-40730 | Aegera Therapeutics Inc. | |  |
| AEOL-10113 | Duke University | 223723-79-3 |  |
| AEOL-10150 | National Jewish Medical & Research Center ; Aeolus pharmaceutical Inc. ; Duke University | 286475-30-7 |  |
| AEOL-11207 | Aeolus Pharmaceuticals Inc. (US) ; Duke University (US) | |  |
| AERAS-402 | Crucell Holland BV (Netherlands) ; Aeras Global TB Vaccine Foundation (US) | | No Structure |
| AeroLEF (Fentanyl) | Delex Therapeutics (YM BioSciences) | 437-38-7 |  |
| Aeruginosamide | | 241483-64-7 |  |
| AES-14 | Aesgen (MGI Pharma) | 56-85-9 |  |
| AEZS-108 | Tulane University ; VeteransAffairs Medical Center | |  |
| AEZS-115 | AEterna Zentaris Inc. (Canada) | | No Structure |
| AEZS-120 | AEterna Zentaris Inc. (Canada) | | No Structure |
| AEZS-123 | AEterna Zentaris Inc. (Canada) | |  |
| AEZS-126 | AEterna Zentaris GmbH (Germany) | |  |
| AEZS-129 | AEterna Zentaris Inc. (Canada) | | No Structure |
| AF-150 | Sigma-Tau | 113168-14-2 |  |
| AF-150(S) | IIBR (Isreal Institute for Biological Research) | |  |
| AF-15846 | GlaxoSmithKline (GSK) | |  |
| AF-21276 | GlaxoSmithKline (GSK) | 397874-11-2 |  |
| AF-220 | Afferent Pharmaceuticals Inc. | | No Structure |
| AF-2968 | Angelini | 161905-64-2 |  |
| AF-2975 | University of Iowa | 1126-71-2 |  |
| AF-36172 | Affymax Inc. (US) | |  |
| AF-3R172 | ACRAF | |  |
| AF-3R276 | ACRAF | |  |
| AF-3R277 | ACRAF | |  |
| AF-3R278 | ACRAF | |  |
| AF-3R292 | ACRAF | |  |
| AF-3R294 | ACRAF | |  |
| AF-3R295 | ACRAF | |  |
| AF-3R299 | ACRAF | |  |
| AF-3R301 | ACRAF | |  |
| AF-3R305 | ACRAF | |  |
| AF-3R331 | ACRAF | |  |
| AF-3R335 | ACRAF | |  |
| AF-792 | F. Hoffmann-La Roche AG | |  |
| Afacifenacin | Dainippon Sumitomo (Japan) | 877606-63-8 |  |
| Afamelanotide | University Patents Inc ; University of Arizona | 75921-69-6 |  |
| Afatinib | Boehringer Ingelheim | 439081-18-2 ; 850140-72-6 ; 850140-73-7 (dimaleate) |  |
| AFD-19 | Nippon Shinyaku | 99465-62-0 |  |
| AFD-21 | Nippon Shinyaku | 99465-44-8 |  |
| Afeletecan | Bayer | 215604-75-4 |  |
| Afelimomab | Knoll (Abbott) | 156227-98-4 | No Structure |
| Affitope AD01 | Affiris | | No Structure |
| AFG-GAL | Sopharma AD | |  |
| Afimoxifene | ICI (Imperial Chemical Industries) | 68047-06-3 ; 68392-35-8 |  |
| Aflibercept | Regeneron | 845771-78-0 | No Structure |
| Afloqualone | Tanabe | 56287-74-2 |  |
| AFP-464 | US Government | |  |
| AFP-SCAN | | | No Structure |
| AFPSiA | AstraZeneca AB (Sweden) | |  |
| AFQ-056 | Novartis AG | |  |
| AFRESA (Insulin inhalation) | Mannkind Corp. (US) | | No Structure |
| Afutuzumab | Glycart Biotechnology AG (Switzerland) | 949142-50-1 | No Structure |
| AFX-9154 | Afecta Pharmaceuticals Inc. | | No Structure |
| AFX-929 | Afecta Pharmaceuticals Inc. | | No Structure |
| AFX-9901 | Afecta Pharmaceuticals Inc. | | No Structure |
| AG-001859 | Agouron (Pfizer) | |  |
| AG-011 | ActoGeniX NV | | No Structure |
| AG-012986 | Pfizer Inc. (US) | |  |
| AG-014699 | Agouron Pharma (Pfizer) | |  |
| AG-028262 | Agouron (Pfizer) | |  |
| AG-041R | Chugai (Roche) | 199800-49-2 |  |
| AG-12037 | Agouron (Pfizer) | 107401-75-2 |  |
| AG-12042 | Agouron (Pfizer) | 223783-88-8 |  |
| AG-12072 | Agouron (Pfizer) | 223783-77-5 |  |
| AG-12073 | Agouron (Pfizer) | 223783-78-6 |  |
| AG-12105 | Agouron (Pfizer) | 223783-98-0 |  |
| AG-12166 | Agouron (Pfizer) | 223784-40-5 |  |
| AG-12186 | Agouron (Pfizer) | |  |
| AG-122005 | Pfizer | |  |
| AG-12252 | Agouron (Pfizer) | 223784-60-9 |  |
| AG-12274 | Agouron (Pfizer) | 223784-69-8 |  |
| AG-12275 | Agouron (Pfizer) | |  |
| AG-12286 | Agouron (Pfizer) | 223784-75-6 |  |
| AG-12578 | Agouron (Pfizer) | |  |
| AG-1284 | Agouron (Pfizer) | |  |
| AG-1295 | Yissum Research Development | 71897-07-9 |  |
| AG-1296 | RPR (Aventis) | 146535-11-7 |  |
| AG-13958 | Pfizer | | No Structure |
| AG-14361 | Agouron (Pfizer) ; Cancer Research Campaign Technology | |  |
| AG-1584 | Pfizer | |  |
| AG-1776 | Japan Energy | 186538-00-1 |  |
| AG-18 | South Florida University | 118409-57-7 |  |
| AG-1801 | Notox | |  |
| AG-2009 | Agouron (Pfizer) | 160743-73-7 |  |
| AG-2024 | Agouron (Pfizer) | |  |
| AG-2034 | Agouron (Pfizer) | 177575-17-6 |  |
| AG-205 | Meiji Seika Kaisha Ltd. | |  |
| AG-213 | Yissum Research Development | 122520-86-9 |  |
| AG-24322 | Pfizer | |  |
| AG-284 | Corixa | 230631-41-1 | No Structure |
| AG-306 | Pfizer | |  |
| AG-3433 | Agouron (Pfizer) | 207118-71-6 |  |
| AG-490 | Mitsubishi | 133550-30-8 |  |
| AG-494 | Michigan University | 133550-35-3 |  |
| AG-5473 | Agouron (Pfizer) | |  |
| AG-5507 | Agouron | |  |
| AG-701 | Antigenics | | No Structure |
| AG-702 | University of Fordham ; Antigenics | | No Structure |
| AG-707 | Antigenics | | No Structure |
| AG-825 | University of South Florida | 149092-50-2 |  |
| AG-858 | Antigenics | | No Structure |
| AG-957 | Sugen | 140674-76-6 |  |
| AG-99 | Pfizer | 118409-59-9 |  |
| AG-GAL | Sopharma AD | |  |
| Ag85B-ESAT-6-IC31 | Statens Serum Institut | | No Structure |
| Agacutin | Guangdong Pharmaceutical University (China) | | No Structure |
| Agalsidase alfa | Transkaryotic therapies (Shire Pharmaceuticals) | | No Structure |
| Agalsidase beta | Sinai School Medicine | | No Structure |
| AgaNase | Novabay Pharmaceuticals | |  |
| Aganepag | Allergan | 910562-18-4 |  |
| Aganepag ethanediol | | 1192760-33-0 |  |
| Aganepag isopropyl | Allergan | 910562-20-8 |  |
| Aganirsen | Gene Signal SAS | 1146887-67-3 |  |
| Agatolimod | Coley Pharmaceutical ; University of Iowa (US) ; Ottawa Civic Hospital Loeb. Reserch (CA) | 541547-35-7 (sodium salt) ; 207623-20-9 | No Structure |
| (-)-Agelastatin A | UFC Limited ; Synergy House | |  |
| AGI-004 (Mecamylamine) | AGI Therapeutics | |  |
| AGI-010 (Omeprazole) | AGI Therapeutics | |  |
| AGI-022 | AGI Therapeutics plc | |  |
| AGI-2048 | Atherogenics | |  |
| AGK-2 | Harvard Medical School (US) ; Scripps Research Institute (US) ; Purdue University (US) | |  |
| AGL-517 | Kirin Brewery | 148289-17-2 |  |
| Aglaiastatin A | Terumo | |  |
| Aglaiastatin B | Terumo | 189232-91-5 |  |
| Aglaiastatin C | Terumo | 209795-43-7 |  |
| Aglycosyl hu5C8 | Biogen Idec | | No Structure |
| AGM-1470 | Takeda | 129298-91-5 |  |
| Agmatine | | 306-60-5 |  |
| AGN-190121 | Allergan | 132032-67-8 |  |
| AGN-190383 | Allergan | 120755-15-9 |  |
| AGN-190521 | Allergan | 126070-23-3 |  |
| AGN-190837 | Allergan | 136527-40-7 |  |
| AGN-192395 | Allergan | |  |
| AGN-192403 | Allergan Pharmaceuticals | |  |
| AGN-193080 | Allergan | 168570-37-4 |  |
| AGN-193198 | Allergan | |  |
| AGN-193376 | Allergen | |  |
| AGN-194204 | Allergan ; Vision Pharm | |  |
| AGN-194310 | Allergan | 229961-45-9 |  |
| AGN-195183 | Allergan | 367273-07-2 |  |
| AGN-199659 | Allergan | |  |
| AGN-204396 | Allergan Inc. (US) | |  |
| Agomelatine | ADIR (Servier: France) | 138112-76-2 |  |
| AGR-540 | Centre d'Etudes Experimentales | 104124-23-4 |  |
| AGS-003 | Argos Therapeutics ; Kirin | | No Structure |
| AGS-004 | Argos Therapeutics Inc. ; Kirin Beer Kabushi Kaisha (Kyowa Hakko Kirin Co. Ltd.) | | No Structure |
| AGS-16M18 | Astellas Pharma Inc. (Japan) | | No Structure |
| AGS-16M8F | | | No Structure |
| AGS-PSCA | Agensys | | No Structure |
| AH-1058 | Ajinomoto | 228123-15-7 |  |
| AH-9700 | Dainippon Pharmaceutical | 184638-09-3 |  |
| AHBS | Novartis AG ; Novartis MBH | |  |
| AHC-93 | Kyorin | 149647-13-2 |  |
| AHL-157 | SS Pharmaceutical | |  |
| AHN-649 | US Army | 143899-90-5 |  |
| AHP | Mayo Foundation for Medical Education and Research (US) ; US Government | |  |
| AHR-10037 | A. H. Robins | 78281-73-9 |  |
| AHR-12234C | Robins | 125651-31-2 |  |
| AHR-12742 | A. H. Robins | 111626-08-5 |  |
| AHR-13268D | Wyeth-Ayerst (Wyeth) | 111627-11-3 |  |
| AHR-14310C | A. H. Robins | 119810-68-3 |  |
| AHR-14749 | A. H. Robins | 118697-12-4 |  |
| AHR-16303B | Alcon | 117023-61-7 |  |
| AHR-16462B | Alcon | 144236-73-7 |  |
| AHR-5360C | Wyeth-Ayerst (Wyeth) | 113800-13-8 |  |
| AHR-9294 | A. H. Robins | 84023-64-3 |  |
| AHU-377 | Novartis Pharmaceuticals | Ciba Geigy |  |
| AI-401 | | | No Structure |
| Aib2 C24 lactam 40 kDa | Indiana University Research and Technology Corp. (US) | | No Structure |
| AIC-246 | Bayer Healthcare AG (AiCuris GmbH & Co. KG) | |  |
| AIC-292 | | | No Structure |
| AIC-316 | | | No Structure |
| AIO-8507L | Synaptic Pharmaceutical | 366490-65-5 | No Structure |
| AIR-645 | Isis Pharmaceuticals Inc. | | No Structure |
| Aironite | Aires Pharmaceuticals | | No Structure |
| AIT-202 | Neo Therapeutics (Spectrum Pharmaceuticals) | 249759-05-5 |  |
| AIT-203 | Neo Therapeutics (Spectrum Pharmaceuticals) | 249278-12-4 |  |
| AIT-297 | Neo Therapeutics (Spectrum Pharmaceuticals) | 138117-91-6 |  |
| AJ-3941 | Dainippon Pharmaceutical | 143110-70-7 |  |
| AJD-101 | Ajinomoto | | No Structure |
| AJI-9561 | Ajinomoto | 339300-34-4 |  |
| AJM-300 | | | No Structure |
| Ajoene | State University of New York | 92284-99-6 |  |
| AJP-117510 | Ajinomoto | |  |
| Ajulemic acid | University of Massachusetts Medical School ; Indevus | 137945-48-3 |  |
| AK-04 | McGill University | |  |
| AK-262 | University of Kansas | |  |
| AKBA | Biophysica Inc, (US) | |  |
| AKD-1022 | Agro Kanesho | |  |
| AKH-7088 | Asahi Chemical | 104459-82-7 |  |
| AKI-001 | Genentech Inc. (US) ; F. Hoffmann-La Roche AG (Switzerland) | |  |
| Aklomide | Salsbury ; May & Baker (Aventis) | 3011-89-0 |  |
| AKP-020 | University of British Columbia | |  |
| AKR-501 | Yamanouchi Pharmaceutical | |  |
| AKT-IN | Hokkaido University | |  |
| Akten (Lidocaine) | Akorn (US) | 137-58-6 |  |
| AL-02 | Avicena Group ; General Hospital Corp. | | No Structure |
| AL-0670 | Green Cross (Mitsubishi Pharma) | 156473-05-1 |  |
| AL-1 | Panorama Research Inc. (US) | |  |
| AL-107 | Scripps Research Inst. ; Knoll (BASF) | 62190-59-4 |  |
| AL-1567 | Alcon | 97677-19-5 |  |
| AL-16049 | Alcon | |  |
| AL-16082 | Alcon | |  |
| AL-34659 | Virginia Commonwealth University | |  |
| AL-34662 | Yamanouchi (Astellas) | |  |
| AL-37662 | Virginia Commonwealth University | |  |
| AL-3818 | Advenchen Laboratories LLC | | No Structure |
| AL-43546 | Alcon Research Ltd. (US) | | No Structure |
| AL-438 | Abbott ; Ligand Pharmaceuticals | |  |
| AL-6598 | Alcon | |  |
| AL-6802 | Advenchen Laboratories LLC | | No Structure |
| Alacepril | Dainippon Pharmaceutical | 74258-86-9 |  |
| Alachlor | Monsanto | 15972-60-8 |  |
| Alagebrium chloride | Alteon (Synvista Therapeutics) ; Picower Institute for Medical Research | 341028-37-3 |  |
| Alamifovir | Mitsubishi Chemical | 193681-12-8 |  |
| Alanosine | University of California | 5854-93-3 |  |
| Alanycarb | Otsuka | 83130-01-2 |  |
| Alaproclate | AstraZeneca | 60719-82-6 |  |
| Alaptide | Spofa | 90058-29-0 |  |
| Alatrofloxacin | Pfizer | 157182-32-6 |  |
| ALB-109564(a) | Albany Molecular Research Inc. (US) | |  |
| Albaconazole | Uriach | 187949-02-6 |  |
| Albendazole | SmithKline (GSK) | 54965-21-8 |  |
| Albiglutide | | 782500-75-8 | No Structure |
| Albinterferon alfa-2b | Human Genome Sciences (HGS) | 472960-22-8 | No Structure |
| Albitiazolium bromide | CNRS (Centre National de Recherche Scientifique) | 321915-72-4 |  |
| Albocycline K3 | Kitasato Institute | |  |
| Albolabrin | Merck & Co. | |  |
| AlbuBNP | CoGenesys (Teva Pharmaceutical)Industries Ltd. (Israel) | | No Structure |
| Alcaftadine | Janssen Pharmaceutica (Johnson & Johnson) | 147084-10-4 |  |
| Alchemix | De Montfort University | |  |
| Alclofenac | Madan | 22131-79-9 |  |
| Alclometasone | Schering Corp (Merck & Co) | 67452-97-5 |  |
| Alclometasone Dipropionate | Schering Corp (Merck & Co) | 66734-13-2 |  |
| Alcloxa | Orsymonde (Cephalon) | 1317-25-5 |  |
| Alcuronium chloride | Hoffmann La Roche (Roche) | 15180-03-7 |  |
| ALD-101 | Aldagen Inc. | | No Structure |
| ALD-201 | Aldagen Inc. | | No Structure |
| ALD-301 | Aldagen Inc. | | No Structure |
| ALDA-1 | Leland Stanford Junior University (US) | |  |
| Aldecalmycin | Microbial Chemical Research Foundation | 139953-58-5 |  |
| Aldesleukin | | | No Structure |
| Aldesulfone | | 144-76-3 |  |
| Aldicarb | Rhone-Poulenc | 116-06-3 |  |
| Aldifen | Oswald Silberrad | 51-28-5 |  |
| Aldioxa | Schuylkill Chem. | 5579-81-7 |  |
| Aldoxycarb | Rhone-Poulenc | 1646-88-4 |  |
| ALE-0540 | Allelix Biopharmaceuticals (NPS Allelix) | 234779-34-1 |  |
| Alefacept | Biogen ; University of Michigan | 222535-22-0 | No Structure |
| Aleglitazar | Hoffmann La Roche | 475479-34-6 |  |
| Alemcinal | Abbott | 150785-53-8 |  |
| Alemtuzumab | British Tech | 216503-57-0 | No Structure |
| Alendronic acid | Henkel KGaA ; Gentili (Abiogen Pharma) | 66376-36-1 |  |
| Alentemol | Upjohn (Pharmacia) | 112891-97-1 |  |
| Aleplasinin | Wyeth Corp. (US) | 481629-87-2 |  |
| Alfacalcidol | Bio Technology General | 41294-56-8 |  |
| Alfaprostol | Carlo Erba (Pharmacia) | 74176-31-1 |  |
| Alfentanil | Janssen Pharmaceutica (Johnson & Johnson) | 71195-58-9 |  |
| Alferminogene tadenovec | Collateral Therapeutics (Schering AG) | 473553-86-5 | No Structure |
| Alfimeprase | Amgen | 259074-76-5 |  |
| Alfuzosin | Synthelabo (Sanofi-Aventis) | 81403-80-7 |  |
| ALG-GAL | Sopharma AD | |  |
| Algenpantucel-L | NewLink Genetics Corporation | | No Structure |
| Alglucosidase alfa | Genzyme | 420794-05-0 | No Structure |
| ALGRX-3268 (Lidocaine) | AlgoRx Pharmaceuticals | |  |
| ALGRX-4975 | | | No Structure |
| Alibendol | Roussel (Aventis) | 26750-81-2 |  |
| Alicaforsen | Isis Pharmaceuticals | 185229-68-9 |  |
| Alifedrine | Degussa | 78756-61-3 |  |
| Alilusem | Mochida | 144506-11-6 |  |
| Alimemazine | Rhone-Poulenc (Aventis) | 84-96-8 |  |
| Alinastine | Espanola Productos Quimicos | 154541-72-7 |  |
| Alinidine | Boehringer Ingelheim | 33178-86-8 |  |
| Alipogene tiparvovec | Amsterdam Molecular Therapeutics (Netherlands) | 929881-05-0 | No Structure |
| Alisertib | Millennium Pharmaceuticals Inc. (US) | 1028486-01-2 |  |
| Aliskiren | Ciba-Geigy (Novartis) | 173334-57-1 ; 173334-58-2 (fumarate) |  |
| Aliskiren & Amlodipine | Novartis AG | 173334-57-1 (Aliskiren) ; 88150-42-9 (Amlodipine) |  |
| Aliskiren & Amlodipine & Hydrochlorothiazide | Novartis AG | 173334-57-1 (Aliskiren) ; 88150-42-9 (Amlodipine) ; 58-93-5 (Hydrochlorothiazide) |  |
| Aliskiren & Valsartan | Novartis AG | 173334-57-1 (Aliskiren) ; 173334-58-2 (Aliskiren fumarate) ; 137862-53-4 (Valsartan) |  |
| Alisol A | Takeda | 19885-10-0 |  |
| Alisol A tetraacetate | Chinese Academy of Sciences (China) | |  |
| Alisporivir | Debiopharm | 254435-95-5 |  |
| Alitame | Pfizer | 99016-42-9 |  |
| Alitretinoin | Ligand Pharmaceuticals ; The Salk Institute For Biological Studies (US) ; Baylor College of Medicine | 5300-03-5 |  |
| Alizapride | Delagrange ((Sanofi-Aventis) | 59338-93-1 |  |
| Alkasar-18 | Zurich University Hospital | 158233-67-1 |  |
| ALKS-29 | | | No Structure |
| ALKS-33 | Rensselaer Polytechic Institute (US) | |  |
| ALKS-36 | Alkermes Inc. | | No Structure |
| ALKS-37 | | | No Structure |
| ALKS-6931 | Alkermes Inc. ; Acceleron Pharma Inc. | | No Structure |
| ALKS-7921 (Olanzapine) | Alkermes Inc. | 132539-06-1 |  |
| ALKS-9070 (Aripiprazole) | Alkermes Inc. | 129722-12-9 |  |
| Allantoin | Merck & Co. | 97-59-6 |  |
| ALLE | Vascular Biogenics Ltd(VBL) | |  |
| Allethrin | Union Carbide | 584-79-2 |  |
| Alliin | | 556-27-4 |  |
| Allithiamine | Generic ; Fuji Sangyo Co (Japan) | 554-44-9 |  |
| Allitridin | Josef Spinka (Czechoslovakia) ; Julius Stampfer (Czechoslovakia) | 2050-87-5 |  |
| Allobarbital | | 52-43-7 |  |
| Alloclamide | C.E.R.M. | 5486-77-1 |  |
| Alloferon-1 | Entopharm | |  |
| Alloferon-2 | Entopharm | |  |
| Allopurinol | Burroughs Wellcome (GSK) | 315-30-0 |  |
| Allotrap-07 | Leland Stanford Junior University | 151232-75-6 |  |
| Alloxydim | Nippon Soda | 55634-91-8 |  |
| Allylestrenol | Organon (Schering Merck & Co) | 432-60-0 |  |
| ALM-43 | Nipri Ltd. | |  |
| ALM-45 | Nipri Ltd. | |  |
| ALM-54 | Nipri Ltd. | |  |
| Alminoprofen | Bouchara | 39718-89-3 |  |
| Almitrine | Science Union | 27469-53-0 |  |
| Almorexant | Actelion Pharmaceuticals Ltd. | 871224-64-5 |  |
| Almotriptan | Almirall Prodesfarma | 154323-57-6 |  |
| Alnespirone | ADIR (Servier) | 138298-79-0 |  |
| Alniditan | Janssen Pharmaceutica (Johnson & Johnson) | 152317-89-0 |  |
| ALO-01 (morphine & naltrexone) | Alpharma Pharmaceuticals LLC (King Pharmaceuticals Inc.) | 850636-73-6 |  |
| ALO-02 (Oxycodone & Naltrexone) | Alpharma Inc. (King Pharmaceuticals Inc.) | 76-42-6 (Oxycodone) ; 16590-41-3 (Naltrexone) |  |
| ALO-04 (Hydrocodone & Naltrexone) | Alpharma Inc. (King Pharmaceuticals Inc.) | 125-29-1 (Hydrocodone) ; 16590-41-3 (Naltrexone) |  |
| Alogliptin | Syrrx | 850649-61-5 ; 850649-62-6 (benzoate) |  |
| Alosetron | Glaxo-Wellcome (GSK) | 122852-42-0 |  |
| Alovudine | Astra (AstraZeneca) | 25526-93-6 |  |
| Alpha Amylase | | 9000-90-2 | No Structure |
| alpha-Cypermethrin | National Research Development Corporation (NRDC) | 67375-30-8 |  |
| alpha-Ketoglutaric acid | Campbell | 328-50-7 |  |
| alpha-Mangostin | Terumo Corp. (Japan) | 6147-11-1 |  |
| alpha-Tocopherol | Roche | 59-02-9 |  |
| alpha-tocotrienol | | 58864-81-6 |  |
| alpha-Tocotrienol quinone | | |  |
| Alpha1-Antitrypsin | Cutter Lab | 9041-92-3 | No Structure |
| alphaGalCer-C20-2 | Albert Einstein College of Medicine of Yeshiva University (US) | |  |
| Alphamethadol | | 17199-54-1 |  |
| Alphastatin | University of Sheffield | | No Structure |
| Alpiropride | Societe d'Etudes Scientifiques et Industrielles de l'Ile-de-France | 81982-32-3 |  |
| Alprazolam | Upjohn (Pharmacia) | 28981-97-7 |  |
| Alprenolol | ICI (AstraZeneca) | 13655-52-2 |  |
| Alprenoxime | University of Florida | 121009-30-1 |  |
| Alprostadil | Schwarz Pharma | 745-65-3 |  |
| ALRT-620 | Ligand Pharmaceuticals | 153559-76-3 |  |
| ALS-858 | Advanced Life Sciences (US) | |  |
| Alsterpaullone | US Department of Health & Human Services | 237430-03-4 |  |
| ALT-004 | Altacor Ltd. | | No Structure |
| ALT-005 | Altacor Ltd. | | No Structure |
| ALT-020-02 | Altacor Ltd. | | No Structure |
| ALT-020-04 | Altacor Ltd. | | No Structure |
| ALT-022 | Altacor Ltd. | | No Structure |
| ALT-024 | Altacor Ltd. | | No Structure |
| ALT-025 | Altacor Ltd. | | No Structure |
| ALT-801 | Altor Bioscience Corp. (US) | | No Structure |
| ALT-946 | Alteon | 192511-71-0 (HCl) |  |
| Altanserin | Janssen Pharmaceutica (Johnson & Johnson) | 79449-96-0 |  |
| Alteplase | Genentech | 105857-23-6 | No Structure |
| Altinicline | Sibia (Merck & Co.) | 179120-92-4 |  |
| Altizide | Pfizer | 5588-16-9 |  |
| Altrenogest | Roussel Uclaf | 850-52-2 |  |
| Altretamine | Casella (Aventis) | 645-05-6 |  |
| Altropane | Organix ; General Hospital ; Harvard College ; Northeastern University | 180468-34-2 |  |
| Altropane (123I) | Organix ; General Hospital ; Harvard College ; Northeastern University | |  |
| ALTU-237 | | | No Structure |
| ALTU-238 (Somatropin) | Altus Pharmaceuticals | |  |
| Aluminium Phosphide | Ernst Freyberg Chem Fab Delit | 20859-73-8 |  |
| ALV-003 | Alvine Pharmaceuticals | | No Structure |
| ALVAC-hIL-2 | Virogenetics | | No Structure |
| Alvameline | Lundbeck | 120241-31-8 |  |
| Alvelestat | Astrazeneca | 848141-11-7 |  |
| Alverine | Sanofi (Sanofi-Aventis) | 150-59-4 |  |
| Alvespimycin | Kaken | 467214-20-6 ; 467214-21-7 (hydrochloride) |  |
| Alvimopan | Eli Lilly | 156053-89-3 |  |
| Alvircept Sudotox | Pharmacia Upjohn | 137487-62-8 | No Structure |
| Alvocidib | Hoechst (Sanofi-Aventis) | 146426-40-6 ; 131740-09-5 (HCl) |  |
| ALX-0061 | Ablynx NV | | No Structure |
| ALX-0081 | Ablynx NV | | No Structure |
| ALX-0141 | Ablynx NV | | No Structure |
| ALX-0171 | Ablynx NV | | No Structure |
| ALX-0388 | Allelix Biopharmaceuticals (NPS Allelix) | |  |
| ALX-0646 | Allelix Biopharmaceuticals (NPS Allelix) | 208464-67-9 |  |
| ALX-0651 | Ablynx NV | | No Structure |
| ALX-0681 | Ablynx NV | | No Structure |
| ALX-2732 | Nps Allelix | |  |
| ALX-4313 | Nps Allelix | |  |
| ALX-5407 | Allelix Neuroscience | |  |
| AM-103 | Amira Pharmaceuticals | |  |
| AM-112 | University of Munich | 461642-40-0 |  |
| AM-114 | University of Johns Hopkins | |  |
| AM-1241 | University of Connecticut | |  |
| AM-132 | Kyowa Hakko | 372513-31-0 |  |
| AM-156 | Amira Pharmaceuticals Inc. | |  |
| AM-1954 | Kyorin Pharmaceutical Co. Ltd. (Japan) | |  |
| AM-206 | Amira Pharmaceuticals Inc. | |  |
| AM-211 | Amira Pharmaceuticals Inc. | | No Structure |
| AM-220 | AnaMar AB | | No Structure |
| AM-2232 | University of Connecticut | |  |
| AM-250 | AnaMar AB | | No Structure |
| AM-251 | | |  |
| AM-260 | AnaMar AB | | No Structure |
| AM-281 | University of Connecticut (US) | 202463-68-1 |  |
| AM-3005 | Kyorin Pharmaceutical Co. Ltd. (Japan) | |  |
| AM-36 | University of Monash | 199467-52-2 |  |
| AM-404 | University of California | 183718-77-6 |  |
| AM-461 | Amira Pharmaceuticals Inc. | | No Structure |
| AM-580 | Shudo Koichi | 102121-60-8 |  |
| AM-630 | Amrad ; Monash University | 164178-33-0 |  |
| AM-643 | Amira Pharmaceuticals Inc. | |  |
| AM-679 | Amira Pharmaceuticals Inc. | |  |
| AM-7 | Amgen Inc. | |  |
| AM-7359 | Merck & Co Inc. ; Kyorin Seiyaku | |  |
| AM-7383 | Merck & Co Inc. ; Kyorin Seiyaku | |  |
| AM-803 | Amira Pharmaceuticals Inc. | |  |
| AM-831 | ACADIA Pharmaceuticals Inc. | | No Structure |
| AM-966 | Amira Pharmaceuticals Inc. | |  |
| AMA1-C1 - Alhydrogel Vaccine | Walter Reed Army Institute Of Research | | No Structure |
| Amamistatin A | Sagami | 225505-59-9 |  |
| Amantadine | Studiengesellschaft Kohle | 768-94-5 ; 665-66-7 (hydrochloride) |  |
| Amantanium bromide | Colgate palmolive Company | 58158-77-3 |  |
| AMAP-102 | | | No Structure |
| Amatuximab | | 931402-35-6 | No Structure |
| Ambamustine | Proter | 85754-59-2 |  |
| Ambazone | Bayer | 539-21-9 |  |
| Ambenonium chloride | Sterling Drug (Sanofi-Aventis) | 115-79-7 |  |
| Ambrisentan | Knoll-BASF AG (Abbott) | 177036-94-1 |  |
| Ambroxol | Thomae (Boehringer Ingelheim) | 18683-91-5 |  |
| Ambucaine | Sterling Drug (Sanofi-Aventis) | 119-29-9 |  |
| Ambucetamide | Janssen Pharmaceutica (Johnson & Johnson) | 519-88-0 |  |
| Ambuphylline | Wm. S. Merill Co. Inc. | 5634-34-4 |  |
| Ambutonium bromide | Wyeth | 115-51-5 |  |
| Amcinonide | American Cyanamid (Wyeth) | 51022-69-6 |  |
| AMD-070 | Anormed Inc. (Genzyme Corp.) | 690656-53-2 |  |
| AMD-3329 | Johnson Matthey | 170861-87-7 |  |
| AMD-3451 | AnorMed (Johnson Matthey) | |  |
| AMD-3465 | AnorMed (Johnson Matthey) | |  |
| AMD-8664 | Johnson Matthey | 255383-00-7 |  |
| AMD-8897 | AnorMED | |  |
| AMD-8936 | AnorMed (Johnson Matthey) | |  |
| AMD-9370 | AnorMed (Johnson Matthey) | |  |
| Amdoxovir | IAF Biochem (Shire Pharmaceuticals) ; University of Georgia ; Emory University | 145514-04-1 |  |
| AME-133v | Eli Lilly & Co. (US) | | No Structure |
| Amediplase | Menarini | 151912-11-7 | No Structure |
| Amelior | Cumberland Pharmaceuticals | |  |
| Amelometasone | Taisho | 123013-22-9 |  |
| Amelubant | Boehringer Ingelheim | 346735-24-8 |  |
| Amenamevir | Yamanouchi (Astellas) ; Rational Drug Design Lab. (US) | 841301-32-4 |  |
| Amersib | | | No Structure |
| Amesergide | Eli Lilly | 121588-75-8 |  |
| Ametoctradin | BASF | 865318-97-4 |  |
| Ametryn | Geigy (Novartis) | 834-12-8 |  |
| Amezinium metilsulfate | BASF (Abbott) | 30578-37-1 |  |
| Amfebutamone | Burroughs Wellcome (GSK) | 34911-55-2 ; 905818-69-1 (hydrobromide salt) |  |
| Amfenac | Robins | 51579-82-9 |  |
| Amfepramone | Temmler | 90-84-6 |  |
| Amfetamine | Alles Gordon A. | 300-62-9 |  |
| Amfetaminil | Voigt ; Josef Klosa | 17590-01-1 |  |
| AMG-009 | Tularik Inc. (Amgen) | |  |
| AMG-0347 | Amgen | |  |
| AMG-076 | Amgen | | No Structure |
| AMG-108 | Amgen | | No Structure |
| AMG-114 | Amgen | | No Structure |
| AMG-151 | Array BioPharma Inc. | | No Structure |
| AMG-157 | Amgen Inc. (US) | | No Structure |
| AMG-167 | Amgen Inc. (US) ; UCB SA (Belgium) | | No Structure |
| AMG-191 | Amgen Inc. (US) | | No Structure |
| AMG-208 | Amgen Inc. | 1002304-34-8 |  |
| AMG-221 | Biovitrum AB (Sweden) | |  |
| AMG-222 | Amgen Inc. (US) | |  |
| AMG-2674 | Amgen | |  |
| AMG-273 | Amgen Inc. (US) | |  |
| AMG-3 | University of Connecticut | |  |
| AMG-317 | | | No Structure |
| AMG-319 | | | No Structure |
| AMG-337 | Amgen | | No Structure |
| AMG-386 | Amgen Inc. (US) | | No Structure |
| AMG-458 | Amgen Inc. (US) | |  |
| AMG-517 | Amgen | |  |
| AMG-548 | Amgen | |  |
| AMG-557 | Amgen Inc. (US) | | No Structure |
| AMG-628 | Amgen Inc. (US) | |  |
| AMG-745 | Amgen Inc. (US) | | No Structure |
| AMG-747 | Amgen Inc. (US) | | No Structure |
| AMG-780 | | | No Structure |
| AMG-785 | Amgen Inc. (US) ; UCB SA (Belgium) | | No Structure |
| AMG-811 | Amgen Inc. (US) | | No Structure |
| AMG-820 | Amgen Inc. (US) | | No Structure |
| AMG-827 | Amgen Inc. (US) | | No Structure |
| AMG-853 | | | No Structure |
| AMG-8562 | Amgen Inc. (US) | |  |
| AMG-888 | Amgen Inc. (US) ; Daiichi Sankyo Co. Ltd. (Japan) | | No Structure |
| AMG-900 | Amgen Inc. | |  |
| AMG-9810 | Amgen | 545395-94-6 |  |
| Amibegron | Sanofi (Sanofi-Aventis) | 121524-09-2 (hydrochloride salt) ; 121524-08-1 |  |
| Amicarbalide | May & Baker (Aventis) | 3459-96-9 |  |
| Amicarbazone | Bayer | 129909-90-6 |  |
| Amidefrine | Mead Johnson | 3354-67-4 |  |
| Amidochlor | Monsanto | 40164-67-8 |  |
| Amidoflumet | Sumitomo Chemical | 84466-05-7 |  |
| Amidosulfuron | Hoechst (Sanofi-Aventis) | 120923-37-7 |  |
| Amidox | Bartholomeus et al. | 95933-72-5 |  |
| Amifampridine | Eli Lilly | 54-96-6 |  |
| Amiflamine | Astra (AstraZeneca) | 77518-07-1 |  |
| Amifloxacin | Sterling Winthrop (Sanofi-Aventis) | 86393-37-5 |  |
| Amifostine | Southern Research Inst. | 20537-88-6 |  |
| Amikacin | Bristol Myers (BMS) | 37517-28-5 |  |
| Amiloride | Merck & Co. | 2609-46-3 |  |
| Aminaphtone | Baldacci | 14748-94-8 |  |
| Amineptine | Servier | 57574-09-1 |  |
| Aminitrozole | Merck & Co. | 140-40-9 |  |
| Aminoacridine | Sterling Winthrop (Sanofi-Aventis) | 90-45-9 |  |
| Aminocandin | Aventis Pharma SA | |  |
| Aminocaproic acid | American Enka | 60-32-2 |  |
| Aminochinol | Taisho | 10023-54-8 |  |
| Aminocyclopyrachlor | Du Pont, | 858956-08-8 |  |
| Aminoflavone | Kyowa Hakko Kogyo Kk (Japan) | |  |
| Aminoglutethimide | Ciba-Geigy (Novartis) | 125-84-8 |  |
| Aminohippuric acid | Merck & Co. | 61-78-9 |  |
| Aminomethylbenzoic acid | Kali Chemie | 56-91-7 |  |
| Aminonitrothiazole | Monsanto (Pharmacia) | 121-66-4 |  |
| Aminophenazone | Scheitlin | 58-15-1 |  |
| Aminophylline | Byk Gulden (Nycomed) | 317-34-0 |  |
| Aminopromazine | Rhone-Poulenc (Aventis) | 58-37-7 |  |
| Aminopropylon | Res. Found. for Practical Life | 3690-04-8 |  |
| Aminopterin | American Cyanamid (Wyeth) | 54-62-6 |  |
| Aminopyralid | Dow AgroSciences | 150114-71-9 |  |
| Aminoquinuride | IG Farben | 2207-50-3 |  |
| Aminosalicylic acid | Robert Gnehm | 65-49-6 |  |
| Amiodarone | Societe Belge de l'Azote et de Produits Chimiques de Marly | 1951-25-3 |  |
| Amiphenazole | Monsanto (Pharmacia) | 490-55-1 |  |
| Amiprilose | Boston Life Sciences | 56824-20-5 |  |
| Amiridin | Scientific Research Inst. of Biological Testing of Chemical Compounds | 90043-86-0 |  |
| Amisulbrom | Nissan Chemical | 348635-87-0 |  |
| Amisulpride | Sanofi-Synthelabo (Sanofi-Aventis) | 71675-85-9 |  |
| Amisulpride-(S) | Sanofi-Synthelabo (Sanofi-Aventis) | 71675-92-8 |  |
| Amitraz | Boots (Abbott) | 33089-61-1 |  |
| Amitriptyline | Hoffmann La Roche (Roche) | 50-48-6 |  |
| Amitriptylinoxide | Dumex | 4317-14-0 |  |
| Amitrole | Amchem (Rhone-Poulenc) | 61-82-5 |  |
| Amlexanox | Takeda | 68302-57-8 |  |
| Amlodipine | Pfizer | 88150-42-9 ; 111470-99-6 (besilate) |  |
| Ammonium tetrathiomolybdate | University of Michigan (US) | 15060-55-6 |  |
| AMN-15 | Gruenenthal GmbH (Germany) | |  |
| AMN-57 | Gruenenthal GmbH (Germany) | |  |
| AMN-61 | Gruenenthal GmbH (Germany) | |  |
| Amobarbital | Eli Lilly | 57-43-2 |  |
| Amodiaquine | Parke, Davis (Pfizer) | 86-42-0 |  |
| Amolimogene bepiplasmid | MGI Pharma | 870524-46-2 | No Structure |
| Amonafide | Laboratorios Made S.A. (Knoll) | 69408-81-7 ; 150091-68-2 (dihydrochloride) |  |
| Amopyroquine | Parke, Davis (Pfizer) | 550-81-2 |  |
| Amorolfine | Hoffmann La Roche (Roche) | 78613-35-1 |  |
| Amosulalol | Yamanouchi (Astellas) | 85320-68-9 |  |
| Amotosalen | Cerus | 161262-29-9 |  |
| Amoxapine | American Cyanamid (Wyeth) | 14028-44-5 |  |
| Amoxicillin | Beecham (GSK) | 61336-70-7 |  |
| AMP-579 | RPR (Aventis) | 143355-09-3 |  |
| Amperozide | Ferrosan | 75558-90-6 |  |
| Amphetamine & Dexamphetamine | | |  |
| Amphidinolide T | Hokkaido University | 262597-82-0 |  |
| Amphinex | PCI Biotech AS | |  |
| Amphotericin B | Olin Mathieson | 1397-89-3 |  |
| Ampicillin | Beecham (GSK) | 69-53-4 |  |
| Ampiroxicam | Pfizer | 99464-64-9 |  |
| Amprenavir | Vertex | 161814-49-9 |  |
| Amprolium | Merck & Co. | 121-25-5 |  |
| Ampropylfos | DuPont | 16606-64-7 |  |
| Amquinate | Merck Sharp & Dohme (Merck & Co) | 17230-85-2 |  |
| AMR-001 | Amorcyte Inc. | | No Structure |
| AMR-MCH-1 | Amr Technology Inc. (US) | |  |
| AMR-MCH-2 | AMR Technology Inc. (US) | |  |
| Amrinone | Sterling Winthrop (Sanofi-Aventis) | 60719-84-8 |  |
| Amrubicin | Sumitomo Chemical | 110267-81-7 ; 110311-30-3 (hydrochloride salt) |  |
| Amsacrine | US NTIS | 51264-14-3 |  |
| Amsilarotene | Taiho | 125973-56-0 |  |
| AMT-021 | Amsterdam Molecular Therapeutics BV , Proyecto de Biomedicina CIMA SL (Spain) | | No Structure |
| AMT-060 | Amsterdam Molecular Therapeutics BV | | No Structure |
| AMT-080 | Università degli Studi di Roma (Italy) | | No Structure |
| AMT-090 | Amgen Inc | | No Structure |
| Amtolmetin Guacil | Medosan Ricerca ; SigmaTau | 87344-06-7 |  |
| Amurensin H | Chinese Academy of Medical Sciences | |  |
| Amustaline | Cerus Corp | 210584-54-6 |  |
| Amuvatinib | Montigen Pharmaceuticals (SuperGen) | 850879-09-3 ; 1055986-67-8 (HCl) |  |
| AMX-213 | Amunix Inc. | | No Structure |
| AMX-256 | Amunix Inc. | | No Structure |
| AMX-295 | Amunix Inc. | | No Structure |
| AMX-509 (Factor IX) | Amunix Inc. | 9001-28-9 | No Structure |
| AMX-537 (Factor VII) | Amunix Inc. | 9001-25-6 | No Structure |
| AMX-583 (Factor VIII) | Amunix Inc. | | No Structure |
| AMX-592 (Alpha1-Antitrypsin) | Amunix Inc. | 9041-92-3 | No Structure |
| Amycolamicin | Microbial Chemistry Research Foundation (Japan) | |  |
| Amylmetacresol | Boots (Abbott) | 1300-94-3 |  |
| Amylocaine | Warner Lambert (Pfizer) | 644-26-8 |  |
| AN-0128 | Anacor Pharmaceuticals | |  |
| AN-015 | Natco Pharma Ltd. (India) | |  |
| AN-019 | Natco Pharma Ltd. (India) | |  |
| AN-0900 | Katholieke Universiteit Leuven | |  |
| AN-132 | Chugai (Roche) | 105668-70-0 |  |
| AN-1677 | Anacor | |  |
| AN-1792 | Athena Neurosciences | |  |
| AN-207 | Tulane University | 179910-83-9 |  |
| AN-215 | Tulane University | |  |
| AN-238 | Tulane University | |  |
| AN-2690 | Anacor Pharmaceuticals | |  |
| AN-2718 | AstraZeneca | |  |
| AN-2728 | Anacor Pharmaceuticals Inc. (US) | |  |
| AN-2898 | Anacor Pharmaceuticals Inc. (US) | |  |
| AN-3031 | Anacor Pharmaceuticals Inc. | |  |
| AN-37124 | Elan ; Ely Lilly | 208255-80-5 |  |
| AN-420 | Ramot at Tel Aviv University Ltd. (Israel) ; Bar-Ilan University (Israel) | |  |
| AN-6415 | Anacor Pharmaceuticals Inc. | |  |
| AN-7 | Hebrew University of Jerusalem | |  |
| AN-8 | Hebrew University of Jerusalem | |  |
| ANA-971 | Anadys Pharmaceuticals | | No Structure |
| ANA-975 | Anadys Pharmaceuticals | |  |
| Anacardic acid | General Foods Corporation | 16611-84-0 |  |
| Anacetrapib | Merck & Co | 875446-37-0 |  |
| Anagliptin | Sanwa Kagaku Kenkyusho Co., Ltd | 739366-20-2 |  |
| Anagrelide | Bristol Myers (BMS) | 68475-42-3 |  |
| Anakinra | Synergen (Amgen) | 143090-92-0 |  |
| Anamorelin | Novo Nordisk | 861998-00-7 (hydrochloride salt) |  |
| Ananain | Genzyme | |  |
| Anandamide | Meito Sangyo | 94421-68-8 |  |
| Anastrozole | ICI (AstraZeneca) | 120511-73-11 |  |
| Anatibant | Fournier (Solvay) | 209733-45-9 |  |
| Anatumomab Mafenatox | Active Biotech | | No Structure |
| ANAVEX 1-41 | Anavex Life Sciences Corp. (Switzerland) | |  |
| Anazolene | Bayer | 7488-76-8 |  |
| Ancer | Zeria Shinyaku (Zeria Pharmaceutical) | |  |
| Ancestim | Amgen Inc. | 163545-26-4 | No Structure |
| Ancitabine | Merck & Co. | 31698-14-3 |  |
| Ancriviroc | Schering Corp (Merck & Co) | 370893-06-4 |  |
| Ancrod | Natresdev | 9046-56-4 | No Structure |
| Ancymidol | Eli Lilly | 12771-68-5 |  |
| Andolast | RottaPharm/Madeus | 132640-22-3 |  |
| ANDP-7 | Kumamoto University | |  |
| ANDP-8 | University of Kumamoto | |  |
| ANDREA-1 | Bayer AG (Germany) | |  |
| Andrographolide | Paracelsian | 5508-58-7 |  |
| Androstanolone | Schering Corp (Merck & Co) | 521-18-6 |  |
| Androstenediol | R. Loria | 521-17-51 |  |
| Androstenetriol | R. Loria | |  |
| Androxolutamide | GTx | |  |
| Anecortave | Alcon | 7753-60-8 |  |
| Anethole | | 4180-23-8 |  |
| Anethole trithione | Boettcher | 532-11-6 |  |
| ANG-1005 | Angiochem | |  |
| ANG-1007 | AngioChem Inc. | | No Structure |
| ANG-1011 | AngioChem Inc. | | No Structure |
| ANG-2002 | AngioChem Inc. | | No Structure |
| ANG-2004 | AngioChem Inc. | | No Structure |
| ANG-2008 | AngioChem Inc. | | No Structure |
| ANG-501 | Angiogene Pharmceuticals Ltd. (GB) | |  |
| ANG-719 | Angiogene ; Gray Cancer Institute | |  |
| Angiostatin | Children's Medical Center | 86090-08-6 | No Structure |
| Angiotensin | University of Southern California | 1407-47-2 |  |
| ANGX-1039 | | | No Structure |
| ANGX-3227 | | | No Structure |
| Anhydrovinblastine | University of British Columbia | 218128-77-9 |  |
| Anidulafungin | Eli Lilly | 166663-25-8 |  |
| Anilazine | Ethyl Corp | 101-05-3 |  |
| Anileridine | Merck & Co. | 144-14-9 |  |
| Anilofos | Hoechst (Sanofi-Aventis) | 64249-01-0 |  |
| Anilopam | Pennwalt | 53716-45-3 |  |
| Aniracetam | Hoffmann La Roche (Roche) | 72432-10-1 |  |
| Anisindione | Bayer Schering Pharma | 117-37-3 |  |
| Anisohydrocinnamol | Promedica | 60883-72-9 |  |
| Anisperimus | Fournier (Solvay Pharmaceuticals) | 170368-04-4 |  |
| Anistreplase | Beecham | 81669-57-0 | No Structure |
| Anisylacetone | Rhone-Poulenc | 104-20-1 |  |
| ANM-138 | | | No Structure |
| Annamycin | M. D. Anderson Cancer Center (University of Texas) ; Ohio State University | 92689-49-1 |  |
| Annulin C | University of British Columbia (CA) | |  |
| Anrukinzumab | Wyeth | 910649-32-0 | No Structure |
| Antagonist G | Imperial Cancer Research Technology | 115150-59-9 |  |
| Antazoline | Ciba (Novartis) | 91-75-8 |  |
| Antheliatin | Pharma Mar | 172335-14-7 |  |
| Anthralin | Ciba-Geigy (Novartis) | 1143-38-0 |  |
| Anthraquinone | Bayer | 84-65-1 |  |
| ANTI | University of Minnesota ; Harvard Medical School | |  |
| ANTI-ApoCIII Vacccine | GSK | | No Structure |
| Anti-clostridium difficile immunoglobuline | Maxygen (Codexis) | 339158-19-9 | No Structure |
| Anti-EAG1 MAb | Max-Planck-Gesellschaft | | No Structure |
| Anti-IGF-1R HuMab 18 | Hoffmann-La Roche (Roche) | | No Structure |
| Anti-MISIIR Antibody | Fox Chase Cancer Center (USA) | | No Structure |
| Antineoplaston A10 | Burzynski Research Institute Inc. | 91531-30-5 |  |
| Antithrombin alfa | Integrated Genetics Inc. | 84720-88-7 | No Structure |
| Antrafenine | Synthelabo (Sanofi-Aventis) | 55300-29-3 |  |
| ANX-201 | University of Southern California (US) | 99107-93-4 |  |
| AOD-9604 | Metabolic Pharmaceuticals (Calzada) | 386264-39-7 |  |
| AP-12009 | Johns Hopkins University | | No Structure |
| AP-155 | Universita di Genova | 168425-51-2 |  |
| AP-158 | Antex Pharma (BioPort) | |  |
| AP-159 | Asahi | 129592-83-2 (Hydrochloride) |  |
| AP-1903 | Ariad Pharmaceuticals | 195514-63-7 |  |
| AP-214 | Action Pharma | |  |
| AP-22161 | Ariad | 268741-42-0 |  |
| AP-2238 | University of Bologna | |  |
| AP-22408 | Ariad | |  |
| AP-23464 | Ariad Pharmaceuticals | |  |
| AP-23848 | Ariad Pharmaceuticals | |  |
| AP-24163 | Ariad Pharmaceuticals Inc. (US) | |  |
| AP-24170 | Ariad Pharmaceuticals | |  |
| AP-24226 | Ariad Pharmaceuticals Inc. (US) | |  |
| AP-521 | Asahi Chemical | 151227-58-6 |  |
| AP-5280 | Access Pharmaceuticals | |  |
| AP-5346 | Access Pharmaceuticals | 674289-90-8 |  |
| Apadenoson | University of Virginia (USA) | 250386-15-3 |  |
| Apadoline | Rhone-Poulenc (Aventis) | 148708-29-6 |  |
| Apafant | Boehringer Ingelheim | 105219-56-5 |  |
| Apalcillin | Sumitomo Chemical | 63469-19-2 |  |
| Apatinib | Advenchen Laboratories LLC | |  |
| Apaxifylline | Boehringer Ingelheim | 151581-23-6 |  |
| Apaziquone | University of Amsterdam | 114560-48-4 |  |
| APC-0576 | Ajinomoto | |  |
| APC-2059 | Axys Pharmaceuticals (Celera Genomics) | 256649-36-2 |  |
| APC-366 | Arris | 158921-85-8 |  |
| APC-6336 | Axys | 263870-19-5 |  |
| APC-8020 | Dendreon | | No Structure |
| APD-597 | | | No Structure |
| APD-811 | Arena Pharmaceuticals Inc. | | No Structure |
| APD-916 | Arena Pharmaceuticals Inc. | |  |
| APF-530 | A.P. Pharma (US) | |  |
| Aphidicolin glycinate | ICI (AstraZeneca) | 123252-56-2 |  |
| APHS | University of Vanderbilt | 209125-28-0 |  |
| API-101.10 | Valorisation Recherche (Canada) | |  |
| API-1252 | Affinium Pharmaceuticals (Canada) | |  |
| API-1401 | Affinium Pharmaceutical | |  |
| Apicidin | Merck & Co., Inc. | 183506-66-3 |  |
| Apicularen B | Biotechnolog Forschung, Germany) | |  |
| Apicularens A | Biotechnolog Forschung, DE) | |  |
| Apigenin | Kyowa Hakko | 520-36-5 |  |
| Apilimod | Synta Pharmaceuticals | 870087-36-8 |  |
| Apixaban | Bristol-Myers Squibb (BMS) | 503612-47-3 |  |
| APJ-2929 | Ajinomoto Co. Inc. (Japan) | |  |
| APL-130277 (Apomorphine) | Adagio Pharmaceuticals Ltd. | |  |
| Aplaviroc | Ono | 461443-59-4 |  |
| Aplenzin (Amfebutamone) | Biovail | |  |
| Aplidine | University of Illinois | 137219-37-5 |  |
| Aplindore | American Home Products (Wyeth) | 189681-71-8 |  |
| APN-01 | Apeiron Biologics (Austria) | | No Structure |
| APO-6617 | Apotex | |  |
| APO-6619 | Apotex | |  |
| Apogossypolone | University of Michigan | |  |
| Apolizumab | | 267227-08-7 | No Structure |
| Apomab 7.3 | Genentech | | No Structure |
| Apomorphine | Riedel de Haen (Honeywell) | 58-00-4 |  |
| Apoptozole 1 | Yonsei University (South Korea) | |  |
| APP-018 | University of California | |  |
| APR-246 | Aprea AB | 5291-32-7 |  |
| Apraclonidine | Alcon | 66711-21-5 |  |
| Apramycin | Eli Lilly | 37321-09-8 |  |
| Apratastat | American Cyanamid (Wyeth) | 287405-51-0 |  |
| Apremilast | Celgene (US) | 666854-78-0 ; 608141-41-9 |  |
| Aprepitant | Merck & Co. | 170729-80-3 |  |
| Apricitabine | IAF Biochem | 160707-69-7 |  |
| Apricoxib | Sankyo | 197904-84-0 |  |
| Aprindine | Christiaens | 37640-71-4 |  |
| Aprinocarsen | Isis Pharmaceuticals | 151879-73-1 |  |
| Aprobarbital | Roche | 77-02-1 |  |
| Aprosulate sodium | Luitpold Werk | 123072-45-7 |  |
| Aprotinin | Bayer AG | 9087-70-1 |  |
| APT-070 | | 507453-82-9 | No Structure |
| Aptiganel | Oregon State University | 137159-92-3 |  |
| APX-366 | Virginia Commonwealth University | |  |
| AQ-0145 | Green Cross (Mitsubishi Pharma) | 175033-29-1 |  |
| AQ-13 | Hoffmann La Roche (Roche) | |  |
| AQ-148 | Arqule | 184294-78-8 |  |
| AQX-016A | University of British Columbia (Canada) | |  |
| AR-00241389 | Array BioPharma | |  |
| AR-00323858 | Array Biopharma | |  |
| AR-00365319 | Array Biopharma | |  |
| AR-00365803 | Array Biopharma | |  |
| AR-00380547 | Array BioPharma | |  |
| AR-10A304.7 | Arius Research | | No Structure |
| AR-12456 | Hydrierwerk Rodleben Veb | 100557-06-0 |  |
| AR-129330 | Taisho | |  |
| AR-132 | Aronex | 170468-37-8 |  |
| AR-231453 | Arena Pharmaceuticals | |  |
| AR-2474 | Arpida AG (Switzerland) | |  |
| AR-36A36.11.1 | Arius Research | | No Structure |
| AR-709 | Arpida AG (Switzerland) | |  |
| AR-726 | University of Texas | 114488-24-3 |  |
| AR-9281 | Arete Therapeutics | | No Structure |
| AR-C102222 | AstraZeneca | |  |
| AR-C64170 | AstraZeneca | | No Structure |
| AR-C67085 | AstraZeneca | 164992-25-0 |  |
| AR-C85016 | AstraZeneca | |  |
| AR-C89855 | AstraZeneca | 189012-09-7 |  |
| AR-D-111421 | AstraZeneca | | No Structure |
| AR-H067637 | AstraZeneca | |  |
| Ara DMAP | Wellcome (GSK) | |  |
| ARA-000002 | AstraZeneca | 393510-21-9 |  |
| ARA-01 | aRigen Pharmaceuticals Inc. | | No Structure |
| ARA-014418 | AstraZeneca | |  |
| ARA-02 | aRigen Pharmaceuticals Inc. | | No Structure |
| ARA-03 | aRigen Pharmaceuticals Inc. | | No Structure |
| ARA-04 | aRigen Pharmaceuticals Inc. | | No Structure |
| Ara-CDP-DL-PTBA | Health Research | 103612-80-2 |  |
| Aragusterol A | Taisho | 152887-09-7 |  |
| Aragusterol C | Taisho | 156009-76-6 |  |
| Aranidipine | Maruko Pharmaceutical | 86780-90-7 |  |
| Aranoza | Blokhin Center for Oncology Research | 167396-23-8 |  |
| Arasertaconazole | Ferrer | 583057-48-1 |  |
| ARB-CF0223 (Tobramycin) | Universite de Montreal (Canada) | 32986-56-4 |  |
| Arbaclofen | AGI Therapeutics | 69308-37-8 |  |
| Arbaclofen placarbil | XenoPort | 847353-30-4 |  |
| Arbaprostil | Upjohn (Pharmacia) | 55028-70-1 |  |
| Arbekacin | Microbiochemical Research Foundation | 51025-85-5 |  |
| Arbutamine | Gensia (Sicor) (Teva) | 128470-16-6 |  |
| Arbutin | Polaroid Corp | 497-76-7 |  |
| ARC-1905 | Archemix Corp. (US) | | No Structure |
| ARC-66096 | Fisons ; Astra (AstraZeneca) | |  |
| ARC-68164AA | Astra (AstraZeneca) | |  |
| ARC-68475AA | Astra (AstraZeneca) | |  |
| ARC-69457AA | Astra (AstraZeneca) | |  |
| ARC-89855AA | Astra (AstraZeneca) | |  |
| ARD-1100 (Liposomal Ciprofloxacin) | | 85721-33-1 |  |
| ARD-3100 (Liposomal Ciprofloxacin) | Aradigm Corp. | 85721-33-1 |  |
| Ardenermin | Human Genome Sciences | 305391-49-5 | No Structure |
| Arecoline | Brantford ; Novo Nordisk | 63-75-2 |  |
| Arenicin | Novozymes AS (Denmark) | |  |
| Arenicin-1 | Russian Academy of Medical Sciences ;Saint-Petersburg State University | |  |
| Arenicin-2 | Russian Academy of Medical Sciences ;Saint-Petersburg State University | |  |
| Arformoterol | Sepracor | 67346-49-0 |  |
| ARG-098 | Santen Pharmaceuticals | | No Structure |
| ARG-201 | University of Tennessee | | No Structure |
| Argatroban | Mitsubishi | 74863-84-6 |  |
| Arginine butyrate | University of Boston | 80407-72-3 |  |
| Arginine Pidolate | Societa Italo-Britannica | 64855-91-0 |  |
| Arglabin-DMA | Paracure | 260983-39-9 (HCl) |  |
| ARH-049020 | AstraZeneca | | No Structure |
| ARH-1029 | aRigen Pharmaceuticals Inc. | | No Structure |
| Arimoclomol | Biorex | 289893-25-0 |  |
| Aripiprazole | Otsuka | 129722-12-9 |  |
| ARL-14995 | Yamanouchi (Astellas) | 123319-03-9 |  |
| ARL-17477 | AstraZeneca | 168895-09-8 |  |
| ARM-036 | Columbia University (US) | |  |
| ARM-107 | Columbia University (US) | |  |
| ARM-250 | Astra pharma (AstraZeneca) | |  |
| ARM-390 | Astra (AstraZeneca) | |  |
| ARM-434 | Astra (AstraZeneca) | |  |
| ARM-AK105 | aRigen Pharmaceuticals Inc. | | No Structure |
| Armodafinil | Cephalon | 112111-43-0 |  |
| Arofylline | Almirall Prodesfarma | 136145-07-8 |  |
| Arotinolol | Sumitomo Chemical | 68377-92-4 |  |
| Arprinocid | Int. Minerals & Chem. | 55779-18-5 |  |
| ARQ-323 | Arqule | |  |
| ARQ-621 | ArQule Inc. | |  |
| ARQ-736 | ArQule Inc. | |  |
| ARQ-761 | ArQule Inc. | |  |
| ARR-12495AA | Sumitomo Chemical | 149756-73-0 |  |
| ARR-17779 | Astra (AstraZeneca) | 178419-45-9 |  |
| ARRY-162 | Array BioPharma Inc. | 1073666-70-2 | No Structure |
| ARRY-300 | Array BioPharma Inc. | | No Structure |
| ARRY-380 | Array BioPharma | |  |
| ARRY-509 | Array BioPharma | |  |
| ARRY-520 | Array Biopharma Inc. (US) | |  |
| ARRY-614 | Array BioPharma Inc. | |  |
| ARRY-797 | Array BioPharma | | No Structure |
| Arsanilic acid | | 98-50-0 |  |
| Arsenamide | | 531-72-6 |  |
| Arsenic Trioxide | Sloan Kettering Cancer Inst. | 1327-53-3 |  |
| ART-123 | Asahi Kasei | | No Structure |
| ART-621 | Peptech Ltd. (Australia) | | No Structure |
| Arteether | | 75887-54-6 ; 109716-83-8 (alpha and beta mixture) |  |
| Arteflene | Roche | 123407-36-3 |  |
| Artelinic acid | US Army | 120020-26-0 |  |
| Artemether | Hoechst (Sanofi-Aventis) | 71963-77-4 |  |
| Artemisinin | US Army (United States of America) | 63968-64-9 |  |
| Artemisone | Bayer | 255730-18-8 |  |
| Artenimol | | 81496-81-3 |  |
| Arterolane | Medicines for Malaria Venture (MMV), International Centre Cointrin (CH) | 664338-39-0 |  |
| Arterolane & Piperaquine | Ranbaxy Laboratories | 83764-65-2 (Piperaquine) ; 664338-39-0 (Arterolane) |  |
| Artesunate | | 88495-63-0 |  |
| Artesunate & Amodiaquine | Hoechst (Sanofi-Aventis) | 88495-63-0 (Artesunate) ; 86-42-0 (Amodiaquine) |  |
| Articaine | Hoechst (Sanofi-Aventis) | 23964-58-1 |  |
| Artilide | Upjohn (Pharmacia) | 133267-19-3 |  |
| Arundic acid | Ono Pharmaceutical | 185517-21-9 |  |
| Arundic acid (Proglia) | Ono Pharmaceutical | 185517-21-9 |  |
| ARYS-01 (Sorivudine) | aRigen Pharmaceuticals Inc. | 77181-69-2 |  |
| Arzoxifene | Eli Lilly | 182133-25-1 |  |
| AS-004 | Fred Hutchinson Cancer Research Center (US) | |  |
| AS-02 | Applied Research Systems | |  |
| AS-101 | University of Bar Ilan | 106566-58-9 |  |
| AS-13 | Kitasato University | 75187-63-2 |  |
| AS-1402 | Imperial Cancer Research Technology (ICRT) | | No Structure |
| AS-1411 | University of Alabama ; Aptamera | | No Structure |
| AS-1437246 | Astellas Pharma Inc. (Japan) | |  |
| AS-1512680 | Astellas Pharma Inc. (Japan) | |  |
| AS-1517499 | Astellas Pharma Inc. (Japan) | |  |
| AS-1552133 | Astellas Pharma Inc. (Japan) | |  |
| AS-16 | King Pharmaceuticals Research & Development Inc. (US) | |  |
| AS-1655619-FM | Yamanouchi (Astellas) | |  |
| AS-1669058 | Yamanouchi Pharma Co. Ltd. (Astellas Pharma Inc.Astellas Pharma Inc.) | |  |
| AS-1810722 | Astellas Pharma Inc. | |  |
| AS-191710 | Astellas Pharma Inc. (Japan) | |  |
| AS-191711 | Astellas Pharma Inc. (Japan) | |  |
| AS-1924601-00 | Astellas Pharma Inc. | |  |
| AS-1950930 | Astellas Pharma Inc. (Japan) | |  |
| AS-210 | Astralis | | No Structure |
| AS-252424 | Serono Pharmaceutical | 900515-16-4 |  |
| AS-2646 | Dainippon | |  |
| AS-35 | Tokyo Tanabe (Mitsubishi) | 108427-72-1 |  |
| AS-6 | Chugai (Roche) | 84435-25-6 |  |
| AS-601245 | Applied Research Systems | |  |
| AS-601811 | Applied Research Systems | 194979-95-8 |  |
| AS-604872 | Applied Research Systems (Serono) | |  |
| AS-605240 | Applied Research Systems (Serono) | |  |
| AS-605858 | Applied Research Systems ARS Holding (Netherlands) | |  |
| AS-606839 | Applied Research Systems ARS Holding NV (Netherlands) | |  |
| AS-702224 | Applied Research Systems ARS Holding NV (Netherlands) | |  |
| AS-703026 | Applied Research Systems ARS Holding NV (Netherlands) | |  |
| AS-8112 | Dainippon Pharmaceutical | 187480-02-0 |  |
| AS-I-145 | Taiho Pharmaceutical Co. Ltd. (Japan) | |  |
| ASB-16165 | Daiichi Asubio Pharma Co. Ltd. (Japan) | |  |
| ASCL-002 | Ewha Womans University (Korea) ; Korea Research Institute of Bioscience and Biotechnology | |  |
| Ascorbic acid | Natural | 50-81-7; 134-03-2 (monosodium salt) |  |
| Ascorbyl gamolenate | Scotia Pharmaceuticals | 109791-32-4 |  |
| Ascosalipyrrolidinone A | Bayer | |  |
| Aselizumab | | 395639-53-9 | No Structure |
| Asenapine | Akzona | 65576-45-6 |  |
| ASF-1096 (Levalbuterol) | Allen & Hanburys (GSK) | 34391-04-3 |  |
| Asfotase alfa | Enobia Pharma Inc. | 1174277-80-5 | No Structure |
| ASG-5ME | | | No Structure |
| Asimadoline | E. Merck KGaA | 153205-46-0 |  |
| ASK-8007 | Immuno-Biological Laboratories Co. Ltd. (Japan) | | No Structure |
| ASKP-1240 | Kyowa Hakko Kirin Co. Ltd. (Japan) | | No Structure |
| ASM-002 | University of Laval | |  |
| ASONEP (Sonepcizumab) | | | No Structure |
| Asoprisnil | Jenapharm | 163883-84-9 |  |
| Asoprisnil ecamate | Jenapharm | 163883-88-3 |  |
| ASP-015K | Astellas Pharma Inc. (Japan) | | No Structure |
| ASP-0265 | Astellas Pharma Inc. (Japan) | | No Structure |
| ASP-0306 | | | No Structure |
| ASP-0777 | Astellas Pharma Inc. (Japan) | | No Structure |
| ASP-1645 | Astellas Pharma Inc. (Japan) | |  |
| ASP-1707 | | | No Structure |
| ASP-2151 | Astellas Pharma Inc. (Japan) | | No Structure |
| ASP-2408 | Maxygen Inc. | | No Structure |
| ASP-2535 | Astellas Pharma Inc. | | No Structure |
| ASP-2905 | Astellas Pharma Inc. (Japan) | | No Structure |
| ASP-3026 | Astellas Pharma Inc. | | No Structure |
| ASP-3291 | Astellas Pharma Inc. (Japan) | | No Structure |
| ASP-3652 | Astellas Pharma Inc. (Japan) | | No Structure |
| ASP-4000 | Fujisawa Pharmaceutical Co. Ltd. (Astellas Pharma Inc.) | |  |
| ASP-4058 | | | No Structure |
| ASP-4178 | Astellas Pharma Inc. (Japan) | | No Structure |
| ASP-4901 | ASKA Pharmaceutical Co. Ltd. | | No Structure |
| ASP-5034 | | | No Structure |
| ASP-5854 | Astellas Pharma Inc. (Japan) | |  |
| ASP-7035 | Astellas Pharma Inc. (Japan) | | No Structure |
| ASP-7147 | | | No Structure |
| ASP-8477 | | | No Structure |
| ASP-8497 | Astellas Pharma Inc. (Japan) | |  |
| ASP-9521 | | | No Structure |
| ASP-9831 | Astellas Pharma Inc. (Japan) | | No Structure |
| Aspalatone | Han Byung | 147249-33-0 |  |
| Asparagoside D | Access Business Group (US) | 60267-24-5 |  |
| Aspartame | Searle (Pharmacia) | 22839-47-0 |  |
| Aspirin & Esomeprazole | Pozen Inc. (US) | 50-78-2 (Acetylsalicylic acid) ; 119141-88-7 (Esomeprazole) |  |
| Aspirochlorine | Lepetit Spa | 59978-04-0 |  |
| Aspoxicillin | Tanabe | 63358-49-6 |  |
| AST-120 | Sankyo | 90597-58-3 | No Structure |
| AST-487 | Novartis AG ; Novartis Pharma GMBH | |  |
| Astaxanthin | Hoffmann La Roche | 472-61-7 |  |
| Astemizole | Janssen Pharmaceutica (Johnson & Johnson) | 68844-77-9 |  |
| Astragaloside A | Osaka Yakuhin | 83207-58-3 |  |
| AstraStim | Pharmagenesis Inc. | | No Structure |
| Astringin | | 29884-49-9 |  |
| Astromicin | Abbott | 55779-06-1 |  |
| Astuprotimut-R | Glaxosmithkline Biologicals (GSK) | 949885-73-8 | No Structure |
| Asulacrine | Development Finance Corporation of New Zealand | 80841-47-0 |  |
| Asulam | May & Baker (Aventis) | 3337-71-1 |  |
| AT-001 | University of California | |  |
| AT-1002 | University of Maryland | |  |
| AT-101 | University of Michigan | 12542-36-8 |  |
| AT-1015 | Ajinomoto | 283614-90-4 |  |
| AT-13148 | Astex Technology Ltd. (Astex Therapeutics Ltd.) ; Cancer Research Technology Ltd. ; The Institute of | |  |
| AT-13387 | Astex Therapeutics Ltd. | |  |
| AT-1391 | Altea Therapeutics | | No Structure |
| AT-1459 | C & C Research ; Chugai | |  |
| AT-281 | Spirogen | |  |
| AT-3510 | Kyorin Seiyaku | |  |
| AT-3639 | Dainippon Pharmaceutical | 108119-03-5 |  |
| AT-7519 | Astex Therapeutics Ltd. (GB) | |  |
| AT-760 | Kyorin Pharmaceutical (Japan) | 341556-98-7 |  |
| AT-814 | University of Denver ; University of Florida ; Oklahoma Medical Research Foundation | |  |
| AT-9283 | Astex Therapeutics Ltd. (GB) | 896466-04-9 ; 896466-61-8 (HCl salt) ; 896466-76-5 ((2S)-2-hydroxy-propanoic acid salt) ; 896466-75- |  |
| AT-9311 | Astex Therapeutics Ltd. | |  |
| Atacicept | St Jude Childrens Research Hospital | 845264-92-8 | No Structure |
| Ataciguat | Aventis Pharma (Sanofi-Aventis) | 254877-67-3 |  |
| Atagabalin | Warner-Lambert (Pfizer) | 223445-75-8 |  |
| Ataluren | PTC Therapeutics | 775304-57-9 |  |
| Atamestane | Schering AG | 96301-34-7 |  |
| Atazanavir | Ciba-Geigy (Novartis) | 198904-31-3 |  |
| ATB-284 | Antibe Therapeutics Inc. | | No Structure |
| ATB-346 | Antibe Therapeutics Inc. | |  |
| ATB-429 | Antibe Therapeutics | |  |
| ATBI | National Chemical Laboratory | 333304-18-0 |  |
| ATC-0015 | Taisho | |  |
| ATC-0021 | Taisho | |  |
| ATC-0044 | Taisho | |  |
| ATC-0065 | Taisho | |  |
| ATC-0175 | Taisho | |  |
| Atecegatran | | 917904-13-3 |  |
| Atecegatran fexenetil | | 433937-93-0 |  |
| Atenolol | ICI (AstraZeneca) | 29122-68-7 |  |
| Atevirdine | Upjohn (Pharmacia) | 136816-75-6 |  |
| ATH-18534 | Athelas (MerLion Pharmaceutical) | |  |
| ATHX-105 | Athersys | | No Structure |
| ATI-0917 (Chlorpropham) | The Procter & Gamble Co. (US) | 101-21-3 |  |
| ATI-1150 (SN-38) | Azaya Therapeutics | 86639-52-3 |  |
| ATI-2001 | Advanced Therapies | 178735-18-7 |  |
| ATI-22-107 | Artesian Therapeutics | |  |
| ATI-9242 | ARYx Therapeutics Inc. | | No Structure |
| ATI-BC-1 | Anticancer Therapeutic Inventions (Algeta) | | No Structure |
| Atilmotin | Ohmeda Pharmaceutical (US) | 533927-56-9 |  |
| Atinumab | Novartis AG (Switzerland) | 1226761-65-4 | No Structure |
| Atipamezole | Farmos | 104054-27-5 |  |
| Atiprimod | SmithKline Beecham (GSK) | 123018-47-3 |  |
| Atizoram | Pfizer | 135637-46-6 |  |
| ATK-0101 | University of Toronto ; University of Western Australia | |  |
| ATL-1 | Brigham and Women's Hospital | |  |
| ATL-104 | Alizyme Therapeutics | | No Structure |
| ATL-1101 | Antisense Therapeutics Pty Ltd. | | No Structure |
| ATL-1103 | Isis Pharmaceuticals Inc. | | No Structure |
| ATL-1222 | Adenosine Therapeutics LLC (Clinical Data Inc.) | | No Structure |
| ATL-193 | University of Virginia | 287179-78-6 |  |
| ATL-313 | Adenosine Therapeutics ; University of Virginia | |  |
| ATL-525 | University of Virginia | |  |
| ATL-801 | Adenosine Therapeutics LLC. (Clinical Data Inc.) | |  |
| ATL-844 | Adenosine Therapeutics LLC (Clinical Data Inc.) | | No Structure |
| Atliprofen | IDPL | 108912-17-0 |  |
| ATN-1124 | Attenuon LLC (US) | |  |
| ATN-161 | University of Michigan (US) | |  |
| ATN-224 | Attenuon ; Michigan University | |  |
| ATN-291 | Attenuon | | No Structure |
| Atocalcitol | EO Pharma A/S | 302904-82-1 |  |
| Atofluding | Okada | 71861-76-2 |  |
| Atomoxetine | Goergens | 83015-26-3 |  |
| Atopaxar | Eisai | 751475-53-3 ; 474550-69-1 (HBr) |  |
| Atorvastatin | Warner Lambert (Pfizer) | 134523-00-5 |  |
| Atorvastatin-Aliskiren | LEK Pharmaceuticals (Slovenia) | |  |
| Atosiban | Ferring | 90779-69-4 |  |
| Atovaquone | Wellcome Foundation (GSK) | 95233-18-4 |  |
| ATPace (adenosine triphosphate) | Duska Therapeutics | 56-65-5 |  |
| ATR-107 | | | No Structure |
| Atracurium besilate | Burroughs Wellcome (GSK) | 64228-81-5 |  |
| Atrasentan | Abbott | 195733-43-8 (HCl) |  |
| Atrazine | Ciba-Geigy (Novartis) | 1912-24-9 |  |
| Atreleuton | Abbott | 154355-76-7 |  |
| Atrimustine | Kyowa Hakko | 75219-46-4 |  |
| Atrinositol | Perstorp (Sweden) | 28841-62-5 |  |
| Atropine | Hoffman-La Roche | 51-55-8 |  |
| Atropine oxide | | 4438-22-6 |  |
| Atrosab | Celonic AG | | No Structure |
| ATX-MS-1467 | The University of Bristol (GB) | | No Structure |
| ATX-S10 | Wyeth Lederle (Japan) ; Photochemical Co., (Japan) | 147444-36-8 |  |
| ATZ-1993 | Teikoku Hormone (Aska Pharmaceuticals) | 219705-77-8 |  |
| AU-130 | Hokuriku | 145727-25-9 (HCl) |  |
| AUDA-BE | University of California | |  |
| Auranofin | SmithKline French (GSK) | 34031-32-8 |  |
| Aurintricarboxylic acid | | 4431-00-9 |  |
| Aurothioglucose | Bayer Schering Pharma | 12192-57-3 |  |
| Aurothiomalic acid | RPR (Aventis) | 70-49-5 |  |
| Aurothioprol | LTM | 27279-43-2 |  |
| Auto TAG | Gradalis Inc. (US) | | No Structure |
| AV-002 | Cornell Research Foundation Inc. (US) | |  |
| AV-100 | Ajinomoto | 164013-29-0 |  |
| AV-101 | Merrell Dow Pharmaceuticals Inc. | |  |
| AV-1101 | A-Viral | |  |
| AV-1142742 | Active Biotech (GB) | | No Structure |
| AV-119 | Laboratoires Expanscience (France) | |  |
| AV-299 | Aveo Pharmaceuticals Inc. (US) | | No Structure |
| AV-411 (Ibudilast) | Avigen | |  |
| AV-650 (Tolperisone) | Sanochemia Pharmazeutika | 728-88-1 |  |
| Avagacestat | Bristol-Myers Squibb Co. (US) | 1146699-66-2 |  |
| Avanafil | Tanabe Seiyaku | 330784-47-9 |  |
| Avandaryl - Glimepiride & Rosiglitazone | | 122320-73-4 (Rosiglitazone) ; 93479-97-1 (Glimepiride) |  |
| Avasimibe | Warner Lambert (Pfizer) | 166518-60-1 |  |
| AVE-0118 | Aventis Pharma | |  |
| AVE-0657 | Sanofi-Aventis | |  |
| AVE-0675 | Sanofi-Aventis | | No Structure |
| AVE-0847 | Sanofi-Aventis | | No Structure |
| AVE-0897 | | | No Structure |
| AVE-1231 | | | No Structure |
| AVE-1642 | ImmunoGen | | No Structure |
| AVE-1701 | | | No Structure |
| AVE-2268 | Sanofi-Aventis | | No Structure |
| AVE-3085 | Aventis Pharma GMBH | 450348-85-3 |  |
| AVE-3247 | | | No Structure |
| AVE-4454 | Sanofi Aventis | | No Structure |
| AVE-4890 | Sanofi Aventis | | No Structure |
| AVE-5376 | | | No Structure |
| AVE-5997 | Aventis | 452917-21-4 |  |
| AVE-6324 | Sanofi-Aventis | | No Structure |
| AVE-6971 | Sanofi-Aventis | |  |
| AVE-8112 | Sanofi-Aventis | | No Structure |
| AVE-8134 | Sanofi-Aventis | | No Structure |
| AVE-8488 | Sanofi-Aventis | | No Structure |
| AVE-8680 | Sanofi-Aventis; Millennium | | No Structure |
| AVE-8923 | Sanofi-Aventis | | No Structure |
| AVE-9423 | Sanofi Aventis | | No Structure |
| AVE-9488 | Aventis Pharma GMBH | 291756-32-6 |  |
| AVE-9633 | Immunogen | | No Structure |
| AVE-9897 | Millennium Pharmaceuticals (Takeda) | | No Structure |
| Avermectin | Merck & Co | 73989-17-0 |  |
| AVG-GAL | Sopharma AD | |  |
| AVI-4020 | AVI BioPharma | | No Structure |
| AVI-4065 | Avi Biopharma | | No Structure |
| AVI-4126 | AVI BioPharma | 180395-27-1 |  |
| AVI-4557 | AVI Biopharma | 494805-69-5 |  |
| Avibactam | Aventis (Sanofi-Aventis) | 1192500-31-4 |  |
| Avicatonin | Mitsubishi | 103451-84-9 | No Structure |
| Avicenol A | Kyoto Prefectural University of Medicine (JP) ; Meijo University (JP) ; National\nUniversity of Sing | |  |
| Avicequinone A | Japan science & Tech Corp\nKyoto Prefectural University of Medicine (JP) ; Meijo University (JP) ; N | |  |
| Avicin D | Research Development Foundation | |  |
| Avicin G | Research Development Foundation | |  |
| Aviglycine | Hoffmann La Roche (Roche) | 49669-74-1 |  |
| Avipox virus recombinant | Health Research Inc. (US) | | No Structure |
| Aviptadil | SENETEK | 40077-57-4 |  |
| Aviscumine | Viscum AG ; Madaus AG | 223577-45-5 |  |
| Avitriptan | Bristol Myers Squibb (BMS) | 151140-96-4 |  |
| AVN-316 | Avalon Pharmaceuticals Inc. (Clinical Data Inc.) | | No Structure |
| Avobenzone | Givaudan | 70356-09-1 |  |
| Avorelin | Ardana Bioscience | 140703-49-7 |  |
| Avosentan | Hoffmann La Roche (Roche) | 290815-26-8 |  |
| AVP-13358 | Avanir Pharmaceuticals | |  |
| AVP-21D9 | Avanir Pharmaceuticals Inc. | | No Structure |
| AVP-28225 | Avanir Pharmaceuticals Inc. | | No Structure |
| AVP-923 (Dextromethorphan & Quinidine) | Avanir Pharmaceuticals (US) | 634202-74-7 ; 125-71-3 (Dextromethorphan) ; 56-54-2 (Quinidine) |  |
| AVR-118 | ADVR (Advanced Viral Research) | |  |
| Avrina | Corgentech (Anesiva) | | No Structure |
| AVT-02 | | | No Structure |
| AVTG | University of Wisconsin-Madison | |  |
| AVTP | University of Wisconsin-Madison | 76664-26-1 |  |
| AVX-001 | Avexxin AS | |  |
| AVX-002 | Avexxin AS | | No Structure |
| AVX-003 | Avexxin AS | | No Structure |
| AVX-13616 | University of Wollongong (Australia) | |  |
| AVX-601 | AlphaVax Inc. | | No Structure |
| AW-054 | Medac GmbH (Germany) | |  |
| AWD-12260 | Arzneimittewerk Dresden (AWD) | 108610-89-5 |  |
| AWD-140190 | Arzneimittelwerk Dresden (AWD) | 135548-66-2 |  |
| AWD-23111 | Arzneimittelwerk Dresden (AWD) | 221639-91-4 |  |
| AWD-33159 | Dresden Arzneimittel | |  |
| AWD-34-022 | Arzneimittelwerk Dresden (AWD) | 308274-02-4 |  |
| AX-048 | University of California | |  |
| AX-7376 | Axxima Pharmaceuticals AG | |  |
| AX-7396 | Axxima Pharmaceuticals AG | |  |
| AX-7543 | Axxima Pharmaceuticals AG (VirGene Pharmaceuticals) | |  |
| AX-8819 | ActivX Biosciences Inc. (US) | |  |
| AX-9657 | Activx Biosciences Inc. (US) ; Kyorin Discovery Research Laboratories (Japan) | |  |
| Axitinib | Agouron (Pfizer) | 319460-85-0 |  |
| Axitirome | Ciba-Geigy (Novartis) | 156740-57-7 |  |
| Axomadol | Gruenenthal GmbH | 187219-99-4 |  |
| Axorid (Ketoprofen & Omeprazole) | Ethypharm | 22071-15-4 (Ketoprofen) ; 73590-58-6 (Omeprazole) |  |
| AY-31906 | American Home Products (Wyeth) | 124788-46-1 |  |
| AZ-001 (Prochlorperazine) | Alexza Molecular Delivery (US) | 58-38-8 |  |
| AZ-002 (Alprazolam) | Alexza Pharmaceuticals (US) | 28981-97-7 |  |
| AZ-003 (Fentanyl) | Alexza Molecular Delivery Corp | 437-38-7 |  |
| AZ-004 (Loxapine) | Alexza Pharmaceuticals (US) | 1977-10-2 |  |
| AZ-007 (Zaleplon) | Alexza Pharmaceuticals (US) | 151319-34-5 |  |
| AZ-10397767 | Astrazeneca UK Ltd. (GB) | |  |
| AZ-11657312 | AstraZeneca AB (Sweden) | |  |
| AZ-11665362 | AstraZeneca AB (Sweden) | |  |
| AZ-12066871 | Astrazeneca AB ; Astex Therapeutics | |  |
| AZ-12235743 | AstraZeneca | |  |
| AZ-12260955 | Astrazeneca AB ; Astrazeneca Ltd. | |  |
| AZ-18 | AstraZeneca | |  |
| AZ-23 | AstraZeneca AB (Sweden) | |  |
| AZ-599 | Astrazeneca AB (Sweden) | |  |
| AZ-628 | AstraZeneca UK Ltd. (GB) | |  |
| AZ-960 | AstraZeneca AB (Sweden) | 905586-69-8 |  |
| Azacitidine | Ceskoslovenska Akademie Ved | 320-67-2 |  |
| Azaconazole | Janssen Pharmaceutica (Johnson & Johnson) | 60207-31-0 |  |
| Azacyclonol | Merrell (Aventis) | 115-46-8 |  |
| AZAD | AstraZeneca AB (Sweden) | |  |
| Azadirachtin | W. R. Grace & Co | 11141-17-6 |  |
| Azafenidin | DuPont | 68049-83-2 |  |
| Azalanstat | Syntex (Roche) | 143393-27-5 |  |
| Azamethiphos | Agripat | 35575-96-3 |  |
| Azanidazole | Inst. Chemioter. Ital. | 62973-76-6 |  |
| Azaperone | Janssen Pharmaceutica (Johnson & Johnson) | 1649-18-9 |  |
| Azapropazone | Siegfried | 13539-59-8 |  |
| Azaresveratrol | Dominion pharmakine | |  |
| Azasetron | Yoshitomi | 123040-69-7 |  |
| Azatadine | Bayer Schering Pharma | 3964-81-6 |  |
| Azathioprine | Burroughs Wellcome (GSK) | 446-86-6 |  |
| AZD-0328 | AstraZeneca | 220099-91-2 | No Structure |
| AZD-0837 | AstraZeneca | |  |
| AZD-0865 | AstraZeneca | | No Structure |
| AZD-1080 | Astrazeneca | | No Structure |
| AZD-1152-HQPA | AstraZeneca | 722544-51-6 |  |
| AZD-1175 | | | No Structure |
| AZD-1236 | | | No Structure |
| AZD-1305 | Astrazeneca | | No Structure |
| AZD-1386 | AstraZeneca | | No Structure |
| AZD-1446 | Targacept Inc. (US) | | No Structure |
| AZD-1480 | AstraZeneca AB (Sweden) | |  |
| AZD-1656 | | | No Structure |
| AZD-1678 | Astrazeneca | | No Structure |
| AZD-1689 | | | No Structure |
| AZD-1704 | | | No Structure |
| AZD-1744 | Astrazeneca | | No Structure |
| AZD-1845 | Astrazeneca | | No Structure |
| AZD-1940 | Astrazeneca | | No Structure |
| AZD-1981 | | | No Structure |
| AZD-2014 | | | No Structure |
| AZD-2066 | AstraZeneca | | No Structure |
| AZD-2207 | Astrazeneca | | No Structure |
| AZD-2327 | AstraZeneca | | No Structure |
| AZD-2392 | Astrazeneca | | No Structure |
| AZD-2423 | AstraZeneca AB (Sweden) | | No Structure |
| AZD-2461 | | | No Structure |
| AZD-2479 | | | No Structure |
| AZD-2516 | AstraZeneca AB (Sweden) | | No Structure |
| AZD-2551 | AstraZeneca AB (Sweden) | | No Structure |
| AZD-2624 | AstraZeneca | | No Structure |
| AZD-2836 | Arrow | | No Structure |
| AZD-3199 | | | No Structure |
| AZD-3241 | | | No Structure |
| AZD-3342 | AstraZeneca | |  |
| AZD-3514 | | | No Structure |
| AZD-3646 | Astrazeneca | | No Structure |
| AZD-3783 | Astrazeneca | | No Structure |
| AZD-3825 | Astrazeneca | | No Structure |
| AZD-4017 | AstraZeneca AB (Sweden) | | No Structure |
| AZD-4121 | Astrazeneca | | No Structure |
| AZD-4547 | | | No Structure |
| AZD-4769 | Astrazeneca | | No Structure |
| AZD-4818 | Astrazeneca | | No Structure |
| AZD-4877 | Astrazeneca | | No Structure |
| AZD-5069 | | | No Structure |
| AZD-5213 | | | No Structure |
| AZD-5363 | | | No Structure |
| AZD-5423 | | | No Structure |
| AZD-5438 | AstraZeneca AB | 602306-29-6 |  |
| AZD-5597 | Astrazeneca AB (Sweden) | |  |
| AZD-5658 | | | No Structure |
| AZD-5672 | Astrazeneca | | No Structure |
| AZD-5847 | | | No Structure |
| AZD-5896 | | | No Structure |
| AZD-5904 | | | No Structure |
| AZD-5985 | AstraZeneca AB (Sweden) | | No Structure |
| AZD-6067 | Astrazeneca | | No Structure |
| AZD-6088 | AstraZeneca AB (Sweden) | | No Structure |
| AZD-6280 | AstraZeneca | | No Structure |
| AZD-6357 | Astrazeneca | | No Structure |
| AZD-6370 | Astrazeneca | | No Structure |
| AZD-6482 | AstraZeneca | 1173900-33-8 |  |
| AZD-6538 | Astrazeneca | | No Structure |
| AZD-6553 | | | No Structure |
| AZD-6605 | Astrazeneca | | No Structure |
| AZD-6610 | AstraZeneca | | No Structure |
| AZD-6703 | Astrazeneca | | No Structure |
| AZD-6714 | AstraZeneca AB (Sweden) | | No Structure |
| AZD-6765 | | | No Structure |
| AZD-6918 | AstraZeneca AB (Sweden) | | No Structure |
| AZD-7268 | AstraZeneca AB (Sweden) | | No Structure |
| AZD-7295 | AstraZeneca ; Arrow Therapeutics | | No Structure |
| AZD-7325 | AstraZeneca | | No Structure |
| AZD-7512 | Astrazeneca | | No Structure |
| AZD-7687 | | | No Structure |
| AZD-7762 | AstraZeneca UK Ltd. | |  |
| AZD-7928 | Astrazeneca | | No Structure |
| AZD-8055 | AstraZeneca AB | 1009298-09-2 |  |
| AZD-8075 | AstraZeneca AB (Sweden) | | No Structure |
| AZD-8081 | Astrazeneca | | No Structure |
| AZD-8309 | | | No Structure |
| AZD-8329 | | | No Structure |
| AZD-8330 | Array Biopharma (US) | |  |
| AZD-8450 | Astrazeneca | | No Structure |
| AZD-8529 | AstraZeneca AB (Sweden) | | No Structure |
| AZD-8566 | AstraZeneca AB (Sweden) | | No Structure |
| AZD-8593 | Astrazeneca | | No Structure |
| AZD-8677 | | | No Structure |
| AZD-8683 | | | No Structure |
| AZD-8797 | Astrazeneca | | No Structure |
| AZD-8848 | Dainippon Sumitomo Pharma Co. Ltd. ; Astrazeneca AB | |  |
| AZD-8931 | Astrazeneca AB (Sweden) | |  |
| AZD-8955 | | | No Structure |
| AZD-9056 | AstraZeneca | | No Structure |
| AZD-9164 | AstraZeneca AB (Sweden) | | No Structure |
| AZD-9215 | Astrazeneca | | No Structure |
| AZD-9272 | | | No Structure |
| AZD-9335 | Astrazeneca | | No Structure |
| AZD-9668 | Astrazeneca | | No Structure |
| AZD-9684 | | | No Structure |
| AZD-9742 | | | No Structure |
| AZD-9819 | | | No Structure |
| AZD-9935 | AstraZeneca | | No Structure |
| Azelaic Acid | Schering AG (Bayer Schering Pharma) | 123-99-9 |  |
| Azelastine | Asta Medica (Meda) | 58581-89-8 |  |
| Azelastine & Fluticasone | Cipla Ltd. | 58581-89-8 (Azelastine) ; 80474-14-2 (Fluticasone) |  |
| Azelnidipine | Sankyo (Daiichi Sankyo) | 123524-52-7 |  |
| Azetirelin | Yamanouchi (Astellas) | 95729-65-0 |  |
| Azficel-T | Isolagen Technologies Inc. (Fibrocell Science, Inc.) | | No Structure |
| Azidamfenicol | Bayer | 13838-08-9 |  |
| Azidocillin | Beecham (GSK) | 17243-38-8 |  |
| Azilsartan | Takeda | 147403-03-0 |  |
| Azilsartan medoxomil | Takeda Pharmaceutical Co., LTD | 863031-21-4 ; 863031-24-7 (potassium salt) |  |
| Azimilide | Norwich Eaton (Procter & Gamble) | 149908-53-2 |  |
| Azimsulfuron | DuPont | 120162-55-2 |  |
| Azinomycin-A | SS Pharmaceutical | 106486-77-5 |  |
| Azinphos-ethyl | Bayer | 2642-71-9 |  |
| Azinphos-methyl | Bayer | 86-50-0 |  |
| Azintamide | Lentia | 1830-32-6 |  |
| Aziprotryn | Ciba-Geigy (Novartis) | 4658-28-0 |  |
| Azithromycin | Pliva | 83905-01-5 |  |
| Azithromycin & Chloroquine | Pfizer Inc. | 83905-01-5 (Azithromycin) ; 54-05-7 (Chloroquine) |  |
| Azlocillin | Bayer | 37091-66-0 |  |
| Azocyclotin | Bayer | 41083-11-8 |  |
| Azodicarbonamide | Hubriphar | 123-77-3 |  |
| Azoluron | Fahlberg | 4058-90-6 |  |
| Azonafide | Res Corp Technologies ; Amplimed | 140917-67-5 |  |
| Azosemide | Boehringer Mannheim (Roche) | 27589-33-9 |  |
| Azoximer bromide | | 892497-01-7 |  |
| Azoxybacilin | Sandoz (Novartis) | 157998-96-4 |  |
| Azoxystrobin | ICI (Syngenta) | 131860-33-8 |  |
| Aztreonam | Squibb (BMS) | 78110-38-0 |  |
| Aztreonam L-Lysine | Corus Pharma (Gilead Sciences) | |  |
| Azulene | Ruetgers | 275-51-4 |  |
| AZX-100 | Arizona State University (US) | |  |
| B-10356 | University of Colorado ; University of Montreal | |  |
| B-17 | Georgetown University | 7515-15-3 |  |
| B-201 | Battelle Memorial Institute ; National Cancer Institute (NCI) | 215713-39-6 |  |
| B-202 | Battelle Memorial Institute ; National Cancer Institute (NCI) | |  |
| B-3962 | University of Pretoria ; Adcock Ingram Pharma | |  |
| B-4112 | University of Pretoria ; Adcock Ingram Pharma | |  |
| B-4126 | University of Pretoria ; Adcock Ingram Pharma | |  |
| B-4128 | University of Pretoria ; Adcock Ingram Pharma | |  |
| B-4157 | University of Pretoria ; Adcock Ingram Pharma | 175447-83-3 |  |
| B-428 | Eisai | 149732-36-5 |  |
| B-50 | Universidade Federal de Santa Maria (Brasil) | |  |
| B-5529D | Sankyo | |  |
| B-956 | Eisai | 171440-21-4 |  |
| B6V10 | Genmedica Therapeutics SL (Spain) ; Barcelona University (Spain) | |  |
| BA-210 | BioAxoneTherapeutic | | No Structure |
| Babim | Research Triangle Inst. | 74733-75-8 |  |
| Bacampicillin | Astra (AstraZeneca) | 50972-17-3 |  |
| Bacillus thuringiensis | Agricultural Genetics CO (GB) | 68038-71-1 | No Structure |
| Baclofen | Ciba (Novartis) | 1134-47-0 |  |
| BAD-BH3 | Dana Farber Cancer Institute | |  |
| BAF-312 | | | No Structure |
| Bafetinib | Nippon Shinyaku | 887650-05-7 ; 859212-16-1 |  |
| Bafilomycin-A1 | AstraZeneca | 88899-55-2 |  |
| BAG-1 | Merck & Co. Inc. | |  |
| BAG-956 | Novartis AG (Switzerland) | |  |
| Baicalein | University of Illinois | 491-67-8 |  |
| Baicalin | University of Illinois | 21967-41-9 |  |
| BAK-G390 | Tsumura | |  |
| BAL-0030205 | Basilea Pharmaceutica | |  |
| BAL-101553 | Basilea Pharmaceutica AG | |  |
| BAL-17662 | Hoffmann La Roche | |  |
| BAL-19403 | Basilea Pharmaceutica AG. | |  |
| BAL-27862 | Basilea Pharmaceutica AG | |  |
| BAL-30072 | Basilea Pharmaceutica AG | |  |
| BAL-30543 | Roche (Basilea Pharmaceutica AG ) (Switzerland) | |  |
| BAL-30544 | Roche (Basilea Pharmaceutica AG ) (Switzerland) | |  |
| BAL-30545 | Roche (Basilea Pharmaceutica AG ) (Switzerland) | |  |
| BAL-4079 (Alitretinoin) | Basilea Pharmaceutica | 5300-03-5 |  |
| BAL-8349 | Roche | |  |
| BAL-ARI8 | Baldacci | 124066-40-6 |  |
| Balaglitazone | Reddy Research Foundation | 199113-98-9 |  |
| Balamapimod | Wyeth | 863029-99-6 |  |
| Balanol | Sphin | 63590-19-2 |  |
| Balapiravir | Roche | 690270-29-2 |  |
| Balazipone | Orion | 137109-71-8 |  |
| Balicatib | Novartis | 354813-19-7 |  |
| Balofloxacin | Warner Lambert (Pfizer) | 127294-70-6 |  |
| Balsalazide | Biorex | 80573-04-2 |  |
| BAM-1110 | Maruko Pharmaceutical | 105579-47-3 |  |
| Bamaquimast | Pierre Fabre | 135779-82-7 |  |
| Bambuterol | Dracco | 81732-65-2 |  |
| Bamet R2 | Salamanca University | |  |
| BAMET-UD2 | Universidad de Salamanca (ES) | |  |
| Bamethan | Boehringer Ingelheim | 3703-79-5 |  |
| Bamifylline | Christiaens | 2016-63-9 |  |
| Baminercept | Biogen Idec (US) | 909110-25-4 | No Structure |
| Bamipine | Knoll (Abbott) | 4945-47-5 |  |
| Bamirastine | Takeda | 215529-47-8 |  |
| Banoxantrone | National Research Development Corporation (British Tech Group, BTG) | 136470-65-0 |  |
| Bapineuzumab | Elan | 648895-38-9 | No Structure |
| Baquiloprim | Wellcome Foundation (GSK) | 102280-35-3 |  |
| Baraban | Aceto agriculture chemicals | 101-27-9 |  |
| Barasertib | Astrazeneca | 722543-31-9 |  |
| Barbexaclone | Knoll (Abbott) | 4388-82-3 |  |
| Barbital | Kendall and Co | 57-44-3 |  |
| Bardoxolone | Dartmouth College | 218600-44-3 |  |
| Bardoxolone methyl | DARTMOUTH COLLEGE | 218600-53-4 |  |
| Barixibat | Aventis Pharma GmbH (Germany) | 263562-28-3 |  |
| Barnidipine | Yamanouchi (Astellas) | 104713-75-4 |  |
| Barusiban | Ferring | 285571-64-4 |  |
| BAS-00674544 | TNO (Netherlands) | 331959-00-3 |  |
| BAS-00674552 | TNO (Netherlands) | 331959-03-6 |  |
| BAS-11-205C | University of Alabama (US) ; Kenyon College (US) | |  |
| BAS-118 | Mitsubishi | 218936-13-1 |  |
| Basifungin | Takara Shuzo | 127785-64-2 |  |
| Basiliximab | Sandoz (Novartis) | 179045-86-4 | No Structure |
| Batabulin | Tularik (Amgen) | 195533-53-0 |  |
| Batanopride | Bristol-Myers Squibb (BMS) | 102670-46-2 |  |
| Batebulast | Nippon Chemiphar | 81907-78-0 |  |
| Batelapine | Ciba-Geigy (Novartis) | 95634-82-5 |  |
| Batimastat | British Biotech | 130370-60-4 |  |
| Batoprazine | Duphar | 105685-11-8 |  |
| Batroxobin | Pentapharm (DSM) | 9039-61-6 | No Structure |
| Bavisant | Janssen Pharmaceutica Nv | 929622-08-2 ; 1103522-80-0 (dihydrochloride) |  |
| Bavituximab | Univ. Texas | 648904-28-3 | No Structure |
| BAY-1000394 | | | No Structure |
| BAY-19-8004 | Bayer | 329306-27-6 |  |
| BAY-27-9955 | Bayer | 202855-56-9 |  |
| BAY-367620 | Bayer | |  |
| BAY-38-7271 | Bayer | 212188-60-8 |  |
| BAY-41-4109 | Bayer | 298708-81-3 |  |
| BAY-41-8543 | Bayer | 256498-66-5 |  |
| BAY-412272 | Bayer | |  |
| BAY-43-9695 | Bayer | |  |
| BAY-50-4798 | Bayer | 315202-94-9 | No Structure |
| BAY-57-1293 | Bayer | 348086-71-5 |  |
| BAY-59-3074 | Bayer | |  |
| BAY-60-4552 | | | No Structure |
| BAY-60-6583 | Bayer Healthcare AG (Germany) | |  |
| BAY-61-3606 | Bayer | |  |
| BAY-65-5811 | Bayer AG (Germany) | |  |
| BAY-65-6207 | Bayer AG | |  |
| BAY-73-6691 | Bayer Healthcare AG | |  |
| BAY-73-7977 | Bayer | | No Structure |
| BAY-74-4113 | Bayer Pharmaceutical | |  |
| BAY-79-4620 | Bayer Pharmaceuticals Corp. | | No Structure |
| BAY-79-4980 | Bayer | | No Structure |
| BAY-80-3000 | Bayer AG | |  |
| BAY-80-6946 | | | No Structure |
| BAY-87-2243 | | | No Structure |
| (±)-Bay-k-8644 | Bayer AG | 71145-03-4 |  |
| Bay-o-2752 | Bayer | 78991-74-9 |  |
| BAY-P-1455 | Bayer | 131185-01-8 |  |
| BAY-R1005 | Bayer | |  |
| BAY-X-7195 | Bayer | 143538-27-6 |  |
| BAY-Y-3118 | Bayer | 144194-96-7 |  |
| BAY-Y-5959 | Bayer | 146136-94-9 |  |
| Bayer-RN-176441-74-0 | Bayer | 176441-74-0 |  |
| Bayer-RN-181261-62-1 | Bayer | 181261-62-1 |  |
| Bazedoxifene | American Home Products (Wyeth) | 198481-32-2 |  |
| BB-012 | Cancer Research Technology Ltd. (GB) | |  |
| BB-1101 | British Biotech | 147783-67-3 |  |
| BB-1277 | British Biotech | 205179-45-9 |  |
| BB-2116 | British Biotech | 166798-77-2 |  |
| BB-21295 | British Biotech | 205179-26-6 |  |
| BB-2275 | British Biotech | 166798-78-3 |  |
| BB-3497 | British Biotech | 235784-88-0 |  |
| BB-76163 | British Biotech | 205179-66-4 |  |
| BBC-1 | Yissum (Israel) | |  |
| BBL-22 | S. Spector ; N. L. Spector | 76988-22-2 |  |
| BBL-454 | | |  |
| BBR-2160 | Boehringer Biochemia (Roche) | 118587-22-7 |  |
| BC-1175 | Biochemie (Sandoz) | |  |
| BC-210 | Biotica Technology | |  |
| BC-274 | Biotica Technology Ltd. (GB) | |  |
| BC-2901 | Sandoz AG | |  |
| BC-3205 | Biochemie GmbH (Austria) | |  |
| BC-3781 | Nabriva Therapeutics AG | |  |
| BC-7013 | Novartis AG (Austria) | |  |
| BCDMH | Drug Research (US) | 16079-88-2 |  |
| BCE-001 | Biogal | 95678-81-2 |  |
| BCEAB | Shionogi | |  |
| BCG.HIVA | Medical Research Council (GB) ; International AIDS Vaccine Initiative (US) ; University of Nairobi ( | | No Structure |
| BCH-1 | BioChem Pharma | |  |
| BCH-1184 | Biochem Pharma | |  |
| BCH-1393 | Biochem | 175072-12-5 |  |
| BCH-1667 | Biochem Pharma | |  |
| BCH-255 | IAF Biochem | 144967-66-8 |  |
| BCH-3567 | Biochem | |  |
| BCH-371 | IAF Biochem | |  |
| BCTC | Neurogen | 393514-24-4 |  |
| BCX-140 | BioCryst | 170447-93-5 |  |
| BCX-1470 | BioCryst | |  |
| BCX-1898 | Biocryst | |  |
| BCX-2798 | BioCryst Pharmaceuticals | |  |
| BCX-2855 | BioCryst | |  |
| BCX-3607 | BioCryst Pharmaceuticals | |  |
| BCX-4208 | Industrial Research (NZ); Yeshiva University (US) | |  |
| BCX-4678 | BioCryst | | No Structure |
| BCX-5 | Biocryst | 132138-76-2 |  |
| BD-1008 | Matsumoto | 138356-08-8 |  |
| BDF-9148 | Beiersdorf | 120838-62-2 |  |
| BDFP | CMIC | |  |
| BDM-31343 | Institut Pasteur de Lille (France) ; Centre National de la Recherche Scientifique (France) ; Univers | |  |
| BDNF | Regeneron Pharmaceuticals ; Amgen | | No Structure |
| BDP-1 | University of Dundee (GB) | |  |
| BDRM-26 | Howard University ; University of Pittsburgh ; University of Oklahoma | |  |
| BDRM-36 | Howard University ; University of Pittsburgh ; University of Oklahoma | |  |
| BDRM-61 | Howard University ; University of Pittsburgh ; University of Oklahoma | |  |
| BDRM-64 | Howard University ; University of Pittsburgh ; University of Oklahoma | |  |
| BDRM-72 | Howard University ; University of Pittsburgh ; University of Oklahoma | |  |
| BDRM-81 | Howard University ; University of Pittsburgh ; University of Oklahoma | |  |
| BDRM-83 | Howard University ; University of Pittsburgh ; University of Oklahoma | |  |
| BDRM-85 | Howard University ; University of Pittsburgh ; University of Oklahoma | |  |
| BDRM-86 | Howard University ; University of Pittsburgh ; University of Oklahoma | |  |
| BDRM-87 | Howard University ; University of Pittsburgh ; University of Oklahoma | |  |
| BE-16627B | Banyu | |  |
| BE-22179 | Banyu | 147816-33-9 |  |
| BE-40644 | Banyu | |  |
| BE-45985X | Banyu | |  |
| BE-54017 | Banyu | |  |
| BE-54238A | Merck & Co. | |  |
| BE-54238B | Merck & Co. | |  |
| BE-54753 | Banyu | 244279-81-0 |  |
| BEA-005 | Bristol Myers Squibb (BMS) | |  |
| Beauvericin | Inst Bioanalytik Umwelt Toxiko | 26048-05-5 |  |
| Becampanel | Novartis | |  |
| Becaplermin | | 165101-51-9 | No Structure |
| Becatecarin | Bristol-Myers Squibb (BMS) | 119673-08-4 |  |
| Beclamide | American Cyanamid (Wyeth) | 501-68-8 |  |
| Becliconazole | Menarini | 112893-26-2 |  |
| Beclobrate | Siegfried | 55937-99-0 |  |
| Beclometasone | Merck & Co | 4419-39-0 |  |
| Beclometasone dipropionate | Glaxo (GSK) | 5534-09-8 |  |
| Beclotiamine | Sankyo | 13471-78-8 |  |
| Becocalcidiol | Wisconsin Alumni Research Foundation | 524067-21-8 |  |
| Bedaquiline | Janssen Pharmaceutica (Johnson & Johnson) | 654653-93-7 ; 843663-66-1 ; 845533-86-0 (fumarate) |  |
| Bederocin | Replidyne | 757942-43-1 |  |
| Bedoradrine | Kissei ; Teikoku Hormone (Aska Pharmaceuticals) | 194785-31-4 ; 194785-19-8 |  |
| Befetupitant | Hoffmann-La Roche | 290296-68-3 |  |
| Befiradol | Pierre Fabre | 208110-64-9 |  |
| Befloxatone | Delalande | 134564-82-2 |  |
| Beflubutamid | Ube | 113604-08-7 |  |
| Befunolol | Kakenyaku Kako | 39552-01-7 |  |
| Begacestat | Wyeth | 769169-27-9 |  |
| Belagenpumatucel-L | NovaRx Corporation | | No Structure |
| Belaperidone | BASF (Abbott) | 156862-51-0 |  |
| Belatacept | BMS | 706808-37-9 | No Structure |
| Belerofon (Interferon alpha) | | | No Structure |
| Belfosdil | SynPhar | 103486-79-9 |  |
| Belimumab | Human Genome Sciences | 356547-88-1 | No Structure |
| Belinostat | Prolifix (TopoTarget) | 414864-00-9 |  |
| Beloranib | Chong Kun Dang | |  |
| Belotecan | Chong Kun Dang | 256411-32-2 |  |
| Bemegride | Sumitomo | 64-65-3 |  |
| Bemesetron | HMR (Aventis) | 40796-97-2 |  |
| Bemetizide | Sanol | 1824-52-8 |  |
| Beminafil | Merck KGaA | 566906-50-1 |  |
| Bemoradan | Ortho McNeil (Johnson & Johnson) | 112018-01-6 |  |
| Benalaxyl | Montedison | 71626-11-4 |  |
| Benalaxyl-M | Novartis | 98243-83-5 |  |
| Benalfocin | SmithKline (GSK) | 73943-10-9 |  |
| Benanomicin A | Microbiochemical Research Foundation | 116249-65-1 |  |
| Benazepril | Ciba-Geigy (Novartis) | 86541-75-5 |  |
| Benazolin | Boots (Abbott) | 3813-05-6 |  |
| Bencarbazone | Bayer | 173980-17-1 |  |
| Benclothiaz | Ciba-Geigy (Novartis) | 89583-90-4 |  |
| Bencyclane | Egyt | 2179-37-5 |  |
| Bendamustine | Fujisawa (Astellas) | 16506-27-7 ; 3543-75-7(HCl) |  |
| Bendazac | Angelini | 20187-55-7 |  |
| Bendazol | Medexport | 621-72-7 |  |
| Bendiocarb | Fisons | 22781-23-3 |  |
| Bendroflumethiazide | Lovens ; Squibb & Sons (BMS) | 73-48-3 |  |
| Benexate | Nippon Chemiphar ; Taikoku | 78718-52-2 |  |
| Benfluorex | Science Union ; Soc Franc. Rech. Med. | 23602-78-0 |  |
| Benfluralin | Eli Lilly | 1861-40-1 |  |
| Benfotiamine | Sankyo | 22457-89-2 |  |
| Benfuracarb | Otsuka | 82560-54-1 |  |
| Benfuresate | Fisons | 68505-69-1 |  |
| Bengamide E | University of California; Syntex | 118477-03-5 |  |
| Benidipine | Kyowa Hakko | 105979-17-7 |  |
| Benodanil | BASF | 15310-01-7 |  |
| Benomyl | DuPont | 17804-35-2 |  |
| Benorilate | Sterling Drug (Sanofi-Aventis) | 5003-48-5 |  |
| Benoxacor | Ciba-Geigy (Novartis) | 98730-04-2 |  |
| Benperidol | Janssen Pharmaceutica (Johnson & Johnson) | 2062-84-2 |  |
| Benproperine | Pharmacia | 2156-27-6 |  |
| Benralizumab | AstraZeneca (MedImmune) | 1044511-01-4 | No Structure |
| Benserazide | Hoffmann La Roche (Roche) | 322-35-0 |  |
| Bensuldazic acid | Hoechst (Sanofi-Aventis) | 1219-77-8 |  |
| Bensulfuron | DuPont | 99283-01-9 |  |
| Bensulide | Stauffer | 741-58-2 |  |
| Bensultap | Takeda | 17606-31-4 |  |
| Bentamapimod | Applied Research Systems ARS Holding NV (Netherlands) | 848344-36-5 |  |
| Bentazepam | Made | 29462-18-8 |  |
| Bentazone | BASF | 25057-89-0 |  |
| Benthiavalicarb | Kumiai | 177406-68-7 |  |
| Bentiacide | Pharmascience | 34914-25-5 |  |
| Bentiromide | Rohm & Haas | 37106-97-1 |  |
| Benzalazine | Henning Berlin | |  |
| Benzarone | Labaz | 1477-19-6 |  |
| Benzathine | Beecham (GSK) | 140-28-3 |  |
| Benzathine Benzylpenicillin | Wyeth | 1538-09-6 |  |
| Benzathine Phenoxymethylpenicillin | | 5928-84-7 |  |
| Benzatropine | Merck & Co. | 86-13-5 |  |
| Benzbromarone | Labaz | 3562-84-3 |  |
| Benzethonium chloride | Parke, Davis (Pfizer) | 121-54-0 |  |
| Benzetimide | Janssen Pharmaceutica (Johnson & Johnson) | 119391-55-8 |  |
| Benzfendizone | FMC | 158755-95-4 |  |
| Benzfetamine | Upjohn (Pharmacia) | 156-08-1 |  |
| Benzilonium bromide | Parke, Davis (Pfizer) | 1050-48-2 |  |
| Benziodarone | Labaz | 68-90-6 |  |
| Benznidazole | Hoffmann La Roche (Roche) | 22994-85-0 |  |
| Benzobicyclon | SDS Biotech | 156963-66-5 |  |
| Benzocaine | American Cyanamid | 94-09-7 |  |
| Benzofenap | Mitsubishi Petrochemicals | 82692-44-2 |  |
| Benzonatate | Ciba-Geigy (Novartis) | 104-31-4 |  |
| Benzophenone-6 | American Cyanamid (Wyeth) | 131-54-4 |  |
| Benzopurpurine 4B | IG Farben | 992-59-6 |  |
| Benzotript | | 39544-74-6 |  |
| Benzoximate | Nippon Soda | 29104-30-1 |  |
| Benzoxiquine | Union Carbide | 86-75-9 |  |
| Benzoxonium chloride | Ciba-Geigy (Novartis) | 19379-90-9 |  |
| Benzoyl peroxide | Dermik Laboratories | 94-36-0 |  |
| Benzoylmetronidazole | Oszkar Fuchs | 13182-89-3 |  |
| Benzpiperylon | Sandoz (Novartis) | 53-89-4 |  |
| Benzquercin | Roques | 13157-90-9 |  |
| Benzquinamide | Pfizer | 63-12-7 |  |
| Benzthiazide | Pfizer | 91-33-8 |  |
| Benzthiazuron | Bayer | 1929-88-0 |  |
| Benzydamine | Angelini | 642-72-8 |  |
| Benzyl Aminolevulinate | PhotoCure | |  |
| Benzyl hydroxybenzoate | Beecham (GSK) | 94-18-8 |  |
| Benzyl mandelate | Much | 890-98-2 |  |
| Benzylacyclouridine | Brown University Research | 82857-69-0 |  |
| Benzylguanine | US Health | 19916-73-5 |  |
| Benzylhydrochlorothiazide | Munich Medical Associates (Ugi) | 1824-50-6 |  |
| Benzylthiouracil | Doms-Adrian | 33086-27-0 |  |
| BEP-1 | Massachusetts Institute of Technology | |  |
| BEP-2 | Massachusetts Institute of Technology | |  |
| BEP-3 | Massachusetts Institute of Technology | |  |
| BEP-4 | Massachusetts Institute of Technology | |  |
| BEP-5 | Massachusetts Institute of Technology | |  |
| Beperminogene perplasmid | Vical | 627861-07-8 | No Structure |
| Bephenium hydroxynaphthoate | Burroughs Wellcome (GSK) | 3818-50-6 |  |
| Bepotastine | Ube | 125602-71-3 |  |
| Bepridil | CERM | 64706-54-3 |  |
| Beractant | Tokyo Tanabe | 108778-82-1 | No Structure |
| Beraprost | Toray | 88430-50-6 |  |
| Berberine chloride | Nippon Mektron KK | 633-65-8 |  |
| Berinert | CSL Behring (US) | 80295-38-1 | No Structure |
| Berlafenone | Lipha (E. Merck KGaA) | 18965-97-4 |  |
| Bermoprofen | Dainippon Pharmaceutical | 78499-27-1 |  |
| Bertilimumab | | 375348-49-5 | No Structure |
| Bertosamil | Kali Chemie | 126825-36-3 |  |
| Berubicin | National Inst. of Health (NIH) | 293736-67-1 (HCl) ; \n677017-23-1 |  |
| Besifloxacin | SSP Pharmaceuticals Co. | 405165-61-9 (HCl) ; 141388-76-3 |  |
| Besigomsin | Tsumura | 58546-54-6 |  |
| Besipirdine | Hoechst Roussel (Sanofi-Aventis) | 119257-34-0 |  |
| Besonprodil | CoCensys ; Warner Lambert (Pfizer) | 253450-09-8 |  |
| Beta-alethine | University of New Mexico (US) | 646-08-2 |  |
| Beta-aminopropionitrile | Bio Products Inc. | 151-18-8 |  |
| beta-Amyloid(12-20) | Roskamp Research LLC (US) | |  |
| beta-Boswellic acid | | 631-69-6 |  |
| Beta-CD-chlorsulfuron complex | Nitrokemia | 102123-03-5 |  |
| beta-Cyfluthrin | Bayer | 68359-37-5 |  |
| Beta-cypermethrin | Chinoin Gyogyszer es Vegyszet | |  |
| beta-D-FddC | US Department of Health & Human Services | 107036-62-4 |  |
| beta-Elemene | Jingang Pharmaceutical | 11029-06-4 |  |
| beta-L-FddC | Yale University | 147058-39-7 |  |
| beta-L-FddG | Yale University | 160962-98-1 |  |
| Beta-Lapachone | Dana-Farber Cancer Institute | 4707-32-8 |  |
| beta-Sitosterin | Medipolar | 83-46-5 |  |
| beta-tocotrienol | Malaysian Palm Oil Board | 490-23-3 |  |
| beta1-ECII-25AA | Julius Maximilians Universitat | | No Structure |
| Betacarotene | | 7235-40-7 |  |
| Betadex | Schering | 7585-39-9 |  |
| Betahistine | Unimed | 5638-76-6 |  |
| Betaine aspartate | | 52921-08-1 |  |
| Betamethasone | Merck & Co. | 378-44-9 |  |
| Betamethasone Acetate | Merck & Co. | 987-24-6 |  |
| Betamethasone Benzoate | Warner Lambert (Pfizer) | 22298-29-9 |  |
| Betamethasone Dipropionate | Glaxo (GSK) | 5593-20-4 |  |
| Betamethasone Phosphate | Merck & Co. | 151-73-5 |  |
| Betamethasone Valerate | Glaxo (GSK) | 2152-44-5 |  |
| Betamipron | Sankyo | 3440-28-6 |  |
| Betanidine | Wellcome Foundation (GSK) | 55-73-2 |  |
| Betanin | Wisconsin Alumni Research Foundation | 7659-95-2 |  |
| Betaxolol | Synthelabo (Sanofi-Aventis) | 63659-18-7 ; 63659-19-8(hydrochloride) |  |
| Bethanechol chloride | Merck & Co. | 590-63-6 |  |
| Bethoxazin | Uniroyal | 163269-30-5 |  |
| Betrixaban | Millennium Pharmaceuticals (Takeda) | 330942-05-7 |  |
| Betulinic acid | University of Illinois (US) | 472-15-1 |  |
| Betulonic acid | Cornell Research Foundation | 4481-62-3 |  |
| Bevacizumab | | 216974-75-3 | No Structure |
| Bevantolol | Parke, Davis (Pfizer) | 59170-23-9 |  |
| Bevasiranib | University of Pennsylvania (US) | 959961-96-7 ; 849758-52-7 (Na) | No Structure |
| Bevirimat | Biotech Research Laboratory ; University of North Carolina | 174022-42-5 ; 823821-85-8 (dimeglumine) |  |
| Bevonium Metilsulfate | Gruenenthal | 33371-53-8 |  |
| Bexarotene | Ligand Pharmaceuticals | 153559-49-0 |  |
| Bexlosteride | Eli Lilly | 148905-78-6 |  |
| BEZ-235 | Novartis | 915019-65-7 |  |
| Bezafibrate | Boehringer Mannheim (Roche) | 41859-67-0 |  |
| Bezitramide | Janssen Pharmaceutica (Johnson & Johnson) | 15301-48-1 |  |
| BF-158 | BF Research Institute | |  |
| BF-170 | BF Research Institute | 87003-33-6 |  |
| BF-389 | Biofor | 127245-22-1 |  |
| BFH-772 | | | No Structure |
| BFOV | Kunming Medical College (CN) ; Nankai University | |  |
| BFX-1001 | Bioflexis | |  |
| BFX-1002 | Bioflexis | |  |
| BFX-1003 | Bioflexis | |  |
| BG-12 | | 624-49-7 |  |
| BG-7 | University of Cincinnati | |  |
| BG-8702 | Betagenon AB | | No Structure |
| BGC-20-0134 | BTG International Ltd. (GB) | | No Structure |
| BGC-20-1531 | Asterand plc (GB) | |  |
| BGC-20-761 | Virginia Commonwealth University | |  |
| BGC-945 | BTG International Ltd. (GB) | |  |
| BGJ-398 | | | No Structure |
| BGP-15 | Chinoin | |  |
| BGS-649 | | | No Structure |
| BGT-226 | | | No Structure |
| bH1-44 | Genentech Inc. (US) | | No Structure |
| BHPIV3-SARS-S | NIH (National Institutes of Health) | | No Structure |
| BHQ-880 | Novartis AG (Switzerland) | | No Structure |
| BI-00601447 | Boehringer Ingelheim Pharma | |  |
| BI-11B3 | ViroPharma | |  |
| BI-201 | BioInvent | | No Structure |
| BI-201335 | Boehringer Ingelheim GmbH | 1214735-15-5 |  |
| BI-2536 | Boehringer Ingelheim Pharmaceuticals | |  |
| BI-310 | Boehringer Ingelheim Pharmaceuticals | |  |
| BI-32169 | Boehringer Ingelheim | | No Structure |
| BI-33 | University of Michigan (US) ; Ascenta Therapeutics Inc. (US) | |  |
| BI-505 | BioInvent International AB | | No Structure |
| BI-78D3 | Burnham Institute for Medical Research (US) | 883065-90-5 |  |
| BI-831266 | Boehringer Ingelheim GmbH | |  |
| BI-97C1 | Sanford-Burnham Medical Research Institute (US) | |  |
| bi-shRNA-STMN1 | Gradalis Inc. | | No Structure |
| BIA-10-2474 | BIAL Portela & Ca. SA | | No Structure |
| BIA-2024 | Portela | |  |
| BIA-3-335 | Portela (Laboratorios Bial - Portela) | 359783-06-5 |  |
| BIA-5-1058 | Portela & Ca. SA (Portugal) | |  |
| Biapenem | Lederle (Wyeth) | 120410-24-4 |  |
| Bibenzonium bromide | DuPont (BMS) | 15585-70-3 |  |
| BIBP-3226 | Thomae (Boehringer Ingelheim) | 159013-54-4 |  |
| BIBR-1532 | Boehringer Ingelheim | 321674-73-1 |  |
| Bibrocathol | Chemische Fabrik von Heyden | 6915-57-7 |  |
| BIBS-39 | Thomae (Boehringer Ingelheim) | 133085-33-3 |  |
| Bicalutamide | ICI (AstraZeneca) | 90357-06-5 |  |
| Bicifadine | American Cyanamid (Wyeth) | 71195-57-8 |  |
| Biclotymol | Doms | 15686-33-6 |  |
| Bicyclol | Taisho Pharma (Japan) ; The Institute Of Material Mederia Medica of Chinese Academy of Medical Scien | |  |
| Bicyclopyrone | Syngenta | 352010-68-5 |  |
| BID-BH3 | Dana Farber Cancer Institute | |  |
| Bietamiverine | Nordmark | 479-81-2 |  |
| Bietaserpine | Dautreville & Lebas | 53-18-9 |  |
| Bifemelane | Mitsubishi | 90293-01-9 |  |
| Bifenazate | Uniroyal (US) | 149877-41-8 |  |
| Bifendate | Isukura Sangyo | 73536-69-3 |  |
| Bifenox | Mobil | 42576-02-3 |  |
| Bifenthrin | FMC | 82657-04-3 |  |
| Bifeprunox | Duphar (Solvay) | 350992-10-8 ; 350992-13-1 (mesylate) |  |
| Bifluranol | Biorex | 34633-34-6 |  |
| Bifonazole | Bayer | 60628-96-8 |  |
| BIIB-015 | Biogen Idec Inc. (US) | | No Structure |
| BIIB-021 | Conforma Therapeutics (Biogen Idec) | |  |
| BIIB-022 | Biogen Idec | | No Structure |
| BIIB-033 | Biogen Idec Inc. | | No Structure |
| BIIE-0246 | Boehringer Ingelheim | 246146-55-4 |  |
| BIIF-1149 | BOEHRINGER INGELHEIM | 350610-25-2 |  |
| BILA-2185-BS | Bio Mega ; Boehringer Ingelheim | |  |
| Bilanafos | Meiji Seika Kaisha (Japan) | 35597-43-4 |  |
| Bilastine | Espanola Productos Quimicos (FAES) | 202189-78-4 |  |
| BILD-1263 | Bio Mega ; Boehringer Ingelheim | |  |
| Bilive | Changchun Institute of Biological Products | | No Structure |
| Bilobalide | | 33570-04-6 |  |
| BILR-355-BS | Boehringer Ingelheim | |  |
| BILS-103BS | Boehringer Ingelheim | |  |
| BILS-179BS | Boehringer Ingelheim | |  |
| BIM-23127 | Ipsen | |  |
| BIM-23190 | Biomeasure | 182153-96-4 |  |
| BIM-23268 | Biomeasure | 181650-80-6 |  |
| BIM-23A760 | Ipsen Pharma SAS | 868562-36-1 |  |
| BIM-28131 | Ipsen Pharma SAS | | No Structure |
| BIM-44058 | Ipsen SA (France) | | No Structure |
| BIM-46068 | Biomeasure | 201487-53-8 |  |
| BIM-46174 | Beaufour Ipsen (S.C.R.A.S) | |  |
| BIM-46187 | Ipsen S.A. (France) | |  |
| BIM-BH3 | Dana Farber Cancer Institute | |  |
| Bimakalim | E. Merck KGaA | 117545-11-6 |  |
| Bimatoprost | Allergan | 155206-00-1 |  |
| Bimoclomol | Biorex | 130493-03-7 |  |
| Bimosiamose | Texas Biotechnology (Encysive Pharmaceuticals) | 187269-40-5 |  |
| Binapacryl | Hoechst (Sanofi-Aventis) | 485-31-4 |  |
| Bindarit | Acraf (Angelini) | 130641-38-2 |  |
| Binetrakin | Schering Corp (Merck & Co) | 207137-56-2 |  |
| Binfloxacin | Pfizer | 108437-28-1 |  |
| Binifibrate | Sociedad Espanola de Especialidades Farmaco-Terapeuticas | 69047-39-8 |  |
| Binodenoson | Whitby Research (Aderis) | 144348-08-3 |  |
| Binospirone | Merrell Dow (Aventis) | 102908-59-8 |  |
| BIO-013529 | Biogen | |  |
| BIO-030 | Bioaccelerate | | No Structure |
| BIO-300 | | | No Structure |
| BIO-5192 | Biogen | |  |
| Biomed-101 | Searle (Pfizer) | 120072-59-5 |  |
| Bioresmethrin | National Research Development Corporation (NRDC) | 28434-01-7 |  |
| Biotin | Hoffmann La Roche (Roche) | 58-85-5 |  |
| BiovaxID | Accentia | | No Structure |
| Bioxalomycin alpha 2 | American Cyanamid (Wyeth) | 157207-83-5 |  |
| Biperiden | Knoll (Abbott) | 514-65-8 |  |
| Biphenyline | Camerino University | |  |
| Biricodar | Vertex Pharmaceuticals | 159997-94-1 |  |
| Biriperone | Council Scient Ind Res | 41510-23-0 |  |
| BIRT-0377 | Boehringer Ingelheim | 213211-10-0 |  |
| Bisacodyl | Thomae (Boehringer Ingelheim) | 603-50-9 |  |
| Bisantrene | American Cyanamid (Wyeth) | 78186-34-2 |  |
| Bisaramil | Gedeon Richter | 89194-77-4 |  |
| Bisdemethoxycurcumin | Sami Chemicals & Extracts Ltd., (India) | 24939-16-0 |  |
| Bisdequalinium diacetate | Allen & Hanburys | 3785-44-2 |  |
| Bisdisulizole | | 180898-37-7 (disodium salt) |  |
| Bisnafide | DuPont Merck (BMS) | 144849-63-8 |  |
| Bisoprolol | E. Merck KGaA | 66722-44-9 |  |
| Bisoprolol PM | Biovail Laboratories Inc. (Valeant Pharmaceuticals International Inc.) | 66722-44-9 |  |
| Bisoxatin | Thomae (Boehringer Ingelheim) | 17692-24-9 |  |
| Bisoxatin acetate | Thomae (Boehringer Ingelheim) | 14008-48-1 ; |  |
| Bispyribac sodium | Kumiai | 125401-92-5 |  |
| Bisthiosemi | Nippon Kayaku | 39603-48-0 |  |
| Bistrifluron | Dongbu Hannong Chemical : Hanwha Corp (Korea) | 201593-84-2 |  |
| Bisulepin | Ortho McNeil (Johnson & Johnson) | 5802-61-9 |  |
| BIT-225 | Biotron | |  |
| Bitertanol | Bayer | 55179-31-2 |  |
| Bithionol | IG Farben | 97-18-7 |  |
| Bitistatin | Cor Therapeutics | 124123-27-9 |  |
| Bitolterol | Sterling Winthrop (Sanofi-Aventis) | 30392-40-6 |  |
| Bivalirudin | Biogen Idec ; Health Research | 128270-60-0 |  |
| Bivatuzumab | | 214559-60-1 | No Structure |
| Bivatuzumab mertansine | Boehringer Ingelheim ; Immunogen | |  |
| BIW-8962 | Kyowa Hakko Kogyo Co. Ltd. (Kyowa Hakko Kirin Co. Ltd.) | | No Structure |
| BIWH-3 | Boehringer Ingelheim International GmbH | | No Structure |
| BIX-02188 | Boehringer Ingelheim GmbH | 1094614-84-2 |  |
| Bixafen | Bayer Cropscience | 581809-46-3 |  |
| Bixalomer | Ilypsa | 851373-13-2 |  |
| Bizelesin | Upjohn (Pharmacia) | 129655-21-6 |  |
| BK-35 | Lek Pharmaceuticals | |  |
| BKM-1740 | University of Colorado (US) | |  |
| BKM-570 | The university of Colorado (US) | |  |
| BL-1020 | Ramot ; Bar-Ilan | |  |
| BL-1021 | Ramot at Tel Aviv University Ltd. ; Bar-Ilan University | |  |
| BL-1040 | Univ. Ben Gurion | | No Structure |
| BL-11282 | Eli Lilly | 227798-41-6 |  |
| BL-1249 | Bristol-Myers Squibb (BMS) | |  |
| BL-1280 | Buckman Laboratories | 21564-17-0 |  |
| BL-2401 | Dainippon | 151774-56-0 |  |
| BL-3730 | Dainippon Pharmaceutical | |  |
| BL-4027 | Dainippon Pharmaceutical | |  |
| BL-5160 | Dainippon Pharmaceutical | |  |
| Bleomycin | Zaidan Hojin Biseibutsu | 11116-31-7 |  |
| BLI-489 | Wyeth Corp. (US) | |  |
| Blinatumomab | Micromet ; MedImmune Inc. | 853426-35-4 | No Structure |
| Blonanserin | Dainippon Pharmaceutical (Dainippon Sumitomo Pharma: Japan) | 132810-10-7 |  |
| BLP-25 | Imperial Cancer Research Technology | 209973-83-1 |  |
| BLX-155 | Biolex Therapeutics Inc. | | No Structure |
| BLX-301 | Biolex Inc. (US) | | No Structure |
| BLZ-945 | Novartis AG | |  |
| BM-0 | University of Otago, New Zealand | |  |
| BM-113 | Meram | 276255-84-6 |  |
| BM-121247 | | 160791-62-8 |  |
| BM-152054 | Bethesda Pharmaceuticals | 213411-84-8 |  |
| BM-170744 | Roche | 221564-97-2 |  |
| BM-2 | University of Otago, New Zealand | |  |
| BM-212 | University of Cagliari | |  |
| BM-27 | Adir | 143214-66-8 |  |
| BM-531 | University of Liege | 284464-46-6 |  |
| BM-567 | University of Liege | 284464-77-3 |  |
| BM-573 | University of Liege ; University of Namur | |  |
| BM-613 | University of Liege | |  |
| BMEC-1217B | Industrial Technology and Research Institute (Taiwan) | | No Structure |
| BMN-103 | BioMarin Pharmaceutical Inc. | | No Structure |
| BMN-110 | BioMarin Pharmaceutical Inc. | | No Structure |
| BMN-111 | BioMarin Pharmaceutical Inc. | | No Structure |
| BMN-168 | BioMarin Pharmaceutical Inc. | |  |
| BMN-185 | BioMarin Pharmaceutical Inc. | | No Structure |
| BMN-673 | | | No Structure |
| BMN-701 | Zystor Therapeutics Inc. (BioMarin Pharmaceutical Inc.) | | No Structure |
| BMP-655 | Wyeth Corp. (Pfizer Inc.) | | No Structure |
| BMP-7 | Curis Inc. (US) | | No Structure |
| BMS-066 | Bristol-Myers Squibb Co. | |  |
| BMS-180431 | Bristol Myers (BMS) | 129829-03-4 |  |
| BMS-180448 | Squibb (BMS) | 144264-47-1 |  |
| BMS-180560 | Squibb (BMS) | 142999-90-4 |  |
| BMS-181100 | Bristol-Myers Squibb (BMS) | 105565-56-8 |  |
| BMS-181101 | Bristol-Myers Squibb (BMS) | 141071-67-2 |  |
| BMS-181139 | Bristol-Myers Squibb (BMS) | 135918-08-0 |  |
| BMS-181162 | Bristol-Myers Squibb (BMS) | 141948-79-0 |  |
| BMS-181184 | Bristol-Myers Squibb (BMS) | 139272-69-8 |  |
| BMS-181885 | Bristol-Myers Squibb (BMS) | 164250-47-5 |  |
| BMS-182657 | Fujisawa ; Squibb (BMS) | 160135-56-8 |  |
| BMS-182874 | Squibb (BMS) | 153042-42-3 |  |
| BMS-184476 | Bristol-Myers Squibb (BMS) | 160237-25-2 |  |
| BMS-185411 | Bristol-Myers Squibb (BMS) | |  |
| BMS-186318 | Squibb (BMS) | 161302-40-5 |  |
| BMS-187413 | Bristol-Myers Squibb (BMS) | 193480-75-0 |  |
| BMS-188107 | Squibb (BMS) | 139232-80-7 |  |
| BMS-188494 | Squibb (BMS) | 191866-32-7 |  |
| BMS-188797 | Bristol-Myers Squibb (BMS) | 172481-83-3 |  |
| BMS-189090 | BMS | |  |
| BMS-189664 | BMS | |  |
| BMS-190394 | Bristol-Myers Squibb (BMS) | |  |
| BMS-1906085 | BMS | |  |
| BMS-191095 | Bristol-Myers Squibb (BMS) | 166095-21-2 |  |
| BMS-193269 | Bristol-Myers Squibb (BMS) | |  |
| BMS-193884 | Bristol-Myers Squibb (BMS) | 176960-47-4 |  |
| BMS-193885 | Bristol-Myers Squibb (BMS) | |  |
| BMS-194449 | Bristol-Myers Squibb (BMS) | 170686-12-1 |  |
| BMS-196085 | Bristol-Myers Squibb (BMS) | 170686-10-9 |  |
| BMS-201620 | BMS | |  |
| BMS-205749 | Bristol-Myers Squibb (BMS) | |  |
| BMS-208782 | Bristol-Myers Squibb (BMS) | 212380-81-9 |  |
| BMS-208783 | Bristol-Myers Squibb (BMS) | 212380-82-0 |  |
| BMS-210285 | Bristol-Myers Squibb (BMS) | 344607-69-8 |  |
| BMS-212122 | Bristol-Myers Squibb (BMS) | |  |
| BMS-214662 | Bristol-Myers Squibb (BMS) | 195987-41-8 |  |
| BMS-229724 | Bristol Myers Squibb (BMS) | 221914-85-8 |  |
| BMS-233866 | Bristol-Myers Squibb (BMS) | 228406-87-9 |  |
| BMS-243117 | BMS | |  |
| BMS-247243 | Bristol-Myers Squibb (BMS) | 307316-55-8 |  |
| BMS-250749 | Bristol-Myers Squibb (BMS) | |  |
| BMS-251873 | Bristol-Myers Squibb (BMS) | |  |
| BMS-262084 | Bristol-Myers Squibb (BMS) | |  |
| BMS-265246 | Bristol-Myers Squibb (BMS) | 227617-06-3 |  |
| BMS-269223 | Bristol-Myers Squibb Co. | |  |
| BMS-275183 | Bristol-Myers Squibb (BMS) | |  |
| BMS-279700 | BMS (Bristol-Myers Squibb) | |  |
| BMS-281384 | Pfizer | |  |
| BMS-284640 | Bristol-Myers Squibb (BMS) | 230640-88-7 |  |
| BMS-285047 | BMS (Bristol-Myers Squibb) | |  |
| BMS-286309 | Research Triangle Institute ; Squibb Bristol Myers (BMS) | |  |
| BMS-292655 | Bristol-Myers Squibb (BMS) | |  |
| BMS-309403 | Bristol-Myers Squibb (BMS) | |  |
| BMS-310705 | Biotechnologie Forschung ; Bristol-Myers Squibb (BMS) | |  |
| BMS-316810 | Bristol-Myers Squibb (BMS) | 660843-57-2 |  |
| BMS-317180 | Bristol-Myers Squibb (BMS) | |  |
| BMS-337197 | Bristol-Myers Squibb (BMS) | |  |
| BMS-340278 | Toyama Chemical Co Ltd. (Japan) | |  |
| BMS-340280 | Toyama Chemical Co Ltd. (Japan) | |  |
| BMS-340281 | Toyama Chemical Co Ltd. (Japan) | |  |
| BMS-341400 | BMS | |  |
| BMS-344577 | Bristol-Myers Squibb Co. | |  |
| BMS-345541 | Bristol-Myers Squibb (BMS) | |  |
| BMS-347070 | Bristol-Myers Squibb (BMS) | 197438-48-5 |  |
| BMS-350751 | BMS | |  |
| BMS-354326 | Bristol-Myers Squibb (BMS) | |  |
| BMS-355249 | Bristol-Myers Squibb (BMS) | |  |
| BMS-356188 | BMS (Bristol-Myers Squibb) | |  |
| BMS-357075 | Bristol-Myers Squibb (BMS) | |  |
| BMS-357597 | Bristol-Myers Squibb (BMS) | |  |
| BMS-363131 | Bristol-Myers Squibb (BMS) | |  |
| BMS-378806 | BMS | |  |
| BMS-379224 | Bristol-Myers Squibb (BMS) | 351227-64-0 |  |
| BMS-386914 | Bristol-Myers Squibb Pharmaceutical | |  |
| BMS-388891 | Bristol-Myers Squibb (BMS) | |  |
| BMS-394136 | Bristol-Myers Squibb (BMS) | |  |
| BMS-411886 | Bristol-Myers Squibb (BMS) | |  |
| BMS-419437 | Bristol-Myers Squibb (BMS) | |  |
| BMS-422461 | Research Triangle Institute ; Squibb Bristol Myers (BMS) | |  |
| BMS-433366 | Toyama Chemical Co Ltd. (Japan) | |  |
| BMS-433771 | BMS (Bristol-Myers Squibb) | 380603-10-1 |  |
| BMS-433796 | Bristol-Myers Squibb (BMS) | |  |
| BMS-469458 | BMS | |  |
| BMS-480404 | Squibb Bristol Myers (BMS) | |  |
| BMS-482404 | Bristol-Myers Squibb (BMS) | |  |
| BMS-488043 | | | No Structure |
| BMS-488078 | Bristol-Myers Squibb | |  |
| BMS-488516 | BMS (Bristol-Myers Squibb) | |  |
| BMS-503519 | Bristol-Myers Squibb (BMS) | |  |
| BMS-505130 | BMS (Bristol-Myers Squibb) | |  |
| BMS-505321 | Bristol-Myers Squibb (BMS) | |  |
| BMS-509701 | Bristol Myers Squibb (BMS) | |  |
| BMS-509744 | BMS (Bristol-Myers Squibb) | |  |
| BMS-536924 | BMS | |  |
| BMS-538158 | Bristol-Myers Squibb Co. (US) | |  |
| BMS-554216 | Bristol-Myers Squibb | |  |
| BMS-561388 | Bristol-Myers Squibb Co. (US) | |  |
| BMS-566419 | Bristol-Myers Squibb (BMS) | |  |
| BMS-568274 | Bristol-Myers Squibb | |  |
| BMS-570520 | Bristol-Myers Squibb (BMS) | |  |
| BMS-585548 | BMS | |  |
| BMS-587101 | Bristol-Myers Squibb (BMS) | |  |
| BMS-591305 | Bristol-Myers Squibb (BMS) | |  |
| BMS-593214 | Bristol Myers Squibb (BSM) | |  |
| BMS-594726 | Bristol Myers Squibb (BMS) | |  |
| BMS-595338 | Bristol Myers Squibb (BMS) | |  |
| BMS-599626 | Bristol-Myers Squibb (BMS) | |  |
| BMS-605541 | Bristol-Myers Squibb (BMS) | |  |
| BMS-606056 | Bristol-Myers Squibb (BMS) | |  |
| BMS-639623 | Bristol-Myers Squibb (BMS) | |  |
| BMS-640994 | Bristol-Myers Squibb (BMS) | |  |
| BMS-641988 | Bristol-Myers Squibb (BMS) | |  |
| BMS-644950 | Bristol-Myers Squibb (BMS) | |  |
| BMS-645737 | Bristol-Myers Squibb (BMS) | |  |
| BMS-650032 | Bristol-Myers Squibb Co. | |  |
| BMS-665139 | Bristol-Myers Squibb (BMS) | |  |
| BMS-673675 | Squibb Bristol Myers (BMS) | |  |
| BMS-687453 | Bristol-Myers Squibb (BMS) | |  |
| BMS-688521 | Bristol-Myers Squibb Co. ; Cerep SA | |  |
| BMS-690514 | Bristol-Myers Squibb (BMS) | |  |
| BMS-690858 | Bristol-Myers Squibb (BMS) | |  |
| BMS-691648 | Bristol-Myers Squibb (BMS) | |  |
| BMS-694153 | Bristol-Myers Squibb (BMS) | |  |
| BMS-695735 | Bristol-Myers Squibb (BMS) | |  |
| BMS-711939 | Bristol-Myers Squibb (BMS) | |  |
| BMS-727740 | Bristol-Myers Squibb Co. | |  |
| BMS-739562 | Bristol-Myers Squibb (BMS) | |  |
| BMS-740808 | Bristol-Myers Squibb (BMS) | |  |
| BMS-743816 | Bristol-Myers Squibb (BMS) | |  |
| BMS-747158-02 | Bristol-Myers Squibb Medical Imaging (BMS) ; Lantheus Medical Imaging | |  |
| BMS-754807 | Bristol-Myers Squibb Co. (US) | |  |
| BMS-759509 | Bristol-Myers Squibb Co. (US) | |  |
| BMS-764459 | Bristol-Myers Squibb Co. (US) | |  |
| BMS-777607 | Bristol-Myers Squibb (BMS) | |  |
| BMS-779333 | Bristol-Myers Squibb Co. | |  |
| BMS-790052 | Bristol-Myers Squibb Co. | 1214735-16-6 |  |
| BMS-791325 | Bristol-Myers Squibb Co. | |  |
| BMS-794833 | Bristol-Myers Squibb Co. | 1174046-72-0 |  |
| BMS-806 | BMS | |  |
| BMS-812204 | Bristol-Myers Squibb Co. (US) | |  |
| BMS-817378 | Bristol-Myers Squibb Co. | |  |
| BMS-856 | Bristol-Myers Squibb (BMS) | |  |
| BMS-906024 | | | No Structure |
| BMS-PCSK9Rx | Isis Pharmaceuticals Inc. | | No Structure |
| BMY-20014 | Alcon | 100305-61-1 |  |
| BMY-20844 | Bristol-Myers Squibb (BMS) | 124886-01-7 |  |
| BMY-21502 | Bristol-Myers Squibb (BMS) | 123259-91-6 |  |
| BMY-25174 | Bristol Myers (BMS) | 91615-54-2 |  |
| BMY-28232 | Bristol-Myers Squibb (BMS) | 107888-46-0 |  |
| BMY-28271 | Bristol-Myers Squibb (BMS) | 107888-50-6 |  |
| BMY-33462 | Bristol Myers (BMS) | |  |
| BMY-40062 | Bristol-Myers Squibb (BMS) | 116143-32-9 |  |
| BMY-40068 | Bristol-Myers Squibb (BMS) | 116163-01-0 |  |
| BMY-41802 | Bristol-Myers Squibb (BMS) | |  |
| BMY-41889 | Bristol-Myers Squibb (BMS) | |  |
| BMY-42393 | Bristol-Myers Squibb (BMS) | 136451-58-6 |  |
| BMY-43748 | Bristol-Myers Squibb (BMS) | 132195-14-6 |  |
| BMY-44621 | Bristol-Myers Squibb (BMS) | 146763-81-7 |  |
| BMY-7378 | Mead Johnson | 21102-94-3 |  |
| BN-50548 | Scras | 123791-21-9 |  |
| BN-50739 | Beaufour Ipsen (S.C.R.A.S) | 128672-07-1 |  |
| BN-52205 | SCRAS (Beaufour Ipsen) | 136533-71-6 |  |
| BN-52207 | SCRAS (Beaufour Ipsen) | 136533-80-7 |  |
| BN-52211 | SCRAS (Beaufour Ipsen) | 136533-74-9 |  |
| BN-80245 | SCRAS (Beaufour Ipsen) | 186668-40-6 |  |
| BN-80933 | Soc. Conseils Rech. App. Sci. | 214348-10-4 |  |
| BN-82002 | SCRAS (Societé de Conseils de Recherches et d'Applications Scientifiques) | |  |
| BN-82204 | Beaufour Ipsen (S.C.R.A.S) | |  |
| BN-82270 | Beaufour Ipsen (S.C.R.A.S) | |  |
| BN-82685 | IPSEN, Institut Henri Beaufour, ( France) | |  |
| BN-83010 | Beaufour Ipsen (S.C.R.A.S) | |  |
| BN-83026 | Ipsen-S.C.R.A.S. | |  |
| BN-83253 | Cambridge University | |  |
| BNC-105 | Bionomics | |  |
| BNC-105P | Bionomics Ltd. (Australia) | |  |
| BND-11624 | | | No Structure |
| BNE-02 | Instytut Biochemii i Biofizyki (Poland) ; Institut Nationale de la Sante et de la Recherche Medicale | |  |
| BO-0742 | Sloan-Kettering institute for Cancer research; Academia Sinica | |  |
| BO-0944 | Academia Sinica ; Memorial Sloan-Kettering Cancer Center ; Universty of Medicine and Dentistry New J | |  |
| BO-1062 | Academia Sinica (Taiwan) | |  |
| (+)-BO-2367 (dextro) | Banyu | 145902-82-5 |  |
| (-)-BO-2367 (levo) | Banyu | 145902-81-4 |  |
| BO-653 | Chugai (Roche) | 157360-23-1 |  |
| Boanmycin | Medical Biolog Technology | 37293-17-7 |  |
| Boc-ET-729 | University of Illinois | 246024-57-7 |  |
| Boc-lysinated betulonic acid | Cornell Research Foundation | |  |
| Boceprevir | Schering Corp (Merck & Co) | 394730-60-0 |  |
| Boldenone Undecylenate | E. Merck KGaA | 13103-34-9 |  |
| Bomyl | Allied Chemicals | 122-10-1 |  |
| Boostrix | GlaxoSmithKline (GSK) | | No Structure |
| Bopindolol | Sandoz (Novartis) | 62658-63-3 |  |
| BOPP | University of California | 132701-58-7 |  |
| Bornaprine | Knoll (Abbott) | 20448-86-6 |  |
| Bornyl salicylate | Mack Pharma | 560-88-3 |  |
| Bortezomib | Proscript (LeukoSite) | 179324-69-7 |  |
| Boscalid | BASF | 188425-85-6 |  |
| Bosentan | Roche | 147536-97-8 |  |
| Bosutinib | American Cyanamid (Wyeth) | 380843-75-4 |  |
| Botulinum Toxin Type B | | | No Structure |
| BP-1003 | | |  |
| BP-102 | Trine Pharmaceuticals | |  |
| BP-107 | Bethesda Pharmaceuticals | |  |
| BP-294 | Bioprojet ; INSERM | 139191-80-3 |  |
| BP-747 | University of Perugia (Italy) ; University of Padova (Italy) ; Istituto di Ricovero e Cura a Caratte | | No Structure |
| BP-897 | INSERM ; Bioprojet | 314776-92-6 |  |
| BP1-01 | Genentech | |  |
| (-)-BPAP | Fujimoto | |  |
| BPD-1 | Merck & Co. Inc. | |  |
| BPDZ-154 | Novo Nordisk | |  |
| BPDZ-259 | Novo Nordisk | |  |
| BPDZ-44 | Novo Nordisk | 152382-67-7 |  |
| BPDZ-73 | Novo Nordisk | 152382-67-7 |  |
| BPDZ-79 | Novo Nordisk | 152382-67-7 |  |
| BPDZ-83 | University of Bruxelles ; University of Liege | |  |
| BPHA | Shionogi | |  |
| BPI-3006 | Beida Medicine Dev Shanghai Co, China ; Zhejiang Beta Pharma, China | |  |
| BPI-702001 | Beta Pharma Inc. | | No Structure |
| BPI-703010 | Beta Pharma Inc. | | No Structure |
| BPI-704001 | Beta Pharma Inc. | | No Structure |
| BPI-705001 | Beta Pharma Inc. | | No Structure |
| BPI-711001 | Beta Pharma Inc. | | No Structure |
| BPI-712001 | Beta Pharma Inc. | | No Structure |
| BPI-713001 | Beta Pharma Inc. | | No Structure |
| bPiDDB | University of Kentucky | |  |
| BPIPP | University of Texas Health Science Center (US) | |  |
| BPR-0L-075 | National Health Research Institutes Taipei | |  |
| BPR-0Y-007 | National Health Research Institutes (Taipei) | |  |
| BPR-1-D | National Health Research Institutes (Taiwan) | |  |
| BPR-1-K-0648 | National Health Research Institutes (Taiwan) | |  |
| BPR-890 | National Health Research Institutes (Taiwan) | |  |
| BPROZ-194 | National Health Research Institutes (Taiwan) | |  |
| BPZE-1 | Institut Pasteur de Lille (France) ; Institut National de la Santé et de la Recherche Médicale (Fran | | No Structure |
| BQ-123 | Banyu | 136553-81-6 |  |
| BQ-485 | Banyu | 141594-26-5 |  |
| BQ-518 | Banyu | 136553-74-7 |  |
| BQ-610 | Banyu Pharmaceutical | 141595-53-1 |  |
| BQ-788 | Banyu | |  |
| BQS-481 | | | No Structure |
| BR-14 | Bracco | 461387-88-2 | No Structure |
| BR-3-FC | | | No Structure |
| BrA-1-Bt | Harvard Medical School and Brigham and Women's Hospital; University of Tennessee | |  |
| BRACO-19 | Institute of Cancer Research | |  |
| Brasilinolide A | Higeta Shoyu | 179041-27-1 |  |
| Brasofensine | NeuroSearch | 171655-91-7 |  |
| Brecanavir | Vertex | 313682-08-5 |  |
| Brefeldin A | ZymoGenetics | 20350-15-6 |  |
| Breflate | US Army ; Starks | 174305-65-8 |  |
| Bremelanotide | Competitive Technologies | 189691-06-3 |  |
| Brentuximab vedotin | Seattle Genetics | 914088-09-8 | No Structure |
| Brequinar | DuPont (BMS) | 96187-53-0 |  |
| Bretylium tosilate | Burroughs Wellcome (GSK) | 61-75-6 |  |
| BrevaRex | Altarex (ViRexx Medical Corp.) | | No Structure |
| Briakinumab | Abbott | 339308-60-0 | No Structure |
| Brifentanil | Anaquest | 101345-71-5 |  |
| Brilliant Green | BASF | 633-03-4 |  |
| Brimonidine | Pfizer | 59803-98-4 |  |
| Brinazarone | Sanofi (Sanofi-Aventis) | 89622-90-2 |  |
| Brinzolamide | Alcon | 138890-62-7 |  |
| Brinzolamide & Timolol | Alcon Laboratories Inc. (US) | 138890-62-7 (Brinzolamide) ; 26839-75-8 (Timolol) |  |
| Briobacept | Genentech | 869881-54-9 | No Structure |
| Brivanib | Bristol-Myers Squibb (BMS) | 649735-46-6 |  |
| Brivanib alaninate | Bristol-Myers Squibb (BMS) | 649735-63-7 |  |
| Brivaracetam | UCB | 357336-20-0 |  |
| Brivudine | University of Birmingham ; Stichting Rega | 69304-47-8 |  |
| BRL-32872 | Beecham (GSK) | 113241-47-7 (HCl) |  |
| BRL-37344 | Beecham (GSK) | 114333-71-0 |  |
| BRL-44154 | Beecham (GSK) | 110717-44-7 |  |
| BRL-44385 | Beecham (GSK) | 114778-60-8 |  |
| BRL-44408 | Beecham (GSK) | 118343-19-4 |  |
| BRL-48962 | Beecham (GSK) | |  |
| BRL-49074 | Beecham (GSK) | |  |
| BRL-50481 | Smithkline Beecham | 433695-36-4 |  |
| BRL-52656 | SmithKline Beecham (GSK) | |  |
| BRL-53114 | SmithKline Beecham (GSK) | |  |
| BRL-54443 | | |  |
| BRL-55792 | Beecham (GSK) | 133884-41-0 |  |
| BRL-55834 | Beecham (GSK) | 131899-25-7 |  |
| BRL-56173 | Beecham (GSK) | |  |
| BRL-56905 | SmithKline Beecham (GSK) | |  |
| Brodifacoum | Ward, Blenkinsop | 56073-10-0 |  |
| Brodimoprim | Hoffmann La Roche (Roche) | 56518-41-3 |  |
| Brofenprox - Halfenprox | Mitsui | 111872-58-3 |  |
| Bromacil | DuPont | 314-40-9 |  |
| Bromadiolone | Lipha (E. Merck KGaA) | 28772-56-7 |  |
| Bromamide | Chugai (Roche) | 332-69-4 |  |
| Bromazepam | Hoffmann La Roche (Roche) | 1812-30-2 |  |
| Bromchlorenone | Trommsdorff | 5579-85-1 |  |
| Bromerguride | Synthelabo (Sanofi-Aventis) | 83455-48-5 |  |
| Bromethalin | Eli Lilly | 63333-35-7 |  |
| Bromfenac | Robins | 91714-94-2 |  |
| Bromhexine | Thomae (Boehringer Ingelheim) | 3572-43-8 |  |
| Bromisoval | Knoll (Abbott) | 496-67-3 |  |
| Bromobutide | Sumitomo Chemical | 74712-19-9 |  |
| Bromocriptine | Sandoz (Novartis) | 25614-03-3 ; 22260-51-1 (mesilate) |  |
| Bromodiphenhydramine | Parke, Davis (Pfizer) | 118-23-0 |  |
| Bromofenoxim | Ciba-Geigy (Novartis) | 13181-17-4 |  |
| Bromohydrin | | |  |
| Bromophos ethyl | Boehringer Ingelheim | 4824-78-6 |  |
| Bromophos methyl | Boehringer Ingelheim | 2104-96-3 |  |
| Bromopride | Delagrange ((Sanofi-Aventis) | 4093-35-0 |  |
| Bromopropylate | Ciba-Geigy (Novartis) | 18181-80-1 |  |
| Bromosalicylchloranilide | Knoll (Abbott) | 3679-64-9 |  |
| Bromoxanide | Ferro | 41113-86-4 |  |
| Bromoxynil | May & Baker (Aventis) | 1689-84-5 |  |
| Bromperidol | Janssen Pharmaceutica (Johnson & Johnson) | 10457-90-6 |  |
| Brompheniramine | Schering Corp (Merck & Co) | 86-22-6 |  |
| Brompyrazon | Hartmann | 3042-84-0 |  |
| Bromuconazole | Rhone-Poulenc | 116255-48-2 |  |
| Bronopol | Boots (Abbott) | 52-51-7 |  |
| Broparestrol | La Roche Navarron | 479-68-5 |  |
| Bropirimine | Egyt | 56741-95-8 |  |
| Brostallicin | Pharmacia (Pfizer) | 203258-60-0 |  |
| Brotianide | Bayer | 23233-88-7 |  |
| Brotizolam | Boehringer Ingelheim | 57801-81-7 |  |
| Brovanexine | Uriach | 54340-61-3 |  |
| Brovincamine | Sandoz (Novartis) | 57475-17-9 |  |
| Broxaterol | Zambon | 76596-57-1 |  |
| Broxuridine | Neopharm | 59-14-3 |  |
| Broxyquinoline | Kalk Chemische Fabrik | 521-74-4 |  |
| Bryostatin-1 | University of Arizona | 83314-01-6 |  |
| BS-0160 | Dainippon Pharmaceutical | |  |
| BS-1417 | Dainippon Pharmaceutical | |  |
| BSB | University of Pennsylvania | 291766-06-8 |  |
| BSC-2118 | | |  |
| BSF-201640 | BASF | 441351-24-2 |  |
| BSF-208791 | KNOLL(Abbott) | 329748-62-1 |  |
| BSF-302146 | BASF (Abbott ) | 318472-14-9 |  |
| BSK-714 | BioSeek ; University of California | |  |
| BST-4944 | BioStratum | |  |
| BST-4996 | BioStratum | |  |
| BST-4997 | BioStratum | |  |
| BST-605 | BioStratum Inc. (US) | |  |
| BSU-1051 | University of Texas | 167319-61-1 |  |
| BT-201 | Oscotec Inc. (South Korea) | | No Structure |
| BTA-188 | Biota | 330600-86-7 |  |
| BTA-798 | Biota Holdings Ltd. | |  |
| BTA-9881 | Biota | |  |
| BTA-EG4 | University of California (US) | |  |
| BTA-EG6 | University of California (US) | |  |
| BTB-07897 | Otsuka Pharmaceuticals | |  |
| BTB-09702 | Otsuka Pharmaceuticals | |  |
| BTCRB | University of Michigan ; University of Erlangen | |  |
| BTG-1640 | BTG International Ltd. (GB) | |  |
| BTS-1 | Univ. Navarra Publica | |  |
| BTS-2 | Purdue University ; Universidad Publica de Navarra | |  |
| BTS-67582 | Boots (Abbott) | 161748-40-9 |  |
| BTS-71091 | Boots (Abbott) | 158720-69-5 |  |
| BTS-71321 | Boots (Abbott) | 151945-64-1 |  |
| BTS-73947 | Boots (Abbott) | 151154-01-7 |  |
| BTS-74398 | Knoll (Abbott) | |  |
| BTS-79018 | Knoll (Abbott) | 170353-17-0 |  |
| BTT-3001 | Biotie Therapies | |  |
| BTZ-043 | Leibniz Institute for Natural Product Research and Infection Biology (Germany) | 1161233-85-7 |  |
| BU-224 | Melbourne University | 187173-05-3 |  |
| BU-4601A | BMS | 148915-76-8 |  |
| BU-E-75 | Heumann | 114667-74-2 |  |
| BU-E-76 | Heumann | 114667-79-7 |  |
| Bucetin | Daiichi | 1083-57-4 |  |
| Bucillamine | Santen | 65002-17-7 |  |
| Bucindolol | Bristol Myers (BMS) | 71119-11-4 |  |
| Bucladesine | Daiichi | 362-74-3 |  |
| Buclizine | UCB | 82-95-1 |  |
| Buclosamide | Hoechst (Sanofi-Aventis) | 575-74-6 |  |
| Bucolome | Takeda | 841-73-6 |  |
| Bucumolol | Sankyo | 58409-59-9 |  |
| Budesonide | Bofors | 51333-22-3 |  |
| Budesonide & Formoterol Easyhaler | Orion Corp. | 51333-22-3 (Budesonide) ; 73573-87-2 (Formoterol) |  |
| Budiodarone | Aryx Therapeutics | 478941-93-4 (tartrate salt) ; 335148-45-3 |  |
| Budipine | Byk Gulden (Nycomed) | 57982-78-2 |  |
| Budralazine | Daiichi | 36798-79-5 |  |
| Bufetolol | Yoshitomi | 53684-49-4 |  |
| Bufexamac | Madan | 2438-72-4 |  |
| Buflomedil | Orsymonde (Cephalon) | 55837-25-7 |  |
| Bulaquine | CDRI (Central Drug Research Institute of India) ; Nicholas Piramal India Ltd | 223661-25-4 |  |
| Bumadizone | Ciba-Geigy (Novartis) | 3583-64-0 |  |
| Bumetanide | Loevens | 28395-03-1 |  |
| Bumetrizole | Ciba-Geigy (Novartis) | 3896-11-5 |  |
| Buminafos | VEB Chemiekombinat Bitterfeld | 51249-05-9 |  |
| Bunaftine | Malesci | 32421-46-8 |  |
| Bunamidine | Burroughs Wellcome (GSK) | 3748-77-4 |  |
| Bunaprolast | Upjohn (Pharmacia) | 99107-52-5 |  |
| Bunazosin | Eisai | 80755-51-7 |  |
| Bunitrolol | Boehringer Ingelheim | 34915-68-9 |  |
| Buparvaquone | Wellcome Foundation (GSK) | 88426-33-9 |  |
| Buphenine | Troponwerke | 447-41-6 |  |
| Bupirimate | ICI (Syngenta) | 41483-43-6 |  |
| Bupivacaine | Bofors | 2180-92-9 |  |
| Bupranolol | Sanol | 14556-46-8 |  |
| Buprenorphine | Reckitt | 52485-79-7 |  |
| Buprenorphine hemiadipate | Reckitt Benckiser Healthcare Ltd. (GB) | |  |
| Buprenorphine-Val-carbamate | Shire LLC (US) | |  |
| Buprofezin | Nihon Nohyaku | 69327-76-0 |  |
| Buquinolate | Norwich Eaton (Procter & Gamble) | 5486-03-3 |  |
| Buramate | Chauny & Cirey | 4663-83-6 |  |
| Burapitant | Sanofi-Synthelabo (Sanofi-Aventis) | 537034-22-3 |  |
| Buserelin | Hoechst Sanofi-Aventis | 57982-77-1 ; 68630-75-1 (acetate salt) |  |
| Buspirone | Bristol-Myers Squibb (BMS) | 36505-84-7 |  |
| Busulfan | Burroughs Wellcome (GSK) | 55-98-1 |  |
| Butabindide | INSERM | 175553-48-7 |  |
| Butacaine | Abbott | 149-16-6 |  |
| Butachlor | Monsanto | 23184-66-9 |  |
| Butafenacil | Ciba-Geigy (Novartis) | 134605-64-4 |  |
| Butafosfan | Bayer | 17316-67-5 |  |
| Butalamine | Aron-Samuel | 22131-35-7 |  |
| Butalbital | Sandoz (Novartis) | 77-26-9 |  |
| Butamben | Abbott | 94-25-7 |  |
| Butamifos | Sumitomo Chemical | 36335-67-8 |  |
| Butamirate | Hommel | 18109-80-3 |  |
| Butamisole | American Cyanamid (Wyeth) | 54400-59-8 |  |
| Butanilicaine | Hoechst (Sanofi-Aventis) | 3785-21-5 |  |
| Butenachlor | Hokko | 87310-66-3 |  |
| Butenafine | Kaken Pharmaceutical | 101828-21-1 |  |
| Butetamate | Hommel | 14007-64-8 |  |
| Buthiobate | Sumitomo Chemical | 51308-54-4 |  |
| Buthionine sulfoximine | National Cancer Inst. ; National Inst. of Health (NIH) ; Cornell Research Foundation | 5072-26-4 |  |
| Buthiopurine | Wellcome Foundation (GSK) | 608-12-8 |  |
| Butibufen | Juste | 55837-18-8 |  |
| Butidrine | Ceresia | 7433-10-5 |  |
| Butinoline | Heumann | 968-63-8 |  |
| Butixocort propionate | Jouveinal | 98449-05-9 |  |
| Butizide | Ciba-Geigy (Novartis) | 2043-38-1 |  |
| Butocarboxim | Consortium fuer Elektrochemische Industrie G.m.b.H. | 34681-10-2 |  |
| Butoconazole | Syntex (Roche) | 64872-76-0 |  |
| Butofilolol | C.M. Industries | 64552-17-6 |  |
| Butopiprine | Castejon | 55837-15-5 |  |
| Butorphanol | Bristol-Myers Squibb (BMS) | 42408-82-2 |  |
| Butoxycain | Squibb (BMS) | 3772-43-8 |  |
| Butoxycarboxim | Consortium fuer Elektrochemische Industrie G.m.b.H. | 34681-23-7 |  |
| Butralin | Amchem (Rhone-Poulenc) | 33629-47-9 |  |
| Butriptyline | Schering Corp (Merck & Co) | 35941-65-2 |  |
| Butropium bromide | Eisai | 29025-14-7 |  |
| Butroxydim | ICI (Syngenta) | 138164-12-2 |  |
| Butylate | Stauffer | 2008-41-5 |  |
| Butylparaben | Merck & Co | 94-26-8 |  |
| Butylscopolammonium bromide | Boehringer Ingelheim | 149-64-4 |  |
| Butyzamide | Shionogi & Co. Ltd. (Japan) | |  |
| Buzepide | Nederlandesche Combinatie Chem. Ind. | 3691-21-2 |  |
| BVF-014 | Amgen Inc. | | No Structure |
| BVF-045 | Biovail Corp. | | No Structure |
| BVF-324 (Tramadol) | DMI Biosciences Inc. | 27203-92-5 |  |
| BVI-007 | BioVascular | | No Structure |
| BVT-115959 | Biovitrum (Sweden) | | No Structure |
| BVT-116429 | Amgen Inc. (US) ; Biovitrum AB (Sweden) | |  |
| BVT-74316 | Biovitrum | |  |
| BVT-A | Biovitrum AB (Sweden) | |  |
| BVX-20 | Vaccinex Inc. | | No Structure |
| BW-1003C87 | Wellcome (GSK) | 144425-86-5 (ethanesulfonate) |  |
| BW-1023U90 | Wellcome (GSK) | 142061-77-6 |  |
| BW-1205U90 | Wellcome (GSK) | 155289-53-5 |  |
| BW-245C | Procter & Gamble | 75693-75-3 |  |
| BW-373U86 | | 150428-54-9 |  |
| BW-534U87 | Burroughs Wellcome (GSK) | 143153-93-9 (HCl) |  |
| BW-723C86 | GlaxoSmithKline (GSK) | 160521-72-2 |  |
| BW-B70C | Wellcome Foundation (GSK) | 134470-38-5 |  |
| BX-320 | Schering AG | |  |
| BX-471 | Schering AG (Bayer Schering) | 288262-96-4 (hydrochloride) |  |
| BX-517 | Berlex Biosciences (Schering AG) | |  |
| BX-528 | Bayer Schering Pharma AG (Germany) | |  |
| BXL-922 | Bioxell | 195527-19-6 |  |
| BYF-1047 | Aventis CropScience (Bayer) | |  |
| BYK-191023 | Altana (Nycomed) | |  |
| BYL-719 | | | No Structure |
| BZ-423 | University of Michigan | 216691-95-1 |  |
| BZA-5B | Genentech | 149786-88-9 |  |
| C-0001 | Progenics Pharmaceuticals Inc. (US) | |  |
| C-0021 | Progenics Pharmaceuticals Inc. (US) | |  |
| C-1311 | British Tech (BTG) | 138154-39-9 |  |
| C-170 | Chinoin | 88338-63-0 |  |
| C-20081 | Concert Pharmaceuticals Inc. (US) | |  |
| C-2053-39 | COR Therapeutics (Millennium Pharmaceuticals Inc.) | |  |
| C-333H | Institute of Pharmacology and Toxicology | |  |
| C-6458 | University of Athens | 478550-49-1 |  |
| C-75 | Fasgen ; Johns University | 218137-86-1 |  |
| C-89-4095 | Casella (Aventis) | 135576-69-1 |  |
| C12 peptide | Kanebo | |  |
| C12K-7alpha8 | Technion Research & Development Foundation Ltd. (Israel) | |  |
| C18-C01 | Glycomedics Inc. (Japan) | |  |
| C450-0730 | Princeton University | |  |
| C6-n-Butylmansonone F | Seoul National University | |  |
| CA030-00240_g1 | UCB SA (Belgium) | | No Structure |
| Cabergoline | Farmitalia Carlo Erba (Pharmacia) | 81409-90-7 |  |
| Cabiotraxetan | Sigma Tau | 451478-45-8 |  |
| Cabozantinib | Exelixis | |  |
| CAD-106 | Cytos Biotechnology | | No Structure |
| CADI-05 | Cadila Pharmaceuticals | | No Structure |
| Cadralazine | ISF | 64241-34-5 |  |
| Cadrofloxacin | Ube | 153808-85-6 |  |
| Cadusafos | Rhone-Poulenc | 95465-99-9 |  |
| CAdVax-DenTV | GenPhar Inc. (US) | | No Structure |
| CAdVax-RVF | GenPhar Inc. ; University of\nTexas Medical Branch (US) ; Medical University of South Carolina (US) | | No Structure |
| Cafaminol | Delmar | 30924-31-3 |  |
| Cafedrine | Chemiewerk Homburg | 58166-83-9 |  |
| Cafenstrole | Chugai (Roche) | 125306-83-4 |  |
| Caffeic acid | | 331-39-5 |  |
| Caffeine | | 58-08-2 |  |
| CAI-1 | Princeton University (US) | |  |
| CAL-100603 | ChemAlong | |  |
| Calanolide A | US Health | 142632-32-4 |  |
| Calcifediol | Upjohn (Pharmacia) | 19356-17-3 |  |
| Calcipotriol | Leo Pharmaceutical | 112965-21-6 |  |
| Calcitonin | Novartis, | 47931-85-1 |  |
| Calcitriol | Upjohn (Pharmacia) | 32222-06-3 |  |
| Calcium Acetate | | 62-54-4 |  |
| Calcium Dobesilate | Esteve | 20123-80-2 |  |
| Calcium Edeteate | | 23411-34-9 (hydrate) ; 62-33-9 (Anhydrous) |  |
| Calcium polystyrene sulfonate | | 37286-92-3 |  |
| Caldaret | Mitsubishi | 133804-44-1 |  |
| Calendula officinalis | University of Grenade ; Bomsund Grupo Asesor | |  |
| Calfactant | | 183325-78-2 | No Structure |
| Calhex-231 | CNRS (France) | |  |
| Calicheamicin gamma(1) | | 108212-75-5 |  |
| Calindol | CNRS | |  |
| Calocoumarin A | Kyoto Prefectural University of Medicine ; Meijo University, Nagoya ; National University of Singapo | |  |
| Caloporoside B | Aventis | 460732-51-8 |  |
| Caloporoside C | Aventis | 460732-52-9 |  |
| Caloporoside D | Aventis | 460732-53-0 |  |
| Caloporoside E | Aventis | 460732-54-1 |  |
| Caloporoside F | Aventis GmbH | 460732-55-2 |  |
| Calothrixin A | Australian National University | 254114-33-5 |  |
| Caloxetic acid | Schering AG | 135306-78-4 |  |
| CALP-2 | University of Alabama at Birmingham;Janssen;Utrecht University | 261969-04-4 |  |
| Calpastatin | | 79079-11-1 |  |
| Calphobindin-I | Kowa Co | | No Structure |
| Calphostin C | | 121263-19-2 |  |
| Calpinactam | Kitasato University (Japan) | |  |
| Calusterone | Upjohn (Pharmacia) | 17021-26-0 |  |
| CAM-2028 (Tramadol) | Camurus (Sweden) | |  |
| CAM-741 | Sandoz Ltd. ; Sandoz AG | |  |
| CAM-89 | Universita degli Studio di Siena (Italy) | |  |
| Camazepam | Siphar | 36104-80-0 |  |
| Cambendazole | Merck & Co. | 26097-80-3 |  |
| Camiglibose | Merrell Dow Pharmaceutical | 127214-23-7 |  |
| Camobucol | University of California | 216167-92-9 |  |
| Camonagrel | Ferrer | 105920-77-2 |  |
| Camostat | Ono Pharmaceutical | 59721-28-7 |  |
| Camptothecin | | 7689-03-4 |  |
| Camylofin | Asta Medica (Degussa) | 54-30-8 |  |
| CAN-508 | Cyclacel (Great Britain) ; Institute of Experimental Botany Of The Academy Of Sciences (Czech Republ | |  |
| Canagliflozin | Tanabe Seiyaku Co, Japan | 928672-86-0 ; 842133-18-0 |  |
| Canakinumab | Novartis | 402710-25-2 (variable heavy gamma1 chain) ; 402710-27-4 (variable light kappa chain) | No Structure |
| Candelalide B | Merck & Co | 326859-44-3 |  |
| Candesartan Cilexetil | Takeda | 145040-37-5 |  |
| Candesartan Cilexetil & Amlodipine | Takeda Pharmaceutical Co. Ltd. | 145040-37-5 (Candesartan Cilexetil) ; 88150-42-9 (Amlodipine) ; 111470-99-6 (Amlodipine besilate) |  |
| Candocuronium iodide | CSIR | 54278-85-2 |  |
| Candoxatril | Pfizer | 123122-55-4 |  |
| Candoxatrilat | Pfizer | 123122-54-3 |  |
| Canertinib | Warner-Lambert (Pfizer) | 289499-45-2 ; 267243-28-7 |  |
| Canfosfamide | Terrapin Technologies (Telik) | 158382-37-7 |  |
| Cangrelor | Astra (AstraZeneca) | 163706-06-7 |  |
| Cannabidiol | Yissum | 13956-29-1 |  |
| Canosimibe | Aventis Pharma GmbH (Germany) | 768394-99-6 |  |
| Canrenoic acid | Searle | |  |
| Cantuzumab Mertansine | Immunogen | 400010-39-1 |  |
| Canventol | National Cancer Center Research Institute of Tokyo | 150956-50-6 |  |
| CAP-1 | University of Maryland | |  |
| Capadenoson | Bayer Healthcare AG (Germany) | 544417-40-5 |  |
| Capecitabine | Hoffmann La Roche (Roche) | 154361-50-9 |  |
| Capeserod | Synthelabo (Sanofi-Aventis) | 191023-43-5 (HCl) |  |
| Capobenic acid | Inst. Chemioter. Ital. | 21434-91-3 |  |
| Capravirine | Shionogi | 178979-85-6 |  |
| Capreomycin | Eli Lilly | 11003-38-6 |  |
| Capridine-beta | University of New York | |  |
| Capromab pendetide | Cytogen Corp. (US) | 145464-28-4 | No Structure |
| Capromorelin | Pfizer | 193273-66-4 |  |
| Caprospinol | Samaritan Pharmaceuticals ; Univ. Georgetown | |  |
| Capsaicin | University of California | 404-86-4 |  |
| Capsanthin | Chen Yong (China) | 465-42-9 |  |
| Capsorubin | Anhui Centre Of Analytical Measurement (China) | 470-38-2 |  |
| Captafol | Chevron | 2425-06-1 |  |
| Captan | Standard Oil | 133-06-2 |  |
| Captodiame | Warner Lambert (Pfizer) | 486-17-9 |  |
| Captopril | Squibb (BMS) | 62571-86-2 |  |
| Capuramycin | Kanto Ishi Pharma (Japan) | 102770-00-3 |  |
| Carabersat | SmithKline Beecham (GSK) | 184653-84-7 |  |
| Caramiphen | Geigy (Novartis) | 77-22-5 |  |
| Carazolol | Boehringer Mannheim (Roche) | 57775-29-8 |  |
| Carbachol | E. Merck KGaA | 51-83-2 |  |
| Carbadox | Pfizer | 6804-07-5 |  |
| Carbamazepine | Geigy (Novartis) | 298-46-4 |  |
| Carbarsone | Hoechst (Sanofi-Aventis) | 121-59-5 |  |
| Carbaryl | Union Carbide | 63-25-2 |  |
| Carbazitaxel | Aventis (Sanofi-Aventis) | 183133-96-2 |  |
| Carbazochrome | Societe Belge de l'Azote et de Produits Chimiques de Marly | 69-81-8 |  |
| Carbendazim | DuPont ; BASF | 10605-21-7 |  |
| Carbenicillin | Pfizer | 4697-36-3 |  |
| Carbenoxolone | Biorex | 5697-56-3 |  |
| Carbetamide | Rhone-Poulenc | 16118-49-3 |  |
| Carbetocin | Ceskoslovenska Akademie Ved | 37025-55-1 |  |
| Carbidopa | Merck & Co. | 38821-49-7 |  |
| Carbimazole | National Research Development Corporation (NRDC) | 22232-54-8 |  |
| Carbinoxamine | Merrell (Aventis) | 486-16-8 |  |
| Carbocalcitonin | ISF | 60731-46-6 |  |
| Carbocisteine | Degussa | 2387-59-9 |  |
| Carbocromen | Casella (Aventis) | 804-10-4 |  |
| Carbofuran | Bayer | 1563-66-2 |  |
| Carbomexx (Carboplatin) | Oasmia Pharmaceutical AB | 41575-94-4 |  |
| Carbon monoxide | Beth Israel Hospital ; Yale University | 630-08-0 |  |
| Carbophenothion | Stauffer | 786-19-6 |  |
| Carboplatin | Research Corporation | 41575-94-4 |  |
| Carboprost | Upjohn Co, (Pfizer) | 35700-23-3 ; 58551-69-2 ; 58551-69-21(tromethamine salt) |  |
| Carboquone | Sankyo | 24279-91-2 |  |
| Carbosulfan | University of California | 55285-14-8 |  |
| Carbovir | Minnesota University | 118353-05-2 |  |
| Carboxin | Uniroyal | 5234-68-4 |  |
| Carboxyamidotriazole | Merck & Co. | 99519-84-3 |  |
| Carboxyamidotriazole Orotate | Savvipharm (Tactical Therapeutics) | |  |
| Carbromal | Bayer | 77-65-6 |  |
| Carbutamide | Boehringer Mannheim (Roche) | 339-43-5 |  |
| Carbuterol | SmithKline French (GSK) | 34866-47-2 |  |
| Carebastine | Fordonal | 90729-42-3 |  |
| Carfecillin | Beecham (GSK) | 21649-57-0 |  |
| Carfenazine | Schering Corp (Merck & Co) | 2622-30-2 |  |
| Carfentanil | Janssen Pharmaceutica (Johnson & Johnson) | 59708-52-0 |  |
| Carfentrazone | FMC | 128621-72-7 |  |
| Carfilzomib | Proteolix, Inc. | 868540-17-4 |  |
| Carglumic acid | | 188-38-1 |  |
| Caricotamide | Protherics | 64881-21-6 |  |
| Carindacillin | Pfizer | 26605-69-6 |  |
| Cariporide | Hoechst (Sanofi-Aventis) | 159138-80-4 |  |
| Cariprazine | Richter Gedeon Vegyeszet (Hungary) | 839712-12-8 |  |
| Carisbamate | SK Biopharmaceuticals | 194085-75-1 |  |
| Carisoprodol | Carter Products (Carter-Wallace) | 78-44-4 |  |
| Carlecortemcel-L | Gamida-Cell | | No Structure |
| Carlumab | Centocor Inc. (Centocor Ortho Biotech Inc.) | 915404-94-3 | No Structure |
| Carmegliptin | Hoffmann La Roche | 813452-18-5 ; 813452-14-1 (dihydrochloride salt) |  |
| Carmofur | Mitsui | 61422-45-5 |  |
| Carmoterol | Tanabe (Mitsubishi Tanabe Pharma) | 147568-66-9 |  |
| Carmoxirole | E. Merck KGaA | 98323-83-2 |  |
| Carmustine | US Health | 154-93-8 |  |
| Carnidazole | Janssen Pharmaceutica (Johnson & Johnson) | 42116-76-7 |  |
| Carnosine | | 305-84-0 |  |
| Carocainide | Delalande | 66203-00-7 |  |
| Caroverine | Donau-Pharm | 23465-76-1 |  |
| Carperitide | Suntory (Daiichi-Sankyo) | 89213-87-6 |  |
| Carpipramine | Yoshitomi | 5942-95-0 |  |
| Carprofen | Hoffmann La Roche (Roche) | 53716-49-7 |  |
| Carpronium chloride | Daiichi Seiyaku | 13254-33-6 |  |
| Carpropamid | Nihon Tokushu (Bayer) | 127641-62-7 |  |
| Carrageenan | | 9000-07-1 |  |
| Cartap | Takeda | 15263-53-3 |  |
| Carteolol | Otsuka | 51781-06-7 |  |
| Carteramine A | Astellas Pharma Inc. (Japan) | |  |
| Carumonam | Takeda | 87638-04-8 |  |
| Carvedilol | Boehringer Mannheim (Roche) | 72956-09-3 |  |
| Carvedilol & Lisinopril | Boehringer Mannheim Pharmaceuticals Corp. | 72956-09-3 (Carvedilol) ; 76547-98-3 (Lisinopril) |  |
| Carvotroline | American Home Products (Wyeth) | 107266-08-0 |  |
| Carzelesin | Upjohn (Pharmacia) | 119813-10-4 |  |
| Carzenide | Constantin Fahlberg | 138-41-0 |  |
| Casopitant | Glaxo (GSK) | 414910-27-3 |  |
| Caspofungin | Merck & Co. | 162808-62-0 |  |
| Castanospermine | Boehringer Mannheim | 79831-76-8 |  |
| Casuarine | Molecular nature Ltd. | |  |
| Casuarine-6-alpha-glucoside | Molecular nature Ltd. | |  |
| CAT-310 | | 1972-08-3 |  |
| CAT-354 | Cambridge Antibody Technology (MedImmune Limited) | | No Structure |
| Cathine | Pfanz & Wieduwilt | 492-39-7 |  |
| Catramilast | Janssen Pharmaceutica (Johnson & Johnson) | 183659-72-5 |  |
| Catridecacog | Novo Nordisk Health Care AG | 606138-08-3 | No Structure |
| Catumaxomab | Trion Pharma | 509077-98-9 | No Structure |
| Caulibugulone A | | |  |
| Caulibugulone B | | |  |
| Caulibugulone C | | |  |
| Caulibugulone D | | |  |
| Caulibugulone E | | |  |
| CAV-21 | Virotarg | | No Structure |
| Cavtratin | University of Yale | |  |
| CB-01-11 (Rifamycin) | Cosmo Technologies Ltd | 6998-60-3 |  |
| CB-03-04 | Cosmo | |  |
| CB-1093 | Leo Pharmaceutical | 167678-65-1 |  |
| CB-1267 | Leo Pharmaceutical | 139174-97-3 |  |
| CB-126898 | Cubist ; Merck & Co | |  |
| CB-130900 | Cubist ; Merck & Co. | 305354-58-9 |  |
| CB-130913 | Cubist ; Merck & Co | 305356-24-5 |  |
| CB-130920 | Cubist ; Merck & Co | |  |
| CB-130976 | Cubist ; Merck & Co | |  |
| CB-182462 | Cubist Pharmaceutical Inc. | |  |
| CB-182804 | | | No Structure |
| CB-183315 | Cubist Pharmaceuticals Inc. | |  |
| CB-300179 | AstraZeneca | |  |
| CB-3304 (Noscapine) | Emory University | 128-62-1 |  |
| CB-610 | Combio ; ProZymex | |  |
| CB-676475 | | |  |
| CB-79 | Combio ; ProZymex | |  |
| CB-NTXOL-BUPOH | Kentucky University | |  |
| CBD-1 | Pasteur Institut ; CNRS | |  |
| CBG-41 | | |  |
| CBI-0997 | Synta Pharmaceuticals Corp. (US) | |  |
| CBiPES | Eli Lilly & Co. (US) | |  |
| CBIQ | University of Cambridge | |  |
| CBM-000302276 | Chugai Pharmaceutical | |  |
| CBM-000302280 | Chugai Pharmaceutical | |  |
| CBM-000302342 | Chugai Pharmaceutical | |  |
| CBM-301940 | Chugai Pharmaceutical | |  |
| CBP-501 | CanBas Res | |  |
| CBR-2092 | Cumbre Pharmaceuticals Inc. | |  |
| CBS-00040 | Combinature Biopharm AG (Germany) | |  |
| CBS-0550 | Taisho Pharmaceutical Co. Ltd. (Japan) | |  |
| CBS-1108 | Laboratoires Chauvin-Blache | 89408-03-7 |  |
| CBS-9106 | CanBas Co. Ltd. (Japan) | |  |
| CBT-1 | CBA Pharma | 848871-07-8 |  |
| CC-11050 | Celgene Corp. (US) | | No Structure |
| CC-223 | | | No Structure |
| CC-3052 | Celgene | 216884-02-5 |  |
| CC-7034 | Celgene | |  |
| CC-9088 | Celgene | |  |
| CCD-3693 | Cocensys | 162883-07-0 |  |
| CCI-779 isomer C | Wyeth | |  |
| CCR5mAb004 | Human Genome Sciences | | No Structure |
| CCT-129202 | Chroma Therapeutics Ltd. (GB) | |  |
| CCT-129524 | Astex Therapeutics Ltd. ; The Institute of Cancer Research (GB) ; Cancer Research Technology Ltd. (G | |  |
| CCT-241533 | Cancer Research Technology Ltd. (GB) | |  |
| CCX-025 | ChemoCentryx | | No Structure |
| CCX-140 | | | No Structure |
| CD-008-0045 | Alla Chem LLC | |  |
| CD-160130 | Curacyte | |  |
| CD-437 | Galderma | 125316-60-1 |  |
| CD-832 | Taisho | 148200-22-0 |  |
| CD-NP | Mayo Foundation (US) | |  |
| CD33-ETA-IT | University of Friedrich Alexander(Germany) | | No Structure |
| CDB-3701 | NIH | |  |
| CDD-0097 | Toledo University | 146422-20-0 (HCl) |  |
| CDD-0102 | University of Toledo | 146422-58-4 |  |
| CDD-0273-A | University of Toledo | |  |
| CDD-0304 | University of Toledo | 370557-18-9 |  |
| CDD-0322 | University of Toledo (US) | |  |
| CDDO-Im | | |  |
| CDNC-24 | University of Virginia ; Washington University of St. Louis (USA) | |  |
| CDP-484 | | | No Structure |
| CDP-571 | Bayer ; Celltech | 336128-48-4 | No Structure |
| CDP-6038 | UCB SA | | No Structure |
| CDP-791 | Celltech (UCB) | | No Structure |
| CDP-840 | Celltech | 162542-90-7 |  |
| CDP-860 | Celltech (UCB) | 339184-09-7 | No Structure |
| CDRI-93-478 | Council of Scientific and Industrial Research | |  |
| CDTA-Monoplatinum | Sonus Pharma | |  |
| CDX-014 | CuraGen Corp. (Celldex Therapeutics Inc.) | | No Structure |
| CDX-085 | Cardax Pharmaceuticals, (US) | |  |
| CDX-1127 | University of Southampton (GB) | | No Structure |
| CDX-1135 | T Cell Sciences (Avant Immunotherapeutics) ; Johns Hopkins University ; Brigham & Womens Hospital | | No Structure |
| CDX-1307 | Medarex Inc. (US) | | No Structure |
| CDX-1401 | Celldex Therapeutics Inc. | | No Structure |
| CDX-301 | Immunex Corp. (Amgen Inc.) | | No Structure |
| CE | Pfizer Inc. (US) | |  |
| CE-1037 | Cortech | 150493-09-7 |  |
| CE-129941 | Pfizer | |  |
| CE-156811 | Pfizer | |  |
| CE-2072 | Cortech | 208840-22-6 |  |
| CE-224535 | Pfizer | | No Structure |
| CE-245677 | Pfizer Inc. (US) | |  |
| CE-326597 | Pfizer | | No Structure |
| CE-355774 | Pfizer Inc. (US) | |  |
| Cebaracetam | Ciba-Geigy (Novartis) | 113957-09-8 |  |
| Cediranib | AstraZeneca | 288383-20-0 ; 857036-77-2 (maleate salt) |  |
| Cefacetrile | Ciba-Geigy (Novartis) | 10206-21-0 |  |
| Cefaclor | Eli Lilly | 70356-03-5 |  |
| Cefadroxil | Bristol Myers (BMS) | 66592-87-8 |  |
| Cefalexin | Eli Lilly | 15686-71-2 |  |
| Cefaloglycin | Eli Lilly | 22202-75-1 |  |
| Cefaloridine | Glaxo (GSK) | 50-59-9 |  |
| Cefalotin | Eli Lilly | 153-61-7 |  |
| Cefamandole | Eli Lilly | 34444-01-4 |  |
| Cefapirin | Bristol-Myers Squibb (BMS) | 21593-23-7 |  |
| Cefatrizine | SmithKline French (GSK) | 51627-14-6 |  |
| Cefazedone | E. Merck KGaA | 56187-47-4 |  |
| Cefazolin | Fujisawa | 25953-19-9 |  |
| Cefbuperazone | Toyama | 76610-84-9 |  |
| Cefcapene Pivoxil | Shionogi | 105889-45-0 |  |
| Cefclidin | Eisai | 105239-91-6 |  |
| Cefdaloxime pentexil | Hoechst (Sanofi-Aventis) | |  |
| Cefdinir | Fujisawa | 91832-40-5 |  |
| Cefditoren Pivoxil | Meiji | 104145-95-1 |  |
| Cefepime | Bristol-Myers Squibb (BMS) | 88040-23-7 |  |
| Cefetamet Pivoxil | Takeda | 65243-33-6 |  |
| Cefixime | Fujisawa | 79350-37-1 |  |
| Cefluprenam | Eisai | 116853-25-9 |  |
| Cefmatilen | Shionogi | 140128-74-1 |  |
| Cefmenoxime | Takeda | 65085-01-0 |  |
| Cefmetazole | Sankyo | 56796-20-4 |  |
| Cefminox | Meiji | 75481-73-1 |  |
| Cefodizime | Hoechst (Sanofi-Aventis) | 69739-16-8 |  |
| Cefonicid | SmithKline (GSK) | 61270-58-4 |  |
| Cefoperazone | Toyama | 62893-19-0 |  |
| Ceforanide | Bristol Myers (BMS) | 60925-61-3 |  |
| Cefoselis | Fujisawa | 122841-10-5 |  |
| Cefotaxime | Roussel-Uclaf (Aventis) | 63527-52-6 ; 64485-93-4 (sodium) |  |
| Cefotetan | Yamanouchi (Astellas) | 69712-56-7 |  |
| Cefotiam | Takeda | 61622-34-2 |  |
| Cefovecin | Beecham Group PLC | 141195-77-9 |  |
| Cefoxazole | Glaxo (GSK) | 36920-48-6 |  |
| Cefoxitin | Merck & Co. | 35607-66-0 |  |
| Cefozopran | Takeda | 113359-04-9 |  |
| Cefpimizole | Ajinomoto | 84880-03-5 |  |
| Cefpiramide | Sumitomo Chemical | 70797-11-4 |  |
| Cefpirome | Hoechst (Sanofi-Aventis) | 84957-29-9 |  |
| Cefpodoxime Proxetil | Sankyo | 87239-81-4 |  |
| Cefprozil | Bristol-Myers Squibb (BMS) | 121123-17-9 |  |
| Cefquinome | Hoechst (Sanofi-Aventis) | 84957-30-2 |  |
| Cefradine | Squibb (BMS) | 38821-53-3 |  |
| Cefroxadine | Ciba-Geigy (Novartis) | 51762-05-1 |  |
| Cefsulodin | Takeda | 62587-73-9 |  |
| Ceftaroline | Takeda | 866021-48-9 |  |
| Ceftazidime | Glaxo (GSK) | 72558-82-8 |  |
| Cefteram Pivoxil | Toyama | 82547-58-8 |  |
| Ceftezole | Fujisawa | 26973-24-0 |  |
| Ceftibuten | Shionogi | 97519-39-6 |  |
| Ceftiofur | Sanofi (Sanofi-Aventis) | 80370-57-6 |  |
| Ceftizoxime | Fujisawa | 68401-81-0 |  |
| Ceftizoxime alapivoxil | Kyoto University | 135821-54-4 |  |
| Ceftobiprole | Roche | 209467-52-7 |  |
| Ceftobiprole medocaril | Roche | 376653-43-9 ; 252188-71-9 |  |
| Ceftriaxone | Hoffmann La Roche (Roche) | 73384-59-5 |  |
| Cefuroxime | Glaxo (GSK) | 55268-75-2 |  |
| Cefuroxime Axetil | Glaxo (GSK) | 64544-07-6 |  |
| Cefuzonam | American Cyanamid (Wyeth) | 82219-78-1 |  |
| CEL-1000 | CEL-SCI Corporation | |  |
| Celecoxib | Searle (Pfizer= US ) | 169590-42-5 |  |
| Celestin Blue | Huguenin | 1562-90-9 |  |
| Celgosivir | Merrell Dow (Sanofi-Aventis) | 121104-96-9 |  |
| Celikalim | American Home Products (Wyeth) | 124916-54-7 |  |
| Celiprolol | Chemie Linz (DSM) | 56980-93-9 |  |
| Celivarone | Sanofi-Aventis | 401925-43-7 |  |
| Cemadotin | BASF (Abbott) | 159776-69-9 |  |
| Cenersen | Nebraska University (UNeMed) | 872847-66-0 |  |
| Cenicriviroc | Takeda | 497223-25-3 ; 497223-28-6 (mesylate) |  |
| Cenisertib | Rigel Pharmaceuticals | 871357-89-0 |  |
| Cenplacel-L | | | No Structure |
| Centchroman | Riker | 31477-60-8 |  |
| CEP-11004 | Kyowa Hakko ; Cephalon | |  |
| CEP-1347 | Kyowa Hakko | 156177-65-0 |  |
| CEP-16233 | Cephalon (Teva) | | No Structure |
| CEP-18770 | Cephalon Inc. (US) ; Cell Therapeutics Inc. (US) | |  |
| CEP-2563 | Kyowa Hakko | 183488-70-2 |  |
| CEP-28122 | Cephalon Inc. (US) | | No Structure |
| CEP-32496 | Cephalon Inc. (US) | | No Structure |
| CEP-37248 | Cephalon (Teva) | | No Structure |
| CEP-37249 | University of Massachusetts (US) | | No Structure |
| CEP-37251 | Evogenix Ltd. (Australia) | | No Structure |
| CEP-37440 | | | No Structure |
| CEP-5 | Cephalon Inc. (US) ; Ligand Pharmaceuticals Inc. (US) | |  |
| CEP-5214 | Cephalon | |  |
| CEP-7055 | Cephalon | |  |
| CEP-751 | Cephalon ; Kyowa Hakko Kogyo | 156177-59-2 |  |
| CEP-8983 | Cephalon | |  |
| CEP-9722 | Cephalon Inc. (US) | |  |
| Cephalomannine (Paclitaxel Xechem) | Xechem International | |  |
| Ceplene (Histamine) | Maxim Pharmaceuticals | 51-45-6 |  |
| CEQ-508 | Cequent Pharmaceuticals Inc. (Marina Biotech Inc.) | | No Structure |
| CER-001 | Cerenis Therapeutics | | No Structure |
| CER-002 | Cerenis Therapeutics | | No Structure |
| Ceratamine A | University of British Columbia | |  |
| Ceratamine B | University of British Columbia | |  |
| CERE-140 | Ceregene Inc. | | No Structure |
| Cericlamine | Jouveinal | 112922-55-1 |  |
| Cerivastatin | Bayer | 143201-11-0 |  |
| Ceronapril | Squibb (BMS) | 111223-26-8 |  |
| Certolizumab pegol | | 339184-10-0 | No Structure |
| Ceruletide | Farmaceutici Italia | 17650-98-5 |  |
| Cetaben | American Cyanamid (Wyeth) | 55986-43-1 |  |
| Cetalkonium chloride | IG Farben | 122-18-9 |  |
| Cetefloxacin | Esteve | 141725-88-4 |  |
| Cethexonium chloride | Sanofi (Sanofi-Aventis) | 58703-78-9 |  |
| Cethromycin | Abbott | 205110-48-1 |  |
| Cetiedil | Innothera | 14176-10-4 |  |
| Cetilistat | Alizyme Therapeutics | 282526-98-1 |  |
| Cetirizine | UCB | 83881-51-0 |  |
| Cetoxime | Boots (Abbott) | 25394-78-9 |  |
| Cetraxate | Daiichi | 34675-84-8 |  |
| Cetrimonium bromide | ICI (AstraZeneca) | 57-09-0 |  |
| Cetrorelix | Asta Medica (AEterna Zentaris) | 120287-85-6 |  |
| Cetuximab | Rhone-Poulenc Rorer (Sanofi-Aventis) | 205923-56-4 | No Structure |
| Cetylpyridinium chloride | Inst. Chemii Ogolnej | 123-03-5 |  |
| CEU-22 | Imotep | |  |
| CEU-98 | Imotep | |  |
| Cevimeline | IIBR (Israel Inst. for Biological Research) | 107233-08-9 |  |
| Cevipabulin | Wyeth | 849550-05-6 ; 849550-69-2 (fumarate) ; 852954-81-5 (succinate) |  |
| Cevoglitazar | Novartis | 839673-52-8 |  |
| CF-101 | US Health | 152918-18-8 |  |
| CF-102 | Can-Fite Biopharma (Israel) | |  |
| CF-1368 | Cardiff University | |  |
| CF-1743 | Rega Foundation ; Cardiff University | |  |
| CF-201 | Can-Fite BioPharma | | No Structure |
| CFM-1571 | University College of London ; Tripos | 268725-86-6 |  |
| CFTR-INH-020 | Institut Giannina Gaslini ; University of California | |  |
| CFTR-INH-172 | University of California | 307510-92-5 |  |
| CG-1521 | CircaGen Pharmaceutical | |  |
| CG-400462 | CrystalGenomics (Korea) | |  |
| CG-400549 | CrystalGenomics (Korea) | |  |
| CG-400587 | CrystalGenomics (Korea) | |  |
| CG-7870 | Cell Genesys | | No Structure |
| CGA-137053 | Novartis | |  |
| CGA-50439 | Ciba-Geigy (Novartis) | 61676-87-7 |  |
| CGEN-855A | Compugen Ltd. (Israel) | |  |
| CGI-17341 | | 127692-13-1 |  |
| CGP-02-01 | Clinigenetics | |  |
| CGP-07-01 | Clinigenetics (France) | |  |
| CGP-13774 | Ciba-Geigy (Novartis) | 65090-31-5 |  |
| CGP-20712 | Ciba-Geigy (Novartis) | 81015-67-0 |  |
| CGP-28014 | Ciba-Geigy (Novartis) | 111757-17-6 |  |
| CGP-28237 | Schering AG | 75360-85-9 |  |
| CGP-35348 | Ciba-Geigy (Novartis) | 123690-79-9 |  |
| CGP-37157 | Ciba-Geigy ; University of Cincinnati College of Medicine | 75450-34-9 |  |
| CGP-38560 | Ciba-Geigy | 122088-76-0 |  |
| CGP-39653 | Ciba-Geigy (Novartis) | 132472-31-2 |  |
| CGP-39937 | Ciba-Geigy (Novartis) | 144205-77-6 |  |
| CGP-40215A | Ciba-Geigy (Novartis) | 211816-91-0 |  |
| CGP-46381 | Ciba-Geigy | 123691-14-5 |  |
| CGP-47969A | Ciba Geigy | 147131-42-8 |  |
| CGP-49823 | Novartis | 150705-88-7 |  |
| CGP-52411 | Ciba Geigy | 157168-02-0 |  |
| CGP-53353 | Ciba-Geigy (Novartis) | 145915-60-2 |  |
| CGP-53716 | Ciba-Geigy (Novartis) | 152459-94-4 |  |
| CGP-56433A | Ciba Geigy (Novartis) | 153994-81-1 |  |
| CGP-59326A | Novartis | 173458-56-5 |  |
| CGP-60474 | Novartis | 164658-13-3 |  |
| CGP-64222 | Ciba-Geigy (Novartis) | 186380-62-1 |  |
| CGP-71683A | Ciba-Geigy (Novartis) | 192322-50-2 (HCl) |  |
| CGP-75136 | Novartis | |  |
| CGP-75254A | Ciba-Geigy (Novartis) | 199485-26-2 |  |
| CGP-75355 | Novartis | |  |
| CGP-76030 | Novartis | |  |
| CGP-77675 | Novartis | 234772-64-6 |  |
| CGP-79807 | Novartis | |  |
| CGS-12066 | Novartis | 109028-09-3 |  |
| CGS-12970 | Ciba-Geigy (Novartis) | 87627-28-9 |  |
| CGS-15943 | Novartis Pharma AG | 104615-18-1 |  |
| CGS-17867A | Ciba-Geigy (Novartis) | 102200-24-8 |  |
| CGS-18320B | Ciba-Geigy (Novartis) | 112808-99-8 |  |
| CGS-21680 | Yamasa | 120225-54-9 |  |
| CGS-25159 | Zyma | 116718-84-4 |  |
| CGS-25462 | Ciba-Geigy (Novartis) | 147862-03-1 |  |
| CGS-25997 | Ciba-Geigy (Novartis) | 161435-44-5 |  |
| CGS-26303 | Ciba-Geigy (Novartis) | 154116-31-1 |  |
| CGS-27913 | Ciba-Geigy (Novartis) | 185970-32-5 | No Structure |
| CGS-32359 | Ciba-Geigy (Novartis) | 209856-24-6 | No Structure |
| CGS-34225 | Novartis | 248262-98-8 |  |
| CGS-34226 | Novartis | 248261-67-8 |  |
| CGS-35066 | Novartis | 261619-50-5 |  |
| CGS-35601 | Novartis | |  |
| CGS-37808 | Novartis | |  |
| CGT-2168 (Clopidogrel & Omeprazole) | Cogentus Pharmaceuticals | |  |
| CH-13584 | Chinoin Gyogyszer Es Vegyeszet (HU) | 115779-20-9 |  |
| CH-1504 | Nair Madhavan (US) | |  |
| CH-223191 | Sigmol (Korea) | |  |
| CH-38083 | Chinoin | 106-973-76-6 |  |
| CH-4892789 | Chugai Pharmaceutical Co. Ltd. (Japan) | |  |
| CH-4893237 | Chugai (Roche) | |  |
| CH-4933468 | Chugai Pharmaceutical Co. Ltd. (Japan) | |  |
| CH-4986399 | Chugai | |  |
| CH-4987655 | Chugai Pharmaceutical Co. Ltd. (Japan) | |  |
| CH-5013072 | Chugai Pharmaceutical Co. Ltd. (Japan) | |  |
| CH-5137291 | Chugai Pharmaceutical Co. Ltd. | |  |
| CH-806 | Ludwig Institute for Cancer Research | | No Structure |
| chAd3-CEA | Istituto di Ricerche di Biologia Molecolare P. Angeletti (Italy) | | No Structure |
| Chaetochromin B | Merck & Co | 75514-37-3 |  |
| Chaetocin | Cell Therapeutics Europ S.R.L. (Italy) | 28097-03-2 |  |
| Chafuroside | Daiichi Suntory Pharma. ; Daiichi Suntory Biomedical Research | |  |
| CHEC-9 | | |  |
| Chelerythrine chloride | Steiner Co Arzneimittle (Germany) | 3895-92-9 |  |
| Chemotrap-1 | Endocube SAS ; Centre National de Recherche Scientifique (CNRS) | | No Structure |
| Chenodeoxycholic acid | Union International | 474-25-9 |  |
| CHF-1024 | Chiesi Farma | 90060-20-1 |  |
| CHF-2363 | Alcon | 98384-62-4 |  |
| CHF-4056 | Chiesi Farmaceutici | |  |
| CHF-4227 | Chiesi Farmaceutici | 444643-64-5 |  |
| CHF-4729 | Chiesi | |  |
| CHF-4732 | Chiesi | |  |
| CHF-4801 | Chiesi | |  |
| CHF-4865 | Chiesi | |  |
| CHF-5022 | Chiesi Farma SpA | |  |
| CHF-5074 | Chiesi Farma SpA | |  |
| CHF-5077 | Chiesi Farma | |  |
| CHF-5096 | Chiesi Farma SpA | |  |
| CHF-5106 | Chiesi Farma SpA | |  |
| CHF-5188 (Carmoterol & Budesonide) | Chiesi | |  |
| CHF-5408 | Chiesi Farmaceutici SpA (Italy) | |  |
| CHF-5480 | Chiesi Farmaceutici SpA (Italy) | |  |
| CHF-5633 | Chiesi farmaceutici SpA (Italy) | | No Structure |
| Chidamide | Chipscreen Biosciences | | No Structure |
| Chinoin-127 | Chinoin Gyogyszer Es Vegyeszet | 71392-29-5 |  |
| Chinomethionate | Bayer | 2439-01-2 |  |
| CHIR-124 | Chiron | |  |
| CHIR-200131 | Chiron | |  |
| CHIR-265 | Chiron | |  |
| CHIR-73911 | Chiron | |  |
| CHIR-99021 | Chiron | 252917-06-9 |  |
| Chitosan-pCETP | China Pharmaceutical University (China) | | No Structure |
| Chlomethoxyfen | Ishihara | 32861-85-1 |  |
| Chloral hydrate | | 302-17-0 |  |
| Chloralose | | 15879-93-3 |  |
| Chloramben | Amchem (Rhone-Poulenc) | 133-90-4 |  |
| Chlorambucil | Burroughs Wellcome (GSK) | 305-03-3 |  |
| Chloraminophenamide | Merck & Co. | 121-30-2 |  |
| Chloramphenicol | Parke, Davis (Pfizer) | 56-75-7 |  |
| Chlorantraniliprole | E.I. Dupont De Nemours and Company | 500008-45-7 |  |
| Chlorazanil | Heumann | 500-42-5 |  |
| Chlorbenzoxamine | UCB | 522-18-9 |  |
| Chlorbromuron | Ciba-Geigy (Novartis) | 13360-45-7 |  |
| Chlorbufam | BASF | 1967-16-4 |  |
| Chlorcyclizine | Wellcome Foundation (GSK) | 82-93-9 |  |
| Chlordane | Velsicol | 57-74-9 |  |
| Chlordiazepoxide | Hoffmann La Roche (Roche) | 58-25-3 |  |
| Chlorethoxyfos | VEB Chemiekombinat Bitterfeld | 54593-83-8 |  |
| Chlorfenapyr | American Cyanamid (BASF) | 122473-73-0 |  |
| Chlorfenvinphos | Shell | 470-90-6 |  |
| Chlorfluazuron | Ishihara Mining & Chemical | 71422-67-8 |  |
| Chlorflurenol | E. Merck KGaA | 2464-37-1 |  |
| Chlorhexidine | ICI (AstraZeneca) | 55-56-1 ; 18472-51-0 (gluconate) |  |
| Chloridazon | Progil , BASF | 1698-60-8 |  |
| Chlorimuron ethyl | DuPont | 90982-32-4 |  |
| Chlorindanol | Esta | 145-94-8 |  |
| Chlormadinone Acetate | E. Merck | 302-22-7 |  |
| Chlormadinone acetate & Ethinylestradiol (Belara) | Grünenthal | |  |
| Chlormephos | Hoechst (Sanofi-Aventis) | 24934-91-6 |  |
| Chlormequat Chloride | Research Corporation | 999-81-5 |  |
| Chlormethine | Merck & Co. | 51-75-2 |  |
| Chlormezanone | Sterling Drug (Sanofi-Aventis) | 80-77-3 |  |
| Chlormidazole | Gruenenthal | 3689-76-7 |  |
| Chlornitrofen | Mitsui | 1836-77-7 |  |
| Chlorobenzilate | Ciba-Geigy (Novartis) | 510-15-6 |  |
| Chlorobutanol | Socony Vacuum Oil Company | 57-15-8 |  |
| Chlorogenic acid | Ergo Forschung (Germany) | 327-97-9 |  |
| Chloroneb | DuPont | 2675-77-6 |  |
| Chlorophacinone | Lipha (E. Merck KGaA) | 3691-35-8 |  |
| Chlorophyllin | Generic | 15611-43-5 |  |
| Chloroprocaine | Wallace | 133-16-4 |  |
| Chloropyramine | American Cyanamid (Wyeth) | 59-32-5 |  |
| Chloropyrilene | Monsanto (Pharmacia) | 148-65-2 |  |
| Chloroquine | Winthrop (Sanofi-Aventis) | 54-05-7 |  |
| Chlorothalonil | Diamond Alkali | 1897-45-6 |  |
| Chlorothiazide | Merck & Co. | 58-94-6 |  |
| Chlorotoluron | Ciba-Geigy (Novartis) | 15545-48-9 |  |
| Chlorotoxin | TransMolecular | 163515-35-3 |  |
| Chlorotrianisene | Merrell (Aventis) | 569-57-3 |  |
| Chloroxine | Union Carbide | 773-76-2 |  |
| Chloroxuron | American Cyanamid (BASF) | 1982-47-4 |  |
| Chloroxylenol | William Wiggins Cocker | 88-04-0 |  |
| Chlorozotocin | | 54749-90-5 |  |
| Chlorphenamine | Schering Corp (Merck & Co) | 132-22-9 |  |
| Chlorphenesin | BDH | 104-29-0 |  |
| Chlorphenesin carbamate | Upjohn (Pharmacia) | 886-74-8 |  |
| Chlorphenoxamine | Asta Medica (Degussa) | 77-38-3 |  |
| Chlorphentermine | Simes | 461-78-9 |  |
| Chlorphonium chloride | Perifleur | 115-78-6 |  |
| Chlorphoxim | Bayer | 14816-20-7 |  |
| Chlorphthalim | Mitsubishi | 39985-63-2 |  |
| Chlorproethazine | Rhone-Poulenc (Aventis) | 84-01-5 |  |
| Chlorproguanil | ICI (AstraZeneca) | 15567-76-5 |  |
| Chlorproguanil & Dapsone & Artesunate | Glaxosmithkline ; Malaria Venture (MMV) | 537-21-3 (chlorproguanil) ;\n80-08-0 (Dapsone) ;\n83507-69-1 (artesunate) |  |
| Chlorpromazine | Rhone-Poulenc (Aventis) | 50-53-3 ; 69-09-0 (hydrochloride) |  |
| Chlorpropamide | Pfizer | 94-20-2 |  |
| Chlorpropham | Columbia Southern Chem Corp | 101-21-3 |  |
| Chlorprothixene | Merck & Co. | 113-59-7 |  |
| Chlorpyrifos | DowElanco | 2921-88-2 |  |
| Chlorpyrifos-methyl | Dow | 5598-13-0 |  |
| Chlorquinaldol | Geigy (Novartis) | 72-80-0 |  |
| Chlorquinox | BASF | 3495-42-9 |  |
| Chlorsulfaquinoxaline | Merck & Co. | 97919-22-7 |  |
| Chlorsulfuron | DuPont | 64902-72-3 |  |
| Chlortalidone | Geigy (Novartis) | 77-36-1 |  |
| Chlortetracycline | American Cyanamid (Wyeth) | 57-62-5 |  |
| Chlorthal | Diamond Alkali | 2136-79-0 |  |
| Chlorthenoxazine | Thomae (Boehringer Ingelheim) | 132-89-8 |  |
| Chlorthiamid | Shell | 1918-13-4 |  |
| Chlorzoxazone | Ortho McNeil (Johnson & Johnson) | 95-25-0 |  |
| Chlozolinate | Sumitomo Chemical | 84332-86-5 |  |
| CHM-1-P-Na | China Medical University (Taiwan) | |  |
| Cholic acid | Armour and Co. (US) | 81-25-4 |  |
| Choline Alfoscerate | | 28319-77-9 |  |
| Choline bitartrate | | 87-67-2 |  |
| Choline chloride | Nopco | 67-48-1 |  |
| Choline salicylate | Mundipharma | 2016-36-6 |  |
| Choline stearate | American Cyanamid (Wyeth) | 60154-01-0 |  |
| Choline theophyllinate | Nepera | 4499-40-5 |  |
| Chondroitin sulfate | | 9007-28-7 |  |
| Choriogonadotropin Alfa | Applied Research Systems ARS Holding NV (Merck Serono SA) | 177073-44-8 | No Structure |
| CHP-486 | Chaperone Technologies Inc. | |  |
| CHP-490 | Chaperone Technologies Inc. | |  |
| CHR-2845 | | | No Structure |
| CHR-3996 | | | No Structure |
| CHR-5154 | Chroma Therapeutics Ltd. | | No Structure |
| CHR-79888 | | |  |
| Chromafenozide | Nippon Kayaku | 143807-66-3 |  |
| Chromium Picolinate | Nutrition 21 | 14639-25-9 |  |
| Chromocarb | Ferlux | 4940-39-0 |  |
| ChronVac-C | Tripep AB (ChronTech Pharma AB) | | No Structure |
| CHS-828 | Leo Pharmaceutical | 200484-11-3 |  |
| CHT-22 | Kyowa Hakko | 288268-09-7 |  |
| CI-1002 | Warner Lambert (Pfizer) | 149028-28-4 |  |
| CI-1007 | Warner Lambert (Pfizer) | 150013-70-0 |  |
| CI-1012 | Warner Lambert (Pfizer) | 2527-57-3 |  |
| CI-1013 | Warner Lambert (Pfizer) | 182149-25-3 |  |
| CI-1015 | Warner-Lambert (Pfizer) | |  |
| CI-1017 | Warner Lambert (Pfizer) | 180050-34-4 (fumarate) |  |
| CI-1018 | Jouveinal | 179024-48-7 |  |
| CI-1020 | Pfizer | |  |
| CI-1021 | Warner Lambert (Pfizer) | 158991-23-2 |  |
| CI-1029 | Warner-Lambert (Pfizer) | |  |
| CI-1040 | Warner Lambert | 212631-79-3 |  |
| CI-1044 | Jouveinal | 197894-84-1 |  |
| CI-201 | Vascular Biogenics Ltd(VBL) | |  |
| CI-922 | Warner Lambert (Pfizer) | 97958-08-2 |  |
| CI-949 | Warner Lambert (Pfizer) | 104961-19-5 |  |
| CI-959 | Warner Lambert (Pfizer) | 104795-68-8 |  |
| CI-966 | Warner Lambert (Pfizer) | 110283-79-9 |  |
| CI-986 | Warner Lambert (Pfizer) | 130116-16-4 |  |
| CI-987 | Warner-Lambert | 127378-46-5 |  |
| CI-988 | Warner Lambert (Pfizer) | 130332-27-3 |  |
| CI-996 | Warner Lambert (Pfizer) | 150438-02-1 |  |
| CI-999 | Warner Lambert (Pfizer) | 142642-31-7 |  |
| CIAA | Pfizer | |  |
| Ciaftalan zinc | New York Blood Center | 14320-04-8 |  |
| Cianidanol | | 154-23-4 |  |
| Cianopramine | Hoffmann La Roche (Roche) | 66834-24-0 |  |
| Cibenzoline | Hexachimie | 53267-01-9 |  |
| Cicaprost | Schering AG | 94079-80-8 |  |
| Ciclacilin | American Home Products (Wyeth) | 3485-14-1 |  |
| Ciclesonide | Elmu | 126544-47-6 |  |
| Cicletanine | SCRAS (Beaufour Ipsen) | 89943-82-8 |  |
| Ciclometasone | Rorer (Aventis) | 86022-88-0 |  |
| Ciclonicate | Takeda | 53449-58-4 |  |
| Ciclonium bromide | Asta Medica | 29546-59-6 |  |
| Ciclopirox | Hoechst (Sanofi-Aventis) | 29342-05-0 |  |
| Cicloprolol | Synthelabo (Sanofi-Aventis) | 94651-09-9 |  |
| Ciclosporin | Sandoz (Novartis) | 59865-13-3 |  |
| Ciclotropium bromide | | 85166-20-7 |  |
| Cicloxilic acid | Guidotti | 57808-63-6 |  |
| Cidofovir | Gilead Sciences | 113852-37-2 |  |
| CIF | Chugai Pharmaceutical Co. Ltd. (Japan) | | No Structure |
| CIGB-300 | Centro de Ingenieria Genetica y Biotecnologia (Cuba) | | No Structure |
| Ciglitazone | Takeda | 74772-77-3 |  |
| Cilansetron | Duphar | 120635-74-7 |  |
| Cilastatin | Merck & Co. | 82009-34-5 |  |
| Cilazapril | Hoffmann La Roche (Roche) | 92077-78-6 |  |
| Cilengitide | E. Merck KGaA | 188968-51-6 |  |
| Cilnidipine | Fujirebio | 132203-70-4 |  |
| Cilomilast | SmithKline French (GSK) | 153259-65-5 |  |
| Cilostazol | Otsuka | 73963-72-1 |  |
| Ciluprevir | Boehringer Ingelheim | 300832-84-2 |  |
| Cimetidine | SmithKline French (GSK) | 51481-61-9 |  |
| Cimetropium bromide | De Angeli | 51598-60-8 |  |
| Cimicoxib | Uriach | 265114-23-6 |  |
| Cimoxatone | Sanofi (Sanofi-Aventis) | 73815-11-9 |  |
| Cinacalcet | NPS Pharmaceuticals | 364782-34-3 (HCl) |  |
| Cinaciguat | Bayer | 329773-35-5 |  |
| Cinametic acid | Anphar | 35703-32-3 |  |
| Cinchocaine | Ciba (Novartis) | 85-79-0 ; 61-12-1 (hydrochloride) |  |
| Cinchonine | Hoffmann La Roche (Roche) | 118-10-5 |  |
| Cinepazet | Delalande | 23887-41-4 |  |
| Cinepazide | Delalande | 23887-46-9 |  |
| Cinflumide | Glaxo-Wellcome (GSK) | 64379-93-7 |  |
| Cinidon-Ethyl | BASF | 132057-06-8 |  |
| Cinitapride | Anphar | 66564-14-5 |  |
| Cinmetacin | Sumitomo Chemical | 20168-99-4 |  |
| Cinmethylin | Shell | 87818-31-3 |  |
| Cinnamedrine | Winthrop (Sanofi-Aventis) | 90-86-8 |  |
| Cinnarizine | Janssen Pharmaceutica (Johnson & Johnson) | 298-57-7 |  |
| Cinolazepam | Gerot Pharmazeutika | 75696-02-5 |  |
| Cinosulfuron | Ciba-Geigy (Novartis) | 94593-91-6 |  |
| Cinoxacin | Eli Lilly | 28657-80-9 |  |
| Cinoxate | Givaudan | 104-28-9 |  |
| Cinryze | | | No Structure |
| Cintredekin besudotox | US National Institute of Health (NIH) | 372075-36-0 | No Structure |
| Cioteronel | CBD | 89672-11-7 |  |
| Cipamfylline | Beecham (GSK) | 132210-43-6 |  |
| Cipemastat | Roche | 174265-38-4 |  |
| Cipralisant | Gliatech | 213027-19-1 |  |
| Ciprodex (Ciprofloxacin & Dexamethasone) | Bayer | |  |
| Ciprofibrate | Sterling Winthrop (Sanofi-Aventis) | 52214-84-3 |  |
| Ciprofloxacin | Bayer | 85721-33-1 |  |
| Ciprokiren | Hoffmann-La Roche | 143631-62-3 |  |
| Ciprostene | Upjohn (Pharmacia) | 81845-44-5 |  |
| Ciproxifan | Inserm | 184025-18-1 |  |
| Ciramadol | American Home Products (Wyeth) | 63269-31-8 |  |
| cis-ACCP | Yissum Research Development Co. (Israel) | 777075-44-2 |  |
| Cisapride | Janssen Pharmaceutica (Johnson & Johnson) | 81098-60-4 |  |
| Cisatracurium Besilate | Wellcome Foundation (GSK) | 96946-42-8 |  |
| Cisplatin | Rosenberg | 15663-27-1 |  |
| Cistinexine | Recordati | 86042-50-4 |  |
| Citalopram | Lundbeck | 59729-33-8 |  |
| Citalopram and Pipamperone (PipCit) | PharmaNeuroBoost N.V. (Belgium) | |  |
| Citatepine | Ciba-Geigy (Novartis) | 65509-66-2 |  |
| Citicoline | Takeda | 987-78-0 |  |
| Citiolone | Degussa | 1195-16-0 |  |
| Civacir | Nabi Biopharmaceuticals | | No Structure |
| Cixutumumab | | 947687-12-9 | No Structure |
| Cizolirtine | Esteve | 142155-43-9 |  |
| CJ-033466 | Pfizer | |  |
| CJ-13454 | Pfizer | |  |
| CJ-13610 | Pfizer | 179420-35-0 |  |
| CJ-13981 | Pfizer | |  |
| CJ-15161 | Pfizer | |  |
| CJ-15208 | Pfizer | |  |
| CJ-17572 | Pfizer | |  |
| CJ-19784 | Pfizer | |  |
| CJ-21058 | Pfizer | |  |
| CJ-23423 | Pfizer | |  |
| CJ-697 | Curacyte Chemistry GMBH | |  |
| CJ-730 | Curacyte Chemistry GMBH | |  |
| CJC-1131 | ConjuChem | |  |
| CJC-1295 | ConjuChem | 863288-34-0 |  |
| CJS-3255 | Cancer Research Technology Ltd. (GB) ; Institute of Cancer Research (GB) ; Astex Therapeutics Ltd. | |  |
| CJS-3678 | Cancer Research Technology Ltd. (GB) ; The Institute of Cancer Research: Royal Cancer Hospital (GB) | |  |
| CK-0106023 | Cytokinetics ; GlaxoSmithKline (GSK) | |  |
| CK-1122697 | Cytokinetics Inc. ; GlaxoSmithKline | |  |
| CK-119 | Yongguang Pharmaceutical | 197917-10-5 |  |
| CK-1200565 | Cytokinetics Inc. (US) ; GlaxoSmithKline (GB) | |  |
| CK-1649C | Schering AG | 125883-03-6 |  |
| CK-2017357 | | | No Structure |
| CK-3197 | Schering AG (Bayer Schering) | 132523-92-3 |  |
| CK-53 | Chern Ji Wang | 149847-76-7 |  |
| CKD-516 | Chong Kun Dang Pharmaceutical Corp. | |  |
| CKD-533 | Chong Kun Dang Pharmaceutical Corp. ; Leadgenex Inc. | |  |
| CKI-27 | Chugai Pharmaceutical Co. Ltd. (Japan) | | No Structure |
| cKM-3413 | Kyowa Hakko Kogyo Co. Ltd. (Japan) | | No Structure |
| CL-142-1 | Laboratorios del Dr. Esteve (Spain) | |  |
| CL-186659 | American Cyanamid (Wyeth) | |  |
| CL-246738 | American Cyanamid (Wyeth) | 81541-32-4 |  |
| CL-275838 | American Cyanamid (Wyeth) | 115931-65-2 |  |
| CL-304,415 | American Cyanamid (BASF) | 31541-57-8 |  |
| CL-306293 | American Cyanamid (Wyeth) | 131745-25-0 |  |
| CL-316243 | American Cyanamid (Wyeth) | 138908-40-4 (2Na) |  |
| CL-331928 | American Cyanamid (Wyeth) | 151922-17-7 |  |
| CL-387626 | American Cyanamid (Wyeth) | 197365-88-1 |  |
| CL-387785 | American Cyanamid (Wyeth) | 194423-06-8 |  |
| Cl-994 | Godecke Research Institute | 112522-64-2 |  |
| Cladribine | Brigham Young University | 4291-63-8 |  |
| Cladribine (Movectro) | | 2-chloro-2'-deoxyadenosine |  |
| Clamikalant | Sanofi-Aventis | 158751-64-5 |  |
| Clanfenur | Duphar | 51213-99-1 |  |
| Clanobutin | Byk Gulden (Nycomed) | 30544-61-7 |  |
| Clarithromycin | Taisho | 81103-11-9 |  |
| Claudiximab | Ganymed Pharmaceuticals AG | | No Structure |
| Clausenamide | Bayer | 103541-15-7 |  |
| Clavalanine | Hoffmann La Roche (Roche) | 74758-63-7 |  |
| Clavaserine | Taiho | 155550-31-5 |  |
| Clavulanic acid | Beecham (GSK) | 58001-44-8 |  |
| Clazosentan | Hoffmann La Roche (Roche) | 180384-56-9 |  |
| Clearazide | | | No Structure |
| Clebopride | Anphar | 55905-53-8 |  |
| Clemastine | Sandoz (Novartis) | 15686-51-8 ; 14976-57-9(Fumarate) |  |
| Clemizole | Schering AG | 442-52-4 |  |
| Clenbuterol | Boehringer Ingelheim | 37148-27-9 |  |
| Clenoliximab | Idec Pharmaceuticals (Biogen Idec) | 182912-58-9 | No Structure |
| Clentiazem | Tanabe | 96125-53-0 |  |
| Clermont-Ferrand-RN-119648-52-1 | Clermont-Ferrand University | 119648-52-1 |  |
| Clethodim | Chevron | 99129-21-2 |  |
| Clevidipine | Astra (AstraZeneca) | 167221-71-8 |  |
| Clevudine | University of Georgia ; Yale University (US) | 163252-36-6 |  |
| Clidanac | Bristol-Myers Squibb (BMS) | 34148-01-1 |  |
| Clidinium bromide | Hoffmann La Roche (Roche) | 3485-62-9 |  |
| Climazolam | Hoffmann La Roche (Roche) | 59467-77-5 |  |
| Climbazol | Bayer | 38083-17-9 |  |
| Clinafloxacin | Kyorin | 105956-97-6 |  |
| Clindamycin | Upjohn (Pharmacia) | 18323-44-9 |  |
| Clindamycin phosphate | Procter Gamble | 24729-96-2 |  |
| Clindamycin phosphate and Tretinoin | Stiefel Laboratories | |  |
| Clinofibrate | Sumitomo Chemical | 30299-08-2 |  |
| ClinOleic | Baxter | | No Structure |
| Clinprost | Teijin | 88931-51-5 |  |
| Clioquinol | Ciba (Novartis) | 130-26-7 |  |
| CLIP-YY | Universita degli studi di Roma tor Vergata | |  |
| CLK-peptide | University of New York | |  |
| Clobazam | Roussel-Uclaf (Aventis) | 22316-47-8 |  |
| Clobenoside | Ciba (Novartis) | 29899-95-4 |  |
| Clobenzorex | S.I.F.A. | 13364-32-4 |  |
| Clobenztropine | Schenley | 5627-46-3 |  |
| Clobetasol propionate | Glaxo (GSK) | 25122-46-7 |  |
| Clobetasone butyrate | Glaxo (GSK) | 25122-57-0 |  |
| Clobutinol | Thomae (Boehringer Ingelheim) | 14860-49-2 |  |
| Clocapramine | Yoshitomi | 47739-98-0 ; 28058-62-0 (hydrochloride) |  |
| Clocinizine | Janssen Pharmaceutica (Johnson & Johnson) | 298-55-5 |  |
| Clocortolone caproate | Schering AG | 4891-71-8 |  |
| Clocortolone pivalate | Schering AG | 34097-16-0 |  |
| Clodantoin | Standard Oil | 5588-20-5 |  |
| Clodinafop-P | Ciba-Geigy (Novartis) | 105512-06-9 |  |
| Clodronic acid | Procter & Gamble | 10596-23-3 |  |
| Cloethocarb | BASF | 51487-69-5 |  |
| Clofarabine | Southern Research Inst. | 123318-82-1 |  |
| Clofazimine | Geigy (Novartis) | 2030-63-9 |  |
| Clofedanol | Bayer | 791-35-5 |  |
| Clofenamide | Merck & Co. | 671-95-4 |  |
| Clofencet | ICI (Syngenta) | 129025-54-3 |  |
| Clofentezine | Fisons | 74115-24-5 |  |
| Clofexamide | CNRS | 1223-36-5 |  |
| Clofezone | SmithKline French (GSK) | 17449-96-6 |  |
| Clofibrate | ICI (AstraZeneca) | 637-07-0 |  |
| Clofibride | Fournier | 26717-47-5 |  |
| Clofoctol | I.R.C.E.B.A. | 37693-01-9 |  |
| Cloforex | Troponwerke | 14261-75-7 |  |
| Clomazone | FMC | 81777-89-1 |  |
| Clomeprop | Mitsubishi Petrochemicals | 84496-56-0 |  |
| Clometacin | Roussel-Uclaf (Aventis) | 25803-14-9 |  |
| Clomethiazole | Hoffmann La Roche (Roche) | 533-45-9 |  |
| Clometocillin | Recher et Ind.Therap. | 1926-49-4 |  |
| Clomifene | Merrell (Aventis) | 911-45-5 |  |
| Clomipramine | Geigy (Novartis) | 303-49-1 |  |
| Clomoxir | Byk Gulden (Nycomed) | 88431-47-4 |  |
| Clonazepam | Hoffmann La Roche (Roche) | 1622-61-3 |  |
| Clonazoline | Secep | 17692-28-3 |  |
| Clonibid (Clonidine hydrochloride) | | 4205-90-7 |  |
| Clonicel (Clonidine hydrochloride) | Joseph H. Horacek | 4205-90-7 |  |
| Clonidine | Boehringer Ingelheim | 4205-90-7 |  |
| Clonixin | Schering Corp (Merck & Co) | 17737-65-4 |  |
| Clopamide | Sandoz (Novartis) | 636-54-4 |  |
| Clopenphendioxan | Recordati | |  |
| Clopenthixol | Kefalas | 982-24-1 |  |
| Cloperastine | Parke, Davis (Pfizer) | 3703-76-2 |  |
| Cloperastine fendizoate | | |  |
| Clopidogrel | Sanofi (Sanofi-Aventis) | 113665-84-2 |  |
| Clopidol | Dow | 2971-90-6 |  |
| Clopimozide | Janssen Pharmaceutica (Johnson & Johnson) | 53179-12-7 |  |
| Cloprednol | Syntex (Roche) | 5251-34-3 |  |
| Cloprop | Rhone-Poulenc | 101-10-0 |  |
| Cloprothiazole | Millet | 6469-36-9 |  |
| Clopyralid | Dow | 1702-17-6 |  |
| Cloquintocet-M | Ciba-Geigy (Novartis) | 99607-70-2 |  |
| Cloracetadol | Roussel (Aventis) | 15687-05-5 |  |
| Cloranolol | Gedeon Richter | 39563-28-5 |  |
| Cloransulam-Methyl | DowElanco | 147150-35-4 |  |
| Clorazepate | Clin-Byla | 20432-69-3 |  |
| Clorexolone | May & Baker (Aventis) | 2127-01-7 |  |
| Cloricromen | Fidia | 68206-94-0 |  |
| Cloridarol | Menarini | 3611-72-1 |  |
| Clormecaine | Wallace & Tiernan | 13930-34-2 |  |
| Clorofene | Lehn & Fink | 120-32-1 |  |
| Cloroqualone | Synlab | 25509-07-3 |  |
| Clorprenaline | Eli Lilly | 3811-25-4 |  |
| Clorsulon | Merck & Co. | 60200-06-8 |  |
| Closantel | Janssen Pharmaceutica (Johnson & Johnson) | 57808-65-8 |  |
| Clostebol acetate | Julian Laboratories | 855-19-6 |  |
| Clostriban | | | No Structure |
| Clothianidin | Takeda | 210880-92-5 |  |
| Clotiapine | Sandoz (Novartis) | 2058-52-8 |  |
| Clotiazepam | Yoshitomi | 33671-46-4 |  |
| Clotrimazole | Bayer | 23593-75-1 |  |
| Clovoxamine | Merckx Gaston | 54739-19-4 |  |
| Cloxacillin | Beecham (GSK) | 61-72-3 |  |
| Cloxazolam | Sankyo | 24166-13-0 |  |
| Cloxiquine | | 130-16-5 |  |
| Cloxyfonac | Ciba (Novartis) | 6386-63-6 |  |
| Clozapine | Wander | 5786-21-0 |  |
| CLS-001 (Omiganan) | Micrologix Biotech (Migenix ) | |  |
| CLT-001 | Novartis AG | | No Structure |
| CLT-003 | Charlesson LLC (US) | |  |
| CLT-008 | Cellerant Therapeutics Inc. | | No Structure |
| CM-101 | University of Vanderbilt | 188417-67-6 | No Structure |
| CM-57493 | Sanofi (Sanofi-Aventis) | 84226-38-0 |  |
| CMC-001 | CMC Contrast AB | | No Structure |
| CMDA | Cancer Research Campaign Technologies | 122665-73-0 |  |
| CMI-392 | CytoMed | 154544-24-8 |  |
| CMP-015 | Amgen Inc. (US) | |  |
| CMS-010.26 | Pepharm | |  |
| CMV-DC | Duke University (US) | | No Structure |
| CMV-MVA | City of Hope (US) | | No Structure |
| CMX-157 | Chinese Academy of Medical Sciences (China) ; Chimerix Inc. (US) | |  |
| CNB-001 | The Salk Institute for Biological Studies (US) | |  |
| CNBA | Radopath | 2516-96-3 |  |
| CNDAC | Sankyo | 135598-68-4 |  |
| CNDR-3 | Acidophil LLC (US) | |  |
| CNF-1010 (Tanespimycin) | Conforma Therapeutics (Biogen Idec) | |  |
| CNIH-0294 | Picower Inst. of Medical Research | |  |
| CnIIIA | Atheris Laboratories (Switzerland) ; Centre National de la Recherche Scientifique (France) | |  |
| CNS-1531 | Cambridge NeuroScience | |  |
| CNS-5161 | Cambridge NeuroScience (CeNeS) | 160754-76-7 |  |
| CNS-5788 | Cambridge NeuroScience | 342047-49-8 |  |
| CNTO-4874 | Centocor | | No Structure |
| CO-101244 | Warner Lambert (Pfizer) | 193359-26-1 |  |
| CO-102862 | Saskatchewan University | 181144-66-1 |  |
| CO-127501 | Cocensys | 171494-14-7 |  |
| CO-134444 | Cocensys | 256955-84-7 |  |
| CO-152791 | Cocensys | 162882-63-5 |  |
| CO-177843 | Cocensys | 256955-85-8 |  |
| CO-21970 | CoCensys | 177080-77-2 |  |
| CO-26749 | CoCensys | |  |
| co-poly (D,L-lactic - glycolic acid) | Southern Research Institut | | No Structure |
| [Co(NH3)5Indo](SO3CF3)2 | Medical Therapies Ltd. (Australia) | |  |
| Cobalarubicin | University of Utah | |  |
| Cobamamide | Yamanouchi Pharma | 13870-90-1 |  |
| Cobicistat | Gilead | 1004316-88-4 |  |
| Cobiprostone | | 333963-42-1 |  |
| COBRA-2 | Parker Hughes Institute | |  |
| Cocaethylene | | 529-38-4 |  |
| Cocarboxylase | E. Merck KGaA | 154-87-0 |  |
| Codeine | | 76-57-3 |  |
| Codlemone | Zoecon | 33956-49-9 |  |
| COG-133 | Cognosci Inc. | |  |
| COG-1410 | Cognosci Inc. (US) | |  |
| Cogane | Phytopharm | 126-18-1 |  |
| COL-003 | | | No Structure |
| COL-121 | | | No Structure |
| Colchicine | | 64-86-8 |  |
| Colecalciferol | Hoffmann La Roche (Roche) | 67-97-0 |  |
| Coleneuramide | Mitsubishi Chemicals (Japan) | 204200-47-5 |  |
| Colesevelam | GelTex | 182815-43-6 ; 182815-44-7 (hydrochloride) |  |
| Colestilan | Mitsubishi | 95522-45-5 |  |
| Colforsin | Schering Corp (Merck & Co) | 66575-29-9 |  |
| Colforsin Daropate | Nippon Kayaku | 113462-26-3 |  |
| Colfosceril Palmitate | University of California | 63-89-8 |  |
| Colistimethate sodium | Wellcome (GSK) | 8068-28-8 |  |
| Colistin sodium methanesulfonate | Kayaku Antibiotic Research Co, (Japan) | 8068-28-8 |  |
| Colivelin | Keio University | |  |
| Collagen | | 9007-34-5 | No Structure |
| Collagenase | BioSpecifics Technologies (BTC) | 9001-12-1 | No Structure |
| Coluracetam | Ono Pharmaceutical | 135463-81-9 |  |
| CombiHIVvac | State Research Center of Virology and Biotechnology “Vector” (Russian Federation) | | No Structure |
| Combretastatin A-4 | University of Arizona | 117048-59-6 |  |
| Combretastatin A4 Phosphate | University of Arizona | 222030-63-9 (disodium salt) ; 404886-32-4 (tromethamine) |  |
| Compound 003 | Parker Hughes Institute | 149560-32-7 |  |
| Compound 343 | University of Illinois (US) | |  |
| Compound A | Merck | 462122-83-4 |  |
| Compound K | Merck & Co. | 160729-91-9 |  |
| Compound W | Shionogi | |  |
| Conagenin | Kanegafuchi | 134381-30-9 |  |
| Conantokin-G | Cognetix | 93438-65-4 |  |
| Conantokin-R | Cognetix ; Univ of Utah ; CytoTherapeutics | |  |
| Conatumumab | UAB Research Fondation | 896731-82-1 | No Structure |
| Coniosetin | Aventis Pharma | |  |
| Conivaptan | Yamanouchi (Astellas) | 179528-39-3 |  |
| Conocurvone | US Department of Health & Human Services | 149572-31-6 |  |
| Contignasterol | InflaZyme | 137571-30-3 |  |
| Contulakin G | Cognetix Inc. ; University of Utah ; Salk Institute (US) | 229180-41-0 |  |
| Contusugene ladenovec | Introgen Therapeutics ; Gendux | 600735-73-7 | No Structure |
| Convivia (Fomepizole) | Convivia (Bennu Pharmaceuticals) | 7554-65-6 |  |
| COR-32-24 | Sarget | 91595-86-7 |  |
| Corbadrine | Winthrop (Sanofi-Synthelabo) | 18829-78-2 |  |
| Cordycepin | Oxigene | 73-03-0 |  |
| Corifollitropin alfa | | 195962-23-3 | No Structure |
| CORM-3 | Northwick Park Institute of Medical Research (NPIMR) ; University of Sheffield | |  |
| Cornexistin | Sankyo | 123068-35-9 |  |
| Cortagine | Max Planck Gesellschaft | |  |
| Cortexolone 17alpha-propionate | Cosmo SpA | 19608-29-8 |  |
| Corticorelin | The Salk Institute | 79804-71-0 |  |
| Cortisone | Upjohn (Pharmacia) | 53-06-5 |  |
| Cortivazol | Merck & Co. | 1110-40-3 |  |
| Cosalane | Purdue Research Foundation ; US Army | 154212-56-3 |  |
| Cositecan | BioNumerik | 203923-89-1 |  |
| Costatolide | US Department of Health & Human Services | |  |
| Cotarnine | | 82-54-2 |  |
| Cotinine | LecTec | 486-56-6 |  |
| Coumachlor | Penick | 81-82-3 |  |
| Coumaphos | Bayer | 56-72-4 |  |
| Coumarin | | 91-64-5 |  |
| Coumatetralyl | Bayer | 5836-29-3 |  |
| Coumetarol | Amsterdamsche Chininefabriek | 4366-18-1 |  |
| CP-0597 | Cortech | 172834-07-0 |  |
| CP-060S | Chugai (Roche) | 162923-77-5 |  |
| CP-105696 | Pfizer | 158081-99-3 |  |
| CP-114271 | Thomae (Boehringer Ingelheim) | |  |
| CP-122288 | Pfizer | 143321-74-8 |  |
| CP-122721 | Pfizer | 145742-28-5 |  |
| CP-154526 | Pfizer | |  |
| CP-195543 | Pfizer | 204981-48-6 |  |
| CP-199331 | Pfizer | |  |
| CP-2117 | Cryptopharma | |  |
| CP-220629 | Pfizer | 162141-96-0 |  |
| CP-2289 | Meiji Seika ; Kouichi Shuto | 159731-41-6 |  |
| CP-248 | Cell Pathways | |  |
| CP-265298 | Pfizer | |  |
| CP-283097 | Pfizer | 171866-31-2 |  |
| CP-288886 | Pfizer | 221332-74-7 |  |
| CP-292597 | Pfizer | |  |
| CP-293019 | Pfizer | 179089-90-8 |  |
| CP-293121 | Pfizer | 223919-71-9 |  |
| CP-31398 | Pfizer | |  |
| CP-316,311 | Pfizer Inc. | |  |
| CP-319340 | Pfizer | |  |
| CP-331 | Zeria | 127966-70-5 |  |
| CP-331684 | Pfizer | 207922-70-1 |  |
| CP-346086 | Pfizer | |  |
| CP-376,395 | Pfizer Inc. (US) | 175140-00-8 (as hydrochloride salt) |  |
| CP-394531 | Pfizer | |  |
| CP-409069 | Pfizer | |  |
| CP-4200 | Mount Sinai School of Medicine (US) | |  |
| CP-432 | Pfizer | |  |
| CP-461 | Cell Pathways (OSI Pharmaceuticals) | 227619-92-3 ; 227619-96-7 (HCl) |  |
| CP-464709 | Pfizer Inc. (US) | |  |
| CP-465022 | Pfizer | 199655-36-2 |  |
| CP-466722 | Pfizer Inc. | 1080622-86-1 |  |
| CP-467688 | Pfizer | |  |
| CP-471474 | Pfizer | 210755-45-6 |  |
| CP-472555 | Pfizer | |  |
| CP-481715 | Pfizer | |  |
| CP-5017808 | Compass Pharmaceuticals | |  |
| CP-5068 | Meiji Seika | 352305-79-4 |  |
| CP-536404 | Pfizer | |  |
| CP-544372 | Taisho ; Pfizer | |  |
| CP-547632 | OSI Pharmaceuticals ; Pfizer | |  |
| CP-5484 | Meiji Seika Kaisha Ltd. (Japan) | |  |
| CP-55,950 | Virginia University | |  |
| CP-55940 | Pfizer | 83003-12-7 |  |
| CP-5609 | Meiji Seika | |  |
| CP-564959 | Pfizer | | No Structure |
| CP-600 | | |  |
| CP-601073 | Pfizer | |  |
| CP-601927 | | | No Structure |
| CP-610 | | |  |
| CP-615003 | Neurogen | |  |
| CP-640922 | Pfizer | |  |
| CP-642959 | Pfizer | 271795-55-2 |  |
| CP-654743 | Pfizer | |  |
| CP-6679 | Meiji Seika | 165666-67-1 |  |
| CP-66948 | Pfizer | 101189-47-3 |  |
| CP-671305 | Pfizer | |  |
| CP-673451 | Pfizer | |  |
| CP-67804 | Pfizer | |  |
| CP-695516 | Pfizer | |  |
| CP-724714 | Pfizer | |  |
| CP-741952 | Pfizer | | No Structure |
| CP-744809 | Pfizer | |  |
| CP-74667 | Pfizer | 108461 |  |
| CP-778875 | Pfizer | | No Structure |
| CP-79328 | Pfizer | 126612-52-0 |  |
| CP-800569 | Pfizer Inc. (US) | |  |
| CP-809101 | Pfizer | |  |
| CP-810123 | Pfizer Inc. | |  |
| CP-83101 | Pfizer | 120360-17-0 |  |
| CP-866087 | Pfizer | | No Structure |
| CP-8661 | Meiji Seika | 532435-69-1 |  |
| CP-868388 | Pfizer Inc. (US) | |  |
| CP-868596 | Pfizer | |  |
| CP-8754 | Meiji Seika | 532435-68-0 |  |
| CP-903397 | Pfizer | | No Structure |
| CP-93129 | Pfizer | 127792-75-0 |  |
| CP-94 | Royal Free Hospital | 115900-75-9 |  |
| CP-94707 | Pfizer | |  |
| CP-96345 | Pfizer | 132746-60-2 |  |
| CP-99994 | Pfizer | 136982-36-0 |  |
| CP-DOX (Doxorubicin) | Duke University (US) | 23214-92-8 |  |
| CPA-4 | Dow | 122-88-3 |  |
| CPA-926 | Kureha | 169673-60-3 |  |
| CPC-410 | Colby Pharmaceutical Co. ; Medical College of Wisconsin Inc. (US) | |  |
| CPC-P-501 | Glaxosmithkline Biologicals | | No Structure |
| Cpd-A | Banyu | |  |
| CPG-52364 | | | No Structure |
| CpG-9328 | | | No Structure |
| CpG-Stat3 siRNA | City of Hope (US) | | No Structure |
| CPI-1189 | Centaur Pharmaceuticals (Renovis) | 183619-38-7 |  |
| CPI-613 | Cornerstone Pharmaceuticals Inc. (US) | |  |
| CPN-01 | Universidad del Pais Vasco (Spain) ; Dominion Pharmakine SL (Spain) | |  |
| CPR-1006 | Clarion Pharmaceuticals (US) | 179458-18-5 |  |
| CPR-2006 | Clarion | 213011-13-3 |  |
| CPR-2015 | Clarion | 195622-32-3 |  |
| CPR-3005 | Clarion pharmaceuticals | |  |
| CPR-7011 | Clarion | 63-89-8 |  |
| CPS-11 | Gruenenthal | 145945-21-7 |  |
| CPS-3 | National Inst. of Health (NIH) | |  |
| CPS-44 | National Inst. of Health (NIH) | 352017-51-7 |  |
| CPS-45 | National Inst. of Health (NIH) | 352017-47-1 |  |
| CPS-48 | National Inst. of Health (NIH) | 352017-42-6 |  |
| CPS-49 | National Inst. of Health (NIH) | 352017-52-8 |  |
| CPSI-2705 | Cytokine PharmaSciences | | No Structure |
| CPT-154 | Ist Naz Stud Cura Dei Tumori ; Sigma Tau Ind Farmaceuti | 292620-93-0 |  |
| CPT-2001 | University of Cardiff | |  |
| CPU-228 | China Pharmaceutical University (China) | |  |
| CPU-II2 | China Pharmaceutical University (China) | |  |
| CPX | Warner Lambert (Pfizer) | 102146-07-6 |  |
| CPX-1 (Irinotecan & Floxuridine) | Celator Technologies Inc. | 97682-44-5 (Irinotecan) ; 50-91-9 (Floxuridine) |  |
| CPX-351 (Cytarabine & Daunorubicin) | Celator Pharmaceuticals | |  |
| CPX-571 (Irinotecan & Cisplatin) | Celator Technologies Inc. | 97682-44-5 (Irinotecan) ; 15663-27-1 (Cisplatin) |  |
| CPyPB | Merck & Co. Inc. (US) | |  |
| CQ-0011 | Cortech | |  |
| CR-002 | Abgenix ; CuraGen Corporation | | No Structure |
| CR-2622 | Rotta Research | 171202-74-7 |  |
| CR-3124 | Rottapharm S.p.A. | |  |
| CR-3210 | Rottapharm | |  |
| CR-3294 | Rotta Reasearch | |  |
| CR-4 | HSC R&D Partnership | |  |
| CR-6261 | Crucell Holland BV (Netherlands) | | No Structure |
| CR-665 | Ferring International Center SA (Switzerland) | |  |
| CR-845 | | | No Structure |
| CRA-013783 | Axys Pharm | |  |
| CRA-024781 | Axys Pharmaceuticals | |  |
| CRA-026440 | Axys Pharmaceuticals (Celera Genomics) | |  |
| CRA-0316 | Taisho Pharmaceutical | |  |
| CRA-1000 | Taisho | 226948-11-4 |  |
| CRA-1001 | Taisho | 229346-94-5 |  |
| CRA-3316 | Axys (Celera Genomics) | |  |
| Crambescidin 816 | Sandoz (Novartis) | 135257-45-3 |  |
| CRC-47 | Hospital For Sick Children | |  |
| CRC-94-17 | Stanford Research Inst. | 167648-73-9 |  |
| CRD-82 | Hospital For Sick Children | |  |
| CRE-16257 | Merck KGaA ; Ono Pharmaceutical | | No Structure |
| CRE-16336 | E. Merck KGaA | 200631-89-6 |  |
| CRE-652 | Cermol | 159063-40-8 |  |
| Creatinolfosfate | Siphar | 6903-79-3 |  |
| CRH-48 | Hospital For Sick Children | |  |
| CRH-58 | Hospital For Sick Children | |  |
| Crilvastatin | Pan Medica | 120551-59-9 |  |
| Crisnatol | Burroughs Wellcome (GSK) | 96389-68-3 |  |
| CRIX-39 | Hospital for Sick Children | |  |
| Crizotinib | Agouron (Pfizer) | 877399-52-5 |  |
| CRL-1072 | CytRx | 223572-54-1 | No Structure |
| CRL-8293 | Lafon | |  |
| CRL-8294 | Lafon | |  |
| CRL-8363 | Lafon | |  |
| CRL-8364 | Lafon | |  |
| CRL-8367 | Lafon | |  |
| CRL-8388 | Lafon | |  |
| CRL-8396 | Lafon | |  |
| CRL-8400 | Lafon | |  |
| CRL-8401 | Lafon | |  |
| CRL-8440 | Lafon | |  |
| CRO-70 | Hospital For Sick Children | |  |
| Crobenetine | Boehringer Ingelheim | 221019-25-6 |  |
| Croconazole | Shionogi | 77175-51-0 |  |
| Crofelemer | Shaman (Napo Pharmaceuticals) | 148465-45-6 |  |
| Crolibulin | Cytovia (EpiCept) | 1000852-17-4 |  |
| Cromafiban | Cor Therapeutics | 916909-03-0 | No Structure |
| Cromoglicic acid | Fisons | 16110-51-3 |  |
| Cropropamide | Geigy (Novartis) | 3544-46-5 |  |
| Crotamiton | Geigy (Novartis) | 483-63-6 |  |
| Crotetamide | Geigy (Novartis) | 6168-76-9 |  |
| Crotoxyphos | Shell | 7700-17-6 |  |
| CRS-207 | Cerus Corp. | | No Structure |
| CRTX-058 | Pfab Lp (Neos Therapeutics Inc.) | | No Structure |
| CRTX-067 (Chlorphenamine & Hydrocodone) | | 132-22-9 (Chlorphenamine) ; 125-29-1 (Hydrocodone) |  |
| CRTX-069 | Cornerstone Therapeutics Inc. | | No Structure |
| CRTX-070 | Cornerstone Therapeutics Inc. | | No Structure |
| CRTX-072 | Cornerstone Therapeutics Inc. | | No Structure |
| CRTX-074 | Cornerstone Therapeutics Inc. | | No Structure |
| CRVIII-51 | Hospital for Sick Children | |  |
| CRx-102 (Prednisolone & Dipyridamole) | CombinatoRx | |  |
| CRX-103 | Corixa | |  |
| CRx-119 (Prednisolone & Amoxapine) | CombinatoRx | |  |
| CRx-170 (Prednisolone & Nortriptyline) | CombinatoRx | |  |
| CRX-395 | Corixa | |  |
| Cryptophycin-52 | University HAWAII (US) ; University WAYNE STATE (US) | 186256-67-7 |  |
| Cryptotanshinone | | 35825-57-1 |  |
| CS-0777 | | | No Structure |
| CS-1036 | | | No Structure |
| CS-17 | Cedars-Sinai Medical Center (US) | | No Structure |
| CS-3030 | Daiichi-Sankyo | | No Structure |
| CS-3955 | Kureha | | No Structure |
| CS-526 | Daiichi Sankyo Co. Ltd. (Japan) ; Ube Industries Ltd. (Japan) | |  |
| CS-560 | Sankyo ; Hayashibara | 358985-10-1 | No Structure |
| CS-570 | Sankyo | 71806-48-9 |  |
| CS-8080 | | | No Structure |
| CS-834 | Sankyo | 157542-49-9 |  |
| CS-8359 | Sankyo | 119670-32-5 |  |
| CS-8635 (Olmesartan Medoxomil & Amlodipine & Hydrochlorothiazide) | Daiichi Sankyo Co Ltd. (Japan) | |  |
| CS-8663 (Olmesartan & Amlodipine) | | | No Structure |
| CS-866AZ (Olmesartan & Azelnidipine) | Sankyo | |  |
| CS-866CMB (Olmesartan & Hydrochlorothiazide) | Sankyo | |  |
| CS-866RN (Olmesartan) | Sankyo (Daiichi-Sankyo) | |  |
| CS-8958 | Sankyo (Daiichi-Sankyo) | | No Structure |
| CS-932 | Sankyo | 138731-25-6 |  |
| CSA-13 | Brigham Young University | |  |
| CSA-8 | Brigham Young University | |  |
| CSL-111 | ZLB Bioplasma AG (CSL Limited) | | No Structure |
| CSL-112 | CSL Behring GmbH (CSL Ltd.) | | No Structure |
| CSL-362 | CSL Ltd. ; University Health Network (Canada) | | No Structure |
| CSL-401 | CSL Ltd. (Australia) | | No Structure |
| CSL-425 | CSL Ltd. | | No Structure |
| CSRF-21 | Alvine Pharmaceuticals Inc. (US) ; Pharmix Corp. (US) | |  |
| CSRF-6 | Alvine Pharmaceuticals Inc. (US) ; Pharmix Corp. (US) | |  |
| CT-052923 | Kyowa Hakko | |  |
| CT-12441 | Cell Therapeutics | 301536-56-1 |  |
| CT-13430 | Cell Therapeutics | 444602-44-2 |  |
| CT-13431 | Cell Therapeutics | 444602-47-5 |  |
| CT-14 | University of Southern California (US) | |  |
| CT-17 | University Of Kentucky Research Foundation, (US) | |  |
| CT-19 | University of Southern California (US) | |  |
| CT-2576 | Cell Therapeutics | 166981-11-9 |  |
| CT-2584 | Cell Therapeutics | |  |
| CT-30146 | Cell Therapeutics | |  |
| CT-30260 | Cell Therapeutics | |  |
| CT-32228 | Cell Therapeutics | 521064-34-6 |  |
| CT-32615 | Cell Therapeutics | |  |
| CT-327 | Creabilis Therapeutics | |  |
| CT-3610 | Hoffmann La Roche ; Virginia Commonwealth University | |  |
| CT-47463 | Cell Therapeutics (Italy) | |  |
| CT-47518 | Cell Therapeutics (Italy) | |  |
| CT-47609 | Cell Therapeutics Inc. (US) | |  |
| CT-47613 | Cell Therapeutics Inc. (US) | |  |
| CT-50547 | COR Therapeutics | |  |
| CT-51464 | Eli Lilly ; COR Therapeutics ; Millennium Pharmaceuticals (Takeda) | |  |
| CT-53605 | Kyowa Hakko Kogyo | |  |
| CT-53986 | Kyowa Hakko Kogyo | |  |
| CT-54254 | Kyowa Hakko Kogyo | |  |
| CT-637 | Creabilis Therapeutics SpA | | No Structure |
| CT-747 | Athena ; American Home Products (AHP) | |  |
| CT-802 | Creabilis Therapeutics SpA | | No Structure |
| CT112K | National Institute of Infectious disease, Japan | | No Structure |
| CTA-018 | Univ. Johns Hopkins (US) ; Cytochroma Inc. (Canada) | 250384-82-8 |  |
| CTAP-101 | Proventiv Therapeutics (Cytochroma) | | No Structure |
| CTAP-201 | Cytochroma | | No Structure |
| CTC-150 | Charterhouse Therapeutics | |  |
| CTC-74 | Charterhouse Therapeutics | |  |
| CTCE-0021 | University of British Columbia ; Chemokine Therapeutics | |  |
| CTCE-0022 | University of British Columbia ; Chemokine Therapeutics | | No Structure |
| CTCE-0214 | Chemokine Therapeutics | |  |
| CTCE-9908 | UBC (University of British Columbia) | |  |
| CTM-228 | Charterhouse Therapeutics | |  |
| CTM-49 | Charterhouse Therapeutics | |  |
| CTM-68 | Charterhouse Therapeutics | |  |
| CTP-37 | | | No Structure |
| CTS-21166 | | | No Structure |
| Cu-GTSM | University of Melbourne (Australia) | |  |
| CUDC-101 | Curis Inc. (US) | |  |
| Cumyluron | Nihon Carlit | 99485-76-4 |  |
| Cuprimyxin | Roche | 28069-65-0 |  |
| CUR-61414 | Curis | |  |
| Curacin A | Oregon State University ; Corvallis | 155233-30-0 |  |
| Curcuma longa curcuminoids | Sami Chemicals & Extracts Ltd., (India) | |  |
| Curcumin | Hoechst (Aventis) | 458-37-7 |  |
| Curdlan sulfate | Ajinomoto | 115743-28-7 |  |
| Curvularol | Taiho | 339293-67-3 |  |
| Custirsen | Isis Pharmaceuticals | 903916-27-8 ; 685922-56-9 (Na) | No Structure |
| Custodiol | Chemie GmbH | 674309-46-7 | No Structure |
| Cutamesine | Santen | 165377-43-5 |  |
| Cuvposa (Glycopyrronium bromide) | First Horizon (Shionogi)) | 596-51-0 |  |
| CV-11194 | Takeda | 136284-47-4 |  |
| CV-3611 | Takeda | 98829-12-0 |  |
| CV-5975 | Takeda | 100277-62-1 |  |
| CV-6209 | Takeda | 100488-87-7 |  |
| CV-6504 | Takeda | 117574-40-0 |  |
| CV-9103 | CureVac GmbH | | No Structure |
| CV-9201 | CureVac GmbH | | No Structure |
| CVD-1208S | University of Maryland | | No Structure |
| CVS-2589 | Corvas | |  |
| CVS-3983 | Corvas (Dendreon Corp)) | |  |
| CVT-12012 | Gilead Sciences Inc. (US) | |  |
| CVT-12805 | Gilead Sciences Inc. (US) | |  |
| CVT-2584 | CV Therapeutics (Gilead) | 287187-93-3 |  |
| CVT-2759 | CV Therapeutics (Gilead) | 342419-10-7 |  |
| CVT-3033 | CV Therapeutics (Gilead) | |  |
| CVT-313 | CV Therapeutics (Gilead) | 199986-75-9 |  |
| CVT-3501 (R) | CV Therapeutics (Gilead) | |  |
| CVT-4325 | CV Therapeutics (Gilead) | |  |
| CVT-4681 | CV Therapeutics (Gilead) | |  |
| CVT-4928 | CV Therapeutics (Gilead) | |  |
| CVT-5299 | CV Therapeutics (Gilead) | |  |
| CVT-5306 | CV Therapeutics (Gilead) | |  |
| CVT-5440 | CV Therapeutics (Gilead) | |  |
| CVT-5450 | CV Therapeutics (Gilead) | |  |
| CVT-6275 | CV Therapeutics (Gilead) | |  |
| CVT-634 | CV Therapeutics (Gilead) | 206005-40-5 |  |
| CVT-6660 | CV Therapeutics (Gilead) | |  |
| CVT-6883 | CV Therapeutics (Gilead) | 752222-83-6 |  |
| CVT-6975 | CV Therapeutics (Gilead) | |  |
| CVT-7136 | CV Therapeutics (Gilead) | |  |
| CVT-E002 | | | No Structure |
| CVT-P040 | CV Technologies | |  |
| CVT-P041 | CV Technologies | |  |
| CVT-P046 | | |  |
| CVT-P047 | CV Technologies | |  |
| CVT-PP019 | CV Technologies | |  |
| CVT-PP022 | CV Technologies | |  |
| CVX-096 | CovX | | No Structure |
| CVX-241 | CovX Technologies Ireland Ltd. (Pfizer Inc.) | | No Structure |
| CX-009 | Krenitsky Pharmaceutical Inc. | |  |
| CX-1535 | Cyclene Pharmaceuticals | |  |
| CX-157 | Krenitsky Pharmaceuticals | |  |
| CX-2614 | Krenitsky Pharmaceutical Inc. | |  |
| CX-295 | Eckmiller Marion | 160399-35-9 |  |
| CX-4328 | Boehringer Ingelheim GmbH | |  |
| CX-5011 | Cylene Pharmaceuticals Inc. (US) | |  |
| CX-516 | University of California | 154235-83-3 |  |
| CX-546 | Cortex ; University of California | 215923-54-9 |  |
| CX-659S | Japan Energy | 204980-81-4 |  |
| CX-717 | Cortex Pharmaceuticals | | No Structure |
| Cx1 | Université Henri Poincaré (France) | |  |
| CXA-101 | Fujisawa Pharmaceutical ; Wakunaga Pharma | |  |
| CXA-201 (CXA-101 & Tazobactam) | | |  |
| CXB-006 | Neuroscienze PharmaNess Scarl | | No Structure |
| CXB-029 | Neuroscienze PharmaNess Scarl | | No Structure |
| CXB-040 | Neuroscienze PharmaNess Scarl | | No Structure |
| CXB-070 | Neuroscienze PharmaNess Scarl | | No Structure |
| CXB-724 | CeNeRx BioPharma Inc. | |  |
| CY-1747 | Cytel (Epimmune) | 197179-37-6 | No Structure |
| CY-1748 | Cytel (Epimmune) | 339186-13-9 | No Structure |
| CYA-246 | Wyeth ; Pfizer | | No Structure |
| Cyamemazine | Rhone-Poulenc (Aventis) | 3546-03-0 |  |
| CYAN-416-B butyrate | Wyeth | |  |
| CYAN-416-B hexanoate | Wyeth | |  |
| CYAN-416-B isobutyrate | Wyeth | |  |
| Cyanazine | DuPont | 21725-46-2 |  |
| Cyanidin | | 13306-05-3 ; 528-58-5 (chloride) |  |
| Cyanocobalamin | Merck & Co | 68-19-9 |  |
| Cyanophos | Sumitomo Chemical | 2636-26-2 |  |
| Cyantraniliprole | Du Pont De Nemours | 736994-63-1 |  |
| Cyazofamid | Ishihara | 120116-88-3 |  |
| Cybutryne | Agripat | 28159-98-0 |  |
| CYC-116 | Cyclacel Pharmaceuticals | |  |
| Cyclamate | DuPont | 100-88-9 |  |
| Cyclandelate | Koninklijke Pharma | 456-59-7 |  |
| Cyclanilide | Rhone-Poulenc | 113136-77-9 |  |
| Cyclipostin R | Aventis | |  |
| Cyclizine | Burroughs Wellcome (GSK) | 82-92-8 |  |
| Cycloastragenol | Geron ; Hong Kong University Of Science & Technology | 84605-18-5 |  |
| Cycloate | Stauffer | 1134-23-2 |  |
| Cyclobarbital | Bayer | 52-31-3 |  |
| Cyclobenzaprine | Hoffmann La Roche (Roche) | 303-53-7 |  |
| Cyclobut A | Squibb (BMS) | 124770-85-0 |  |
| Cyclobut G | Squibb (BMS) | 126062-18-8 |  |
| Cyclobutyrol | Logeais | 512-16-3 |  |
| Cyclocreatine | Amira | 35404-50-3 |  |
| Cyclodrine | University of Michigan | 52109-93-0 |  |
| Cyclofenil | Ferrosan | 2624-43-3 |  |
| Cycloguanil | Children's Cancer Research Foundation | 516-21-2 |  |
| Cycloleucine | US Department of Health & Human Services | 52-52-8 |  |
| Cyclomarin-A | University of Minnesota | 169062-92-4 |  |
| Cyclomethycaine | Eli Lilly | 139-62-8 |  |
| Cyclopamine | John Hopkins University | 4449-51-8 |  |
| Cyclopenthiazide | Ciba (Novartis) | 742-20-1 |  |
| Cyclopentolate | Schieffelin & Co | 512-15-2 |  |
| Cyclophosphamide | Bristol-Myers Squibb (BMS) | 50-18-0 |  |
| Cycloplatam | Russian Academy of Sciences | 109837-67-4 |  |
| Cycloproparadicicol | Sloan-Kettering Institute | |  |
| Cyclopropavir | University of Michigan | |  |
| Cycloprothrin | Commowealth Scientific & Industrial Research Organization | 63935-38-6 |  |
| Cycloserine | Pfizer | 68-41-7 |  |
| Cyclosin | | 20575-57-9 |  |
| Cyclosulfamuron | American Cyanamid (BASF) | 136849-15-5 |  |
| Cyclothiazide | Thomae (Boehringer Ingelheim) | 2259-96-3 |  |
| Cyclovalone | Waldheim | 579-23-7 |  |
| Cycloxydim | BASF | 101205-02-1 |  |
| Cyenopyrafen | Nissan Chemical | 560121-52-0 |  |
| Cyflufenamid | Nippon Soda | 180409-60-3 |  |
| Cyflumetofen | Otsuka | 400882-07-7 |  |
| Cyfluthrin | Bayer | 68359-37-5 |  |
| Cyhalofop-butyl | DowElanco | 122008-78-0 |  |
| Cyhexatin | Dow | 13121-70-5 |  |
| Cymoxanil | DuPont | 57966-95-7 |  |
| CyMVectin | Vical Inc. | | No Structure |
| Cynarine | Farmitalia Carlo Erba (Pharmacia) | 1884-24-8 |  |
| CYP-PA1 | Cypros Pharmaceuticals | |  |
| Cypermethrin | National Research Development Corporation (NRDC) | 52315-07-8 |  |
| Cyphenothrin | Sumitomo Chemical | 39515-40-7 |  |
| Cyproconazole | Sandoz (Syngenta) | 113096-99-4 |  |
| Cyprodenate | Menarini | 15585-86-1 |  |
| Cyprodinil | Ciba-Geigy (Novartis) | 121552-61-2 |  |
| Cyproheptadine | Merck & Co. | 129-03-3 |  |
| Cyproquinate | Ciba (Novartis) | 19485-08-6 |  |
| Cyprosulfamide | Bayer | 221667-31-8 |  |
| Cyproterone acetate | Schering AG | 427-51-0 |  |
| Cyromazine | Ciba-Geigy (Novartis) | 66215-27-8 |  |
| Cysmethynil | Duke University | |  |
| Cystadrops (Mercaptamine) | Sigma-Tau Industrie Farmaceutiche Riunite SpA | 60-23-1 |  |
| Cysteine-125 | Chiron Corporation | | No Structure |
| Cystemustine | CNRS | 79955-36-5 |  |
| CYT-007-TNFQb | Cytos Biotechnology AG | | No Structure |
| CYT-009-GhrQb | Cytos Biotechnology AG | | No Structure |
| CYT-387 | Cytopia Research Pty Ltd. (Australia) | |  |
| CYT-500 | Cytogen Corporation | | No Structure |
| CYT-99007 | Cytheris | | No Structure |
| CYT-997 | Cytopia Research Pty Ltd. (Australia) | |  |
| CYT006-AngQb | Cytos Biotechnology AG (Switzerland) | | No Structure |
| Cytarabine | Upjohn (Pfizer) | 147-94-4 |  |
| Cytarabine elaidate | Norsk Hydro AS (Clavis Pharma) | 188181-42-2 |  |
| Cythioate | American Cyanamid (Wyeth) | 115-93-5 |  |
| Cytidine | Ursapharm | 65-46-3 |  |
| Cytochlor | Halogenetics | 32387-56-7 |  |
| CytoFab (TM) | | | No Structure |
| Cytolin | Allen D. Allen ; CytoDyn | 53663-71-1 | No Structure |
| Cytomodulin | University of California | |  |
| Cytosporone B | Xiamen University (China) | 321661-62-5 |  |
| Cytotrienin-A | Rikagaku Kenkyusho | 189010-85-3 |  |
| CZ-112 | Stehlin Foundation for Cancer | 194414-80-7 |  |
| CZ-236 | Stehlin Foundation for Cancer Research | |  |
| CZ-48 | | |  |
| CZEN-002 | Zengen (US) | 457605-12-8 |  |
| D-[113-122]apoJ | University of California | |  |
| D-004 | Laboratorios Dalmer | | No Structure |
| D-106669 | AEterna Zentaris GmbH (Germany) | |  |
| D-14 | Universita degli Studi di Firenze ; Universita degli Studi di Pisa ; Sanofi-Synthelabo | 488760-80-1 |  |
| D-159404 | deCODE Genetics EHF | |  |
| D-159687 | deCODE Genetics EHF | |  |
| D-2,4 | US Rubber | 94-75-7 |  |
| D-20317 | AEterna Zentaris Inc. (Canada) | |  |
| D-21004 | Asta Medica (Baxter Oncology) | |  |
| D-21005 | Asta Medica (Baxter Oncology) | |  |
| D-21805 | Asta Medica (Baxter Oncology) | 156825-86-4 |  |
| D-237 | Wayne State University (US) | |  |
| D-3252 | Protein Sciences Corp. | | No Structure |
| D-3263 | Dendreon Corp. (US) | | No Structure |
| D-3862 | Nippon Soda | 216572-01-9 |  |
| D-43787 | Asta Medica | 198016-44-3 |  |
| D-4418 | Chiroscience (CellTech) | 199871-60-8 |  |
| D-4476 | Smithkline Beecham Corp. (GlaxoSmithKline plc) | 301836-43-1 |  |
| D-609 | Merz | 83373-60-8 |  |
| D-69429 | Asta Medica (Zentaris) | |  |
| D-69491 | Sugen | 499134-60-0 |  |
| D-70166 | Sugen | 346600-00-8 |  |
| D-709119 | University of Portsmouth | 260544-29-4 |  |
| D-723333-P | Albert Einstein College of Medicine of Yeshiva University ; Industrial Research | |  |
| D-726582-V | Albert Einstein College of Medicine of Yeshiva University ; Industrial Research | |  |
| D-7991 | University of Newcastle | |  |
| D-80815 | Zentaris | |  |
| D-80816 | Zentaris | |  |
| D-80819 | Zentaris | |  |
| D-82 | Yang Zhenhua | |  |
| D-87503 | Zentaris GmbH | |  |
| D-allo-IIeu3 PYY(3-36) | Imperial Innovations Ltd. | |  |
| D-FDOC | Merck & Co. | |  |
| D-Galactose Palmitic Acid | Schering AG | | No Structure |
| D-Luciferin | | 2591-17-5 |  |
| D-Penicillamine | | 52-67-5 |  |
| D-pinitol | University of Washington | 10284-63-6 |  |
| D3 | IMB Institut für Molekulare Biotechnologie (Germany) | |  |
| D4A | Neuren Pharmaceuticals Ltd (New Zealand) | |  |
| D6A | Neuren Pharmaceuticals Ltd (New Zealand) | |  |
| DA-1090 | Academia Sinica (Taiwan) | |  |
| DA-11004 | Dong-A | |  |
| DA-3003 | Dong-A | 383907-47-9 |  |
| DA-3934 | Daiichi | 183176-50-3 |  |
| DA-6034 | Dong-A Pharma | |  |
| DA-7858 | Dong-A Pharmaceuticals | |  |
| DA-7867 | Dong-A Pharmaceuticals | |  |
| DA-9102 | | | No Structure |
| DA-9601 | | 217818-42-3 | No Structure |
| dA-CLB | Fundacja Rozwoju Diagnostyki I Terapii (Poland) | |  |
| DAA-1097 | Nihon Nohyaku ; Taisho | |  |
| DAA-1106 | Nihon Nohyaku; Taisho | |  |
| Dabelotine | ADIR (Servier) | 152985-36-9 |  |
| Dabigatran | Boehringer Ingelheim | 211914-51-1 |  |
| Dabigatran Etexilate | Boehringer Ingelheim | 211915-06-9 ; 593282-20-3 (mesylate salt) |  |
| Dabuzalgron | Hoffman-La Roche | 219311-43-0 |  |
| Dacarbazine | Southern Research Inst. | 4342-03-4 |  |
| Dacetuzumab | Seattle Genetics | 880486-59-9 | No Structure |
| Dacinostat | Novartis | 404951-53-7 |  |
| Daclizumab | PROTEin DESIGN Labs | 152923-56-3 | No Structure |
| Dacomitinib | | 1110813-31-4 |  |
| Dacopafant | Rhone-Poulenc (Aventis) | 125372-33-0 |  |
| Dactimicin | Meiji | 73196-97-1 |  |
| Dactinomycin | Bayer | 50-76-0 |  |
| Dactylorhin B | Chinese Academy of Medical Sciences | |  |
| DADME-Immucillin-G | Industrial Research (NZ); Yeshiva University | |  |
| Daglutril | Kali (Solvay) | 182821-27-8 |  |
| Daidzein | Nichimo | 486-66-8 |  |
| Daidzin | Endowment RES Inhuman Biology (US) | 552-66-9 |  |
| Daiichi-RN-159877-27-7 | Daiichi | 159877-27-7 |  |
| Daimuron | Showa Denko | 42609-52-9 |  |
| Dainippon RN-625124-20-1 | Dainippon Pharmaceutical | 625124-20-1 |  |
| Daivobet (Calcipotriol & Betamethasone) | Leo Pharmaceutical Products | |  |
| DAIZAC | University of Vanderbilt | 179871-95-5 |  |
| Dalapon | Dow | 75-99-0 |  |
| Dalbavancin | Lepetit | 171500-79-1 |  |
| Dalcetrapib | Japan Tobacco | 211513-37-0 |  |
| Dalfopristin | Rhone-Poulenc (Aventis) | 112362-50-2 |  |
| Dalfopristin - Quinupristin | Rhone-Poulenc (Aventis) | 126202-89-9 |  |
| Dalotuzumab | Pierre Fabre Medicament (France) | 1005389-60-5 | No Structure |
| Dalteparin | Kabi | 9041-08-1 | No Structure |
| Dalvastatine | RPR (Aventis) | 132100-55-1 |  |
| Daminozide | US Rubber | 1596-84-5 |  |
| Danaparoid | Merck | 308068-55-5 | No Structure |
| Danazol | Sterling Drug (Sanofi-Aventis) | 17230-88-5 |  |
| Danegaptide | Zealand Pharma | 943134-39-2 |  |
| Daniplestim | Searle (Pharmacia) | 161753-30-6 |  |
| Danofloxacin | Pfizer | 112398-08-0 |  |
| Danoprevir | Intermune Inc. ; Array Biopharma Inc. | 916881-67-9 ; 850876-88-9 ; 916826-48-7 (sodium salt) |  |
| Dantrolene | Norwich Eaton (Procter & Gamble) | 7261-97-4 |  |
| Dantron | Riker | 117-10-2 |  |
| Danusertib | Pharmacia (Pfizer) | 827318-97-8 |  |
| DAP-092 | University of North Carolina | 200878-40-6 |  |
| Dapagliflozin | Bristol-Myers Squibb (BMS) | 461432-26-8 |  |
| Dapagliflozin & Metformin | Bristol-Myers Squibb Co. (US) | 461432-26-8 (Dapagliflozin) ; 657-24-9 (Metformin) |  |
| DAPH-12 | Ciba Geigy | |  |
| Daphnodorin A | Taisho | 95733-03-2 |  |
| Dapiclermin | Regeneron | 444069-80-1 |  |
| Dapiprazole | Angelini | 72822-12-9 |  |
| Dapitant | RPR (Aventis) | 153438-49-4 |  |
| Dapivirine | Janssen Pharmaceutica (Johnson & Johnson) | 250231-80-2 ; 244767-67-7 |  |
| Daporinad | Fujisawa (Astellas) | 201034-75-5 |  |
| Dapoxetine | Eli Lilly | 119356-77-3 |  |
| Dapsone | Merck & Co. | 80-08-0 |  |
| Daptomycin | Eli Lilly | 103060-53-3 |  |
| Darapladib | GlaxoSmithKline (GSK) | 356057-34-6 |  |
| Daratumumab | Genmab | 945721-28-8 | No Structure |
| Darbepoetin alfa | Kirin Amgen | 209810-58-2 | No Structure |
| Darbufelone | Warner Lambert (Pfizer) | 139226-28-1 |  |
| Darexaban | | 912273-64-4 | No Structure |
| Darifenacin | Pfizer | 133099-04-4 |  |
| Darinaparsin | University of Texas | 69819-86-9 |  |
| Darotropium bromide | | 850607-58-8 |  |
| Darotropium bromide & Vilanterol | | 850607-58-8 (Darotropium bromide) ; 503068-34-6 (Vilanterol) |  |
| Darunavir | University of Illinois | 206361-99-1 |  |
| Darusentan | BASF (Abbott) | 171714-84-4 |  |
| DAS-181 | NexBio (US) | | No Structure |
| Dasantafil | Schering-Plough (Merck & Co) | 569351-91-3 |  |
| Dasatinib | Bristol-Myers Squibb (BMS) | 302962-49-8 ; 863127-77-9 |  |
| DASM | University of California ; Tian Xin | 138898-71-2 ; 138898-72-3 |  |
| DAU-6285 | De Angeli | 127595-33-9 |  |
| Daunorubicin | Rhone-Poulenc (Aventis) | 20830-81-3 |  |
| Davalintide | | 879197-42-9 (acetate salt) | No Structure |
| Davasaicin | Korea Research Institute of Chemical Technology (KRICT) | 147497-64-1 |  |
| Davunetide (intranasal formulation) | Ramot (Israel) | 211439-12-2 |  |
| Davunetide (parenteral formulation) | Ramot (Israel) | 211439-12-2 |  |
| Daxalipram | Schering AG | 189940-24-7 |  |
| Dazepinil | Hoechst (Sanofi-Aventis) | 75991-50-3 |  |
| Dazomet | Generic | 533-74-4 |  |
| DB-160 | Nuada LLC | | No Structure |
| DB-2,4 | ICI (Syngenta) | 94-82-6 |  |
| DB-340 | Georgia State University | 213972-23-7 |  |
| DB-51630 | Taiho | |  |
| DB-67 | University of Pittsburgh ; National Cancer Inst. (NCI) ; Tigen | 220913-32-6 |  |
| DB-75 | University of Georgia ; University of North Carolina ; University of Auburn | 73819-26-8 |  |
| DB-772d | Daiichi Seiyaku (Japan) | |  |
| DB-959 | Bayer AG | | No Structure |
| DB2-121 | The University of Western Ontario (Canada) | |  |
| DBDMH | Drug Research Inc. | 77-48-5 |  |
| DBM-819 | SmithKline Beckman (GSK) | 331686-58-9 |  |
| DBNPA | Ciba Ltd. | 10222-01-2 |  |
| DBO-11 | Lepetit ; Riace Est | 59038-10-7 |  |
| DBO-83 | Sanofi (Sanofi-Aventis) | 195211-53-1 |  |
| DC-159a | Daiichi Seiyaku | |  |
| DC-51-43 | US National Institutes of Health ; Tulane University (USA) | |  |
| DC-TCL | CHU Montpellier ; CellGen | | No Structure |
| DC1-SMe | Immunogen | |  |
| DC2 | Immunogen | |  |
| DC2-SMe | Immunogen | |  |
| DC3 | Immunogen | |  |
| DC3-SMe | Immunogen | |  |
| DC4 | Immunogen | |  |
| DC4-SMe | Immunogen | |  |
| DCCCyB | Merck Sharp & Dohme Ltd. (GB) | |  |
| DCD | Garbil Pharma | |  |
| DCDMH | Drug Research Inc. (US) | 118-52-5 |  |
| DCEBIO | Agfa-Gaevert | 60563-36-2 |  |
| DCF-987 | University of British Columbia ; University of Alberta | | No Structure |
| DCIP | Dow | 108-60-1 |  |
| DCM-205 | University of California (US) | |  |
| DCOI | Rohm & Haas | 64359-81-5 |  |
| DCPA | Diamond Alkali | 1861-32-1 |  |
| DCVax-Brain | Northwest Biotherapeutics Inc. | | No Structure |
| DCVax-Head & Neck | Northwest Biotherapeutics Inc. | | No Structure |
| DCVax-Liver | Northwest Biotherapeutics Inc. | | No Structure |
| DCVax-Lung | Northwest Biotherapeutics Inc. | | No Structure |
| DCVax-Ovarian | Northwest Biotherapeutics Inc. | | No Structure |
| DCVax-Pancreas | Northwest Biotherapeutics Inc. | | No Structure |
| DCVax-Prostate | Northwest Biotherapeutics Inc. | | No Structure |
| DD-161515 | DiverDrugs | |  |
| DD-6110 | DiverDrugs | |  |
| DD-612 | DiverDrugs | |  |
| DD2 | University of California (US) ; St. Jude Children’s Research Hospital (US) | |  |
| DDA | Ajinomoto | 4097-22-7 |  |
| DDB-S | Daewoo Pharmaceuticals | 213456-57-6 (HCl) |  |
| DDE-261 | Wayne Hughes Institute | |  |
| DDE-933 | Parker Hughes Institute | |  |
| DDE-934 | Parker Hughes Institute | |  |
| DDE-935 | Parker Hughes Institute | |  |
| DDE-946 | Parker Hughes Institute | |  |
| DDP-225 | Mitsubishi Pharma | 135991-48-9 |  |
| DDS-04A (Trazodone) | Labopharm (Canada) | | No Structure |
| DDS-04F (Propofol) | Labopharm Inc. | 2078-54-8 |  |
| DDS-06A (Paracetamol) | Labopharm Inc. | 103-90-2 |  |
| DDS-06C (Tramadol & Paracetamol) | Labopharm Inc. | 27203-92-5 (Tramadol) ; 103-90-2 (Paracetamol) |  |
| DDS-06E (SN-38) | Labopharm Inc. (Canada) | |  |
| DDS-08B (Oxycodone & Paracetamol) | Labopharm Inc. | 76-42-6 (Oxycodone) ; 103-90-2 (Paracetamol) |  |
| ddUTP | Kikyoya Tadashi | 84445-38-5 |  |
| DE-096 | Santen Pharmaceutical Co. Ltd. (Japan) | |  |
| DE-102 | Santen Pharmaceuticals | | No Structure |
| DE-104 | Santen Pharmaceutical Co. Ltd. ; Ube Industries Ltd. | | No Structure |
| DE-105 | Santen Pharmaceutical Co. Ltd. | | No Structure |
| DE-110 | Santen Pharmaceutical Co. Ltd. | | No Structure |
| Deanol acetamidobenzoate | Riker | 3635-74-3 |  |
| Debio-0507 | Toudai Tlo Ltd. (Japan) | |  |
| Debio-0617 | Aurigene Discovery Technologies Ltd. (India) | | No Structure |
| Debio-0721 | Debiopharm Group (Switzerland) | | No Structure |
| Debio-0826 | Debiopharm Group (Switzerland) | | No Structure |
| Debio-0928 | Moffitt Cancer Center (US) | | No Structure |
| Debio-0929 | MSM Protein Technologies Inc. (US) | | No Structure |
| Debio-0930 | Mercury Therapeutics Inc. (US) | | No Structure |
| Debio-0932 | Curis Inc. (US) | | No Structure |
| Debio-9902 SR | Shangahi Institute of Materia Medica | |  |
| Deboxamet | Istituto Biologico Chemioterapico (ABC) | 34024-41-4 |  |
| Debrisoquine | Hoffmann La Roche (Roche) | 1131-64-2 |  |
| Decamethonium bromide | | 541-22-0 |  |
| Decitabine | Ceskoslovenska Akademie Ved | 2353-33-5 |  |
| Declenperone | Janssen Pharmaceutica (Johnson & Johnson) | 63388-37-4 |  |
| Declopramide | Oxigene | 891-60-1 |  |
| Decoquinate | May & Baker (Aventis) | 18507-89-6 |  |
| Decursin | | 5928-25-6 |  |
| Decursin angelate | | |  |
| Decursinol | Scigenic Co Ltd. ; Biosynergen Inc. | 23458-02-8 |  |
| Deethylatrazine | Univiversity of Nebraska | |  |
| Deferasirox | Ciba-Geigy (Novartis) | 201530-41-8 |  |
| Deferiprone | National Research Development Corporation (NRDC) | 30652-11-0 |  |
| Deferitrin | University of Florida | 239101-33-8 |  |
| Deferoxamine | Ciba-Geigy (Novartis) | 70-51-9 |  |
| Defibrotide | Gentium | 83712-60-1 | No Structure |
| Deflazacort | Lepetit | 14484-47-0 |  |
| Defoslimod | Laboratoires OM | 171092-39-0 |  |
| Degarelix | Ferring | 214766-78-6 ; 934246-14-7 (acetate salt) |  |
| Dehydroascorbic acid | Memorial Sloan-Kettering Cancer Center | 33124-69-5 |  |
| Dehydrocholic acid | Merck & Co. | 81-23-2 |  |
| Dehydroequol bisphosphate | Novogen Research Pty Ltd. | |  |
| Dekafin-1 | Enkam Pharmaceuticals (Denmark) | |  |
| Dekafin-10 | Enkam Pharmaceuticals (Denmark) | |  |
| Delafloxacin | Wakunaga | 189272-58-1 ; 352458-37-8 (meglumine salt) |  |
| Delamanid | Otsuka Pharmaceuticals | 681492-22-8 |  |
| Delapril | Takeda | 83435-66-9 |  |
| Delavirdine | Pharmacia & Upjohn (Pharmacia) | 136817-59-9 |  |
| Delequamine | Synte | 119905-05-4 |  |
| Deligoparin | Incara Pharmaceuticals | 9041-08-1 | No Structure |
| Delimotecan | Menarini | 187852-63-7 (for Na salt) |  |
| Delmitide | A & Science Invest (Genzyme) | 287096-87-1 |  |
| Delmopinol | Ferrosan | 79874-76-3 |  |
| Delorazepam | Sapos | 2894-67-9 |  |
| Delta-Tocopheryl glucoside | Sunstar | |  |
| delta-tocotrienol | | 25612-59-3 |  |
| Delta2-TG-6 | Ohio State Research Foundation | |  |
| DeltaD2L2 PA mutant | Harvard College ; University Oklahoma | | No Structure |
| Deltamethrin | National Research Development Corporation (NRDC) | 52918-63-5 |  |
| Deltibant | Cortech | 140661-97-8 |  |
| Delucemine | NPS Pharmaceuticals | 186495-99-8 |  |
| Dembrexine | Boehringer Ingelheim | 83200-09-3 |  |
| Demecarium bromide | Chemie Linz | 56-94-0 |  |
| Demeclocycline | American Cyanamid (Wyeth) | 127-33-3 |  |
| Demegestone | Roussel-Uclaf (Aventis) | 10116-22-0 |  |
| Demethoxy-fumitremorgin C | American Cyanamid (Wyeth) | 111768-16-2 |  |
| Demethoxycurcumin | Sami Chemicals & Extracts Ltd., (India) | 24939-17-1 |  |
| Demeton-S-methyl | Bayer | 919-86-8 |  |
| Demexiptilline | Bayer | 24701-51-7 |  |
| Demiditraz | | 944263-65-4 |  |
| Denagliptin | SmithKline Beecham (GSK) | 483369-58-0 ; 811432-66-3 (tosylate) |  |
| Denatonium benzoate | Macfarlen Smith | 86398-53-0 |  |
| Denatonium Saccharide | T. & H. Smith | 90823-38-4 |  |
| Denaverine | J. Klosa | 3579-62-2 |  |
| Denenicokin | ZymoGenetics | 716840-32-3 | No Structure |
| Denibulin | Angiogene Pharmaceuticals | 779356-64-8 |  |
| Denileukin Diftitox | The university Hospital | 173146-27-5 | No Structure |
| Denopamine | Tanabe | 71771-90-9 |  |
| Denosumab | Immunex (Amgen) | 615258-40-7 | No Structure |
| Denotivir | Polfa Rzeszowskie Zaklady Farm (Poland) | 51287-57-1 |  |
| Denufosol | Inspire Pharmaceuticals | 211448-85-0 |  |
| Denzimol | Kissei | 73931-96-1 |  |
| Deoxyvariolin B | PharmaMar | |  |
| Depelestat | Dyax | 506433-25-6 |  |
| DepoMethotrexate | DepoTech Corp. (Pacira Pharmaceuticals Inc.) | 59-05-2 |  |
| DepoNSAID | Pacira Pharmaceuticals Inc. | | No Structure |
| Deprodone Propionate | Boots (Abbott) | 20423-99-8 (Deprodone) 20424-00-4 (Deprodone propionate) |  |
| Deptropine | Generic | 604-51-3 |  |
| Depudecin | Shionogi | 139508-73-9 |  |
| Dequalinium chloride | Allen & Hanburys (GSK) | 522-51-0 |  |
| Deracoxib | Searle (Pharmacia) | 169590-41-4 |  |
| Deramciclane | Egyt | 120444-71-5 |  |
| Derenofylline | Solvay Pharm GmbH (Germany) | 251945-92-3 |  |
| Dermatan sulfate | Opocrin Spa | 24967-94-0 |  |
| Derpanicate | | 99518-29-3 |  |
| Derquantel | | 187865-22-1 |  |
| Dersalazine | Uriach | |  |
| Des-oxo-amiodarone | Tennessee University | 116523-57-0 |  |
| Desciclovir | Burroughs Wellcome (GSK) | 84408-37-7 |  |
| Deserpidine | Penick | 131-01-1 |  |
| Desflurane | Airco ; Ohmeda Pharmaceuticals | 57041-67-3 |  |
| Desipramine | Geigy (Novartis) | 50-47-5 |  |
| Desirudin | Transgene ; Novartis | 120993-53-5 |  |
| Desloratadine | Schering Corp (Merck & Co) | 100643-71-8 |  |
| Deslorelin | Abbott | 57773-65-6 |  |
| Deslorelin-Docetaxel | University of Colorado (US) ; University of Nebraska Medical Center (US) | |  |
| Desmedipham | Schering AG | 13684-56-5 |  |
| Desmetryn | Ciba-Geigy (Novartis) | 1014-69-3 |  |
| Desmopressin | Sandoz | 16679-58-6 |  |
| Desmoteplase | Schering AG | 145137-38-8 | No Structure |
| Desogestrel | Akzona | 54024-22-5 |  |
| Desonide | Squibb | 638-94-8 |  |
| Desoximetasone | Roussel-Uclaf (Aventis) | 382-67-2 |  |
| Desoxycorticosterone Pivalate | | 808-48-0 |  |
| Desoxycortone acetate | | 56-47-3 |  |
| Desoxyepothilone F | Sloan Kettering Institute | |  |
| Desoxypeganine | Inst Khim Rastitelnykh Veshche (USSR) | 495-59-0 ; 61939-05-7 (hydrochloride salt) |  |
| Desoxyrhapontin | | 30197-14-9 |  |
| Desvenlafaxine | American Home Products (Wyeth) | 93413-62-8 |  |
| Detomidine | Farmos | 76631-46-4 |  |
| Deutolperisone | Birds Pharma GmbH | 474641-19-5 |  |
| Devazepide | Merck & Co | 103420-77-5 |  |
| Dexamethasone | Merck & Co. | 50-02-2 |  |
| Dexamethasone 21-isonicotinate | Boehringer Ingelheim | 2265-64-7 |  |
| Dexamethasone 21-linolate | ISF | 39026-39-6 |  |
| Dexamethasone acetate | Upjohn | 1177-87-3 |  |
| Dexamethasone Beloxil | Alcon | 150587-07-8 |  |
| Dexamethasone cipecilate | SS Pharmaceutical | 132245-57-9 |  |
| Dexamethasone iontophoretic | University od California, US | 2392-39-4 (di sodium salt) |  |
| Dexamethasone Palmitate | | 14899-36-6 |  |
| Dexamethasone phosphate | Merck & Co. | 312-93-6 |  |
| Dexamethasone pivalate | Ciba Geigy | 1926-94-9 |  |
| Dexamethasone Sodium Phosphate | Merck & Co. | 2392-39-4 |  |
| Dexamethasone tert-butylacetate | Merck & Co. | 24668-75-5 |  |
| Dexamethasone valerate | Inst. Luso Farmaco | 33755-46-3 |  |
| Dexamfetamine | SmithKline French (GSK) | 51-64-9 |  |
| Dexaminoglutethimide | Chiroscience (CellTech) | 55511-44-9 |  |
| Dexanabinol | Yissum Research Development | 112924-45-5 |  |
| Dexbrompheniramine | Schering Corp (Merck & Co) | 132-21-8 |  |
| Dexchlorpheniramine | Schering Corp (Merck & Co) | 25523-97-1 |  |
| Dexecadotril | Bioprojet (GSK) | 112573-72-5 |  |
| Dexefaroxan | Reckitt & Colmann ; Pierre Fabre Medicament | 143249-88-1 |  |
| Dexelvucitabine | Emory University | 134379-77-4 |  |
| Dexetimide | Janssen Pharmaceutica (Johnson & Johnson) | 21888-98-2 |  |
| Dexfenfluramine | Servier | 3239-44-9 |  |
| Dexibuprofen | Merck & Co | 51146-56-6 |  |
| Dexketoprofen | Menarini | 167300-68-7 |  |
| Dexlansoprazole | Takeda Chemical Industries Ltd. | 138530-94-6 |  |
| Dexlipotam | Asta Medica (Viatris) | 1200-22-2 |  |
| Dexloxiglumide | Rotta | 119817-90-2 |  |
| Dexmedetomidine | Farmos | 113775-47-6 |  |
| Dexmethylphenidate | Celgene | 19262-68-1 (hydrochloride) |  |
| Dexnebivolol | Janssen Pharmaceutica (Johnson & Johnson) | 118457-15-1 |  |
| Dexpanthenol | Hoffmann La Roche (Roche) | 81-13-0 |  |
| Dexpirronium | | | No Structure |
| Dexpramipexole | Synthon | 104632-28-2 ; 104632-27-1 (anhydrous) ; 908244-04-2 (dihydrochloride) |  |
| Dexrazoxane | National Research Development Corporation (NRDC) | 24584-09-6 |  |
| Dexsotalol | Mead Johnson | 30236-32-9 |  |
| Dextofisopam | Janus Pharmaceuticals (Pharmos Corporation) | 82059-50-5 |  |
| Dextrin 2-sulfate | ML Laboratories (Innovata) | 142985-55-5 |  |
| Dextromethorphan | Hoffmann La Roche (Roche) | 125-71-3 |  |
| Dextromoramide | Janssen Pharmaceutica (Johnson & Johnson) | 357-56-2 |  |
| Dextropropoxyphene | Eli Lilly | 469-62-5 |  |
| Dextrothyroxine | Baxter | 51-49-0 |  |
| Dexverapamil | Knoll (Abbott) ; AGI Therapeutics | 38321-02-7 |  |
| Dezinamide | A. H. Robins | 91077-32-6 |  |
| Dezocine | American Home Products (Wyeth) | 53648-55-8 |  |
| DF-1012 | Dompe | 163220-65-3 |  |
| DF-1111301 | Dompe | 127842-07-3 |  |
| DF-1689A | Dompe | |  |
| DF-203 | Campaign Tech | 178804-04-1 |  |
| DF-2297A | Dompe SpA | |  |
| DG-041 | deCODE Genetics | |  |
| DG-051 | Decode genetics | |  |
| DG-071 | deCODE genetics | | No Structure |
| dh-404 | Reata Pharmaceuticals Inc. | |  |
| DH-XP-0090 | State University of New York (US) ; Health Research Inc. (US) | |  |
| DHA-HCPT | Panorama Research | |  |
| DHA-Paclitaxel | Neuromedica | |  |
| DHA-SB-T-1214 | State University of New York at Stony Brook ; Roswell Park Cancer Institute | |  |
| DHG-1 | Taiho | |  |
| DHL-HisZn | Iwaki Co. ; Oga Reasearch Inc. (Japan) | |  |
| DI-17E6 | Merck Patent GmbH (Merck KGaA) | 1105038-73-0 | No Structure |
| Diabact UBT ([13C]-Urea) | Diabact AB | 58069-82-2 |  |
| DiabeCell | Diabcell (Living Cell Technologies) | | No Structure |
| Diacerein | C.A. Friedmann | 13739-02-1 |  |
| Diafenthiuron | Ciba-Geigy (Novartis) | 80060-09-9 |  |
| Dialifor | Hercules | 10311-84-9 |  |
| Diamfenetide | Burroughs Wellcome (GSK) | 36141-82-9 |  |
| Diamyd | Diamyd Therapeutics | | No Structure |
| Dianex | Kasturba Medical College (India) | | No Structure |
| Dianicline | Sanofi-Synthelabo (Sanofi-Aventis) | 292634-27-6 |  |
| DiaPep-277 | DeveloGen Israel | | No Structure |
| Diaplasinin | Wyeth | 481631-45-2 |  |
| Diaveridine | Burroughs Wellcome (GSK) | 5355-16-8 |  |
| Diazepam | Hoffmann La Roche (Roche) | 439-14-5 |  |
| Diazinon | Ciba-Geigy (Novartis) | 333-41-5 |  |
| Diaziquone | Bayer | 57998-68-2 |  |
| Diazoxide | Schering Corp (Merck & Co) | 364-98-7 |  |
| Diazoxide choline | Essentialis Inc. (US) | |  |
| Dibekacin | Microbial Chem Res Found | 34493-98-6 |  |
| Dibenzepin | Wander | 4498-32-2 |  |
| Dibotermin alfa | Genetics Institue (Wyeth) | 246539-15-1 |  |
| Dibromopropamidine | May & Baker (Aventis) | 496-00-4 |  |
| Dibromotyrosine | | 537-24-6 |  |
| Dibromsalan | Fine Organics | 87-12-7 |  |
| DIBRT | University of California | |  |
| Dicamba | Velsicol | 1918-00-9 |  |
| Dichlobenil | North American Philips Company | 1194-65-6 |  |
| Dichlofenthion | University of Virginia | 97-17-6 |  |
| Dichlofluanid | Bayer | 1085-98-9 |  |
| Dichlone | Monsanto | 117-80-6 |  |
| Dichlorisone | Schering Corp (Merck & Co) | 79-61-8 |  |
| Dichlormid | E. Gy. T. Gyogyszervegyeszeti Gyar | 37764-25-3 |  |
| Dichlorophen | Burton Bush | 97-23-4 |  |
| Dichlorprop | Boots (Abbott) | 120-36-5 |  |
| Dichlorprop-P | Boots (Abbott) | 15165-67-0 |  |
| Dichlorvos | Shell | 62-73-7 |  |
| Diclazuril | Janssen Pharmaceutica (Johnson & Johnson) | 101831-37-2 |  |
| Diclobutrazol | ICI (Syngenta) | 75736-33-3 |  |
| Diclocymet | Sumitomo Chemical | 139920-32-4 |  |
| Diclofenac | Geigy (Novartis) | 15307-86-5 ; 15307-79-6 (sodium) |  |
| Diclofenamide | Merck & Co. | 120-97-8 |  |
| Diclofensine | Roche | 67165-56-4 |  |
| Diclofop | Hoechst (Sanofi-Aventis) | 40843-25-2 |  |
| Diclomezine | Sankyo | 62865-36-5 |  |
| Dicloran | Boots (Abbott) | 99-30-9 |  |
| Diclosulam | DowElanco | 145701-21-9 |  |
| Dicloxacillin | Beecham (GSK) | 3116-76-5 |  |
| Dicofol | Rohm & Haas | 115-32-2 |  |
| Dicoumarol | Merrell Dow (Aventis) | 66-76-2 |  |
| Dicrotophos | Shell | 141-66-2 |  |
| Dicyclanil | Ciba-Geigy (Novartis) | 112636-83-6 |  |
| Dicyclonon | BASF | 79260-71-2 |  |
| Dicyclopentadiene | | 77-73-6 |  |
| Dicycloplatin | University of Beijing | |  |
| Dicycloverine | Merrell (Aventis) | 77-19-0 |  |
| Didanosine | Wellcome Foundation (GSK) | 69655-05-6 |  |
| Didemnin B | University of Illinois | 77327-05-0 |  |
| Didox | Van Riet et al. | 69839-83-4 |  |
| Dieckol | Pukyong National University (Korea) ; Pusan National University (Korea) | |  |
| Dienestrol | Boots (Abbott) | 84-17-3 |  |
| Dienochlor | Hooker | 2227-17-0 |  |
| Dienogest | Jenapharm | 65928-58-7 |  |
| Diethatyl | Sumitomo Chemical | 38727-95-0 |  |
| Diethazine | Rhone-Poulenc (Aventis) | 60-91-3 |  |
| Diethofencarb | Sumitomo Chemical | 87130-20-9 |  |
| Diethyl-lactam | University of Washington | 175698-05-2 |  |
| Diethylcarbamazine | American Cyanamid (Wyeth) | 90-89-1 |  |
| Diethylhomospermine | University of Florida | 119422-08-1 |  |
| Diethylnorspermine | University of Florida | 121749-39-1 |  |
| Diethylstilbestrol | Eli Lilly | 56-53-1 |  |
| Diethyltoluamide | US Secretary of Agriculture | 134-62-3 |  |
| Difebarbamate | Roche | 15687-09-9 |  |
| Difemerine | UPSA | 30387-96-8 |  |
| Difenacoum | Ward, Blenkinsop | 56073-07-5 |  |
| Difenidol | Ciba (Novartis) | 972-02-1 |  |
| Difenoconazole | Ciba-Geigy (Novartis) | 119446-68-3 |  |
| Difenoxin | Janssen Pharmaceutica (Johnson & Johnson) | 28782-42-5 |  |
| Difenoxuron | Ciba-Geigy (Novartis) | 14214-32-5 |  |
| Difenpiramide | Zambeletti | 51484-40-3 |  |
| Difenzoquat metilsulfate | American Cyanamid (BASF) | 43222-48-6 |  |
| Difetarsone | Specia (Aventis) | 3639-19-8 |  |
| Difethialone | Lipha (E. Merck KGaA) | 104653-34-1 |  |
| Diflomotecan | SCRAS (Ipsen) | 220997-97-7 |  |
| Diflorasone diacetate | Upjohn (Pharmacia) | 33564-31-7 |  |
| Diflovidazin | Chinoin | 162320-81-2 |  |
| Difloxacin | Abbott | 98106-17-3 |  |
| Diflubenzuron | Philips-Duphar | 35367-38-5 |  |
| Diflucortolone valerate | Schering AG (Bayer Schering) | 59198-70-8 |  |
| Diflufenican | May & Baker (Aventis) | 83164-33-4 |  |
| Diflufenzopyr | Sandoz (Syngenta) ; BASF | 109293-97-2 |  |
| Diflumetorim | Ube | 130339-07-0 |  |
| Diflunisal | Merck & Co. | 22494-42-4 |  |
| Difluprednate | Warner Lambert (Pfizer) | 23674-86-4 |  |
| Digeranyl bisphosphonate | University of Iowa | |  |
| Digoxin | | 20830-75-5 |  |
| Dihexyverine | Crinex | 561-77-3 |  |
| Dihydralazine | Ciba (Novartis) | 484-23-1 |  |
| Dihydroartemisinin & Piperaquine | Chongqing Kincare Medicinal Development Co. (China) | 71939-50-9 (Dihydroartemisinin) ; 4085-31-8 (Piperaquine) |  |
| (+)-Dihydrocalanolide A | University of Texas, | 183904-53-2 |  |
| Dihydrocodeine | | 125-28-0 |  |
| Dihydroergocristine | Roussel Uclaf | 17479-19-5 |  |
| Dihydroergocryptine | Sandoz | 25447-66-9 |  |
| Dihydroergotamine | Sandoz (Novartis) | 511-12-6 ; 6190-39-2 (Mesilate) |  |
| Dihydroergotoxine | Dresden Arzneimittel (Germany) | 8067-24-1 |  |
| Dihydroetorphine | | 14357-76-7 |  |
| Dihydromycoplanecin A | Sankyo (Japan) | 79003-68-2 |  |
| Dihydrostreptomycin | Merck & Co. | 128-46-1 |  |
| Dihydrotachysterol | Winthrop (Sanofi-Synthelabo) | 67-96-9 |  |
| Dihydroxydibutyl ether | Joulty | 821-33-0 |  |
| Dihydroxypropyladenine | | 55904-02-4 |  |
| Diindolylmethane | | 1968-05-4 |  |
| Diiodohydroxyquinoline | Friedrich Passek | 83-73-8 |  |
| Diiodotyrosine | Basic | 66-02-4 |  |
| Diisopromine | Janssen Pharmaceutica (Johnson & Johnson) | 5966-41-6 |  |
| Dikegulac | Hoffmann La Roche (Roche) | 18467-77-1 |  |
| Dilazep | Asta Medica (Degussa) | 35898-87-4 |  |
| Dilevalol | Schering Corp (Merck & Co) | 75659-07-3 |  |
| Dilmapimod | Glaxo Group | 444606-18-2 ; 937169-00-1 (tosylate salt) |  |
| Dilopetine | Esteve | 247046-52-2 |  |
| Diloxanide Furoate | Boots (Abbott) | 3736-81-0 |  |
| Diltiazem | Tanabe | 42399-41-7 |  |
| DIM-c-pPhC6H5 | Texas A&M University | |  |
| DIM-C-pPhCF | Texas A&M University | |  |
| DIM-C-pPhtBu | Texas A&M University | |  |
| Dimazole | Hoffmann La Roche (Roche) | 95-27-2 |  |
| Dimebolin | Shadurskij KS et al. | 3613-73-8 ; 12687-54-6 |  |
| Dimecrotic acid | Unicler | 7706-67-4 |  |
| Dimefline | Recordati | 1165-48-6 |  |
| Dimefluthrin | Sumitomo Chemical | 271241-14-6 |  |
| Dimefuron | Rhone-Poulenc | 34205-21-5 |  |
| Dimemorfan | Yamanouchi (Astellas) | 36309-01-0 |  |
| Dimenhydrinate | Searle (Pharmacia) | 523-87-5 |  |
| Dimepiperate | Mitsubishi | 61432-55-1 |  |
| Dimercaprol | DuPont (BMS) | 59-52-9 |  |
| Dimesna | Bionumerik | 16208-51-8 |  |
| Dimetacrine | Kefalas | 4757-55-5 |  |
| Dimetamfetamine | Temmler | 17279-39-9 |  |
| Dimethachlor | Ciba-Geigy (Novartis) | 50563-36-5 |  |
| Dimethametryn | Ciba-Geigy (Novartis) | 22936-75-0 |  |
| Dimethandrolone undecanoate | Department of Health and Human Services (US) | |  |
| Dimethenamid | Sandoz (Syngenta) ; BASF | 87674-68-8 |  |
| Dimethenamid-P | Sandoz (Syngenta) | 163515-14-8 |  |
| Dimethipin | Uniroyal | 55290-64-7 |  |
| Dimethirimol | ICI (Syngenta) | 5221-53-4 |  |
| Dimethisterone | British Drug Houses | 79-64-1 |  |
| Dimethoate | American Cyanamid (BASF) | 60-51-5 |  |
| Dimethomorph | Shell ; American Cyanamid (BASF) | 110488-70-5 |  |
| Dimethoxanate | Ayerst (Wyeth) | 477-93-0 |  |
| Dimethyl phthalate | | 131-11-3 |  |
| Dimethyl sulfone | | 67-71-0 |  |
| Dimethylcarbate | Hoechst (Sanofi-Aventis) | 39589-98-5 |  |
| Dimethylcurcumin | University of North Carolina (US) | |  |
| Dimethylsphingosine | | 122314-67-4 |  |
| Dimethyltubocurarinium chloride | Lilly Co Eli | 33335-58-9 |  |
| Dimethylvinphos | American Cyanamid (BASF) | 2274-67-1 |  |
| Dimetindene | Ciba (Novartis) | 5636-83-9 |  |
| Dimetofrine | Zambeletti | 229-50-29-4 |  |
| Dimetotiazine | Rhone-Poulenc (Aventis) | 7456-24-8 |  |
| Dimevamide | Bristol (BMS) | 60-46-8 |  |
| Diminazene diaceturate | Hoechst (Sanofi-Aventis) | 536-71-0 |  |
| Dimiracetam | ISF | 126100-97-8 |  |
| Dimoxystrobin | Shionogi | 149961-52-4 |  |
| Dimyristoylphosphatidylcholine | The Liposome Company, Inc. | 13699-48-4 |  |
| Dimyristoylphosphatidylglycerol | The Liposome Company, Inc. | 61361-72-6 |  |
| Dinaciclib | Pharmacopeia ; Schering-Plough | 779353-01-4 |  |
| Dinaphine | Taiwan National Defense Medical Center | | No Structure |
| Dinapsoline | Purdue Research Foundation | 221032-27-5 |  |
| Dinex | Pestcontrol | 131-89-5 |  |
| Diniconazole | Sumitomo Chemical | 76714-88-0 ; 83657-24-3 |  |
| Diniconazole-M | Sumitomo Chemical | 83657-18-5 |  |
| Dinitolmide | Dow | 148-01-6 |  |
| Dinitramine | US Borax & Chemicals | 29091-05-2 |  |
| Dinobuton | Murphy | 973-21-7 |  |
| Dinocap | Rohm & Haas | 131-72-6 |  |
| Dinoprost | Upjohn (Pharmacia) | 551-11-1 |  |
| Dinoprostone | Upjohn (Pharmacia) | 363-24-6 |  |
| Dinoseb | Dow | 88-85-7 |  |
| Dinotefuran | Mitsui | 165252-70-0 |  |
| Dinoterb | Pechiney | 1420-07-1 |  |
| Dinoterbon | A. H. Marks & Co. | 6073-72-9 |  |
| Dinoxyline | UNIV NORTH CAROLINA ; PURDUE RESEARCH FOUNDATION | |  |
| Dinsed | | 96-62-8 |  |
| DIO-901(Glucagon) | DiObex (US) | 16941-32-5 |  |
| DIO-902 | Cortendo | |  |
| Diofenolan | Ciba-Geigy (Novartis) | 63837-33-2 |  |
| Dioncoquinone A | Julius-Maximilians-Universität (Germany) | |  |
| Dioncoquinone B | Julius-Maximilians-Universität (Germany) | |  |
| Diosmin | | 520-27-4 |  |
| Dioxabenzofos | Sumitomo Chemical | 3811-49-2 |  |
| Dioxacarb | Ciba-Geigy (Novartis) | 6988-21-2 |  |
| Dioxybenzone | American Cyanamid (Wyeth) | 131-53-3 |  |
| Diperodon | | 51552-99-9 |  |
| Diphacinone | Upjohn (Pharmacia) | 82-66-6 |  |
| Diphemanil methylsulfate | Schering Corp (Merck & Co) | 62-97-5 |  |
| Diphenamid | Eli Lilly | 957-51-7 |  |
| Diphenatrile | Mallinckrodt | 86-29-3 |  |
| Diphencyprone | R. Happle, B. Hausen | 868-38-4 |  |
| Diphenhydramine | Parke, Davis (Pfizer) | 58-73-1 |  |
| Diphenoxylate | Janssen Pharmaceutica (Johnson & Johnson) | 915-30-0 |  |
| Diphenylamine | | 122-39-4 |  |
| Diphenylpyraline | Nopco | 147-20-6 |  |
| Dipipanone | Wellcome Foundation (GSK) | 167-83-4 |  |
| Dipivefrin | Klinge (Fujisawa) | 52365-63-6 |  |
| DIPOA | Novo Nordisk | |  |
| Diprafenone | Helopharm | 81447-80-5 |  |
| Dipraglurant | Addex Pharmaceuticals | 872363-17-2 |  |
| Diprenorphine | | 14357-78-9 |  |
| Dipropalin | Chevron | 1918-08-7 |  |
| Dipropetryn | Nippon Kayaku | 4147-51-7 |  |
| Diprophylline | State University of Iowa | 479-18-5 |  |
| Dipropyl pyridine-2,5-dicarboxylate | Phillips Petroleum | 136-45-8 |  |
| Diproqualone | Bouchard | 36518-02-2 |  |
| Diproteverine | Beecham (GSK) | 69373-95-1 |  |
| Dipyridamole | Thomae (Boehringer Ingelheim) | 58-32-2 |  |
| Dipyrithione | Olin Mathieson | 3696-28-4 |  |
| Dipyrocetyl | Erich Rietz (Germany) | 486-79-3 |  |
| Diquafosol | University of North Carolina | 266356-23-4 |  |
| Diquat dibromide | ICI (Syngenta) | 85-00-7 |  |
| Diractin (Ketoprofen) | IDEA AG (Germany) | 22071-15-4 |  |
| Dirithromycin | Thomae (Boehringer Ingelheim) | 62013-04-1 |  |
| Dirlotapide | Pfizer | 481658-94-0 |  |
| Dirucotide | University of Alberta | 152074-97-0 ; 781666-30-6 (acetate salt) |  |
| Disalazine | Vyzkustav Farm Biochem | |  |
| (+)-Discodermolide | Harbor Branch Oceanographics Institution | 127943-53-7 |  |
| Discorhabdin U | Harbor Branch Oceanographic Institution | |  |
| Disitertide | Instituto Cientifico Y Tecnologico De Navarra | 272105-42-7 |  |
| Disopyramide | Searle (Pharmacia) | 3737-09-5 |  |
| Distigmine bromide | Chemie Linz | 15876-67-2 |  |
| Disufenton | University of Kentucky | 168021-79-2 (2Na salt) |  |
| Disulfiram | Roessler & Hasslacher | 97-77-8 |  |
| Disulfoton | Bayer | 298-04-4 |  |
| Ditazole | Serono | 18471-20-0 |  |
| Ditekiren | Upjohn (Pharmacia) | 103336-05-6 |  |
| Dithiaden | Institute of Experimental Pharmacology (Slovakia) | 1154-12-7 |  |
| Dithianon | E. Merck KGaA | 3347-22-6 |  |
| Dithiazanine iodide | Ilford | 514-73-8 |  |
| Dithiopyr | Monsanto | 97886-45-8 |  |
| Dithranol | | 480-22-8 |  |
| DITPA | University of Arizona | 1158-10-7 |  |
| Diuron | DuPont | 330-54-1 |  |
| Divalproex | Abbott | 76584-70-8 |  |
| Divaplon | Roussel-Uclaf (Aventis) ; General Hospital | 90808-12-1 |  |
| Dixyrazine | UCB | 2470-73-7 |  |
| Dizocilpine | Merck & Co. | 77086-21-6 |  |
| DK-507K | Daiichi Seiyaku | |  |
| DKA-24 | Eszakmagyar Vegyimuvek | 97454-00-7 |  |
| DKK1-mAb-A | Merck & Co. Inc. (US) | | No Structure |
| DLAM-01 | Riken | |  |
| DLAM-1P | Riken | |  |
| DLS-206 | University of Emory | |  |
| DLS-207 | University of Emory | |  |
| DLS-223 | University of Emory | |  |
| DM-CHOC-PEN | Dekk-Tec Inc. (US) | |  |
| DM-CHX | Max-Planck-Gesellschaft | |  |
| DM4 | Eli Lilly | | No Structure |
| DMAMI | National Taipei College of Nursing | 219135-20-3 |  |
| DMDC | Yamasa | 119804-96-5 |  |
| DMDMH | Glyco Chemicals Inc. | 6440-58-0 |  |
| DMHCA | University of Chicago (US) | |  |
| DMNQ-S-52 | Kuhnil Pharmaceutical Co Ltd. (KR) | |  |
| DMP-323 | DuPont Merck | 151867-81-1 |  |
| DMP-444 | DuPont (BMS) | 206763-88-4 |  |
| DMP-543 | DuPont Merck (BMS) | 160588-45-4 |  |
| DMP-565 | DuPont Merck (BMS) | 199480-80-3 |  |
| DMP-695 | DuPont Merck (BMS) | 197799-44-3 |  |
| DMP-696 | DuPont | |  |
| DMP-728 | DuPont Merck (BMS) | 155158-97-7 |  |
| DMP-777 | DuPont Merck (BMS) | 157341-41-8 |  |
| DMP-802 | DuPont Merck (BMS) | 185536-58-7 |  |
| DMP-811 | DuPont (US) | 139964-19-5 |  |
| DMP-850 | DuPont Merck (BMS) | 180302-29-8 |  |
| DMP-851 | DuPont Merck (BMS) | 188978-02-1 |  |
| DMP-904 | DuPont Pharmaceutical | |  |
| DMPO | | 3317-61-1 |  |
| DMR-106 | Fujifilm RI Pharma Co. Ltd. (Japan) ; Daiichi Sankyo Co. Ltd. (Japan) | |  |
| DMU-117 | Cancer Research Technology Ltd. (Great Britain) | |  |
| DMU-135 | Cancer Research Technology (Great Britain) | |  |
| DN-101 (Calcitriol) | Novacea | 32222-06-3 |  |
| DN-1417 | Takeda | 77026-81-4 |  |
| DN-30 | Farmitalia Carlo Erba SpA (Pfizer Inc.) | | No Structure |
| DNCn | Nihon University | |  |
| DNK-333 | Novartis | |  |
| DNOC | Truffaut | 534-52-1 |  |
| DNP-004089 | De Novo Pharmaceuticals | |  |
| DNP-60502 | Dainippon Sumitomo Pharma Co. Ltd. (Japan) | |  |
| Dobutamine | Eli Lilly | 34368-04-2 |  |
| Docarpamine | Tanabe | 74639-40-0 |  |
| Docecal (Docetaxel) | Ardenia Investment Ltd. | 114977-28-5 ; 148408-66-5 (hydrate) |  |
| Docetaxel | Rhone-Poulenc (Sanofi-Aventis) | 114977-28-5 ; 148408-66-5 (hydrate) |  |
| Doconexent | | 6217-54-5 |  |
| Doconexent ethyl | | 81926-94-5 |  |
| doconexent ethyl ester and icosapent ethyl ester | | |  |
| Docosanol | IRCEBA | 85865-74-3 |  |
| Docusate sodium | American Cyanamid (Wyeth) | 577-11-7 |  |
| Dodecarbonium chloride | Patchem | 100-95-8 |  |
| Dodeclonium bromide | Ciba (Novartis) | 15687-13-5 |  |
| Dodecyltriphenylphosphonium bromide | Basotherm | 15510-55-1 |  |
| Dodemorph | BASF | 1593-77-7 |  |
| Dodicin | Goldschmidt | 6843-97-6 |  |
| Dodine | American Cyanamid (BASF) | 2439-10-3 |  |
| Dofequidar | Mitsui (Merck & Co) | 158681-49-3 |  |
| Dofetilide | Pfizer | 115256-11-6 |  |
| Dolasetron | Merrell Dow (Aventis) | 115956-12-2 |  |
| Dolastatin 15 | Arizona State University | 123884-00-4 |  |
| Dolastatin-10 | Arizona State University | 110417-88-4 |  |
| Dolutegravir | Shionogi & Co. Ltd. | 1172581-47-3 |  |
| Domiodol | Maggioni | 61869-07-6 |  |
| Domiphen bromide | Ciba (Novartis) | 538-71-6 |  |
| Domitroban | Shionogi | 112966-96-8 |  |
| Domperidone | Janssen Pharmaceutica (Johnson & Johnson) | 57808-66-9 |  |
| Donepezil | Eisai | 120014-06-4 |  |
| Donetidine | Smith Kline French (SKF) | 99248-32-5 |  |
| Donitriptan | Pierre Fabre | 170911-68-9 |  |
| Dopamine | K. W. Rosenmund | 51-61-6 |  |
| Dopexamine | Fisons | 86197-47-9 |  |
| Dops | Sumitomo Chemical | 492-46-6 |  |
| DORA-1 | Merck & Co Inc. | |  |
| Doramapimod | Boehringer Ingelheim | 285983-48-4 |  |
| Doramectin | Pfizer | 117704-25-3 |  |
| Doranidazole | Pola Chemical Industries, Inc. | 149838-23-3 |  |
| Doripenem | Shionogi | 148016-81-3 |  |
| Dornase alfa | Roche Diagnostics | 143831-71-4 | No Structure |
| Dorsomorphin | The General Hospital Corp. (US) ; The Brigham and Women's Hospital Inc. (US) | 866405-64-3 |  |
| Dorzolamide | Merck & Co. | 130693-82-2 |  |
| Dosmalfate | FAES | 122312-55-4 |  |
| Dosulepin | Spofa | 113-53-1 |  |
| Dotarizine | Ferrer | 84625-59-2 |  |
| DOV-102677 | Dov Pharmaceuticals | |  |
| DOV-216303 | American Cyanamid (Wyeth) | |  |
| DOV-21947 | American Cyanamid (Wyeth) | |  |
| DOV-51892 | DOV Pharmaceutical | |  |
| Dovitinib | Chiron | 405169-16-6 ; 915769-50-5 (lactate) ; 804551-71-1 |  |
| Doxacurium Chloride | Wellcome Foundation (GSK) | 106819-53-8 |  |
| Doxapram | Robins | 309-29-5 |  |
| Doxazosin | Pfizer | 74191-85-8 |  |
| Doxefazepam | Sumitomo Chemical | 40762-15-0 |  |
| Doxepin | Boehringer Mannheim (Roche) | 1668-19-5 |  |
| Doxercalciferol | Nisshin Flour Milling | 54573-75-0 |  |
| Doxifluridine | Hoffmann La Roche (Roche) | 3094-09-5 |  |
| DOXO-EMCH | KTB Tumorforschungs GmbH | 151038-96-9 |  |
| Doxofylline | ABC | 69975-86-6 |  |
| Doxophos (Doxorubicin) | Ardenia Investment Ltd. | 23214-92-8 |  |
| Doxorubicin | Farmitalia Carlo Erba (Pharmacia) | 23214-92-8 |  |
| Doxycycline | American Cyanamid (Wyeth) | 564-25-0 |  |
| Doxylamine | Merrell Dow (Aventis) | 469-21-6 |  |
| DP-001 | Wisconsin Alumni Res Found, (US) | |  |
| DP-035 | Wisconsin Alumni Research Foundation | |  |
| DP-107 | Trimeris | 186673-22-3 |  |
| DP-109 | D-Pharm | |  |
| DP-155 | D-Pharm Ltd. (Israel) | |  |
| DP-44MT | Unisearch | |  |
| DP-460 | D-Pharm | |  |
| DP-4AT | Unisearch | |  |
| DP-4ET | Unisearch | |  |
| DP-4MT | Unisearch | |  |
| DP-4PT | Unisearch | |  |
| DP-893 | Pfizer | |  |
| DP-b99 | D-Pharm | 222315-88-0 |  |
| DP-VPA | D-Pharm | |  |
| DP6-001 | University of Massachusetts (US) ; Advanced Bioscience Lab. Inc. (US) | | No Structure |
| DPC-082 | DuPont (BMS) | |  |
| DPC-083 | DuPont (BMS) | 214287-99-7 |  |
| DPC-168 | Bristol-Myers Squibb (BMS) | |  |
| DPC-333 | DuPont Pharmaceuticals (BMS) | |  |
| DPC-423 | DuPont (BMS) | |  |
| DPC-602 | DuPont (BMS) | |  |
| DPC-681 | DuPont (BMS) | |  |
| DPC-684 | DuPont (BMS) | |  |
| DPC-961 | DuPont (BMS) | 214287-88-4 |  |
| DPC-963 | DuPont (BMS) | 214287-71-5 |  |
| DPC-A78277 | BMS | |  |
| DPD-207 | Destiny Pharma Ltd. (GB) ; Solvias AG (Switzerland) | |  |
| DPH-067517 | DuPont\nPharmaceutical (BMS) | |  |
| DPH-3-98 | Univerity of Virginia (USA) | |  |
| DPI-221 | Ardent Pharmaceuticals | |  |
| DPI-3290 | Delta Pharmaceuticals (Ardent Pharmaceuticals) ; Enhance Biotech | 182417-73-8 |  |
| DPJ-489 | Panjab University ;\nStrathclyde University | |  |
| DPO-1 | Merck & Co | 43077-30-1 |  |
| DPP-728 | Novartis | 247016-69-9 |  |
| DPP-CNDAC | Sankyo | |  |
| DQ-113 | Daiichi | 190954-07-5 |  |
| DR-2313 | Meiji Seika Kaisha | |  |
| DR-4485 | Meiji Seika Kaisha | 402942-54-5 |  |
| DR-5001 | | | No Structure |
| Draflazine | Janssen Pharmaceutica (Johnson & Johnson) | 120770-34-5 |  |
| Drazoxolon | ICI (Syngenta) | 5707-69-7 |  |
| DRC-1339 | US Secretary of Agriculture | 7745-89-3 |  |
| DRF-1042 | Dr. Reddy's | |  |
| DRF-2189 | Sankyo | 172647-53-9 |  |
| DRF-2519 | | |  |
| DRF-2655 | Dr. Reddy's Research Foundation | |  |
| DRF-4367 | Dr. Reddy's Research Foundation | 346670-76-6 |  |
| DRF-8417 | Dr. Reddy’s Research Foundation (India) | |  |
| DRG-16 | Portsmouth University ; SPIROGEN | |  |
| Drinabant | Aventis Pharma | 358970-97-5 |  |
| DRL-17822 | | | No Structure |
| DRL-19440 | Dr. Reddy's Laboratories Ltd. | | No Structure |
| DRL-21994 | | | No Structure |
| DRL-21995 | | | No Structure |
| Drofenine | Ciba (Novartis) | 1679-76-1 |  |
| Droloxifene | Klinge (Fujisawa) | 82413-20-5 |  |
| Drometrizole | Geigy (Novartis) | 2440-22-4 |  |
| Dronabinol | Boehringer Ingelheim | 1972-08-3 |  |
| Dronedarone | Sanofi (Sanofi-Aventis) | 141626-36-0 |  |
| Droperidol | Janssen Pharmaceutica (Johnson & Johnson) | 548-73-2 |  |
| Droprenilamine | Maggioni | 57653-27-7 |  |
| Dropropizine | UCB | 17692-31-8 |  |
| Drospirenone | Schering AG | 67392-87-4 |  |
| Drospirenone & Ethinylestradiol | Bayer Schering Pharma AG | |  |
| Drospirenone & Ethinylestradiol & Levomefolate calcium | Schering AG ; Merck Eprova AG | |  |
| Drostanolone | Syntex (Roche) | 58-19-5 |  |
| Drotaverine Acephyllinate | Chinoin | 61954-97-0 |  |
| Drotrecogin alfa | Eli Lilly | 98530-76-8 | No Structure |
| Droxicam | Laboratorios Del Dr. Esteve S.A. | 90101-16-9 |  |
| Droxidopa | Hoffmann La Roche (Roche) | 23651-95-8 |  |
| Droxinavir | Searle (Pharmacia) | 159910-86-8 |  |
| Drozitumab | Genentech | 912628-39-8 | No Structure |
| DS-121 | Upjohn (Pfizer) | 150336-90-6 |  |
| DS-973-R | Pharmamens (France) | |  |
| DS-998 | University of Chicago | |  |
| DSM-74 | University of Texas (US) | |  |
| DSP-3235 | Kissei Pharmaceutical Co. Ltd. (Japan) | | No Structure |
| DSP-7238 | Dainippon Sumitomo Pharma Co. Ltd. (Japan) | |  |
| DSP-8153 (Amlodipine & Irbesartan) | | 88150-42-9 (Amlodipine) ; 138402-11-6 (Irbesartan) |  |
| DSP-8658 | Dainippon Sumitomo Pharma Co. Ltd. (Japan) | | No Structure |
| DSPC | | 4539-70-2 |  |
| DT-0738 | Faust Pharmaceuticals (Domain Therapeutics) | |  |
| DT-1133 | Domain Therapeutics SA | |  |
| DT-1687 | Domain Therapeutics SA | | No Structure |
| DT-2228 | Domain Therapeutics SA | | No Structure |
| DT-831j | Daiichi Sankyo Co. Ltd. (Japan) | |  |
| DTA-H19 | Yissum | | No Structure |
| DTPw-HepB-Hib | Chiron | | No Structure |
| DTS-101 | Diatos | |  |
| DTS-108 | Diatos | |  |
| DTS-201 | Universite de Louvain (Belgium) | |  |
| DU-125530 | Duphar (Solvay Pharmaceuticals B.V.) | 161611-99-0 |  |
| DU-1301 | CNRS (France) | |  |
| DU-86 | Kyowa Hakko | |  |
| Dulaglutide | Eli Lilly & Co. (US) | 923950-08-7 | No Structure |
| Dulanermin | Genentech | 867153-61-5 | No Structure |
| Duloxetine | Eli Lilly | 116539-59-4 |  |
| Duocarmycin A | Kyowa Hakko (Japan) | 118292-34-5 |  |
| Duocarmycin SA | Kyowa Hakko (Japan) | 130288-24-3 |  |
| Duocarmycin-B1 | Kyowa Hakko (Japan) | 124325-93-5 |  |
| Duocarmycin-B2 | Kyowa Hakko (Japan) | 124325-94-6 |  |
| DUP-654 | DuPont (BMS) | 36441-32-4 |  |
| DUP-697 | DuPont (BMS) | 88149-94-4 |  |
| DUP-734 | DuPont (BMS) | 135135-80-7 |  |
| DUP-983 | DuPont (BMS) | 137103-53-8 |  |
| Duramycin | Molichem Medicines (Lantibio) | 1391-36-2 |  |
| Dutacatib | Novartis | 501000-36-8 |  |
| Dutasteride | Glaxo (GSK) | 164656-23-9 |  |
| Dutasteride & Tamsulosin | Smithkline Beecham Corp. (GlaxoSmithKline plc) | 164656-23-9 (Dutasteride) ; 106133-20-4 (Tamsulosin) |  |
| Dutogliptin | Phenomix | 890402-81-0 (tartrate salt) ; 852329-66-9 |  |
| Duvoglustat | Amicus Therapeutics | 19130-96-2 ; 73285-50-4 (hydrochloride salt) |  |
| DV-7028 | Daiichi | 133364-63-3 |  |
| DV-7751a | Daiichi | 151390-79-3 |  |
| DW-1350 | Dong-Wha | |  |
| DW-2143 | Dong Wha | 203860-97-3 |  |
| DW-2282 | Dong Wha | 203861-05-6 |  |
| DW-286a | Dong Wha Pharmaceutical Industry | |  |
| DW-908e | Daiichi | | No Structure |
| DWK-1339 | Digital Biotech Co. Ltd. (South Korea) | |  |
| DWKH-0090 | Dongwoo Syntech Co. Ltd. | |  |
| DWP-401 | Daewoong Pharma | | No Structure |
| DWP-418 | Yonsei University (Korea) | | No Structure |
| DX-2220 | Dyax | | No Structure |
| DX-2240 | Dyax Corp. | | No Structure |
| DX-306 | Dyax | |  |
| DX-619 | Daiichi Seiyaku | |  |
| DX-9065a | Daiichi (Daiichi-Sankyo) | 150612-55-8 |  |
| DY-9760 | Daiichi (Daiichi Sankyo) | 160522-00-9 |  |
| Dyclonine | Allied Chemicals | 586-60-7 |  |
| Dydrogesterone | North American Philips | 152-62-5 |  |
| Dyloject (Diclofenac) | Shimoda Biotech (South Africa) (Abraxis BioScience) | 15307-86-5 ; 15307-79-6 (Diclofenac sodium) |  |
| Dyofin-1 | Enkam Pharmaceuticals (Denmark) | |  |
| Dyofin-2 | Enkam Pharmaceuticals (Denmark) | |  |
| Dyofin-9 | Enkam Pharmaceuticals (Denmark) | |  |
| Dypnone | | 495-45-4 |  |
| Dysidiolide | University of Columbia ; Sloan Kettering Institute for Cancer Research | 182136-94-3 |  |
| (-)-Dysiherbaine | Suntory | |  |
| DZ-2002 | General Atomics | |  |
| DZ-697b | | | No Structure |
| E-0017 | Fujisawa Pharmaceutical (Astellas) | |  |
| E-0471 | Ebewe | |  |
| E-0747 | Eisai | 99599-78-7 |  |
| E-1 | Innogenetics | | No Structure |
| E-1010 | Eisai | 175077-32-4 (HCl) |  |
| E-1101 | Eisai | 142494-87-9 (HCl) |  |
| E-1210 | Eisai R&D Management Co. Ltd. | |  |
| E-1224 | Eisai | | No Structure |
| E-2040 | Eisai | 172732-21-7 |  |
| E-2050 | Eisai | 351011-41-1 |  |
| E-2100 | Eisai | 214611-53-7 |  |
| E-2101 | Eisai | 265667-22-9 |  |
| E-2212 | Eisai Co. Ltd. | |  |
| E-3024 | Eisai | |  |
| E-3040 | Eisai | 145096-30-6 |  |
| E-3309 | Teikoku Chemical | |  |
| E-3330 | Eisai | 136164-66-4 |  |
| E-3620 | Eisai | 151213-85-3 |  |
| E-3710 | Eisai R&D Management Co. Ltd. (Eisai Co. Ltd.) | |  |
| E-3810 | Advenchen Lab LLC | |  |
| E-3846 | Bayer | 106891-93-4 |  |
| E-4010 | Eisai | 178308-66-2 |  |
| E-4031 | Eisai | 113558-89-7 |  |
| E-4345 | Esteve | |  |
| E-4441 | Esteve | 124668-12-8 |  |
| E-4474 | Esteve | 124668-18-4 |  |
| E-4500 | Esteve | 124668-44-6 |  |
| E-4501 | Esteve | 124668-42-4 |  |
| E-4502 | Esteve | 124668-43-5 |  |
| E-4695 | Esteve | 132832-30-5 |  |
| E-4767 | Esteve | 157378-77-3 |  |
| E-4804 | Esteve | 162559-34-4 |  |
| E-4884 | Esteve | 158112-70-0 |  |
| E-5068 | Esteve | 147293-60-5 |  |
| E-5324 | Eisai | 141799-76-0 |  |
| E-5608 | Esteve | 172463-03-5 |  |
| E-5700 | Eisai | |  |
| E-5842 | Esteve | 177945-46-9 |  |
| E-6087 | Esteve | 251442-94-1 |  |
| E-6123 | Eisai | 131614-02-3 |  |
| E-6199 | Laboratorios Dr. Esteve SA (Spain) | |  |
| E-6201 | Eisai Co. Ltd. (Japan) | |  |
| E-6700 | Eisai | 144562-61-8 |  |
| E-6801 | Laboratorios del Dr. Esteve | |  |
| E-6837 | Laboratorios del Dr. Esteve | |  |
| E-7050 | Eisai Co. Ltd. (Japan) | |  |
| E-7820 | Eisai | 289483-69-8 |  |
| E-7974 | Eisai | |  |
| E-913 | Ono Pharmaceutical | |  |
| [E7K]-N-WASP(181-200) | University of Hiroshima | |  |
| EAA-129 | Wyeth Pharmaceuticals | |  |
| EAB-309 | Mitsubishi Kasei | 137073-91-7 |  |
| EAB-318 | American Home Products (Wyeth) | |  |
| EB | Wisconsin Alumni Research Foundation | | No Structure |
| EB-1053 | Leo Pharmaceutical | 125946-91-0 |  |
| EB-1213 | Leo Pharmaceutical | 139137-13-6 |  |
| EB-47 | Inotek (US) | |  |
| Ebalzotan | Astra (AstraZeneca) | 149494-37-1 |  |
| Ebastine | Almirall Prodesfarma | 90729-43-4 |  |
| Eberconazole | Espanola Farma Therapeut | 128326-82-9 |  |
| Ebrotidine | Ferrer | 100981-43-9 |  |
| Ebselen | Nattermann (sanofi-Aventis) | 60940-34-3 |  |
| EC-0169 | Endocyte Inc. | | No Structure |
| EC-0225 | Endocyte Inc. (US) | |  |
| EC-0489 | Endocyte Inc. | |  |
| EC-0565 | Endocyte Inc. | |  |
| EC-0746 | Endocyte Inc. | | No Structure |
| EC-118 | Endocyte | |  |
| EC-145 | Endocyte | |  |
| EC-17 | Purdue Research Foundation (US) | |  |
| EC-72 | Endocyte | |  |
| Ecabapide | Daiichi | 104775-36-2 |  |
| Ecabet | Tanabe ; Nippon Boehringer Ingelheim | 33159-27-2 |  |
| Ecadotril | Bioprojet (GSK) | 112573-73-6 |  |
| Ecalcidene | Johnson & Johnson ; Farmatis | 150337-94-3 |  |
| Ecallantide | Dyax | 460738-38-9 |  |
| Ecamsule | L'Oreal | 92761-26-7 |  |
| Ecenofloxacin | Cheil Jedfang | 162205-61-5 |  |
| Echistatin | Merck & Co. | 118337-11-4 |  |
| ECO-3396 | Ecopia BioSciences | |  |
| ECO-7942 | Ecopia BioSciences | |  |
| Ecomustine | Choay | 98383-18-7 |  |
| Econazole | Janssen Pharmaceutica (Johnson & Johnson) | 27220-47-9 |  |
| Ecopipam | Schering Corp (Merck & Co) | 190133-94-9 (HCl) |  |
| Ecopladib | Wyeth | 381683-92-7 |  |
| Ecothiopate iodide | Campbell | 513-10-0 |  |
| ECPDAT | Darwin Pharma Inc. | |  |
| Ecraprost | Asahi ; Seikagaku | 136892-65-3 |  |
| Ecromeximab | | 292819-64-8 | No Structure |
| Ecteinascidin 1560 | University of Illinois | 246041-06-5 |  |
| Ecteinascidin 722 | University of Illinois | |  |
| Ecteinascidin 757 | University of Illinois | 246041-03-2 |  |
| Ecteinascidin 775 | Pharma Mar | 215035-11-3 |  |
| Ecteinascidin 875 | University of Illinois | 246041-05-4 |  |
| Eculizumab | Alexion Pharmaceuticals | 219685-50-4 | No Structure |
| ED-110 | Banyu | 139112-73-5 |  |
| Edaglitazone | Boehringer Mannheim (Roche) | 213411-83-7 |  |
| Edaravone | Mitsubishi Chemical | 89-25-8 |  |
| Edatrexate | NCI | 80576-83-6 |  |
| EDC-11 | | |  |
| EDC-12 | | |  |
| Edelfosine | Thomae (Boehringer Ingelheim) | 70641-51-9 |  |
| Edifenphos | Bayer | 17109-49-8 |  |
| Edifoligide | Corgentech ; Bristol-Myers Squibb (BMS) | 328538-04-1 |  |
| Edivoxetine | Eli Lilly | 1194508-25-2 ; 1194374-05-4 (HCl) |  |
| EDO-P4 | University of Michigan | |  |
| Edonentan | Bristol Myers Squibb (BMS) | 264609-13-4 |  |
| Edotecarin | Banyu (Merck Co.) | 174402-32-5 |  |
| Edotreotide | Novartis | 204318-14-9 |  |
| Edoxaban | Daiichi Seiyaku Co, (Japan) | 480449-70-5 |  |
| Edoxudine | Robugen | 15176-29-1 |  |
| EDP-239 | Enanta Pharmaceuticals Inc. | | No Structure |
| EDP-322 | | | No Structure |
| Edratide | Yeda Research & Development | 433922-67-9 |  |
| Edrecolomab | Igenon Krebs (Austria) | 156586-89-9 | No Structure |
| Edrophonium chloride | Hoffmann La Roche (Roche) | 116-38-1 |  |
| EEP | US Army | 85541-78-2 |  |
| EF-1502 | Lundbeck | |  |
| EF-5 | University of Pennsylvania ; University of Rochester | 152721-37-4 |  |
| EF-6265 | Meiji Seika | |  |
| EF13D | Department of Health (US) | | No Structure |
| Efalizumab | | 214745-43-4 | No Structure |
| Efaproxiral | The Center for Innovative Technology (US) | 131179-95-8 |  |
| Efatutazone | Sankyo | 223132-37-4 |  |
| Efavirenz | Merck & Co. | 154598-52-4 |  |
| Efavirenz & Lamivudine & Tenofovir Disoproxil | Matrix Laboratories Ltd. | 154598-52-4 (Efavirenz) ; 134678-17-4 (Lamivudine) ; 201341-05-1 (Tenofovir Disoproxil) ; 202138-50- |  |
| Efegatran | Gedeon Richter | 105806-65-3 |  |
| Efepristin | RPR (Aventis) | 57206-57-9 |  |
| Effirma (Flupirtine) | The Mclean Hospital Corporation (US) | |  |
| Efinaconazole | Kaken Pharmaceutical | 164650-44-6 |  |
| Efipladib | | 381683-94-9 |  |
| Efletirizine | UCB | 150756-35-7 |  |
| Eflornithine | Merrell (Aventis) | 67037-37-0 |  |
| Efloxate | Recordati | 119-41-5 |  |
| Eflucimibe | Pierre Fabre | 202340-45-2 |  |
| Eflusilanat | Schering AG | |  |
| Efomycin G | Bayer | 114013-52-4 |  |
| Efonidipine | Nissan | 111011-63-3 ; 11011-76-8 (hydrochloride) |  |
| Efrotomycin | Merck & Co. | 56592-32-6 |  |
| Efungumab | NeuTec Pharma | 762260-74-2 | No Structure |
| EG-005 (Imidapril) | Ark Therapeutics | 89371-37-9 |  |
| EG-006 (Imidapril) | Ark Therapeutics (UK) | 89371-37-9 |  |
| EG-3287 | Ark Therapeutics | |  |
| Egaptivon pegol | Archemix (US) | 934868-74-3 | No Structure |
| EGF4KDEL 7mut | University of Minnesota (US) | | No Structure |
| EGIS-10609 | EGIS Pharmaceuticals | |  |
| EGIS-11004 | Egyt Gyogyszervegyeszeti Gyar | |  |
| EGIS-11148 | EGIS Pharmaceuticals PLC (Hungary) | |  |
| EGIS-11150 | Egyt Gyogyszervegyeszeti Gyar(Hungary) | |  |
| EGIS-11229 | Egyt Gyogyszervegyeszeti Gyar (Hungary) | |  |
| EGIS-3966 | Egyt | 170489-36-8 |  |
| EGIS-7229 | Egis | 150800-12-7 |  |
| EGIS-7304 | Egis | 161685-71-8 |  |
| EGIS-8332 | EGIS Pharmaceuticals | |  |
| EGIS-8858 | Egyt | 181516-17-6 |  |
| EGIS-9377 | Egis | 255733-90-5 |  |
| EGIS-9637 | Egis | 220669-66-9 |  |
| EGIS-9933 | Egis | 190670-74-7 |  |
| Eglinazine | W. R. Grace | 68228-19-3 |  |
| Eglumegad | Eli Lilly | 209216-09-1 |  |
| EGS-21 | | | No Structure |
| Egualen | Kotobuki | 99287-30-6 |  |
| EH-169 | Yissum ; Hadasit | |  |
| EH-22900 | ExonHit Therapeutics | |  |
| EH-36 | Yissum ; Hadasit | |  |
| EH-40 | Yissum ; Hadasit | |  |
| EHC-18 | Enzo | | No Structure |
| EHT-0202 | ExonHit Therapeutics | 51022-77-6 |  |
| EHT-1864 | Exonhit Therapeutics | |  |
| EHT-5743 | Exonhit Therapeutics | |  |
| EHT-8560 | Exonhit Therapeutics | |  |
| EHT-899 | Enzo Therapeutics | | No Structure |
| EHT-9241 | Exonhit Therapeutics | |  |
| EHT-9299 | ExonHit Therapeutics | |  |
| EI-13 | Royal College Of Surgeons | |  |
| Eicosyl Cidofovir | University of California (US) | |  |
| EK-399 | Takeda | 98849-86-6 |  |
| EK-6136 | Korea Research Institute of Chemical Technology (South Korea) | |  |
| EL-532 | Elan | 1716-12-7 |  |
| Elacridar | Glaxo (GSK) | 143664-11-3 |  |
| Eladur (Bupivacaine) | Durect Corp. | 2180-92-9 |  |
| Elafin | Artes Biotechnology GmbH ; Rhein Biotech Gesellschaft Für Neue Biotechnologische Prozesse Und Produk | |  |
| Elagolix | Neurocrine Biosciences (US) | 834153-87-6 ; 832720-36-2 (sodium salt) |  |
| Elan-G | Elan Pharmaceuticals | |  |
| Elan-Z | Elan Pharmaceuticals | |  |
| Elansolid A2 | Helmholtz-Zentrum für Infektionsforschung GmbH (Germany) | |  |
| Elansolid C1 | Helmholtz-Zentrum für Infektionsforschung GmbH (Germany) | |  |
| Elarofiban | Ortho McNeil (Johnson & Johnson) | 198958-88-2 |  |
| ELB-139 | Dresden Arzneimittel (Elbion AG) | |  |
| ELB-353 | Elbion AG (Biotie Therapies Corp.) | |  |
| Elcatonin | Toyo Jozo | 60731-46-6 | No Structure |
| Elcometrine | E. Merck KGaA | 7759-35-5 |  |
| Eldacimibe | American Home Products (Wyeth) | 141993-70-6 |  |
| Eldecalcitol | Chugai (Roche) | 104121-92-8 |  |
| Elesclomol | Shionogi | 488832-69-5 |  |
| Eletriptan | Pfizer | 143322-58-1 |  |
| Eleutherobin | University of California | |  |
| Elfazepam | Sumitomo Chemical | 52042-01-0 |  |
| Elgodipine | Inst. Investigacion Desarrollo | 119413-55-7 |  |
| Eliglustat | University of Michigan (US) | 491833-29-5 ; 928659-70-5 (Eliglustat tartrate) |  |
| Elinafide | BASF (Abbott) | 162706-37-8 |  |
| Elinogrel | Portola Pharmaceuticals | 936500-94-6 ; 936501-01-8 (potassium salt) |  |
| Eliprodil | Synthelabo (Sanofi-Aventis) | 119431-25-3 |  |
| Elisidepsin | PharmaMar (Spain) | 915713-02-9 |  |
| Ellagic acid | | 476-66-4 |  |
| Ellagic acid 4-gallate | Kikkoman Corp. (Japan) | |  |
| Elliptinium acetate | ANVAR | 58337-35-2 |  |
| ELN-441958 | Elan | |  |
| ELN-475516 | Elan Corporation plc (Ireland) | |  |
| ELND-002 | Elan Corp. plc (Ireland) | | No Structure |
| ELND-004 | Elan Corp. plc (Ireland) | | No Structure |
| ELND-006 | Elan Corp. plc (Ireland) | | No Structure |
| ELND-007 | Elan Corp. plc (Ireland) | | No Structure |
| Elocalcitol | Hoffmann La Roche | 199798-84-0 |  |
| Elomotecan | S.C.R.A.S. (Beaufour Ipsen) | 220998-10-7 |  |
| Elotuzumab | Protein Design Labs (PDL BioPharma) ; Bristol-Myers Squibb (BMS) | 915296-00-3 | No Structure |
| Elpamotide | Oncotherapy Science | 673478-49-4 |  |
| Elpetrigine | Wellcome Foundation (GSK) | 212778-82-0 |  |
| Elsamitrucin | Bristol-Myers Squibb (BMS) | 97068-30-9 |  |
| Elsibucol | AtheroGenics | 216167-95-2 |  |
| Elsilimomab | Diaclone (EUSA Pharma) | 468715-71-1 | No Structure |
| Eltenac | Byk Gulden (Nycomed) | 72895-88-6 |  |
| Eltoprazine | Duphar | 98224-03-4 |  |
| Eltrombopag | Smithkline Beecham (GSK) ; Ligand Pharmaceuticals | 496775-62-3 |  |
| Elvitegravir | Japan Tobacco | 697761-98-1 |  |
| Elvitegravir & Emtricitabine & Tenofovir Disoproxil & Cobicistat | Gilead Sciences Inc. | 697761-98-1 (Elvitegravir) ; 143491-57-0 (Emtricitabine) ; 201341-05-1 (Tenofovir Disoproxil) ; 2021 |  |
| Elvucitabine | Yale University | 181785-84-2 |  |
| Elzasonan | Pfizer | 220322-05-4 (HCl)\n361343-20-6 (citrate) |  |
| EM-012 | Emory University | |  |
| EM-015 | Emory University | |  |
| EM-2487 | Eisai | |  |
| EM-4283 | Endorecherche | |  |
| EM-4977 | Endorecherche | |  |
| EM-523L | Kitasato Institute (Japan) | |  |
| EM-703 | Kitasato Institute (Japan) | |  |
| EM-800 | Endorecherche | 182167-03-9 |  |
| EM-905 | The Kitasato Institute (Japan) ; Aphoenix Inc. (Japan) | |  |
| EM-914 | The Kitasato Institute (Japan) ; Aphoenix Inc. (Japan) | |  |
| Emakalim | E. Merck KGaA | 129729-66-4 |  |
| Emamectin | Merck & Co. | 137335-79-6 |  |
| Emapunil | Dainippon Pharmaceutical (Dainippon Sumitomo) | 226954-04-7 |  |
| Embeconazole | Sankyo | 329744-44-7 |  |
| Embramine | Spofa | 3565-72-8 |  |
| Embusartan | Bayer | 156001-18-2 |  |
| EMD-1204831 | Merck Patent GmbH (Merck KGaA) | | No Structure |
| EMD-1214063 | Merck Patent GmbH | |  |
| EMD-273063 | E. Merck KGaA | | No Structure |
| EMD-393210 | E. Merck KGaA | |  |
| EMD-408407 | E. Merck KGaA | |  |
| EMD-409849 | E. Merck Gmbh | |  |
| EMD-409915 | E. Merck Gmbh | |  |
| EMD-534085 | Merck Patent GmbH | |  |
| EMD-53998 | E. Merck KGaA | 120223-04-3 |  |
| EMD-57033 | E. Merck KGaA | 147527-31-9 |  |
| EMD-58265 | E. Merck KGaA | 286930-48-1 |  |
| EMD-584847 | Merck GmbH (Germany) | |  |
| EMD-60263 | E. Merck KGaA | 158623-12-2 |  |
| EMD-60400 | E. Merck KGaA ; Alcon ; Adolor | 142773-98-6 |  |
| EMD-607830 | Merck Patent GmbH (Germany) | |  |
| EMD-614684 | Merck Patent GmbH | |  |
| EMD-61650 | E. Merck KGaA | 145047-15-0 |  |
| EMD-66398 | Merck KGaA | |  |
| EMD-87322 | Merck KGaA | |  |
| EMD-94246 | E. Merck KGaA | 182012-09-5 |  |
| Emedastine | Kanebo | 87233-61-2 |  |
| Emepepimut-S | Biomira (Oncothyreon) | |  |
| Emepronium bromide | Recip | 3614-30-0 |  |
| Emestrin | Kyowa Hakko Kogyo | 97816-62-1 |  |
| Emfilermin | Amrad (Zenyth Therapeutics) | 159075-60-2 |  |
| Emicerfont | GlaxoSmithKline plc (GB) ; Neurocrine Biosciences Inc. (US) | 786701-13-1 |  |
| Emitefur | Otsuka | 110690-43-2 |  |
| Emivirine | Mitsubishi | 149950-60-7 |  |
| Emodepside | Fujisawa Pharmaceutical | 155030-63-0 |  |
| Emodin | University of Texas, (US); University Degli Studi Di Padova (Italy) | 518-82-1 |  |
| Emorfazone | Morishita | 38957-41-4 |  |
| EMP-6 | Ortho McNeil (Johnson & Johnson) | |  |
| Empatic (Zonisamide & Amfebutamone) | Duke University | |  |
| Empenthrin | Sumitomo Chemical | 54506-48-3 |  |
| Emricasan | Idun Pharmaceuticals (Pfizer) | 254750-02-2 |  |
| Emtricitabine | Biochem pharma | 143491-57-0 |  |
| Emtricitabine & Tenofovir Disoproxil & Rilpivirine | Tibotec Pharmaceuticals Ltd. (Johnson & Johnson) | 143491-57-0 (Emtricitabine) ; 201341-05-1 (Tenofovir Disoproxil) ; 202138-50-9 (Tenofovir Disoproxil |  |
| EMZ-702 | | | No Structure |
| EN-1761KA | Kyowa Hakko Kogyo | |  |
| EN-3215 | Endo Pharmaceuticals | |  |
| Enadoline | Warner Lambert (Pfizer) | 124378-77-4 |  |
| Enalapril | Merck & Co. | 75847-73-3 |  |
| Enalaprilat | Merck & Co. | 76420-72-9 |  |
| Enavatuzumab | PDL BioPharma Inc. (US) | 1062149-33-0 ; 62149-33-0 | No Structure |
| Enazadrem | Pfizer | 107361-33-1 |  |
| Enbucrilate | Rohm & Haas | 6606-65-1 |  |
| Enclomiphene | Zonagen Inc. (Repros Therapeutics Inc.) | 15690-57-0 |  |
| EncorStat | Oxford BioMedica Ltd. | | No Structure |
| EndoAngio-GT | Oxford BioMedica Ltd. | | No Structure |
| Endostatin | Children's Medical Center | 252030-01-6 |  |
| Endosulfan | Hoechst (Sanofi-Aventis) | 115-29-7 |  |
| Endosulfan-alpha | CSIRO (Australia) | 959-98-8 |  |
| EndoTAG-1 (Lipid Complexed Paclitaxel) | Medigene | 33069-62-4 | No Structure |
| Endothal | Sharples Chemicals | 145-73-3 |  |
| Endralazine | Sandoz (Novartis) | 39715-02-1 |  |
| Enecadin | Nippon Shinyaku | 259525-01-4 |  |
| Enfenamic acid | Council Scient Ind Res | 23049-93-6 |  |
| Enflurane | Air Reduction | 13838-16-9 |  |
| Enfuvirtide | Duke University | 159519-65-0 |  |
| Engerix-B | Smithkline Beecham Biologicals (GlaxoSmithKline plc) | 351186-51-1 | No Structure |
| Englerin A | Department of Health and Human Services (US) | |  |
| Englitazone | Pfizer | 109229-58-5 ; 122228-35-7 |  |
| Enilconazole | Janssen Pharmaceutica (Johnson & Johnson) | 35554-44-0 |  |
| Eniluracil | University of Birmingham ; Wellcome Foundation (GSK) | 59989-18-3 |  |
| Eniporide | E. Merck KGaA | 176644-21-6 |  |
| Enkorten (Tridecactide and Met-enkephalin) | Tuzla (Bosnia) | |  |
| ENMD-0995 | Children's Medical Center (US) | |  |
| ENMD-1068 | EntreMed Inc. (US) | |  |
| ENMD-1198 | EntreMed | |  |
| ENMD-2076 | Miikana Therapeutics Inc. (EntreMed Inc.) | |  |
| Enocitabine | Asahi Chemical | 55726-47-1 |  |
| Enofelast | Boehringer Ingelheim | 125722-16-9 |  |
| Enokizumab | | 909875-08-7 | No Structure |
| Enoxacin | Dainippon Pharmaceutical | 74011-58-8 |  |
| Enoxaparin | Rhone-Poulenc Rorer (Sanofi-Aventis) | 9041-08-1 ; 679809-58-6 (Enoxaparin Na) | No Structure |
| Enoximone | Richardson-Merrell (Aventis) | 77671-31-9 |  |
| Enoxolone | Erba Carlo | 471-53-4 |  |
| Enpiroline | Walter Reed Army Inst. | 66364-73-6 |  |
| Enprofylline | Dracco | 41078-02-8 |  |
| Enrasentan | SmithKline Beecham (GSK) | 167256-08-8 |  |
| Enrofloxacin | Bayer | 93106-60-6 |  |
| Ensaculin | Schwabe Willmar | 155773-59-4 |  |
| Ensituximab | Neogenix Oncology, Inc. | 1092658-06-4 | No Structure |
| Ensulizole | | 27503-81-7 |  |
| ENT-103 | Entropin | |  |
| ENT-8184 | VanDyke | 113-48-4 |  |
| ent-Estriol | Schering AG | 300853-07-0 |  |
| Entacapone | Orion (Finland) | 130929-57-6 |  |
| Entecavir | Bristol-Myers Squibb (BMS) | 142217-69-4 |  |
| Entinostat | Mitsui (Nihon Schering) | 209783-80-2 |  |
| Entsufon | Rohm & Haas | 55837-16-6 |  |
| Enviomycin | Toyo Jozo | 33103-22-9 |  |
| Enviroxime | Eli Lilly | 72301-79-2 |  |
| Enzastaurin | Eli Lilly | 359017-79-1 (HCl) ; 170364-57-5 |  |
| EP-014598 | Enanta Pharmaceuticals Inc. (US) | |  |
| EP-014831 | Enanta Pharmaceuticals | |  |
| EP-017796 | Enanta Pharmaceuticals Inc. | |  |
| EP-1052 | Enanta Pharmaceuticals | |  |
| EP-1090 | Epimmune (Pharmexa ) | | No Structure |
| EP-1112 | Enanta Pharmaceuticals | |  |
| EP-1113 | EpiCept Corp. (US) | |  |
| EP-12344 | Enanta | |  |
| EP-128265 | Cytovia (EpiCept) ; Myriad Genetics Inc. (US) | |  |
| EP-1304 | Enanta | |  |
| EP-13043 | Enanta Pharmaceuticals | |  |
| EP-13118 | Enanta Pharmaceuticals | |  |
| EP-14008 | Enanta Pharmaceuticals | |  |
| EP-14389 | Enanta Pharmaceuticals | |  |
| EP-14401 | Enanta Pharmaceuticals | |  |
| EP-14413 | Enanta Pharmaceuticals (US) | |  |
| EP-14912 | Enanta Pharmaceuticals | |  |
| EP-14922 | Enanta Pharmaceuticals | |  |
| EP-14940 | Enanta Pharmaceuticals | |  |
| EP-1562 | Enanta Pharmaceuticals | |  |
| EP-1579 | Enanta Pharmaceuticals | |  |
| EP-2302 | Elpen Pharmaceutical | |  |
| EP-2306 | Elpen Pharmaceutical | |  |
| EP-51216 | Deghenghi | 219517-98-3 |  |
| EP-51389 | Mediolanum Farmaceutici | 192387-85-2 |  |
| Epab | Takabe Reiho | 41653-21-8 |  |
| Epalrestat | Ono Pharmaceutical | 82159-09-9 |  |
| Epanolol | ICI (AstraZeneca) | 86880-51-5 |  |
| EPC-K1 | Senju Pharmaceutical | 127061-56-7 |  |
| Eperezolid | Upjohn (Pharmacia) | 165800-04-4 |  |
| Eperisone | Eisai | 64840-90-0 |  |
| Epervudine | Biogal | 134785-30-1 |  |
| Epetirimod | 3M Innovative Properties | 227318-71-0 ; 885483-02-3 (esylate salt) ; 896444-34-1 (esylate hydrate) |  |
| EPH-116 | University of Insbruck | |  |
| EPH-136 | University of Insbruck | |  |
| EPH-349 | University of Insbruck | |  |
| EPH-350 | University of Insbruck | |  |
| EPH-355 | University of Insbruck | |  |
| EPH-362 | University of Insbruck | |  |
| Ephedrine | Bilhuber | 299-42-3 |  |
| EPI-0030 | Epitomics Inc. (US) | | No Structure |
| EPI-2010 | Chiesi Farmaceutici | | No Structure |
| Epibatidine | NIH | 140111-52-0 |  |
| Epiceram(TM) | | | No Structure |
| Epicillin | Squibb (BMS) | 26774-90-3 |  |
| Epidioxymanadic acid A | Pharma Mar | 178152-21-1 |  |
| Epidioxymanadic acid B | Pharma Mar | 178152-20-0 |  |
| Epidoxoform | Univrsity of Colorado | |  |
| Epigallocatechin gallate | Mitsui Morin | 989-51-5 |  |
| Epimestrol | Searle | 7004-98-0 |  |
| Epinastine | Boehringer Ingelheim | 80012-43-7 |  |
| Epinephrine | Hoechst (Sanofi-Aventis) | 51-43-4 |  |
| Epirizole | Daiichi | 18694-40-1 |  |
| Epirubicin | Farmitalia Carlo Erba (Pharmacia) | 56420-45-2 |  |
| Epitalon | Russian Academy of Medical Sciences (RU) | |  |
| Epitiostanol | Shionogi | 2363-58-8 |  |
| Epitizide | Pfizer | 1764-85-8 |  |
| Eplerenone | Ciba-Geigy (Novartis) | 107724-20-9 |  |
| Eplivanserin | Sanofi (Sanofi-Aventis) | 130580-02-8 |  |
| EPN | DuPont | 2104-64-5 |  |
| Epocholeone | Nippon Kayaku ; Tama Biochemical | 162922-31-8 |  |
| Epoetin alfa | Kirin Amgen | 113427-24-0 |  |
| Epoetin beta | Chugai (Roche) | 122312-54-3 | No Structure |
| Epoetin delta | Transkaryotic Therapies | 261356-80-3 |  |
| Epofolate | Bristol-Myers Squibb (BMS) | |  |
| Eponemycin | Bristol Meyer Squibb (BMS) | 126509-46-4 |  |
| Epoprostenol | Ono Pharmaceutical | 35121-78-9 |  |
| Epothilone A | GBF mbH (De) | 152044-53-6 |  |
| Epothilone C | GBF mbH (De) | 186692-73-9 |  |
| Epothilone D | Biotechnologie Forschung | 189453-10-9 |  |
| Epoxiconazole | BASF | 133855-98-8 |  |
| Epratuzumab | Immunomedics, Inc. | 205923-57-5 | No Structure |
| Eprazinone | Riom | 10402-90-1 |  |
| Eprinomectin | Merck & Co. | 123997-26-2 |  |
| Epristeride | SmithKline Beecham (GSK) | 119169-78-7 |  |
| Eprodisate | Neurochem | 162193-40-0 (disodium salt) |  |
| Eprosartan | SmithKline Beecham (GSK) | 133040-01-4 |  |
| Eprotirome | KaroBio AB | 355129-15-6 |  |
| Eprozinol | Riom | 32665-36-4 |  |
| Epsiprantel | Beecham (GSK) | 98123-83-2 |  |
| Eptacog Alfa | Zymogenetics | 102786-61-8 | No Structure |
| Eptapirone | Pierre Fabre | 179756-85-5 |  |
| Eptastigmine | Consiglio Nazionale Delle Ricerche | 101246-68-8 |  |
| Eptazocine | Nihon Iyakuhin Kogyo | 72522-13-5 |  |
| EPTC | Stauffer | 759-94-4 |  |
| Eptifibatide | Cor Therapeutics | 188627-80-7 |  |
| Equisetin | US Agriculture | 57749-43-6 |  |
| Equol | | 531-95-3 |  |
| ER-017996 | Eisai | 150450-00-3 |  |
| ER-076349 | Eisai | |  |
| ER-119884 | Eisai | |  |
| ER-121958-06 | Eisai | |  |
| ER-127528 | Eisai | 290309-12-5 |  |
| ER-129614-06 | Eisai | |  |
| ER-132781 | Eisai | |  |
| ER-181304 | Eisai | |  |
| ER-308698 | Eisai | |  |
| ER-319711 | Eisai | |  |
| ER-33635 | Eisai | |  |
| ER-34122 | Eisai | 179325-62-3 |  |
| ER-34410 | Eisai | 163308-08-5 |  |
| ER-35794 | Eisai | |  |
| ER-36009 | Eisai | |  |
| ER-37326 | Eisai | |  |
| ER-38925 | Eisai | 196517-43-8 |  |
| ER-41114 | Eisai | 214616-13-4 |  |
| ER-68378 | Eisai | |  |
| ER-68384 | Eisai | |  |
| ER-803064 | Eisai Co. Ltd. | |  |
| ER-805751 | Eisai | |  |
| ER-807446 | Eisai | |  |
| ER-808977 | Eisai | |  |
| ER-811243 | Eisai | |  |
| ER-812011 | Eisai | |  |
| ER-818561 | Eisai | |  |
| ER-819543 | Eisai Co. Ltd. (Japan) | |  |
| ER-819549 | Eisai Co. Ltd. (Japan) | |  |
| ER-819582 | Eisai Co. Ltd. (Japan) | |  |
| Erabulenol A | Kitasato University | 212068-89-8 |  |
| Erastin | Prolexys Pharmaceuticals Inc. (US) ; Whitehead Institute for Biomedical Research (US) ; Columbia Uni | 571203-78-6 |  |
| ERB-009 | Acadia Pharmaceuticals | |  |
| ERB-037 | Acadia Pharmaceuticals | |  |
| ERB-196 | Wyeth | |  |
| Erbstatin | UNIVersity of MICHIGAN ; Searle | 100827-28-9 |  |
| Erdosteine | Refarmed | 84611-23-4 |  |
| Ergocalciferol | | 50-14-6 |  |
| Ergometrine | Sandoz (Novartis) | 60-79-7 |  |
| Eribaxaban | Pfizer Inc. (US) | 536748-46-6 |  |
| Eribulin | Eisai | 253128-41-5 ; 441045-17-6 (mesylate) |  |
| Erismodegib | Irm LLC (Novartis AG) | 956697-53-3 |  |
| Eritoran | Akzo (Akzo Nobel) ; Sanofi (Sanofi-Aventis) | 261504-30-7 |  |
| Erlizumab | Genentech | 211323-03-4 | No Structure |
| Erlotinib | Pfizer | 183321-74-6 |  |
| ERr-731 | Chemisch-Pharmazeutische Fabrik Carl Mueller Apotheker GmbH | |  |
| Ersentilide | Schering AG | 125279-79-0 |  |
| Ertapenem | Zeneca (AstraZeneca) | 153832-46-3 |  |
| Erteberel | Eli Lilly and Company | 533884-09-2 |  |
| Ertiprotafib | American Home Products (Wyeth) | 251303-04-5 |  |
| Ertumaxomab | Trion Pharma | 509077-99-0 | No Structure |
| Erucylphosphocholine | Max Planck Institut | 143317-74-2 |  |
| Eryloside F | Harbor Branch Oceanographic Inst. ; GlaxoSmithKline (GSK) | |  |
| (+)-erythro-Mefloquine | Arakis (Sosei) | 51688-68-7 |  |
| Erythromycin | Eli Lilly | 114-07-8 |  |
| Erythromycin estolate | Eli Lilly | 3521-62-8 |  |
| Erythromycin ethylsuccinate | Abbott | 1264-62-6 |  |
| Erythromycin gluceptate | Eli Lilly | 23067-13-2 |  |
| Erythromycin lactobionate | Abbott | 3847-29-8 |  |
| Erythromycin salnacedin | Pietro Ismardi & CSP | 149908-23-6 (2H2O) |  |
| Erythrosine | Societe Chimique des Usines du Rhone | 49746-10-3 |  |
| ES-1005 | Sankyo | 112785-22-5 |  |
| ES-1537 | Dainippon Pharmaceuticals | |  |
| ES-2133 | Dainippon | |  |
| Esafloxacin | Dainippon Pharmaceutical | 79286-77-4 |  |
| Esatenolol | ICI (AstraZeneca) | 93379-54-5 |  |
| Escin | Klinge | 6805-41-0 ; 20977-05-3 (sodium salt) |  |
| Escitalopram | Lundbeck | 128196-01-0 |  |
| Eseroline | | 469-22-7 |  |
| Esfenvalerate | Sumitomo Chemical | 66230-04-4 |  |
| Esflurbiprofen | Syntex (Roche) | 51543-39-6 |  |
| Esketamine | | 33643-46-8 |  |
| Eslicarbazepine | Portela | 104746-04-5 |  |
| Eslicarbazepine acetate | Bial - Portela | 236395-14-5 |  |
| Esmirtazapine | Akzo Nobel | 61337-87-9 |  |
| Esmolol | Haessle | 103598-03-4 |  |
| Esomeprazole | Astra (AstraZeneca) | 119141-88-7 ; 161796-84-5 (potassium salt) |  |
| Esonarimod | Taisho | 101973-77-7 |  |
| Esoxybutynin | Sepracor (Dainippon Sumitomo Pharma) | 119618-22-3 |  |
| ESP-24232 | Esperion Therapeutics (Pfizer) | |  |
| ESP-55016 | Esperion Therapeutics | |  |
| ESP-7 | New England Medical Center Hospital | 288142-57-4 |  |
| Espindolol | AGI Therapeutics | |  |
| Esprocarb | Stauffer | 85785-20-2 |  |
| Esprolol | Selectus Pharmaceuticals | | No Structure |
| ESR-1150-CL | Boehringer Ingelheim | |  |
| Estazolam | Takeda | 29975-16-4 |  |
| Estetrol | Pantarhei Bioscience | 15183-37-6 |  |
| Estradiol | Schering AG (Bayer Schering) | 50-28-2 |  |
| Estradiol acetate | | 4245-41-4 |  |
| Estradiol benzoate | Schering AG | 50-50-0 |  |
| Estradiol cypionate | Upjohn | 313-06-4 |  |
| Estradiol MDTS | Acrux Limited | |  |
| Estradiol undecylate | Syntex | 3571-53-7 |  |
| Estradiol valerate | Ciba Geigy | 979-32-8 |  |
| Estramustine | Leo | 2998-57-4 |  |
| Estramustine phosphate | Leo Lab | 52205-73-9 (disodium salt ) |  |
| Estriol | | 50-27-1 |  |
| Estriol succinate | Organon (Schering Merck & Co) | 514-68-1 |  |
| Estrogen | Prejay Holdings | | No Structure |
| Estrone | PRESIDENT And BOARD | 53-16-7 |  |
| Estropipate | Abbott | 7280-37-7 |  |
| Esuprone | BASF (Abbott) | 91406-11-0 |  |
| Eszopiclone | RPR (Aventis) | 138729-47-2 |  |
| ET-216 | Pfizer | | No Structure |
| ET-642 | Esperion Therapeutics (Pfizer) | |  |
| Et-NPOX | Instituto Politécnico Nacional (Mexico) | |  |
| Etacrynic acid | Merck & Co. | 58-54-8 |  |
| Etafedrine | Parke, Davis (Pfizer) | 7681-79-0 |  |
| Etafenone | Guidotti | 90-54-0 |  |
| Etalocib | Eli Lilly | 161172-51-6 |  |
| Etamicastat | Portela | 760173-05-5 |  |
| Etamiphyllin | Alexis Jean Marie Moussalli et al. | 314-35-2 |  |
| Etamivan | Chemie Linz | 304-84-7 |  |
| Etamsylate | OMS | 2624-44-4 |  |
| Etanercept | Immunex (Amgen) | 185243-69-0 | No Structure |
| Etanidazole | US Department of Health & Human Services | 22668-01-5 |  |
| Etanterol | Valeas | 93047-39-3 |  |
| ETAR | Southern Research Institute (US) ; New Mexico State University (US) | |  |
| Etaracizumab | MedImmune | 892553-42-3 | No Structure |
| ETC-1001 | Esperion Therapeutics (Pfizer) | |  |
| Eteplirsen | Avi Biopharma | 1173755-55-9 |  |
| Eterobarb | Kendall | 27511-99-5 |  |
| Etersalate | Alter | 62992-61-4 |  |
| ETH-615 | Leo Pharmaceutical | 133430-69-0 |  |
| Ethaboxam | Lucky | 162650-77-3 |  |
| Ethacridine | Optische Anstalt | 442-16-0 |  |
| Ethadione | Schering AG | 520-77-4 |  |
| Ethalfluralin | Eli Lilly | 55283-68-6 |  |
| Ethambutol | American Cyanamid (Wyeth) | 74-55-5 |  |
| Ethametsulfuron-methyl | DuPont | 97780-06-8 |  |
| Ethanolamine Oleate | Hoffmann La Roche (Roche) | 2272-11-9 |  |
| Ethaverine | Wolf | 486-47-5 |  |
| Ethchlorvynol | Pfizer | 113-18-8 |  |
| Ethenzamide | Lundbeck | 938-73-8 |  |
| Ethephon | Amchem (Rhone-Poulenc) | 16672-87-0 |  |
| Ethiazide | Ciba (Novartis) | 1824-58-4 |  |
| Ethidimuron | Bayer | 30043-49-3 |  |
| Ethinylestradiol | Ciba (Novartis) | 57-63-6 |  |
| Ethiofencarb | Bayer | 29973-13-5 |  |
| Ethion | FMC | 563-12-2 |  |
| Ethionamide | Chimie et Atomistique | 536-33-4 |  |
| Ethiozin | Bayer | 64529-56-2 |  |
| Ethiprole | Rhone-Poulenc | 181587-01-9 |  |
| Ethirimol | ICI (Syngenta) | 23947-60-6 |  |
| Ethisterone | Ciba Pharm Prod | 434-03-7 |  |
| Ethofumesate | Tysons | 26225-79-6 |  |
| Ethoheptazine | American Home Products (Wyeth) | 77-15-6 |  |
| Ethohexadiol | Carbide & Carbon Chemicals | 94-96-2 |  |
| Ethonafide | University of Arizona (US) | |  |
| Ethopabate | Merck & Co. | 59-06-3 |  |
| Ethoprophos | Mobil | 13194-48-4 |  |
| Ethosuximide | Parke, Davis (Pfizer) | 77-67-8 |  |
| Ethotoin | Abbott | 86-35-1 |  |
| Ethoxyfen | Suntory | 131086-42-5 ; 188634-90-4 |  |
| Ethoxyquin | ICI (Syngenta) | 91-53-2 |  |
| Ethoxysulfuron | Hoechst (Sanofi-Aventis) | 126801-59-9 |  |
| Ethoxzolamide | Upjohn (Pharmacia) | 452-35-7 |  |
| Ethychlozate | Fujisawa | 27512-72-7 |  |
| Ethyl 1-naphthyl acetate | ICI (Syngenta) | 2122-70-5 |  |
| Ethyl ascorbic acid | Generic | 86404-04-8 |  |
| Ethyl Biscoumacetate | Spojen | 548-00-5 |  |
| Ethyl Loflazepate | Hoffmann La Roche (Roche) | 29177-84-2 |  |
| Ethylestrenol | Organon (Schering Merck & Co) | 965-90-2 |  |
| Ethylmorphine | E. Merck KGaA | 76-58-4 |  |
| Ethylnorepinephrine | Winthrop (Sanofi-Synthelabo) | 536-24-3 |  |
| Ethynylcytidine | Taiho | 9026-39-5 |  |
| ETI-201 | Elusys Therapeutics | | No Structure |
| ETI-211 | Elusys Therapeutics | | No Structure |
| Etibendazole | Janssen Pharmaceutica (Johnson & Johnson) | 64420-40-2 |  |
| Etidocaine | Astra (AstraZeneca) | 36637-18-0 |  |
| Etidronic acid | Procter & Gamble | 2809-21-4 |  |
| Etifelmine | Giuliani | 341-00-4 |  |
| Etifoxine | Hoechst (Sanofi-Aventis) | 21715-46-8 |  |
| Etilefrin | Helmut Legerlotz | 709-55-7 |  |
| Etilevodopa | Hebrew University | 37178-37-3 |  |
| Etinofen | IFPCL | 2544-94-7 |  |
| Etiprednol Dicloacetate | Soft Drugs (Teva) | 199331-40-3 |  |
| Etizolam | Yoshitomi | 40054-69-1 |  |
| ETM-305 | Pharma Mar | 250159-76-3 |  |
| Etobenzanid | Hodogaya | 79540-50-4 |  |
| Etocrilene | Sharp & Dohme (Merck & Co.) | 5232-99-5 |  |
| Etodolac | American Home Products (Wyeth) | 41340-25-4 |  |
| Etodolac-(R) | Salmedix (Cephalon) | |  |
| Etodroxizine | UCB | 17692-34-1 |  |
| Etofenamate | Troponwerke | 30544-47-9 |  |
| Etofenprox | Mitsui | 80844-07-1 |  |
| Etofibrate | Merz | 31637-97-5 |  |
| Etofylline | Gane's Chem. Works | 519-37-9 |  |
| Etofylline Clofibrate | Merckle | 54504-70-0 |  |
| Etoglucid | ICI (AstraZeneca) | 1954-28-5 |  |
| Etomidate | Janssen Pharmaceutica (Johnson & Johnson) | 33125-97-2 |  |
| Etomidoline | Farmitalia Carlo Erba (Pharmacia) | 21590-92-1 |  |
| Etomoxir | Byk Gulden (Nycomed) | 124083-20-1 |  |
| Etonogestrel | Schering Ag | 54048-10-1 |  |
| Etoperidone | Angelini | 52942-31-1 |  |
| Etoposide | Sandoz (Novartis) | 33419-42-0 |  |
| Etoposide Phosphate | Bristol Myers (BMS) | 117091-64-2 |  |
| Etoricoxib | Merck Frosst (Merck & Co.) | 202409-33-4 |  |
| Etoxazole | Yashima | 153233-91-1 |  |
| Etozolin | Warner Lambert (Pfizer) | 73-09-6 |  |
| Etrabamine | Laboratoires Jacques Logeais | 70590-58-8 |  |
| Etravirine | Janssen Pharmaceutica (Johnson & Johnson) | 269055-15-4 |  |
| Etretinate | Hoffmann La Roche (Roche) | 54350-48-0 |  |
| Etriciguat | Bayer | 402595-29-3 |  |
| Etridiazole | Uniroyal | 2593-15-9 |  |
| Etrimfos | Sandoz (Syngenta) | 38260-54-7 |  |
| Etrolizumab | Genentech Inc. (US) | 1044758-60-2 | No Structure |
| ETS-2101 (Dexanabinol) | e-Therapeutics plc | 112924-45-5 |  |
| ETS-2123 | e-Therapeutics plc | | No Structure |
| ETS-6218 | e-Therapeutics plc | | No Structure |
| ETS-7211 | e-Therapeutics plc | | No Structure |
| ETX-6107 | | | No Structure |
| ETX-6201 | e-Therapeutics plc | | No Structure |
| ETX-6765 | e-Therapeutics plc | | No Structure |
| ETX-9101 | | | No Structure |
| Etybenzatropine | Sandoz (Novartis) | 524-83-4 |  |
| Etymemazine | Rhone-Poulenc (Aventis) | 523-54-6 |  |
| EUG-NMS | Panacea Biotec Ltd. (India) | |  |
| Eugeniin | Showa Shell Sekiyu ; | 58970-75-5 |  |
| Eugenodilol | | 242796-68-5 |  |
| Eugenol | | 97-53-0 |  |
| Eugenosedin A | Kaohsiung Medical University (Taiwan) | |  |
| EUK-134 | Eukarion | 81065-76-1 |  |
| EUK-189 | Eukarion | 186350-27-6 |  |
| EUK-207 | Eukarion | 478020-50-7 |  |
| EUK-401 | Eukarion | |  |
| EUK-8 | Eukarion | 53177-12-1 |  |
| Euphodendroidin A | CNRS ; INSERM ; University of Campobasso ; University of Napoli ; \nUniversity of Novara | |  |
| Euphodendroidin D | CNRS ; INSERM ; University of Campobasso ; University of Napoli ; \nUniversity of Novara | |  |
| EUR-1008 (pancrealipase) | Eurand | | No Structure |
| EUrd | Taiho | 180300-49-6 |  |
| Eurocin | Novozymes | |  |
| EV-021 | Evolva SA | | No Structure |
| EV-050 | Evolva SA | | No Structure |
| EV-075 | Evolva SA | | No Structure |
| EV-077 | | | No Structure |
| EV-086 | Evolva SA | | No Structure |
| Evatanepag | Pfizer | 223488-57-1 ; 223490-49-1 (sodium salt) |  |
| Everninomycin | Schering Corp (Merck & Co) | 109545-84-8 |  |
| Everolimus | Sandoz (Novartis) | 159351-69-6 |  |
| Eviprostat | | 59738-67-9 | No Structure |
| EVK-203 | University of Kansas (US) | |  |
| EVP-5141 | Bayer Healthcare AG (Germany) | |  |
| EVT-101 | Hoffmann La Roche (Switzerland) | |  |
| EVT-103 | Evotec AG (Germany) | | No Structure |
| EVT-201 | F. Hoffmann-La Roche AG (Switzerland) | |  |
| EVT-302 | | | No Structure |
| EVT-401 | Renovis | | No Structure |
| EW-A-401 | Edwards Lifesciences Corporation | | No Structure |
| EX-1314 | Bristol-Myers Squibb (BMS) | |  |
| EX-2 | S*Bio Pte. Ltd. (Singapore) | |  |
| EX-527 | Elixir Pharmaceuticals Inc. | 49843-98-3 |  |
| Exalamide | Herts Pharm | 53370-90-4 |  |
| Exametazime | | 105613-48-7 |  |
| Examorelin | Ardana Bioscience | 140703-51-1 |  |
| Exatecan | Daiichi (Daiichi Sankyo) | 171335-80-1 |  |
| Exbivirumab | XTL Biopharmaceuticals | | No Structure |
| EXC-001 | Isis Pharmaceuticals Inc. | | No Structure |
| EXC-002 | Excaliard Pharmaceuticals Inc. | | No Structure |
| EXC-003 | Excaliard Pharmaceuticals Inc. | | No Structure |
| Exebryl-1 | ProteoTech | |  |
| Exemestane | Farmitalia Carlo Erba (Pharmacia) | 107868-30-4 |  |
| Exenatide | Amylin | 141732-76-5 |  |
| Exenatide nasal | Nastech Pharmaceutical Co. Inc.(MDRNA Inc.) | 141732-76-5 |  |
| Exenatide transdermal patch | Altea Therapeutics Corp. | 141732-76-5 |  |
| Exenatide-LAR (Exenatide) | Alkermes ; Amylin Pharmaceuticals | |  |
| Exendin-3 | Amylin | 130391-54-7 |  |
| Exendin(9-39)amide | University of Pennsylvania (US) ; Children's Hospital of Philadelphia (US) | 133514-43-9 |  |
| Exherin | McGill University | |  |
| Exiproben | Boehringer Ingelheim | 26281-69-6 |  |
| Exisulind | Merck & Co. | 59973-80-7 |  |
| EXO-226 | | 307927-65-7 | No Structure |
| EXP-3174 | Du Pont ; Merck & Co | 124750-92-1 |  |
| EXP-9270 | DuPont (BMS) | 114798-32-2 |  |
| Ezatiostat | Terrapin Technologies | 168682-53-9 ; 286942-97-0 (hydrochloride salt) |  |
| Ezetimibe | Schering Corp (Merck & Co) | 163222-33-1 |  |
| Ezlopitant | Pfizer | 147116-64-1 |  |
| EZN-3920 | Santaris Pharma AS (Denmark) | | No Structure |
| Ezogabine | ASTA Medica (Meda) | 150812-12-7 |  |
| F-0401 | Fujirebio | 123852-99-3 |  |
| F-10863A | Sankyo | 191474-81-4 |  |
| F-10863B | Sankyo | 191474-82-5 |  |
| F-11461 | Pierre Fabre | |  |
| F-1201 | Fulcrum Pharmaceuticals | 380430-62-6 |  |
| F-12434 | Sankyo | 196793-29-0 |  |
| F-12682 | Pierre Fabre | 194942-63-7 |  |
| F-1322 | Fujirebio | 143964-80-1 |  |
| F-1327 | FMC | 119545-30-1 |  |
| F-13459 | Institute of Physical and Chemical Research ; RIKEN (JP) ; Nihon University (JP) | |  |
| F-13714 | Pierre Fabre | |  |
| F-1394 | Fujirebio | 162490-89-3 |  |
| F-14329 | Daiichi Sankyo Co. Ltd. (Japan) | |  |
| F-14512 | Pierre Fabre Medicament (France) | |  |
| F-15063 | Pierre Fabre Medicament, (France) | |  |
| F-15078A | Sankyo | |  |
| F-15078C | Sankyo | 458523-28-9 | No Structure |
| F-15078D | Sankyo | 458523-29-0 | No Structure |
| F-15599 | Pierre Fabre Medicament (France) | |  |
| F-15603 | Sankyo | |  |
| F-15845 | Pierre Fabre Medicament (France) | 470454-73-0 |  |
| F-15905 | Sankyo | |  |
| F-15949-1 | Sankyo | |  |
| F-16357 | Pierre Fabre Medicament | |  |
| F-16615 | Pierre Fabre Medicament (France) | |  |
| F-16618 | Pierre Fabre Medicament | |  |
| F-19-6 | Centro de Ingenieria Genetica y Biotechnologia | |  |
| F-19-7 | Centro de Ingenieria Genetica y Biotechnologia | |  |
| F-2692 | Fabre | 133220-91-4 |  |
| F-3121 | Fabre | 133220-93-6 |  |
| F-351 | GNI ; Shanghai Genomics | | No Structure |
| F-598 | Brigham and Women's Hospital (US) ; Beth Israel Deaconess Medical Center Inc. (US) | | No Structure |
| F-721 | Norwich Eaton (Procter & Gamble) | 73269-30-4 |  |
| F-7946T | FAES (Spain) | |  |
| F-91495A | Sankyo Co. | |  |
| F-991 | Fornix Biosciences | |  |
| F-992 | Ferring | 162277-99-8 |  |
| F10-IgG1 | Dana Farber Cancer Institute Inc. (US) ; Burnham Institute for Medical Research (US) | | No Structure |
| FA-103 | SS Pharmaceutical | 154187-69-6 |  |
| FA-131 | University of Sydney (Australia) | |  |
| FA-15 | Wakayama Prefecture ; Japan Science & Technology | |  |
| FA-401 | Green Cross (Mitsubishi Pharma) | |  |
| Fabesetron | Fujisawa | 129300-27-2 |  |
| Factor IX | Scripps Clinic And Research Foundation(US) | 9001-28-9 | No Structure |
| Fadolmidine | Orion | 189353-32-0 (HCl) |  |
| Fadrozole | Ciba-Geigy (Novartis) | 102676-47-1 |  |
| Fagaridine | Nippon Kayaku | 143201-31-4 |  |
| FAHF-2 | Mount Sinai School Medicine (US) | | No Structure |
| Falecalcitriol | Wisconsin Alumni Research Foundation | 83805-11-2 |  |
| Falimarev | Therion Biologics | 685563-14-8 | No Structure |
| Fallypride F18 | University of Chicago | |  |
| Falnidamol | Thomae (Boehringer Ingelheim) | 196612-93-8 |  |
| Famciclovir | Beecham (GSK) | 104227-87-4 |  |
| Famotidine | Yamanouchi (Astellas) | 76824-35-6 |  |
| Famoxadon | DuPont | 131807-57-3 |  |
| Famphur | American Cyanamid (BASF) | 52-85-7 |  |
| Fampridine | Elan ; Accorda | 504-24-5 |  |
| Fampronil | Schering Agrochemicals (Bayer) | 134183-95-2 |  |
| Fananserin | Rhone-Poulenc (Aventis) | 127625-29-0 |  |
| Fandofloxacin | Dong Wha | 164151-00-2 |  |
| Fandosentan | Warner Lambert (Pfizer) | 221241-63-0\n221246-12-4 (potassium salt) |  |
| Fantofarone | Sanofi (Sanofi-Aventis) | 114432-13-2 |  |
| Farampator | University of California | 211735-76-1 |  |
| Faranoxi | Lithuanian Oncology Center | |  |
| Farglitazar | Glaxo (GSK) | 196808-45-4 |  |
| Farletuzumab | Morphotek | 896723-44-7 | No Structure |
| Farnesyl Thiosalicylic acid | | |  |
| Faropenem | Suntory | 106560-14-9 |  |
| Faropenem daloxate | Suntory (Daiichi Sankyo) | 141702-36-5 |  |
| FAS-93 | Fasgen Inc. ; Univ Johns Hopkins | |  |
| Fascaplysin | Novartis Pharma AG ; Solvias AG | 114719-57-2 |  |
| Fasidotril | Bioprojet | 135038-57-2 |  |
| Fasitibant chloride | Menarini | 1157852-02-2 |  |
| Fasobegron | Fujisawa Pharmaceutical Co. (Japan) | 643094-49-9 |  |
| Fasoracetam | Nippon Shinyaku | 110958-19-5 |  |
| Fasudil | Asahi Chemical | 103745-39-7 |  |
| Fatostatin | Baylor College of Medicine (US) | |  |
| FAU | US Government | |  |
| FAU-PA | Wayne State University (US) | |  |
| FAUC-113 | Friedrich-Alexander-University | |  |
| FAUC-179 | Friedrich-Alexander-University | |  |
| FAUC-2020 | Friedrich-Alexander University (Germany) | |  |
| FAUC-206 | Friedrich-Alexander-University | |  |
| FAUC-213 | Friedrich-Alexander University | |  |
| FAUC-299 | Friedrich-Alexander-University | 313972-96-2 |  |
| FAUC-312 | Friedrich-Alexander-University | |  |
| FAUC-316 | Friedrich-Alexander University | 313973-04-5 |  |
| FAUC-327 | Friedrich-Alexander-University | |  |
| FAUC-73 | Friedrich-Alexander-University | |  |
| Favipiravir | Toyama | 259793-96-9 |  |
| Faxeladol | Grünenthal GmbH | 433265-65-7 |  |
| Fazadinium bromide | Allen & Hanburys (GSK) | 49564-56-9 |  |
| Fazarabine | University of Florida | 65886-71-7 |  |
| FBCx (alpha-cyclodextrin) | ArtJen Complexus Holdings Corp. | 10016-20 | No Structure |
| FBT-A05 | TRION Pharma GmbH | | No Structure |
| FC-131 | Kyoto University ; St. Marianna University School of Medicine ; Medical College of Georgia | |  |
| FCC-13 | Monash University | 119200-45-2 |  |
| FCC-5 | Monash University | 142741-00-2 |  |
| FCE-25450 | Farmitalia Carlo Erba (Pharmacia) | 132268-27-0 |  |
| FCE-25876 | Pharmacia & Upjohn (Pharmacia) | |  |
| FCE-28068 | Pharmacia & Upjohn (Pharmacia) | 171714-74-2 |  |
| FCE-28260 | Farmitalia Carlo Erba (Pharmacia) | 155651-56-2 |  |
| FCE-29138 | Pharmacia & Upjohn (Pharmacia) | |  |
| FCE-29272 | Pharmacia & Upjohn (Pharmacia) | |  |
| FCE-293250 | Pharmacia & Upjohn (Pharmacia) | 187802-33-1 |  |
| FCE-29330 | Pharmacia & Upjohn (Pharmacia) | 187144-01-0 |  |
| FCE-29331 | Pharmacia & Upjohn (Pharmacia) | 155651-56-2 |  |
| FD-1 | Agouron Pharma (Pfizer Inc.) (US) | |  |
| FD-22 | National Research Council | |  |
| FD-501 | SS Pharmaceutical | 154187-73-2 |  |
| FD-891 | Taisho | 142383-53-7 |  |
| FdC | Pharmasset | |  |
| FDC-2-4 | Forbes Medi Tech | |  |
| FE-200041 | Ferring | |  |
| FE-399 | Ajinomoto | 200127-94-2 |  |
| FEAOX-6 | University of Ferrara | |  |
| FEAU | Sloan Kettering Cancer Inst. | 83546-42-3 |  |
| Febantel | Bayer | 58306-30-2 |  |
| Febarbamate | Sapos | 13246-02-1 |  |
| Febrifugine | US Army | 24159-07-7 |  |
| Febuprol | Klinge (Fujisawa) | 3102-00-9 |  |
| Febuxostat | Teijin Pharma | 144060-53-7 |  |
| Feclemine | UCB | 3590-16-7 |  |
| Fedotozine | Jouveinal | 123618-00-8 |  |
| Fedovapagon | Ferring Pharmaceuticals | 347887-36-9 |  |
| Fedrilate | UCB | 23271-74-1 |  |
| Feglymycin | Hoechst (Sanofi-Aventis) | 209335-49-9 |  |
| FEIBA | Immuno AG | 78690-39-8 | No Structure |
| Felbamate | Carter-Wallace | 25451-15-4 |  |
| Felbinac | Lederle (Wyeth) | 5728-52-9 |  |
| Felodipine | Haessle | 72509-76-3 |  |
| Feloprentan | BASF | 204267-33-4 |  |
| Felypressin | Sandoz AG | 56-59-7 |  |
| Fenadiazole | Logeais | 1008-65-7 |  |
| Fenalamide | Schering AG | 4551-59-1 |  |
| Fenalcomine | La Roche Navarron | 34616-39-2 |  |
| Fenamidone | Rhone-Poulenc | 161326-34-7 |  |
| Fenamiphos | Bayer | 22224-92-6 |  |
| Fenarimol | Eli Lilly | 60168-88-9 |  |
| Fenazaquin | Eli Lilly | 120928-09-8 |  |
| Fenbendazole | Hoechst (Sanofi-Aventis) | 43210-67-9 |  |
| Fenbuconazole | Rohm & Haas | 114369-43-6 |  |
| Fenbufen | American Cyanamid (Wyeth) | 36330-85-5 |  |
| Fenbutatin oxide | Shell | 13356-08-6 |  |
| Fenbutrazate | Ravensberg | 4378-36-3 |  |
| Fencamfamine | E. Merck KGaA | 1209-98-9 |  |
| Fencamine | Inst. de Investigaciones Terape | 28947-50-4 |  |
| Fencarbamide | Bayer | 3735-90-8 |  |
| Fenchlorazole | Hoechst (Sanofi-Aventis) | 103112-36-3 |  |
| Fencibutirol | Maggioni | 5977-10-6 |  |
| Fenclofenac | Reckitt & Colmann | 34645-84-6 |  |
| Fenclorim | Ciba-Geigy (Novartis) | 3740-92-9 |  |
| Fendiline | Chinoin | 13042-18-7 |  |
| Fendizoic acid | | 84627-04-3 ; 432106-71-3 |  |
| Fendosal | Hoechst (Sanofi-Aventis) | 53597-27-6 |  |
| Fendrix | GlaxoSmithKline (GSK) | | No Structure |
| Fenetylline | Degussa | 3736-08-1 |  |
| Fenfluramine | Servier | 458-24-2 |  |
| Fenfluthrin | Bayer | 75867-00-4 |  |
| Fenfuram | Shell | 24691-80-3 |  |
| Fenhexamid | Bayer | 126833-17-8 |  |
| Fenipentol | Thomae (Boehringer Ingelheim) | 583-03-9 |  |
| Fenitropan | Egyt | 65934-94-3 |  |
| Fenitrothion | Sumitomo Chemical | 122-14-5 |  |
| Fenobucarb | Sumitomo Chemical | 3766-81-2 |  |
| Fenocinol | Lafon (Cephalon) | 3671-05-4 |  |
| Fenofibrate | Fournier | 49562-28-9 |  |
| Fenofibrate & Pravastatin | Galephar Pharmaceutical (Belgium) | |  |
| Fenofibric acid | Fournier (Solvay Pharmaceuticals) | 856676-23-8 |  |
| Fenofibric acid (Fibricor) | | |  |
| Fenoldopam | SmithKline (GSK) | 67227-56-9 |  |
| Fenoprofen | Eli Lilly | 31879-05-7 |  |
| Fenoterol | Boehringer Ingelheim | 13392-18-2 |  |
| Fenothiocarb | Kumiai | 62850-32-2 |  |
| Fenoverine | A. Buzas ; R. Pierre | 37561-27-6 |  |
| Fenoxanil | Shell | 115852-48-7 |  |
| Fenoxaprop | Hoechst (Sanofi-Aventis) | 65617-09-7 |  |
| Fenoxaprop-P | Hoechst (Sanofi-Aventis) | 113158-40-0 |  |
| Fenoxasulfone | Kumiai Chemical Industry Co., Ltd. (Japan) | 639826-16-7 |  |
| Fenoxazoline | Dausse | 4846-91-7 |  |
| Fenoxedil | Cerpha | 54063-40-0 |  |
| Fenoxycarb | Hoffmann La Roche (Roche) | 79127-80-3 |  |
| Fenozan 50 | Pharma Mar | 159911-27-0 |  |
| Fenozolone | Dausse | 15302-16-6 |  |
| Fenpiclonil | Nippon Soda | 74738-17-3 |  |
| Fenpipramide | Hoechst (Sanofi-Aventis) | 14007-53-5 |  |
| Fenpiverinium bromide | Hoechst (Sanofi-Aventis) | 125-60-0 |  |
| Fenpropathrin | Sumitomo Chemical | 64257-84-7 |  |
| Fenpropidin | Hoffmann La Roche (Roche) | 67306-00-7 |  |
| Fenpropimorph | Hoffmann La Roche (Roche) ; BASF | 67564-91-4 |  |
| Fenproporex | Bottu | 15686-61-0 |  |
| Fenprostalene | Syntex | 69381-94-8 |  |
| Fenpyrazamine | Sumitomo Chemical Co., Ltd. | 473798-59-3 |  |
| Fenpyroximate | Nihon Nohyaku | 134098-61-6 |  |
| Fenquizone | Maggioni | 20287-37-0 |  |
| Fenretinide | Johnson & Johnson | 65646-68-6 |  |
| Fenspiride | Servier | 5053-06-5 |  |
| Fensulfothion | Bayer | 115-90-2 |  |
| Fentadur (Fentanyl patch) | Lavipharm Laboratories Inc. (US) | 437-38-7 |  |
| Fentanyl | Janssen Pharmaceutica (Johnson & Johnson) | 437-38-7 |  |
| Fenthion | Bayer | 55-38-9 |  |
| Fentiazac | Wyeth | 18046-21-4 |  |
| Fenticlor | IG Farben | 97-24-5 |  |
| Fenticonazole | Recordati | 72479-26-6 |  |
| Fentin acetate | Hoechst (Sanofi-Aventis) | 900-95-8 |  |
| Fentin chloride | Hoechst (Sanofi-Aventis) | 639-58-7 |  |
| Fentin hydroxide | Hoechst (Sanofi-Aventis) | 76-87-9 |  |
| Fentonium bromide | Whitefin Holding | 5868-06-4 |  |
| Fentrazamide | Bayer | 158237-07-01 |  |
| Fenuron | DuPont | 101-42-8 |  |
| Fenvalerate | Sumitomo Chemical | 51630-58-1 |  |
| Fenyramidol | Neisler | 553-69-5 |  |
| Fepradinol | Gentili | 63075-47-8 |  |
| Feprazone | De Angeli | 30748-29-9 |  |
| Ferimzone | Takeda | 89269-64-7 |  |
| Fermagate | Ineos Healthcare Limited | 119175-48-3 |  |
| Ferpifosate sodium | Byk Gulden (Nycomed) | 138708-32-4 |  |
| ferric carboxymaltose | Vifor International AG | 9007-72-1 | No Structure |
| Ferristene | Nycomed AS | 155773-56-1 | No Structure |
| Ferrocin | | 14038-43-8 |  |
| Ferroquine | Universite de Lille, France | 185055-67-8 |  |
| Ferrous fumarate | Mallinckrodt Chemical Works | 141-01-5 ; 871-44-3 |  |
| Fertirelin | Takeda | 38234-21-8 ; 66002-66-2 (acetate) | No Structure |
| Ferucarbotran | Meito Sangyo | | No Structure |
| Ferulic acid | Generic | 1135-24-6 |  |
| Ferumoxtran-10 | Advanced Magnetics | 189047-99-2 | No Structure |
| Ferumoxytol | Advanced Magnetics (AMAG Pharmaceuticals) | 1309-38-2 | No Structure |
| Fesoterodine | Schwarz Pharma (UCB) | 286930-03-8 |  |
| Fexofenadine | Richardson-Merrell (Sanofi-Aventis) | 83799-24-0 ; 138452-21-8 (hydrochloride) |  |
| Fezakinumab | | 1007106-86-6 | No Structure |
| FF-44 | Wisconsin Alumni Research Foundation (US) | |  |
| FF-55 | Wisconsin Alumni Research Foundation (US) | |  |
| FG-020318 | Sun Yat-Sen University | |  |
| FG-020326 | Zhongshan University | |  |
| FG-020327 | Zhongshan University | |  |
| FG-2216 | FibroGen | | No Structure |
| FG-3019 | University of South Florida | | No Structure |
| FG-3409 | F2G Ltd. (GB) | |  |
| FG-3622 | F2G Ltd. | |  |
| FG-5865 | Pharmacia & Upjohn (Pharmacia) | 150527-35-8 |  |
| FG-5893 | Pharmacia & Upjohn (Pharmacia) | 150527-23-4 |  |
| FG-7080 | Ferrosan | 100332-18-1 |  |
| FG-7142 | Schering AG | 78538-74-6 |  |
| FG-8035 | Ferrosan | |  |
| FGI-103 | US Army Research Institute of Infectious Diseases (US) | |  |
| FGI-104 | Functional Genetics Inc. (US) | |  |
| FGIN-1-27 | Fidia-Georgetown Institute | 142720-24-9 |  |
| FGL-L | Enkam Pharmaceuticals | |  |
| FI-700 | Kyowa Hakko Kogyo Co. Ltd. (Japan) | |  |
| Fiacitibine | Sloan Kettering Cancer Inst. | 69123-90-6 |  |
| Fialuridine | Sloan Kettering Cancer Inst. | 69123-98-4 |  |
| FID-201261 | Fidia | |  |
| FID-203152 | Fidia | |  |
| Fidarestat | Sanwa Kagaku | 136087-85-9 |  |
| Fidaxomicin | Abbott | 873857-62-6 |  |
| Fidexaban | Berlex | 183305-24-0 |  |
| Fiduxosin | Abbott | 208993-54-8 ; 208992-74-9 (hydrochloride) |  |
| Figitumumab | Pfizer | 943453-46-1 | No Structure |
| Filenadol | Ferrer | 78168-92-0 |  |
| Filgrastim | Kirin - Amgen (US) | 121181-53-1 | No Structure |
| Filibuvir | Agouron Pharmaceuticals Inc. (Pfizer Inc.) (US) | 877130-28-4 |  |
| Fimasartan | Boryung pharma (Korea) | 247257-48-3 |  |
| Finafloxacin | Bayer | 209342-40-5 |  |
| Finasteride | Merck & Co. | 98319-26-7 |  |
| Fingolimod | Yoshitomi | 162359-55-9 |  |
| Finrozole | Orion | 204714-56-7 |  |
| Fipamezole | Orion | 150586-72-4 |  |
| Fipexide | Bouchard | 34161-24-5 |  |
| Fipronil | May & Baker (Aventis) | 120068-37-3 |  |
| Firategrast | Tanabe Seiyaku | 402567-16-2 |  |
| Firocoxib | Merck Frosst (Merck & Co.) | 189954-96-9 |  |
| Fispemifene | Hormos (QuatRx) | 341524-89-8 |  |
| FJ-9 | University of California (US) | |  |
| FK-041 | Fujisawa | 163009-62-9 |  |
| FK-143 | Fujisawa | 163136-03-6 |  |
| FK-1706 | Fisons Plc | |  |
| FK-317 | Fujisawa | |  |
| FK-3311 | Fujisawa | 116686-15-8 |  |
| FK-352 | Fujisawa (Astellas) | |  |
| FK-355 | Fujisawa | |  |
| FK-614 | Fujisawa Pharmaceutical | 400608-02-8 |  |
| FK-664 | Fujisawa | 94936-90-0 |  |
| FK-706 | Fujisawa | 144055-51-6 |  |
| FK-788 | Fujisawa Pharmaceutical (Astellas Pharma) | 227951-89-5 |  |
| FK-838 | Fujisawa Pharmaceutical | |  |
| FK-888 | Fujisawa | 138449-07-7 |  |
| FK-949E | AstraZeneca AB (Sweden) | | No Structure |
| FK-960 | Fujisawa (Astellas Pharma) | 133920-70-4 |  |
| FK-962 | Fujisawa Pharmaceutical (Astellas Pharma) | |  |
| FKI-3389 | The Kitasato Instiitute (Japan) | |  |
| FL-B-12 | Albert Einstein College of Medicine (US) | |  |
| Flamprop-M-Isopropyl | Shell | 63752-90-1 |  |
| Flamprop-M-Methyl | Shell | 63729-98-6 |  |
| Flamprop-methyl | Shell | 37924-13-3 |  |
| Flavodic acid | Mesanguy Maurice | 37470-13-6 |  |
| Flavoxate | Recordati | 15301-69-6 |  |
| Flazasulfuron | Ishihara | 104040-78-0 |  |
| Flecainide | Riker | 54143-55-4 |  |
| Flector Patch (Diclofenac epolamine) | Altergon SA (IBSA Institut Biochimique SA) | 119623-66-4 |  |
| Flerobuterol | Lafon (Cephalon) | 82101-10-8 |  |
| Fleroxacin | Kyorin | 79660-72-3 |  |
| Flesinoxan | Duphar | 98206-10-1 |  |
| Flestolol | DuPont (BMS) | 87721-62-8 |  |
| Flezelastine | Asta Medica | 135381-77-0 |  |
| Flibanserin | Boehringer Ingelheim | 167933-07-5 |  |
| Flindokalner | Bristol-Myers Squibb (BMS) | 187523-35-9 |  |
| Flobufen | Spofa | 112344-52-2 |  |
| Flocoumafen | Shell | 90035-08-8 |  |
| Floctafenine | Roussel-Uclaf (Aventis) | 23779-99-9 |  |
| Flomoxef | Fujisawa | 99665-00-6 |  |
| Flonicamid | Ishihara | 158062-67-0 |  |
| Flopristin | Aventis Pharma (Sanofi-Aventis) | |  |
| Flopropione | US Secretary of Agriculture | 2295-58-1 |  |
| Florantyrone | Miles | 519-95-9 |  |
| Florasulam | Dow | 145701-23-1 |  |
| Florbenazine F 18 | University of Pennsylvania ; Univ Michigan | 956903-29-0 |  |
| Florbetaben (18F) | University of Pennsylvania | 902143-01-5 |  |
| Florbetapir F18 | University of Pennsylvania (US) | 956103-76-7 |  |
| Flordipine | USV | 77590-96-6 |  |
| Floredil | Orsymonde (Cephalon) | 53731-36-5 |  |
| Florfenicol | Schering Corp (Merck & Co) | 76639-94-6 |  |
| Florifenine | Ferrer | 83863-79-0 |  |
| Flosatidil | Synthelabo (Sanofi-Aventis) | 113593-34-3 |  |
| Flosequinan | Boots (Abbott) | 76568-02-0 |  |
| Flosulide | Schering AG | 80937-31-1 |  |
| Flovagatran | Trigen | 871576-03-3 |  |
| Floxuridine | Hoffmann La Roche (Roche) | 50-91-9 |  |
| FLT-3 ligand | Immunex | | No Structure |
| flt3-flk2 ligand | Schering Corp. (Merck) | 391964-42-4 | No Structure |
| Fluacizine | Inst. Pharmacol. Chemother. | 30223-48-4 |  |
| Fluacrypyrim | BASF | 229977-93-9 |  |
| Fluanisone | Janssen Pharmaceutica (Johnson & Johnson) | 1480-19-9 |  |
| Fluarix | Saechsisches Serumwerk (GlaxoSmithKline plc ) | | No Structure |
| Fluasterone | Research Corporation Technologies | 112859-71-9 |  |
| Fluazifop | Ciba-Geigy (Novartis) | 69335-91-7 |  |
| Fluazifop-P | Ishihara | 83066-88-0 |  |
| Fluazinam | Ishihara | 79622-59-6 |  |
| Fluazolate | Monsanto | 174514-08-0 |  |
| Fluazuron | Ciba-Geigy (Novartis) | 86811-58-7 |  |
| Flubendazole | Janssen Pharmaceutica (Johnson & Johnson) | 31430-15-6 |  |
| Flubendiamide | Nihon Nohyaku (Japan) | 272451-65-7 |  |
| FluBlok | Protein Sciences | | No Structure |
| Flubrocythrinate | Shanghai Zhong-Xi Pharmaceuticals | 160791-64-0 |  |
| Flucarbazone | Bayer | 145026-88-6 |  |
| Flucetosulfuron | Korea Research Inst. of Chemical Technology (KRICT) | 412928-75-7 |  |
| Fluchloralin | BASF | 33245-39-5 |  |
| Fluciclatide (18F) | G.E. Healthcare | 879894-01-6 |  |
| Fluciclovine (18F) | G.E. Healthcare | 222727-39-1 |  |
| Flucloxacillin | Beecham (GSK) | 5250-39-5 |  |
| Fluconazole | Pfizer | 86386-73-4 |  |
| Flucycloxuron | Duphar | 113036-88-7 |  |
| Flucythrinate | American Cyanamid (BASF) | 70124-77-5 |  |
| Flucytosine | Hoffmann La Roche (Roche) | 2022-85-7 |  |
| Fludarabine | US Department of Health & Human Services | 21678-14-1 |  |
| Fludelone | Memorial Sloan-Kettering Cancer Center (MSKCC) | |  |
| Fludeoxyglucose 18F | General Electric | 105851-17 |  |
| Fludiazepam | Hoffmann La Roche (Roche) | 3900-31-0 |  |
| Fludioxonil | Ciba-Geigy (Novartis) | 131341-86-1 |  |
| Fludrocortisone | Olin Mathieson | 127-31-1 |  |
| Fludrocortisone Acetate | Merck & Co. | 514-36-3 |  |
| Fluensulfone | Bayer Cropscience | 318290-98-1 |  |
| Flufenacet | Bayer | 142459-58-3 |  |
| Flufenamic acid | Parke-Davis (Pfizer) | 530-78-9 |  |
| Flufenerim | Ube | 170015-32-4 |  |
| Flufenoxine | Faes Farma | |  |
| Flufenoxuron | DuPont | 101463-69-8 |  |
| Flufenprox | ICI (Syngenta) | 107713-58-6 |  |
| Flufenpyr-ethyl | Sumitomo Chemical | 188489-07-8 |  |
| Flufiprole | | 704886-18-0 |  |
| Fluindione | USV | 957-56-2 |  |
| Flumatinib | China | |  |
| Flumazenil | Hoffmann La Roche (Roche) | 78755-81-4 |  |
| Flumecinol | Gedeon Richter | 56430-99-0 |  |
| Flumedroxone acetate | Leo Pharm Prod | 987-18-8 |  |
| Flumequine | Riker | 42835-25-6 |  |
| Flumethasone | Upjohn (Pharmacia) | 2135-17-3 |  |
| Flumethasone Acetate | Upjohn | |  |
| Flumethasone Pivalate | | 2002-29-1 |  |
| Flumethrin | Bayer | 69770-45-2 |  |
| Flumetralin | Ciba-Geigy (Novartis) | 62924-70-3 |  |
| Flumetsulam | DowElanco | 98967-40-9 |  |
| Flumiclorac | Sumitomo Chemical | 87547-04-4 |  |
| Flumioxazine | Sumitomo Chemical | 103361-09-7 |  |
| Flumorph | Shenyang Research Inst. | 211867-47-9 |  |
| Flunarizine | Janssen Pharmaceutica (Johnson & Johnson) | 52468-60-7 |  |
| FluNhance | | | No Structure |
| Flunidazole | Merck & Co. | 4548-15-6 |  |
| Flunisolide | American Cyanamid (Wyeth) | 3385-03-3 |  |
| Flunitrazepam | Hoffmann La Roche (Roche) | 1622-62-4 |  |
| Flunixin | Schering Corp (Merck & Co) | 38677-85-9 |  |
| Flunoxaprofen | Eli Lilly | 66934-18-7 |  |
| Fluocinolone Acetonide | Syntex | 67-73-2 |  |
| Fluocinonide | Olin Matheison | 356-12-7 |  |
| Fluocortin butyl | Schering AG | 41767-29-7 |  |
| Fluocortolone | Schering AG | 152-97-6 |  |
| Fluocortolone caproate | Schering AG | 303-40-2 |  |
| Fluocortolone pivalate | Schering AG | 29205–06–9 |  |
| Fluoglizine (Fluoxetine & Glycyrrhizinic acid) | Novosibirskij Institut Organicheskoj Khimii | 54910-89-3 + 1405-86-3 |  |
| Fluometuron | Ciba (Novartis) | 2164-17-2 |  |
| Fluopicolide | Bayer Cropscience | 239110-15-7 |  |
| Fluopyram | Bayer Cropscience | 658066-35-4 |  |
| Fluoramphenicol | Zambon ; Agrimont | 49648-37-5 |  |
| Fluoratec | General Hospital ; Harvard College ; Organix (US) | 306741-05-9 |  |
| Fluorescein | | 2321-07-5 |  |
| Fluoresone | Lab. Franc. Chimiother. | 2924-67-6 |  |
| Fluoridamid | Minesota Mining | 47000-92-0 |  |
| Fluoroacetamide | M.A. Phillips & Associates | 640-19-7 |  |
| Fluorodaunorubicine | Sagami | 121351-02-8 |  |
| Fluorodopa F18 | University of California (US) | 92812-82-3 |  |
| Fluoroglycofen | BASF | 77501-60-1 |  |
| Fluoroimide | Mitsubishi | 41205-21-4 |  |
| Fluoroindolocarbazole C | Bristol Myers Squibb (BMS) | 138829-46-6 |  |
| Fluorometholone | Upjohn | 426-13-1 |  |
| Fluoronitrofen | Mitsui | 13738-63-1 |  |
| Fluorouracil | Hoffmann La Roche | 51-21-8 |  |
| Fluosol | Green Cross Corp. | 83271-20-9 | No Structure |
| Fluoxastrobin | Bayer | 361377-29-9 |  |
| Fluoxetine | Eli Lilly | 54910-89-3 |  |
| Fluoxymesterone | Ciba Geigy | 76-43-7 |  |
| Fluparoxan | Glaxo (GSK) | 105182-45-4 |  |
| Flupentixol | SmithKline French (GSK) | 2709-56-0 |  |
| Fluphenazine | Olin Mathieson | 69-23-8 |  |
| Flupirtine | Degussa | 56995-20-1 |  |
| Flupoxam | Kureha ; Monsanto | 119126-15-7 |  |
| Fluprednidene | Merck & Co | 2193-87-5 |  |
| Fluprednidene Acetate | Merck & Co | 1255-35-2 |  |
| FluPro | The University Of Warwick (GB) | | No Structure |
| Flupropadine | May & Baker (Aventis) | 81613-59-4 |  |
| Flupropanate | DuPont | 756-09-2 |  |
| Fluprostenol | Hoechst (Sanofi-Aventis) | 40666-16-8 |  |
| Flupyrazofos | Korea Research Inst. of Chemical Technology (KRICT) | 122431-24-7 |  |
| Flupyrsulfuron | DuPont | 150315-10-9 |  |
| Fluquinconazole | Schering AG ; Agrevo | 136426-54-5 |  |
| Flurandrenolide | Syntex | 1524-88-5 |  |
| Flurazepam | Hoffmann La Roche (Roche) | 17617-23-1 |  |
| Flurazole | Monsanto | 72850-64-7 |  |
| Flurbiprofen | Boots (Abbott) | 5104-49-4 |  |
| Flurbiprofen Axetil | Kaken Pharmaceutical | 91503-79-6 |  |
| Flurenol-butyl | E. Merck KGaA | 2314-09-2 |  |
| Fluridone | Eli Lilly | 59756-60-4 |  |
| Flurithromycin | Pierrel | 82664-20-8 |  |
| Flurochloridone | Stauffer | 61213-25-0 |  |
| Flurogestone Acetate | Searle | 2529-45-5 |  |
| Fluroxypyr-meptyl | DowElanco | 69377-81-7 |  |
| Flurpiridaz (18F) | Bristol-Myers Squibb Medical Imaging (BMS) ; Lantheus Medical Imaging | 863887-89-2 |  |
| Flurprimidol | Eli Lilly | 56425-91-3 |  |
| Flurtamone | Chevron | 96525-23-4 |  |
| Flusalan | Wallace & Tiernan | 4776-06-1 |  |
| Flusilazole | DuPont | 85509-19-9 |  |
| Fluspirilene | Janssen Pharmaceutica (Johnson & Johnson) | 1841-19-6 |  |
| Flusulfamide | Mitsui | 106917-52-6 |  |
| Flutamide | Schering Corp (Merck & Co) | 13311-84-7 |  |
| Flutazolam | Hoffmann La Roche (Roche) | 27060-91-9 |  |
| Flutemetamol (18F) | University of Pittsburgh (US) | 765922-62-1 |  |
| Fluthiacet-Methyl | Kumiai | 117337-19-6 |  |
| Flutianil | | 958647-10-4 |  |
| Fluticasone | Glaxo (GSK) | 80474-14-2 |  |
| Fluticasone furoate | Glaxo Group | 779352-12-4 ; 397864-44-7 |  |
| Flutiform (fluticasone proprionate & formoterol fumarate) | Jago pharma (SkyePharma) | |  |
| Flutolanil | Nihon Nohyaku | 66332-95-5 |  |
| Flutoprazepam | Sumitomo Chemical | 25967-29-7 |  |
| Flutriafol | ICI (Syngenta) | 76674-21-0 |  |
| Flutrimazole | Uriach | 119006-77-8 |  |
| Flutropium bromide | Boehringer Ingelheim | 63516-07-4 |  |
| FluVacc | | | No Structure |
| Fluval P | Omninvest Ltd. | | No Structure |
| Fluvalinate | Zoecon | 69409-94-5 |  |
| Fluvastatin | Sandoz (Novartis) | 93957-54-1 ; 93957-55-2 (sodium) |  |
| Fluviral | | | No Structure |
| Fluvoxamine | Philips-Duphar | 54739-18-3 |  |
| Fluxapyroxad | BASF Corporation | 907204-31-3 |  |
| Fluxofenin | Ciba-Geigy (Novartis) | 88485-37-4 |  |
| FM-19 | Thromgen Inc. (US) ; University of Michigan (US) ; TSRL Inc. (US) | |  |
| FM-VP4 | FMI Holdings Ltd. | 396080-03-8 |  |
| FM19G11 | Centro Investigación Príncipe Felipe (Spain) | |  |
| FMA-0713 | Taisho | |  |
| FMA-122 | Taisho | |  |
| FMA-1419 | Taisho Pharmaceutical | |  |
| FMA-1485 | Taisho Pharmaceutical | |  |
| FMA-1492 | Taisho Pharmaceutical | |  |
| FMO-52a | Takeda | |  |
| FMO-53 | Takeda | |  |
| FMP2.1-AS02A | Walter Reed Army Institute of Research (US) | | No Structure |
| FMPA | Meiji Milk | 171611-77-1 |  |
| FMPD | Eli Lilly | |  |
| FMS-586 | Meiji Seika Kaisha | |  |
| FN-22 | National Research Council | |  |
| FN-23 | Section of Infectious Diseases, Department of Medicine, University of Arizona, | |  |
| FNQ-3 | Japan Science & Technology | 4512-56-5 |  |
| FO-152 | Fuji Chemical ; Sankyo | 84998-29-8 |  |
| FO-152-1 | Japan Science & Technology | |  |
| FO-152-2 | Japan Science & Technology | |  |
| Focetria | Medimmune LLC | | No Structure |
| FolateScan | Purdue Research Foundation | |  |
| Folic acid | American Cyanamid (Wyeth) | 59-30-3 |  |
| Folinic acid | Research Corporation | 58-05-9 |  |
| Follistatin | Genentech | 9002-68-0 | No Structure |
| Follitropin Alfa | Bernstine Edward George | 146479-72-3 ; 56832-30-5 (alpha-subunit) ; 110909-60-9 (beta-subunit) | No Structure |
| Follitropin beta | | 146479-72-3 | No Structure |
| Folpet | Standard Oil | 133-07-3 |  |
| FOM-8108 | Kitasato Institute | |  |
| Fomepizole | Orphan Medical | 7554-65-6 |  |
| Fomesafen | ICI (Syngenta) | 72128-02-0 |  |
| Fominoben | Thomae (Boehringer Ingelheim) | 18053-31-1 |  |
| Fomivirsen | ISIS | 144245-52-3 |  |
| Fondaparin Sodium | Choay | 104993-28-4 |  |
| Fonofos | Stauffer | 944-22-9 |  |
| Fontolizumab | Protein Design Labs (PDL Biopharma) | 326859-36-3 | No Structure |
| Fonturacetam | Leningradskij Gosudarstvennyj Pedagogicheskij Institut im. AI Gertsena. (Russia) ; Volgogradskij Gos | 77472-70-9 |  |
| Foramsulfuron | Hoechst (Sanofi-Aventis) | 173159-57-4 |  |
| Forasartan | Searle (Pharmacia) | 145216-43-9 |  |
| Foravirumab | Crucell Holland (Netherlands) | 944548-38-3 |  |
| Forchlorfenuron | Sandoz (Syngenta) | 68157-60-8 |  |
| Foretinib | Exelixis | 849217-64-7 |  |
| Forfenimex | Microbial Chemical Research Foundation | 72937-11-6 |  |
| Forigerimod | CNRS (France) | 497156-60-2 ; 1160237-55-7 (acetate) |  |
| Formebolone | Prodotti Biolog Braglia | 2454-11-7 |  |
| Formestane | Ciba Geigy | 566-48-3 |  |
| Formetanate | Schering AG | 22259-30-9 |  |
| Formocortal | Farmaceutici | 2825-60-7 |  |
| Formosulfathiazole | Hosbon | 13968-86-0 |  |
| Formoterol | Yamanouchi (Astellas) | 73573-87-2 |  |
| Formoterol Novolizer | Asta Medica AG (Meda AB) | 73573-87-2 |  |
| Formothion | Sandoz (Syngenta) | 2540-82-1 |  |
| Forodesine | Albert Einstein College of Medicine of Yeshiva University ; Industrial Research | 209799-67-7 |  |
| Foropafant | Sanofi (Sanofi-Aventis) | 136468-36-5 |  |
| Fosalvudine Tidoxil | Boehringer Mannheim (Roche) | 763903-67-9 |  |
| Fosamine | DuPont | 59682-52-9 |  |
| Fosamprenavir | Vertex | 226700-79-4 |  |
| Fosaprepitant | Merck & Co. | 172673-20-0 ; 265121-04-8 (dimeglumine) |  |
| Foscarnet sodium | DuPont (BMS) | 63585-09-1 |  |
| Fosdevirine | Idenix Pharmaceuticals | 1018450-26-4 |  |
| Fosetyl-aluminium | Pepro (Philagro) | 39148-24-8 |  |
| Fosfestrol | Ciba (Novartis) | 522-40-7 |  |
| Fosfluconazole | Pfizer | 194798-83-9 |  |
| Fosfluridine tidoxil | Heidelberg Pharma | 174638-15-4 |  |
| Fosfocreatinine | C.F.M.C. | 5786-71-0 |  |
| Fosfomycin | Merck & Co. | 23155-02-4 |  |
| Fosfosal | Uriach | 6064-83-1 |  |
| Fosfructose | Cypros (Questcor) | 488-69-7 |  |
| Fosinopril | Squibb (BMS) | 98048-97-6 |  |
| Fosinopril & Lovastatin | Psivida Inc. (US) | |  |
| Fosinopril & Simvastatin | Psivida Inc. (US) | |  |
| Fosmethilan | Neviki Research Inst. for Heavy Chem. | 83733-82-8 |  |
| Fosphenytoin | Intrex Research Co. | 93390-81-9 |  |
| Fospirate | Dow | 5598-52-7 |  |
| Fospropofol | University of Kansas | 258516-87-9 |  |
| Fostamatinib | Rigel Pharmaceuticals | 901119-35-5 ; 914295-16-2 (sodium salt) |  |
| Fosthiazate | Ishihara | 98886-44-3 |  |
| Fostriecin | Warner Lambert (Pfizer) | 87810-56-8 |  |
| Fotemustine | ADIR (Servier) | 92118-27-9 |  |
| FOV-1101 (Prednisolone acetate & Ciclosporin) | CombinatoRx Inc. | 52-21-1 (Prednisolone acetate) ; 59865-13-3 (Ciclosporin) |  |
| FOV-2304 | | | No Structure |
| Fowlicidin-1 (6-26) | Oklahoma State University (US) | |  |
| Fozivudine tidoxil | Roche | 141790-23-0 |  |
| FP-0004 | Faust Pharmaceuticals | |  |
| FP-0006 | Faust Pharmaceuticals | |  |
| FP-0007 | Faust Pharmaceuticals | |  |
| FP-0009 | Faust Pharmaceuticals | |  |
| FP-0011 | Faust Pharmaceuticals S.A. | | No Structure |
| FP-0013 | Faust Pharmaceuticals | |  |
| FP-0015 | Faust Pharmaceuticals | |  |
| FP-0023 | Faust Pharmaceuticals (Domain Therapeutics) | | No Structure |
| FP-0040 | Faust Pharmaceuticals | |  |
| FP-0041 | Faust Pharmaceuticals | |  |
| FP-0110 | | | No Structure |
| FP-0141 | Faust Pharmaceuticals | |  |
| FP-0142 | Faust Pharmaceuticals | |  |
| FP-0145 | Faust Pharmaceuticals | |  |
| FP-0210 | Formac Pharmaceuticals NV | | No Structure |
| FP-0220 | Formac Pharmaceuticals NV | | No Structure |
| FP-0230 | Formac Pharmaceuticals NV | | No Structure |
| FP-0240 | | | No Structure |
| FP-0250 (Fenofibrate) | Formac Pharmaceuticals NV | |  |
| FP-0429 | Faust Pharmaceuticals | |  |
| FP-1 | Universitá degli Studi di Milano - Bicocca (Italy) | |  |
| FP-1039 | Five Prime Therapeutics Inc. | | No Structure |
| FP-1097 | FemmePharma Global Healthcare (US) | |  |
| FP-1198 | FemmePharma Global Healthcare (US) | 17230-88-5 |  |
| FP-16CM | Florida University | 191999-13-0 |  |
| FP-16CMAc | Florida University | 191999-15-2 |  |
| FP-21399 | Fuji Photo Film | 170020-61-8 |  |
| FP-7832 | Faust Pharmaceuticals | |  |
| FPFS-410 | Fujimoto Brothers | |  |
| FPL-13210 | AstraZeneca | 143305-97-9 |  |
| FPL-62129 | Fisons | 95445-79-7 |  |
| FPL-63012AR | Fisons | 112430-91-8 |  |
| FPMDD | | |  |
| FPMPA | Rega Stichting;Inst. Of Organic Chemistry | 135295-27-1 |  |
| FPMPDAP | | 135295-28-2 |  |
| FPMTrD | | |  |
| FPT-025 | Five Prime Therapeutics Inc. | | No Structure |
| FPT-033 | Five Prime Therapeutics Inc. | | No Structure |
| FPT-038 | Five Prime Therapeutics Inc. | | No Structure |
| FPT-042 | Five Prime Therapeutics Inc. | | No Structure |
| FPT-046 | Five Prime Therapeutics Inc. | | No Structure |
| FPT-057 | Five Prime Therapeutics Inc. | | No Structure |
| FPT-069 | Five Prime Therapeutics Inc. | | No Structure |
| FPT-091 | Five Prime Therapeutics Inc. | | No Structure |
| FR-113680 | Fujisawa | 126088-92-4 |  |
| FR-115092 | Fujisawa | |  |
| FR-115427 | Fujisawa | 126114-66-7 |  |
| FR-118487 | Fujisawa | 142186-14-9 |  |
| FR-121196 | Fujisawa | 133920-65-7 |  |
| FR-122047 | Fujisawa | 130717-51-0 |  |
| FR-133605 | Fujisawa | 144752-64-7 |  |
| FR-137316 | Fujisawa | |  |
| FR-139317 | Fujisawa | 142375-60-8 |  |
| FR-140423 | Taisho | 151506-44-4 |  |
| FR-143166 | Fujisawa | 521972-71-4 |  |
| FR-149175 | Fujisawa | 152357-12-5 (HCl) |  |
| FR-149470 | Fujisawa | |  |
| FR-167356 | Fujisawa | |  |
| FR-167653 | Fujisawa | |  |
| FR-168888 | | |  |
| FR-172516 | Fujisawa ; Daicel Chem Ind | 188564-74-1 |  |
| FR-173657 | Fujisawa | 167838-64-4 |  |
| FR-180204 | Astellas Pharma Inc. (Japan) | |  |
| FR-181877 | Fujisawa | 172936-99-1 |  |
| FR-183998 | Fujisawa | 177733-06-1 |  |
| FR-188582 | Fujisawa | 189699-82-9 |  |
| FR-190997 | Fujisawa | 193344-25-1 |  |
| FR-193262 | Fujisawa Pharmaceutical | |  |
| FR-193879 | Fujisawa | |  |
| FR-194738 | Fujisawa | 204067-52-7 |  |
| FR-194921 | Fujisawa | |  |
| FR-198248 | Fujisawa | 197316-54-4 |  |
| FR-217840 | Fujisawa | |  |
| FR-218944 | Fujisawa | |  |
| FR-221647 | Fujisawa Pharmaceutical | |  |
| FR-225654 | Fujisawa Pharmaceutical | |  |
| FR-226807 | Fujisawa | 247568-68-9 |  |
| FR-226928 | Fujisawa | |  |
| FR-227244 | Fujisawa Pharmaceutical | |  |
| FR-227369 | Fujisawa | |  |
| FR-229934 | Fujisawa (Astellas) | 405551-89-5 |  |
| FR-233074 | Fujisawa Pharmaceutical | |  |
| FR-235208 | Fujisawa Pharmaceutical | |  |
| FR-238831 | Fujisawa Pharmaceutical | |  |
| FR-247304 | Fujisawa | |  |
| FR-252921 | Fujisawa | |  |
| FR-255031 | Fujisawa Pharmaceutical | |  |
| FR-255595 | Fujisawa Pharmaceutical | |  |
| FR-258900 | Fujisawa Pharmaceutical | |  |
| FR-260330 | Fujisawa Pharmaceutical | |  |
| FR-261529 | Fujisawa | |  |
| FR-276457 | Astellas Pharma Inc. (Japan) | |  |
| FR-900098 | Fujisawa | 66508-32-5 |  |
| Fradafiban | Thomae (Boehringer Ingelheim) | 148396-36-5 |  |
| Frakefamide | Astra (AstraZeneca) | 188196-22-7 |  |
| Framycetin | Rutgers Res & Educational Fo | 119-04-0 |  |
| Freselestat | Cortech | 208848-19-5 |  |
| Fresolimumab | | 948564-73-6 | No Structure |
| FRI-20 | Temple Univ | |  |
| Friulimicin B | Aventis (Sanofi-Aventis) | 239802-15-4 |  |
| Frovatriptan | SmithKline Beecham (GSK) | 158747-02-5 |  |
| FSN-0503 | Queen’s University of Belfast (GB) | | No Structure |
| FT-011 | Fibrotech Therapeutics Pty. Ltd. (Australia) ; University of Melbourne (Australia) | |  |
| FT-023 | Fibrotech Therapeutics Pty Ltd. ; University of Melbourne (Australia) | |  |
| FT-026 | Fibrotech Therapeutics Pty Ltd. ; University of Melbourne (Australia) | |  |
| FT-0554A | Kitasato | |  |
| FT-061 | Fibrotech Therapeutics Pty Ltd. | | No Structure |
| FT-071 | Fibrotech Therapeutics Pty Ltd. | | No Structure |
| FTC | Emory University (US) | 143491-54-7 |  |
| FTC-092 | Taiho | 96141-37-6 |  |
| FTI-2220 | Washington University ; Yale University | |  |
| FTI-2600 | Chugai | |  |
| FTI-277 | University of Pittsburgh | 170006-73-2 |  |
| FUB-593 | Bioprojet ; INSERM | |  |
| Fuberidazole | Bayer | 3878-19-1 |  |
| Fucoxanthin | | 3351-86-8 |  |
| Fudosteine | Seiyaku | 13189-98-5 |  |
| Fujisawa-RN-152817-70-4 | Fujisawa | 152817-72-6 |  |
| Fulranumab | Amgen | 902141-80-4 | No Structure |
| Fulvestrant | ICI (AstraZeneca) | 129453-61-8 |  |
| Fumagalone | Johns Hopkins University | |  |
| Fumagillin | Upjohn (Pharmacia) | 23110-15-8 |  |
| Fumitremorgin C | University of Maryland | 118974-02-0 |  |
| Furalaxyl | Ciba-Geigy (Novartis) | 57646-30-7 |  |
| Furaltadone | Norwich | 139-91-3 |  |
| Furametpyr | Sumitomo Chemical | 123572-88-3 |  |
| Furathiocarb | Ciba-Geigy (Novartis) | 65907-30-4 |  |
| Furazabol | Daiichi Seiyaku | 1239-29-8 |  |
| Furazolidone | Norwich | 67-45-8 |  |
| Furilazole | Monsanto | 141980-03-2 |  |
| Furmecyclox | BASF | 60568-05-0 |  |
| Furnidipine | Cermol | 138661-03-7 |  |
| Furosemide | Hoechst (Sanofi-Aventis) | 54-31-9 |  |
| Fursultiamine | Takeda | 804-30-8 ; 10238-39-8 (hydrochloride) |  |
| Furyloxyfen | Mitsui | 80020-41-3 |  |
| Fusidic Acid | Leo Pharmaceutical | 6990-06-3 |  |
| FV-100 | Cardiff University ; Katholieke Universiteit Leuven | |  |
| FX-06 | Fibrex Medical GmbH | |  |
| FX-11 | The Johns Hopkins University (US) | |  |
| FYK-1388 | Fuji Yakuhin | |  |
| FZ-202-1 | Emory University (US) | |  |
| G-009 | Il Yang Pharm. | |  |
| G-1 | Centro de Bioactivos Químicos (CBQ) University de Las Villas (Santa Clara, Cuba) | |  |
| G-15 | University of New Mexico (US) ; ChemDiv Inc. (US) | |  |
| G-17DT | Aphton Corporation (US) | 250693-48-2 |  |
| G-207 | Georgetown University | | No Structure |
| G-4544 | Genta Inc. | | No Structure |
| G-573 | Genentech Inc. | |  |
| G-619 | Manetti & Roberts | 108828-56-4 |  |
| G-7453 | Genentech | 167854-60-6 |  |
| G2-25 | Kumamoto Technology And Industry Foundation | | No Structure |
| G25 | Virbac | 201849-42-5 |  |
| GA-0056 | Asahi Glass ; Green Cross (Mitsubishi Pharma) | 153465-66-8 |  |
| GA-0113 | Asahi Glass ; Mitsubishi Pharma | 200639-61-8 |  |
| Gabadur | State University of New York (US) | |  |
| Gabapentin | Goedecke (Pfizer) | 60142-96-3 |  |
| Gabapentin (Gralise) | Depomed | 60142-96-3 |  |
| Gabapentin enacarbil | Xenoport | 478296-72-9 |  |
| Gabexate | Ono Pharmaceutical | 39492-01-8 ; 56974-61-9 (Mesilate) |  |
| Gaboxadol | Lundbeck | 64603-91-4 |  |
| Gacyclidine | CNRS | 68134-81-1 |  |
| Gadobenic acid | Bracco | 113662-23-0 |  |
| Gadobutrol | Schering AG | 770691-21-9 ; 138071-82-6 |  |
| Gadocoletic Acid | Bracco | 280776-87-6 |  |
| Gadodenterate | Schering AG | 544697-52-1 |  |
| Gadodiamide | Salutar (Nycomed-Amersham) | 131410-48-5 |  |
| Gadofosveset | Metasyn | 193901-90-5 (Ligand); 211570-55-7 (trisodium) |  |
| Gadolinium texaphyrin | Pharmacyclics ; Texas University (US) | 156436-89-4 |  |
| Gadomelitol | Guerbet | 308814-41-7 |  |
| Gadopentetic Acid | Schering AG | 80529-93-7 |  |
| Gadoteric acid | University of Texas | 72573-82-1 |  |
| Gadoteridol | Squibb (BMS) | 120066-54-8 |  |
| Gadoversetamide | Mallinckrodt | 131069-91-5 |  |
| Gadoxetic acid | Schering AG (Bayer Schering Pharma) | 135326-11-3 |  |
| Galactolipid | Hansen (Hyben Vital ; Denmark) | |  |
| Galantamine | Synaptech | 357-70-0 |  |
| Galarubicin | Dong-A ; Zaidan Hojin Biseibutsu | 195612-80-7 |  |
| Galasomite | Synsorb Biotech (Canada) | |  |
| Galdansetron | Glaxo-Wellcome (GSK) | 116684-92-5 |  |
| Galegine | Academie des sciences de paris (France) | 543-83-9 |  |
| Galgenprostucel-L & Litgenprostucel-L | Whitehead Institute for Biomedical Research (US) ; Johns Hopkins University School of Medicine (US) | | No Structure |
| Galiximab | | 357613-77-5 | No Structure |
| Gallacetophenone | Kodak | 528-21-2 |  |
| Gallamine triethiodide | Rhone-Poulenc (Aventis) | 65-29-2 |  |
| Gallium maltolate | Geomed | 108560-70-9 |  |
| Gallopamil | Knoll (Abbott) | 16662-47-8 |  |
| Galocitabine | Roche | 124012-42-6 |  |
| Gambogic acid | Cytovia | 2752-65-0 |  |
| Gamithromycin | Merial Limited | 145435-72-9 |  |
| Gamma Cyhalothrin | ICI (Syngenta) | 76703-62-3 |  |
| Gamma Oryzanol | Agency of Industrial Science & Technology;; | 11042-64-1 ; 21238-33-5 |  |
| Gamma-amino-beta-hydroxybutyric acid | Kaken Pharmaceutical | 352-21-6 |  |
| gamma-aminobutyric acid | | 56-12-2 |  |
| gamma-tocotrienol | | 14101-61-2 |  |
| Gamolenic acid | Roche | 506-26-3 |  |
| Ganaxolone | Glaxo (GSK) | 38398-32-2 |  |
| Ganciclovir | Syntex (Roche) | 82410-32-0 |  |
| Ganciclovir Elaidic Acid | Norsk Hydro | 206748-99-4 |  |
| Ganirelix | Syntex (Roche) | 123246-29-7 |  |
| Ganite (Gallium nitrate) | | 13494-90-1 |  |
| Ganitumab | Amgen | 905703-97-1 | No Structure |
| Ganoderic acid X | Academia Sinica ; National Taiwan University | |  |
| Ganstigmine | Chiesi Farmaceutici | 223585-99-7 ; 457075-21-7 |  |
| Gantacurium chloride | Cornell Res Foundation ; Glaxo Wellcome ; Avera Pharmaceuticals | 213998-46-0 |  |
| Gantenerumab | F. Hoffmann-LaRoche | 89957-37-9 ; 1043556-46-2 | No Structure |
| Gantofiban | E. Merck KGaA | 183547-57-1 |  |
| Gardasil | Merck & Co | | No Structure |
| Garenoxacin | Toyama | 194804-75-6 |  |
| Garnocestim | GlaxoSmithKline (GSK) | 246861-96-1 |  |
| Gastrazole | James Black Foundation (Johnson & Johnson) | |  |
| Gasulfase | BioMarin Pharmaceutical | 552858-79-4 | No Structure |
| Gataparsen | Isis | 1065019-70-6 ; 928768-71-2 (heptadecasodium salt) | No Structure |
| Gatifloxacin | Kyorin | 112811-59-3 |  |
| Gavestinel | Glaxo (GSK) | 153436-22-7 |  |
| Gavilimomab | Abgenix (Amgen) ; SangStat | 244096-20-6 | No Structure |
| Gaxilose | Consejo Superior Investigacion (Spain) | 14087-31-1 |  |
| GB-1057 | Mitsubishi Pharma Corp. (Mitsubishi Tanabe Pharma Corp. ) | | No Structure |
| GB-115 | Russian Academy of Medical Sciences | |  |
| GBR-500 | Chromos Molecular Systems Inc. | | No Structure |
| GBR-600 | Glenmark Pharmaceuticals SA | | No Structure |
| GBR-900 | Lay Line Genomics SpA | | No Structure |
| GC-1102 | Green Cross Corp. | | No Structure |
| GC-1107 | | | No Structure |
| GC-1109 | Korea Center for Disease Control and Prevention (South Korea) ; Green Cross Corp. | | No Structure |
| GC-1111 | Green Cross Corp. | | No Structure |
| GC-1113 | Green Cross Corp. | | No Structure |
| GC-2101 | Green Cross Corp. | | No Structure |
| GC-2107 | Green Cross Corp. | | No Structure |
| GC-3 | Wisconsin Alumni Research Foundation | |  |
| GC-33 | Chugai | | No Structure |
| GC-7101 | Green Cross Corp. | | No Structure |
| GCA-186 | | 149950-61-8 |  |
| GCAN-101 | ARP Biomed Ltd. | | No Structure |
| GCC-1290K | Green Cross Corp. | |  |
| GCC-2680 | Green Cross Corp. | |  |
| GCK-75b | New York University | |  |
| GCM-11i | New York University | |  |
| GCPGC | Mogam Biotechnology Research Institute | | No Structure |
| GCS-100 | GlycoGenesys | 531508-98-2 | No Structure |
| GCSB-5 | Shin Jun Sik (South Korea) | | No Structure |
| GD-423 | University of Michigan | |  |
| Gd[N-4ab-Q-7ab]Abeta30 | Mayo Foundation for Medical Education and Research (US) | |  |
| GD17scFv-PE40 | Forerunner Pharma Research Co. Ltd. (Japan) | | No Structure |
| GDC-0834 | CGI Pharmaceuticals Inc. (Gilead Sciences Inc.) | |  |
| GDC-0879 | Genentech Inc. (US) ; Array BioPharma Inc. (US) | |  |
| GDC-0941 | Piramed Limited (F. Hoffmann-La Roche AG) (Switzerland) | 957054-30-7 (bismesylate salt) |  |
| GDC-0980 | F. Hoffmann-La Roche AG (Switzerland) | | No Structure |
| GDC-151 | University of Strathclyde (GB) | |  |
| GE-23077-A | Biosearch Italia | |  |
| GE-81112 Factor B | Vicuron | |  |
| GED-aPC | Ely Lilly | | No Structure |
| Gedocarnil | Schering AG | 109623-97-4 |  |
| Gefarnate | De Angeli | 51-77-4 |  |
| Gefitinib | Zeneca (AstraZeneca) | 184475-35-2 |  |
| Geldanamycin | Upjohn (Pfizer) | 30562-34-6 |  |
| Gelsolin | Brigham and Women's Hospital; US | | No Structure |
| GEM-21s | BioMimetic | | No Structure |
| GEM-231 | Worcester Foundation for Experimental Biology | 255810-66-3 | No Structure |
| Gemcabene | Warner Lambert (Pfizer) | 183293-82-5 |  |
| Gemcitabine | Eli Lilly | 95058-81-4 |  |
| Gemcitabine elaidate | ConPharma AS (Clavis Pharma) | |  |
| Gemeprost | Ono Pharmaceutical | 64318-79-2 |  |
| Gemfibrozil | Parke, Davis (Pfizer) | 25812-30-0 |  |
| Gemifloxacin | LG Chemical | 175463-14-6 |  |
| Gemigliptin | LG Life Sciences | 911637-19-9 |  |
| Gemopatrilat | Squibb (BMS) | 160135-92-2 |  |
| Gemtuzumab | American Cyanamid | 220578-59-6 |  |
| Genistein | Roche Vitamins AG | 446-72-0 |  |
| Genoconazole | Sumitomo Chemical | 120924-80-3 |  |
| Gentamicin | Schering Corp (Merck & Co) | 1403-66-3 |  |
| Gentisic acid | Monsanto (Pharmacia) | 490-79-9 |  |
| Genz-123346 | Genzyme | |  |
| GENZ-644131 | Genzyme Corp. | |  |
| Gepefrine | Helopharm | 18840-47-6 |  |
| Gepirone | Mead Johnson (US) | 83928-76-1 |  |
| GERI-E7 | Questcor Pharmaceuticals | |  |
| Gestodene | Schering AG | 60282-87-3 |  |
| Gestonorone caproate | Schering AG | 1253-28-7 |  |
| Gestrinone | Roussel-Uclaf (Aventis) | 16320-04-0 |  |
| Gevokizumab | | 1129435-60-4 | No Structure |
| Gevotroline | American Home Products (Wyeth) | 107266-06-8 |  |
| GF-015535-00 | Ferrer Internacional SA | |  |
| GF-109203X | Goedecke | 133052-90-1 |  |
| GFB-204 | University of South Florida ; University of Yale | |  |
| GFT-1229 | Genfit | | No Structure |
| GFT-14 | Genfit | | No Structure |
| GFT-679 | Genfit | | No Structure |
| GGF-2 | Cenes (Paion) | | No Structure |
| GGTI-2154 | University of Pittsburgh | |  |
| GGTI-2418 | Yale University (US) | |  |
| GGTI-286 | Pittsburgh University ; Pennsylvania University | |  |
| GGTI-298 | University of Pittsburgh ; University of South Florida ; Yale University | 180977-44-0 |  |
| GGTI-2Z | Purdue Research Foundation (US) | |  |
| GGTI-DU40 | Duke University | |  |
| Ghrelin | Suntory research Institut (Japan) | 304853-26-7 |  |
| GHS-001 | Acadia Pharmaceuticals Inc. (US) | |  |
| GI-10001 | GlobeImmune Inc. | | No Structure |
| GI-104313 | GlaxoSmithKline (GSK) | 149998-19-6 |  |
| GI-129471 | British Biotech | 130370-59-1 |  |
| GI-264879A | Wellcome Foundation (GSK) | 338776-71-9 (trifluoroacetate) |  |
| GI-270384 | GlaxoSmithKline (GSK) | | No Structure |
| GI-3000 | GlobeImmune Inc. | | No Structure |
| GI-4000 | GlobeImmune Inc. | | No Structure |
| GI-448 | Hokuriku | |  |
| GI-5005 | GlobeImmune Inc. | | No Structure |
| GI-6207 | GlobeImmune Inc. | | No Structure |
| GI-8000 | GlobeImmune Inc. | | No Structure |
| Gibberellic Acid | ICI (Syngenta) | 77-06-5 |  |
| Gibberellin A4 | ICI (Syngenta) | 468-44-0 |  |
| Gibberellin A7 | ICI (Syngenta) | 510-75-8 |  |
| Gidazepam | Russian Academy of Sciences | 129186-29-4 |  |
| Gilatide | University of Jefferson | 308357-01-9 |  |
| Gimatecan | Ist. Naz. Stud. Cura Dei Tumori ; Sigma Tau | 292618-32-7 |  |
| GINA-220 | Chiron (Novartis) | |  |
| GINA-301 | Chiron (Novartis) | |  |
| Ginkgo EGB-761 | Dr. Willmar Schwabe GmbH | 122933-57-7 | No Structure |
| Ginkgolide B | SCRAS (Beaufour-Ipsen) | 15291-75-5 ; 99796-69-7 |  |
| Ginsenoside Rb2 | Yamanouchi (Astellas) | 11021-13-9 |  |
| Girentuximab | Warnaar S. ; Oosterwijk E. (University of Leiden) | 916138-87-9 | No Structure |
| Giripladib | Wyeth | 865200-20-0 |  |
| Girisopam | Egis | 82230-53-3 |  |
| Gisadenafil | Pfizer | 334826-98-1 ; 334827-98-4 (besylate salt) |  |
| Givinostat | Italfarmaco | 497833-27-9 ; 199657-29-9 |  |
| GKA-50 | AstraZeneca | |  |
| GKK-1032B | Kyowa Hakko | |  |
| GL-1001 | | | No Structure |
| GL-2002 | | |  |
| GL-331 | Genelabs Technologies | 127882-73-9 |  |
| Glatiramer acetate | Yeda Res & Dev (Teva) | 147245-92-9 | No Structure |
| Glemanserin | Merrell Dow (Aventis) | 107703-78-6 |  |
| Glembatumumab | CuraGen Corporation (Celldex Inc.) ; Abgenix Inc, US | 1020264-78-1 | No Structure |
| Glembatumumab vedotin | CuraGen Corporation (Celldex Inc.) ; Abgenix Inc, US | 1182215-65-1 | No Structure |
| Glenvastatin | HMR (Aventis) | 122254-45-9 |  |
| GLG-V-13 | Oklahoma State University | 89398-07-2 |  |
| Glibenclamide | Hoechst (Sanofi-Aventis) | 10238-21-8 |  |
| Glibornuride | Hoffmann La Roche (Roche) | 26944-48-9 |  |
| Gliclazide | Servier | 21187-98-4 |  |
| Glimepiride | Hoechst (Sanofi-Aventis) | 93479-97-1 |  |
| Glionitrin A | Korea Institute of Science and Technology (South Korea) | |  |
| Glionitrin B | Korea Institute of Science and Technology (South Korea) | |  |
| Glipizide | Farmitalia Carlo Erba (Pharmacia) | 29094-61-9 |  |
| Gliquidone | Boehringer Ingelheim | 33342-05-1 |  |
| Glisentide | Uriach | 32797-92-5 |  |
| Glisolamide | IFI | 24477-37-0 |  |
| Glisoxepide | Bayer | 25046-79-1 |  |
| Globorix (TM) | Glaxosmithkline | | No Structure |
| [Glu10,Nle17,Nle30]-Pancreatic Polypeptide(2-36) | 7TM Pharma AS (Denmark) | |  |
| Glucagon | Ely Lilly | 16941-32-5\n9007-92-5 |  |
| Glucametacin | SIR Lab. Chem. Biol. | 52443-21-7 |  |
| Glucarpidase | Protherics (UK) | 9074-87-7 | No Structure |
| Glucoprime | Novogen (Australa) | 39443-53-3 | No Structure |
| Glucoraphanin | | 21414-41-5 |  |
| Glucoraphenin | | 28463-24-3 |  |
| Glucosamine | | 90-77-7 ; 3416-24-8 ; 29031-19-4 (Glucosamine sulfate ) |  |
| Glufosfamide | Deutsches Krebsforschungsinstitut | 132682-98-5 |  |
| Glufosinate | Hoechst (Sanofi-Aventis) | 51276-47-2 |  |
| Glufosinate-P | | 35597-44-5 Sodium salt: 70033-13-5 |  |
| GLURP-MSP3 hybrid vaccine | Statens Serum Institut (Denmark) | | No Structure |
| Glutamine | Generic | 56-85-9 |  |
| Glutapyrone | Latvian Institute of Organic Synthesis | 125387-12-4 |  |
| Glutathione | Schering AG | 70-18-8 |  |
| Glutethimide | Ciba (Novartis) | 77-21-4 |  |
| GLV-1h99 | Genelux Corp. (US) ; Sloan Kettering Institute for Cancer Research (US) | | No Structure |
| GLY-202 | Glycoform Ltd. | | No Structure |
| GLY-205 | Glycoform Ltd. | | No Structure |
| GLY-230 | Glycadia | |  |
| GLY-302 | Glycoform Ltd. | | No Structure |
| GLY-515n | Glycoform Ltd. | | No Structure |
| Gly-Pro-Melphalan | University of Michigan | |  |
| Gly-Val-Saquinavir | University of Missouri | |  |
| Glybuthiazol | Rhone-Poulenc (Aventis) | 535-65-9 |  |
| Glybuzole | Smith & Nephew | 1492-02-0 |  |
| Glycarsamide | IG Farben | 144-87-6 |  |
| Glycitein | Archer Daniels Midland (US) | 40957-83-3 |  |
| Glycobiarsol | STS | 116-49-4 |  |
| Glycol salicylate | | 87-28-5 |  |
| Glycopine | Shemyakin | 70280-03-4 |  |
| Glycopyrronium bromide | Robins | 596-51-0 |  |
| Glycosaminoglycan polysulfate | Luitpold | 122992-77-2 ; 63449-40-1 | No Structure |
| Glycovir | Searle (Pharmacia) | 131262-82-3 |  |
| Glycyclamide | Rhone-Poulenc (Aventis) | 664-95-9 |  |
| Glycyrrhizin | | 1405-86-3 |  |
| Glymidine | Schering AG | 339-44-6 |  |
| Glyminox | Biosyn (Cellegy Pharmaceutical) | 86903-77-7 ; 664323-11-9 |  |
| Glyodin | Union Carbide | 556-22-9 |  |
| Glyphosate | Monsanto | 1071-83-6 |  |
| Glypinamide | Upjohn (Pharmacia) | 1228-19-9 |  |
| Glypromate | Kabigen AB (Pfizer) | 32302-76-4 |  |
| Glysobuzole | Sankyo | 3567-08-6 |  |
| GM-109 | Chugai | |  |
| GM-160575 | GlaxoSmithKline (GSK) | |  |
| GM-237354 | Glaxo (GSK) | 199013-04-2 |  |
| GM3PhAc-KLH | | | No Structure |
| GMC-1111 | University of Groningen | |  |
| GMC-2021 | Lundbeck | 167845-91-2 |  |
| GMC-5-193 | University of Virgina (US) | |  |
| GMDP | Immunotherapeutics | |  |
| GMI-1070 | GLYCOMIMETICS | | No Structure |
| GMK | | | No Structure |
| GNE-477 | F. Hoffmann-La Roche AG (Switzerland) ; Genentech Inc. (US) | |  |
| GNE-493 | Genentech Inc. (US) ; F. Hoffmann-La Roche AG (Switzerland) | |  |
| GNE-900 | Genentech Inc. | |  |
| GNE-A | Array BioPharma Inc. ; Genentech Inc. | |  |
| GNF-5 | Irm Llc (US) | |  |
| GNTI | McLean Hospital | 219655-56-8 |  |
| GNX-865 | Congenia SRL | |  |
| GOE-6070 | Goedecke (Pfizer) | 103498-08-4 |  |
| GOE-6976 | Goedecke (Pfizer) | 136194-77-9 |  |
| GOE-7716 | Goedecke (Pfizer) | 153207-37-5 |  |
| Gold (III) Porphyrin 1a | University of Hong Kong | |  |
| Golimumab | University of New York ; Centocor Inc. | 476181-74-5 | No Structure |
| Golnerminogene pradenovec | | 957472-14-9 | No Structure |
| Golotimod | Verta | 66471-20-3 ; 229305-39-9 |  |
| Gomphostinin | Defence Research and Development Organisation (India) | |  |
| Gonadorelin | Hoechst (Sanofi-Aventis) | 33515-09-2 |  |
| Goralatide | INSERM | 120081-14-3 |  |
| Goserelin | ICI (AstraZeneca) | 65807-02-5 |  |
| Gosogliptin | Pfizer | 869490-23-3 |  |
| Gossypol | Southern California University | 303-45-7 |  |
| Goxalapladib | Smithkline Beecham | 412950-27-7 |  |
| GP-0210 | Centre National de la Recherche Scientifique (CNRS, France) ; Greenpharma (France) | |  |
| GP-0212 | Centre National de la Recherche Scientifique (CNRS, France) ; Greenpharma (France) | |  |
| GP-1515 | Genisa | 144928-48-3 |  |
| GP-3269 | Gensia | 186393-42-0 |  |
| GP-3789 | Alcon | 214679-60-4 |  |
| GP-531 | Genisa | 142344-87-4 |  |
| GP-683 | Gensia | 144928-17-6 |  |
| GPB-001 | Geneprot | |  |
| GPB-003 | Geneprot | |  |
| GPD-002 | Geneprot | |  |
| GPD-003 | Geneprot | | No Structure |
| GPD-004 | Geneprot | | No Structure |
| GPD-008 | Geneprot | | No Structure |
| GPE-005 | Geneprot | | No Structure |
| GPE-006 | Geneprot | | No Structure |
| GPE-007 | Geneprot | | No Structure |
| GPG-NH2 | Tripep | 141497-12-3 |  |
| GPI-0100 | Galenica Pharmaceuticals | 328056-98-0 |  |
| GPI-1046 | Guilford Pharmaceuticals (Eisai Co) | |  |
| GPI-1234 | Guilford Pharmaceuticals (Eisai Co) | |  |
| GPI-16072 | Guilford Pharmaceuticals Inc | | No Structure |
| GPI-16552 | Guilford | |  |
| GPI-19410 | Guilford Pharmaceuticals (Eisai Co) | |  |
| GPI-21016 | Guilford Pharmaceuticals | | No Structure |
| GPI-3000 | Nova Pharm | 144301-37-1 |  |
| GPI-5232 | Guilford Pharmaceuticals (Eisai Co) | 200698-26-6 |  |
| GPI-6150 | Guilford Pharmaceuticals (Eisai Co) | 220938-17-0 |  |
| GPI-688 | AstraZeneca | |  |
| GPJN-52 | Gilead ; Univ. Katholieke Leuven | |  |
| GPM-1 | Seoul National University (South Korea) ; Korea Research Institute of Chemical Technology (South Kor | |  |
| GPX-100 | Gem Pharmaceuticals | |  |
| GPX-150 | Gem Pharmaceuticals | |  |
| GR-103545 | Sankyo | 126766-32-3 |  |
| GR-113808 | Glaxo-Wellcome (GSK) | 144625-51-4 |  |
| GR-125487 | Glaxo-Wellcome (GSK) | 144625-67-2 |  |
| GR-127935 | Glaxo (GSK) | 148672-13-3 |  |
| GR-144053 | Glaxo (GSK) | |  |
| GR-159897 | Glaxo (GSK) | 158848-32-9 |  |
| GR-199114X | Glaxo-Wellcome (GSK) | |  |
| GR-203040 | Glaxo (GSK) | 168398-02-5 (HCl) |  |
| GR-213487 | Megabios (Valentis) | | No Structure |
| GR-242468 | GlaxoSmithKline | |  |
| GR-250495X | GlaxoSmithKline (GSK) | 192057-17-3 |  |
| GR-44821 | Glaxo (GSK) | 125348-52-9 |  |
| GR-63799 | Glaxo (GSK) | |  |
| GR-73632 | GlaxoSmithKline (GSK) | 133156-06-6 |  |
| GR-79236 | Glaxo (GSK) | 124555-18-6 |  |
| GR-82334 | Glaxo (GSK) | |  |
| GR-89696 | Glaxo (GSK) | 149715-43-5 |  |
| GR-91272 | Glaxo (GSK) | 132537-23-6 (HCl) |  |
| GR-91669 | GlaxoSmithKline (GSK) | |  |
| GR-95168 | Glaxo (GSK) | 91661-22-2 |  |
| GR-99060 | GlaxoSmithKline (GSK) | 149756-68-3 |  |
| GRA-334 | Kyorin | |  |
| Granisetron | Beecham (GSK) | 109889-09-0 |  |
| Granulosin | Vision 7 GmbH ; Chemotherapeutisches Forschunginstitut (Germany) | | No Structure |
| Grape seed polyphenols | Interhealth Nutraceuticals (US) | 84929-27-1 | No Structure |
| GRC-17536 | Glenmark Pharmaceuticals Ltd. | | No Structure |
| GRC-6211 | Glenmark Pharmaceuticals Ltd. | 1166398-35-1 | No Structure |
| Greenstatin | Mogam Biotechnology Research Institute (South Korea) | | No Structure |
| Grepafloxacin | Otsuka | 119914-60-2 |  |
| GRH-624 | Hodogaya | 118876-48-5 |  |
| Griffithsin | US Government | | No Structure |
| Grippol Neo | | | No Structure |
| Griseofulvin | Glaxo (GSK) | 126-07-8 |  |
| Griseusin C | Oncotest GmbH (Germany) | |  |
| Griseusin D | Oncotest GmbH (Germany) | | No Structure |
| GRL-0026A | | |  |
| GRL-0036A | | |  |
| GRL-06579A | University of Illinois (US) | |  |
| GRL-7234 | CoMentis Inc. (US) ; University of Illinois (US) ; Oklahoma Medical Research Foundation (US) | |  |
| GRL-8234 | CoMentis Inc. (US) ; Unversity of Illinois (US) ; Oklahoma Medical Research Foundation (US) | |  |
| GRL-98065 | Tibotec Nv (Belgium) ; US Health (US) | |  |
| GRN-5384 | Geron | |  |
| GRT-1539R | Grunenthal | 354809-23-7 |  |
| GRTE-6859 | Grünenthal GmbH (Germany) | |  |
| GRTE-7235 | Grünenthal GmbH (Germany) | |  |
| GS-1101 | Icos Corp. | 870281-82-6 |  |
| GS-143 | GeneCare Research Institute Co. Ltd. (Japan) | |  |
| GS-21 | Tel Aviv University | |  |
| GS-3333 | Gilead Sciences | 179402-61-0 |  |
| GS-3857 | Gilead Sciences | |  |
| GS-4012 | General Hospital Corp. | |  |
| GS-4071 | Gilead Sciences | 187227-45-8 |  |
| GS-424020 | Gilead Sciences Inc. | |  |
| GS-6201 | | | No Structure |
| GS-7340 | Gilead Sciences | |  |
| GS-8374 | Gilead Sciences Inc. (US) | |  |
| GS-9160 | Gilead Sciences Inc. (US) | |  |
| GS-9191 | Gilead Sciences Inc. | |  |
| GS-9219 | Gilead Sciences | |  |
| GS-9256 | | | No Structure |
| GS-930 | Gilead Sciences | 127757-45-3 |  |
| GS-9310-11 (Fosfomycin & Tobramycin) | Corus Pharma (Gilead Sciences) | 23155-02-4 (Fosfomycin) ; \n32986-56-4 (Tobramycin) |  |
| GS-9411 | Parion Sciences Inc. | | No Structure |
| GS-9441 | Gilead Sciences Inc. ; Korea Research Institute of Chemical Technology (South Korea) | |  |
| GS-9667 | | | No Structure |
| GSI-578 | Chugai | |  |
| GSK-0052 | GlaxoSmithKline (GB) | |  |
| GSK-006A | Smithkline Beecham Corp. (GlaxoSmithKline plc) | |  |
| GSK-1004723D | GlaxoSmithKline plc (GB) | |  |
| GSK-1014802 | | | No Structure |
| GSK-1018921 | | | No Structure |
| GSK-1034702 | | | No Structure |
| GSK-1070806 | | | No Structure |
| GSK-1070916A | GlaxoSmithKline plc (GB) | |  |
| GSK-1119711A | | | No Structure |
| GSK-1120212 (GSK-212) | Japan Tobacco Inc. (Japan) | |  |
| GSK-1144814 | | | No Structure |
| GSK-1223249 | | | No Structure |
| GSK-1247446A | | | No Structure |
| GSK-1265744 | | | No Structure |
| GSK-1278863 | | | No Structure |
| GSK-1292263 | Smithkine Beecham Corp. (GlaxoSmithKline plc) | |  |
| GSK-1322322 | Smithkline Beecham Corp. (GlaxoSmithKline plc) | |  |
| GSK-1322888 | | | No Structure |
| GSK-1325756 | | | No Structure |
| GSK-1331258 | GlaxoSmithKline plc | |  |
| GSK-1331268 | GlaxoSmithKline plc | |  |
| GSK-1360707 | Glaxo Group Ltd. (GlaxoSmithKline plc) | |  |
| GSK-1362885 | | | No Structure |
| GSK-138842A | | | No Structure |
| GSK-1399686 | | | No Structure |
| GSK-1437173A | | | No Structure |
| GSK-1440115 | Smithkline Beecham Corp. (GlaxoSmithKline plc) | 1003878-16-7 |  |
| GSK-1440233A | GlaxoSmithKline plc | |  |
| GSK-1482160 | | | No Structure |
| GSK-1492903A | | | No Structure |
| GSK-1521498 | Smithkline Beecham Corp. (GlaxoSmithKline plc) | |  |
| GSK-1572932A | | | No Structure |
| GSK-159802 | Glaxosmithkline ; Theravance | | No Structure |
| GSK-1605786 | ChemoCentryx (US) | | No Structure |
| GSK-163090 | | | No Structure |
| GSK-1674330A | | | No Structure |
| GSK-171B | Chiron Corp. ; GlaxoSmithKline | |  |
| GSK-1720070 | GlaxoSmithKline plc (GB) | |  |
| GSK-1827771 | | | No Structure |
| GSK-1838705A | GlaxoSmithKline plc (GB) | |  |
| GSK-188909 | GlaxoSmithKline (GB) | |  |
| GSK-189254 | GlaxoSmithKline | |  |
| GSK-2018682 | | | No Structure |
| GSK-206136 | | | No Structure |
| GSK-207040 | GlaxoSmithKline | |  |
| GSK-208108 | | | No Structure |
| GSK-209762 | | | No Structure |
| GSK-2110183 | | | No Structure |
| GSK-21110183 | | | No Structure |
| GSK-2115160A | | | No Structure |
| GSK-2126458 | SmithKline Beecham Corp. (GlaxoSmithKline plc) | |  |
| GSK-2130579A | GlaxoSmithKline plc (GB) | | No Structure |
| GSK-2141795 | | | No Structure |
| GSK-2146888B | GlaxoSmithKline LLC | |  |
| GSK-2186877A | | | No Structure |
| GSK-2189241A | | | No Structure |
| GSK-2202083A | | | No Structure |
| GSK-2212836 | | | No Structure |
| GSK-2239633 | | | No Structure |
| GSK-2241658A | | | No Structure |
| GSK-2245840 | Sirtris Pharmaceuticals Inc. (GlaxoSmithKline plc) | | No Structure |
| GSK-2251052 | Anacor Pharmaceuticals Inc. | |  |
| GSK-2256098 | | | No Structure |
| GSK-2282512A | Glaxo Smithkline Biologic | | No Structure |
| GSK-2302024A | GlaxoSmithKline plc | | No Structure |
| GSK-2302032A | | | No Structure |
| GSK-2315698 | | | No Structure |
| GSK-2321138A | | | No Structure |
| GSK-232802 | GlaxoSmithKline | | No Structure |
| GSK-2334470 | GlaxoSmithKline plc | |  |
| GSK-2336805 | | | No Structure |
| GSK-2340273A | | | No Structure |
| GSK-2392019A | | | No Structure |
| GSK-2392102A | | | No Structure |
| GSK-2392103A | | | No Structure |
| GSK-2392105A | | | No Structure |
| GSK-2392106A | | | No Structure |
| GSK-239512 | | | No Structure |
| GSK-246 | Smithkline Beecham Corp. (GlaxoSmithKline plc) | |  |
| GSK-248451 | GSK | |  |
| GSK-2485852 | | | No Structure |
| GSK-249320 | Glaxo Group Ltd, (GlaxoSmithKline plc) | | No Structure |
| GSK-256066 | GlaxoSmithKline plc (GB) | |  |
| GSK-256073 | | | No Structure |
| GSK-256471 | GlaxoSmithKline plc (GB) | |  |
| GSK-2584786A | | | No Structure |
| GSK-2590066A | | | No Structure |
| GSK-2696273 | Fondazione Centro San Raffaele del Monte Tabor (Italy) ; Fondazione Telethon (Italy) | | No Structure |
| GSK-269984A | GlaxoSmithKline plc (GB) | |  |
| GSK-299423 | Glaxo Group Ltd. (GlaxoSmithKline plc) | |  |
| GSK-3082 | GlaxoSmithKline (GB) | |  |
| GSK-315234 | Glaxo Group Ltd, (GlaxoSmithKline plc) | | No Structure |
| GSK-319129A | Smithkline Beecham | 19911-67-2 |  |
| GSK-326416 | GlaxoSmithKline plc (GB) | |  |
| GSK-334429 | GlaxoSmithKline | |  |
| GSK-345931A | GlaxoSmithKline plc (GB) | |  |
| GSK-356278 | Glaxo Group Ltd. (GlaxoSmithKline plc) | |  |
| GSK-357941A | | | No Structure |
| GSK-360A | Smithkline Beecham Corp. (GlaxoSmithKline plc) | |  |
| GSK-364735 | Smithkline Beecham Corp. (GlaxoSmithKline plc) ; Shionogi & Co. | |  |
| GSK-366074 | | | No Structure |
| GSK-376501 | | | No Structure |
| GSK-3986A | GlaxoSmithKline plc (GB) | |  |
| GSK-3987 | Smithkline Beecham (GSK) | |  |
| GSK-406725 | | | No Structure |
| GSK-4082 | GlaxoSmithKline | |  |
| GSK-424887 | | | No Structure |
| GSK-461364 | Smithkline Beecham Corp. | |  |
| GSK-523338 | | | No Structure |
| GSK-554418 | Glaxo Group Ltd. (GlaxoSmithKline plc) | |  |
| GSK-557296 | | | No Structure |
| GSK-565154 | | | No Structure |
| GSK-568893A | | | No Structure |
| GSK-5737 | GlaxoSmithKline (GSK) | |  |
| GSK-573719 | | |  |
| GSK-573719 & Vilanterol | | | No Structure |
| GSK-576389A | | | No Structure |
| GSK-580416 | | | No Structure |
| GSK-586529 | | | No Structure |
| GSK-597901 | Glaxo group | |  |
| GSK-5981 | GlaxoSmithKline | |  |
| GSK-598809 | | | No Structure |
| GSK-610677 | | | No Structure |
| GSK-615 | GlaxoSmithKline plc (GB) | |  |
| GSK-615915 | | | No Structure |
| GSK-618334 | | | No Structure |
| GSK-625433 | Glaxo Group Ltd. | |  |
| GSK-626616AC | Smithkline Beecham Corp. (GlaxoSmithKline plc) | | No Structure |
| GSK-650394 | GlaxoSmithKline plc (GB) | 890842-28-1 |  |
| GSK-656398 | Theravance | | No Structure |
| GSK-678007 | GlaxoSmithKline (GSK) | | No Structure |
| GSK-678103A | GlaxoSmithKline | |  |
| GSK-679586 | | | No Structure |
| GSK-690693 | Smithkline Beecham Corp. | |  |
| GSK-704838 | | | No Structure |
| GSK-706769 | | | No Structure |
| GSK-719125 | Corixa Corp. (GlaxoSmithKline plc) ; Smithkline Beecham (GlaxoSmithKline plc) | | No Structure |
| GSK-7227 | GlaxoSmithKline plc (GB) | |  |
| GSK-729327 | | | No Structure |
| GSK-732461 | | | No Structure |
| GSK-732462 | | | No Structure |
| GSK-742457 | Glaxo Group Ltd. | |  |
| GSK-742510 | GlaxoSmithKline | | No Structure |
| GSK-768974 | Unigene | | No Structure |
| GSK-799943 | GlaxoSmithKline (GSK) | | No Structure |
| GSK-8062 | GlaxoSmithKline plc (GB) | |  |
| GSK-812397 | Smithkline Beecham (GSK) | |  |
| GSK-813893 | | | No Structure |
| GSK-823296 | | | No Structure |
| GSK-835726 | | | No Structure |
| GSK-844582B | Smithkline Beecham | |  |
| GSK-856464 | | | No Structure |
| GSK-8698 | GlaxoSmithKline plc (GB) | |  |
| GSK-870086 | | | No Structure |
| GSK-876008 | | | No Structure |
| GSK-894281 | GlaxoSmithKline plc (GB) | |  |
| GSK-894490A | GlaxoSmithKline plc (GB) | |  |
| GSK-9089 | GSK | |  |
| GSK-923295 | Cytokinetics Inc. ; Smithkline Beecham Corp. (GlaxoSmithKline plc) | |  |
| GSK-929 | Smithkline Beecham | |  |
| GSK-932121 | GlaxoSmithKline plc (GB) | | No Structure |
| GSK-933776A | | | No Structure |
| GSK-945237 | | | No Structure |
| GSK-958108 | Glaxo Group Ltd. (GlaxoSmithKline plc) | |  |
| GSK-961081 | GlaxoSmithKline | | No Structure |
| GSK-962040 | GlaxoSmithKline plc (GB) | |  |
| GSK-971086 | | | No Structure |
| GSK-9772 | GlaxoSmithKline plc (GB) | |  |
| GSK-982 | GlaxoSmithKline plc (GB) | |  |
| GSK-983 | GlaxoSmithKline | |  |
| GSKI-181771X | | | No Structure |
| GsMtx-4 | University of New York | 367514-78-1 |  |
| GSQ-1530 | Genesoft | |  |
| GT-094 | Queen's University (Canada) | |  |
| GT-2342 | Gliatech | 223420-11-9 |  |
| GT-389255 | | | No Structure |
| GT-715 | Kingston Queen's University | 179677-60-2 |  |
| GT-MAB 2.5-GEX | | | No Structure |
| GTP-5 | Gastrotech Pharma | |  |
| GTP-6 | Gastrotech Pharma | |  |
| GTS-21 | Florida University | 148372-04-7 |  |
| GTU-Multi-HIV B-clade vaccine | FIT Biotech Oyj Plc (Finland) | | No Structure |
| GTx-758 | | | No Structure |
| Guacetisal | Bayer | 55482-89-8 |  |
| Guaiacol | Sulphite Products | 90-05-1 |  |
| Guaiapate | Maggioni | 852-42-6 |  |
| Guaiazulene | Joos | 489-84-9 |  |
| Guaietolin | Robins | 63834-83-3 |  |
| Guaifenesin | British Drug Houses | 93-14-1 |  |
| Guaimesal | Dr. L. Zambeletti (GSK) | 81674-79-5 |  |
| Guanabenz | Shell | 5051-62-7 |  |
| Guanacline | Bayer | 1463-28-1 |  |
| Guanadrel | Cutter | 40580-59-4 |  |
| Guanethidine | Ciba (Novartis) | 55-65-2 |  |
| Guanfacine | Wander | 29110-47-2 |  |
| Guanochlor | Pfizer | 5001-32-1 |  |
| Guazatine | Murphy | 13513-37-3 |  |
| Gugulipid | Cipla | 95975-55-6 |  |
| Gusperimus | Microbiochemical Research Foundation | 85468-01-5 |  |
| GV-129606 | Glaxo (GSK) | |  |
| GV-196771 | Glaxo-Wellcome (GSK) | |  |
| GV-228869 | Glaxo-Wellcome (GSK) | 182314-66-5 |  |
| GVS-111 | Russian American Inst. | 157115-85-0 |  |
| GW-0072 | Glaxo (GSK) | |  |
| GW-0464 | Smithkline Beecham (GSK) | |  |
| GW-0622 | Smithkline Beecham (GSK) | |  |
| GW-0791 | GlaxoSmithKline (GSK) | |  |
| GW-1929 | Glaxo-Wellcome (GSK) | 196808-24-9 |  |
| GW-215864 | Glaxo-Wellcome (GSK) | 192056-79-4 (3R) ; 192056-77-2 (3S) |  |
| GW-2433 | GlaxoSMithKline (GSK) | |  |
| GW-2580 | GlaxoSmithKline | |  |
| GW-273225 | | | No Structure |
| GW-273629 | Glaxo (GSK) | |  |
| GW-274150 | Glaxo (GSK) | 210354-22-6 |  |
| GW-280430 | Cornell Research Foundation ; Glaxo-Wellcome (GSK) | 287980-51-2 |  |
| GW-286103 | Wellcome Foundation (GSK) | |  |
| GW-289013 | GlaxoSmithKline (GSK) | |  |
| GW-3011 | GlaxoSmithKline (GSK) | |  |
| GW-311616 | GlaxoSmithKline (GSK) | 198062-54-3 |  |
| GW-3333 | GlaxoSmithKline (GSK) | 212609-68-2 |  |
| GW-3430 | GlaxoSmithKline | |  |
| GW-3600 | Glaxo-Wellcome (GSK) | |  |
| GW-3965 | GlaxoSmithKline (GSK) | |  |
| GW-3995 | GlaxoSmithKline (GSK) | 329981-69-3 |  |
| GW-406381 | Glaxo Group Ltd. (GSK) | 478702-57-7 |  |
| GW-409544 | GlaxoSmithKline (GSK) | 335149-19-4 |  |
| GW-4123X | GlaxoSmithKline (GSK) | |  |
| GW-419458 | GlaxoSmithKline (GSK) | | No Structure |
| GW-432042 | GlaxoSmithKline (GSK) | 511272-61-0 |  |
| GW-4459 | Glaxo (GSK) | 260270-56-2 |  |
| GW-4511 | GlaxoSmithKline (GSK) | |  |
| GW-468816 | GlaxoSmithKline (GSK) | 502641-02-3 | No Structure |
| GW-471552 | GlaxoSmithKline (GSK) | 250243-97-1 |  |
| GW-471558 | GlaxoSmithKline (GSK) | 250243-99-3 |  |
| GW-4751 | GlaxoSmithKline (GSK) | |  |
| GW-475151 | GlaxoSmithKline (GSK) | 221323-43-9 |  |
| GW-479821 | GlaxoSmithKline (GSK) | |  |
| GW-501516 | Glaxo (GSK) | 317318-70-0 |  |
| GW-505524B | Glaxo (GSK) | 305809-64-7 |  |
| GW-515716 | GlaxoSmithKline (GSK) | |  |
| GW-5181 | GlaxoSmithKline (GSK) | |  |
| GW-531920 | GlaxoSmithKline (GSK) | |  |
| GW-532 | Glaxo (GSK) | 320589-95-5 |  |
| GW-5393 | Glaxo (GSK) | 329981-52-4 |  |
| GW-5634 | Smithkline Beecham(GSK) | |  |
| GW-5638 | Glaxo-Wellcome (GSK) | 155701-61-4 |  |
| GW-570009 | GlaxoSmithKline (GSK) | |  |
| GW-577 | Glaxo-Wellcome (GSK) | 179410-97-0 |  |
| GW-5823 | Glaxo-Wellcome (GSK) | |  |
| GW-587270 | GlaxoSmithKline (GSK) | 385815-08-7 |  |
| GW-590735 | GlaxoSmithKline (GB) | 622402-22-6 |  |
| GW-5950X | Vertex | 240127-97-3 |  |
| GW-597901X | | | No Structure |
| GW-610 | University of Nottingham (UK) | |  |
| GW-627368X | GlaxoSmithKline (GSK) | 439288-66-1 |  |
| GW-637185X | GlaxoSmithKline plc (GB) | |  |
| GW-644784 | | | No Structure |
| GW-654652 | GlaxoSmithKline (GSK) | |  |
| GW-6604 | Glaxo Group Ltd. | |  |
| GW-697465A | GlaxoSmithKline (GSK) | |  |
| GW-708408 | GSK | |  |
| GW-7282 | Warner Lambert | 403986-40-3 |  |
| GW-7647 | GlaxoSmithKline (GSK) | 265129-71-3 |  |
| GW-766944 | | | No Structure |
| GW-766994 | GlaxoSmithKline (GSK) | |  |
| GW-773546 | GSK | |  |
| GW-773812 | | | No Structure |
| GW-784568X | Glaxo Group Ltd. (GlaxoSmithKline plc) | |  |
| GW-788388 | Smithkline Beecham Corp. | |  |
| GW-791343 | AstraZeneca AB | 309712-55-8 |  |
| GW-803430 | GlaxoSmithKline (GSK) | |  |
| GW-805858 | | | No Structure |
| GW-813893 | Glaxo Group Ltd. (GlaxoSmithKline plc) | |  |
| GW-8248 | Smithkline Beecham (GlaxoSmithKline) | |  |
| GW-832924X | Smithkline Beecham (GSK) | |  |
| GW-833972 | GlaxoSmithKline plc (GB) | |  |
| GW-842166X | Glaxo Group Ltd. | |  |
| GW-842470 | Arzneimittewerk Dresden (AWD) | 257892-33-4 |  |
| GW-8547 | GSK | 317318-62-0 |  |
| GW-870086X | | | No Structure |
| GW-877017X | Smithkline Beecham | 19394-101-8 |  |
| GW-9508 | GlaxoSmithKline (GB) | 885101-89-3 |  |
| GW-9578 | Glaxo (GSK) | |  |
| GWL-78 | Spirogen | |  |
| GX-015-003 | Gemin X Biotechnologies | |  |
| GX-15 | Gemin X Biotechnologies | |  |
| GYKI-12735 | Chinoin | 110858-79-2 |  |
| GYKI-16084 | Gedeon Richter | |  |
| GYKI-16638 | Gyogyszerki KFT ; Szent-Gyorgyi Albert Orvostudo | 307556-59-8 (HCl) |  |
| GYKI-22441 | Egis | 76674-41-4 |  |
| GYKI-38233 | Biogal | 100752-33-8 |  |
| GYKI-46903 | Yogyszerkutato Ntezet | 143017-25-8 |  |
| GYKI-47261 | GyogySzerkutato (Teva) | 220445-20-5 |  |
| GYKI-52466 | Egis | 102771-26-6 |  |
| GYKI-52895 | Biogal | 114460-08-1 |  |
| GYKI-53655 | Cyogyszerkutato Intezet (Egis) | 143692-48-2 |  |
| GYKI-53784 | Gedeon Richter | |  |
| H-104 | Grünenthal GmbH | |  |
| H-29051 | Haessle | 180685-70-5 |  |
| H-32 | University of Pittsburgh | |  |
| H-327-86 | Procter & Gamble | 139602-29-2 |  |
| H-34552 | AstraZeneca | | No Structure |
| H-40502 | AstraZeneca | | No Structure |
| H-409-22 | AstraZeneca | 221666-59-7 |  |
| H-89 | Tobishi Pharmaceutical Co. | 127243-85-0 |  |
| h12A11v1 | Wyeth | | No Structure |
| h224G11 | Pierre Fabre Medicament (France) | | No Structure |
| H5N1 CA Influenza Vaccine | Medimmune Vaccines Inc. (US) | | No Structure |
| H7N3 BC 2004-AA-ca | MedImmune Vaccines Inc. (AstraZeneca AB) ; National Institutes of Health (US) | | No Structure |
| HA-14-1 | Thomas Jefferson University (US) | 65673-63-4 |  |
| HA-7 | | 201943-88-6 |  |
| HA200-223 | US Health | |  |
| HAI-105 | Hisamitsu | 129412-11-9 |  |
| Halazepam | Schering Corp (Merck & Co) | 23092-17-3 |  |
| Halazone | Esseff Chemische | 80-13-7 |  |
| Halcinonide | Squibb | 3093-35-4 |  |
| Haliangicin | Ajinomoto | |  |
| Halocarban | Geigy (Novartis) | 369-77-7 |  |
| Halofantrine | SmithKline Beecham (GSK) | 69756-53-2 |  |
| Halofenate | Merck Sharp & Dohme (Merck & Co) | 26718-25-2 |  |
| Halofenozide | Rohm & Haas | 112226-61-6 |  |
| Halofuginone | American Cyanamid (Wyeth) | 55837-20-2 |  |
| Halometasone | Ciba Geigy | 50629-82-8 |  |
| Haloperidol | Janssen Pharmaceutica (Johnson & Johnson) | 52-86-8 |  |
| Halopredone acetate | Pierrel | 57781-14-3 |  |
| Haloprogin | Meiji | 777-11-7 |  |
| Halosulfuron-methyl | Nissan ; Monsanto | 100784-20-1 |  |
| Halothane | ICI (AstraZeneca) | 151-67-7 |  |
| Haloxazolam | Sankyo | 59128-97-1 |  |
| Haloxon | Cooper, Macdougall & Robertson | 321-55-1 |  |
| Haloxyfop-etotyl | Dow | 87237-48-7 |  |
| Haloxyfop-methyl | Ishihara | 69806-40-2 |  |
| Haloxyfop-P methyl | Dow | 72619-32-0 |  |
| Halquinol | Olin Mathieson | 8067-69-4 |  |
| Haperforine B 1 | CNRS | |  |
| hArg-Amp | KemPharm Inc. (US) | |  |
| HARP(13-39) | CNRS | |  |
| HARP(65-97) | CNRS | |  |
| Havrix | | | No Structure |
| HBC | Sejong University | |  |
| HBc-N144-PA-loop2 | Microbe Epidemic Disease Institute (China) | | No Structure |
| HBJ-10 | Johns Hopkins University | |  |
| HBJ-34a | Johns Hopkins University | |  |
| HBPA-1 | Northwestern University (US) | |  |
| HBPA-2 | Northwestern University (US) | |  |
| hBU12-vcMMAE | Seattle Genetics Inc. (US) | | No Structure |
| HBX-41108 | Hybrigenics SA (France) | |  |
| HC-030031 | Hydra Biosciences Inc. (US) | 349085-38-7 |  |
| HCT-2040 | NicOx | |  |
| HCV2a (2251-2260) | Kurume University (Japan) | |  |
| HD-03-ES | The Himalaya Drug Company | | No Structure |
| HDP-15.0022 | F. Hoffmann-La Roche AG (Switzerland) | |  |
| HDP-CDV | University of California | |  |
| HE-2000 | Research Corporation Technologies | 28507-02-0 |  |
| HE-2300 | Hollis-Eden Pharmaceuticals | |  |
| HE-2400 | Hollis-Eden Pharmaceuticals | |  |
| HE-30582 | Heumann | 126856-36-8 |  |
| HE-3210 | Hollis-Eden Pharmaceuticals (US) | |  |
| HE-3235 | Hollis-Eden Pharmaceuticals Inc. (US) | |  |
| HE-3286 | Hollis-Eden Pharmaceuticals Inc. (US) | |  |
| Healive | Changchun Institute of Biological Products | | No Structure |
| Hederacolchiside E | SK Chemicals Co. Ltd. (South Korea) | |  |
| Hederacolchiside F | Research Dev Corp, (US) | 96193-64-5 |  |
| Helioxanthin | Yale University (US) | 18920-47-3 |  |
| Heliprobe System ([14C]-Urea) | Diabact AB | |  |
| Helizide (Bismuth subcitrate potassium & Metronidazole &Tetracycline) | Axcan Pharma Inc. (Canada) | 318471-79-3 |  |
| Heme Iron Polypeptide | Colorado Biolabs ; General Electric (US) | 14875-96-8 |  |
| Hemin | | 16009-13-5 |  |
| Hemocoagulase acutus | | 9001-13-2 |  |
| Hemoglobin glutamer-256 (Human) | Northfield Laboratories Inc. (US) | 679404-95-6 | No Structure |
| HEP-689 | SmithKline Beecham (GSK) | 180869-32-3 |  |
| Hepaconda | Prof. Borody Thomas (Australia) | |  |
| Heparin calcium | Sanofi SA | 37270-89-6 | No Structure |
| Hepatitis B Vaccine (Recombinant) | | | No Structure |
| Hepcidin | INSERM (Institut National de la Sante et de la Recherche Medicale) | |  |
| HepeX-B (Exbivirumab & Libivirumab) | XTL Biopharmaceuticals | | No Structure |
| Heplisav | Dynavax Technologies | | No Structure |
| Hepronicate | Yoshitomi | 7237-81-2 |  |
| Hepsulfam | Ortho McNeil (Johnson & Johnson) | 96892-57-8 |  |
| HEPT | Mitsubishi | 123027-56-5 |  |
| Heptabarb | Geigy (Novartis) | 509-86-4 |  |
| Heptachlor | Shell | 76-44-8 |  |
| Heptaminol | Bilhuber | 372-66-7 |  |
| Heptavalent pneumococcal conjugate vaccine | | 852805-36-8 | No Structure |
| Heptenophos | Ciba-Geigy (Novartis) | 23560-59-0 |  |
| Heptopargil | Egyt | 73886-28-9 |  |
| Her-2 | | | No Structure |
| Her-2-Neu ICD protein vaccine | Corixa | | No Structure |
| Hesperadin | Boehringer Ingelheim | |  |
| Hesperidin | | 520-26-3 |  |
| Hetacillin | Bristol-Myers Squibb (BMS) | 3511-16-8 |  |
| Heteronium bromide | Eli Lilly | 7247-57-6 |  |
| Hetolin | Hoechst (Sanofi-Aventis) | 2390-22-9 |  |
| Hexaconazole | Sandoz (Syngenta) | 79983-71-4 |  |
| Hexadecylbetaine | | 693-33-4 |  |
| Hexaflumuron | Dow Chemical | 86479-06-3 |  |
| Hexafluorenium bromide | Irwin | 317-52-2 |  |
| Hexamidine | May & Baker (Aventis) | 3811-75-4 |  |
| Hexapropymate | Labaz | 358-52-1 |  |
| Hexavalent Group A Streptococcal Vaccine | ID Biomedical (GSK) ; University of Tennessee | | No Structure |
| Hexazinone | DuPont | 51235-04-2 |  |
| Hexedine | Warner Lambert (Pfizer) | 5980-31-4 |  |
| Hexetidine | Commercial Solvents | 141-94-6 |  |
| Hexobarbital | IG Farben | 56-29-1 |  |
| Hexobendine | OSSW | 54-03-5 |  |
| Hexocyclium metilsulfate | Abbott | 115-63-9 |  |
| Hexoprenaline | Lentia | 3215-70-1 |  |
| Hexyl Aminolevulinate | PhotoCure | 140898-91-5 |  |
| Hexylresorcinol | Merck Sharp & Dohme (Merck & Co) | 136-77-6 |  |
| Hexythiazox | Nippon Soda | 78587-05-0 |  |
| HF-0220 | Hunter-Fleming Ltd. | |  |
| HF-10 | Nagoya University (Japan) | | No Structure |
| HFT-290 (Fentanyl) | Hisamitsu Pharmaceutical | |  |
| HGP-30W | Cel-Sci | |  |
| HGS-1029 | Aegera Therapeutics Inc. | 1107664-44-7 | No Structure |
| HGS-TR2J | Kirin Brewery ; Human Genome Sciences | | No Structure |
| HGT-1110 | Shire plc | | No Structure |
| HGT-1410 | Shire Human Genetic Therapies | | No Structure |
| HGT-2610 | Shire Human Genetic Therapies | | No Structure |
| HH-AG-1.2 | Curis | 364590-54-5 |  |
| HI-236 | Wayne | 233271-65-3 |  |
| HI-240 | Parker Hughes Inst. | 279664-37-6 |  |
| HI-244 | Parker Hughes Inst. | |  |
| HI-280 | Wayne | |  |
| HI-346 | Medivir | |  |
| HI-443 | Hughes Inst. | 258340-15-7 |  |
| HI-445 | Medivir | |  |
| HI-8 MEL | Oxxon Therapeutics Ltd. (Oxford Biomedica plc) (GB) | | No Structure |
| Hib-MenCY-TT | | | No Structure |
| Hiberix | Glaxosmithkline Biologcals SA (Belgium) | | No Structure |
| HibMenC | | | No Structure |
| HIE-124 | Friedrich Schiller University of Jena (Germany) | |  |
| Himantane | Inst. General Pathology & Pathophysiology ; State University of New York Stony Brook | |  |
| Himbacine | Schering Corp (Merck & Co) | 6879-74-9 |  |
| [His3,Leu10]-GLP-2(1-33) | Novo Nordisk | |  |
| Hispitolide C | Sequoia Sciences Inc. (US) ; Anadys Pharmaceuticals Inc. (US) | |  |
| Histamine | | 51-45-6 |  |
| Histapyrrodine | BASF (Abbott) | 493-80-1 |  |
| Histidine | Dr. KOHLER Chemie | 71-00-1 |  |
| Histrelin | Salk Inst. for Biological Studies | 76712-82-8 |  |
| HIV-Lipo-5 | Agence Nationale de Recherche sur le Sida et les Hépatites Virales (France) | | No Structure |
| HKI-10311129 | Leibniz Inst Fuer Naturstoff (DE) | |  |
| HKI-357 | Wyeth | |  |
| HKI-46-F08 | Institute for Microbiology and Genetics (Germany) ; Technical University of Ilmenau (Germany) ; Germ | |  |
| HKY-73 | Japan Energy | |  |
| HL-004 | Taisho | 144288-97-1 |  |
| HL-9 | University of New York | |  |
| HL2-052-2 | University of South Florida (US) ; H. Lee Moffitt Cancer Center and Research Institute (US) | |  |
| HLF(1-11) | AM-Pharma | |  |
| HM-12 | Rega Institute for Medical Research (Belgium) ; University of Perugia (Italy) ; University of Calabr | |  |
| HM-13 | Rega Institute for Medical Research (Belgium) ; University of Perugia (Italy) ; University of Calabr | |  |
| HM-30181 | Hanmi Pharmaceutical Co. Ltd. (South Korea) | 849675-87-2 (as MeSO3H salt) |  |
| HM-897 | Cytran | |  |
| Hmaxi-K | Einstein college of medecine (AECOM) | | No Structure |
| HMN-1152 | Nippon Shinyaku (Japan) | 194031-95-3 |  |
| HMN-176 | Nippon Shinyaku | |  |
| HMN-214 | Nippon Shinyaku | |  |
| HMPL-004 | Hutchison Medipharma Ltd. (China) | | No Structure |
| HMR-1069 | | | No Structure |
| HMR-1279 | Roussel-Uclaf (Aventis) | 185915-32-6 |  |
| HMR-1426 | Aventis (Sanofi-Aventis) | 262376-75-0 |  |
| HMR-1556 | Hoechst (Sanofi-Aventis) | 223749-46-0 |  |
| HMR-3004 | Roussel-Uclaf (Sanofi-Aventis) | 172678-62-5 |  |
| HMR-3832 | Aventis | 334778-45-9 |  |
| hNGF-61 | Lay Line Genomics SpA (Italy) | | No Structure |
| HOE-BAY-793 | Hoechst (Sanofi-Aventis) | 137755-25-0 |  |
| Holmium Ho 166M DOTMP | Dow Chemical | 91987-74-5 (DOTMP) |  |
| Holmium Ho166 Chitosan | Dong-Wha Pharma | | No Structure |
| Homatropine | | 87-00-3 |  |
| Homidium bromide | Boots (Abbott) | 1239-45-8 |  |
| Homochlorcyclizine | Abbott | 848-53-3 |  |
| Homofenazine | Degussa | 3833-99-6 |  |
| Homosalate | Fries Bros. | 118-56-9 |  |
| HON-0001 | Taisho ; Hoshi University (JP) | |  |
| Honey | | 8028-66-8 | No Structure |
| Honokiol | | 35354-74-6 |  |
| Hordenine | Hoffmann La Roche (Roche) | 539-15-1 |  |
| HP-228 | Houghten (Lion Biosciences) | 109022-88-0 |  |
| HP-236 | Hoechst (Sanofi-Aventis) | 131540-60-8 |  |
| HP-370 | Hoechst (Sanofi-Aventis) | 113389-11-0 |  |
| HP-392 | HMR (Aventis) | |  |
| HP-406 | HMR (Aventis) | 99579-49-4 |  |
| HPH-1155 | ADIR (Servier) | 146728-25-8 |  |
| HPIV3-DeltaF-HN-EboGP | National Institutes of Health (US) ; Canadian Science Centre for Human and Animal Health (Canada) ; | | No Structure |
| HPN-100 | Brusilow Enterprises LLC (Medicis Pharmaceutical Corp.) | |  |
| HPPH | Health Research | |  |
| HPW-RX2 | Kaohsiung Medical University | |  |
| HR-916B | Hoechst (Sanofi-Aventis) | 125181-57-9 |  |
| HRB1a | AplaGen GmbH (Germany) | |  |
| HRB3 | AplaGen GmbH (Germany) | |  |
| HS-357 | University of Virginia (US) | |  |
| HS-599 | Vyzkumny Ustav pro Farmacii a Biochemii | 155203-05-7 |  |
| HSP-990 | Vernalis plc | | No Structure |
| HSR-175 | Hokuriku | 125961-37-7 |  |
| HSR-6071 | Hokuriku | 111374-21-1 |  |
| HSR-609 | Hokuriku Seiyaku (Abbott Japan) | 161522-25-4 |  |
| HT-0712 | Inflazyme Pharmaceuticals | |  |
| HT-90B | Chugai (Roche) | 150710-80-8 |  |
| HTI-042 | Wyeth | |  |
| HU-210 | Yissum Research Development | 112830-95-2 |  |
| HU-243 | Yissum Research Development | 140835-18-3 |  |
| HU-308 | Yissum Research Development | 256934-39-1 |  |
| HU-433 | Yissum Research Development Company of The Hebrew University of Jerusalem Ltd. (Israel) | |  |
| huATN-658 | Attenuon LLC (US) | | No Structure |
| HuC242-DM4 | ImmunoGen | | No Structure |
| Human Protein C | Baxter AG; Immuno AG (Austria) | | No Structure |
| Human thrombin | Omrix Biopharmaceuticals Ltd. (Israel) | | No Structure |
| HuMax-CD32b | Genmab AS (Denmark) | | No Structure |
| HuMax-TF | Genmab AS (Denmark) | | No Structure |
| Humenza | Sanofi Pasteur (Sanofi-aventis) | | No Structure |
| Huperzine A | Shanghai Institute of Materia Medica | 102518-79-6 |  |
| HW-165 | Astra (AstraZeneca) | 95651-08-4 (HBr) |  |
| HWA-131 | Hoechst (Sanofi-Aventis) | 118788-41-3 |  |
| HX-1171 | Nippon Hypox | 148081-72-5 |  |
| HX-531 | Institute of Medicinal Molecular Design | |  |
| HX-603 | Institute of Medicinal Molecular Design | |  |
| HX-630 | Institute of Medicinal Molecular Design | |  |
| HX-640 | Institute of Medicinal Molecular Design | |  |
| HX-771 | Institute of Medicinal Molecular Design | |  |
| HY-10427 | Hypnion | |  |
| HY-2901 | Hypnion | |  |
| HY-52 | Disgene | |  |
| HY-53 | Disgene | |  |
| Hyaluronic acid | Seikagaku | 9004-61-9\n9067-32-7 (Sodium salt) |  |
| Hyaluronic acid-Paclitaxel bioconjugate | Fidia Farmaceutici SpA | | No Structure |
| Hyaluronidase | Advanced Corneal Systems (Ista Pharmaceuticals) | 488712-31-8 | No Structure |
| Hycanthone | Sterling Drug (Sanofi-Aventis) | 3105-97-3 |  |
| Hydralazine | Ciba (Novartis) | 86-54-4 |  |
| Hydramacin-1 | Christian-Albrechts-University Kiel (Germany) | | No Structure |
| Hydramethylnon | American Cyanamid (BASF) | 67485-29-4 |  |
| Hydrochlorothiazide | Ciba (Novartis) | 58-93-5 |  |
| Hydrocodone | E. Merck KGaA | 125-29-1 |  |
| Hydrocortisone | Merck & Co | 50-23-7 |  |
| Hydrocortisone 17-butyrate | Lab. Chimico Farma Untico | 13609-67-1 |  |
| Hydrocortisone aceponate | | 74050-20-7 |  |
| Hydrocortisone acetate | Roche-Orgamon | 50-03-3 |  |
| Hydrocortisone Butyrate Propionate | Taisho Pharma | 72590-77-3 |  |
| Hydrocortisone Hemisuccinate | | 2203-97-6 ; 125-04-2 (sodium salt) |  |
| Hydrocortisone sodium phosphate | Merck & Co | 6000-74-4 |  |
| Hydroflumethiazide | Lovens | 135-09-1 |  |
| Hydromorphone | Knoll (Abbott) | 466-99-9 |  |
| Hydroprene | Zoecon | 41205-09-8 |  |
| Hydroprene-S | Zoecon | 65733-18-8 |  |
| Hydroxocobalamin | Merck & Co | 13422-51-0 |  |
| Hydroxy-4-benzylpenicillin | Upjohn (Pharmacia) | 5985-13-7 |  |
| Hydroxyamphetamine | K. W. Rosenmund et al. | 1518-86-1 |  |
| Hydroxycarbamide | DuPont (BMS) | 127-07-1 |  |
| Hydroxychloroquine | Sterling Drug (Sanofi-Aventis) | 118-42-3 |  |
| Hydroxyethyl starch | Fresenius AG | 9005-27-0 | No Structure |
| Hydroxymethylnicotinamide | | 3569-99-1 |  |
| Hydroxymethylsulbactam | Pfizer | |  |
| Hydroxyphenyl-N-glycine | | 122-87-2 |  |
| Hydroxyprogesterone caproate | Schering AG | 630-56-8 |  |
| Hydroxypropyl cellulose | Merck & Co | 9004-64-2 | No Structure |
| HYDROXYPROPYL-BETA-CYCLODEXTRIN | Janssen Pharmaceutica Nv | 128446-35-5 |  |
| Hydroxyquinoline-8-sulfate | | 134-31-6 |  |
| Hydroxyzine | UCB | 68-88-2 |  |
| Hygromycin B | Eli Lilly | 31282-04-9 |  |
| Hymecromone | Lipha (E. Merck KGaA) | 90-33-5 |  |
| Hymexazol | Sankyo | 10004-44-1 |  |
| Hyperacute Prostate Cancer Vaccine | Central Iowa Health System (US) | | No Structure |
| Hyperforin | | 11076-53-1 |  |
| Hyperforin Acetate | Indena | |  |
| Hypericin | Schenley Industries | 548-04-9 |  |
| Hypnorm (Fentanyl & Fluanisone) | | |  |
| Hypocholaride | University of Chicago (US) | |  |
| Hypoestoxide | Immune Modulation | |  |
| Hypoxoside | Phytopharm | 83643-94-1 |  |
| Hystatin 2 | | |  |
| HZN-602 (Naproxen & Famotidine) | Horizon Therapeutics Inc. (Horizon Pharma Inc.) | 22204-53-1 (Naproxen) ; 76824-35-6 (Famotidine) |  |
| HZT-501 (Ibuprofen and Famotidine) | Horizon Therapeutics | |  |
| I-131-L19-SIP | Philogen SpA (Italy) ; Bayer Schering Pharma AG (Germany) | | No Structure |
| I-152 | CNRS ; CEA | 311343-11-0 |  |
| I-A-85380 | Yale University | |  |
| I-A09 | Indiana University Research & Technology Corp. (US) | |  |
| i-BD cancer vaccine | Harvard College (US) ; Dana Farber Cancer Institute Inc. ((US) | | No Structure |
| IACVITA | Medestea Internazionale SpA (Italy) | |  |
| IB-201 | Innovative Biologics Inc. | |  |
| Ibacitabine | M. Hartmann ; H. Venner | 611-53-0 |  |
| Ibafloxacin | 3M | 91618-36-9 |  |
| Ibalizumab | Tanox (Genentech) | 680188-33-4 | No Structure |
| Ibandronic acid | Boehringer Mannheim (Roche) | 114084-78-5 |  |
| Ibipinabant | Solvay | 464213-10-3 |  |
| IBIS-00554842 | Isis Pharmaceuticals | |  |
| IBIS-00554844 | Isis Pharmaceuticals | |  |
| IBIS-00560047 | Isis Pharmaceuticals | |  |
| IBIS-00560102 | Isis Pharmaceuticals | |  |
| IBIS-00560146 | Isis Pharmaceuticals | |  |
| IBIS-00560799 | Isis Pharmaceuticals | |  |
| IBIS-00560973 | Isis Pharmaceuticals | |  |
| Iboctadekin | GlaxoSmithKline | 479198-61-3 | No Structure |
| Ibodutant | Menarini | 522664-63-7 |  |
| Ibogaine | Howard Lotsof | 83-74-9 |  |
| Ibopamine | Simes | 66195-31-1 |  |
| Ibritumomab Tiuxetan | IDEC Pharmaceuticals | 206181-63-7 |  |
| Ibrolipim | Otsuka | 133208-93-2 |  |
| IBU-PD | Israel Institute for Biological Research | |  |
| IBU-PO | Israel Institute for Biological Research | |  |
| Ibudilast | Kyorin | 50847-11-5 |  |
| Ibuprofen | Boots (Abbott) | 15687-27-1 ; 527688-20-6 (sodium salt) |  |
| Ibuprofen Guaiacol | Angelini | 66332-77-2 |  |
| Ibuprofen Piconol | Hisamitsu | 64622-45-3 |  |
| Ibuproxam | Manetti & Roberts | 53648-05-8 |  |
| Ibutamoren | Merck & Co. | 159634-47-6 ; 1599752-10-0 (Ibutamoren mesylate) |  |
| Ibutilide | Upjohn (Pharmacia) | 142647-31-8 |  |
| IC-202B | Microbial Chemical Research Foundation | 251301-97-0 |  |
| IC-202C | Microbial Chemical Research Foundation | 251301-98-1 |  |
| IC-261 | Sugen Inc. (Pfizer Inc.) | 186611-52-9 |  |
| IC-41 | Intercell AG | | No Structure |
| IC-43 | | | No Structure |
| IC-47 | Intercell AG | | No Structure |
| IC-485 | | | No Structure |
| IC-491791 | Eli Lilly & Co. (US) | |  |
| IC-491835 | Eli Lilly & Co. (US) | |  |
| IC-492231 | Icos Corp. (US) | |  |
| IC-51 | Cheil Jedang Corporation (US) ; US Army | | No Structure |
| IC-83 | ICOS Corp. (Eli Lilly & Co.) | 911222-45-2 |  |
| IC-84 | Techlabs Inc. | | No Structure |
| IC-86621 | Icos | |  |
| IC-87114 | ICOS | |  |
| ICA-105665 | Icagen | |  |
| ICA-27243 | Icagen | |  |
| Icaridin | Bayer | 119515-38-7 ; 658051-75-3 |  |
| Icatibant | Hoechst (Sanofi-Aventis) | 130308-48-4 |  |
| ICG-001 | Choongwae | |  |
| ICGD | Vision 7 GmbH ; Chemotherapeutisches Forschunginstitut (Germany) | | No Structure |
| ICI-118551 | ICI (AstraZeneca) | 72795-19-8 |  |
| ICI-1259 | Immune Control Inc. | |  |
| ICI-1260 | Immune Control Inc. | |  |
| ICI-147798 | ICI (AstraZeneca) | 83812-65-1 |  |
| ICI-164384 | Schering AG | 98007-99-9 |  |
| ICI-185282 | ICI (AstraZeneca) | 106393-80-0 |  |
| ICI-192605 | ICI Pharmaceuticals | 117621-64-4 |  |
| ICI-198615 | AstraZeneca | 104448-53-5 |  |
| ICI-200355 | ICI (AstraZeneca) | 105080-32-8 |  |
| ICI-206970 | ICI (AstraZeneca) | 119646-52-5 |  |
| ICI-207828 | ICI (AstraZeneca) | 119778-11-9 |  |
| ICI-215918 | AstraZeneca | 122263-14-3 |  |
| ICI-715 | Immune Control Inc. (US) | |  |
| ICIA-0858 | Stauffer | 112860-04-5 |  |
| Iclaprim | Roche | 192314-93-5 ; 474793-41-4 (mesylate salt) |  |
| ICM-0201 | MCRF (Microbial Chemistry Research Foundation) ; Mercian | |  |
| ICM-I-136 | University of Virginia (USA) | |  |
| ICM-I-40N | Univ of Virginia | |  |
| ICN-16064 | ICN Pharmaceuticals (Valeant) | 244214-89-9 |  |
| iCo-007 | Isis Pharmaceuticals | 215860-80-3 | No Structure |
| Icodextrin | ML Laboratories | 337376-15-5 |  |
| Icofungipen | Bayer | 198022-65-0 |  |
| Icomucret | Alcon | 54845-95-3 |  |
| Icopezil | Pfizer | 145508-78-7 |  |
| Icosapent | | 10417-94-9 |  |
| Icosapent - Doconexent | Pronova ; Inst. of Biology of the Sea | 10417-94-9 (eicosapentaenoic acid) ; 6217-54-5 (docosahexaenoic acid) |  |
| Icosapentate Ethyl | Inst. of Biology of the Sea Vladivostock | 86227-47-6 |  |
| Icotinib | BetaPharma Inc. (US) | |  |
| Icrocaptide | Italfarmaco | 169543-49-1 |  |
| Icrucumab | ImClone Systems Inc. (Eli Lilly & Co.) | 1024603-92-6 | No Structure |
| ICT-2700 | University of London (GB) | |  |
| ICX-56258231 | Iconix PHARMACEUTICALS | |  |
| ICX-56259537 | Iconix PHARMACEUTICALS | |  |
| ID-1101 | Innodia Inc. | |  |
| Idanpramine | Ibis | 25466-44-8 |  |
| Idarubicin | Farmaceutici Italia | 58957-92-9 |  |
| Idazoxan | Reckitt & Colmann | 79944-58-4 |  |
| IDB-1031 | Inverni della Beffa | 95272-99-4 |  |
| IDD-3 | Sanofi-Synthelabo | | No Structure |
| Idebenone | Takeda | 58186-27-9 |  |
| IDN-1965 | Idun Pharmaceuticals (Pfizer) | 204919-14-2 |  |
| IDN-5005 | Indena | 76129-16-3 |  |
| IDN-5174 | Indena | |  |
| IDN-5370 | Idun Pharmaceuticals (Pfizer) | 369354-70-1 |  |
| IDN-5390 | Indena | |  |
| IDN-5404 | Indena | |  |
| IDN-5491 | Indena | |  |
| IDN-5890 | CNR | |  |
| IDN-6140 | Indena SpA (Italy) | | No Structure |
| IDN-6156 | Indena SpA (Italy) | |  |
| IDN-6734 | | | No Structure |
| Idoxifene | National Research Development Corporation (NRDC) | 116057-75-1 |  |
| Idoxuridine | Roussel-Uclaf (Aventis) | 54-42-2 |  |
| IDP-107 | Dow Pharmaceutical Sciences Inc. (Valeant Pharmaceuticals International Inc.) | | No Structure |
| IDP-113 | Dow Pharmaceutical Sciences Inc. (Valeant Pharmaceuticals International Inc.) | | No Structure |
| IDP-115 | Dow Pharmaceutical Sciences Inc. (Valeant Pharmaceuticals International Inc.) | | No Structure |
| Idrabiotaparinux | Sanofi-Synthelabo (Sanofi-Aventis) | 405159-59-3 (nonasodium) |  |
| Idraparinux Sodium | Akzo (Akzo Nobel) | 149920-56-9 |  |
| Idremcinal | Takeda Chemical Industries | 110480-13-2 |  |
| Idrocilamide | Lipha (E. Merck KGaA) | 6961-46-2 |  |
| Idronoxil | Novogen | 81267-65-4 |  |
| Idursulfase | Womens Childrens Hospital (Australia) | 50936-59-9 | No Structure |
| IDX-184 | | | No Structure |
| Ifenprodil | Robert et Carriere | 23210-56-2 ; 23210-58-4 (tartrate) |  |
| Iferanserin | Mead Johnson & Co. | 58754-46-4 |  |
| Ifetroban | Squibb (BMS) | 143443-90-7 |  |
| Ifosfamide | Asta Medica (Degussa) | 3778-73-2 |  |
| IG-08 | Immugen PHARMACEUTICALS | |  |
| IG-105 | Institute of Medicinal Biotechnology (China) ; Georgia State University (US) | |  |
| Igmesine | Oreal (Juvenial, Parke, Davis (Pfizer)) | 140850-73-3 |  |
| IGN-101 | Igeneon | | No Structure |
| IGN-2098 | Ikeda Mohando | 126868-88-0 |  |
| IGN-301 | | | No Structure |
| IGN-311 | Sandoz AG (Novartis AG) ; Protein Design Labs (PDL) | | No Structure |
| IgPro20 | CSL Behring AG | | No Structure |
| Iguratimod | Toyama (Japan) | 123663-49-0 |  |
| IHVR-0039 | University of Philadelphia ; Hepatitis B Foundation (USA) | |  |
| IIIM1 | Yissum Research Development Co. (Israel) | |  |
| IIIM1C | Yissum Research Development Co. (Israel) | |  |
| IK-312532 | Hokkaido University ; University of Shizuoka | |  |
| IKA-2002 | | |  |
| IKP-104 | Kumiai | 114231-14-0 |  |
| IL-488 | DuPont Pharmaceuticals | |  |
| Ilaprazole | Il-Yang (South Korea) | 172152-36-2 |  |
| Ilepatril | Aventis (Sanofi-Aventis) | 473289-62-2 |  |
| Iliparcil | Fournier | 137214-72-3 |  |
| Illimaquinone | University of Virginia | 71678-03-0 |  |
| Ilmofosine | Boehringer Mannheim (Roche) | 83519-04-4 |  |
| Ilodecakin | | 149824-15-7 | No Structure |
| Ilomastat | Galardy et al | 142880-36-2 |  |
| Iloperidone | Hoechst Roussel (Sanofi-Aventis) | 133454-47-4 |  |
| Iloprost | Schering AG (Bayer Schering Pharma Ag) | 78919-13-8 |  |
| Iloprost Cyclodextrin Clathrate | Schering AG (Bayer Schering) | 175387-26-5 |  |
| ILS-920 | Wyeth Corp. (US) | |  |
| Iluvien (Fluocinolone Acetonide) | Control Delivery Systems Inc.(pSivida Corp.) | 67-73-2 |  |
| ILX-237553 | Hoffmann La Roche (Roche) | 118694-43-2 |  |
| ILX-295501 | Eli Lilly | 150869-74-2 |  |
| IM-094482 | ImClone Systems Inc. (US) | |  |
| IM-491 | BMS (Du Pont Pharmaceuticals) | |  |
| IM-8008-763 | Ironwood Pharmaceuticals Inc. | |  |
| IMA-901 | Immatics Biotechnologies GmbH | | No Structure |
| Imagabalin | Pfizer | 610300-07-7 ; 610300-00-0 (hydrochloride salt) |  |
| Imanixil | Hoechst (Sanofi-Aventis) | 75689-93-9 |  |
| Imatinib | Ciba-Geigy (Novartis) | 152459-95-5 ; 220127-57-1 (mesilate) |  |
| Imazamethabenz-methyl | American Cyanamid (BASF) | 100728-84-5 |  |
| Imazamox | Shell | 114311-32-9 |  |
| Imazapic | American Cyanamid (BASF) | 104098-48-8 |  |
| Imazapyr | American Cyanamid (BASF) | 81334-34-1 |  |
| Imazaquin | American Cyanamid (BASF) | 81335-37-7 |  |
| Imazethapyr | American Cyanamid (BASF) | 81335-77-5 |  |
| Imazosulfuron | Takeda | 122548-33-8 |  |
| IMB-10 | CTT (Cancer Targeting Technologies)(Finland) | |  |
| IMC-EB10 | Imclone LLC (US) | | No Structure |
| IMD-0560 | Institute of Medicinal Molecular Design Inc. (Japan) | |  |
| IMD-1622 | Institute of Medicinal Molecular Design Inc. (Japan) | |  |
| Imeglimin | Merck Serono (Merck KGaA) | 775351-65-0 |  |
| Imepitoin | Arzneimittelwerk Dresden (AWD) | 188116-07-6 |  |
| Imetelstat | Geron Corporation | 868169-64-6 ; 1007380-31-5 (sodium salt) | No Structure |
| Imexon | Boehringer Mannheim (Roche) | 59643-91-3 |  |
| Imibenconazole | Hokko | 86598-92-7 |  |
| Imidacloprid | Nihon Tokushu Noyaku Seizo | 138261-41-3 |  |
| Imidafenacin | Kyorin (Japan) | 170105-16-5 |  |
| Imidapril | Tanabe | 89371-37-9 |  |
| Imidate | ICI (Syngenta) | 123679-26-5 |  |
| Imidazenil | Roche | 151271-08-8 |  |
| Imidazole salicylate | Italfarmaco | 36364-49-5 |  |
| Imidocarb | Wander | 27885-92-3 |  |
| Imiglitazar | Takeda | 250601-04-8 |  |
| Imiglucerase | Genzyme | 154248-97-2 | No Structure |
| Imiloxan | Syntex (Roche) | 81167-16-0 |  |
| Iminoctadine | Glaxo (GSK) | 13516-27-3 |  |
| Imipenem | Merck & Co. | 74431-23-5 |  |
| Imipramine | Geigy (Novartis) | 50-49-7 |  |
| Imipramineoxide | Dumex | 6829-98-7 |  |
| Imiprothrin | Sumitomo Chemical | 103585-79-1 |  |
| Imiquimod | Riker | 99011-02-6 |  |
| Imirestat | Alcon | 89391-50-4 |  |
| Imisopasem manganese | Searle (Pfizer) | 218791-21-0 |  |
| Imitrodast | Sankyo | 114686-12-3 |  |
| Immethridine | UCB Pharma | |  |
| IMMU-110 | Immunomedics | | No Structure |
| Immune Globulin | Generic | 9007-83-4 | No Structure |
| ImmunoVEX HSV2 | | | No Structure |
| IMO-2055 | Hybridon (Idera Pharmaceuticals) | | No Structure |
| IMO-2125 | Idera Pharmaceuticals Inc. | | No Structure |
| IMOJEV | St. Louis University ; Acambis Inc. (Sanofi Pasteur) | | No Structure |
| IMOL-881 | Free University Brussels | 134018-76-1 |  |
| Imolamine | Aron-Samuel | 318-23-0 |  |
| Imoproxifan | Bioprojet | |  |
| IMP-321 | Immutep (France) | | No Structure |
| Impede PSE (Pseudoephedrine) | Acura Pharmaceuticals Inc. | 90-82-4 |  |
| Implitapide | Bayer | 177469-96-4 |  |
| IMPY | University of Pennsylvania | |  |
| Imrecoxib | Research Institute of Materia Medica (Chinese Academy of: Medical Sciences); Jiangsu Hengrui Medicin | |  |
| IMT-504 | Immunotech | | No Structure |
| IMVAMUNE | Bavarian Nordic Research Institute AS | 1026718-04-6 | No Structure |
| IN-1130 | In2Gen ; SK Chemicals ; Ewha University | |  |
| IN-1166 | Ewha Womans University (South Korea) ; In2Gen Co. Ltd. (South Korea) ; Sungkyunkwan University (Sout | |  |
| Inabenfide | Chugai (Roche) | 82211-24-3 |  |
| Inakalant | AstraZeneca | 335619-18-6 |  |
| Inalimarev | Therion Biologics | 685563-13-7 | No Structure |
| Inaperisone | Hokuriku | 99323-21-4 |  |
| Incadronic acid | Yamanouchi (Astellas) | 124351-85-5 |  |
| INCB-003284 | Incyte ; Pfizer | |  |
| INCB-003344 | Incyte ; Pfizer | |  |
| INCB-012659 | Incyte | |  |
| INCB-13739 | | | No Structure |
| INCB-16562 | Incyte Corp. | |  |
| INCB-24360 | Incyte Corp. | | No Structure |
| INCB-28050 | | | No Structure |
| INCB-28060 | Incyte Corp. | |  |
| INCB-3619 | Incyte | |  |
| INCB-9471 | Incyte | 925701-76-4 |  |
| Incobotulinumtoxin A | Merz Pharmaceuticals GmbH | | No Structure |
| Incyclinide | University of New York | 15866-90-7 |  |
| Indacaterol | Novartis | 312753-06-3 ; 753498-25-8 (maleate salt) |  |
| Indanazoline | Nordmark | 40507-78-6 |  |
| Indanocine | Drug Innovation & Design | 265646-19-3 |  |
| Indanofan | Mitsubishi | 133220-30-1 |  |
| Indantadol | Chiesi Farmaceutici | 202914-18-9 (HCl) |  |
| Indanthrene | Bayer | 81-77-6 |  |
| Indapamide | Servier | 26807-65-8 |  |
| Indaziflam | Bayer | 950782-86-2 |  |
| Indeglitazar | Plexxicon Inc | 835619-41-5 |  |
| Indeloxazine | Yamanouchi (Astellas) | 60929-23-9 |  |
| Indenolol | Yamanouchi (Astellas) | 60607-68-3 |  |
| Indibulin | Asta Medica | 204205-90-3 |  |
| Indinavir | Merck & Co. | 150378-17-9 |  |
| INDIP | University of British Columbia (Canada) | |  |
| Indiplon | American Cyanamid (Wyeth) | 325715-02-4 |  |
| Indisetron | Nisshin Flour Milling | 141549-75-9 |  |
| Indisulam | Eisai | 165668-41-7 |  |
| Indium In-111 CYK4-013 | Endocyte ; Purdue | |  |
| Indium In-111 pentetreotide | Novartis | 159201-00-0 |  |
| Indobufen | Farmitalia Carlo Erba (Pharmacia) | 63610-08-2 |  |
| Indocarbazostatin B (-) | Toyama University | 334831-87-7 |  |
| Indocyanine Green | Kodak | 3599-32-4 |  |
| Indol-3-ylacetic acid | Redell Industries | 87-51-4 |  |
| Indolebutyric acid | Union Carbide | 133-32-4 |  |
| Indolepyruvic acid | Cardiff & Vale NHS Trust | 392-12-1 |  |
| Indolicidin-11 | Council of Scientific and Industrial Research | |  |
| Indolicidin-4 | Council of Scientific and Industrial Research | |  |
| Indolicidin-8 | Council of Scientific and Industrial Research | |  |
| Indolidan | Eli Lilly | 100643-96-7 |  |
| Indometacin | Merck & Co. | 53-86-1 |  |
| Indometacin farnesil | Eisai | 85801-02-1 |  |
| Indomethacin & Simvastatin | Harvard College (US) | |  |
| Indoprofen | Ciba-Geigy (Novartis) | 31842-01-0 |  |
| Indoramin | Wyeth | 26844-12-2 |  |
| Indoxacarb | DuPont | 173584-44-6 |  |
| Inecalcitol | Theramex (Merck KGaA) | 163217-09-2 |  |
| INF-401 | Influx | |  |
| Infanrix | Smithkline Beecham Biologicals (GlaxoSmithKline plc) | | No Structure |
| Infliximab | University of New York ; Centocor | 170277-31-3 | No Structure |
| Influenza A (H1N1) 2009 monovalent vaccine | Sanofi Pasteur (Sanofi-aventis) | | No Structure |
| Influenza A (H1N1) 2009 monovalent vaccine live intranasal | | | No Structure |
| Influenza A(H1N1) monovalent vaccine | Novartis AG | | No Structure |
| Influenza vaccine (surface antigen, inactivated, prepared in cell culture) | Novartis AG (Switzerland) | | No Structure |
| Influenza Virus Vaccine | | | No Structure |
| Influvac TC | Duphar International Research BV (Abbott Laboratories) | | No Structure |
| Ingenol mebutate | Peplin Biotech | 75567-37-2 |  |
| Ingliforib | Pfizer | 186392-65-4 |  |
| INH-A21 | Inhibitex | | No Structure |
| INH-I001 | University of Georgia (US) | |  |
| Iniparib | BiPar Sciences (US) | 160003-66-7 |  |
| Innacell gammadelta | Innate Pharma (France) | | No Structure |
| INO-1001 | Inotek Pharmaceuticals | 624747-02-0 |  |
| INO-4885 | Inotek Pharmaceuticals Corp. (US) | |  |
| INO-5042 | Innothera | 14782-19-5 |  |
| Inocoterone | Roussel-Uclaf (Aventis) | 83646-86-0 |  |
| Inogatran | Astra (AstraZeneca) | 155415-08-0 |  |
| Inolimomab | | 152981-31-2 | No Structure |
| Inositol Nicotinate | Bofors | 6556-11-2 |  |
| Inotuzumab ozogamicin | Wyeth (Pfizer Inc.) | 635715-01-4 |  |
| INS-115644 (Latrunculin B) | Wisconsin Alumni Research Foundation (US) ; Yeda Research and Development Co. Ltd. (Israel) | 76343-94-7 |  |
| INS-117548 | | |  |
| INS-2 | University of Virginia | |  |
| INS-48506 | Inspire Pharmaceuticals | |  |
| INS-49266 | Inspire Pharmaceuticals | |  |
| INSM-18 | | 500-38-9 |  |
| Insulin Aspart | Novo Nordisk | 116094-23-6 | No Structure |
| Insulin chain B (9-23) peptide | University of Colorado | |  |
| Insulin degludec | Novo Nordisk AS | 844439-96-9 | No Structure |
| Insulin Detemir | Novo Nordisk AS | 169148-63-4 | No Structure |
| Insulin Glargine | Hoechst (Sanofi-Aventis) | 160337-95-1 | No Structure |
| Insulin Glulisine | Aventis Pharma (Sanofi-Aventis) | 207748-29-6 | No Structure |
| Insulin LisPro Recombinant | Lilly Co Eli | 133107-64-9 | No Structure |
| Insuplant (Insulin) | | | No Structure |
| INT-0001-2004 (Metoprolol) | IntelGenx Corp. | |  |
| INT-0005-2005 | IntelGenx Corp. | | No Structure |
| INT-0007-2006 | | | No Structure |
| INT-0008-2007 | | | No Structure |
| INT-0014-2008 (Cannabidiol) | | 13956-29-1 |  |
| INT-0015-2008 | IntelGenx Corp. | | No Structure |
| INT-0018-2008 (Pravastatin) | IntelGenx Corp. | 81093-37-0 |  |
| INT-0019-2009 | IntelGenx Corp. | | No Structure |
| INT-131 | Tularik ; Japan Tobacco | |  |
| INT-777 | Intercept Pharmaceuticals Inc. | |  |
| Intedanib | Boehringer Ingelheim Pharmaceuticals | 928326-83-4 ; 656247-17-5 |  |
| Integric acid | Merck & Co | |  |
| Interferon Alfa-2A | Nat. Res. Dev | 76543-88-9 | No Structure |
| Interferon Alfa-N1 | The Wellcome Foundation Ltd. (GlaxoSmithKline plc) | 308067-63-2 | No Structure |
| Interferon Alfacon-1 | Wellcome Foundation (GSK) | 118390-30-0 | No Structure |
| Interferon Beta | Toray | 74899-71-1 |  |
| Interferon Beta-1a | Biogen | 145258-61-3 | No Structure |
| Interferon Beta-1b | Olin Mathieson | 145155-23-3 | No Structure |
| Interferon Gamma-1B | Genentech | 98059-61-1 | No Structure |
| Interleukin-15 | Immunex (Amgen) | 412112-66-4 | No Structure |
| Intermezzo (Zolpidem) | Transcept Pharmaceuticals | 82626-48-0 |  |
| Intetumumab | Centocor | 725735-28-4 | No Structure |
| Intoplicine | Rhone-Poulenc (Aventis) | 125974-72-3 |  |
| Invicorp | Senetek | |  |
| INX-08002A | University of Georgia Research Foundation Inc. (US) | |  |
| INX-08189 | Cardiff University (GB) ; Inhibitex Inc. | |  |
| IO-21 | Nissan Food | 114833-91-9 |  |
| Iobenguane-(131I) | Daiichi | 77679-27-7 |  |
| Iobitridol | Guerbet | 136949-58-1 |  |
| Iocarmic acid | Mallinckrodt | 10397-75-8 |  |
| Iocetamic acid | Dagra | 16034-77-8 |  |
| Iodamide | Eprova (E. Merck KGaA) | 440-58-4 |  |
| Iodine 124I Girentuximab | Wilex AG | 1011710-99-8 | No Structure |
| Iodine Povacrylex | | 845736-10-9 | No Structure |
| Iodixanol | Nyegaard ; Nycomed-Amersham | 92339-11-2 |  |
| Iodo I-123 I-5-I-R-91150 | Janssen Pharmaceutica (Johnson & Johnson) | |  |
| Iododoxorubicin | Farmitalia Carlo Erba (Pfizer) | 83997-75-5 |  |
| Iodofenphos | Ciba-Geigy (Novartis) | 18181-70-9 |  |
| Iodofiltic acid I-123 | Biostream (now: Molecular Insight Pharmaceuticals) | 123748-56-1 |  |
| Iodomethane chloropicrin | Arysta LifeScience Corporation | |  |
| Iodomethyllycaconitine iodine 125I | Research Triangle Inst. | |  |
| Iodomethyllycaconitine-(125I) | Research Triangle Institute | |  |
| Iodosulfuron-methyl | Hoechst (Sanofi-Aventis) | 185119-76-0 |  |
| Iodoxamic acid | Bracco | 31127-82-9 |  |
| Iofetamine-(123I) | Hoffmann La Roche (Roche) | 75917-92-9 |  |
| Ioflubenzamide (131I) | Bayer Schering Pharma AG (Germany) | 1214283-52-9 |  |
| Ioflupane 123I | Research Biochemicals | 155798-07-5 |  |
| Ioforminol | Biophysica Inc (US) | 1095110-48-7 |  |
| Iofratol | Bracco | 141660-63-1 |  |
| Ioglicic acid | Schering AG | 49755-67-1 |  |
| Iohexol | Nyegaard | 66108-95-0 |  |
| Iolopride-(123I) | | 113716-48-6 |  |
| Iomazenil | Hoffmann La Roche (Roche) | 127396-36-5 |  |
| Iomeprol | Bracco | 78649-41-9 |  |
| Iometopane (I-123) | Research Triangle Institute | 136794-86-0 |  |
| Iopamidol | Savac | 60166-93-0 |  |
| Iopanoic acid | Sterling Drug (Sanofi-Aventis) | 96-83-3 |  |
| Iopentol | Nycomed | 89797-00-2 |  |
| Iopromide | Schering AG | 73334-07-3 |  |
| Iopydol | IG Farben | 5579-92-0 |  |
| Iosimenol | Schering AG ; Biophysica Inc. | 181872-90-2 |  |
| Iotalamic acid | Mallinckrodt | 2276-90-6 |  |
| Iotriside | Schering AG | 79211-34-0 |  |
| Iotrolan | University of California, Berkley | 79770-24-4 |  |
| Iotroxic acid | Schering AG | 51022-74-3 |  |
| Ioversol | Mallinckrodt | 87771-40-2 |  |
| iOWH-032 | Institute for OneWorld Health (US) | |  |
| Ioxaglic acid | Guerbet | 59017-64-0 |  |
| Ioxilan | Cook Imaging | 107793-72-6 |  |
| Ioxitalamic acid | Nyegaard | 28179-44-4 |  |
| Ioxynil | May & Baker (Aventis) | 1689-83-4 |  |
| IP-IV-41 | University of South Florida (US) ; Yale University (US) | |  |
| IP-IV-49 | University of South Florida (US) ; Yale University (US) | |  |
| IP-IV-67 | University of South Florida (US) ; Yale University (US) | |  |
| IPA | University of New York ; University of South Alabama | 830-96-6 |  |
| IPA-3 | Mitsui Toatsu Chemicals Inc. (Japan) | 42521-82-4 |  |
| Ipazilide | Sterling Drug (Sanofi-Aventis) | 115436-73-2 |  |
| Ipazin | Ciba-Geigy (Novartis) | 1912-25-0 |  |
| IPBC | Troy Chemicals | 55406-53-6 |  |
| Ipconazole | Kureha | 125225-28-7 |  |
| Ipenoxazone | Nippon Chemiphar | 104454-71-9 |  |
| Ipfencarbazone | | 212201-70-2 |  |
| IPH -2301 | | | No Structure |
| IPH-2101 | Innate Pharma SA (France) ; University of Genoa (Italy) ; Novo Nordisk AS, (Denmark) | | No Structure |
| IPI-493 | Kaken Pharmaceutical Co. Ltd. (Japan) | |  |
| IPI-926 | Infinity Pharmaceuticals Inc. (US) | |  |
| IPI-940 | | | No Structure |
| Ipidacrine | Inst. Biolog. Ispytaniyam Khim. So | 62732-44-9 |  |
| Ipilimumab | Medarex | 477202-00-9 | No Structure |
| IPL-512602 | | | No Structure |
| IPL-576092 | Inflazyme | 202415-99-4 |  |
| Ipodic acid | Lentia | 5587-89-3 |  |
| Ipragliflozin | Kotobuki | 761423-87-4 |  |
| Ipratropium bromide | Boehringer Ingelheim | 22254-24-6 |  |
| Iprazochrome | Farmos | 7248-21-7 |  |
| Ipriflavone | Chinoin | 35212-22-7 |  |
| Iprindole | American Home Products (Wyeth) | 5560-72-5 |  |
| Iprobenfos | Kumiai | 26087-47-8 |  |
| Iprodione | Rhone-Poulenc | 36734-19-7 |  |
| Iproniazid | Hoffmann La Roche (Roche) | 54-92-2 |  |
| Ipronidazole | Hoffmann La Roche (Roche) | 14885-29-1 |  |
| Iprovalicarb | Bayer | 140923-17-7 |  |
| Ipsapirone | Troponwerke | 95847-70-4 |  |
| IPX-054 (Carbidopa & Levodopa) | | |  |
| IPX-066 (extended release Carbidopa & Levodopa) | Impax Laboratories Inc. | 38821-49-7 (Carbidopa) ; 59-92-7 (Levodopa) |  |
| IQM-97423 | CSIC (ES) ; Univ de Navarra (ES) | |  |
| IQP-0528 | Samjin Pharmaceutical Co. Ltd. (South Korea) | |  |
| IR-208 | Immune Response CORP. | 189941-59-1 |  |
| IR-6396 | Isagro Ricerca Srl | | No Structure |
| IRA-378 | Kyorin | 180579-61-7 |  |
| Iralukast | Ciba-Geigy (Novartis) | 151581-24-7 |  |
| Irampanel | Boehringer Ingelheim | 206260-33-5 |  |
| Iratumumab | Medarex (Bristol-Myers Squibb) | 640735-09-7 | No Structure |
| Irbesartan | Sanofi (Sanofi-Aventis) | 138402-11-6 |  |
| IRBM-D | Istituto di Ricerche di Biologia Molecolare P. Angeletti S.p.A. (Italy) | |  |
| IRC-083864 | SCRAS (Societe de Conseils de Recherches et d'Applications Scientifiques) (France) | |  |
| IRC-083927 | Societe des Conseils de Recherches et d’Applications Scientifiques (France) | |  |
| Irdabisant | | 1005402-19-6 |  |
| IRFI-042 | IRFI | 134867-62-2 |  |
| IRFI-165 | Biomedica Foscama | 191349-26-5 |  |
| Irinotecan | Yakult Honsha | 97682-44-5 |  |
| Irisquinone | Shandong Xinghua ; Tianjin institute of Materia Medica | 56495-82-0 |  |
| Irloxacin | Esteve | 91524-15-1 |  |
| Irofulven | University of California | 158440-71-2 |  |
| Iron Protein Succinylate | Italfarmaco Spa (Italy) | 93615-44-2 | No Structure |
| Iron sucrose | | 8047-67-4 | No Structure |
| Irosustat | Sterix (Ipsen) | 288628-05-7 |  |
| Iroxanadine | Biorex | 276690-58-5 |  |
| IRS-954 | Dynavax Technologies | | No Structure |
| Irsogladine | Nippon Shinyaku | 57381-26-7 |  |
| Irtemazole | Janssen Pharmaceutica (Johnson & Johnson) | 115574-30-6 |  |
| IS-159 | Immunotech | 133790-13-3 |  |
| IS-2 | University of Catania | |  |
| IS-50 | University of Catania | |  |
| IS-741 | Ishihara | 141283-87-6 |  |
| IS-811 | Bristol Myers Squibb (BMS) | |  |
| IS5MN PM | Biovail Laboratories Inc. (Valeant Pharmaceuticals International Inc.) | 16051-77-7 |  |
| Isalmadol | Vita Invest (Laboratorios Vita) | 269079-62-1 |  |
| Isalsteine | Farmaceutici Caber | 116818-99-6 |  |
| Isatoribine | Brigham Young University (US) | 122970-40-5 |  |
| Isavuconazole | Hoffmann La Roche | 241479-67-4 |  |
| Isavuconazonium chloride | Hoffmann-La Roche | 338990-84-4 |  |
| Isazofos | Ciba-Geigy (Novartis) | 42509-80-8 |  |
| Isbogrel | Takeda | 89667-40-3 |  |
| ISCK-03 | AmorePacific Corp. (South Korea) | 945526-43-2 |  |
| Iscotrizinol | 3V Inc. | 154702-15-5 |  |
| Iseganan | UCLA ; IntraBiotics | 244015-05-2 (HCl, H2O) |  |
| Isepamicin | Scherico | 58152-03-7 |  |
| ISIS-104838 | Isis Pharmaceuticals | | No Structure |
| ISIS-107248 | Isis Pharmaceuticals | 350263-41-1 |  |
| ISIS-107772 | ISIS | 350266-75-0 |  |
| ISIS-113715 | Isis | 350267-87-7 | No Structure |
| ISIS-13312 | Isis | 214841-85-7 | No Structure |
| ISIS-14803 | Isis Pharmaceuticals | | No Structure |
| ISIS-17044 | Isis Pharmaceuticals | 246519-46-0 |  |
| ISIS-183891 | Isis Pharmaceuticals | | No Structure |
| ISIS-22023 | Isis Pharmaceuticals | 300410-53-1 |  |
| ISIS-325568 | | | No Structure |
| ISIS-333611 | Isis Pharmaceuticals | | No Structure |
| ISIS-353512 | Isis Pharmaceuticals | | No Structure |
| ISIS-394814 | Isis Pharmaceuticals, Inc. (US) | | No Structure |
| ISIS-APOCIIIRx | Isis Pharmaceuticals Inc. | | No Structure |
| ISIS-FXIRx | Isis Pharmaceuticals Inc. | | No Structure |
| ISIS-GCCRRx | Isis Pharmaceuticals Inc. | | No Structure |
| ISIS-SGLT2Rx | Isis Pharmaceuticals Inc. | | No Structure |
| ISIS-SMNRx | Isis Pharmaceuticals Inc. | | No Structure |
| ISO-1 | Picower Institute For Medical Research | |  |
| ISO-63 | The Feinstein Institute for Medical Research (US) | |  |
| Iso-ET-743 | University of Illinois | 246041-04-3 |  |
| Isoaminile | Kali Chemie | 77-51-0 |  |
| Isobromindione | Gentili | 1470-35-5 |  |
| IsoCA-4 | Centre National de la Recherche Scientifique (France) | |  |
| Isocarbofos | Bayer | 24353-61-5 |  |
| Isocarboxazid | Hoffmann La Roche (Roche) | 59-63-2 |  |
| Isochaihulactone | Buddhist Tzu Chi General Hospital | |  |
| Isocil | DuPont | 314-42-1 |  |
| Isoconazole | Janssen Pharmaceutica (Johnson & Johnson) | 27523-40-6 |  |
| Isoetharine | IG Farben | 530-08-30 |  |
| Isofagomine | University of Maryland | 919364-56-0 (tartrate salt) ; 169105-89-9 |  |
| Isofenphos | Bayer | 25311-71-1 |  |
| Isofloxythepin | Spofa | 70931-18-9 |  |
| Isoflupredone Acetate | Ciba | 338-98-7 |  |
| Isoflurane | Air Reduction | 26675-46-7 |  |
| Isoflurophate | Monsanto (Pharmacia) | 55-91-4 |  |
| Isohomohalichondrin B | Pharma Mar | 157078-48-3 |  |
| Isometheptene | Bilhuber | 503-01-5 |  |
| iSONEP (Sonepcizumab) | | | No Structure |
| Isoniazid | Hoffmann La Roche (Roche) | 54-85-3 |  |
| Isonixin | Hermes | 57021-61-1 |  |
| Isopamphos | Chemol Trading | 16728-62-4 |  |
| Isoprenaline | Boehringer Ingelheim | 7683-59-2 |  |
| Isoprocarb | Bayer ; Mitsubishi | 2631-40-5 |  |
| Isopropalin | Eli Lilly | 33820-53-0 |  |
| Isopropamide | Janssen Pharmaceutica (Johnson & Johnson) | 71-81-8 |  |
| Isopropyl Myristate | Piedmont | 110-27-0 |  |
| Isoprothiolane | Nihon Nohyaku | 50512-35-1 |  |
| Isoproturon | DuPont | 34123-59-6 |  |
| Isopyrazam | Syngenta | 881685-58-1 |  |
| Isoquine | University of Liverpool | 1643-45-4 |  |
| Isosorbide Dinitrate | Sanol Schwarz-Monheim | 87-33-2 |  |
| Isosorbide mononitrate | | 16051-77-7 |  |
| Isosorbide mononitrate & L-arginine | Nitrosystems | |  |
| Isosulfan Blue | | 68238-36-8 |  |
| Isothipendyl | Degussa | 482-15-5 |  |
| Isotianil | Bayer Cropscience ; Sumitomo Chemical | 224049-04-1 |  |
| Isotretinoin | Hoffmann La Roche (Roche) | 4759-48-2 |  |
| Isouron | Shionogi | 55861-78-4 |  |
| Isovaleramide | NPS Pharmaceuticals | 541-46-8 |  |
| Isoxaben | Eli Lilly | 82558-53-7 |  |
| Isoxachlortole | Rhone-Poulenc | 141112-06-3 |  |
| Isoxadifen-ethyl | AgrEvo (BAYER CROPSCIENCE) | 163520-33-0 ; 209866-92-2 (free acid) |  |
| Isoxaflutole | Rhone-Poulenc | 141112-29-0 |  |
| Isoxapyrifop | Hokko | 87757-18-4 |  |
| Isoxathion | Sankyo | 18854-01-8 |  |
| Isoxazoledehydelone | Kosan Biosciences (BMS) | |  |
| Isoxazolefludelone | Kosan Biosciences (BMS) | |  |
| Isoxepac | Daiichi | 55453-87-7 |  |
| Isoxicam | Warner Lambert (Pfizer) | 34552-84-6 |  |
| Isoxsuprine | Philips-Duphar | 395-28-8 |  |
| ISPI-55 | Yoshitomi (Mitsubishi) | |  |
| Ispinesib | Cytokinetics (US) | 336113-53-2 ; 514820-03-2 (mesylate) |  |
| Ispronicline | Reynolds Tobacco | 252870-53-4 |  |
| ISQ-1 | University of Liverpool | 459133-36-9 |  |
| ISQ-2 | University of Liverpool | 459133-38-1 |  |
| ISQ-4 | University of Liverpool | 459133-40-5 |  |
| ISQ-5 | University of Liverpool | 459133-41-6 |  |
| Isradipine | Sandoz (Novartis) | 75695-93-1 |  |
| Israpafant | Yoshitomi (Japan) | 117279-73-9 |  |
| ISST-002 | Istituto Superiore di Sanita | | No Structure |
| IST-622 | Ishihara | 128201-92-3 |  |
| IST-FS-29 | University of Genova ; Istituto Nazionale Ricerca sul Cancro | 218948-55-1 |  |
| IST-FS-35 | National Institute for Cancer Research (Italy) ; University of Genoa (Italy) | |  |
| Istaroxime | Sigma-Tau | 203737-93-3 |  |
| Istradefylline | Kyowa Hakko | 155270-99-8 |  |
| ISV-101 (Bromfenac) | InSite Vision Inc. | 91714-94-2 |  |
| ISV-102 | InSite Vision Inc. | | No Structure |
| ISV-215 | InSite Vision Inc. | | No Structure |
| ISV-303 (Bromfenac) | InSite Vision Inc. | 91714-94-2 |  |
| ISV-305 (Dexamethasone) | InSite Vision Inc. | 50-02-2 |  |
| ISV-401 (Azithromycin) | InSite Vision Inc. | 83905-01-5 |  |
| ISV-405 (Azithromycin) | InSite Vision Inc. | 83905-01-5 |  |
| ISV-502 (Azithromycin & Dexamethasone) | InSite Vision Inc. | 83905-01-5 (Azithromycin) ; 50-02-2 (Dexamethasone) |  |
| ISV-620 | InSite Vision Inc. | | No Structure |
| IT-101 | Insert Therapeutics | |  |
| IT-121 | Intezyne Technologies Inc. | | No Structure |
| IT-141 (SN-38) | Intezyne Technologies Inc. (US) | |  |
| IT-143 (Doxorubicin) | Intezyne Technologies Inc. | 23214-92-8 |  |
| IT-145 | Intezyne Technologies Inc. | | No Structure |
| IT-657 | Dupont Pharmaceuticals | |  |
| Itameline | Roussel-Uclaf (Aventis) | 121750-57-0 |  |
| Itarnafloxin | Cylene Pharmaceuticals | 865311-47-3 |  |
| Itasetron | De Angeli | 123258-84-4 |  |
| Itavastatin | Nissan Chemical | 141750-63-2 |  |
| Itazigrel | Upjohn (Pharmacia) | 70529-35-0 |  |
| ITB | Univ. Murcia ; Univ.Valencia | |  |
| ITH-4012 | Laboratorio de Radicales Libres (CSIC) ; Universidad Autonoma de Madrid | |  |
| ITI-007 | | | No Structure |
| ITI-367 | Cytokine Pharmasciences Inc. | |  |
| ITMN-520 | Intermune Inc. | | No Structure |
| Itolizumab | Biocon Ltd | 1116433-11-4 | No Structure |
| Itopride | Hokuriku | 122898-67-3 |  |
| Itraconazole | Janssen Pharmaceutica (Johnson & Johnson) | 84625-61-6 |  |
| ITRI-227 | Industrial Technology Research Institute (Taiwan) | |  |
| Itriglumide | Rotta Research | 201605-51-8 |  |
| Itrocinonide | Dracco | 106033-96-9 |  |
| Iturelix | Asta Medica ; Biotech Australia | 112568-12-4 |  |
| ITZ-1 | Takeda Chemical Industries Ltd. (Takeda Pharmaceutical Co. Ltd.) | |  |
| Ivabradine | ADIR (Servier) | 155974-00-8 |  |
| Ivacaftor | Vertex Pharma | 873054-44-5 |  |
| Ivermectin | Merck & Co. | 70288-86-7 |  |
| IVL-745 | Rhone Poulenc Rorer (Sanofi-Aventis) | |  |
| IW-001 | | | No Structure |
| IW-6118 | | | No Structure |
| Ixabepilone | Bristol Myers Squibb (BMS) | 219989-84-1 |  |
| Izonsteride | Eli Lilly | 176975-26-1 |  |
| J-104129 | Banyu | 244277-89-2 |  |
| J-104132 | Banyu ; (Merck & Co.) | 198279-45-7 |  |
| J-104134 | Banyu | 202262-89-3 (Na) |  |
| J-104871 | Banyu | 191088-19-4 |  |
| J-105859 | Banyu | 325476-78-6 |  |
| J-106366 | Banyu | |  |
| J-109404 | Banyu | |  |
| J-111225 | Banyu | 232284-57-0 |  |
| J-113397 | Banyu | 256640-45-6 |  |
| J-113863 | Banyu | 353791-85-2 |  |
| J-114870 | Banyu | 228267-11-6 (HCl) |  |
| J-114871 | Banyu | 228267-12-7 (HCl) |  |
| J-115814 | Banyu | 329716-61-2 |  |
| J-124131 | Banyu | |  |
| J-1879 | Jenapharm | |  |
| J-1924 | Jenapharm | |  |
| J-2156 | Juvantia Pharma | |  |
| J-2581 | US Secretary of Agriculture | 71712-08-8 |  |
| J-30 | Taipei Medical University (China) ; National Health Research Institutes (China) ; National Defense M | |  |
| J-995 | Imperial College | 172377-52-5 |  |
| JAK-1 | Trinity College of Dublin | |  |
| JAK-4D | Trinity College of Dublin | |  |
| Janumet (Sitagliptin & Metformin) | Merck & Co | |  |
| Janus Green B | Udylite Res. Corp. | 2869-83-2 |  |
| JAY-2-22-33 | Medical College of Georgia Research Institute (US) ; The University of Georgia Research Foundation I | |  |
| JBP-485 | Japan Bioproducts ; Nippon Seibutsu Seizai | 211868-63-2 |  |
| JCF-177 | Case Western Reserve University ; Virginia Commonwealth University | |  |
| JF-10-81 | Tulane University (US) | |  |
| JG-03-14 | University of North Carolina (US) | |  |
| JH-388 | Enichem | 94343-59-6 |  |
| JH-8194-Y | Japan Science and Technology Agency (Japan) ; Hiroshima University (Japan) ; Two Cells Co. Ltd. (Jap | |  |
| JH-8944 | Japan Science and Technology | |  |
| JI-101 | CGI Pharmaceuticals Inc. | |  |
| JJ-137 | Washington University ; Yale University | |  |
| JJ-139 | Washington University ; Yale University | |  |
| JK-1624-2 | | |  |
| JK-1624-3 | | |  |
| JK-1624SO2 | Gary Posner | 250384-79-3 |  |
| JK-1626-2 | | |  |
| JL-13 | Therabel | 149859-10-9 |  |
| JM-1232 (-) | Maruishi Pharmaceutical Co. Ltd. (Japan) | |  |
| JM-1590 | Johnson Matthey | 106096-53-1 |  |
| JM-1596 | Johnson Matthey | 101347-05-1 |  |
| JM-2659 | Johnson Matthey | 167639-20-5 |  |
| JM-2763 | Johnson Matthey | 110078-40-5 |  |
| JM-3057 | Johnson Matthey | 157398-07-7 |  |
| JM-335 | Johnson Matthey | |  |
| JM-6 | J. David Gladstone Institutes (US) ; University of Maryland (US) | |  |
| JMF-2-1 | Pharmaton SA (Switzerland) | |  |
| JMV-1195 | CNRS (Centre National de la Recherche Scientifique) | |  |
| JMV-1609 | Fournier | 250762-99-3 |  |
| JMV-2764 | CNRS (Centre National de la Recherche Scientifique) | |  |
| JMV-2810 | AEterna Zentaris Inc. (Canada) | |  |
| JN7-119 | Forskarpatent i Syd AB | |  |
| JN7-139 | Forskarpatent i Syd AB | |  |
| JN7-155 | Forskarpatent i Syd AB | |  |
| JN7-156 | Forskarpatent i Syd AB | |  |
| JNJ-10181457 | Ortho-McNeil-Janssen (Johnson & Johnson) (US) | |  |
| JNJ-10258859 | Ortho McNeil (Johnson & Johnson) | |  |
| JNJ-10275798 | Johnson & Johnson | |  |
| JNJ-10287069 | Ortho Mcneil (Johnson & Johnson) | |  |
| JNJ-10329670 | Ortho McNeil (Johnson & Johnson) | |  |
| JNJ-10335572 | Janssen Pharmaceutica (Johnson & Johnson) | |  |
| JNJ-1250132 | US Health | |  |
| JNJ-141 | Janssen Pharmaceutica NV (Johnson & Johnson Inc.) | |  |
| JNJ-16567083 | Janssen Pharmaceutica (Johnson & Johnson) | |  |
| JNJ-1661010 | Takeda Pharmaceutical (Japan) | 681136-29-8 |  |
| JNJ-17029259 | Celltech | |  |
| JNJ-17069546 | Johnson & Johnson | |  |
| JNJ-17070885 | Johnson & Johnson | |  |
| JNJ-17156516 | Janssen Pharmaceutica (Johnson & Johnson) (Belgium) | |  |
| JNJ-17166864 | Johnson & Johnson Pharmaceutical | | No Structure |
| JNJ-17203212 | Janssen Pharmaceutica (Johnson & Johnson) | |  |
| JNJ-1930942 | Janssen Pharmaceutica NV | |  |
| JNJ-19567470 | Taisho Pharmaceutical Co. Ltd. | |  |
| JNJ-20788560 | Janssen Pharmaceutica NV (Belgium) | |  |
| JNJ-25918646 | Janssen Pharmaceutica (Johnson & Johnson) | |  |
| JNJ-26076713 | Janssen Pharmaceutica (Johnson & Johnson) (Belgium) | |  |
| JNJ-26146900 | Janssen Pharmaceutica (Johnson & Johnson) | |  |
| JNJ-26273364 | Janssen Pharmaceutica NV (Johnson & Johnson Inc.) | |  |
| JNJ-26481585 | Janssen Pharmaceutica (Johnson & Johnson) (Belgium) | 875320-29-9 |  |
| JNJ-26483327 | Janssen Pharmaceutica (Johnson & Johnson) | |  |
| JNJ-26489112 | Janssen Pharmaceutica NV | |  |
| JNJ-26990990 | Janssen Pharmaceutica NV | |  |
| JNJ-26993135 | Janssen Pharmaceutica (Johnson & Johnson) (Belgium) | |  |
| JNJ-27141491 | Johnson & Johnson | |  |
| JNJ-27265732 | Johnson & Johnson Services Inc. (US) | |  |
| JNJ-27390467 | Johnson & Johnson Pharmaceutical | |  |
| JNJ-28583867 | Janssen Pharmaceutica (Johnson & Johnson) (Belgium) | |  |
| JNJ-28833155 | Janssen Pharmaceutica (Johnson & Johnson) (Belgium) | |  |
| JNJ-28871063 | Janssen Pharmaceutica (Johnson & Johnson) (Belgium) | 944341-54-2 (HCl) |  |
| JNJ-31020028 | Janssen Pharmaceutica NV | |  |
| JNJ-37654032 | Janssen Pharmaceutica (Johnson & Johnson) (Belgium) | |  |
| JNJ-37822681 | Janssen Pharmaceutica NV | |  |
| JNJ-38480416 | Janssen Pharmaceutica (Johnson & Johnson) | |  |
| JNJ-388 | Janssen Pharmaceutica (Johnson & Johnson) | | No Structure |
| JNJ-38877605 | Janssen Pharmaceutica (Johnson & Johnson) (Belgium) | |  |
| JNJ-40355003 | Janssen Pharmaceutica NV (Johnson & Johnson Inc.) | |  |
| JNJ-40569321-AAA | Janssen Pharmaceutica NV (Belgium) | |  |
| JNJ-42041935 | Janssen Pharmaceutica NV (Johnson & Johnson Inc.) | |  |
| JNJ-5207787 | Johnson & Johnson | |  |
| JNJ-5207852 | Johnson & Johnson Pharmaceutical | |  |
| JNJ-5234801 | Johnson & Johnson | |  |
| JNJ-6115980 | Ortho Pharma | |  |
| JNJ-6333314 | Ortho Pharma | |  |
| JNJ-7706621 | Ortho McNeil (Johnson & Johnson) | |  |
| JNJ-7737782 | Ortho McNeil (Johnson & Johnson) | |  |
| JNJ-7777120 | Ortho McNeil (Johnson & Johnson) | |  |
| JNJ-7853417 | Johnson & Johnson | |  |
| JNJ-Q2 | Janssen Pharmaceutica (Johnson & Johnson) (Belgium) | |  |
| JNK-930 | Celgene Corp. (US) | | No Structure |
| Josamycin | Microbial Chemical Research Foundation | 16846-24-5 |  |
| JOT-01007 | China Medical University (China) | |  |
| JP-7 | University of Virginia Commonwealth ; Center Innovative Tech ; Allos Therapeutics | |  |
| JPC-1084 | Jacobus Pharamaceutical | |  |
| JPC-2056 | Jacobus Pharamaceutical | |  |
| JPC-2058 | Jacobus Pharamaceutical | |  |
| JPC-2059 | Jacobus Pharamaceutical | |  |
| JPE-1375 | Jerini AG | |  |
| JPL-133 | Uniroyal Chemical | |  |
| JS-389 | Yissum Research Development Company of The Hebrew University of Jerusalem Ltd. (Israel) | |  |
| JS-403 | Yissum Research Development Company of The Hebrew University of Jerusalem Ltd. (Israel) | |  |
| JS-8 | Palacky University of Olomouc ; Karlova University of Prague (Czech Republic) | |  |
| JS-K | US Department of Health & Human Services | 205432-12-8 |  |
| JSM-10292 | Jerini AG (Germany) | |  |
| JSM-6427 | Jerini AG | | No Structure |
| JTC-017 | Japan Tobacco | |  |
| JTC-801 | Japan Tobacco | |  |
| JTE-607 | Japan Tobacco | 188791-09-5 |  |
| JTE-907 | Japan Tobacco | |  |
| JTK-003 | Japan Tobacco | |  |
| JTK-101 | Japan Tobacco | |  |
| JTP-27536 | Japan Tobacco Inc. | |  |
| JTP-2942 | Japan Tobacco | 148152-77-6 |  |
| JTP-4819 | Japan Tobacco | 162203-65-8 |  |
| JTP-59557 | Japan Tobacco Inc. | |  |
| JTP-70902 | Japan Tobacco Inc. (Japan) | |  |
| JTT-010 | Japan Tobacco Inc. | |  |
| JTV-506 | Japan Tobacco | 170148-29-5 |  |
| JTV-519 | Kirin Brewery | 145903-06-6 |  |
| JTV-605 | Japan Tobacco | |  |
| JTV-803 | Japan Tobacco | 247131-79-9 |  |
| JTZ-132 | Japan Tobacco | |  |
| JUN-1111 | University of Pittsburgh | |  |
| JWB1-84-1 | Medical College of Georgia Research Institute (US) ; University of Georgia (US) | |  |
| JWH-015 | | 155471-08-2 |  |
| JWH-133 | | 259869-55-1 |  |
| JWS-USC-75IX | | 142744-34-1 |  |
| JX-401 | Jexys Pharmaceuticals Ltd. | 349087-34-9 |  |
| JX-594 | Jennerex Biotherapeutics | | No Structure |
| JYL-1421 | Pacific Corp | 401907-26-4 |  |
| JZP-4 | Jazz Pharmaceuticals (US) | |  |
| JZP-7 (Ropinirole) | Jazz Pharmaceuticals (US) | |  |
| JZP-8 (clonazepam) | Jazz Pharmaceuticals (US) | |  |
| K-01-162 | University of California (US) ; University of Pennsylvania (US) | |  |
| K-01-186 | University of California (US) ; University of Pennsylvania (US) | |  |
| K-101 | Sookmyung Women's University (Korea) | |  |
| K-104 | Sook Myung Women’s University (South Korea) ; STC Nara Co. Ltd. (South Korea) | |  |
| K-111 | Roche Diagnostics GmBH | |  |
| K-12 | Ube | 153468-00-9 |  |
| K-123 | | | No Structure |
| K-130 | Saarstickstoff Fatol | 111452-88-1 |  |
| K-134 | D. Western Therapeutics Institute | 189362-06-9 |  |
| K-245-14 | Harvard Medical School (US) ; RRC Kurchatov Institute (RU) ; Scripps Research Institute (US) | |  |
| K-252a | Kyowa Hakko | 99533-80-9 |  |
| K-37 | Daiichi | 210647-56-6 |  |
| K-38 | Ube | |  |
| K-412 | | | No Structure |
| K-42 | Daiichi | 210647-57-7 |  |
| K-454 | Kyowa Hakko Kirin Co. Ltd. | |  |
| K-579 | Kyowa Hakko Kogyo | |  |
| K-604 | Kowa Co. (Japan) | |  |
| K-7174 | Kowa | 191089-59-5 |  |
| K-7259 | Kowa | 133667-88-6 |  |
| K-76 | Tokyo Tanabe (Mitsubishi) | |  |
| K-76COOH | Otsuka | 71114-22-1 |  |
| K-832 | Kowa Company Limited | | No Structure |
| K-858 | Kyowa Hakko Kogyo Co. Ltd. (Japan) ; Fuji Photo Film Co. Ltd. (Japan) | |  |
| K6PC-5 | NeoPharm | |  |
| K6PC-9P | Neopharm Co. Ltd. (South Korea) | |  |
| KA-8 | CNRS-INSERM | |  |
| KABI-2161 | Kabivitrum | 104418-78-2 |  |
| Kadethrine | Roussel-Uclaf (Aventis) | 58769-20-3 |  |
| KAE-393 | Yamanouchi (Astellas) | 132036-36-3 |  |
| Kaempferol | Generic | 520-18-3 |  |
| KAF-200207 | Korea Research Institute of Chemical Technology | |  |
| Kahalalide F | Pharma Mar | 149204-42-2 |  |
| KAI-1455 | | | No Structure |
| KAI-9803 | KAI Pharmaceuticals | |  |
| Kaitocephalin | Meiji | 198710-92-8 |  |
| Kanamycin | Bristol Myers (BMS) | 59-01-8 |  |
| Kappa-Conotoxin P VIIA | Cognetix ; University of Utah | |  |
| Karetazan | Rohm & Haas | 81052-29-1 (K salt) |  |
| Kathon-886 | Rohm & Haas | 26172-55-4 ; 2682-20-4 |  |
| Kawain | Spezialchemie | 500-64-1 |  |
| KB-001 | | | No Structure |
| KB-130015 | Karo Bio | |  |
| KB-3305 | Abbott | |  |
| KB-5246 | Kanebo | 119474-55-4 |  |
| KB-7943 | Kanebo | |  |
| KB-R-8498 | Kanebo | 184825-96-5 |  |
| KBF-611 | University of Sciences In Philadelphia (US) | |  |
| KBPA-101 | Kenta Biotech AG | | No Structure |
| KBR-6806 | Kanebo | 148014-93-1 |  |
| KBR-7785 | Kanebo | |  |
| KBR-9032 | Kanebo | 179950-67-5 |  |
| KC-11458 | Kali Chemie (Solvay) | |  |
| KC-399 | Chugai (Roche) | 163394-97-6 |  |
| KC-515 | Chugai (Roche) | 152661-26-2 |  |
| KC-764 | Kyorin | 94457-09-7 |  |
| KCL-1999000269 | Kyorin Seiyaku | 311769-66-1 |  |
| KCN-1 | Emory University (US) | |  |
| KCN-67 | Emory University (US) | |  |
| KCO-912 | Novartis | |  |
| KCP-256 | Kyowa Hakko Kogyo KK | |  |
| KCT-0809 (Ozagrel) | Teika Pharmaceutical Co. Ltd. | 82571-53-7 |  |
| KD-3010 | Kalypsys Inc. | |  |
| KD-5150 | Kalypsys | |  |
| KD-5170 | Kalypsys Inc. (US) | |  |
| KD-7040 | Kalypsys Inc. | |  |
| KD-7332 | Kalypsys Inc. | |  |
| KDI-792 | Fujisawa | 130047-27-7 |  |
| KDR-5169 | Kissei | |  |
| Kebuzone | Geigy (Novartis) | 853-34-9 |  |
| Keliximab | GlaxoSmithKline (GSK) | 174722-30-6 | No Structure |
| Kendine-91 | Universidad del Pais Vasco (Spain) ; Centro Nacional de Investigaciones Oncológicas (Spain) | |  |
| Ketamine | Parke, Davis (Pfizer) | 6740-88-1 |  |
| Ketamine & Amitriptyline | EpiCept Corp. (US) | 6740-88-1 (Ketamine) ; 50-48-6 (Amitriptyline) |  |
| Ketanserin | Janssen Pharmaceutica (Johnson & Johnson) | 74050-98-9 |  |
| Ketasyn | Accera, Inc. | | No Structure |
| Ketazolam | Upjohn (Pharmacia) | 27223-35-4 |  |
| Ketobemidone | Ciba (Novartis) | 469-79-4 |  |
| Ketocaine | Recordati | 1092-46-2 |  |
| Ketoconazole | Janssen Pharmaceutica (Johnson & Johnson) | 65277-42-1 |  |
| KeTop-44 | University of Texas | |  |
| Ketoprofen | Rhone-Poulenc (Sanofi-Aventis) | 22071-15-4 |  |
| Ketorolac | Syntex (Roche) | 74103-06-3 |  |
| Ketospiradox | Du Pont (US) | 192708-91-1 (potassium) |  |
| Ketotifen | Sandoz (Novartis) | 34580-13-7 ; 34580-14-8 (fumarate) |  |
| KF-10632 | Kyowa Hakko | 105919-37-7 |  |
| KF-13218 | Kyowa Hakko Kogyo | 127654-03-9 |  |
| KF-15766 | Kyowa Hakko | 124907-44-4 |  |
| KF-15832 | Kyowa Hakko | 124294-43-5 |  |
| KF-17625 | Kyowa Hakko | 139339-02-9 |  |
| KF-17828 | Kyowa Hakko | 144170-10-5 |  |
| KF-17837 | Kyowa Hakko | 141807-96-7 |  |
| KF-18259 | Kyowa Hakko | 139094-48-7 |  |
| KF-19418 | Kyowa Hakko | |  |
| KF-19514 | Kyowa Hakko | 139482-55-6 |  |
| KF-20170 | Kyowa Hakko | 145970-12-3 |  |
| KF-20274 | Kyowa Hakko | 143394-68-7 |  |
| KF-20444 | Kyowa Hakko | 154015-73-3 |  |
| KF-21213 | Kyowa Hakko | 155271-17-3 |  |
| KF-24345 | Kyowa Hakko | |  |
| KF-25706 | Kyowa Hakko | |  |
| KF-26777 | Kyowa Hakko | |  |
| KF-31327 | Kyowa Hakko | 204077-66-7 (HCl) |  |
| KF-38789 | Kyowa Hakko | |  |
| (+)-KF-4 | Research Triangle Institute | |  |
| KF-41399 | Kyowa Hakko Kogyo | |  |
| KF-58333 | Kyowa Hakko ; National Cancer Institute | |  |
| KF-66854 | Kyowa Hakko Kogyo | 244788-22-5 |  |
| KF-72926 | Kyowa Hakko | 348165-49-1 |  |
| KFA-1411 | Kissei | |  |
| KFA-1982 | Kissei Pharmaceuticals | |  |
| KGA-2727 | Kissei Pharmaceutical | | No Structure |
| KGGCLK-peptide | University of New York | |  |
| KH-1266 | Leo | |  |
| KH-902 | Chengdu Kanghong Biotechnologies Co. Ltd. (China) | | No Structure |
| KHD-161 | CNRS (Centre National De La Recherche Scientifique) | |  |
| KHG-25967 | Korea Institute of Science and Technology (South Korea) | |  |
| KHK-6188 | | | No Structure |
| KHPC-001 | Kyung Hee University | 137174-46-0 |  |
| KHPC-002 | Noh Young Soo | 169275-60-9 |  |
| KI-105 | Taiho Pharmaceutical | |  |
| KI-111 | Taiho ; Riken | |  |
| Ki-11502 | Kirin Brewery (Japan) | |  |
| KI-414 | Kanto Ishi Pharmaceutical | 100937-84-6 |  |
| KI-60606 | Korea Institute of Science and Technology | 299423-07-7 |  |
| KI-6783 | Kirin Brewery | 190726-45-5 |  |
| KI-8751 | Kirin Brewery | |  |
| KID-24 | Raven Biotechnologies Inc. (US) | | No Structure |
| Kigamicin D | National Cancer Center-Japan | |  |
| kigamicinone | Microbial Chemical Research Foundation | |  |
| Kinetin | Senetek | 525-79-1 |  |
| Kinrix | | | No Structure |
| KIOM-79 | Korea Institute Of Oriental Medicin (South Korea) | | No Structure |
| KISS-305 | Takeda | |  |
| KJM-429 | Pacific Corp | 401907-57-1 |  |
| KK-117 | Kodama Kabushiki Kaisha | 128202-33-5 |  |
| KKDC Dimer | Hadasit Medical Research Services and Development Ltd. (Israel) | |  |
| KKHA-761 | Korea Institute of Science and Technology ; Korea Research Institute of Chemical Technology | |  |
| KL-3744 | Kyoto Pharmaceutical | |  |
| KL-3758 | Kyoto Pharmaceutical | |  |
| KLH-2109 | | | No Structure |
| KLVFF-(EEX)3 | Tokyo University ; AIST (National Institute of Advanced Industrial Science and Technology) | |  |
| KM-007 | Kyoto University | 133226-24-1 |  |
| KM-0118 | University of Minnesota | |  |
| KM-043 | Toyo Suisan | 207976-87-2 |  |
| KM-1 | | 215785-47-0 |  |
| KM-2760 | Kyowa Hakko Kogyo | | No Structure |
| KM-3821 | Kyowa Hakko Kogyo Co., Ltd. (Japan) ; National Cancer Center (Japan) | | No Structure |
| KMI-574 | Kyoto University | |  |
| KML-001 | Komipharm International (South Korea) | 7784-46-5 |  |
| KMS-80013 | Korea Institute of Science and Technology (South Korea) ; Hanmi Pharmaceutical Co. Ltd. (South Korea | |  |
| KMUP-880602 | Kaohsiung Medical College (Taiwan) | |  |
| KMUP-880708 | Kaohsiung Medical College | |  |
| KMV-0207 (Mitiglinide & Voglibose) | Takeda Chemical Industries Ltd. (Takeda Pharmaceutical Co. Ltd.) | 145375-44-6 (Mitiglinide) ; 83480-29-9 (Voglibose) |  |
| KN-387271 | | | No Structure |
| KN-62 | Nagoya University (Japan) | 127191-97-3 |  |
| KNC-1206 | Kopran | | No Structure |
| KNC-6 | Kopran | | No Structure |
| KNI-1224 | Abbott ; Kyoto Pharmaceutical | 521275-27-4 |  |
| KNI-413 | Japan Energy ; Kyoto Pharma University | 184955-03-1 |  |
| KNI-684 | Takeda | 226225-77-0 |  |
| KNI-694 | Takeda | 226225-86-1 |  |
| KNK-437 | Kanegafuchi | 218924-25-5 |  |
| KO-132 | The Netherlands Cancer Institute | |  |
| KO-134 | The Netherlands Cancer Institute | |  |
| KO-143 | The Netherlands Cancer Institute | |  |
| KO-202125 | Korea Research Institute of Chemical Technology (South Korea) | |  |
| KOS-1584 | Bristol-Myers Squibb (BMS) | |  |
| KOS-2464 | | | No Structure |
| KOS-953 (Tanespimycin) | Kosan Biosciences (BMS) | 75747-14-7 |  |
| KOSN-1604 | Kosan | |  |
| KOSN-1643 | Kosan | |  |
| KP-1255 | University of Vienna | 182865-15-2 |  |
| KP-1461 | Koronis | |  |
| KP-372-1 | Kinetek Pharmaceuticals | |  |
| KP-496 | Kaken Pharma | | No Structure |
| KP-544 | Krenitsky Pharmaceuticals | |  |
| KP-736 | Kaken Pharmaceutical | 114875-57-9 |  |
| KP-772 | Faustus Forschungs Company ; Translational Cancer Research | 198340-86-2 |  |
| KP-776 | Faustus Forschungs Company ; Translational Cancer Research | |  |
| KPE-02003002 (Artenimol) | Kemin Pharma Europ B V B A (US) | |  |
| KPP-421 | Kaken Pharmaceutical | 141772-53-4 |  |
| KR-055015 | KRICT (Korea Research Institute of Chemical Technology) | |  |
| KR-21012 | Korea Research Inst. of Chemical Technology (KRICT) | 265117-20-2 |  |
| KR-31372 | Dongbu Hannong Chemical | 327614-26-6 |  |
| KR-31378 | Korea Research Inst. of Chemical Technology (KRICT) | 335381-68-5 |  |
| KR-31612 | Korea Research Inst. of Chemical Technology (KRICT) | 335381-69-6 |  |
| KR-31761 | Dongbu Hannong Chemical Co. Ltd. (South Korea) | |  |
| KR-31831 | Korea Research Institute of Chemical Technology (KRICT) | |  |
| KR-32560 | Korea Research Institute of Chemical Technology (KR) | |  |
| KR-32568 | Korea Research Institute of Chemical Technology | |  |
| KR-32570 | Korea Research Institute of Chemical Technology ; Yu Yu Industrial Co. | |  |
| KR-33028 | Yuyu Inc. (Korea) ; Korea Research Institute of Chemical Technology | |  |
| KR-34008 | Korea Research Institute of Chemical Technology | |  |
| KR-34020 | Korea Research Institute of Chemical Technology | |  |
| KR-60436 | Korea Research Institute of Chemical Technology | |  |
| KR-61170 | American Home Products Corporation | |  |
| KR-61639 | Korea Research Institute of Chemical Technology | |  |
| KR-62436 | Korea Research Institute of Chemical Technology | |  |
| KR-62980 | Korea Research Institute of Chemical Technology ; Jeil Pharmaceutical Co. Ltd. ; Korea Research Inst | |  |
| Kresoxim-methyl | BASF | 143390-89-0 |  |
| KRH-1636 | Kureha | |  |
| KRH-594 | Wakunaga | 167006-13-5 |  |
| KRI-BB3 | Synta Pharmaceuticals Corp. (US) | 129414-88-6 |  |
| KRICT-RN-154472-47-6 | Korea Research Inst. Of Chemical Research | 154472-47-6 |  |
| KRICT-RN-154472-48-7 | Korea Research Inst. Of Chemical Research | 154472-48-7 |  |
| KRN-23 | Kyowa Hakko Kirin Co. Ltd. | | No Structure |
| KRN-2391 | Kirin Brewery | 133299-87-3 |  |
| KRN-330 | Kyowa Hakko Kirin Co. Ltd. | | No Structure |
| KRN-5500 | Kirin Brewery | 151276-95-8 |  |
| KRN-633 | Kirin Brewery | |  |
| KRN-7000 | Kirin Brewery | 158021-47-7 |  |
| KRN-8602 | Microbial Chemical Research Foundation | 105026-50-4 |  |
| KRP-101 | Kyorin Seiyaku KK | |  |
| KRP-103 | Kyorin | |  |
| KRP-104 | Kyorin Pharma | |  |
| KRP-105 | Kyorin Pharma | | No Structure |
| KRP-199 | Kyorin | |  |
| KRP-203 | Kyorin Pharma | |  |
| KRX-123 | Children's Medical Center | 398137-68-3 |  |
| KS-01018 (Lovastatin & Nicotinic acid) | KOS Pharmaceuticals (Abbott) | |  |
| KS-119 | Yale University | |  |
| KS-30 | University of California | |  |
| KST-48 | College of Pharmacy ; Seoul National University | |  |
| KT-1-785 | Kotobuki | 99287-31-7 |  |
| KT-2-962 | Kotobuki | 129648-97-1 |  |
| KT-5720 | | 108068-98-0 |  |
| KT-5823 | | 126643-37-6 |  |
| KT-6352 | Kyowa Hakko | |  |
| KT6-207 | Kotobuki | |  |
| KTC-5 | Chang Gung University | 336100-71-1 |  |
| KU-0060648 | KuDOS Pharmaceuticals Ltd. (GB) ; Cancer Research Technology Ltd. (GB) | |  |
| KU-1-A4 | University of Kansas ; Department Of Health And Human Services | |  |
| KU-2285 | Daikin | 121077-11-0 |  |
| KU-3-A2 | University of Kansas ; Department Of Health And Human Services | |  |
| KU-32 | University of Kansas (US) | |  |
| KU-55933 | Kudos Pharmaceuticals | |  |
| KU-60019 | KuDOS Pharmaceuticals (AstraZeneca AB) | |  |
| KUL-7211 | Kissei Pharmaceutical Co. (Japan) | 220129-58-8 |  |
| KV-2920 | Kyoto Pharmaceuticals Ind. | 288462-23-7 |  |
| KW-2149 | Kyowa Hakko | 118359-59-4 |  |
| KW-2170 | Kyowa Hakko Kogyo | 207862-44-0 (dihydrochloride) |  |
| KW-2449 | Kyowa Hakko Kogyo Co. Ltd. (Japan) | |  |
| KW-2450 | | | No Structure |
| KW-2478 | Kyowa Hakko Kirin Co. Ltd. | |  |
| KW-2581 | Duquesne University (US) ; Kyowa Hakko Kogyo Co. Ltd. (Japan) | |  |
| KW-3033 | Kyowa Hakko | 144170-10-5 |  |
| KW-3357 | Kyowa Hakko Kogyo Co. Ltd. (Kyowa Hakko Kirin Co. Ltd.) | | No Structure |
| KW-4099 | Kyowa Hakko | 146917-45-5 |  |
| KW-5092 | Kyowa Hakko | 135017-85-5 (fumarate) |  |
| KW-7158 | Kyowa Hakko | |  |
| KW-8232 | Kyowa Hakko | 217813-15-5 (methanesulfonate) |  |
| KX-010107 | | | No Structure |
| KX-1-004 | University of New York (US) ; Roswell Park Cancer Institute (US) | |  |
| KX-2391 | Kinex Pharmaceuticals | |  |
| KX2-377 | Kinex Pharmaceuticals | |  |
| KY-021 | Kyoto Pharmaceutical | |  |
| KY-151 | Kyoto Pharmaceutical | |  |
| KYN-54 | Kuraray | |  |
| Kynostatin | Nippon Mining | 147318-81-8 |  |
| Kynostatin-227 | Nippon Mining | 147384-69-8 |  |
| KYP-2047 | Kuopio University (Finland) | |  |
| KYS-05001 | Korea Institute of Science and Technology | |  |
| KYS-05041 | Korea Institute of Science and Technology | |  |
| KYS-05042 | Korea Institute of Science and Technology | |  |
| KYS-05044 | Korea Institute of Science and Technology | |  |
| KYT-0353 | Mitsubishi Tanabe Pharma Corp. | |  |
| L-054852 | Merck & Co. | 214471-63-3 |  |
| L-117 | Lipitek International | |  |
| L-14165 | SDS Biotech | 142923-20-4 |  |
| L-156602 | Merck & Co. | 107231-21-0 and 125228-51-5. (SEE NOTE IN REFERENCE) |  |
| L-158338 | Merck & Co. | 133240-38-7 |  |
| L-158809 | Merck & Co. | 135145-96-9 |  |
| L-158978 | Merck & Co. | |  |
| L-159061 | Takeda | 137416-45-6 |  |
| L-159282 | Merck & Co. | 157263-00-8 |  |
| L-161177 | Merck & Co. | 145004-82-6 |  |
| L-162154 | Sanofi (Sanofi-Aventis) | 186537-37-1 |  |
| L-162234 | Merck & Co. | 146948-75-6 |  |
| L-165041 | Merck & Co. | |  |
| L-165666 | Merck & Co. | 170842-63-4 |  |
| L-1NAII | Royal Free Hospital | 126055-15-0 |  |
| L-2264 | National Academy of Sciences of Ukraine | |  |
| L-2286 | University of Pécs (Hungary) | |  |
| L-365031 | Merck & Co. | 111035-59-7 |  |
| L-366509 | Merck & Co. | 138382-23-7 |  |
| L-368935 | Merck & Co. | 145878-31-5 |  |
| L-369466 | Merck & Co. | 154273-70-8 |  |
| L-371257 | Merck & Co. | 162042-44-6 |  |
| L-372460 | Merck & Co. | 177582-82-0 |  |
| L-373890 | Merck & Co. | 187162-33-0 |  |
| L-375378 | Merck & Co. | |  |
| L-377202 | Merck & Co. | 322722-69-0 |  |
| L-4-Boronophenylalanine | US Energy | 80994-59-8 |  |
| L-452493-001X | Merck & Co. | |  |
| L-454560 | Merck Frosst Canada | |  |
| L-5-hydroxytryptophan | | 56-69-9 |  |
| L-651896 | Merck & Co. | 99134-29-9 |  |
| L-652343 | Merck & Co. | 102565-09-3 |  |
| L-656224 | Merck & Co. | 102612-16-8 |  |
| L-658758 | Merck & Co. | 116507-04-1 |  |
| L-659699 | Kitasato Institute | 29066-42-0 |  |
| L-659989 | Merck & Co. | 113787-28-3 |  |
| L-662583 | Merck & Co. | 119731-42-9 |  |
| L-663536 | Merck Frosst (Merck & Co.) | 118414-82-7 |  |
| L-668750 | (Merck & Co | |  |
| L-670596 | Merck Frosst (Merck & Co.) | 121083-05-4 |  |
| L-680573 | Merck & Co. | 135947-75-0 |  |
| L-680833 | Merck & Co. | 127063-08-5 |  |
| L-683845 | Merck & Co. | 142935-34-0 |  |
| L-685458 | Merck & Co. | 292632-98-5 |  |
| L-687414 | Merck & Co. | 130931-65-6 |  |
| L-689560 | Merck & Co. | 139051-78-8 |  |
| L-689660 | Merck & Co. | 125059-87-2 |  |
| L-692429 | Merck & Co. | 145455-23-8 |  |
| L-693549 | Merck & Co. | |  |
| L-694247 | Merck & Co. | 137403-12-4 |  |
| L-695256 | Merck & Co. | 137323-79-6 |  |
| L-699333 | Merck Frosst (Merck & Co.) | 147936-06-9 |  |
| L-700462 | Merck & Co. | 144494-65-5 |  |
| L-701324 | Merck Sharp & Dohme (Merck & Co) | 142326-59-8 |  |
| L-702958 | Merck & Co. | 136078-58-5 |  |
| L-703717 | Merck & Co. | 142326-92-9 |  |
| L-708906 | Merck & Co. ; Tularik (Amgen) | 251963-74-3 |  |
| L-731988 | Merck & Co. | 251922-77-7 |  |
| L-733060 | Merck Sharp & Dohme (Merck & Co) | 148700-85-0 |  |
| L-734005 | Merck & Co. | 148473-16-9 |  |
| L-734115 | Merck & Co. | 163213-03-4 |  |
| L-734217 | Merck & Co. | 146144-48-1 |  |
| L-735882 | Merck & Co. | |  |
| L-737488 | Merck & Co. | 154775-33-4 |  |
| L-738167 | Merck & Co. | |  |
| L-738872 | Merck & Co. | 159565-70-5 |  |
| L-739010 | Merck Frosst (Merck & Co.) | 158930-07-5 |  |
| L-739594 | Merck & Co. | 156879-13-9 |  |
| L-740093 | Merck & Co. | 154967-59-6 |  |
| L-741519 | Merck & Co. | 154594-20-4 |  |
| L-741604 | Merck & Co. | 154594-22-6 |  |
| L-741671 | Merck Sharp & Dohme (Merck & Co) | 187724-85-2 |  |
| L-741742 | Merck & Co. | 156337-32-5 |  |
| L-742694 | Merck & Co. | |  |
| L-742728 | Merck & Co. | 169957-63-5 |  |
| L-743345 | Merck & Co. | 182368-67-8 |  |
| L-744832 | Merck & Co. | 160141-09-3 |  |
| L-745337 | Merck Frosst (Merck & Co.) | 158205-05-1 |  |
| L-745870 | Merck Sharp & Dohme (Merck & Co) | 158985-00-3 |  |
| L-749372 | Merck & Co. | 159183-70-7 |  |
| L-750355 | Merck & Co. | 159183-92-3 |  |
| L-751788 | Merck & Co. | 166174-54-5 |  |
| L-751891 | Merck & Co. | |  |
| L-755507 | Merck & Co. | |  |
| L-756568 | Merck & Co. | 190261-01-9 |  |
| L-758354 | Merck & Co. | 188048-85-3 |  |
| L-759274 | Merck, Sharp and Dohme | 737803-81-5 | No Structure |
| L-764406 | Merck & Co. | 227002-04-2 |  |
| L-768673 | Merck & Co. | 177954-68-6 |  |
| L-770644 | Merck & Co. | 173901-95-6 |  |
| L-771688 | Synaptic | 200050-59-5 |  |
| L-772405 | Merck Sharp & Dohme | |  |
| L-775606 | Merck Sharp & Dohme (Merck & Co) | 188400-51-3 |  |
| L-776967 | Merck Frosst (Merck & Co.) | 212126-32-4 |  |
| L-778123 | Merck & Co. | |  |
| L-783281 | Merck & Co. | 78860-34-1 |  |
| L-786392 | Merck & Co. | 198472-47-8 |  |
| L-791515 | Merck Frosst Canada | |  |
| L-791943 | Merck & Co. | |  |
| L-796449 | Merck & Co | |  |
| L-803-MTS | Tel Aviv University | |  |
| L-806978 | Merck & co. | |  |
| L-822179 | Merck Sharp Dohme | |  |
| L-826141 | Merck Frosst (Merck & Co.) | |  |
| L-838417 | Merck & Co. | 286456-42-6 |  |
| L-838751 | Merck Sharp & Dohme | |  |
| L-870810 | Merck & Co | |  |
| L-870812 | Merck & Co | |  |
| L-888607 | Merck Frosst | |  |
| L-900564 | Merck | |  |
| L-902688 | Merck Frosst (Canada) | |  |
| L-97-1 | Endacea | |  |
| L-Asp-BDCRB | University of Michigan | |  |
| L-Asparaginase | | 9015-68-3 | No Structure |
| L-chicoric acid | US Department of Health & Human Services | 70831-56-0 |  |
| L-Citrulline | Dimaphar | 372-75-8 |  |
| L-Dopa 3-O-glucoside | Evolva AG | |  |
| L-Dopa 4-O-glucoside | Evolva AG | |  |
| L-Dopamide | Yissum Res. Dev. Co. | 59-92-7 |  |
| L-glutamine monofluorophosphate | Rotta Research | 116420-36-1 | No Structure |
| L-Hyd4FC | Max-Delbrück Centrum für Molekulare Medizin (Germany) | |  |
| L-IDO-AMP-DNM | Genzyme Corp. | |  |
| L-MDAM | Bionumerik | 176857-41-3 |  |
| L-NAME | SCRAS (Beaufour Ipsen) | 50903-99-6 |  |
| L-propionylcarnitine | Sigma Tau | 20064-19-1 |  |
| L-Simexonyl homocysteine | University of Arizona (US) | |  |
| L-t-C6-Pyr-Cer | Medical University of South Carolina (MUSC) Foundation for Research Development | |  |
| L-Threitol ceramide | Ludwig Institute for Cancer Research (US) | |  |
| L-Tryptophan | Ajinomoto | 73-22-3 |  |
| L-Tyrosine | | 60-18-4 |  |
| L19-TNFalpha | Philogen SpA (Italy) | | No Structure |
| L2G7 | Galaxy Biotech LLC | | No Structure |
| LA-419 | Lacer S.A. (Spain) | |  |
| LA-480 | Eli Lilly & Co. | | No Structure |
| LA-PLUS | Univ of California | |  |
| Labetalol | Allen & Hanburys (GSK) | 36894-69-6 |  |
| Labetuzumab | Immunomedics | 219649-07-7 | No Structure |
| Labradimil | Alkermes | 159768-75-9 |  |
| Lac-L-Leu | Metastat Inc. (US) | |  |
| Lacidipine | Glaxo (GSK) | 103890-78-4 |  |
| Lacosamide | Research Corporation Technologies (US) | 175481-36-4 |  |
| Lactitol | Amsterdam Chem Comb | 585-86-4 |  |
| Lactobionic acid | | 96-82-2 |  |
| Lactofen | Rohm & Haas | 77501-63-4 |  |
| Lactonamycin | Microbial Chemical Research Foundation | 182234-02-2 |  |
| Lactulose | | 4618-18-2 |  |
| Ladasten | NII Farmakologii Ramn | |  |
| Ladirubicin | Farmitalia Carlo Erba (Pharmacia) | 171047-47-5 |  |
| Ladostigil | Teva ; Yissum | 209394-27-4 |  |
| LAF-389 | Novartis | |  |
| Laflunimus | Roussel-Uclaf (Aventis) | 147076-36-6 |  |
| Lafutidine | Fujirebio | 118288-08-7 |  |
| Lagociclovir | Medivir | 92562-88-4 |  |
| Laidlomycin propionate | Syntex (Roche) | 84799-02-0 (K salt) |  |
| Lambda Cyhalothrin | ICI (Syngenta) | 91465-08-6 |  |
| Lamifiban | Roche | 144412-49-7 |  |
| Lamivudine | IAF Biochem | 134678-17-4 |  |
| Lamivudine & Adefovir dipivoxil | Glaxo Group Ltd. (GlaxoSmithKline plc) | 134678-17-4 (Lamivudine) ; 142340-99-6 (Adefovir dipivoxil) |  |
| Lamotrigine | Wellcome Foundation (GSK) | 84057-84-1 |  |
| LAMS | National Institute of Immunology (India) ; Council of Scientific and Industrial Research (India) ; U | |  |
| Landiolol | Ono Pharmaceutical | 133242-30-5 |  |
| Lanepitant | Eli Lilly | 170566-84-4 |  |
| Lanicemine | Fisons | 153322-05-5 |  |
| Lanimostim | Eximias Pharmaceutical | 117276-75-2 | No Structure |
| Laninamivir | Sankyo | 203120-17-6 |  |
| Laniquidar | Janssen Pharmaceutica (Johnson & Johnson) | 197509-46-9 |  |
| Lanoconazole | Nihon Nohyaku | 101530-10-3 |  |
| Lanoteplase | Genetics Inst. Suntory | 171870-23-8 |  |
| Lanperisone | Nippon Kayaku | 116287-14-0 |  |
| Lanreotide | Tulane University | 108736-35-2 |  |
| Lansoprazole | Takeda | 103577-45-3 |  |
| Lanthanum carbonate | Rhone-Poulenc (Sanofi-Aventis) | 587-26-8 |  |
| Lapaquistat | Takeda Chemical Industries | 189060-13-7 |  |
| Lapatinib | GlaxoSmithKline (GSK) | 231277-92-2 ; 388082-78-8 |  |
| Lapisteride | Sankyo | 142139-60-4 |  |
| LAPULEUCEL-T | Dendreon | 845680-07-1 | No Structure |
| Laquinimod | Active Biotech (Sweden) | 248281-84-7 |  |
| Laromustine | Yale University | 173424-77-6 |  |
| Laronidase | Harbor Ucla Research & Education ; Biomarin | 210589-09-6 | No Structure |
| Laropiprant | Merck & Co | 571170-77-9 |  |
| Larotaxel | Rhone Poulenc Rorer (Sanofi-Aventis) | 156294-36-9 |  |
| LAS-186323 | | | No Structure |
| LAS-186368 | Almirall SA | | No Structure |
| LAS-187247 | Almirall SA | | No Structure |
| LAS-30538 | Almirall Prodesfarma | 145067-04-5 |  |
| LAS-34475 | Almirall-Prodesfarma | | No Structure |
| LAS-38096 | Almirall Prodesfarma S.A. (Spain) | |  |
| LAS-40369 | Almirall SA | | No Structure |
| LAS-40464 (Aclidinium bromide & Formoterol) | Almirall SA | 320345-99-1 (Aclidinium bromide) ; 73573-87-2 (Formoterol) |  |
| LAS-41001 | Almirall SA | | No Structure |
| LAS-41002 | | | No Structure |
| LAS-41003 | | | No Structure |
| LAS-41004 | | | No Structure |
| LAS-41005 | | | No Structure |
| LAS-41007 | | | No Structure |
| Lasalocid A | Hoffmann La Roche (Roche) | 25999-31-9 |  |
| Lasinavir | Vertex | 175385-62-3 |  |
| Lasmiditan | Eli Lilly And Co. | 439239-90-4 |  |
| Lasofoxifene | Pfizer | 180915-93-9 |  |
| LASSBIO-294 | University of Maryland ; Universidade Federal do Rio de Janeiro | 314021-07-3 |  |
| LASSBio-468 | CNRS; Univ Federal do Rio de Janeiro | |  |
| LASSBio-772 | Universidade Federal Do Rio De Janeiro (Brazil) | |  |
| LASSBio-897 | Universidade Federal do Rio de Janeiro (Brazil) | |  |
| LASSBio-947 | Universidade Federal Do Rio De Janeiro (Brazil) | |  |
| LASSBio-998 | Universidade Federal Do Rio De Janeiro (Brazil) | |  |
| Latamoxef | Shionogi | 64952-97-2 |  |
| Latanoprost | Pharmacia | 130209-82-4 |  |
| Latrepirdine | Medivation | 3613-73-8 ; 12687-54-6 (hydrochloride) ; 97657-92-6\n(dihydrochloride) |  |
| Laurocapram | Nelson | 59227-89-3 |  |
| Lauroguadine | Farmitalia Carlo Erba (Pharmacia) | 135-43-3 |  |
| Laurolinium acetate | Allen & Hanburys (GSK) | 146-37-2 |  |
| Lavendustin | | 133530-35-5 |  |
| Lawsone | | 83-72-7 |  |
| LAX-101 | Laxdale (Amarin) | |  |
| Lazabemide | Hoffmann La Roche (Roche) | 103878-84-8 |  |
| LB-10522 | Lucky | 162706-10-7 |  |
| LB-10827 | LG Chemical | 250597-40-1 |  |
| LB-11058 | LG Life Science | 591207-81-7 |  |
| LB-152 | Taipei Medical University | |  |
| LB-18 | Osaka University | |  |
| LB-20222 | LG Chemical | 193534-06-4 |  |
| LB-20226 | LG Chemical | |  |
| LB-20277 | LG Chemical | |  |
| LB-30057 | LG Chemical | |  |
| LB-30812 | LG Life Sciences | |  |
| LB-30870 | LG Life Sciences | |  |
| LB-42908 | LG Chemical | |  |
| LB-50016 | Abbott | 228579-02-0 |  |
| LB-71116 | Lucky | 160742-41-6 |  |
| LB-71119 | Lucky | 160742-38-1 |  |
| LB-71350 | LG Chemical | 187083-08-5 |  |
| LBM-415 | Vicuron Pharmaceutical (Pfizer) | 700861-89-8 |  |
| LBW-242 | Novartis AG (Switzeland) ; Novartis Pharma GmbH (Austria) | |  |
| LBY-135 | Novartis AG | | No Structure |
| LC-1 | University of Kentucky | |  |
| LCB-2183 | Lipha (E. Merck KGaA) | 158454-08-1 |  |
| LCB-2853 | Lipha (E. Merck KGaA) | 141335-11-7 |  |
| LCB01-0371 | LegoChem Bioscience Inc. (South Korea) | |  |
| LCB01-577 | LegoChem Bioscience Ltd. | |  |
| LCI-699 | | | No Structure |
| LCI-765 | IRM | |  |
| LCL-161 | | | No Structure |
| LCL-204 | MUSC Foundation for Research Development | |  |
| LCM-1910 | SmithKline Beecham (GSK) | 144838-47-1 |  |
| LCQ-908 | | | No Structure |
| LCTA-1246 | Gause Institute of New Antibiotics (Russia) | |  |
| LCZ-696 | | |  |
| LD22-4 | Scripps Research Institute | | No Structure |
| LDK-733 | Novartis AG | |  |
| LDN-11230 | Harvard College, US ; Brigham and Women’s Hospital (US) | |  |
| LDN-112341 | Brigham and Women’s Hospital (US) ; Harvard Medical School | |  |
| LDN-193189 | The General Hospital Corp. (US) ; The Brigham and Women's Hospital Inc. (US) | 1062368-24-4 |  |
| LDN-57446 | Harvard College (US) | |  |
| LE-EK06 | University of Jena ; University of Panjab | |  |
| LE-SN38 (SN-38) | Tanabe Seiyaku | 86639-52-3 |  |
| Leakadin | Latvian Institute of Organic Synthesis | 91433-16-8 |  |
| Lebrikizumab | | 953400-68-5 | No Structure |
| Lecimibide | DuPont Merck (BMS) | 130804-35-2 |  |
| Leconotide | University of Queensland | 483328-93-4 |  |
| Lecozotan | Wyeth | 434283-16-6\n433282-68-9 (HCl) |  |
| Ledoxantrone | Warner Lambert (Pfizer) | 113457-05-9 |  |
| LEE-011 | Astex Therapeutics Ltd. | | No Structure |
| Lefetamine | Res. Found. for Practical Life | 7262-75-1 |  |
| Leflunomide | Hoechst Marion Roussel (Sanofi-Aventis) | 75706-12-6 |  |
| Lefradafiban | Thomae (Boehringer Ingelheim) | 149503-79-7 |  |
| LEK-8804 | LEK tovarna farmacevtskih (Slovenia) ; Respiratorius AB (Swed) | 153415-44-2 |  |
| Lemildipine | Banyu | 125729-29-5 |  |
| Leminoprazole | Nippon Chemiphar | 104340-86-5 |  |
| Lemuteporfin | University of British Colombia | 215808-49-4 |  |
| Lenacil | DuPont | 2164-08-1 |  |
| Lenalidomide | Celgene | 191732-72-6 |  |
| Lenampicillin | Kanebo | 86273-18-9 |  |
| Lenapenem | Banyu | 149951-16-6 |  |
| Lenograstim | Chugai (Roche) | 135968-09-1 | No Structure |
| Lensiprazine | Solvay Pharmaceuticals | 327026-93-7 |  |
| Lentinan | Ajinomoto | 37339-90-5 |  |
| Lenvatinib | Eisai | 417716-92-8 ; 857890-39-2 (mesylate) |  |
| LEO-22811 | | | No Structure |
| LEO-27847 | | | No Structure |
| LEO-29102 | | | No Structure |
| Leo-80190 | Leo Pharmaceutical Products | |  |
| LEO-90100 | Leo Pharma AS | | No Structure |
| LEP-ETU (liposom formulation of Paclitaxel) | University of Georgetown | |  |
| Lepimectin | Sankyo | 171249-10-8 (6'-methyl)\n171249-05-1 (6'-ethyl) |  |
| Lepirudin | Hoechst (Sanofi-Aventis) | 138068-37-8 |  |
| Leptocillin | Meiji Seika ; Mitsubishi Kasei | 123949-57-5 |  |
| LEQ-506 | | | No Structure |
| Lercanidipine | Recordati | 100427-26-7 |  |
| Lercanidipine & Enalapril | | 100427-26-7 (Lercanidipine) ; 75847-73-3 (Enalapril) |  |
| Lerdelimumab | Cambridge Antibody Technology | 285985-06-0 | No Structure |
| Leridistim | Pharmacia | 193700-51-5 | No Structure |
| Lerisetron | Espanola Productos Quimicos (FAES) | 143257-98-1 |  |
| Lersivirine | Pfizer | 473921-12-9 |  |
| Lesinurad | Ardea Biosciences | 1151516-14-1 |  |
| Lesogaberan | AstraZeneca AB (Sweden) | 805251-29-0 |  |
| Lesopitron | Esteve | 132449-46-8 |  |
| Lestaurtinib | Kyowa Hakko | 111358-88-4 |  |
| Letaxaban | Takeda Pharmaceutical Co. Ltd. | 870262-90-1 |  |
| Leteprinim | Neo Therapeutics (Spectrum Pharmaceuticals) | 138117-50-7 |  |
| Letosteine | Ferlux | 53943-88-7 |  |
| Letrazuril | Janssen Pharmaceutica (Johnson & Johnson) | 103337-74-2 |  |
| Letrozole | Ciba-Geigy (Novartis) | 112809-51-5 |  |
| Leu-Gly-Floxuridine | TSRL (Therapeutic Systems Research Laboratories) | |  |
| Leu13-motilin acetate | Kyowa Hakko | 59530-69-7 |  |
| Leucocianidol | UPSA | 480-17-1 |  |
| Leuprorelin | Takeda | 74381-53-6 |  |
| Leurubicin | Inst. International de Pathologie Cellulaire ; University of Louvain | 70774-25-3 |  |
| Levacetylmethadol | National Inst. for Drug Abuse | 509-74-0 |  |
| Levalbuterol | Allen & Hanburys (GSK) | 34391-04-3 ;661464-94-4 (Levalbuterol tartrate) |  |
| Levamisole | Janssen Pharmaceutica (Johnson & Johnson) | 14769-73-4 |  |
| Levcromakalim | Beecham (GSK) | 94535-50-9 |  |
| Levcycloserine | California University | 339-72-0 |  |
| Levetiracetam | UCB | 102767-28-2 |  |
| Levobetaxolol | Synthelabo (Sanofi-Aventis) | 93221-48-8 |  |
| Levobunolol | Warner Lambert (Pfizer) | 47141-42-4 |  |
| Levobupivacaine | Sterling Drug (Sanofi-Aventis) | 27262-47-1 |  |
| Levocabastine | Janssen Pharmaceutica (Johnson & Johnson) | 79547-78-7 |  |
| Levocarnitine | | 541-15-1 |  |
| Levocarnitine acetate | | 14992-62-2 |  |
| Levocetirizine | UCB | 130018-77-8 ; 130018-87-0 (dihydrochloride salt) |  |
| Levocloperastine | Esculapius Farma (Italia) | 132301-89-4 |  |
| Levocloperastine fendizoate | | 220329-19-1 |  |
| Levodopa | Merck & Co. | 59-92-7 |  |
| Levodopa methyl | Chiesi Farmaceutici | 7101-51-1 |  |
| Levodropropizine | Dompe | 99291-25-5 |  |
| Levofloxacin | Daiichi | 100986-85-4 |  |
| Levofolinic acid | | 80433-71-2 (calcium) |  |
| Levoglucose | Hershey Foods Corporation | 921-60-8 |  |
| Levolansoprazole | Astra AB (AstraZeneca) | 138530-95-7 |  |
| Levomefolic acid | | 31690-09-2 ; 151533-22-1 (calcium salt) |  |
| Levomenol | Kuraray | 23089-26-1 |  |
| Levomenthol | | 2216-51-5 |  |
| Levomepromazine | Rhone-Poulenc (Aventis) | 60-99-1 ; 4185-80-2 (hydrochloride) ; 7104-38-3 (maleate) |  |
| Levomequitazine | Pharmuka Laboratories (France) | 88598-74-7 |  |
| Levomethadone | Hoechst (Sanofi-Aventis) | 125-58-6 |  |
| Levomilnacipran | PF Medicament (France) | 96847-55-1 |  |
| Levomoprolol | ICI (AstraZeneca) | 77164-20-6 |  |
| Levonadifloxacin | Wockhardt | 154357-42-3 |  |
| Levonebivolol | Janssen Pharmaceutica (Johnson & Johnson) | 118457-16-2 |  |
| Levonorgestrel | Hoffmann La Roche (Roche) | 797-63-7 |  |
| Levopropicillin | Eli Lilly | 3736-12-7 |  |
| Levopropoxyphen | Eli Lilly | 2338-37-6 |  |
| Levormeloxifene | Council Scient Ind Res | 78994-23-7 |  |
| Levorphanol | Hoffmann La Roche (Roche) | 77-07-6 |  |
| Levosemotiadil | Santen | 116476-16-5 |  |
| Levosimendan | Orion | 141505-33-1 |  |
| Levosulpiride | Ravizza | 23672-07-3 |  |
| Levothyroxine | Hoechst (Sanofi-Aventis) | 51-48-9 |  |
| levotofisopam | Vela Pharmaceuticals | 82059-51-6 |  |
| Levoverapamil | Knoll (Abbott) | |  |
| Levovirin | ICN Pharmaceuticals (Valeant) | 206269-27-4 |  |
| Lexacalcitol | Leo Pharmaceutical | 131875-08-6 |  |
| Lexatumumab | | 845816-02-6 | No Structure |
| Lexgenleucel-T | VIRxSYS Corporation | | No Structure |
| Lexipafant | British Biotech (Vernalis) | 139133-26-9 |  |
| LF-22-0542 | Fournier | |  |
| LFM-A12 | Parker Hughes Inst. | 139442-47-0 |  |
| LFM-A13 | Parker Hughes Inst. ; The Mathilda & Terence Kennedy Inst. of Rheumatology | 244240-24-2 |  |
| LG-101392 | Ligand | |  |
| LG-101506 | Ligand | |  |
| LG-120794 | Ligand Pharmaceuticals | 179895-52-4 |  |
| LG-120838 | Ligand Pharmaceuticals | |  |
| LG-120920 | Ligand Pharmaceuticals | |  |
| LG-190178 | Ligand Pharmaceuticals Inc. | 233268-81-0 |  |
| LG-5460 | | | No Structure |
| LG-6102 | Laevosan | 132798-30-2 (HCl) |  |
| LGD-1550 | Ligand Pharmaceuticals | 178600-20-9 |  |
| LGD-2226 | Ligand Pharmaceuticals Inc. | 432493-87-3 |  |
| LGD-2941 | Ligand Pharmaceuticals Inc. | |  |
| LGD-3303 | Ligand Pharmaceuticals Inc. (US) | |  |
| LGD-4033 | | | No Structure |
| Liarozole | Janssen Pharmaceutica (Johnson & Johnson) | 115575-11-6 |  |
| Libivirumab | XTL Biopharmaceuticals | 569658-79-3 | No Structure |
| Licarbazepine | Geigy (Novartis) | 29331-92-8 |  |
| Licofelone | Merckle | 156897-06-2 |  |
| Licofelone choline | C-A-I-R Biosciences GmbH | |  |
| Licostinel | Oregon University ; California University | 153504-81-5 |  |
| Lidamidine | Rorer (Aventis) | 66871-56-5 |  |
| Lidanserin | Schering AG | 73725-85-6 |  |
| Lidocaine | Astra (AstraZeneca) | 137-58-6 |  |
| Lidoflazine | Janssen Pharmaceutica (Johnson & Johnson) | 3416-26-0 |  |
| Lidorestat | The Institute for Pharmaceutical Discovery (US) | 245116-90-9 |  |
| LIF-247 | | | No Structure |
| Lifarizine | Synte | 119514-66-8 |  |
| Lifibrol | Klinge (Fujisawa) | 96609-16-4 |  |
| Lificiguat | Yung Shin Pharma | 170632-47-0 |  |
| Limaprost | Ono Pharmaceutical | 74397-12-9 |  |
| Limazocic | Santen | 128620-82-6 |  |
| Limonin | | 1180-71-8 ; 1392-24-1 |  |
| Linaclotide | Microbia, Inc. (Ironwood Pharmaceuticals) | 851199-59-2 |  |
| Linagliptin | Boehringer Ingelheim Pharma | 668270-12-0 |  |
| Linalool | Idemitsu Kosan (Japan) | 78-70-6 |  |
| Linaprazan | Astrazeneca AB. (Sweden) | 248919-64-4 |  |
| Linazolast | Terumo | 110501-66-1 |  |
| Lincomycin | Upjohn (Pharmacia) | 154-21-2 |  |
| Lindane | ICI | 58-89-9 |  |
| Linetastine | Hokuriku | 159776-68-8 |  |
| Linezolid | Upjohn (Pharmacia) | 165800-03-3 |  |
| Lingshuiol | Chinese Academy of Sciences | |  |
| Linifanib | Abbott | 796967-16-3 |  |
| Linopirdine | DuPont Merck (BMS) | 105431-72-9 |  |
| Linopristin | Aventis (Sanofi-Aventis) | 325965-23-9 |  |
| Linotroban | CL Pharma | 120824-08-0 |  |
| Linsidomine | Casella (Aventis) | 33876-97-0 |  |
| Linsitinib | OSI Pharmaceuticals | 867160-71-2 |  |
| Lintitript | Sanofi (Sanofi-Aventis) | 136381-85-6 |  |
| Lintopride | Societe d'Etudes Scientifiques et Industrielles de l'Ile-de-France | 107429-63-0 |  |
| Lintuzumab | Protein Design Labs | 166089-32-3 | No Structure |
| Linuron | Hoechst (Sanofi-Aventis) | 330-55-2 |  |
| Liothyronine | Nat Res Dev | 6893-02-3 |  |
| LiPlaCis (Cisplatin) | LiPlasome Pharma AS (Denmark) | |  |
| Lipoplatin (Cisplatin) | Regulon Inc. | |  |
| Liposome-encapsulated OGG1 | | | No Structure |
| Lipoxin A | Brigham & Womens Hospital | 89663-86-5 |  |
| Liprostin (liposome encapsulated Alprostadil) | Endovasc | |  |
| Liprotamase | Altus Pharmaceuticals ; Cystic Fibrosis Foundation Therapeutics (CFFT) | 884502-91-4 | No Structure |
| Lipsovir (Aciclovir & Hydrocortisone) | Medivir | 439279-66-0 |  |
| Liquiritigenin | Bionovo | 41680-09-5 (racemic) ; 578-86-9 (S enantiomer) |  |
| Liraglutide | Scios | 204656-20-2 |  |
| Liranaftate | Tosoh | 88678-31-3 |  |
| Lirequinil | Hoffmann La Roche (Roche) | 143943-73-1 |  |
| Lirexapride | Logeais | 145414-12-6 |  |
| Lirimilast | Bayer | 329306-27-6 |  |
| Lisdexamfetamine | New River Pharmaceuticals (Shire PLC) | 608137-33-3 (Mesylate) |  |
| Lisinopril | Merck & Co. | 76547-98-3 |  |
| Lisofylline | Cell Therapeutics | 100324-81-0 |  |
| Lithium carbonate | | 554-13-2 |  |
| Lithium perfluorooctane sulfonate | | 29457-72-5 |  |
| Litomeglovir | Bayer AG (Germany) | 321915-31-5 |  |
| Litoxetine | Synthelabo (Sanofi-Aventis) | 86811-09-8 |  |
| Litronesib | Kyowa Hakko Kogyo (Japan) ; Fujifilm Corp. (Japan) | 910634-41-2 |  |
| Lixisenatide | Zealand Pharma AS. (Denmark) | 320367-13-3 |  |
| Lixisenatide & Insulin glargine | | 320367-13-3 (Lixisenatide) ; 160337-95-1 (Insulin glargine) | No Structure |
| Lixivaptan | American Cyanamid (Wyeth) | 168079-32-1 |  |
| LJ-529 | Ewha Womans University (Korea) ; US Government | |  |
| LJC-11036 | Lederle (Wyeth) | 161715-21-5 |  |
| LJP-1207 | La Jolla Pharmaceutical | 65814-30-4 |  |
| LJP-1406 | La Jolla | |  |
| LJP-1586 | La Jolla Pharmaceutical Co. (US) | |  |
| LK-121 | University of Minnesota (US) | |  |
| LK-157 | Lek Pharmaceuticals dd (Slovenia) | |  |
| LK-732 | Univerza V Ljubljani ; Lek Tovarna Farmacevtskih (Slovenia) | |  |
| LK-9140 | Lek Pharmaceuticals D.D. (Slovenia) | |  |
| LL-15 | Salamanca University | |  |
| LL-Z-1640-2 | Sandoz | 66018-38-0 |  |
| LLP2A-Cy5.5 | University of California (US) | |  |
| LM-1669 | Menarini | |  |
| LM-3339 | Lipha (E. Merck KGaA) | 157987-31-0 |  |
| LM-4108 | Vanderbilt University | |  |
| LM-4777 | Vanderbilt University (US) | |  |
| Lm-LLO-PSA | Advaxis Inc. (US) | | No Structure |
| LMV-601 | Shogoo Pharmaceuticals AG (Lumavita AG) | 1096687-52-3 |  |
| LN-1-255 | Research Corporation Technologies | |  |
| LNP-509 | ADIR (Servier) | 341501-92-6 (HCl) |  |
| LNP-911 | Universite Louis Pasteur | |  |
| LNS-5310 | | | No Structure |
| Lo Loestrin Fe | Warner Chilcott plc | |  |
| Lobaplatin | Asta Medica (Aeterna Zentaris) | 135558-11-1 |  |
| Lobeglitazone | Chong Kun Dang Pharm (Korea) | 607723-33-1 |  |
| Lobeline | Dynagen | 90-69-7 |  |
| Lobendazole | SmithKline French (GSK) | 6306-71-4 |  |
| Lobenzarit | Chugai (Roche) | 63329-53-3 |  |
| Lobucavir | Squibb (BMS) | 127759-89-1 |  |
| Locteron | Biolex Therapeutics Inc. | | No Structure |
| Lodaxaprine | Sanofi (Sanofi-Aventis) | 93181-81-8 |  |
| Lodenafil | Cristalia (Brazil) | 398507-55-6 |  |
| Lodenosine | US Department of Health & Human Services | 110143-10-7 |  |
| Lodoxamide tromethamine | Allergan Pharma | 63610-09-3 |  |
| Lofepramine | Leo | 23047-25-8 |  |
| Lofexidine | Nordmark | 31036-80-3 |  |
| Loflucarban | Madan | 790-69-2 |  |
| Lomefloxacin | Hokuriku | 98079-51-7 |  |
| Lomeguatrib | Cancer Research Campaign Technology | 192441-08-0 |  |
| Lomerizine | Kanebo | 101477-55-8 |  |
| Lometrexol | University of Princeton | 106400-81-1 |  |
| Lomifylline | Chemische Werke Albert (Kalle Albert) | 10226-54-7 |  |
| Lomitapide | BMS | 182431-12-5 ; 202914-84-9 (mesylate salt) |  |
| Lomustine | Rhone-Poulenc (Aventis) | 13010-47-4 |  |
| Lonafarnib | Schering (Merck & Co) | 193275-84-2 |  |
| Lonaprisan | Schering AG (Bayer Schering) | 211254-73-8 |  |
| Lonazolac | Byk Gulden (Nycomed) | 53808-88-1 |  |
| Lonidamine | Angelini | 50264-69-2 |  |
| Loperamide | Janssen Pharmaceutica (Johnson & Johnson) | 53179-11-6 |  |
| Loperamide oxide | Janssen Pharmaceutica (Johnson & Johnson) | 106900-12-3 |  |
| Lopinavir | Abbott | 192725-17-0 |  |
| Loprazolam | Roussel-Uclaf (Aventis) | 61197-73-7 |  |
| LOR-2040 | Lorus Therapeutics | | No Structure |
| LOR-253 | Lorus Therapeutics Inc. (Canada) | |  |
| Loracarbef | Kyowa Hakko | 76470-66-1 |  |
| Loratadine | Schering Corp (Merck & Co) | 79794-75-5 |  |
| Lorazepam | American Home Products (Wyeth) | 846-49-1 |  |
| Lorcainide | Janssen Pharmaceutica (Johnson & Johnson) | 59729-31-6 |  |
| Lorcaserin | Arena Pharmaceuticals | 616202-92-7 ; 846589-98-8 (Hydrochloride) |  |
| Loreclezole | Janssen Pharmaceutica (Johnson & Johnson) | 117857-45-1 |  |
| Lorglumide | RottaPharm/Madeus | 97964-56-2 |  |
| Lormetazepam | American Home Products (Wyeth) | 848-75-9 |  |
| Lornoxicam | Hoffmann La Roche (Roche) | 70374-39-9 |  |
| lorvotuzumab mertansine | ImmunogGen | 1008106-64-6 |  |
| Losartan | DuPont Merck (BMS) | 114798-26-4 |  |
| Losigamone | Schwabe Willmar | 112856-44-7 |  |
| Losmapimod | Smithkline Beecham Corp. (GlaxoSmithKline plc) | 585543-15-3 |  |
| Losoxantrone | Warner Lambert (Pfizer) | 88303-60-0 |  |
| Loteprednol | OTSUKA PHARMACEUTical | 82034-46-6 |  |
| Loteprednol & Tobramycin | Bausch Lomb (US) | |  |
| Lotilibcin | | 169148-84-9 |  |
| Lotrafiban | SmithKline Beecham (GSK) | 171049-14-2 |  |
| Lotrafilcon B | Ciba Vision Corporation | 203170-33-3 | No Structure |
| Lotrifen | Lepetit | 66535-86-2 |  |
| Lovastatin | Merck & Co. | 75330-75-5 |  |
| Lovaxin C | University of Pennsylvania | | No Structure |
| Loviride | Janssen Pharmaceutica (Johnson & Johnson) | 147362-57-0 |  |
| Loxapine | American Cyanamid (Wyeth) | 1977-10-2 |  |
| Loxiglumide | Rotta | 107097-80-3 |  |
| Loxoprofen | Sankyo (Daiichi-Sankyo) | 68767-14-6 |  |
| LP-261 | Locus Pharmaceuticals ; | | No Structure |
| LP-661438 | Lexicon Pharmaceuticals Inc. (US) | |  |
| LP-805 | Pola | 129909-32-6 |  |
| LPBNAH | TS Pharma ; Universite d'Avignon (France) | |  |
| LPCN-1002 | | | No Structure |
| LPCN-1012 | | | No Structure |
| LPCN-1018 (Ziprasidone) | Lipocine Inc. | 146939-27-7 |  |
| LPCN-1021 (Testosterone) | Lipocine Inc. | 58-22-0 |  |
| LPCN-1035 | | | No Structure |
| LPCN-1084 | | | No Structure |
| LPCN-1090 | Lipocine Inc. | | No Structure |
| LPCN-1098 | | | No Structure |
| LPCN-1105 | | | No Structure |
| LPD-343 | Lipideon Biotechnology AG | |  |
| LPD-608 | Lipideon Biotechnology AG | | No Structure |
| LPK-26 | Chinese Academy of Sciences (China) | 492451-07-7 (hydrochloride salt) |  |
| LPM Leuprolide (Leuprorelin) | DOR Biopharma Inc. (Soligenix Inc.) | 74381-53-6 |  |
| LPV-OMP | Abbott Laboratories (US) | |  |
| LR-33 | Hope City | |  |
| LR-90 | Lipha (E. Merck KGaA) | 255718-36-6 |  |
| LR-D-009 | Menarini | 197069-90-2 (HCl) |  |
| LRN-281 | Largren Ltd. | | No Structure |
| LRN-672 | Largren Ltd. | | No Structure |
| LRN-884 | Largren Ltd. | | No Structure |
| LS-104 | | | No Structure |
| LS-80707 | Rhone-Poulenc | 90936-96-2 |  |
| LSN-2120310 | Eli Lilly | |  |
| LSN-2434074 | Eli Lilly | |  |
| LSP-1-2111 | Centre National de la Recherche Scientifique (France) | |  |
| LT-00786 | LEAD Therapeutics Inc. (BioMarin Pharmaceutical Inc.) | |  |
| LT-1951 | Lumen Therapeutics | | No Structure |
| LTX-109 | Lytix Biopharma | |  |
| LTX-200 | Lytix Biopharma AS | | No Structure |
| LTX-302 | Lytix Biopharma AS | |  |
| LTX-315 | Lytix Biopharma AS | |  |
| LU-02-750 | | | No Structure |
| Lu-177-DOTATATE | BioSynthema Inc. | |  |
| LU-224332 | BASF (Abbott) | |  |
| LU-26042 | Lundbeck | 139773-28-7 |  |
| Lu-32-176B | Lundbeck | |  |
| LU-35138 | Lundbeck | |  |
| LU-73068 | Lundbeck ; Abbott | 164329-75-3 |  |
| LU-AA-21004 | H. Lundbeck AS (Denmark) | 508233-74-7 |  |
| Lu-AA-24530 | | | No Structure |
| Lu-AA-34893 | Lundbeck | | No Structure |
| Lu-AA33810 | Synaptic Pharma Corp. (H. Lundbeck AS) (Denmark) | |  |
| LU-AA38466 | H. Lundbeck A/S | | No Structure |
| LU-AA39959 | H. Lundbeck A/S | | No Structure |
| Lu-AA47070 | | | No Structure |
| Lu-AE-00654 | H. Lundbeck A/S | |  |
| LU-AE04621 | | | No Structure |
| Lu-AE51090 | H. Lundbeck AS | |  |
| Lu-AE58054 | Eli Lilly | |  |
| LU-AF11167 | | | No Structure |
| Lu-AMBA | Bracco Imaging | |  |
| Lubazodone | Yamanouchi (Astellas) | 161178-10-5 |  |
| Lubeluzole | Janssen Pharmaceutica (Johnson & Johnson) | 144665-07-6 |  |
| Lubiprostone | Ueno Seiyaku Oyo Kenkyujo | 136790-76-6 |  |
| Lucanthone | | 548-57-2 |  |
| Lucatumumab | Chiron (Novartis) | 903512-50-5 | No Structure |
| LUF-5417 | University of Leiden ; University of Vrije | 331472-31-2 |  |
| LUF-5437 | University of Leiden ; University of Vrije | 331472-34-5 |  |
| LUF-5735 | University of Leiden | |  |
| LUF-5771 | Leiden University (Netherlands) | |  |
| LUF-5942 | University of Leiden | |  |
| LUF-5962 | Leiden/Amsterdam Center for Drug Research (Netherlands) | |  |
| LUF-6000 | Leiden/Amsterdam Center for Drug Research (Netherlands) | |  |
| Lufenuron | Ciba-Geigy (Novartis) | 103055-07-8 |  |
| Luliconazole | Nihon Nohyaku | 187164-19-8 |  |
| Lumefantrine | Inst. of Microbiology & Epidemiology | 82186-77-4 |  |
| Lumiliximab | Idec Pharmaceuticals (Biogen Idec) | 357613-86-6 | No Structure |
| Luminacin D | Eisai | 251449-91-9 |  |
| Lumiracoxib | Novartis | 220991-20-8 ; 346610-74-4 |  |
| Lunacalcipol | Labaz | 37681-00-8 |  |
| Luprostiol | E. Merck KGaA | 67110-79-6 |  |
| Lurasidone | Sumitomo Pharmaceuticals (Dainippon Sumitomo) | 367514-87-2 |  |
| Lurosetron | Glaxo (GSK) | 128486-54-4 |  |
| Lurtotecan | Glaxo Inc. (GSK) | 149882-10-0 |  |
| Lusaperidone | Janssen Pharmaceutica (Johnson & Johnson) (Belgium) | 214548-46-6 |  |
| Lusupultide | Byk Gulden (Nycomed) | 200074-80-2 |  |
| Lutetium texaphyrin | Pharmacyclics ; University of Texas | 156436-90-7 |  |
| Lutropin Alfa | Serono | 152923-57-4 | No Structure |
| LX-1031 | | | No Structure |
| LX-2931 | Lexicon Genetics Inc. (Lexicon Pharmaceuticals Inc.) | |  |
| LX-4211 | Lexicon Pharmaceuticals | |  |
| LX-6171 | Lexicon Pharmaceuticals | | No Structure |
| LX-7101 | Lexicon Pharmaceuticals | | No Structure |
| LXM-10 | Pekin University (China) | |  |
| LXR-1035 | LXR Biotechnology | 213738-69-3 |  |
| LXS-4-HPR (Fenretinide) | Yesair David | |  |
| LY-042826 | Eli Lilly | |  |
| LY-117018 | Eli Lilly | 63676-25-5 |  |
| LY-150310 | Eli Lilly | 103294-48-0 (HNO3) |  |
| LY-156735 | Eli Lilly | 118702-11-7 |  |
| LY-181837 | Eli Lilly | |  |
| LY-181984 | Eli Lilly | 3955-50-8 |  |
| LY-2033298 | Eli Lilly & Co. (US) | |  |
| LY-203647 | Eli Lilly | 122009-61-4 |  |
| LY-2059346 | Eli Lilly | |  |
| LY-2066948 | Eli Lilly | |  |
| LY-207702 | Eli Lilly | 156130-57-3 |  |
| LY-2090314 | Eli Lilly & Co. | |  |
| LY-2108491 | Eli Lilly | |  |
| LY-2109761 | Eli Lilly | |  |
| LY-2109866 | Eli Lilly | |  |
| LY-2121260 | Eli Lilly | |  |
| LY-2127399 | | | No Structure |
| LY-213024 | Eli Lilly | 117423-95-7 |  |
| LY-215490 | Eli Lilly | 150131-78-5 |  |
| LY-2157299 | Eli Lilly | |  |
| LY-2228820 | Eli Lilly | |  |
| LY-2275796 | Isis Pharmaceuticals Inc. (US) ; Eli Lilly & Co. (US) | | No Structure |
| LY-228729 | Eli Lilly | 115994-31-5 |  |
| LY-233053 | Eli Lilly | 125546-04-5 |  |
| LY-235723 | Eli Lilly | 142923-40-8 |  |
| LY-235959 | | 137433-06-8 |  |
| LY-2401401 | Eli Lilly & Co. (US) | |  |
| LY-2405319 | Eli Lilly | | No Structure |
| LY-2463665 | Eli Lilly & Co. (US) | |  |
| LY-246701 | Eli Lilly | 142121-60-0 |  |
| LY-255283 | Eli Lilly | 117690-79-6 |  |
| LY-2584702 | Eli Lilly & Co. | | No Structure |
| LY-2599506 | OSI Pharmaceuticals Inc. (US) | | No Structure |
| LY-2606368 | Eli Lilly & Co. | | No Structure |
| LY-2624587 | | | No Structure |
| LY-266514 | Eli Lilly | 142121-56-0 |  |
| LY-267108 | Eli Lilly | 105882-69-7 |  |
| LY-269415 | Eli Lilly | 132392-65-5 |  |
| LY-274600 | Eli Lilly | 132873-35-9 |  |
| LY-2780301 | | | No Structure |
| LY-2784544 | Eli Lilly & Co. | 1229236-86-5 |  |
| LY-2801653 | | | No Structure |
| LY-281389 | Eli Lilly | 119904-03-9 |  |
| LY-287192 | Eli Lilly | 138786-63-7 |  |
| LY-2874455 | | | No Structure |
| LY-2886721 | Eli Lilly & Co. | |  |
| LY-289612 | Eli Lilly | 148314-61-8 |  |
| LY-290154 | Eli Lilly | 140639-61-8 |  |
| LY-290181 | Angiotech Pharma | |  |
| LY-293284 | Eli Lilly | 141318-62-9 |  |
| LY-294002 | Lilly | 154447-36-6 |  |
| LY-2940680 | | | No Structure |
| LY-296416 | Eli Lilly | |  |
| LY-302679 | Eli Lilly | |  |
| LY-309887 | Eli Lilly | 127228-54-0 |  |
| LY-311912 | Eli Lilly | |  |
| LY-314177 | Eli Lilly | 199291-57-1 |  |
| LY-315902 | Eli Lilly | 176435-10-2 | No Structure |
| LY-320135 | Eli Lilly | |  |
| LY-32262 | Lilly | |  |
| LY-329146 | Eli Lilly | 191043-78-4 |  |
| LY-329201 | Univ. Princeton ; Eli Lilly | |  |
| LY-33169 | Eli Lilly | 477844-47-6 |  |
| LY-334370 | Eli Lilly | 182563-08-2 |  |
| LY-335518 | Lilly | |  |
| LY-338387 | Eli Lilly | 185902-61-8 |  |
| LY-343814 | Eli Lilly | 208103-05-3 |  |
| LY-344545 | Eli Lilly | 201851-20-9 |  |
| LY-349950 | Eli Lilly | |  |
| LY-353433 | Eli Lilly | 176390-32-2 |  |
| LY-354400 | Eli Lilly | |  |
| LY-366094 | Eli Lilly | 200564-93-8 |  |
| LY-366853 | Lilly | 200564-92-7 |  |
| LY-367265 | Eli Lilly | 210751-39-6 |  |
| LY-367366 | Eli Lilly | |  |
| LY-367385 | Eli Lilly | |  |
| LY-368177 | Eli Lilly | |  |
| LY-377604 | Eli Lilly | |  |
| LY-379268 | Eli Lilly | 191471-52-0 |  |
| LY-382884 | Eli Lilly | 211566-75-5 |  |
| LY-389795 | Eli Lilly | |  |
| LY-392098 | Eli Lilly | 211311-66-9 |  |
| LY-393613 | Eli Lilly | 334826-64-1 (HCl) |  |
| LY-393615 | Eli Lilly | |  |
| LY-402913 | Eli Lilly | 334970-65-9 |  |
| LY-404039 | Eli Lilly | 635318-11-5 |  |
| LY-404040 | Eli Lilly | |  |
| LY-404187 | Eli Lilly | 211311-95-4 |  |
| LY-411575 | Elan Pharmaceuticals ; Ely Lilly | |  |
| LY-418094 | Eli Lilly | |  |
| LY-418426 | Eli Lilly | 296231-81-7 |  |
| LY-444711 | Eli Lilly | 220541-10-6 |  |
| LY-450108 | | | No Structure |
| LY-456066 | Eli Lilly | |  |
| LY-456219 | Eli Lilly | |  |
| LY-456220 | Eli Lilly | |  |
| LY-457691 | Eli Lilly | |  |
| LY-458545 | Eli Lilly | |  |
| LY-459477 | Eli Lilly | |  |
| LY-465608 | Ligand ; Eli Lilly | |  |
| LY-466195 | Eli Lilly | |  |
| LY-466195 diethyl ester | Eli Lilly | |  |
| LY-467711 | Eli Lilly | |  |
| LY-479754 | Eli Lilly | |  |
| LY-487355 | Eli Lilly | |  |
| LY-487379 | Eli Lilly | |  |
| LY-503429 | Eli Lilly | |  |
| LY-503430 | Lilly | |  |
| LY-50886 | Eli Lilly | 353229-45-5 |  |
| LY-510929 | Ligand ; Eli Lilly | |  |
| LY-517717 | Lilly Co Eli | |  |
| LY-518674 | Eli Lilly | |  |
| LY-525327 | Eli Lilly | |  |
| LY-53857 | Eli Lilly | 60634-51-7 |  |
| LY-686017 | Eli Lilly & Co. (US) | |  |
| Lycopene | Bayer AG | 502-65-8 |  |
| Lymecycline | Carlo Erba | 992-21-2 |  |
| Lynestrenol | Organon (Schering Merck & Co) | 52-76-6 |  |
| [Lys4,Leu17,Met(O)30,Gln34]-hPP | 7TM Pharma AS (Denmark) | |  |
| Lysostaphin | Ambi | 9011-93-2 | No Structure |
| M-0002 | Ortho McNeil (Johnson & Johnson) | |  |
| M-0003 | Janssen Pharmaceutica NV (Johnson & Johnson Inc.) | |  |
| M-0004 | Janssen Pharmaceutica NV (Johnson & Johnson Inc.) | |  |
| M-0012 | Movetis NV | | No Structure |
| M-0014 | Movetis NV | | No Structure |
| M-19791 | Upjohn (Pharmacia) | 99570-57-7 |  |
| M-2000 | Westfalische Wilhelms Universitat Munster | |  |
| M-21 | Wyeth Corp. (US) | |  |
| M-216765 | ICI (AstraZeneca) | |  |
| M-241247 | ICI (AstraZeneca) | |  |
| M-344 | Alcon | |  |
| M-368100 | AstraZeneca | |  |
| M-402 | Momenta Pharmaceuticals Inc. (US) | | No Structure |
| M-40401 | Monsanto (Pharmacia) | 218791-28-7 |  |
| M-40419 | MetaPhore Pharmaceuticals (ActivBiotics) ; Searle (Pfizer) | |  |
| M-43068 | Mochida | |  |
| M-5011 | Toyama | 76604-64-3 |  |
| M-50367 | Mochida | 201411-46-3 |  |
| M-55190 | Mochida | |  |
| M-55529 | Mochida Pharmaceutical | |  |
| M-55551 | Mochida | 229646-76-8 |  |
| M-58373 | Mochida Pharmaceutical | |  |
| M-58539 | Mochida Pharmaceutical | |  |
| M-58996 | Mochida Pharmaceutical | |  |
| M-62812 | Mochida Pharmaceutical Co. Ltd. (Japan) | |  |
| M-HA | Mukogawa Women's University ; University of Yokohama | 475598-45-9 |  |
| M-HA-Ac | Mukogawa Women's University ; University of Yokohama | 543725-85-5 |  |
| M01ZH09 | Microscience | | No Structure |
| M2e-HBc | Vlaams Interuniversitair Instituut voor Biotechnologie (Belgium) | | No Structure |
| M2e-NP-ISS | Dynavax Technologies Corp. (US) | | No Structure |
| M3A6S | University of Kentucky | 175479-21-7 |  |
| M6P (Mannose-6-phosphate) | BTG International Ltd. (GB) | 3672-15-9 |  |
| M87o | Vision 7 GmbH ; Chemotherapeutisches Forschunginstitut (Germany) | | No Structure |
| m8B5R-let7a-LG | Hokkaido Technology Licensing Office Co. Ltd. (Japan) | | No Structure |
| MA-342 | Svenska Lantmaennen Riksfoerbu | | No Structure |
| mAb 7A6 | Beth Israel Hospital (US) | | No Structure |
| MAb 9G11 | Medarex | | No Structure |
| mAb F8-33 | Yissum Research Development Company of the Hebrew University of Jerusalem | | No Structure |
| MAb I-HH-I-KC | Glycart Biotechnology AG | | No Structure |
| MAb mu-anti-LUCA2 | Raven Biotechnologies | | No Structure |
| MAb PACA4 | Raven Biotechnologies | | No Structure |
| MAb SPL1 | Raven Biotechnologies | | No Structure |
| mAb-1.5.3 | Amgen Inc. (US) ; AstraZeneca AB (Sweden) | | No Structure |
| MAb-101F | Centocor | | No Structure |
| MAb-163.5 | Yale University | | No Structure |
| MAb-17C7 | University of Massachusetts ; Centers For Disease Control And Prevention | | No Structure |
| MABT-5102-A | AC Immune SA (Switzerland) | | No Structure |
| Mabuprofen | Calzada | 82821-47-4 |  |
| Mabuterol | Thomae (Boehringer Ingelheim) | 56341-08-3 |  |
| Macimorelin | Zentaris | 381231-18-1 |  |
| Macitentan | Actelion Pharmaceuticals Ltd. | 441798-33-0 |  |
| Maduramicin | Hoffmann LaRoche | 84878-61-5 |  |
| MAE-106 | Karlsruhe Forschzent | |  |
| MAE-87 | Karlsruhe Forschzent | |  |
| Mafenide | Winthrop (Sanofi-Synthelabo) | 138-39-6 |  |
| Mafoprazine | Tanabe | 80428-29-1 |  |
| Mafosfamide | Asta Medica | 88859-04-5 |  |
| MAG-283 | Florida University | 300578-84-1 |  |
| Magenta I | | 632-99-5 |  |
| Magnolol | Jumoku Chushutsu Seibun Ryo | 528-43-8 |  |
| Malachite Green | | 569-64-2 |  |
| Malathion | American Cyanamid (BASF) | 121-75-5 |  |
| Maleic hydrazide | US Rubber | 123-33-1 |  |
| Mallotochromene | Aichi Cancer Center | 98569-62-1 |  |
| Mallotojaponin | | 86828-07-1 |  |
| Malotilate | Nihon Nohyaku | 59937-28-9 |  |
| Maltolyl p-coumarate | Hanmi Pharmaceutical Co. Ltd. (South Korea) | |  |
| Managlinat dialanetil | Metabasis Therapeutics | 280782-97-0 |  |
| Mancozeb | Rohm & Haas | 8018-01-7 |  |
| Mandipropamid | Syngenta | 374726-62-2 |  |
| Mangafodipir | Salutar (Nycomed-Amersham) | 155319-91-8 |  |
| Manidipine | Takeda | 89226-50-6 |  |
| Manifaxine | Wellcome Foundation (GSK) | 135306-39-7 |  |
| Manitimus | Roussel-Uclaf (Sanofi-Aventis) | 185915-33-7 ; 202057-76-9 |  |
| Mannitol | | 69-65-8 |  |
| MAP0004 (Dihydroergotamine) | MAP Pharmaceuticals | 511-12-6 ; 6190-39-2 (Mesilate) |  |
| Mapatumumab | Human Genome Sciences | 658052-09-6 | No Structure |
| Mapinastine | Esteve | 140945-32-0 |  |
| Mapracorat | Bayer Schering Pharma AG (Germany) | 887375-26-0 |  |
| Maprotiline | Ciba (Novartis) | 10262-69-8 |  |
| Maraba MG1 | Ottawa Health Research Institute (Canada) | | No Structure |
| Maraciclatide 99mTc | GE Healthcare | 489427-17-0 |  |
| Maraviroc | Pfizer | 376348-65-1 |  |
| Marbofloxacin | Hoffmann La Roche (Roche) | 11550-35-1 |  |
| Maribavir | Glaxo-Wellcome (GSK) | 176161-24-3 |  |
| Marimastat | British Biotech | 154039-60-8 |  |
| Marinopyrrole A | University of California (US) | |  |
| Marizomib | University of California | 437742-34-2 |  |
| Marmelin | University of Oklahoma Health Sciences Center (US) ; Swaasth Inc. (US) ; Anna University (India) ; C | |  |
| Maropitant | Pfizer | 147116-67-4 ; 359875-09-5 |  |
| Marqibo (Vincristine) | Inex Pharmaceuticals | 57-22-7 |  |
| Masilukast | ICI (AstraZeneca) | 136564-68-6 |  |
| Masitinib | AB Science | 790299-79-5 |  |
| Masoprocol | Chemex | 27686-84-6 |  |
| Matuzumab | E. Merck GMBH | 339186-68-4 | No Structure |
| Mavacoxib | Searle & Co (Pfizer) | 170569-88-7 |  |
| Mavrilimumab | Cambridge Antibody Tech. ; Zenyth Operations Pty Ltd | 1085337-57-0 | No Structure |
| Maxacalcitol | Chugai (Roche) | 103909-75-7 |  |
| Maxy-VII | University of Minnesota ; Maxygen | | No Structure |
| MAZ-51 | Karlsruhe Forschzent | 163655-37-6 |  |
| Mazapertine | Ortho McNeil (Johnson & Johnson) | 134208-17-6 |  |
| Mazaticol | Tanabe | 42024-98-6 |  |
| Mazindol | Sandoz (Novartis) | 22232-71-9 |  |
| MB-007 | University of Iowa (US) | |  |
| MB-009 | University of Iowa (US) | |  |
| MB-07344 | Metabasis Therapeutics | |  |
| MB-07729 | Metabasis Therapeutics Inc. | |  |
| MB-07803 | Metabasis Therapeutics Inc. (US) | |  |
| MB-07811 | Metabasis Therapeutics | |  |
| MB-243 | Merck | |  |
| MB-7133 | Metabasis Therapeutics | 685111-92-6 |  |
| MBI-1396 | Micrologix (Migenix) | |  |
| MBL-HCV1 | University of Massachusetts (US) | | No Structure |
| MBP-104 | CNRS | |  |
| MBP-426 | Mebiopharm Co. Ltd. (Japan) | |  |
| MBX-037 | Microbiotix | |  |
| MBX-1143 | US Army Medical Research & Materiel Command (US) | |  |
| MBX-1196 | Microbiotix Inc. | |  |
| MBX-1240 | Microbiotix Inc. (US) | |  |
| MBX-1684 | Microbiotix Inc. (US) | |  |
| MBX-2044 | Metabolex, Inc. | | No Structure |
| MBX-500 | Microbiotix | |  |
| MBX-8025 | Janssen Pharmaceutica (Johnson & Johnson) (Belgium) | |  |
| MC-02306 | Essential Therapeutics | 214541-87-4 |  |
| MC-04112 | Daiichi ; Essential Therapeutics | |  |
| MC-1 | Pfizer Inc. | |  |
| MC-1288 | Leo Pharmaceutical | 134523-84-5 |  |
| MC-1357 | Leo Pharmaceutical | 139137-06-7 |  |
| MC-4232 (Pyridoxal-5-phosphate (MC-1) & lisinopril) | Medicure | |  |
| MC-4262 | | | No Structure |
| MC-45308 | Medicure Inc. | | No Structure |
| MC-510027 | Merck ; Microcide Pharmaceuticals ; Sankyo | 51596-14-6 |  |
| MC-867 | Novirio Pharmaceuticals (Idenix Pharmaceuticals) | 221122-06-1 |  |
| MC21-A | University of Saga | |  |
| MCB-3681 | Morphochem AG | |  |
| MCC-134 | Mitsubishi Chemical | 181238-67-5 |  |
| MCC-977 | Mitsubishi Pharma | | No Structure |
| mCD4-HS12 | Institut Pasteur (France) ; Commissariat a l'Energie Atomique (France) ; Universite Paris-Sud (Franc | | No Structure |
| McDS | Kumamoto University (Japan) | |  |
| MCI-727 | Mitsubishi | 132197-26-3 |  |
| MCL-0020 | Taisho | |  |
| MCL-0042 | Taisho | |  |
| MCL-0129 | Taisho | |  |
| MCL-101 | McLean Hospital | 259192-07-9 |  |
| MCL-139 | Harvard Medical School (US) ;\nUniversity of Rochester Medical Center (US) | |  |
| MCL-144 | Harvard Medical School (US) ;\nUniversity of Rochester Medical Center (US) | |  |
| MCL-145 | Harvard Medical School (US) ;\nUniversity of Rochester Medical Center (US) | |  |
| MCLS-1374-173-2 | deCODE Genetics EHF (Iceland) | |  |
| MCLS-1407-012-1 | deCODE Genetics EHF (Iceland) | |  |
| MCLS-1486-130-2 | deCODE Genetics EHF (Iceland) | |  |
| MCM-09 | Morphochem | |  |
| MCN-5652 | Ortho McNeil (Johnson & Johnson) | 96795-89-0 |  |
| MCOPPB | Pfizer Inc. (US) | |  |
| MCPA | ICI (Syngenta) | 94-74-6 |  |
| MCPA-thioethyl | Hokko | 25319-90-8 |  |
| MCPB | Rhone-Poulenc | 94-81-5 |  |
| MCPCA | Shell | 2453-96-5 |  |
| MCR-14 | University of Ludwig-Maximilian, Munich | |  |
| MCR-3006 | Kyung Hee University (Korea) | |  |
| MCR-4 | University of Ludwig-Maximilian, Munich | |  |
| MCW-EE | | |  |
| MD-0727 | | | No Structure |
| MD-354 | University of Virginia | |  |
| MD-39AM | Guillermo Tene Lab Morrith | 72564-74-0 |  |
| MDAM | N. Madhavan & A. Abraham | 131216-21-2 |  |
| MDCO-2010 | Curacyte Discovery GmbH (The Medicines Company) | | No Structure |
| MDE-8 | Medarex | | No Structure |
| MDKP-67b | Université de Lausanne (Switzerland) | | No Structure |
| MDL-100240 | Merrel Dow (Sanofi-Aventis) | 142695-08-7 |  |
| MDL-100453 | Merrell Dow | 129938-34-7 |  |
| MDL-100458 | Merrell Dow (Aventis) | 138847-83-3 |  |
| MDL-101002 | Merrell Dow (Aventis) | 148671-62-9 |  |
| MDL-101146 | Merrell Dow (Aventis) | 149859-17-6 |  |
| MDL-101986 | Merrell Dow Pharma (Aventis) | |  |
| MDL-103323 | Merrell Dow (Aventis) | 165536-41-4 |  |
| MDL-103371 | Merrell Pharma | |  |
| MDL-104653 | Merck Sharp & Dohme (Merck & Co) | 28563-19-1 |  |
| MDL-105172A | Merrell (Aventis) | 193694-35-8 (HCl) |  |
| MDL-105212A | Merrell Dow (Aventis) | 167261-60-1 (HCl) |  |
| MDL-105519 | Merrell Dow (Aventis) | 161230-88-2 |  |
| MDL-20610 | Merrell Dow (Aventis) | 102830-69-3 |  |
| MDL-27032 | Merrell Dow (Aventis) | 110124-55-5 |  |
| MDL-27192 | Merrell Dow (Aventis) | 31409-32-2 |  |
| MDL-27324 | | 123285-50-7 |  |
| MDL-27531 | Merrell Dow (Aventis) | 116850-44-3 |  |
| MDL-28133A | Marion Merrel Dow (Aventis) | 136861-96-6 (HCl) |  |
| MDL-28170 | Merrell Dow (Aventis) ; Senju Pharma | 88191-84-8 |  |
| MDL-28842 | Merrell Dow (Aventis) | 122289-05-8 |  |
| MDL-43291 | Merrell Dow (Aventis) | 129357-91-1 |  |
| MDL-63246 | Lepetit | 148868-06-8 |  |
| MDL-72145 | Merrell Dow (Aventis) | 85278-04-2 (hydrochloride) |  |
| MDL-73811 | Merrell Dow (Aventis) | 123642-27-3 |  |
| MDL-74695 | Merrell (Aventis) | 167486-23-9 |  |
| MDL-74721 | Hoechst (Sanofi-Aventis) | 191226-04-7 |  |
| MDL-74722 | Hoechst (Sanofi-Aventis) | 183142-37-2 |  |
| MDL-74968 | Merrell Dow (Aventis) | 176434-89-2 |  |
| MDL-813272 | Aventis Pharma | |  |
| MDL-813728 | Aventis Pharma | |  |
| MDL-814608A | Aventis Pharma | |  |
| MDL-815541 | AVENTIS | 453539-06-5 |  |
| MDL-815994 | Aventis | 452916-72-2 |  |
| MDL-816002 | Aventis | 452918-72-8 |  |
| MDM2-319-5 | University Michigan (US) | |  |
| MDMA | | 42542-10-9 |  |
| MDT-22 | Chevron | |  |
| MDV-3100 | Univ. California | 915087-33-1 |  |
| MDX-066 | Medarex | | No Structure |
| MDX-067 | Medarex ; Celltech | | No Structure |
| MDX-070 | Northwest Biotherapeutics | | No Structure |
| MDX-1100 | Medarex | | No Structure |
| MDX-1105 | Ono Pharmaceutical (Japan) ; Medarex Inc, (US) | | No Structure |
| MDX-1106 | Ono Pharmaceutical ; Medarex | | No Structure |
| MDX-1203 | Medarex Inc. (Bristol-Myers Squibb Co.) | | No Structure |
| MDX-1303 | Medarex Inc. (Bristol-Myers Squibb Co.) | | No Structure |
| MDX-1338 | Medarex Inc. | | No Structure |
| MDX-1342 | Medarex Inc. (Bristol-Myers Squibb Co.) | | No Structure |
| MDX-1388 | University of Massachusetts ; Medarex Inc. (Bristol-Myers Squibb Co.) | | No Structure |
| MDX-1401 | Medarex Inc. (US) | | No Structure |
| MDX-1411 | Medarex Inc. (Bristol-Myers Squibb Co.) | | No Structure |
| MDY-1001 | UC Tech (US) | | No Structure |
| ME-1071 | Meiji Seika Kaisha (Japan) | |  |
| ME-1209 | Meiji Seika | 165665-73-6 |  |
| ME-2303 | Microbial Chemical Research Foundation | 116521-53-0 |  |
| ME-3229 | Meiji Seika | |  |
| ME-3277 | Meiji Seika | 165948-72-1 |  |
| ME-3407 | Meiji Seika | 133903-90-9 |  |
| ME-3738 | Meiji Seika | |  |
| ME-5343 | Meiji Seika Kaisha Ltd. ; The Kitasato Institute (Japan) | | No Structure |
| MEB | University of Arkansas | |  |
| Mebendazole | Janssen Pharmaceutica (Johnson & Johnson) | 31431-39-7 |  |
| Mebeverine | Philips-Duphar | 3625-06-7 |  |
| Mebhydroline | Bayer | 524-81-2 |  |
| Mebutamate | Lafare | 64-55-1 |  |
| Mebutizide | Carter Products (Carter-Wallace) | 3568-00-1 |  |
| Mecamylamine | Merck & Co. | 60-40-2 |  |
| Mecarbam | Murphy | 2595-54-2 |  |
| Mecasermin rinfabate | Celtrix Pharma (Insmed) | 478166-15-3 |  |
| Mecetronium etilsulfate | Bade | 3006-10-8 |  |
| Mecillinam | Leo Pharmaceutical | 32887-01-7 |  |
| Meclinertant | Sanofi (Sanofi-Aventis) | 146362-70-1 |  |
| Meclocycline | Pfizer | 2013-58-3 |  |
| Meclofenamic acid | Parke, Davis (Pfizer) | 644-62-2 |  |
| Meclofenoxate | CNRS | 51-68-3 |  |
| Meclonazepam | Hoffmann La Roche (Roche) | 58662-84-3 |  |
| Mecloqualone | Diamant | 340-57-8 |  |
| Mecloxamine | Asta Medica | 56668-06-4 |  |
| Meclozine | UCB | 569-65-3 |  |
| Mecobalamin | Eisai Co. | 13422-55-4 |  |
| Mecoprop | Boots (Abbott) | 7085-19-0 |  |
| Mecoprop-P | BASF | 16484-77-8 |  |
| Mecysteine | | 2485-62-3 |  |
| MED-2219 | Medarex (US) | |  |
| MED-2220 | Medarex | |  |
| MED-2220 anti-PSMA Conjugate | Medarex | |  |
| Medazepam | Hoffmann La Roche (Roche) | 2898-12-6 |  |
| Medetomidine | Farmos | 86347-14-0 |  |
| MEDI-3250 | AstraZeneca AB (Sweden) | | No Structure |
| MEDI-3617 | Medimmune Ltd. (GB) | | No Structure |
| MEDI-517 (Cervarix) | MedImmune | | No Structure |
| MEDI-534 | | | No Structure |
| MEDI-546 | Medarex Inc. (Bristol-Myers Squibb Co.) | | No Structure |
| MEDI-547 | MedImmune LLC (AstraZeneca AB) ; Seattle Genetics Inc. | | No Structure |
| MEDI-551 | MedImmune LLC (AstraZeneca AB) | | No Structure |
| MEDI-557 | MedImmune | | No Structure |
| MEDI-559 | AstraZeneca AB (Sweden) | | No Structure |
| MEDI-560 | AstraZeneca (MedImmune) | | No Structure |
| MEDI-566 | MedImmune | | No Structure |
| MEDI-570 | | | No Structure |
| MEDI-571 | AstraZeneca AB ; Cambridge Antibody Technology Ltd. (AstraZeneca AB) | | No Structure |
| MEDI-573 | Amgen Fremont Inc. (US) ; Astrazeneca AB (Sweden) | | No Structure |
| MEDI-575 | AstraZeneca AB (Sweden) | | No Structure |
| MEDI-578 | | | No Structure |
| Medica-16 | Epis | 87272-20-6 |  |
| Medifoxamine | Gerda | 32359-34-5 |  |
| Medroxyprogesterone | Upjohn; Farmitalia | 520-85-4 |  |
| Medroxyprogesterone Acetate | Upjohn (Pharmacia) | 71-58-9 |  |
| Medrylamine | UCB | 524-99-2 |  |
| Medrysone | Upjohn Co | 2668-66-8 |  |
| Mefenacet | Bayer | 73250-68-7 |  |
| Mefenamic acid | Parke, Davis (Pfizer) | 61-68-7 |  |
| Mefenorex | Hoffmann La Roche (Roche) | 17243-57-1 |  |
| Mefenpyr-diethyl | Hoechst (Sanofi-Aventis) | 135590-91-9\n\n |  |
| Mefloquine | BASF (Abbott) | 53230-10-7 |  |
| Mefluidide | 3M | 53780-34-0 |  |
| Mefolinate | Eprova AG (Merck AG) | 134-35-0 ; 151533-22-1 (Ca salt) |  |
| Mefruside | Bayer | 7195-27-9 |  |
| Megestrol Acetate | British Drug Houses | 595-33-5 |  |
| Meglumine | RPR (Aventis) | 6284-40-8 |  |
| Meglutol | | 503-49-1 |  |
| Melagatran | Astra (AstraZeneca) | 159775-70-2 |  |
| Melanoma peptide vaccine | | | No Structure |
| Melanotan II | Competitive Technologies ; University of Arizona | 121062-08-6 |  |
| Melarsomine | Rockefeller University | 128470-15-5 |  |
| Melarsoprol | Friedheim | 494-79-1 |  |
| Melatonin | | |  |
| Melengestrol Acetate | British Drug Houses | 2919-66-6 |  |
| Melitracen | Kefalas | 5118-29-6 |  |
| Melogliptin | Glenmark Pharmaceuticals (India) | 868771-57-7 |  |
| Meloxicam | Thomae (Boehringer Ingelheim) | 71125-38-7 |  |
| Melperone | Ferrosan | 3575-80-2 |  |
| Melphalan | National Research Development Corporation (NRDC) | 148-82-3 |  |
| Meluadrine | Hokuriku (Abbott) | 134865-40-0 |  |
| MEM-1003 | Bayer | |  |
| MEM-1414 | Memory Pharmaceuticals | | No Structure |
| MEM-3454 | Memory Pharmaceuticals | | No Structure |
| MEM-63908 | Memory Pharmaceuticals | | No Structure |
| Memantine | Eli Lilly | 19982-08-2 |  |
| Memoquin | Bologna University | |  |
| MEN-10207 | Menarini | 126050-12-2 |  |
| MEN-10627 | Menarini | 157351-81-0 |  |
| MEN-10690 | Menarini | 158150-64-2 |  |
| MEN-10700 | Luso Farmaco; Menarini | 195874-55-6 |  |
| MEN-10710 | Menarini | 159269-60-0 |  |
| MEN-10930 | Menarini | |  |
| MEN-10979 | Menarini | |  |
| MEN-11066 | Menarini | 207288-29-7 |  |
| MEN-11149 | Menarini | |  |
| MEN-11467 | Menarini | 214487-46-4 |  |
| MEN-11622 | Menarini | 328404-67-7 |  |
| MEN-11623 | Menarini | 328404-65-5 |  |
| MEN-13510 | Menarini | |  |
| MEN-14295 | Menarini | |  |
| MEN-15658 | Menarini | |  |
| MenACWY-CRM | Chiron Srl (Novartis) | | No Structure |
| MenACWY-TT | | | No Structure |
| Menadiol | Boots (Abbott) | 481-85-6 |  |
| Menadiol diacetate | | 573-20-6 |  |
| Menadione | University of Minnesota | 58-27-5 |  |
| Menatetrenone | Nisshin Flour Milling | 863-61-6 |  |
| Menfegol | Eisai | 57821-32-6 |  |
| Menogaril | Upjohn (Pharmacia) | 71628-96-1 |  |
| Menotropins | Generic | 61489-71-2 | No Structure |
| Menthyl isovalerate | | 89-47-4 |  |
| Meobentine | Burroughs Wellcome (GSK) | 46464-11-3 |  |
| Mepacrine | IG Farben | 83-89-6 |  |
| Mepanipyrim | Kumiai | 110235-47-7 |  |
| Mepenzolate bromide | Lakeside | 76-90-4 |  |
| Meperfluthrin | Bestchem Co Ltd Guiyang , (China) | 915288-13-0 |  |
| Mephenesin | Carrol & Boake Roberts | 59-47-2 |  |
| Mephenoxalone | Robins | 70-07-5 |  |
| Mephentermine | Wyeth | 100-92-5 |  |
| Mephenytoin | Sandoz (Novartis) | 50-12-4 |  |
| Mephosfolan | American Cyanamid (BASF) | 950-10-7 |  |
| Mepifylline | Lab. Made | 57383-74-1 |  |
| Mepindolol | Sandoz (Novartis) | 23694-81-7 |  |
| Mepiprazole | E. Merck KGaA | 20326-12-9 |  |
| Mepiquat chloride | | 24307-26-4 |  |
| Mepitiostane | SHIONOGI | 21362-69-6 |  |
| Mepivacaine | Bofors (AkzoNobel) | 96-88-8 |  |
| Mepixanox | Mondi | 17854-59-0 |  |
| Mepolizumab | | 196078-29-2 | No Structure |
| Meprobamate | Carter Products (Carter-Wallace) | 57-53-4 |  |
| Mepronil | Kumiai | 55814-41-0 |  |
| Meptazinol | Wyeth | 54340-58-8 |  |
| Meptazinol-Val-carbamate | Shire LLC (US) | |  |
| Mepyramine | Rhone-Poulenc (Aventis) | 91-84-9 |  |
| Mequinol | Promedica (France) | 150-76-5 |  |
| Mequitazine | Sogeras | 29216-28-2 |  |
| MER-101 (Zoledronic acid) | Merrion Pharmaceuticals Ltd. | 118072-93-8 ; 165800-06-6 (hydrate) |  |
| MER-102 | Elan Corp Plc, Ireland | | No Structure |
| MER-103 (Alendronic acid) | Merrion Pharmaceuticals Ltd. | 66376-36-1 |  |
| MER-104 (Acyline) | Merrion Pharmaceuticals Ltd. | 170157-13-8 |  |
| MER-N5075A | Fujisawa | |  |
| Merafloxacin | Warner Lambert (Pfizer) | 110013-21-3 |  |
| Merbarone | Uniroyal | 97534-21-9 |  |
| Merbromin | | 129-16-8 |  |
| Mercaptamine | Wakunaga Yakuhin KK | 60-23-1 |  |
| Mercaptopurine | Burroughs Wellcome (GSK) | 50-44-2 |  |
| Merck-3A | Merck & Co | |  |
| Merimepodib | Vertex | 198821-22-6 |  |
| Merocyanine 540 | | 62796-23-0 |  |
| Meropenem | Sumitomo (Dainippon-Sumitomo) | 96036-03-2 |  |
| Mersanex | | | No Structure |
| MES-10948 | Message Pharmaceuticals | |  |
| Mesalazine | Geigy (Novartis) | 89-57-6 |  |
| Mesna | UCB | 19767-45-4 |  |
| Mesoridazine | Sandoz (Novartis) | 5588-33-0 |  |
| Mesosulfuron-methyl | Hoechst (Sanofi-Aventis) | 208465-21-8 |  |
| Mesotrione | Stauffer | 104206-82-8 |  |
| Mestanolone | | 521-11-9 |  |
| Mesterolone | Schering AG | 1424-00-6 |  |
| Mesulergine | | 64795-35-3 |  |
| Mesulfen | Bayer | 135-58-0 |  |
| Mesupron | Wilex AG | |  |
| Met-enkephalin | TNI Pharmaceuticals | 58569-55-4 |  |
| MetaboliteX | Tripep AB | |  |
| Metabromsalan | Unilever | 2577-72-2 |  |
| Metaclazepam | Kali Chemie | 84031-17-4 |  |
| Metadoxine | Baldacci | 74536-44-0 |  |
| Metaflumizone (Agro) | Nihon Nohyaku | 139968-49-3 |  |
| Metaflumizone (Veterinary) | Wyeth Corp | 139968-49-3 |  |
| Metaglidasen | MetaBolex | 24136-23-0 |  |
| Metahexamide | Boehringer Ingelheim | 565-33-3 |  |
| Metalaxyl | Ciba-Geigy (Novartis) | 57837-19-1 |  |
| Metalaxyl-M | Ciba-Geigy (Novartis) | 70630-17-0 |  |
| Metaldehyde | PUBLICKER Industries | 9002-91-9 |  |
| Metamfepramone | Temmler | 15351-09-4 |  |
| Metamfetamine | Fujisawa | 537-46-2 |  |
| Metamifop | Hoechst (Sanofi-Aventis) | 256412-89-2 |  |
| Metamitron | Bayer | 41394-05-2 |  |
| Metamizole sodium | Hoechst (Sanofi-Aventis) | 5907-38-0 |  |
| Metampicillin | ERASME | 6489-97-0 |  |
| Metapramine | Rhone-Poulenc (Aventis) | 21730-16-5 |  |
| Metaraminol | IG Farben | 54-59-9 |  |
| Metaxalone | A. H. Robins | 1665-48-1 |  |
| Metazachlor | BASF | 67129-08-2 |  |
| Metazosin | Research Inst. for Pharmacy & Biochemistry (Spofa) | 95549-92-1 |  |
| Metazosulfuron | Nissan Chemical Industries, Ltd. | 868680-84-6 |  |
| Metazym | Zymenex As | | No Structure |
| Metconazole | Kureha | 125116-23-6 |  |
| Metelimumab | Cambridge Antibody Technology (CAT) | 272780-74-2 | No Structure |
| Metenolone | Schering AG | 153-00-4 |  |
| Metesind | Agouron (Pfizer) | 140695-21-2 |  |
| Metformin | Lipha (E. Merck KGaA) | 657-24-9 |  |
| Metformin glycinate | Laboratorios Silanes (Mexico) | 121369-64-0 |  |
| Methabenzthiazuron | Bayer | 18691-97-9 |  |
| Methacholine chloride | Merck & Co. | 62-51-1 |  |
| Methacrifos | Ciba-Geigy (Novartis) | 62610-77-9 |  |
| Methadone | Abbott | 76-99-3 |  |
| Methamidophos | Chevron | 10265-92-6 |  |
| methanesulfonyl fluoride | Texas University | 558-25-8 |  |
| Methaniazide | Carlo Erba | 13447-95-5 |  |
| Methanthelinium bromide | | 5818-17-7 |  |
| Methaqualone | Toraude | 72-44-6 |  |
| Methasulfocarb | Nippon Kayaku | 66952-49-6 |  |
| Methazolamide | American Cyanamid (Wyeth) | 554-57-4 |  |
| Methazole | Velsicol | 20354-26-1 |  |
| Methdilazine | Mead Johnson | 1982-37-2 |  |
| Methfuroxam | Uniroyal | 28730-17-8 |  |
| Methidathion | Ciba-Geigy (Novartis) | 950-37-8 |  |
| Methimepip | Schering Corp (Merck & Co) | |  |
| Methiocarb | Bayer | 2032-65-7 |  |
| Methioninase | Anticancer Inc. | | No Structure |
| Methiotriazamine | Monsanto | 6043-86-3 |  |
| Methiozolin | Moghu Research Center | 403640-27-7 |  |
| Methisazone | Wellcome Foundation (GSK) | 1910-68-5 |  |
| Methocarbamol | Robins | 532-03-6 |  |
| Methohexital | Eli Lilly | 151-83-7 |  |
| Methomyl | DuPont | 16752-77-5 |  |
| Methoprene | Zoecon | 40596-69-8 |  |
| Methopromazine | May & Baker (Aventis) | 61-01-8 |  |
| Methoprotryne | Ciba-Geigy (Novartis) | 841-06-5 |  |
| Methopterosin | University of California | |  |
| Methosorbinil | Eisai | 82319-87-7 |  |
| Methotrexate | American Cyanamid (Wyeth) | 59-05-2 |  |
| Methoxamine | Burroughs Wellcome (GSK) | 61-16-5 |  |
| Methoxsalen | USDA | 298-81-7 |  |
| Methoxy-fasudil | Amnestix Inc. (SYGNIS Pharma AG) | |  |
| Methoxyamine | Case Western Reserve University, US) | 67-62-9 ; 593-56-6 (HCl) |  |
| Methoxychlor | Geigy (Novartis) | 72-43-5 |  |
| Methoxyfenozide | Rohm & Haas | 161050-58-4 |  |
| Methoxyphenamine | Nippon Shinyaku | 93-30-1 |  |
| Methscopolamine methylsulfate | Daiichi Seiyaku | 18067-13-5 |  |
| Methsuximide | Parke, Davis (Pfizer) | 77-41-8 |  |
| Methyclothiazide | Abbott | 135-07-9 |  |
| Methyl Aminolevulinate | PhotoCure | 79416-27-6 (HCl) |  |
| Methyl Inosine Monophosphate | University of South Florida | 141673-59-8 |  |
| Methyl jasmonate | | 1211-29-6 |  |
| Methyl Neodecanamide | Colgate-Palmolive | 105726-67-8 |  |
| Methyl Parathion | Bayer | 298-00-0 |  |
| Methyl salicylate | | 119-36-8 |  |
| Methyl-fasudil | Amnestix Inc. (SYGNIS Pharma AG) | |  |
| Methylarsonic acid | | 124-58-3 |  |
| Methylbenzethonium chloride | | 25155-18-4 |  |
| Methylchromone | Lab. Franc. Chimiother. | 85-90-5 |  |
| Methyldopa | Merck & Co. | 555-30-6 |  |
| Methyldymron | SDS Biotech | 42609-73-4 |  |
| Methylene bis(thiocyanate) | | 6317-18-6 |  |
| Methylenetetrahydrofolic acid | University Of Southern California (US) | 3432-99-3 ; 133978-75-3 (calcium salt) |  |
| Methylephedrine | Klinge (Fujisawa) | 552-79-4 |  |
| Methylhydroxyquinoline methylsulfate | Agfa-Gaevert | 38746-10-0 |  |
| Methylmethioninesulfonium bromide | Degussa | 2766-51-0 |  |
| Methylnaltrexone bromide | UR Labs | 83387-25-1 ; 73232-52-7 (bromide salt) |  |
| Methylpentynol | Bayer | 77-75-8 |  |
| Methylphenidate | Ciba (Novartis) | 113-45-1 |  |
| Methylphenobarbital | IG Farben | 115-38-8 |  |
| Methylprednisolone | Upjohn (Pharmacia) | 83-43-2 |  |
| Methylprednisolone Aceponate | Schering Ag | 86401-95-8 |  |
| Methylprednisolone Acetate | Syntex | 53-36-1 |  |
| Methylprednisolone Hemisuccinate | Upjohn CO | 2921-57-5 ; 2375-03-3 (sodium salt) |  |
| Methylprednisolone suleptanate | Upjohn Company | 90350-40-6 |  |
| Methylrosanilinium chloride | | 548-62-9 |  |
| Methyltestosterone | | 58-18-4 |  |
| Methylthioinosine | Southern Research Inst. | 342-69-8 |  |
| Methylthioninium chloride | | 61-73-4 |  |
| Methylthiouracil | | 56-04-2 |  |
| Methyprylon | Hoffmann La Roche (Roche) | 125-64-4 |  |
| Methysergide | Sandoz (Novartis) | 361-37-5 |  |
| Metiazinic acid | Rhone-Poulenc (Aventis) | 13993-65-2 |  |
| Meticillin | Beecham (GSK) | 61-32-5 |  |
| Meticrane | S.I.F.A. | 1084-65-7 |  |
| Metipamide | Spofa | 85683-41-6 |  |
| Metipranolol | Spofa | 22664-55-7 |  |
| Metirosine | Merck & Co. | 672-87-7 |  |
| Metixene | Wander | 4969-02-2 |  |
| Metizoline | E. Merck KGaA | 17692-22-7 |  |
| Metobenzuron | Mitsui | 111578-32-6 |  |
| Metobromuron | Ciba-Geigy (Novartis) | 3060-89-7 |  |
| Metochalcone | Glaxo (GSK) | 18493-30-6 |  |
| Metoclopramide | Societe d'Etudes Scientifiques et Industrielles de l'Ile-de-France | 364-62-5 |  |
| Metocurine iodide | Eli Lilly | 7601-55-0 |  |
| Metofluthrin | Sumitomo Chemical | 240494-70-6 |  |
| Metolachlor | Ciba-Geigy (Novartis) | 51218-45-2 |  |
| Metolazone | Wallace & Tiernan | 17560-51-9 |  |
| Metolcarb | Sumitomo Chemical | 1129-41-5 |  |
| Metomidate | Janssen Pharmaceutica (Johnson & Johnson) | 5377-20-8 |  |
| Metominostrobin | Shionogi | 133408-50-1 |  |
| Metopimazine | Rhone-Poulenc (Aventis) | 14008-44-7 |  |
| Metoprolol | Haessle | 37350-58-6 |  |
| Metoserpate | Ciba (Novartis) | 1178-28-5 |  |
| Metosulam | DowElanco | 139528-85-1 |  |
| Metoxuron | Sandoz (Syngenta) | 19937-59-8 |  |
| Metrafenone | American Cyanamid (BASF) | 220899-03-6 |  |
| Metralindole | All Union Scientific Research Chemical Pharmaceutical Inst. | 54188-38-4 |  |
| Metreleptin | Rockefeller University | 186018-45-1 | No Structure |
| Metrenperone | Janssen Pharmaceutica (Johnson & Johnson) | 81043-56-3 |  |
| Metribuzin | Bayer | 21087-64-9 |  |
| Metrizamide | Nyegaard | 31112-62-6 |  |
| Metronidazole | Rhone-Poulenc (Aventis) | 443-48-1 |  |
| Metsulfuron | DuPont | 79510-48-8 |  |
| Metvan | Hughes Inst. | 276879-81-3 |  |
| Metyrapone | Ciba (Novartis) | 54-36-4 |  |
| Mevastatin | Sankyo Co | 73573-88-3 |  |
| Mevinphos | Shell | 7786-34-7 |  |
| Mexacarbate | Rhone-Poulenc | 315-18-4 |  |
| Mexazolam | Sankyo | 31868-18-5 |  |
| Mexenone | American Cyanamid (Wyeth) | 1641-17-4 |  |
| Mexidol | L. D. Smirnow et al. | 127464-43-1 |  |
| Mexiletine | Boehringer Ingelheim | 31828-71-4 |  |
| Mexiprostil | | 88980-20-5 |  |
| Mezlocillin | Bayer | 51481-65-3 |  |
| MF-10058 | Mediolanum Farmaceutici | 315719-45-0 |  |
| MF-13 | Istituto Sieroterapico | 39256-65-0 |  |
| MF-438 | Merck Frosst Canada Ltd. | |  |
| MF-482 | Merck Frosst Canada Ltd. (Canada) | |  |
| MF-498 | Merck Frosst Canada Ltd. (Canada) | |  |
| MF-5112 | Mediolanum Farmaceutici | 189364-31-6 |  |
| MF-5168 | Mediolanum Farmaceutici | 93106-56-0 |  |
| MF-63 | Merck Frosst Canada Ltd. (Canada) | |  |
| MF-766 | Merck Frosst Canada Ltd. | |  |
| MF-961 | Mediolanum Farmaceutici | 138372-62-0 |  |
| MG-1106 | Green Cross Corp. | | No Structure |
| MG-1109 | | | No Structure |
| MG-132 | | 133407-82-6 |  |
| MG-2394 | MethylGene | |  |
| MG-3 | CTG Pharma SRL (Italy) | |  |
| MG-4101 | Green Cross Corp. ; Seoul National University Hospital (South Korea) | | No Structure |
| MGAWN-1 | MacroGenics | | No Structure |
| MGC-19 | Mitsubishi Gas | 132425-23-1 |  |
| MGC-4 | Dabur Research Foundation (IN) | |  |
| MGCD-265 | MethylGene | |  |
| MGCD-290 | MethylGene | | No Structure |
| MGI-4184 | University of California (US) | |  |
| MGK-264 | Generic | 113-48-4 |  |
| MGM-9 | Chiba University (Japan) ; Chulalongkorn University (Thailand) ; Josai University (Japan) | |  |
| MGS-0008 | Taisho | 234085-20-2 |  |
| MGS-0039 | Taisho PHARMA (Japan) | |  |
| MGS-0210 | Taisho Pharma | |  |
| MHP-34a | Johns Hopkins University | 300656-01-3 |  |
| MI-1544 | A. V. Schally | 87565-51-3 |  |
| MI-219 | Michigan University | |  |
| MI-22 | Osaka University ; The New Industry Research Organization | |  |
| MI-319-12 | University Michigan (US) | |  |
| MI-319-17 | University Michigan (US) | |  |
| MI-63 | Ascenta Therapeutics Inc. (US) ; University of Michigan (US) | |  |
| Mianserin | Organon (Schering Merck & Co) | 24219-97-4 |  |
| Mibampator | Eli Lilly | 375345-95-2 |  |
| Mibefradil | Hoffmann La Roche (Roche) | 116666-53-2 |  |
| Mibolerone | Upjohn (Pharmacia) | 3704-09-4 |  |
| Micafungin | Fujisawa (Astellas Pharma) | 208538-73-2 (Na salt) |  |
| Michellamine B | US Department of Health & Human Services | 137893-48-2 |  |
| Micinicate | Ravizza (Abbott) | 39537-99-0 |  |
| Miconazole | Janssen Pharmaceutica (Johnson & Johnson) | 22916-47-8 |  |
| Microcin J25 | Universidad de Tucumán | |  |
| Midafotel | British Tech | 117414-74-1 |  |
| Midaxifylline | Biomedica Foscama | 151159-23-8 |  |
| Midazolam | Hoffmann La Roche (Roche) | 59467-70-8 |  |
| Midecamycin | MEIJI SEIKA KAISHA | 35457-80-8 |  |
| Midesteine | Medea Research | 94149-41-4 |  |
| Midodrine | OSSW | 42794-76-3 |  |
| Midoriamin | Green Cross (Mitsubishi Pharma) | 87211-44-7 |  |
| Midostaurin | Ciba-Geigy (Novartis) | 120685-11-2 |  |
| MIF-1 | Tulane University | 77133-61-0 |  |
| MIF-TTX | Hokkaido University Graduate School of Medicine (Japan) ; GeneticLab Co. (Japan) | | No Structure |
| Mifamurtide | Ciba-Geigy (Novartis) | 83461-56-7 ; 838853-48-8 (sodium salt) |  |
| Mifepristone | Roussel-Uclaf (Aventis) | 84371-65-3 |  |
| Migalastat | Amicus Therapeutics | 108147-54-2 ; 75172-81-5 (hydrochloride) |  |
| Miglitol | Bayer | 72432-03-2 |  |
| Miglustat | Searle (Pfizer) | 72599-27-0 |  |
| Milacainide | Roche | 106134-32-1 ; 141725-10-2 (tartrate) |  |
| Milacemide | Continental Pharma | 76990-56-2 |  |
| Milameline | Roussel-Uclaf (Aventis) | 139886-32-1 |  |
| Milataxel | University of Florida, | 393101-41-2 |  |
| Milatuzumab | | 899796-83-9 | No Structure |
| Milbemycin Oxime | Sankyo | 129496-10-2 |  |
| Mildronate | Latvian Inst. of Organic Synthesis | 76144-81-5 |  |
| Milfasartan | Menarini | 148564-47-0 |  |
| Milnacipran | Fabre | 92623-85-3 ; 101152-94-7 (hydrochloride salt) |  |
| Miloxacin | Sumitomo Chemical | 37065-29-5 |  |
| Milrinone | Sterling Winthrop (Sanofi-Aventis) | 78415-72-2 |  |
| Miltefosine | Max-Planck-Gesellschaft | 58066-85-6 |  |
| Milverine | Italiana Schoum | 75437-14-8 |  |
| Milveterol | Theravance | 652990-07-3 ; 804518-03-4 (hydrochloride) |  |
| Mimopezil | | 180694-97-7 |  |
| Minalrestat | American Home Products (Wyeth) | 129688-50-2 |  |
| Minaprine | CNRS | 25905-77-5 |  |
| Minerval | Scripps Research Institute | |  |
| Minitran (Nitroglycerin) | Riker Laboratories Inc. (3M) | 55-63-0 |  |
| Minocycline | American Cyanamid (Wyeth) | 10118-90-8 |  |
| Minodronic acid | Yamanouchi (Astellas) | 127657-42-5 |  |
| Minopafant | Eisai | 128420-61-1 |  |
| Minoxidil | Upjohn (Pharmacia) | 38304-91-5 |  |
| Minozac | Northwestern University ; University Louis Pasteur De Strasbourg | |  |
| Miokamycin | Meiji Seika | 55881-07-7 |  |
| Mipomersen | Isis Pharmaceuticals | 629167-92-6 (Na) ; 1000120-98-8 | No Structure |
| Miproxifene | Taiho | 129612-87-9 |  |
| Miproxifene phosphate | Taiho | 115767-74-3 |  |
| Mirabegron | Astellas Pharma Inc. (Japan) | 223673-61-8 |  |
| Mircera | | | No Structure |
| Mirfentanil | BOC | 117523-47-4 |  |
| Miriplatin | Sumitomo Pharma (Dainippon Sumitomo) | 141977-79-9 |  |
| Miristalkonium chloride | Hiroshi | 139-08-2 |  |
| Mirodenafil | In2Gen (South Korea) ; SK Chemicals | 862189-95-5 |  |
| Mirostipen | Human Genome Sciences | 244130-01-6 | No Structure |
| Mirtazapine | Akzo (Akzo Nobel) | 61337-67-5 |  |
| Misonidazole | Hoffmann La Roche (Roche) | 13551-87-6 |  |
| Misoprostol | Searle (Pharmacia) | 59122-46-2 |  |
| Mispyric acid | University of Virginia | 240810-84-8 |  |
| Mitaplatin | Massachusetts Institute of Technology (US) | |  |
| Mitemcinal | Chugai Pharma (Roche) | 154738-42-8 |  |
| Mithramycin SK | University of Kentucky (US) ; Universidad de Oviedo (France) | |  |
| Mitiglinide | Kissei Pharmaceutical | 145375-44-6 |  |
| Mitobronitol | Chinoin | 488-41-5 |  |
| Mitoguazone | Generic | 459-86-9 |  |
| Mitolactol | Biopharmaceutics | 10318-26-0 |  |
| Mitomycin C | Kyowa Hakko Kogyo | 50-07-7 |  |
| Mitonafide | Made Labor | 54824-17-8 |  |
| Mitoquinone | University of Otago | |  |
| Mitotane | Bristol-Myers (BMS) | 53-19-0 |  |
| Mitoxantrone | American Cyanamid (Wyeth) | 65271-80-9 |  |
| Mitratapide | Janssen Pharmaceutica (Johnson & Johnson) | 179602-65-4 |  |
| Mitumprotimut-T | Favrille (US) | | No Structure |
| MIV-150 | Medivir | |  |
| MIV-410 | Medivir AB | | No Structure |
| MIV-701 | Medivir | | No Structure |
| MIV-710 | Medivir AB | | No Structure |
| MIV-711 | Medivir AB | | No Structure |
| Mivacurium chloride | Burroughs Wellcome (GSK) | 10686-44-3 |  |
| Mivazerol | UCB | 125472-02-8 |  |
| Mivobulin | Southern Research Inst. | 122332-18-7 |  |
| Mivotilate | Yuhan | 130112-42-4 |  |
| Mizolastine | Synthelabo (Sanofi-Aventis) | 108612-45-9 |  |
| Mizoribine | Toyo Jozo ; Asahi Chemical | 50924-49-7 |  |
| MJ-15 | Institute of Pharmacology and Toxicology, Academy of Military Medical Sciences (China) | |  |
| MJ-III-65 | US Health ; Purdue Research Foundation | |  |
| MJ2-7 | Wyeth | | No Structure |
| MJV-101 | | | No Structure |
| MK-0249 | Merck & Co | | No Structure |
| MK-0354 | | |  |
| MK-0429 | Merck & Co | | No Structure |
| MK-0431C (Sitagliptin & Pioglitazone) | Merck & Co. Inc. | 486460-32-6 (Sitagliptin) ; 111025-46-8 (Pioglitazone) |  |
| MK-0431D (Sitagliptin & Simvastatin) | Merck & Co. Inc. | 486460-32-6 (Sitagliptin) ; 79902-63-9 (Simvastatin) |  |
| MK-0434 | Merck & Co. | 134067-56-4 |  |
| MK-0448 | Merck & Co | | No Structure |
| MK-0454 | Merck & Co | | No Structure |
| MK-0476C | | | No Structure |
| MK-0489 | Merck & Co. Inc. | |  |
| MK-0493 | Merck & Co | | No Structure |
| MK-0524A (Nicotinic acid & Laropiprant) | Merck & Co | |  |
| MK-0524B (MK-0524A & Simvastatin) | Merck & Co | |  |
| MK-0533 | Merck & Co | | No Structure |
| MK-056 | Pacific Corporation (Kr) | |  |
| MK-0594 | Merck & Co | | No Structure |
| MK-0608 | Isis Pharmaceuticals ; Merck & Co. | |  |
| MK-0617 | Merck & Co. Inc. | |  |
| MK-0634 | Merck & Co | | No Structure |
| MK-0657 | Merck & Co | |  |
| MK-0668 | Merck & Co. Inc. (US) | |  |
| MK-0674 | Merck Frosst Canada Ltd. | |  |
| MK-0686 | Merck & Co | | No Structure |
| MK-0731 | Merck & Co | |  |
| MK-0736 | Merck & Co | | No Structure |
| MK-0752 | Merck & Co | | No Structure |
| MK-0759 | Merck & Co | | No Structure |
| MK-0773 | Merck & Co | |  |
| MK-0893 | Merck & Co | | No Structure |
| MK-0913 | Merck & Co. Inc. (US) | |  |
| MK-0941 | Merck & Co | |  |
| MK-0952 | Merck & Co | | No Structure |
| MK-0954A | Du Pont, (US) | 58-93-5 (Hydrochlorothiazide) ; 114798-26-4 (Losartan) |  |
| MK-0994 | Merck & Co | | No Structure |
| MK-13089A | Meiji Seka | 307335-05-3 |  |
| MK-13089B | Meiji Seka | 307335-06-4 |  |
| MK-13089C | Meiji Seka | 307335-07-5 |  |
| MK-1496 | | | No Structure |
| MK-1597 | Actelion Pharmaceuticals Ltd. | |  |
| MK-171 | Pacific Corporation | |  |
| MK-1775 | Banyu Pharmaceutical Co. Ltd. (Merck & Co. Inc.) | |  |
| MK-1809 | | | No Structure |
| MK-1903 | | | No Structure |
| MK-1925 | Banyu Pharma Co. Ltd. (Japan) | |  |
| MK-212 | Merck & Co. | 64022-27-1 |  |
| MK-2206 | Merck & Co Inc. (US) | |  |
| MK-223 | Merck & co. | | No Structure |
| MK-2461 | Merck & Co Inc. | 1196681-15-8 |  |
| MK-2578 | GlycoFi Inc. (Merck & Co. Inc.) | | No Structure |
| MK-271 | Digitalbiotech Co. Ltd. (South Korea) | |  |
| MK-2918 | Merck & Co. Inc. (US) | |  |
| MK-306 | Chinoin | |  |
| MK-3102 | | | No Structure |
| MK-3118 | | | No Structure |
| MK-3281 | | | No Structure |
| MK-3614 | | | No Structure |
| MK-3697 | | | No Structure |
| MK-386 | Merck & Co. | |  |
| MK-4074 | | | No Structure |
| MK-4101 | Merck & Co. Inc. | | No Structure |
| MK-4305 | Merck & Co. Inc. | |  |
| MK-4409 | Merck & Co. Inc. | | No Structure |
| MK-447 | Merck & Co. | 58456-91-0 |  |
| MK-4618 | | | No Structure |
| MK-4827 | Istituto di Ricerche di Biologia Molecolare P. Angeletti SpA (Italy) | |  |
| MK-4965 | Merck & Co. Inc. (US) | |  |
| MK-499 | Merck & Co. | 150481-98-4 |  |
| MK-5108 | Banyu Pharmaceutical Co. Ltd. (Merck & Co. Inc.) | |  |
| MK-5172 | Merck & Co Inc. ; Istituto di Richerche Biologia Molecolare P. Angeletti SpA (Italy) | |  |
| MK-5596 | Merck & Co Inc. | |  |
| MK-571 | Merck Frosst (Merck & Co.) | 115104-28-4 |  |
| MK-6096 | | | No Structure |
| MK-6186 | | | No Structure |
| MK-6213 | | | No Structure |
| MK-6406 | | | No Structure |
| MK-6592 | | | No Structure |
| MK-6892 | Merck & Co. Inc. | |  |
| MK-6913 | | | No Structure |
| MK-7246 | | | No Structure |
| MK-7288 | Merck & Co. Inc. | | No Structure |
| MK-7634 | Meiji Seika Kaisha ; Mitsubishi | 179046-25-4 | No Structure |
| MK-7655 | Merck & Co. Inc. | |  |
| MK-767 | Kyorin | 213252-19-8 |  |
| MK-771 | Merck & Co. | 64784-01-6 |  |
| MK-7725 | Merck & Co. Inc. | |  |
| MK-800-62F1 | Keio University; Microbial Research Found. | 291299-41-7 |  |
| MK-8033 | Merck & Co. Inc. | |  |
| MK-8141 | Merck & Co. Inc. (US) ; Actelion Pharmaceuticals Ltd (Switzerland) | | No Structure |
| MK-8245 | | | No Structure |
| MK-8368 | | | No Structure |
| MK-852 | Merck & Co. | 138199-64-1 |  |
| MK-8984 | | | No Structure |
| MK-8998 | | | No Structure |
| MK-912 | Merck & Co. | 111466-41-2 |  |
| MK-927 | Merck & Co. | 133562-93-3 |  |
| MK-944A | Merck & Co. | 216863-66-0 |  |
| MK-963 | Merck & Co. | 103497-68-3 |  |
| MK-V114 | Merck & Co. Inc. | | No Structure |
| MKC-1 | Hoffmann La Roche (Roche) | |  |
| MKC-1106-MT | MannKind Corp. | | No Structure |
| MKC-1106-PP | Mannkind Corp. (US) | | No Structure |
| MKC-204 | MannKind Corp. | | No Structure |
| MKC-253 | MannKind Corp. | | No Structure |
| MKT-077 | Dana Farber Cancer Inst. ; Fuji Photo Film | 147366-41-4 |  |
| MKT-3003 | Microbial Chemistry Research Foundation (Japan) | |  |
| ML-00253764 | Millennium Pharmaceuticals (Takeda) | |  |
| ML-01 | | |  |
| ML-03 | | |  |
| ML-06 | | |  |
| ML-07 | | |  |
| ML-08 | | |  |
| ML-1035 | Aventis | 125557-35-9 |  |
| ML-120B | Millenium Pharmeceuticals | |  |
| ML-3403 | Merckle GmbH (Germany) | |  |
| ML-72A | Yamanouchi | |  |
| MLL-1-WIN peptide | Syracuse University (US) | | No Structure |
| MLN-0415 | Millennium Pharmaceuticals Inc. (Takeda Pharmaceutical Co. Ltd.) | |  |
| MLN-1202 | Millennium Pharmaceuticals (Takeda) | | No Structure |
| MLN-2704 | Millennium Pharmaceuticals (Takeda) | |  |
| MLN-273 | Proscript | |  |
| MLN-4760 | Millennium Pharmaceuticals (Takeda) | |  |
| MLN-4924 | | | No Structure |
| MLN-519 | Proscript | 211866-70-5 |  |
| MLN-591 | Millennium Pharmaceuticals (Takeda) | | No Structure |
| MLN-591RL | Millennium Pharmaceuticals (Takeda) | | No Structure |
| MLN-8054 | Millennium Pharmaceuticals (Takeda) | |  |
| MLN-9708 | Millennium Pharmaceuticals Inc. (Takeda Pharmaceutical Co. Ltd.) | |  |
| MLN-977 | CytoMed | 175212-04-1 |  |
| MLP-92 | Neurim Pharmaceuticals | 311343-61-0 |  |
| MM-093 | McGill University | | No Structure |
| MM-111 | Merrimack Pharmaceuticals Inc. (US) | | No Structure |
| MM-121 | Merrimack Pharmaceuticals Inc. (US) | | No Structure |
| MM-131 | Merrimack Pharmaceuticals Inc. | | No Structure |
| MM-141 | Merrimack Pharmaceuticals Inc. | | No Structure |
| MM-151 | Merrimack Pharmaceuticals Inc. | | No Structure |
| MM-302 | Hermes Biosciences Inc. (Merrimack Pharmaceuticals Inc.) | | No Structure |
| MM-398 (Irinotecan) | Hermes Biosciences Inc. (Merrimack Pharmaceuticals Inc.) | 97682-44-5 |  |
| MMI-166 | Shionogi | |  |
| MMI-270 | Novartis | 169799-04-6 |  |
| MMP-145 | Pfizer Inc. (US) | |  |
| MMP-2200 | The University of Arizona (US) | |  |
| MMP-408 | Pfizer Inc. (US) | |  |
| MMPQ | Karamchand Premchand | 3214-64-0 |  |
| MN-100 | University of British Columbia (Canada) | |  |
| MN-201 | | 187935-17-7 |  |
| MN-447 | Meiji Seika Kaisha Ltd. | |  |
| MN-462 | Meiji Seika Kaisha Ltd. | | No Structure |
| MnB rLP2086 | Wyeth Corp. (Pfizer Inc.) | | No Structure |
| MO-1659 | National Center For Biological Sciences (India) | |  |
| Mocetinostat | MethylGene | 726169-73-9 ; 944537-89-7 (dihydrobromide salt) |  |
| Moclobemide | Hoffmann La Roche (Roche) | 71320-77-9 |  |
| Modafinil | Lafon (Cephalon) | 68693-11-8 |  |
| Modithromycin | Enanta | 736992-12-4 |  |
| Moexipril | Warner Lambert (Pfizer) | 103775-10-6 |  |
| Mofarotene | Hoffmann La Roche (Roche) | 125533-88-2 |  |
| Mofebutazone | Comm. Farmaceutica Milanese | 2210-63-1 |  |
| Mofegiline | Merrell Dow (Aventis) | 119386-96-8 |  |
| Mofezolac | Cdc Life Sciences (Canada) | 78967-07-4 |  |
| Mogamulizumab | Kyowa Hakko Kirin Co. Ltd. (Japan) | 1159266-37-1 | No Structure |
| Moguisteine | Recordati | 119637-67-1 |  |
| MOL-376 | Molecumetics | 237754-57-3 |  |
| Molgramostim | Sandoz Ag | 99283-10-0 | No Structure |
| Molinate | Stauffer | 2212-67-1 |  |
| Molindone | Endo | 7416-34-4 |  |
| Molsidomine | Takeda | 25717-80-0 |  |
| Mometasone Furoate | Schering Corp (Merck & Co) | 83919-23-7 |  |
| Mometasone furoate & Formoterol | Novartis | |  |
| Mometasone furoate & Oxymetazoline | Schering-Plough Corp. (Merck & Co. Inc.) | 83919-23-7 (Mometasone furoate) ; 1491-59-4 (Oxymetazoline) |  |
| Monalazone | Temmler | 61477-95-0 |  |
| Monalide | Schering AG | 7287-36-7 |  |
| Monatepil | Dainippon Pharmaceutical | 132019-54-6 |  |
| Monatin | Ajinomoto KK. | |  |
| Monensin | Eli Lilly | 17090-79-8 |  |
| Monepantel | Novartis AG | 887148-69-8 |  |
| Moniliastat | | | No Structure |
| Monobenzone | | 103-16-2 |  |
| Monocrotophos | Shell | 6923-22-4 |  |
| Monolaurin | Cellegy | 27215-38-9 |  |
| Monolinuron | Hoechst (Sanofi-Aventis) | 1746-81-2 |  |
| Monophosphoryl lipid A | Ribi Immunochem Research (GSK) | 143110-73-0 |  |
| Montelukast | Merck & Co. | 158966-92-8 |  |
| Monteplase | ZymoGenetics | 156616-23-8 |  |
| Montirelin | Gruenenthal GMBH (germany | 90243-66-6 |  |
| MoNuDin | Oxford BioMedica Ltd. | | No Structure |
| Moperone | Janssen Pharmaceutica (Johnson & Johnson) | 1050-79-9 |  |
| Mopidamol | Thomae (Boehringer Ingelheim) | 13665-88-8 |  |
| Mopyridone | | 82822-14-8 |  |
| MOR-103 | MorphoSys | | No Structure |
| MOR-202 | MorphoSys AG (Germany) | | No Structure |
| MORAb-004 | Morphotek Inc. (US) | | No Structure |
| MORAb-022 | | | No Structure |
| MORAb-028 | | | No Structure |
| MORAb-047 | Morphotek Inc. (Eisai Co. Ltd.) ; US Army Medical Research Institute of Infectious Diseases (US) | | No Structure |
| MORAb-048 | Morphotek Inc. (Eisai Co. Ltd.) | | No Structure |
| Morantel | Pfizer | 20574-50-9 |  |
| Morazone | Ravensberg | 6536-18-1 |  |
| Morclofone | Farmitalia Carlo Erba (Pharmacia) | 31848-01-8 |  |
| Moricizine | Acad. Med. Sci. U.R.S.S. | 31883-05-3 |  |
| Morinamide | Bracco | 952-54-5 |  |
| Morniflumate | Yamanouchi (Astellas) | 65847-85-0 |  |
| Moroctocog Alfa | | | No Structure |
| Moroxydine | Kabi | 3731-59-7 |  |
| Morphine | | 57-27-2 |  |
| Morphine-6-glucuronide | Cenes | 168276-70-8 |  |
| Morsuximide | Chinoin | 3780-72-1 |  |
| Mosapramine | Yoshitomi | 89419-40-9 |  |
| Mosapride | Dainippon | 112885-41-3 |  |
| Mosquirix | | | No Structure |
| Motavizumab | MedImmune (AstraZeneca) | 677010-34-3 | No Structure |
| Motesanib | Amgen | 453562-69-1 ; 857876-30-3 (diphosphate salt) |  |
| Motretinide | Hoffmann La Roche (Roche) | 56281-36-8 |  |
| Moveltipril | Chugai (Roche) | 85856-54-8 |  |
| Moviprep (PEG-3350 & ascorbic acid) | Norgine | 50-81-7 |  |
| Moxastine | Leciva | 3572-74-5 |  |
| Moxaverine | Orgamol | 10539-19-2 |  |
| Moxetumomab pasudotox | AstraZeneca AB (Sweden) | 1020748-57-5 | No Structure |
| Moxidectin | Glaxo (GSK) | 113507-06-5 |  |
| Moxifloxacin | Bayer | 151096-09-2 |  |
| Moxilubant | Ciba-Geigy (Novartis) | 161172-35-6 |  |
| Moxiraprine | Sanofi (Sanofi-Aventis) | 82239-52-9 |  |
| Moxisylyte | Diwag | 54-32-0 |  |
| Moxonidine | Beiersdorf | 75438-57-2 |  |
| Mozavaptan | Otsuka | 137975-06-5 |  |
| Mozenavir | DuPont Merck (BMS) | 174391-92-5 |  |
| MP-01028 | Mpex Pharmaceuticals Inc. (US) | |  |
| MP-10 | Pfizer | |  |
| MP-124 | Mitsubishi Tanabe Pharma Corp. | | No Structure |
| MP-136 | Mitsubishi Tanabe Pharma Corp. | | No Structure |
| MP-2269 | Mallinckrodt | 207917-73-5 |  |
| MP-277 | Supergen | |  |
| MP-376 (Levofloxacin) | Mpex Pharmaceutical | |  |
| MP-4 | Alexion | 1623-15-0 |  |
| MP-4 (Hemospan) | Sangart | | No Structure |
| MP-412 | Mitsubishi Pharma | |  |
| MP-435 | Mitsubishi Tanabe Pharma Corp. | | No Structure |
| MPC-0920 | | | No Structure |
| MPC-1001 | Kyowa Hakko Kogyo | |  |
| MPC-2130 | | | No Structure |
| MPC-9055 | Myriad Genetics | | No Structure |
| MPEP | Novartis ; SIBIA Neurosciences | 96206-92-7 |  |
| MPZP | Bristol-Myers Squibb (BMS) | |  |
| MQT-100 | Mediquest Therapeutics | |  |
| MQT-600 | Mediquest Therapeutics | |  |
| MQX-503 | | | No Structure |
| MR-708 | Medea Research | 79380-99-7 |  |
| MRG-621 | Acadia | |  |
| MRG-632 | Acadia | |  |
| MRK-1 | Merck & Co. | |  |
| MRK-560 | Merck Sharp & Dohme Ltd. | |  |
| MRL-1237 | Maruishi Pharmaceutical ; Osaka Medical College | |  |
| MRL-I | | |  |
| MRL-II | Merck & Co. | |  |
| MRS-1523 | NIH | |  |
| MRS-1754 | University of Virginia | 264622-58-4 |  |
| MRS-2279 | University of North Carolina | 367909-40-8 |  |
| MRS-2365 | National Institutes of Health (NIH) ; University of North Carolina | |  |
| MRX-4 | | | No Structure |
| MRX-801 | ImaRx Therapeutics | | No Structure |
| MRX-815 | ImaRx Therapeutics | | No Structure |
| MRZ-2-1010 | Merz | |  |
| MRZ-2-1013 | Merz | |  |
| MRZ-2-570 | Merz | 202807-82-7 |  |
| MRZ-2-571 | Merz | 201948-30-3 |  |
| MRZ-2-576 | Merz | 202807-80-5 |  |
| MRZ-2-705 | Merz | |  |
| MRZ-2-759 | Merz | |  |
| MS-073 | Mitsui | 129716-45-6 |  |
| MS-1060 | Synthelabo (Sanofi-Aventis) | |  |
| MS-153 | Mitsui | 130775-79-0 |  |
| MS-16-056 | Mitsui | 137187-91-8 |  |
| MS-180 | Mitsui (Merck & Co) | |  |
| MS-245 | Virginia Commonwealth University | |  |
| MS-322 | Mitsui | 134378-93-1 |  |
| MS-8209 | Mayoly Spindler | 136458-97-4 |  |
| MS-857 | Mitsui | 107189-96-8 |  |
| MSC | Roswell Park Cancer Institute | |  |
| MSFTZ | Zhejiang University (China) | |  |
| MSK-039 | Scripps Research Institute (US) ; Sidney Kimmel Cancer Center (US) | |  |
| MSX-122 | University of Emory | |  |
| MT-104 | Myotec Therapeutics Ltd. | | No Structure |
| MT-111 | Micromet AG (Germany) | | No Structure |
| MT-203 | Micromet AG | | No Structure |
| MT-204 | Micromet AG | | No Structure |
| MT-210 | Mitsubishi Tanabe Pharma Corp. | | No Structure |
| MT-319 | Sosei ; Tokyo University of Agriculture and Technology | |  |
| MT-320 | Sosei ; Tokyo University of Agriculture and Technology | |  |
| MT-DADMe-ImmA | Industrial Research Limited ; Albert Einstein College of Medicine of Yeshiva University | |  |
| Mtb72F-AS02A | Corixa Corporation (GSK) | | No Structure |
| MTEP | Merck & Co. | |  |
| MTH-TRP | Lankenau Institute for Medical Research | |  |
| MTI-790 | Mitsui | 89764-65-8 |  |
| MTIP | Eli Lilly Co. (US) | |  |
| MTR-105 (MTR-104) | Meditor Pharmaceuticals | 21704-46-1 |  |
| MTR-106 (MTR-104) | Meditor Pharmaceuticals | 21704-46-1 |  |
| MTR-107 (MTR-104) | Meditor Pharmaceuticals | 21704-46-1 |  |
| MU-HSSKLQ-L12ADT | Univ. Johns Hopkins | |  |
| Mubritinib | Takeda | 366017-09-6 |  |
| Multikine | CEL-SCI Corporation | | No Structure |
| MuO-Conotoxin Mr VIB | University of Utah | |  |
| MUP-98176 | University of Manchester | |  |
| Mupirocin | Beecham (GSK) | 115074-43-6 |  |
| Muplestim | Sandoz (Novartis) | 148641-02-5 | No Structure |
| Muraglitazar | Bristol-Myers Squibb (BMS) | 331741-94-7 |  |
| Muromonab-CD3 | Ortho Pharma | 140608-64-6 | No Structure |
| Muscalure | Sandoz (Syngenta) | 27519-02-4 |  |
| Muscimol | Geigy AG | 2763-96-4 |  |
| MUT-056399 | Mutabilis SA (France) | |  |
| MUT-11931 | Mutabilis (France) | |  |
| Muzolimine | Bayer | 55294-15-0 |  |
| MV-9411 | Miravant | | No Structure |
| MVA-85A | Isis Innovation (University of Oxford) | | No Structure |
| MVA-BN Anthrax | Bavarian Nordic AS | | No Structure |
| MVA-BN HIV polytope | Bavarian Nordic AS (Denmark) | | No Structure |
| MVA-BN Measles | Bavarian Nordic AS | | No Structure |
| MVA-BN PRO | BN ImmunoTherapeutics Inc. (Bavarian Nordic AS) | | No Structure |
| MVA-BN-HER2 | BN Immunotherapeutics Inc. (Bavarian Nordic AS) | | No Structure |
| MVA-EL | The Chinese University of Hong Kong (Hong Kong) ; YK Pao Cancer Centre (Hong Kong) ; Li Ka Shing Ins | | No Structure |
| MVA-IL-15-5Mtb | Veterans Affairs Medical Center (US) ; United States Food and Drug Administration (US) ; Nihon Unive | | No Structure |
| MW01-2-069A-SRM | Northwestern University (US) ; Université Louis Pasteur (France) | |  |
| MW01-5-188WH | Northwestern University (USA) | |  |
| MX-1013 | Cytovia | 223568-55-6 |  |
| MX-1122 | Cytovia (Maxim Pharmaceuticals) | |  |
| MX-1153 | Cytovia | |  |
| MX-126374 | Cytovia (EpiCept Corporation) | |  |
| MX-126911 | Cytovia (EpiCept Corporation) | |  |
| MX-170 | Pharmacor | |  |
| MX-221 | Pharmacor | |  |
| MX-222 | Pharmacor | |  |
| MX-2401 | Migenix | |  |
| MX-58151 | Maxim Pharmaceuticals (EpiCept) | |  |
| MX-6 | Galderma | |  |
| MX-6162 | Maxia | |  |
| MX-68 | Chugai (Roche) | 156579-02-1 |  |
| MX-7091 | Maxia (Incyte) | |  |
| MX-74420 | Cytovia (EpiCept Corporation) | |  |
| MX-76629 | Cytovia (EpiCept) | |  |
| MX-77356 | Cytovia (EpiCept Corporation) | |  |
| MX-86 | Pharmacor | |  |
| MY-17493 | Myogen Inc. | |  |
| My9-6-DM1 | ImmunoGen | | No Structure |
| Mycaperoxide A | Pharma Mar | 149260-79-7 |  |
| Mycaperoxide B | Pharma Mar | 149260-80-0 |  |
| Myclobutanil | Rohm & Haas | 88671-89-0 |  |
| Mycophenolate mofetil | Syntex (Roche) | 128794-94-5 |  |
| Mycophenolic acid | | 24280-93-1 ; 37415-62-6 (Sodium salt) |  |
| Mycoplanecin A | Sankyo | 72993-51-2 |  |
| Myo-inositol | | 87-89-8 |  |
| Myonovin | University of Manitoba (Canada) | |  |
| Myriceric acid A | Shionogi | 142877-49-4 |  |
| Myristamine oxide | | 3332-27-2 |  |
| Myristyl nicotinate | US Agriculture | |  |
| Myrtecaine | O. P. Gaudin | 7712-50-7 |  |
| MZ-3 | Zhejiang University (China) | |  |
| N-0861 | Nelson Res & Dev | 141696-90-4 |  |
| N-1177 | Photogen Technologies (Imcor) | |  |
| N-1379 | Nisshin Flour Milling | 104845-40-1 |  |
| N-3256 | Nisshin Flour Milling | 135971-79-8 |  |
| N-3393 | Nisshin Flour Milling | 141546-86-3 |  |
| N-3554S | Nisshin Flour Milling | 169869-86-7 |  |
| N-4472 | | |  |
| N-5984 | Nisshin Flour Milling | 220475-76-3 |  |
| N-acetyl-D-cysteine | | 26117-28-2 |  |
| N-acetylcarnosine | Babizhayev Mark (Russia)) | 56353-15-2 |  |
| N-acetyldinaline | Goedecke (Pfizer) | 112522-64-2 |  |
| N-acetylsphingosine | | 3102-57-6 |  |
| N-Allylsecoboldine | National Science Council (Taiwan) | |  |
| N-Butyl Chloride | | 109-69-3 |  |
| N-Chlorotaurine | | 51036-13-6 |  |
| N-desmethylclozapine | Acadia Pharmaceuticals | 6104-71-8 |  |
| N-Ethyl-3-Nitro PABA | | 2788-74-1 |  |
| N-Etilamfetamine | Sterling Drug (Sanofi-Aventis) | 457-87-4 |  |
| N-Hydroxyethylpromethazine chloride | Recip | 2090-54-2 |  |
| N-methylnaltrindole | (Minnesota University) | 111555-57-8 |  |
| N-phenylethyl amitriptyline | Brigham & Women's Hospital | |  |
| N-phenylphthalamic acid | DuPont | 4727-29-1 |  |
| N-retinoyl-D-glucosamine | Lion Corp. | |  |
| (N145-322Q)-Factor VIIa | Novo Nordisk Health Care AG | | No Structure |
| N20C | Universidad Miguel Hernandez ; Universidad de Extremadura ; Universidad de Valencia | |  |
| N5-PAN | Cornell University (US) ; St. Jude Children's Research Hospital (US) ; University of Tennessee (US) | |  |
| N7-PAN | Cornell University (US) ; St. Jude Children's Research Hospital (US) ; University of\nTennessee (US) | |  |
| NA-255 | Chugai | |  |
| NA-808 | Chugai Pharmaceutical Co. Ltd. (Japan) | |  |
| NAA-004 | Nobex (Biocon) | |  |
| NAB-7061 | Northern Antibiotics Ltd. | | No Structure |
| NAB-741 | Northern Antibiotics Oy (Finland) | |  |
| Nabi-3700.001 | University of Maryland ; Nabi | 224789-90-6 |  |
| Nabilone | Eli Lilly | 51022-71-0 |  |
| Nabiximols | GW Pharmaceuticals | 56575-23-6 |  |
| Nabumetone | Beecham (GSK) | 42924-53-8 |  |
| Nadifloxacin | Otsuka | 124858-35-1 |  |
| Nadolol | Squibb (BMS) | 42200-33-9 |  |
| Nadoxolol | Orsymonde (Cephalon) | 54063-51-3 |  |
| Nadroparin | Choay SA (Sanofi-aventis) | |  |
| Nafadotride | Inst. Nat. Sante Rech. Med. | 149649-22-9 |  |
| Nafamostat | Torii | 81525-10-2 |  |
| Nafarelin | Syntex (Roche) | 76932-56-4 |  |
| Nafcillin | Beecham (GSK) | 147-52-4 |  |
| Naftalofos | Bayer | 1491-41-4 |  |
| Naftazone | Nippon Shinyaku | 15687-37-3 |  |
| Naftidrofuryl | Lipha (E. Merck KGaA) | 31329-57-4 |  |
| Naftifine | Sandoz (Novartis) | 65472-88-0 |  |
| Naftopidil | Boehringer Mannheim (Roche) | 57149-07-2 |  |
| Nafuredin | Kitasato | 224427-79-6 |  |
| Naglivan | Pan Medica | 122575-28-4 |  |
| NAI-107 | Vicuron Pharmaceuticals Inc. (US) | | No Structure |
| Nalbuphine | Endo | 20594-83-6 |  |
| NALDA | Yissum Res. Dev. Co. | |  |
| Naled | California Spray Chemical | 300-76-5 |  |
| Nalfurafine | Toray | 152657-84-6 ; 152658-17-8 (hydrochloride) |  |
| Nalidixic acid | Sterling Drug (Sanofi-Aventis) | 389-08-2 |  |
| Nalmefene | DuPont (BMS) | 55096-26-9 |  |
| Nalorphine | Merck & Co. | 62-67-9 |  |
| Naloxone | Sankyo Co. | 465-65-6 |  |
| Naltrexone | Endo | 16590-41-3 |  |
| Naltrindole | Minnesota University | 111555-53-4 |  |
| Naluzotan | Predix Pharmaceuticals (Epix Pharmaceuticals) | 740873-06-7 ; 740873-82-9 (hydrochloride salt) |  |
| NAMI-A | Sigea | |  |
| Naminidil | Squibb (BMS) | 220641-11-2 |  |
| Namitecan | SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. ; Istituto Nazionale per lo Studio e la Cura dei Tu | |  |
| Nandrolone | Syntex (Roche) | 434-22-0 |  |
| Nandrolone decanoate | Organon (Schering Merck & Co) | 360-70-3 |  |
| Nandrolone phenylpropionate | Upjohn (Pharmacia) | 62-90-8 |  |
| Nandrolone undecylate | N. Gueritee | 862-89-5 |  |
| Nanterinone | Pfizer | 102791-47-9 |  |
| Naphazoline | Ciba (Novartis) | 835-31-4 |  |
| Naphthalene-1-acetamide | Rhone-Poulenc | 86-86-2 |  |
| Naphthalene-1-acetic acid | Rhone-Poulenc | 86-87-3 |  |
| Naphthyloxy-2-acetic acid | Synchemicals | 120-23-0 |  |
| Napitane | Abbott | 148152-63-0 |  |
| Naproanilide | Takazawa Yoshito | 52570-16-8 |  |
| Napropamide | Stauffer | 15299-99-7 |  |
| Naproxcinod | NicOx | 163133-43-5 |  |
| Naproxen | Syntex (Roche) | 22204-53-1 |  |
| Naproxen etemesil | Medinox (US) | 385800-16-8 |  |
| Napsagatran | Roche | 154397-77-0 |  |
| Naptalam | US Rubber | 132-66-1 |  |
| Naptumomab estafenatox | Pharmacia (Pfizer) | 676258-98-3 |  |
| Narafilcon B | Johnson & Johnson Vision Care, Inc. | 909294-16-2 |  |
| Narasin | Eli Lilly | 55134-13-9 |  |
| Naratriptan | Glaxo-Wellcome (GSK) | 143388-64-1 |  |
| Nardeterol | Boehringer Ingelheim | 73865-18-6 |  |
| Naringenin | | 480-41-1 |  |
| Narlaprevir | Schering Corp. (US) | 865466-24-6 |  |
| Naronapride | Aryx Therapeutics | 860174-12-5 ; 860169-57-9 (hydrochloride) |  |
| Nartograstim | Kirin Amgen Inc | 62683-29-8 ; 134088-74-7 | No Structure |
| NAS-181 | AstraZeneca | |  |
| Nasaruplase | Green Cross (Mitsubishi Pharma) | 99821-44-0 | No Structure |
| Nasaruplase beta | Green Cross (Mitsubishi Pharma) | 136653-69-5 |  |
| Natalizumab | Medinox | 189261-10-7 | No Structure |
| Natamycin | Konigl. NiederlL Gist & Spiritusfabr. | 7681-93-8 |  |
| Natazia (Dienogest & estradiol valerate) | Schering Ag | |  |
| Nateglinide | Ajinomoto | 105816-04-4 |  |
| Naveglitazar | Ely lilly ; Ligand | 476436-68-7 |  |
| Navitoclax | Abbott Laboratories | 923564-51-6 ; 1093851-28-5 (dihydrochloride) |  |
| Navuridine | Novirio Pharmaceuticals (Idenix Pharmaceuticals) | 84472-85-5 |  |
| NAX-5055 | University of Utah Research Foundation (US) | |  |
| Naxifylline | Florida University | 166374-49-8 |  |
| NB-001 | NanoBio | | No Structure |
| NB-1008 | NanoBio Corp. | | No Structure |
| NB-3 | Columbia University (US) ; University of Nebraska (US) | |  |
| NB-355 | Banyu | 122551-95-5 |  |
| NB-401 | University of Michigan (US) | |  |
| NB-506 | Banyu | 1510690-12-4 |  |
| NB-533 | Novartis AG (Switzerland) | |  |
| NB-544 | Novartis AG (Switzerland) | |  |
| NB-598 | Banyu | 131060-14-5 |  |
| NB-6 | Columbia University (US) ; University of Nebraska (US) | |  |
| NBC-1 | Nordic Bioscience | |  |
| NBC-2 | Nordic Bioscience | |  |
| NBDHEX | Universita degli Studi di Roma"Tor Vergata"(Italy) | |  |
| NBI-12i | Neurocrine Biosciences | |  |
| NBI-27155 | Neurocrine Biosciences | 186342-55-2 |  |
| NBI-27914 | Neurocrine Biosciences | 184241-44-9 |  |
| NBI-30545 | Neurocrine Biosciences | |  |
| NBI-31772 | Neurocrine Biosciences | 374620-70-9 |  |
| NBI-35583 | Neurocrine Biosciences (US) | |  |
| NBI-35965 | Neurocrine Biosciences | |  |
| NBI-42902 | Neurocrine Biosciences | |  |
| NBI-59159 | Neurocrine Biosciences ; Wyeth | |  |
| NBI-6024 | Neurocrine Biosciences | |  |
| NBI-74330 | Tularik (Amgen) | |  |
| NBI-98854 | Neurocrine Biosciences Inc. | | No Structure |
| NBTA | University of California; Torrey Pines Institute for Molecular Studies | 344361-02-0 |  |
| NC-077 | University of Freiburg ; Cancer Research Campaign | |  |
| NC-100150 | Nycomed | 321309-50-6 | No Structure |
| NC-1175 | Wayne State University ; University of Saskatchewan | |  |
| NC-196 | Nissan | 133456-86-7 |  |
| NC-2100 | Nippon Chemiphar | 179068-64-5 |  |
| NC-3 | Diamyd Medical AB | | No Structure |
| NC-324 | Nissan | 120101-22-6 |  |
| NC-330 | Nissan | 104770-29-8 |  |
| NC-381 | Childrens Medical Center ; Harvard College ; Ion Pharmaceuticals | |  |
| NC-4 | Nippon Chemiphar Co. (Japan) | |  |
| NCA-0424 | Taisho | 208446-44-0 |  |
| NCI-366218 | Enzo Biochem | |  |
| NCI-8642 | Enzo Biochem | |  |
| NCQ-616 | AstraZeneca | |  |
| NCS-382 | CNRS | 131733-92-1 |  |
| NCS-708069 | University of Camerino ; Consiglio Nazionale Ricerche | |  |
| NCX-1000 | NicOx | 175033-36-0 |  |
| NCX-1005 | NicOx | 206197-04-8 |  |
| NCX-1015 | NicOx ; William Harvey Research | |  |
| NCX-1022 | NicOx | |  |
| NCX-1047 | NicOx SA ; Grupo Ferrer Internacional SA | | No Structure |
| NCX-1102 | NicOx | 326850-47-9 |  |
| NCX-1510 (Cetirizine) | NicOx SA | |  |
| NCX-2111 | NicOx | 302543-76-6 |  |
| NCX-2213 | NicOx | 302543-95-9 |  |
| NCX-4016 | NicOx | 175033-36-0 |  |
| NCX-4040 | NicOx | |  |
| NCX-4050 | NicOx | 290335-23-8 |  |
| NCX-4215 | NicOx | 171781-26-3 |  |
| NCX-456 | NicOx | 256499-26-0 |  |
| NCX-530 | NicOx | 204268-63-3 |  |
| NCX-6560 | NicOx S.A. (France) | |  |
| NCX-701 | NicOx | 326850-30-0 |  |
| NCX-899 | NicOx (Italy) | |  |
| NCX-972 | Nicox | |  |
| [Ncy(isopropyl)7]acyline | Ferring ; Salk Institute for Biological Studies | |  |
| ND-0117 | Nova Decision (OriBase Pharma) | |  |
| ND-0118 | Nova Decision (OriBase Pharma) | |  |
| ND-0119 | Nova Decision (OriBase Pharma) | |  |
| ND-6732 | University of Notre Dame du Lac (US) | |  |
| NDC-052 | Korea Research Institute of Bioscience and Biotechnology (South Korea) | | No Structure |
| NDC-1022 | Endece LLC (US) | |  |
| NDC-1033 | Endece LLC (US) | |  |
| NDC-1044 | Endece LLC (US) | |  |
| NDC-1308 | Endece LLC | |  |
| NDC-1353 | Endece LLC | | No Structure |
| NDC-1363 | Endece LLC | | No Structure |
| NDD-094 | Sandoz (Novartis) | 148257-48-1 |  |
| NDT-9513727 | Neurogen Corp. (US) | |  |
| NDT-9530021 | Neurogen Corp. (US) | |  |
| NE-0080 | Neose Technologies | | No Structure |
| NE-100 | Taisho | 149409-57-4 |  |
| NE-10790 | Procter & Gamble | |  |
| NE-2001 | University of Nanjing | |  |
| NE-535 | Taisho | |  |
| NE-537 | Taisho | 177587-59-6 |  |
| Nebentan | Yamanouchi (Astellas) | 403604-85-3 |  |
| Nebicapone | Portela (Portugal) | 274925-86-9 |  |
| Nebivolol | Janssen Pharmaceutica (Johnson & Johnson) | 99200-09-6 |  |
| Neboglamine | RottaPharm/Madeus | 163000-63-3 |  |
| Nebracetam | Boehringer Ingelheim | 116041-13-5 |  |
| Neburon | DuPont | 555-37-3 |  |
| Necitumumab | Imclone Systems Inc. (US) | 906805-06-9 | No Structure |
| Nedaplatin | Shionogi | 95734-82-0 |  |
| Nedocromil | Fisons | 69049-73-6 |  |
| Nefazodone | Mead Johnson | 83366-66-9 |  |
| Nefiracetam | Nattermann (Aventis) | 77191-36-7 |  |
| Nefopam | Riker | 13669-70-0 |  |
| NEL | Wisconsin Alumni Research Foundation (US) | |  |
| Nelarabine | Wellcome Foundation (GSK) | 121032-29-9 |  |
| Nelfinavir | Agouron (Pfizer) | 159989-65-8 |  |
| Nelivaptan | Sanofi-Synthelabo (Sanofi-Aventis) | 439687-69-1 |  |
| Nelotanserin | Arena Pharmaceuticals | 839713-36-9 |  |
| Neltenexine | Pulitzer Italiana | 99453-84-6 |  |
| Nemifitide | Innapharma (Tetragenex) | 173240-15-8 |  |
| Nemonapride | Yamanouchi (Astellas) | 75272-39-8 |  |
| Nemonoxacin | Procter & Gamble Pharmaceuticals | 378746-64-6 |  |
| Nemorubicin | Farmitalia Carlo Erba (Pfizer) | 108852-90-0 |  |
| NEO-356 | NeoTherapeutics | |  |
| NEO-376 | Neotherapeutics | |  |
| NEO-377 | Neotherapeutics | |  |
| NEO-392 | Neotherapeutics | |  |
| NEO-6002 | Neopharm | |  |
| Neoamphimedine | GSK | |  |
| Neoarsphenamine | A. K. Philip | 457-60-3 |  |
| Neocimicigenoside A | Asahi Breweries Ltd. (Japan) | |  |
| Neocimicigenoside B | Asahi Breweries Ltd. (Japan) | |  |
| NeoFuse | Medvet Science Pty Ltd. (Australia) | | No Structure |
| Neostigmine | Hoffmann La Roche (Roche) | 114-80-7 |  |
| Neotame | NutraSweet (Monsanto) | 165450-17-9 |  |
| Neotripterifordin | | |  |
| Neovastat | Aeterna Laboratories (Aeterna Zentaris) | 305838-77-1 | No Structure |
| Nepadutant | Menarini | 183747-35-5 |  |
| Nepafenac | Robins | 78281-72-8 |  |
| Nepicastat | Roche Bioscience | 173997-05-2 |  |
| Nepidermin | Hitachi Chemical Co. (Japan) | 62253-63-8 |  |
| Neplanocin A | Saitama Cancer Center | 72877-50-0 |  |
| NEPP-11 | Osaka Bioscience Institute | |  |
| Nequinate | ICI (AstraZeneca) | 13997-19-8 |  |
| Neramexane | Merz | 219810-59-0 |  |
| Neratinib | Wyeth (Pfizer ) | 698387-09-6 |  |
| Neridronic acid | | 79778-41-9 |  |
| Nerispirdine | Hoechst Roussel Pharma (Sanofi-Aventis) | 119229-65-1 |  |
| Neristatin 1 | University of Arizona | 135004-30-7 |  |
| Nesbuvir | ViroPharma ; Wyeth Corp. | 691852-58-1 |  |
| Nesiritide | California Biotechnology | 124584-08-3 |  |
| NESS-070-C5 | Neuroscienze PharmaNess Scarl | |  |
| Nestifylline | Chem Spa | 116763-36-1 |  |
| NEt-3IP | National University Corp. Okayama University (Japan) | |  |
| Neticonazole | SS Pharmaceutical | 130726-68-0 |  |
| Netilmicin | Scherico | 56391-56-1 |  |
| Netobimin | Schering Corp (Merck & Co) | 88255-01-0 |  |
| Netoglitazone | Mitsubishi Chemicals | 161600-01-7 |  |
| Netupitant | Hoffmann-La Roche | 290297-26-6 |  |
| NEU-2000 | Neurotech Pharmaceuticals (South Korea) | |  |
| Neuraben | Biondustria Farmaceutici | |  |
| Neuradiab | Duke University | | No Structure |
| Neuropeptide S | University of California | |  |
| Neurosolve | | | No Structure |
| NeuroTriptin | Pharmagenesis Inc. | | No Structure |
| NeuVax | University of Texas | |  |
| Nevirapine | Boehringer Ingelheim | 129618-40-2 |  |
| Nexvax-2 | Isis Innovation Ltd. (GB) | | No Structure |
| NF-11491 | Takeda | 464177-59-1 |  |
| NF-115 | CSIC ; Hospital Universitario Puerta de Hierro | |  |
| NF-242479 | Nippon Soda | 102800-64-6 |  |
| NF-546 | Rheinische Friedrich-Wilhelms Universität Bonn (Germany) | |  |
| NF-676 | University of Bonn (Germany) ; University of Vienna (Austria) | |  |
| NFD-37 | Chungbuk National University (Korea) ; Yeungnam University (Korea) | |  |
| NFPS | Merck & Co | |  |
| NG-061 | Taisho | 142984-71-2 |  |
| NG-2 | University of Pittsburgh (US) | | No Structure |
| NG2-83 | Neurogen Corp. (US) | |  |
| NGB-2849 | Neurogen (US) | |  |
| NGB-2904 | Neurogen (US) | |  |
| NGD-91-3 | Pfizer | | No Structure |
| NGD-96-1 | Neurogen | | No Structure |
| NGD-96-3 | Neurogen | | No Structure |
| NGD-97-1 | Neurogen | | No Structure |
| NGD-98-1 | Neurogen | 245733-79-3 |  |
| Ngercheumicin D | Marine Biotechnology Institute Co. Ltd. (Japan) | |  |
| NGP-328 | NeuroGenetics Inc. | |  |
| NGP-921 | Wisconsine University (US) | 154-17-6 |  |
| NGX-267 | IIBR (Isreal Institute for Biological Research) | |  |
| NGX-426 | Eli Lilly | |  |
| Nialamide | Pfizer | 51-12-7 |  |
| Niaprazine | CERM | 27367-90-4 |  |
| Nibentan | Ts Khim Lekarstvennykh Sredstv | |  |
| NIBR-1282 | Novartis AG (Switzerland) | |  |
| NIBR-785 | Novartis AG ; Novartis Pharma GmbH | |  |
| NIC-002 | Cytos Biotechnology Ltd. | | No Structure |
| Nicainoprol | | 76252-06-7 |  |
| Nicametate | Lafon (Cephalon) | 3099-52-3 |  |
| Nicaraven | Chugai (Roche) | 79455-30-4 |  |
| Nicarbazin | Merck & Co. | 330-95-0 |  |
| Nicardipine | Yamanouchi (Astellas) | 55985-32-5 |  |
| Nicergoline | Farmitalia Carlo Erba (Pharmacia) | 27848-84-6 |  |
| Niceritrol | Societe d'etudes et de recherches pharmacotechniques | 5868-05-3 |  |
| Niclofolan | Bayer | 10331-57-4 |  |
| Niclosamide | Bayer | 50-65-7 |  |
| Nicoboxil | Boehringer Ingelheim | 13912-80-6 |  |
| Nicoclonate | Kuhlmann | 10571-59-2 |  |
| Nicofetamide | Cilag | 553-06-0 |  |
| Nicofibrate | Merck & Co. | 31980-29-7 |  |
| Nicofuranose | Eprova (E. Merck KGaA) | 15351-13-0 |  |
| Nicomol | Irikura | 27959-26-8 |  |
| Nicorandil | Chugai (Roche) | 65141-46-0 |  |
| Nicosulfuron | DuPont ; Ishihara Sangyo | 111991-09-4 |  |
| Nicotinamide | SMA | 98-92-0 |  |
| Nicotine | | 54-11-5 |  |
| Nicotinic acid | Abbott | 59-67-6 |  |
| Nicotinic acid benzyl ester | Nordmark | 94-44-0 |  |
| Nicotinyl alcohol | Hoffmann La Roche (Roche) | 100-55-0 |  |
| NicVAX | Nabi Biopharmaceuticals | | No Structure |
| NIDA-41020 | National Institute on Drug Abuse | |  |
| NIDA-52189 | National Institute on Drug Abuse (NIDA) ; National Instute of Health (NIH) | |  |
| Niduline | Chosun University (Korea) | |  |
| Nifedipine | Bayer | 21829-25-4 |  |
| Nifekalant | Mitsui | 130636-43-0 |  |
| Nifenalol | Selvi | 7413-36-7 |  |
| Nifenazone | Dr. Werner Heid | 2139-47-1 |  |
| Niflumic acid | UPSA | 4394-00-7 |  |
| Nifuradene | Norwith | 555-84-0 |  |
| Nifuratel | Polichimica | 4936-47-4 |  |
| Nifurfoline | Esteve | 3363-58-4 |  |
| Nifuroxazide | Robert et Carriere | 965-52-6 |  |
| Nifuroxime | Norwich | 6236-05-1 |  |
| Nifurpirinol | Dainippon Pharmaceutical | 13411-16-0 |  |
| Nifurprazine | Boehringer Mannheim (Roche) | 1614-20-6 |  |
| Nifursemizone | Norwich Eaton (Procter & Gamble) | 5579-89-5 |  |
| Nifursol | Salsbury | 16915-70-1 |  |
| Nifurtimox | Bayer | 23256-30-6 |  |
| Nifurtoinol | Norwich | 1088-92-2 |  |
| Nifurzide | Lipha (E. Merck KGaA) | 39978-42-2 |  |
| (+)-Niguldipine | Byk Gulden (Nycomed) | 120054-86-6 |  |
| NIH-11082 | Virginia Commonwealth Universit | |  |
| NIK-12192 | Nikem Research | |  |
| Nikethamide | Ciba (Novartis) | 59-26-7 |  |
| Nikkomycin-Z | Bayer | 59456-70-1 |  |
| NIL-A | Guilford Pharmaceuticals (Eisai Co) | 848859-43-8 |  |
| Nilotinib | Novartis | 641571-10-0 |  |
| Nilutamide | Roussel-Uclaf (Aventis) | 63612-50-0 |  |
| Nilvadipine | Fujisawa | 75530-68-6 |  |
| NIM-811 | Novartis | 143205-42-9 |  |
| Nimesulide | Riker | 51803-78-2 |  |
| Nimetazepam | Hoffmann La Roche (Roche) | 2011-67-8 |  |
| Nimidane | American Cyanamid (BASF) | 50435-25-1 |  |
| Nimodipine | Bayer | 66085-59-4 |  |
| Nimorazole | Farmitalia Carlo Erba (Pharmacia) | 6506-37-2 |  |
| Nimotuzumab | CIMAB | 828933-51-3 | No Structure |
| Nimustine | Sankyo | 42471-28-3 |  |
| NIP-121 | Nissan Chemical | 135244-62-1 |  |
| NIP-141 | Nissan Chemical | |  |
| NIP-222 | Nissan Chemical Industries | |  |
| NIP-520 | Nissan Chemical | |  |
| NIP-530 | Nissan chemical | |  |
| Niperotidine | Ausonia | 84845-75-0 |  |
| Nippon Soda New Herbicide | Nippon Soda | |  |
| Nipradilol | Kowa | 81486-22-8 |  |
| Niprisan | United Nations Development Programme (Nigeria) ; National Institute for Pharmaceutical Research and | | No Structure |
| Niravoline | Hoechst (Sanofi-Aventis) | 130610-93-4 |  |
| Niridazole | Ciba (Novartis) | 61-57-4 |  |
| Nisin | Applied Microbiology (AMBI) | 1414-45-5 |  |
| Nisoldipine | Bayer | 63675-72-9 |  |
| Nitarsone | Federal Security Agency | 98-72-6 |  |
| Nitazoxanide | Phavic (Romark) | 55981-09-4 |  |
| NITD-008 | Novartis AG | |  |
| NITD-203 | Novartis AG | |  |
| NITD-609 | Novartis AG | |  |
| Nitecapone | Orion | 116313-94-1 |  |
| Nitenpyram | Takeda | 120738-89-8 |  |
| Nithiazine | Shell | 58842-20-9 |  |
| Nitisinone | Stauffer (Syngenta) | 104206-65-7 |  |
| Nitracrine | Polfa | 4533-39-5 |  |
| Nitrapyrin | DowElanco | 1929-82-4 |  |
| Nitrazepam | Hoffmann La Roche (Roche) | 146-22-5 |  |
| Nitrefazole | E. Merck KGaA | 21721-92-6 |  |
| Nitrendipine | Bayer | 39562-70-4 |  |
| Nitric oxide | | 10102-43-9 | No Structure |
| Nitrodexketoprofen | NicOx | |  |
| Nitrofen | Rohm & Haas | 1836-75-5 |  |
| Nitroflurbiprofen | NicOx | 158836-71-6 |  |
| Nitrofluvastatin | NicOx | 733034-56-5 |  |
| Nitrofural | Eaton | 59-87-0 |  |
| Nitrofurantoin | Eaton | 67-20-9 |  |
| Nitroglycerin | | 55-63-0 |  |
| Nitromersol | | 133-58-4 |  |
| Nitromide | | 121-81-3 |  |
| Nitropravastatin | NicOx | |  |
| Nitroscanate | Agripat | 19881-18-6 |  |
| Nitrosopine | University of Tokushima (Japan) | |  |
| Nitrothal-Isopropyl | BASF | 10552-74-6 |  |
| Nitrovin | Toyama | 804-36-4 |  |
| Nitroxazepine | Ciba (Novartis) | 16398-39-3 |  |
| Nitroxinil | May & Baker (Aventis) | 1689-89-0 |  |
| Nitroxoline | Sanders | 4008-48-4 |  |
| Nivocasan | LG Life Sciences Ltd. (South Korea) | 1001913-20-7 ; 908253-63-4 |  |
| Nizatidine | Eli Lilly | 76963-41-2 |  |
| Nizofenone | Yoshitomi | 54533-85-6 |  |
| NK-012 (SN-38) | Nippon Kayaku | 86639-52-3 |  |
| NK-026680 | Nippon Kayaku | |  |
| NK-105 (polymeric micelle Paclitaxel) | Nippon Kayaku | |  |
| NK-30424B | Nippon Kayaku | |  |
| NK-314 | Nippon Kayaku | |  |
| NK-3201 | Nippon Kayaku | |  |
| NK-33882LA | Nippon Kayaku | |  |
| NK-5807 | Nippon Kayaku | |  |
| NK-611 | Microbial Chemical Research Foundation | 105760-98-3 |  |
| NK-911 (Doxorubicin) | Tokyo Women Medical University ; Japan Science & Technology. | |  |
| NKI-42650 | Bayer | 165675-52-5 |  |
| NKP-608 | Novartis | |  |
| NKS-01 | Snow Brand Milk | 120051-39-0 |  |
| NKT-343 | Sandoz (Novartis) | 180046-99-5 |  |
| NKTR-061 (Amikacin) | Nektar Therapeutics | 37517-28-5 |  |
| NKTR-063 (Vancomycin) | Nektar Therapeutics | 1404-90-6 |  |
| NKTR-102 | Nektar Therapeutics AL Corp. (US) | |  |
| NKTR-105 | Nektar Therapeutics | |  |
| NKTR-118 | Nektar Therapeutics | |  |
| NKTR-119 | Nektar Therapeutics | | No Structure |
| NKTR-125 | Nektar Therapeutics | |  |
| NKTR-140 | Nektar Therapeutics | | No Structure |
| NKTR-171 | Nektar Therapeutics | | No Structure |
| NKTR-181 | Nektar Therapeutics | | No Structure |
| NKTR-194 | Nektar Therapeutics | | No Structure |
| NLCPQ-1 | Evanston Hospital | 187985-19-9 |  |
| NLCQ-1 | Evanston Hospital | |  |
| NLNQ-1 | Evanston Northwestern Healthcare | |  |
| NM-100060 (Terbinafine) | NexMed | 91161-71-6 ; 78628-80-5 (hydrochloride) |  |
| NM-135 | Nissin Food Products | 169453-84-3 |  |
| NM-3 | Mercian | 181427-78-1 |  |
| NM-324 | University of Michigan | 144796-42-9 |  |
| NMI-1182 | NitroMed | |  |
| NMI-187 | Nitromed | 242140-32-5 |  |
| NMI-377 | NitroMed | |  |
| NMI-EPB | Research Triangle Institute (US) | |  |
| NML-120B | Millenium Pharmaceuticals | |  |
| NMRC-M3V-Ad-PfCA | GenVec Inc. (US) ; Navy Naval Medical Research Center (US) | | No Structure |
| NMS-60 | Sumitomo Chemical | |  |
| NMSO3 | Nissin Food Products | 199601-01-9 |  |
| NN-1218 | | | No Structure |
| NN-1810 | Novo Nordisk AS | | No Structure |
| NN-1841 | ZymoGenetics Inc. | | No Structure |
| NN-1952 | | | No Structure |
| NN-344 | Novo Nordisk | | No Structure |
| NN-4440 (Repaglinide & Metformin) | Novo Nordisk AS (Denmark) | 135062-02-1 (Repaglinide) ; 657-24-9 (Metformin) |  |
| NN-5401 (Insulin Degludec & Insulin Aspart) | Novo Nordisk AS | 844439-96-9 (Insulin Degludec) ; 116094-23-6 (Insulin Aspart) | No Structure |
| NN-7008 | | | No Structure |
| NN-7088 | Novo Nordisk AS | | No Structure |
| NN-7129 | | | No Structure |
| NN-7415 | Novo Nordisk AS | | No Structure |
| NN-7999 | | | No Structure |
| NN-8209 | | | No Structure |
| NN-8226 | ZymoGenetics Inc. | | No Structure |
| NN-8630 | | | No Structure |
| NN-8828 | Zymogenetics Inc. (Bristol-Myers Squibb Co.) | | No Structure |
| NN-9068 | Novo Nordisk AS | 844439-96-9 (Insulin degludec) ; 204656-20-2 (Liraglutide) | No Structure |
| NN-9161 | | | No Structure |
| NN-9924 | | | No Structure |
| NN-9925 | | | No Structure |
| NNC-079202 | Schering AG | 118876-58-7 |  |
| NNC-1202 | Boehringer Ingelheim; Novo Nordisk | |  |
| NNC-13-8199 | Map Medical Technologies ; Merck & Co. ; Aktieselskabet Ferrosan (Den) | 106937-64-8 |  |
| NNC-13-8241 | Aktieselskabet Ferrosan (Den) | 106447-61-4 |  |
| NNC-14-0189 | Novo Nordisk | 150867-91-7 |  |
| NNC-210136 | Novo Nordisk | 162684-35-7 |  |
| NNC-22-0031 | Novo Nordisk | 150396-89-7 |  |
| NNC-25-0926 | Novo Nordisk A/S | |  |
| NNC-252504 | Agouron ; Novo Nordisk | 280134-25-0 |  |
| NNC-38-1049 | Boehringer Ingelheim; Novo Nordisk | |  |
| NNC-52-0956 | Novo Nordisk ; Ontogen | |  |
| NNC-521246 | Novo Nordisk ; Ontogen | |  |
| NNC-55-9216 | Novo Nordisk | |  |
| NNC-550118 | Novo Nordisk | |  |
| NNC-550396 | Novo Nordisk | |  |
| NNC-57-0558 | Novo Nordisk | |  |
| NNC-63-0532 | Novo Nordisk | |  |
| NNC-77-0020 | Novo Nordisk | |  |
| NNC-77-0074 | Novo Nordisk | |  |
| NNI-9768 | Nihon Nohyaku | 183053-92-1 |  |
| NNZ-2566 | Neuren Pharmaceuticals | |  |
| NNZ-3006 | Neuren Pharmaceuticals Ltd. | | No Structure |
| NNZ-8000 | Neuren Pharmaceuticals Ltd. | | No Structure |
| Nobiletin | Kgk Synergize (Canada); US AGRICULTURE (US) ; Amgen (US) | 29043-07-0 ; 478-01-3 |  |
| Nocathiacin IV | Bristol-Myers Squibb (BMS) | |  |
| Nociceptin | | 170713-75-4 |  |
| Nocloprost | Schering AG | 79360-43-3 |  |
| Nocodazole | Janssen Pharmaceutica (Johnson & Johnson) | 31430-18-9 |  |
| Nolatrexed | Agouron (Pfizer) | 147149-76-6 |  |
| Nolomirole | Chiesi Farmaceutici | 90060-42-7 |  |
| Nolpitantium besilate | Sanofi (Sanofi-Aventis) | 155418-06-7 |  |
| Nolpitantium chloride | Sanofi (Sanofi-Aventis) | 153050-21-6 |  |
| NOMAC-E2 (Nomegestrol acetate & Estradiol) | Theramex (Merck KgaA) | | No Structure |
| Nomegestrol | | 58691-88-6 |  |
| Nomegestrol acetate | Gastaud Jean M | 58652-20-3 |  |
| Nomifensine | Hoechst (Sanofi-Aventis) | 24526-64-5 |  |
| Nonacog alfa | BTG International | 181054-95-5 | No Structure |
| Nonivamide | Boehringer Ingelheim | 2444-46-4 |  |
| Nonoxynol 9 | Ortho McNeil (Johnson & Johnson) | 26027-38-3 |  |
| Nooglutil | Nauchno Issledovatelsky Inst. | 112193-35-8 |  |
| Nootkatone | Firmenich | 4674-50-4 ; 91416-23-8 |  |
| Norathiol | Medinox | | No Structure |
| Nordazepam | Hoffmann La Roche (Roche) | 1088-11-5 |  |
| Nordihydroguaiaretic acid | Sulphite Products | 500-38-9 |  |
| Norea | Hercules | 18530-56-8 |  |
| Norelgestromin | Richter Gedeon Vegyeszet | 53016-31-2 |  |
| Norepinephrine | Sterling Drug (Sanofi-Aventis) | 51-41-2 |  |
| Norethandrolone | Searle | 52-78-8 |  |
| Norethisterone | Syntex (Roche) | 68-22-4 |  |
| Norethisterone acetate | Schering AG | 51-98-9 |  |
| Norethisterone enanthate | Schering AG | 3836-23-5 |  |
| Norfenefrine | Ciba (Novartis) | 536-21-0 |  |
| Norfloxacin | Kyorin | 70458-96-7 |  |
| Norfloxacin succinyl | Farmades | 100587-52-8 |  |
| Norflurazon | Sandoz (Syngenta) | 27314-13-2 |  |
| Norgestimate | Ortho McNeil (Johnson & Johnson) | 35189-28-7 |  |
| Norgestrel | Smith Herchel | 6533-00-2 |  |
| Norgestrienone | Roussel Uclaf | 848-21-5 |  |
| Norisoboldine | China Pharmaceutical University (China) | 23599-69-1 |  |
| Normethadone | Hoechst (Sanofi-Aventis) | 467-85-6 |  |
| Nortopixantrone | Boehringer Mannheim (Roche) ; Vermont University | 156090-17-4 |  |
| Nortriptyline | Merck & Co. | 72-69-5 |  |
| Norzoanthamine | Sagami Chemical | 164991-65-5 |  |
| Nostocyclopeptide M1 | University of Helsinki (Finland) ; Bergen Teknologioverfoering AS (Norway) | |  |
| NOV-205 | Novelos Therapeutics Inc., US | |  |
| Novaluron | Donegani Guido IST | 116714-46-6 |  |
| Noviflumuron | Hoechst (Sanofi-Aventis) | 121451-02-3 |  |
| Novobiocin | Merck & Co. | 303-81-1 |  |
| NOX-700 | | 634912-57-5 | No Structure |
| NOX-B11 | Noxxon Pharma AG | | No Structure |
| NOX-F37 | Noxxon Pharma AG | | No Structure |
| Noxiptiline | Bayer | 3362-45-6 |  |
| Noxytiolin | Bayer | 15599-39-0 |  |
| NP-04634 | Neuropharma SA (Noscira SA) | |  |
| NP-06-1 | KKgk Synergize (Canada); US AGRICULTURE (US) ; Amgen (US) | |  |
| NP-118809 | Neuromed Technologies Inc. (CombinatoRx Inc.) | |  |
| NP-2 | University of Pittsburgh (US) | | No Structure |
| NP-213 | NovaBiotics Ltd. (GB) | |  |
| NP-339 | NovaBiotics Ltd. | |  |
| NP-432 | Novabiotics Ltd. | |  |
| NPB-001-05 | Piramal Life Sciences Ltd. | | No Structure |
| NPB-11 | Lead Chemical | |  |
| NPC-15437 | Tulane University | 136449-85-9 |  |
| NPC-15669 | Nova Pharmaceutical | 132684-62-9 |  |
| NPC-17731 | Nova Technology | 147267-10-5 |  |
| NPH-30907 | Nicholas Piramal India Ltd. (Piramal Healthcare Ltd.) | 24393-56-4 |  |
| NPI-32101 | Nucryst Pharmaceuticals | | No Structure |
| NPS-1407 | NPS Pharmaceuticals | 186495-93-2 (HCl) |  |
| NPS-2390 | NPS Pharmaceuticals | |  |
| NPS-31807 | Nicholas Piramal India Ltd. (Piramal Healthcare Ltd.) | |  |
| NPS-53574 | NPS Pharmaceuticals | |  |
| NQ-12 | Seoul University | 62101-44-4 |  |
| NR-584 | NeoRx | |  |
| NRA-0045 | Taisho ; Nihon Nohyaku | 183949-64-6 |  |
| NRA-0562 | Taisho ; Nihon Nohyaku | 244276-65-1 |  |
| NRC-13 | National Research Council of Canada | |  |
| NRC-2694 | Natco Pharma Ltd. (India) | |  |
| NRGN-16 | Neurogen | |  |
| NRX-195183 | | | No Structure |
| NS-004 | NeuroSearch | 141797-92-4 |  |
| NS-11394 | NeuroSearch AS (Denmark) | 951650-22-9 |  |
| NS-1209 | NeuroSearch | 205645-02-9 (sodium salt) |  |
| NS-1231 | NeuroSearch | |  |
| NS-1619 | NeuroSearch | 153587-01-0 |  |
| NS-1643 | Neurosearch | |  |
| NS-1738 | NeuroSearch AS (Denmark) | 501684-93-1 |  |
| NS-220 | Nippon Shinyaku | |  |
| NS-2359 | National Institue Drug Abuse (NIDA) | 843660-54-8 | No Structure |
| NS-245852 | Nippon Soda | 158350-38-0 |  |
| NS-257 | NeuroSearch | 147750-87-6 |  |
| NS-2710 | NeuroSearch (Denmark) | |  |
| NS-309 | Neurosearch AS | |  |
| NS-3623 | NeuroSearch | |  |
| NS-3736 | NeuroSearch | |  |
| NS-3763 | NeuroSearch | |  |
| NS-3956 | Neurosearch AS | |  |
| NS-398 | Taisho | 123653-11-2 |  |
| NS-409 | Warner Lambert (Pfizer) | 156694-78-9 |  |
| NS-4591 | NeuroSearch AS (Denmark) | |  |
| NS-49 | Nippon Shinyaku | 137431-02-8 |  |
| NS-521 | NeuroSearch | 198969-52-7 |  |
| NS-649 | NeuroSearch | 146828-02-6 |  |
| NS-7051 | NeuroSearch AS (Denmark) | |  |
| NS-8 | Nippon Shinyaku | |  |
| NS-8593 | Neurosearch | 875755-24-1 |  |
| NS-9 | Nippon Shinyaku | | No Structure |
| NSC-134754 | | |  |
| NSC-13755 | Government Of The USA | |  |
| NSC-13759 | Government Of The USA | 87076-01-5 |  |
| NSC-13771 | Government Of The USA | |  |
| NSC-13778 | Government Of The USA | |  |
| NSC-13793 | Government Of The USA | 5430-42-2 |  |
| NSC-17318 | Department of Veterans Affairs ; Wellesley College | |  |
| NSC-20625 | | |  |
| NSC-23766 | Childrens Hospital Medical Center ; St Jude Childrens Research Hospital | 733767-34-5 |  |
| NSC-281612 | US National Cancer Institute | |  |
| NSC-28620 | Government Of The USA | |  |
| NSC-287474 | Goedecke (Pfizer) | 60050-95-5 |  |
| NSC-314622 | US Health ; Purdue Research Foundation | |  |
| NSC-361456 | Alabama University | 103829-46-5 |  |
| NSC-403178 | Beijing Normal University | |  |
| NSC-4493 | National Cancer Institute | 5398-51-6 |  |
| NSC-606985 | US Health | |  |
| NSC-607097 | National Cancer Institute | 96251-59-1 |  |
| NSC-620055 | Texas Southern | |  |
| NSC-624151 | Tennessee University | 120586-49-4 |  |
| NSC-639365 | Sphinx | |  |
| NSC-643735 | | |  |
| NSC-644221 | US Government | |  |
| NSC-651016 | Farmitalia Carlo Erba (Pharmacia) | 208576-37-8 |  |
| NSC-652287 | Industrial Technology Research Inst. | 213261-59-7 |  |
| NSC-663284 | National Cancer Institute; University of Pittsburg | |  |
| NSC-672121 | Pfizer | |  |
| NSC-67657 | National Cancer Institute | |  |
| NSC-676693 | ADIR (Servier) | |  |
| NSC-710305 | Cancer Research Campaign Technology | 328087-38-3 |  |
| NSC-721782 | Medical College of Georgia (USA) | |  |
| NSC-725671 | Purdue University | |  |
| NSC-726189 | University of Oklahoma ; Oklahoma State University | |  |
| NSC-727357 | Purdue University | |  |
| NSC-733436 | University of Pisa | |  |
| NSC-95397 | Pfizer | |  |
| NSC-95580 | | 3073-59-4 |  |
| NSC-D699126 | University of Reading ; Institut of Cancer Research ; University of Belfast | |  |
| NSC-D699127 | University of Reading ; Institut of Cancer Research ; University of Belfast | |  |
| NSC-D701062 | University of Reading ; Institut of Cancer Research ; University of Belfast | |  |
| NSD-721 | | | No Structure |
| NSD-788 | NeuroSearch AS | | No Structure |
| NSFQ-105 | Bouchara | 154269-12-2 |  |
| NSK-905 | Tokuyama | 111168-06-0 |  |
| NSP-513 | Nippon Soda | 179185-30-9 |  |
| NSP-804 | Nippon Soda | 125068-43-1 |  |
| NST-141 | Nippon Shinyaku | | No Structure |
| NT-13 | Nyxis Neurotherapies | 424-020-8 |  |
| NT-501 | Neurotech Pharmaceuticals | | No Structure |
| NT-69L | Mayo Foundation | 246871-37-4 |  |
| NT-77 | Mayo Foundation | |  |
| NT-79 | Mayo Foundation for Medical Education and Research (US) | |  |
| NT4(8-13)-MTX | Universita degli Studio di Siena (Italy) | |  |
| NTC-801 | Nissan Chemical Industries Ltd. | | No Structure |
| NTN-32692 | Nihon Tokushu Noyaku Seizo | 101336-63-4 |  |
| NTX-NTX | University of Kentucky | |  |
| NU-1025 | Cancer Research Campaign Technology | 90417-38-2 |  |
| NU-1085 | University of Newcastle | |  |
| NU-172 | Archemix (US) | | No Structure |
| NU-2058 | Cancer Research Campaign Technology | 161058-83-9 |  |
| NU-206 | Nuvelo ; Kirin | | No Structure |
| NU-6027 | University of Newcastle Upon Tyne | 220036-08-8 |  |
| NU-7026 | KuDOS Pharmaceuticals | 154447-35-5 |  |
| NU-7279 | Cancer Research Technology | 500169-73-3 |  |
| NU-7427 | Cancer Research Technology (UK) | |  |
| NU-7441 | Cancer Research Technology | |  |
| NU-8231 | | |  |
| Nuarimol | Eli Lilly | 63284-71-9 |  |
| Nubiotic 2 | Oligo Therapeutics | |  |
| NUCB-1000 | Nucleonics | | No Structure |
| Nutlin-1 | Hoffmann La Roche | |  |
| Nutlin-2 | Hoffmann La Roche | |  |
| Nutlin-3 | Hoffmann La Roche | 548472-68-0 |  |
| Nuvenzepine | Dompe | 96487-37-5 |  |
| NV-1020 | Roizman Bernard | | No Structure |
| NV-128 | Novogen Research Pty Ltd. | |  |
| NV-143 | Novogen Ltd. | | No Structure |
| NV-27 | | | No Structure |
| NV-31 | Philipps Universitat Marburg | 335259-33-1 |  |
| NV-344 | | | No Structure |
| NV-52 | | | No Structure |
| NV1FGF | | | No Structure |
| NVB-302 | Novacta Biosystems Ltd. (GB) | | No Structure |
| NVC-101 | NovaCal Pharmaceuticals (NovaBay Pharmaceuticals, Inc.) | | No Structure |
| NVP-AAM077 | Novartis | 459836-30-7 |  |
| NVP-ABE171 | Novartis | |  |
| NVP-ACQ-090 | Novartis | |  |
| NVP-ADW-742 | Novartis | |  |
| NVP-AEW541 | Novartis | |  |
| NVP-AFA873 | Novartis AG ; Novartis Pharma GMBH | |  |
| NVP-AUY-922 | Vernalis Ltd. ; Cancer Research Technology Ltd. ; The Institute of Cancer Research | 747412-49-3 |  |
| NVP-BEP800 | Vernalis Ltd. (GB) ; Cancer Research Technology Ltd. (GB) ; The Institute of Cancer Research (GB) | |  |
| NVP-BHG-712 | Novartis AG | 940310-85-0 |  |
| NVP-BKM-120 | Novartis AG | |  |
| NVP-QAV-572 | Novartis AG (Switzerland) | |  |
| NVP-TAE684 | Novartis AG (Switzerland) ; Novartis Pharma GmbH (Austria) | |  |
| NVX-207 | Novelix Pharmaceuticals Inc. (US) | |  |
| NW-1100 | Newron | |  |
| NW-1772 | Newron Pharmaceuticals SpA | |  |
| NW-3509 | Newron Pharmaceuticals SpA (Italy) | |  |
| NX CP-105 | Neuronyx Inc. (US) | | No Structure |
| NX-1207 | Nymox Pharmaceutical (Canada) | 1215219-81-0 | No Structure |
| NXL-103 (RPR-132552 & RPR-202868) | Aventis Pharma (Novexel) | |  |
| NY-ESO-1 Vaccine | CSL Ludwig Institute for Cancer Research | | No Structure |
| NY-ESO-1(157-170)-IFA Vaccine | US Government | |  |
| Nystatin | Research Corporation | 1400-61-9 |  |
| NYVAC-B | Sanofi Pasteur (France) | | No Structure |
| NZ-17074 | Novozymes AS | |  |
| NZ-314 | Nippon Zoki | 128043-99-2 |  |
| NZ-419 | Nippon Zoki | |  |
| O-1057 | Univ Virginia Commonwealth | |  |
| O-1812 | Virginia Commonwealth University | |  |
| O-2371 | Harvard College ; Organix Inc. | |  |
| O-2545 | Virginia Commonwealth University | |  |
| O-3262 | Virginia Commonwealth University (USA) | |  |
| O-3367 | Organix ; Univeristy of Aberdeen (UK) | |  |
| O-3804 | Organix | |  |
| O-3944 | Organix | |  |
| O-4309 | Organix | |  |
| O-6-methylguanine | Univ Southern California | |  |
| O-desmethyl venlafaxine-N-oxide | Solvay Pharmaceuticals BV (Netherlands) | |  |
| OA-5D5 | Genentech, Inc. | | No Structure |
| OAS-PAC-100 (Paclitaxel) | Ardenia Investment Ltd. | 33069-62-4 |  |
| OBA-09 | SH Pharma Ltd. | |  |
| Obatoclax | Gemin X Biotechnologies | 803712-79-0 |  |
| OBE-1999 | Obe Therapy Biotechnology | |  |
| OBE-2000 | Obe Therapy Biotechnology | |  |
| OBE-2001 | Obe Therapy Biotechnology (France) | |  |
| OBE-2002 | Obe Therapy Biotechnology | |  |
| Obenoxazine | NII Farmakologii Rossiiskoi AK | 173352-21-1 |  |
| Oberadilol | Teikoku Hormone (Aska Pharmaceuticals) | 114856-44-9 |  |
| Obeticholic acid | Intercept Pharmaceuticals (US) | 459789-99-2 |  |
| Obidoxime | E. Merck KGaA | 114-90-9 |  |
| Obinepitide | 7TM Pharma | 348119-84-6 |  |
| Oblimersen | | 190977-41-4 |  |
| OBP-301 | Kansai Technology Licensing Organization Co. Ltd. (Japan) | 1160991-31-0 | No Structure |
| OBP-401 | Oncolys BioPharma Inc. | | No Structure |
| OBP-601 | Yale University (US) | 1097733-37-3 |  |
| OBP-701 | Benitec Ltd. | | No Structure |
| OBP-AI 1 | Oncolys BioPharma Inc. | | No Structure |
| OBP-AI 2 | Oncolys BioPharma Inc. | | No Structure |
| OC-000459 | | | No Structure |
| OC-002417 | Oxagen Ltd. | | No Structure |
| OC-297963 | Novo Nordisk ; Ontogen | |  |
| Ocaperidone | Janssen Pharmaceutica (Johnson & Johnson) | 129029-23-8 |  |
| Ocfentanil | BOC | 101343-69-5 |  |
| OCID-0363 | Orchid Chemicals & Pharmaceuticals | |  |
| OCID-0434 | Orchid Chemicals & Pharmaceuticals | |  |
| Ocinaplon | American Cyanamid (Wyeth) | 96604-21-6 |  |
| Ocrelizumab | Genentech | 637334-45-3 | No Structure |
| Ocriplasmin | Thromb X NV (ThromboGenics NV) | 1048016-09-6 | No Structure |
| Octabenzone | DuPont | 1843-05-6 |  |
| Octacaine | Geistlich | 13912-77-1 |  |
| Octahydrohyperforin | Indena SpA | |  |
| Octamylamine | Knoll (Abbott) | 502-59-0 |  |
| Octaparine | | | No Structure |
| Octaplex | Octapharma AG | | No Structure |
| Octatropine methylbromide | Endo | 80-50-2 |  |
| Octenidine | Sterling Winthrop (Sanofi-Aventis) | 71251-02-0 |  |
| Octhilinone | Rohm & Haas | 26530-20-1 |  |
| Octocog Alfa | | 139076-62-3 | No Structure |
| Octocrilene | General Aniline & Film Corp | 6197-30-4 |  |
| Octodrine | SmithKline French (GSK) | 543-82-8 |  |
| Octopamine | Hartford National Bank And Trust | 104-14-3 |  |
| Octotiamine | Fujisawa | 137-86-0 |  |
| Octoxinol | Ortho McNeil (Johnson & Johnson) | 9002-93-1 |  |
| Octreotide | Sandoz (Novartis) | 83150-76-9 ; 79517-01-4 (acetate) |  |
| Octrizole | American Cyanamid (Wyeth) | 3147-75-9 |  |
| Octyl Methoxycinnamate | Givaudan | 5466-77-3 |  |
| Octylthio-2-ethanol | Phillips Petroleum | 3547-33-9 |  |
| OCV-101 | OncoTherapy Science Inc. | | No Structure |
| Odanacatib | Merck & Co | 603139-19-1 |  |
| ODE-PPen-G | Univerisity of California (US) | |  |
| Odiparcil | Fournier | 137215-12-4 |  |
| ODK-0801 | | | No Structure |
| ODK-0901 | | | No Structure |
| ODK-0902 | | | No Structure |
| Oenothein B | Roussel Uclaf | 104987-36-2 |  |
| Oestramate | Imperial College | 148672-09-7 |  |
| Ofatumumab | Genmab | 679818-59-8 | No Structure |
| Ofloxacin | Daiichi | 82419-36-1 |  |
| Ofurace | Chevron | 58810-48-3 |  |
| Oglemilast | Glenmark Pharmaceuticals Ltd. | 778576-62-8 |  |
| Oglufanide | Cytran | 38101-59-6 |  |
| OGP-(10-14)-L | Yissum Research Development | |  |
| OGT-2378 | Oxford Glycosciences ; Univ Oxford | |  |
| OGT-719 | Oxford Glycosciences | 186967-00-0 |  |
| OGX-427 | Univ British Columbia | | No Structure |
| OJ-R9188 | Kanebo Pharmaceuticals | |  |
| OK-8910 | Otsuka | 111041-81-7 |  |
| OK-9201 | Otsuka | 138655-93-3 |  |
| OK-9601 | Otsuka | 187607-75-6 |  |
| OK-9602 | Otsuka | |  |
| OL-135 | Scripps Research Institute | |  |
| OL-92 | Scripps Research Institute | |  |
| Olaflur | SmithKline Beecham (GSK) | 6818-37-7 |  |
| Olamufloxacin | Hokuriku | 167887-97-0 |  |
| Olanexidine | Otsuka | 218282-71-4 (HCl) |  |
| Olanzapine | Eli Lilly | 132539-06-1 |  |
| Olanzapine LAI (Olanzapine Pamoate) | Eli Lilly | |  |
| Olaparib | KuDoS Pharmaceuticals (AstraZeneca) | 763113-22-0 |  |
| Olaquindox | Bayer | 23696-28-8 |  |
| Olaratumab | | 1024603-93-7 | No Structure |
| Olcegepant | Boehringer Ingelheim | 204697-65-4 |  |
| OLE-PPen-G | Univerisity of California (US) | |  |
| Oleandomycin | Pfizer | 3922-90-5 |  |
| Oleoyl-estrone | Laboratorios Salvat | |  |
| Olesoxime | Trophos | 22033-87-0 |  |
| Oleuropein | | 32619-42-4 |  |
| OligoG CF-5-20 | AlgiPharma IPR AS | | No Structure |
| Oligonol | Amino Up Chemical Co. Ltd. (Japan) ; Usaien Pharmaceutical Co. Ltd. (Japan) | | No Structure |
| Olmesartan Medoxomil | Sankyo | 144689-63-4 |  |
| Olodaterol | Boehringer Ingelheim International GmbH (Germany) | 868049-49-4 |  |
| Olopatadine | Kyowa Hakko | 140462-76-6 |  |
| Olpadronic acid | Henkel ; Gador ; Leiden University | 63132-39-8 |  |
| Olprinone | E. Merck KGaA | 136117-89-0 |  |
| Olsalazine | Pharmacia | 15722-48-2 |  |
| Oltipraz | Rhone-Poulenc (Sanofi-Aventis) | 64224-21-1 |  |
| OM-991 | Oklahoma Medical Research Foundation | 271601-63-9 |  |
| OM-992 | Oklahoma Medical Research Foundation | 314266-76-7 |  |
| Omacetaxine mepesuccinate | Chemgenex | 26833-87-4 |  |
| Omaciclovir | Karolinska Inst. | 124265-89-0 |  |
| Omadacycline | Paratek ; Tufts College | 389139-89-3 ; 1075240-43-5 (tosylate) |  |
| Omalizumab | | 242138-07-4 | No Structure |
| Omapatrilat | Bristol-Myers Squibb (BMS) | 167305-00-2 |  |
| Ombrabulin | Ajinomoto | 181816-48-8 ; 253426-24-3 |  |
| OMDM-2 | Università La Sapienza | |  |
| Omecamtiv Mecarbil | Cytokinetics | 873697-71-3 |  |
| Omeprazole | Haessle | 73590-58-6 |  |
| Omethoate | Bayer | 1113-02-6 |  |
| Omiganan | University of British Columbia | 269062-93-3 (5HCl) |  |
| Omigapil | Ciba-Geigy (Novartis) | 181296-84-4 |  |
| Omocianine | Schering AG ; Fugi Photo | 154082-13-0 |  |
| Omoconazole | Siegfried | 74512-12-2 |  |
| OMS-103HP (Morphine & Nociceptin) | Omeros Corporation | |  |
| Omtriptolide | Pharmagenesis | 195883-09-1 (sodium salt) |  |
| ON-01060 | Temple University | |  |
| ON-01210 | Temple University (US) | |  |
| ON-012380 | Onconova Therapeutics | |  |
| ON-11 | Università degli Studi di Catania | |  |
| ON-12 | Università degli Studi di Catania | |  |
| ON-13 | Università degli Studi di Catania | |  |
| ON-14 | Universita degli Studi di Catania | |  |
| ON-1910Na | Onconova Therapeutics ; University of Temple | |  |
| ON-24160 | Temple University (US) ; Onconova Therapeutics Inc. (US) | |  |
| ON-579 | Taisho | 141286-14-8 |  |
| Onaclostox | | 93384-43-1 | No Structure |
| Onapristone | Ono Pharmaceutical | 96346-61-1 |  |
| Onartuzumab | Genentech Inc. (US) | 1133766-06-9 | No Structure |
| ONC-201 | | | No Structure |
| Oncarex | Max-Planck-Gesellschaft | | No Structure |
| Oncrasin-1 | University of Texas (US) | 75629-57-1 |  |
| Ondansetron | Glaxo (GSK) | 99614-20-5 |  |
| Onercept | Yeda R&D | 199685-57-9 |  |
| ONO-1301 | Ono Pharmaceutical | 153814-73-4 |  |
| ONO-1505 | Ono Pharmaceutical | 211117-00-9 |  |
| ONO-1603 | Ono Pharmaceutical | 117427-00-6 |  |
| ONO-1608 | Ono Pharmaceutical | |  |
| ONO-1714 | Ono Pharmaceutical | 214479-33-1 (HCl) |  |
| ONO-1924H | ONO Pharmaceutical | |  |
| ONO-3403 | Ono Pharmaceutical | 181586-07-2 |  |
| ONO-4007 | Ono Pharmaceutical | 111250-67-0 |  |
| ONO-4057 | Ono Pharmaceutical | 134578-96-4 |  |
| ONO-4641 | | | No Structure |
| ONO-4817 | Ono Pharmaceutical | 223472-31-9 |  |
| ONO-5129 | | | No Structure |
| ONO-5334 | | | No Structure |
| ONO-6818 | Ono Pharmaceutical | |  |
| ONO-6950 | | | No Structure |
| ONO-7746 | Nissan Chemical Industries Ltd. | | No Structure |
| ONO-8539 | | | No Structure |
| ONO-8711 | Ono Pharmaceutical | 216158-34-8 |  |
| ONO-8713 | Ono Pharmaceutical | 389627-65-0 |  |
| ONO-AE-248 | Ono Pharmaceutical | 211230-67-0 |  |
| Onsolis (Fentanyl buccal) | QLT USA Inc. (US) | 437-38-7 |  |
| ONT-093 | Ontogen | |  |
| ONT-10 | Biomira Inc. (Oncothyreon Inc.) | | No Structure |
| Ontazolast | Boehringer Ingelheim | 147432-77-7 |  |
| Ontianil | Hoechst (Sanofi-Aventis) | 35727-72-1 |  |
| ONYX-015 | Onyx | | No Structure |
| ONYX-411NTR-SN-28343 | Auckland UniServices Ltd. (New Zealand) | | No Structure |
| Oolonghomobisflavan C | Suntory Ltd. | |  |
| OP-145 | Leiden University | | No Structure |
| Opaviraline | Hoechst (Sanofi-Aventis) | 178040-94-3 |  |
| OPB-31121 | | | No Structure |
| OPB-51602 | | | No Structure |
| OPB-9195 | Otsuka | 163107-50-4 |  |
| OPC-14117 | Otsuka | 103233-65-4 |  |
| OPC-14523 | Otsuka | 145969-30-8 |  |
| OPC-21268 | Otsuka | 131631-89-5 |  |
| OPC-28326 | Otsuka | 167621-24-1 |  |
| OPC-33509 | Western Therapeutics | 189362-06-9 |  |
| OPC-33540 | Otsuka | 189362-27-4 |  |
| OPC-34712 | | | No Structure |
| OPC-51803 | Otsuka | 192514-54-8 |  |
| Opebacan | Xoma | 206254-79-7 |  |
| Opebecan | Xoma | 206254-79-7 | No Structure |
| Opicapone | BIAL Portela & Ca. SA | 923287-50-7 |  |
| Opipramol | Geigy (Novartis) | 315-72-0 |  |
| OPN-302 | Nestle SA | | No Structure |
| OPN-305 | Opsona Therapeutics Ltd. | | No Structure |
| OPN-401 | Opsona Therapeutics Ltd. | | No Structure |
| OPN-501 | College of Holy and Undivided Trinity of Queen Elizabeth, Near Dublin (Ireland) | | No Structure |
| Oprelvekin | Genetics Institute | 145941-26-0 | No Structure |
| OpsoVac | College of Holy and Undivided Trinity of Queen Elizabeth, Near Dublin (Ireland) | | No Structure |
| OPT-822 & OPT-821 | Sloan-Kettering Institute for Cancer Research (US) | | No Structure |
| OPT-88 | The Scripps Research Institute (US) | | No Structure |
| Opticin | University of Manchester | | No Structure |
| OR-2370 | Orion | |  |
| Oracin | Vyzkumny Ustav Pro Farmacii A Biochemii - VUFB (Zentiva) | 148317-76-4 |  |
| Oralgam | Research Corporation Technologies | | No Structure |
| Orange B | Stange | 15139-76-1 |  |
| Orantinib | Sugen (Pfizer) | 210644-62-5 ; 252916-29-3 |  |
| Orazamide | Fujisawa | 60104-30-5 |  |
| Orazipone | Orion | 137109-78-5 |  |
| Orbec (Beclometasone dipropionate) | Enteron Pharmaceuticals (Dor Biopharma) | 5534-09-8 |  |
| Orbencarb | Kumiai | 34622-58-7 |  |
| Orbifloxacin | Dainippon Pharmaceutical | 113617-63-3 |  |
| Orbofiban | Searle (Pharmacia) | 163250-90-6 |  |
| Orciprenaline | Boehringer Ingelheim | 586-06-1 |  |
| Ordopidine | Carlsson Research | | No Structure |
| Oreganic acid | Merck & Co. | 181527-69-5 |  |
| Oregovomab | Altarex (ViRexx Medical Corp.) | 213327-37-8 | No Structure |
| Orfralure | | 37338-40-2 |  |
| ORG-12962 | Akzo Nobel | 210821-63-9 |  |
| ORG-20091 | Akzo (Akzo Nobel) | |  |
| ORG-201745 | | | No Structure |
| ORG-20549 | Akzo | 233256-47-8 |  |
| ORG-20599 | Akzo (Akzo Nobel) | 187652-71-7 (methanesulfonate) |  |
| ORG-207788 | Organon | | No Structure |
| ORG-211559 | Organon | | No Structure |
| ORG-214007 | Organon | | No Structure |
| ORG-21465 | Akzo Nobel | |  |
| ORG-219517 | Organon | | No Structure |
| ORG-223119 | Organon | | No Structure |
| ORG-224283 | Organon | | No Structure |
| ORG-23366 | Akzo Nobel | |  |
| ORG-25435 | Akzo Nobel | 256456-73-2 |  |
| ORG-25935 | Organon (Schering Merck & Co) | 258886-37-2 (Li salt) |  |
| ORG-26041 | | | No Structure |
| ORG-26576 | | | No Structure |
| ORG-26828 | | | No Structure |
| ORG-27306 | Organon | | No Structure |
| ORG-27889 | Organon (Schering Merck & Co) | |  |
| ORG-27899 | Organon | |  |
| ORG-28312 | Akzo Nobel | |  |
| ORG-28611 | | | No Structure |
| ORG-30035 | Akzo (Akzo Nobel) | 92122-44-6 |  |
| ORG-31433 | University of Wayne State ; Akzo (Akzo Nobel) | 132031-83-5 |  |
| ORG-31710 | Akzo (Akzo Nobel) | 118968-41-5 |  |
| ORG-33628 | Akzo (Akzo Nobel) | 155768-17-5 |  |
| ORG-34167 | Akzo (Netherlands) | |  |
| ORG-34517 | Akzo Nobel Nv (Netherlands) | |  |
| ORG-37476 | Organon (Schering Merck & Co) | |  |
| ORG-37663 | Akzo Nobel | |  |
| ORG-39430 | Akzo Nobel | |  |
| ORG-39970 | Organon BioSciences (Merck & Co.) | | No Structure |
| ORG-41749 | Organon | | No Structure |
| ORG-42152 | Organon | | No Structure |
| ORG-42669 | Organon | | No Structure |
| ORG-42675 | Akzo Nobel | |  |
| ORG-43228 | | | No Structure |
| ORG-43902 | Organon | | No Structure |
| ORG-4419 | Akzo Nobel | |  |
| ORG-45414 | Organon | | No Structure |
| ORG-47241 | Organon | | No Structure |
| ORG-48762-0 | Uriach | |  |
| ORG-48775 | Organon | | No Structure |
| ORG-50189 | Organon | | No Structure |
| ORG-50426 | Organon | | No Structure |
| ORG-52186 | Organon | | No Structure |
| ORG-5878 | Akzo (Akzo Nobel) | 74174-40-6 |  |
| ORG-6632 | Akzo (Akzo Nobel) | |  |
| ORG-9731 | Akzo (Akzo Nobel) | 142648-47-3 |  |
| ORI-1313 | Oridigm (MediQuest Therapeutics) | 287968-59-6 |  |
| Oritavancin | Eli Lilly | 192564-14-0 (diphosphate) |  |
| Orlistat | Roche | 96829-58-2 |  |
| Ormaplatin | US Department of Health & Human Services | 62816-98-2 |  |
| Ormetoprim | Hoffmann La Roche (Roche) | 6981-18-6 |  |
| Orn-Amp | KemPharm Inc. (US) | |  |
| Ornidazole | Hoffmann La Roche (Roche) | 16773-42-5 |  |
| Ornipressin | Sandoz | 3397-23-7 |  |
| Ornithine phenylacetate | UCL Biomedica PLC (GB) | 952154-79-9 |  |
| Ornoprostil | Ono Pharmaceutical | 70667-26-4 |  |
| Orotic acid | Diamalt | 65-86-1 |  |
| Orphenadrine | Parke, Davis (Pfizer) | 83-98-7 |  |
| Ortataxel | Indena ; New York University | 186348-23-2 |  |
| Orthosulfamuron | Isagro | 213464-77-8 |  |
| ORV-116E | | | No Structure |
| Orvepitant | Glaxo Group Ltd. (GB) | 579475-18-6 ; 579475-24-4 (maleate) |  |
| Orysastrobin | BASF | 248593-16-0 |  |
| Oryzalin | Eli Lilly | 19044-88-3 |  |
| Osalmid | | 526-18-1 |  |
| Osanetant | Sanofi Elf (Sanofi-Aventis) | 173050-51-6 |  |
| Osaterone | Teikoku Hormone (Aska Pharmaceuticals) | 105149-04-0 |  |
| OSB-207M | Osteopharm | |  |
| Oseltamivir | Gilead Sciences | 196618-13-0 ; 204255-11-8 (Oseltamivir Phosphate) |  |
| Osemozotan | Mitsubishi Chemical | 137275-81-1 |  |
| OSI-005 | OSI Pharmaceuticals | |  |
| OSI-027 | OSI Pharmaceuticals Inc. | |  |
| OSI-420 | Pfizer Inc. | 183320-51-6 |  |
| OSI-7836 | Southern Research Institute | |  |
| OSI-7904L | Wellcome (GSK) | 139987-54-5 |  |
| OSI-8455 | Latvian Inst. of Organic Synthesis | 362515-39-7 |  |
| OSI-930 | OSI Pharmaceuticals | |  |
| OSL-5 | | |  |
| OSL-7 | | |  |
| OSL-95II | OrgSyn Laboratory Inc. ; University of Illinois | |  |
| Ospemifene | Orion | 128607-22-7 |  |
| OST-4077 | Dong A Pharm Co Ltd. ; Yuhan Co Ltd. | |  |
| Ostarine | | |  |
| Osthole | Generic | 484-12-8 |  |
| OSU-02067 | University of Ohio State | |  |
| OSU-03012 | University of Ohio State | 742112-33-0 |  |
| OSU-03013 | University of Ohio State | |  |
| Osutidine | Toyama | 140695-21-2 |  |
| OSW-1 | | 145075-81-6 |  |
| OT-551 | Othera Pharmaceuticals | |  |
| OT-7100 | Otsuka | 174858-27-6 |  |
| OT-7999 | OTSUKA PHARMA | |  |
| Otamixaban | Aventis (Sanofi-Aventis) | 193153-04-7 |  |
| Otelixizumab | British Tech Group (BTG) | 881191-44-2 | No Structure |
| Otenabant | Pfizer | 686344-29-6 ; 686347-12-6 (hydrochloride salt) |  |
| Otenzepad | Thomae (Boehringer Ingelheim) | 100158-38-1 |  |
| Oteromycin | Merck & Co | 170591-45-4 |  |
| OTI-010 | Osiris Therapeutics | | No Structure |
| Otilonium bromide | Menarini | 26095-59-0 |  |
| OTO-104 (Dexamethasone) | Otonomy Inc. ; University of California (US) | 50-02-2 |  |
| OTO-203 | Otonomy Inc. ; University of California (US) | | No Structure |
| Otsuka-RN-132251-55-9 | Otsuka | 132251-55-9 |  |
| Otsuka-RN-173348-54-4 | Otsuka | 173348-54-4 |  |
| OUP-16 | Azwell | |  |
| Ovex | Diamond Alkali | 80-33-1 |  |
| OX-17 (Famotidine & Omeprazole) | Orexo AB | 76824-35-6 (Famotidine) ; 73590-58-6 (Omeprazole) |  |
| OX-19 (Desmopressin) | Ferring BV | |  |
| OX-219 (Buprenorphine & Naloxone) | PharmaKodex Ltd. (Orexo AB) | 52485-79-7 (Buprenorphine) ; 465-65-6 (Naloxone) |  |
| OX-CLI | Orexo AB ; Ortho-McNeil-Janssen Pharmaceuticals Inc. (Johnson & Johnson Inc.) ; Janssen Pharmaceutic | | No Structure |
| OX-ESI | Orexo AB ; Ortho-McNeil-Janssen Pharmaceuticals Inc. (Johnson & Johnson Inc.) ; Janssen Pharmaceutic | | No Structure |
| OX-MPI | Orexo AB ; Boehringer Ingelheim GmbH | | No Structure |
| OXA-01 | OSI Pharmaceuticals Inc. (US) | |  |
| Oxabetrinil | Ciba-Geigy (Novartis) | 74782-23-3 |  |
| Oxabolone Cipionate | Farmitalia Carlo Erba (Pharmacia) | 1254-35-9 |  |
| Oxaceprol | Richardson-Merrell (Aventis) | 33996-33-7 |  |
| Oxacillin | Beecham (GSK) | 66-79-5 |  |
| Oxadiargyl | Rhone-Poulenc | 39807-15-3 |  |
| Oxadiazon | Rhone-Poulenc | 19666-30-9 |  |
| Oxadixyl | Sandoz (Syngenta) | 77732-09-3 |  |
| Oxaflozane | CERM | 26629-87-8 |  |
| Oxaflumazine | Roussel-Uclaf (Aventis) | 16498-21-8 |  |
| Oxaliplatin | Nagoya University | 61825-94-3 |  |
| Oxametacin | ABC | 27035-30-9 |  |
| Oxamflatin | Shionogi | |  |
| Oxamisole | Pennwalt | 99258-56-7 |  |
| Oxamniquine | Pfizer | 21738-42-1 |  |
| Oxamyl | DuPont | 23135-22-0 |  |
| Oxandrolone | Searle | 53-39-4 |  |
| Oxantel | Pfizer | 36531-26-7 |  |
| Oxapium iodide | Toyama | 6577-41-9 |  |
| Oxaprotiline | | 56433-44-4 |  |
| Oxaprozin | Wyeth | 21256-18-8 |  |
| Oxaquin | Morphochem AG | |  |
| Oxasulfuron | Ciba-Geigy (Novartis) | 144651-06-9 |  |
| Oxatomide | Janssen Pharmaceutica (Johnson & Johnson) | 60607-34-3 |  |
| Oxazepam | American Home Products (Wyeth) | 604-75-1 |  |
| Oxaziclomefone | Mitsubishi Petrochemicals ; Daicel Chemical Industries | 153197-14-9 |  |
| Oxazolam | Sankyo | 24143-17-7 |  |
| Oxcarbazepine | Geigy (Novartis) | 28721-07-5 |  |
| Oxeclosporin | Sandoz (Novartis) | 135548-15-1 |  |
| Oxedrine | Boehringer Ingelheim | 94-07-5 |  |
| Oxeglitazar | Merck KGaA | 280585-34-4 |  |
| Oxeladin | Brit. Drug Houses | 468-61-1 |  |
| Oxelumab | F. Hoffmann-La Roche AG (Switzerland) | 89957-37-9 ; 1186098-83-8 | No Structure |
| Oxetacaine | American Home Products (Wyeth) | 126-27-2 |  |
| Oxetorone | Labaz | 26020-55-3 |  |
| Oxfendazole | Syntex (Roche) | 53716-50-0 |  |
| OXI-4503 | Arizona State University ; Oxigene | 288847-34-7 |  |
| Oxibendazole | SmithKline French (GSK) | 20559-55-1 |  |
| Oxiconazole | Siegfried | 64211-45-6 |  |
| Oxiglutatione | Novelos Therapeutics, Inc | 27025-41-8 |  |
| Oxilofrine | Albert-Roussel (Aventis) | 52671-39-3 |  |
| Oxiracetam | ISF | 62613-82-5 |  |
| Oxitriptan | May & Baker (Aventis) | 4350-09-8 |  |
| Oxitropium bromide | Boehringer Mannheim (Roche) | 30286-75-0 |  |
| Oxodipine | Delagrange ((Sanofi-Aventis) | 90729-41-2 |  |
| Oxolamine | Angelini | 959-14-8 |  |
| Oxolinic acid | Warner Lambert (Pfizer) | 14698-29-4 |  |
| Oxomemazine | Rhone-Poulenc (Aventis) | 3689-50-7 |  |
| Oxpoconazole | Ube | 174212-12-5 |  |
| Oxprenolol | Ciba (Novartis) | 6452-71-7 |  |
| Oxybenzone | American Cyanamid (Wyeth) | 131-57-7 |  |
| Oxybuprocaine | Wander | 99-43-4 |  |
| Oxybutynin | Mead Johnson | 1508-65-2 |  |
| Oxybutynin transdermal | Theratech (Watson Pharmaceuticals) | 1508-65-2 |  |
| Oxycarboxin | Jin Hung Fine Chem. | 5259-88-1 |  |
| Oxyclozanide | ICI | 2277-92-1 |  |
| Oxycodone | E. Merck KGaA | 76-42-6 |  |
| Oxycodone (Durect) | Durect | 76-42-6 |  |
| Oxycodone & Naloxone | Euro Celtique SA | |  |
| Oxydemeton-methyl | Bayer | 301-12-2 |  |
| Oxydeprofos | | 2674-91-1 |  |
| Oxydiphenoxarsine-10,10' | Dow | 58-36-6 |  |
| Oxyfedrine | Degussa | 15687-41-9 |  |
| Oxyfluorfen | Rohm & Haas | 42874-03-3 |  |
| Oxymesterone | Farmaceutici Italia | 145-12-0 |  |
| Oxymetazoline | E. Merck KGaA | 1491-59-4 |  |
| Oxymetholone | Syntex | 434-07-1 |  |
| Oxymorphazole | University of Illinois | |  |
| Oxymorphone | | 76-41-5 |  |
| Oxymorphone-Val-carbamate | Shire LLC (US) | |  |
| Oxynor | Ophidia | |  |
| Oxypendyl | Degussa | 5585-93-3 |  |
| Oxypertine | Sterling Drug (Sanofi-Aventis) | 153-87-7 |  |
| Oxyphenbutazone | Geigy (Novartis) | 129-20-4 |  |
| Oxyphencyclimine | Pfizer | 125-53-1 |  |
| Oxyphenisatine | Hoffmann La Roche (Roche) | 125-13-3 |  |
| Oxyphenonium bromide | Ciba (Novartis) | 50-10-2 |  |
| Oxypurinol | Henning Berlin ; Johns Hopkins University | 2465-59-0 |  |
| Oxyquinoline | Dr. Z. H. Skraup | 148-24-3 |  |
| Oxytetracycline | Pfizer | 79-57-2 |  |
| Oxytocin | Roussel Uclaf | 50-56-6 |  |
| Oxytrex (Oxycodone & Naltrexone) | Albert Einstein College of Medicine ; Pain Therapeutics | |  |
| Oystrisin | Novozymes | |  |
| OZ-03 | Medicines For Malaria Venture (MMV) | |  |
| OZ-05 | Medicines For Malaria Venture (MMV) | |  |
| OZ-177 | Medicines for Malaria Venture (MMV) | |  |
| OZ-199 | Medicines for Malaria Venture (MMV) | |  |
| OZ-209 | Medicines For Malaria Venture (Switzerland) | |  |
| OZ-288 | Medicines For Malaria Venture (Switzerland) | |  |
| OZ-439 | | | No Structure |
| OZ-78 | Medicines For Malaria Venture (Switzerland) | |  |
| Ozagrel | Ono Pharmaceutical ; Kissei | 82571-53-7 |  |
| Ozarelix | Zentaris AG (AEterna Zentaris) | 295350-45-7 |  |
| Ozenoxacin | Toyama | 245765-41-7 |  |
| Ozoralizumab | | 1167985-17-2 | No Structure |
| P-005631 | Paratek Pharmaceuticals Inc. (US) | |  |
| P-0666 | Helix Biomedix (US) | |  |
| P-1025 | Actinova | 320350-56-9 |  |
| P-1032 | Helix Biomedix (US) | |  |
| P-11149 | Hoechst (Sanofi-Aventis) | 164724-79-2 |  |
| P-113 | Periodontix (Demegen) ; University of Boston | |  |
| P-113D | Periodontix (Demegen) ; University of Boston | 190673-60-0 |  |
| P-1201 | Eli Lilly & Co. | | No Structure |
| P-1268 | Poli | 154382-94-27 |  |
| P-1432 | Poli | 131627-55-9 |  |
| P-1446 | | | No Structure |
| P-1450 | Poli | 133849-96-4 |  |
| P-15 | University of California | 134335-45-8 |  |
| P-16CM | Florida Agricultural & Mecha | 111802-47-2 |  |
| P-1736 | | | No Structure |
| P-175A | Wyeth | |  |
| P-1933 | Pharmacor (Procyon Biopharma) | |  |
| P-1935 | Pharmacor (Procyon Biopharma) | |  |
| P-1939 | Pharmacor (Procyon Biopharma) | |  |
| P-1946 | Pharmacor (Procyon Biopharma) | |  |
| P-1999 | Pharmacor (Procyon Biopharma) | |  |
| P-216 | Aquapharm (UK) | | No Structure |
| P-2202 | Eli Lilly & Co. | | No Structure |
| P-3298 | Probiodrug | 251572-86-8 |  |
| P-3914 | Piramal Life Sciences Ltd. | | No Structure |
| P-396 | Eli Lilly Co. (US) | |  |
| P-57 | South African Council for Scientific and Industrial Research (CSIR) | |  |
| P-61A6 | University of California (US) | |  |
| P-91022 | Konkuk University;\nKorea Institute of\nScience and Technology; Kyung Hee University; Yonsei Univers | |  |
| P-91028 | Konkuk University;\nKorea Institute of\nScience and Technology; Kyung Hee University; Yonsei Univers | |  |
| P-979 | Nicholas Piramal India Ltd. (Piramal Healthcare Ltd.) | |  |
| P-HA | Mukogawa Women's University ; University of Yokohama | 250257-17-1 |  |
| P-HA-Ac | Mukogawa Women's University ; University of Yokohama | 543725-84-4 |  |
| p-XSC | American Health Foundation | |  |
| P007-PMO | Avi Biopharma Inc. (US) | | No Structure |
| P1 H10 mAb | Brigham & Women's Hospital (US) | | No Structure |
| P13-TT | Albert Einstein College of Medicine (US) ; Uniformed Services University (US) ; Biosynexus Inc. (US) | | No Structure |
| P2-Peptide | University of Copenhagen | |  |
| P276-00 | Nicholas Piramal India Ltd. | |  |
| P53R3 | Schering Corp (Merck & Co) | |  |
| PA-082 | Hoffmann La Roche | |  |
| PA-1026 | Palumed ; Sanofi-Aventis ; CNRS(Centre National de la Recherche Scientifique) | |  |
| PA-1050040 | | | No Structure |
| PA-109 | Pf Medicament (France) | 158828-01-4 | No Structure |
| PA-1103 | Sanofi-aventis (France) ; Centre National de la Recherche Scientifique (France) ; Palumed SA (France | |  |
| PA-1409 | Palumed SA (France) ; Centre National de la Recherche Scientifique (France) | |  |
| PA-1806 | Squibb (BMS) | 142654-34-0 |  |
| PA-2789 | Chiron | |  |
| PA-2808 | Chiron | |  |
| PA-32540 (Aspirin & Omeprazole) | POZEN | 50-78-2 (Acetylsalicylic acid) ; 73590-58-6 (omeprazole) |  |
| PA-344 | Panacos Pharmaceuticals ; University of North Carolina | |  |
| PA-48153C | Shionogi | 151519-02-7 |  |
| PA-824 | Pathogenesis (Chiron) | 187235-37-6 |  |
| PAA-3352 | Kyorin Pharmaceutical Co. Ltd. (Japan) | |  |
| PAB | Maruishi Pharma | |  |
| PAC-1 | University of Illinois | |  |
| PAC-625L | Pacgen Biopharmaceuticals | |  |
| PAC-626L | Pacgen Biopharmaceuticals | |  |
| PAC-627L | Pacgen Biopharmaceuticals | |  |
| PAC-628L | Pacgen Biopharmaceuticals | |  |
| Pachymedusa dacnicolor Tryptophyllin-1 | University of Ulster | |  |
| Paclitaxel | Rhone-Poulenc (Sanofi-Aventis) | 33069-62-4 |  |
| Paclitaxel ceribate | Biophysica Foundation | 186040-50-6 |  |
| Paclitaxel OncoGel | Macromed (Protherics) | | No Structure |
| Paclitaxel poliglumex | PG TLX Company | 263351-82-2 |  |
| Paclobutrazol | ICI (Syngenta) | 76738-62-0 |  |
| Pactimibe | Sankyo | 189198-30-9 |  |
| PAD-I.17 | Boston Medical Center | |  |
| Padeliporfin | Yeda Research & Development Co. Ltd. (Israel) | 759457-82-4 |  |
| Padimate | Ayerst (Wyeth) | 14779-78-3 |  |
| Padimate O | VanDyke | 21245-02-3 |  |
| Pafenolol | Chemie Linz (DSM) | 75949-61-0 |  |
| Pafuramidine | University of North Carolina (US) ; University of Georgia (US) | 186953-56-0 ; 837369-26-3 (maleate) |  |
| Pagibaximab | Biosynexus | 595566-61-3 | No Structure |
| Pagoclone | Rhone-Poulenc (Sanofi-Aventis) | 133737-32-3 |  |
| PAK-104P | Nissan Chemical | 131356-86-0 |  |
| PAK-200 | Nissan Chemical | 142857-52-1 |  |
| Palifermin | | 162394-19-6 |  |
| Paliflutine | Hoffmann-La Roche | 845614-11-1 |  |
| Palifosfamide | Dekk Tec Inc. | 31645-39-3 |  |
| Palinavir | Bio-Mega (Boehringer Ingelheim) | 154612-39-2 |  |
| Paliperidone | Janssen Pharmaceutica (Johnson & Johnson) | 144598-75-4 |  |
| Paliperidone palmitate | Johnson & Johnson | 199739-10-1 |  |
| Paliroden | Sanofi (Sanofi-Aventis) | |  |
| Palivizumab | MedImmune | 188039-54-5 | No Structure |
| Palmidrol | Slovakofarma | 544-31-0 |  |
| Palmidrol (Veterinary) | Lifegroup Spa (Italy) | 544-31-0 |  |
| Palmitoylethanolamine | | |  |
| Palmitoylrhizoxin | Sankyo | 135819-69-1 |  |
| Palonidipine | Teijin | 96515-73-0 |  |
| Palonosetron | Syntex (Roche) | 135729-56-5 |  |
| Palosuran | Actelion | 540769-28-6 |  |
| Palovarotene | Hoffmann La Roche | 410528-02-8 |  |
| Pamabrom | Chattanooga | 606-04-2 |  |
| Pamapimod | Hoffmann La Roche | 449811-01-2 |  |
| Pamaqueside | Pfizer | 150332-35-7 |  |
| Pamicogrel | Kanebo | 101001-34-7 |  |
| Pamidronic acid | Henkel | 40391-99-9 ; 57248-88-1 (disodium) |  |
| Pamiteplase | | 151912-42-4 |  |
| Pamoic acid | Vick Chem. | 130-85-8 |  |
| PAN-622 | Massachusetts Institute Of Technology (US) | | No Structure |
| Panamesine | E. Merck KGaA | 139225-22-2 |  |
| PanBlok | | | No Structure |
| Pancreate | CureDM | |  |
| Pancrelipase | Eurand Pharmaceuticals Ltd, Ireland) | | No Structure |
| Pancuronium bromide | Organon (Schering Merck & Co) | 15500-66-0 |  |
| Pandemrix | GlaxoSmithKline plc (GB) | | No Structure |
| Panenza | Sanofi Pasteur (Sanofi-aventis) | | No Structure |
| Panepophenanthrin | Microbial Chemistry Res. Foundation (Japan) | |  |
| PANFLU.1 | Sinovac Biotech Ltd. | | No Structure |
| Panipenem | Sankyo | 87726-17-8 |  |
| Panitumumab | Abgenix (Amgen) | 339177-26-3 | No Structure |
| Panobinostat | Novartis | |  |
| Panomifene | Egyt | 77599-17-8 |  |
| Pantethine | Parke, Davis (Pfizer) | 16816-67-4 |  |
| Pantolactone | Nopco | 599-04-2 |  |
| Pantoprazole | Byk Gulden (Nycomed) | 102625-70-7 |  |
| Pantothenic acid | Commercial Solvents | 79-83-4 |  |
| PAOA | The Scripps Research Institute (US) | |  |
| PAP-1 | University of California | |  |
| PAP(112-120) | Kurume University (JP) | |  |
| Papaverine | Chinoin | 58-74-2 |  |
| Papaveroline | Yamanouchi (Astellas) | 574-77-6 |  |
| PapMV-CP-M2e | Université Laval (Canada) | | No Structure |
| PAPS | Unitika | 482-67-7 |  |
| Papuamide A | University of British Columbia ; National Cancer Institute | |  |
| Paquinimod | Active Biotech | 248282-01-1 |  |
| PAR-NMS | Panacea Biotec Ltd. (India) | |  |
| Paracetamol | Warner Lambert (Pfizer) | 103-90-2 |  |
| Paraflutizide | Dausse | 1580-83-2 |  |
| Parahydroxycinnamic acid | | 7400-08-0 |  |
| Paramethadione | Abbott | 115-67-3 |  |
| Paraoxon | Sandoz (Syngenta) | 311-45-5 |  |
| Paraquat | ICI (Syngenta) | 1910-42-5 |  |
| Parathion | | 56-38-2 |  |
| Parathyroid hormone | Allelix Biopharmaceuticals (NPS Pharmaceuticals) | |  |
| Parbendazole | SmithKline French (GSK) | 14255-87-9 |  |
| Pardoprunox | Duphar | 269718-83-4 ; 269718-84-5 ; 269718-83-4 (hydrochloride salt) |  |
| Parecoxib | Searle (Pharmacia) | 198470-84-7 |  |
| Parethoxycaine | Squibb (BMS) | 94-23-5 |  |
| Pargeverine | Roche | 13479-13-5 |  |
| Pargyline | Abbott | 555-57-7 |  |
| Paricalcitol | Wisconsin Alumni Research Foundation | 131918-61-1 |  |
| Parion-552-02 | Parion Sciences Inc. (US) | |  |
| Parogrelil | Nissan Chemical | 139145-27-0 |  |
| Paromomycin | Pfizer | 7542-37-2 |  |
| Paroxetine | Ferrosan (Novo Nordisk) | 61869-08-7 |  |
| Parozotide | University of Maryland | 881851-50-9 (acetate) ; \n258818-34-7 |  |
| Parsalmide | ERASME | 30653-83-9 |  |
| Parstatin | University of Massachusetts (US) | 1065755-99-8 | No Structure |
| Parthenolide | ALS Therapy Development Foundation | 29552-41-8 |  |
| Parvaquone | Research Corporation | 4042-30-2 |  |
| Pascolizumab | GlaxoSmithKline (GSK) ; PDL BioPharma | 331243-22-2 | No Structure |
| Pasiniazid | Hoffmann La Roche (Roche) | 2066-89-9 |  |
| Pasireotide | Novartis | 396091-73-9 |  |
| PAT | Quantum biotechnologies | |  |
| PAT-5A | Reddy Research Foundation ; Reddy Cheminor | |  |
| Patupilone | Biotechnolog Forschung | 152044-54-7 |  |
| Pavettamine | CSIR (South Africa) ; University of Pretoria (South Africa) ; Agricultural Research Council (South A | |  |
| Pazelliptine | ANVAR | 65222-35-7 |  |
| Pazopanib | Glaxo Group (GSK) | 444731-52-6 ; 635702-64-6 (hydrochloride) |  |
| Pazufloxacin | Toyama | 127045-41-4 ; 136905-87-8 (mesilate) |  |
| PB-127 | | | No Structure |
| PBI-05204 (Oleandrin) | Phoenix Biotechnology Inc. | 465-16-7 |  |
| PBI-1308 | ProMetic BioSciences | |  |
| PBI-3540 | Prometic Biosciences Inc. (Canada) | |  |
| PBN | | 3376-24-7 |  |
| PBOX-15 | Trinity College Dublin ; University Di Siena | |  |
| PBOX-6 | Trinity College Dublin ; University Di Siena | |  |
| PBS-31 | The Scripps Research Institute (US) ; The Univesristy of Chicago (US) ; Brigham Young University (US | |  |
| PBS-32 | The Scripps Research Institute (US) ; The Univesristy of Chicago (US) ; Brigham Young University (US | |  |
| PBT-1 | Hospital for Sick Children | |  |
| PBT-2 (Hepoxilin) | Hospital for Sick Children | |  |
| PBT-3 | Hospital for Sick Children | |  |
| PBT-4 | Hospital for Sick Children | |  |
| PC-102 | Pharmaton SA | | No Structure |
| PC-190723 | Prolysis Ltd. (GB) | |  |
| PC-815 (Carrageenan & MIV-150) | | | No Structure |
| PCALC-36 | Universidade Federal do Rio de Janeiro | |  |
| PCH-163 | Yang Ji Chemical Company Ltd. | |  |
| PCHPC | University of London | |  |
| PCI-27483 | Pharmacyclics Inc. (US) | |  |
| PCI-32765 | Pharmacyclics Inc. (US) | |  |
| PCI-34051 | Pharmacyclics Inc. (US) | 950762-95-5 |  |
| PCI-45292 | Pharmacyclics Inc. | | No Structure |
| PClPhT-DADMe-ImmA | Industrial Research Limited ; Albert Einstein College of Medicine of Yeshiva University | |  |
| PCNU | Pharmacia & Upjohn (Pharmacia) | 13909-02-9 |  |
| pConNS3-NS4A | University of Pennsylvania (US) ; VGX Pharmaceuticals (US) | | No Structure |
| PCPB | Pfizer Inc. (US) | |  |
| PD-0118057 | Yamanouchi (Astellas) | |  |
| PD-0202091 | Yamanouchi (Astellas) | |  |
| PD-0318088 | Warner-Lambert (Pfizer) | |  |
| PD-0332991 | Warner-Lambert (Pfizer) | |  |
| PD-089828 | Warner Lambert (Pfizer) | 179343-17-0 |  |
| PD-102807 | Warner Lambert (Pfizer) | |  |
| PD-118717 | Warner Lambert (Pfizer) | 104229-37-0 |  |
| PD-125354 | Parke, Davis (Pfizer) | 151895-27-1 |  |
| PD-128483 | Warner Lambert (Pfizer) | 115688-97-6 |  |
| PD-128763 | Warner Lambert (Pfizer) | 129075-56-5 |  |
| PD-129337 | Warner Lambert (Pfizer) | 124804-56-4 |  |
| PD-130527 | Sandoz (Novartis) | 120667-17-6 |  |
| PD-130908 | Warner Lambert (Pfizer) | 131505-02-7 |  |
| PD-131112 | Warner Lambert (Pfizer) | 122536-21-4 |  |
| PD-131199 | Warner Lambert (Pfizer) | 118829-10-0 |  |
| PD-131628 | Warner Lambert (Pfizer) | 127967-03-7 |  |
| PD-1323012 | Warner Lambert (Pfizer) | 133825-80-6 |  |
| PD-134308 | Warner Lambert (Pfizer) | 130404-91-0 |  |
| PD-135144 | Warner Lambert (Pfizer) | 116162-91-5 |  |
| PD-135158 | Warner Lambert | 130325-35-8 |  |
| PD-138312 | Warner Lambert (Pfizer) | 143158-16-1 |  |
| PD-138387 | Warner Lambert (Pfizer) | 139226-53-2 |  |
| PD-140248 | Warner Lambert (Pfizer) | 143383-20-4 |  |
| PD-142505 | Warner Lambert (Pfizer) | 149929-08-8 |  |
| PD-144418 | Warner Lambert (Pfizer) | 154130-99-1 |  |
| PD-145065 | Warner Lambert (Pfizer) | 153049-49-1 |  |
| PD-145709 | Warner Lambert (Pfizer) | 156135-84-1 |  |
| PD-147714 | Warner Lambert (Pfizer) | 158276-60-9 |  |
| PD-149163 | Pfizer | |  |
| PD-151307 | Parke, Davis (Pfizer) | 225925-12-2 |  |
| PD-153103 | Warner Lambert (Pfizer) | |  |
| PD-158771 | Warner Lambert (Pfizer) | 189152-50-9 |  |
| PD-158780 | Warner Lambert (Pfizer) | 171179-06-9 |  |
| PD-160678 | Warner Lambert (Pfizer) | 198959-83-0 |  |
| PD-161182 | Warner Lambert (Pfizer) | 168570-35-2 |  |
| PD-161314 | Warner Lambert (Pfizer) | 116163-02-1 |  |
| PD-161315 | Pfizer | |  |
| PD-161570 | Warner Lambert (Pfizer) | 192705-80-9 |  |
| PD-164199 | Warner Lambert (Pfizer) | 185039-63-8 |  |
| PD-164387 | Warner Lambert (Pfizer) | 223585-60-2 |  |
| PD-164771 | Warner Lambert (Pfizer) | 185039-67-2 |  |
| PD-164800 | Warner Lambert (Pfizer) | 215648-26-3 |  |
| PD-166114 | Warner Lambert (Pfizer) | |  |
| PD-166285 | Warner Lambert (Pfizer) | 185039-89-8 |  |
| PD-166326 | Warner-Lambert (Pfizer) | |  |
| PD-166557 | Warner Lambert (Pfizer) | |  |
| PD-166866 | Warner Lambert (Pfizer) | 192705-79-6 |  |
| PD-168077 | | 190383-31-4 |  |
| PD-168368 | Warner-Lambert | |  |
| PD-168393 | Warner Lambert (Pfizer) ; American Cyanamid (Wyeth) | 194423-15-9 |  |
| PD-169414 | Warner-Lambert (Pfizer) | |  |
| PD-169540 | Warner Lambert (Pfizer) | 198959-99-8 |  |
| PD-170262 | Warner Lambert (Pfizer) | |  |
| PD-172760 | Warner Lambert (Pfizer) | 200195-01-3 |  |
| PD-172938 | Warner Lambert (Pfizer) | 210688-71-4 |  |
| PD-173074 | Warner-Lambert (Pfizer) | 219580-11-7 |  |
| PD-173606 | Warner Lambert (Pfizer) | 207736-02-5 |  |
| PD-173956 | Warner Lambert (Pfizer) | 305820-76-2 |  |
| PD-174265 | Parke, Davis (Pfizer) | 216163-53-0 |  |
| PD-174424 | Warner Lambert | |  |
| PD-175069 | Warner Lambert (Pfizer) | 217170-95-1 |  |
| PD-177298 | Warner Lambert (Pfizer) | 207736-04-7 |  |
| PD-178390 | Warner Lambert (Pfizer) | 207736-05-8 |  |
| PD-178392 | Warner Lambert (Pfizer) | 207736-06-9 |  |
| PD-180849 | Pfizer | |  |
| PD-180970 | Warner Lambert (Pfizer) | 287204-45-9 |  |
| PD-198306 | Warner Lambert (Pfizer) | 212631-61-3 |  |
| PD-254552 | Warner-Lambert | |  |
| PD-297447 | WARNER LAMBERT | |  |
| PD-298459 | Warner-Lambert | |  |
| PD-299685 | | | No Structure |
| PD-313052 | WARNER LAMBERT | |  |
| PD-325901 | Warner-Lambert (Pfizer) | 870474-62-7 |  |
| PD-332334 | Pfizer | | No Structure |
| PD-360324 | | | No Structure |
| PD-404182 | Pfizer | |  |
| PD-7 | Virginia Commonwealth University (US) | |  |
| PD-81723 | Medco | 132861-87-1 |  |
| PD-98059 | Warner Lambert (Pfizer) | 167869-21-8 |  |
| PD-E7-AS02B Vaccine | | | No Structure |
| PD1-17 | Wyeth ; Cambridge Antibody Technology | | No Structure |
| pDV-U-DIII | VGX Pharmaceuticals Inc. (Inovio Pharmaceuticals Inc.) | | No Structure |
| PE2I-123I | CIS Bio International (Schering AG) | |  |
| Pebulate | Stauffer | 1114-71-2 |  |
| Pecazine | Promonta | 60-89-9 |  |
| Pediarix | Smithkline Beecham Biologicals (GlaxoSmithKline plc) | 812649-60-8 | No Structure |
| Pefloxacin | Roger Bellon | 70458-92-3 |  |
| Peforelin | | 147859-97-0 |  |
| Pefurazoate | Ube | 101903-30-4 |  |
| PEG-20000-PN2S | Uni Degli Studi Di Padova | |  |
| PEG-25 PABA | | 116242-27-4 |  |
| PEG-5000-PN2S | Uni Degli Studi Di Padova | |  |
| PEG-Interferon lambda | ZymoGenetics (US) | | No Structure |
| PEG-PAL | BioMarin Pharmaceutical Inc. | | No Structure |
| PEG-PN-509 | Nastech | | No Structure |
| PEG-SN-38 | Enzon Pharmaceuticals | 86639-52-3 |  |
| PEG-T3C | Bolder Biotechnology Inc. (US) | | No Structure |
| Pegacaristim | Amgen | 187139-68-0 | No Structure |
| Pegamotecan | Enzon | 581079-18-7 |  |
| Pegaptanib | | 222716-86-1 |  |
| Pegaspargase | Sanofi-Aventis | 130167-69-0 | No Structure |
| Pegdinetanib | Bristol-Myers Squibb (BMS) | 906450-24-6 | No Structure |
| Pegfilgrastim | Amgen | 208265-92-3 | No Structure |
| Peginesatide | Johnson & Johnson ; Affymax | 913976-27-9 ; 1185870-58-9 (acetate) |  |
| PegInterferon Alfa-2A | Hoffmann–La Roche and Schering (Merck) (US) | 198153-51-4 | No Structure |
| Peginterferon alfa-2b | | 215647-85-1 | No Structure |
| Pegloticase | Mountain View Pharmaceuticals ; Univ. Duke | 885051-90-1 | No Structure |
| Pegmusirudin | Knoll AG (Abbott Laboratories) | 186638-10-8 | No Structure |
| Pegsiticase | | 1040753-26-1 | No Structure |
| Pegsunercept | Amgen | 330988-75-5 |  |
| Pegvisomant | Ohio University ; Edison Biotech | |  |
| PEHRG-214 | Probe International (Virionyx) | | No Structure |
| Pelargonic acid | Mycogen | 112-05-0 |  |
| Peldesine | BioCryst | 133432-71-0 |  |
| Pelitinib | American Cyanamid (Wyeth) | 257933-82-7 |  |
| Pelitrexol | Agouron (Pfizer) | 446022-33-9 |  |
| Pelrinone | American Home Products (Wyeth) | 89232-84-8 |  |
| Pelubiprofen | Sankyo | 69956-77-0 |  |
| Pemaglitazar | Merck GmbH | 496050-39-6 |  |
| Pemetrexed | Princeton University | 137281-23-3 |  |
| Pemirolast | Bristol-Myers Squibb (BMS) | 69372-19-6 |  |
| Pemoline | Boehringer Ingelheim | 2152-34-3 |  |
| Pempidine | ICI (AstraZeneca) | 79-55-0 |  |
| PEN-12 | Actice | |  |
| Penamecillin | American Home Products (Wyeth) | 983-85-7 |  |
| Penbutolol | Hoechst (Sanofi-Aventis) | 38363-40-5 |  |
| Penciclovir | Beecham (GSK) | 39809-25-1 |  |
| Penclomedine | Dow Chemical | 108030-77-9 |  |
| Penconazole | Ciba-Geigy (Novartis) | 66246-88-6 |  |
| Pencycuron | Bayer | 66063-05-6 |  |
| Pendimethalin | American Cyanamid (BASF) | 40487-42-1 |  |
| Penflufen | Bayer CropScience | 494793-67-8 |  |
| Penfluridol | Janssen Pharmaceutica (Johnson & Johnson) | 28864-56-2 |  |
| Penicillin G | Borroughs Wellcome (GSK) | 61-33-6 |  |
| PENNVAX-B | University of Pennsylvania (US) | | No Structure |
| PENNVAX-G | University of Pennsylvania (US) | | No Structure |
| PENNVAX-GP | University of Pennsylvania (US) | | No Structure |
| Penoxsulam | Dow Agrosciences | 219714-96-2 |  |
| Pentacea | Immunotech Partners | | No Structure |
| Pentamidine | May & Baker (Aventis) | 100-33-4 ; 140-64-7 (isethionate) |  |
| Pentamorphone | Reckitt & Colman | 68616-83-1 |  |
| Pentanochlor | FMC | 2307-68-8 |  |
| Pentapiperide | Cilag | 7009-54-3 |  |
| Pentazocine | Sterling Drug (Sanofi-Aventis) | 359-83-1 |  |
| Pentetrazol | Knoll (Abbott) | 54-95-5 |  |
| Penthienate bromide | University of Michigan | 60-44-6 |  |
| Penthiopyrad | Mitsui Chemicals | 183675-82-3 |  |
| Pentifylline | Chemische Werke Albert (Kalle Albert) | 1028-33-7 |  |
| Pentigetide | Dura Parma | 62087-72-3 |  |
| Pentisomide | Clin Midy | 96513-83-6 |  |
| Pentobarbital | | 76-74-4 |  |
| Pentosan polysulfate | University of California | 37319-17-8 |  |
| Pentostatin | Parke, Davis (Pfizer) | 53910-25-1 |  |
| Pentoxazone | Kaken Pharmaceutical | 110596-75-7 |  |
| Pentoxifylline | Chemische Werke Albert (Kalle Albert) | 6493-05-6 |  |
| Pentoxyverine | Union Chimique Belge | 77-23-6 ; 23142-01-0 (citrate) |  |
| Pentrix | | | No Structure |
| PEP-2675 | Istituto di Ricerche di Biologia Molecolare P. Angeletti SpA (Merck Research Laboratories) | |  |
| PEP-35 | Cangene Corp. (Canada) | |  |
| PEPA | Taisho ; Nippon Suisan Kaisha | |  |
| Pepluanin A | CNRS ; INSERM ; Universita di Napoli"Federico II" | |  |
| Peptide NLS-E | Curepeptide Ltd. | |  |
| Peramivir | BioCryst | 330600-85-6 |  |
| Perampanel | Eisai | 380917-97-5 |  |
| Perazine | Rhone-Poulenc (Aventis) | 84-97-9 |  |
| Peretinoin | Nikken Chemicals (Japan) | 81485-25-8 |  |
| Perflenapent | Sonus Ultrasound Imaging | 678-26-2 |  |
| Perflexane | Imarx Pharmaceutical | 355-42-0 |  |
| Perflisobutane | Nycomed Imaging | 354-92-7 |  |
| Perflubron | Alliance Pharmaceutical | 423-55-2 |  |
| Perflubutane | Acusphere | 355-25-9 |  |
| Perflutren | Du Pont Merck Pharma | 76-19-7 |  |
| Pergolide | Eli Lilly | 66104-22-1 |  |
| Pergoveris (Follitropin Alfa & Lutropin Alfa) | Merck Serono SA | 146479-72-3 ; 56832-30-5 (alpha-subunit) ; 110909-60-9 (beta-subunit) (Follitropin Alfa) ; 152923-57 | No Structure |
| Perhexiline | Richardson-Merrell (Aventis) | 6621-47-2 |  |
| Periciazine | Rhone-Poulenc (Aventis) | 2622-26-6 |  |
| Perifosine | Asta Medica (Aeterna Zentaris) | 157716-52-4 |  |
| Perillyl alcohol | Wisconsin Alumni Research Foundation | 536-59-4 |  |
| Perimethazine | Rhone-Poulenc (Aventis) | 13093-88-4 |  |
| Perindopril | Servier | 82834-16-0 |  |
| Periplocoside E | Chinese Academy of Sciences | |  |
| Perisoxal | Shionogi | 2055-44-9 |  |
| Perlapine | Wander | 1977-11-3 |  |
| Permethrin | Sumitomo Chemical | 52645-53-1 |  |
| Perospirone | Sumitomo Chemical | 150915-41-6 |  |
| Perphenazine | Schering Corp (Merck & Co) | 58-39-9 |  |
| PerT-GUS | Saint Louis University (US) | | No Structure |
| Pertuzumab | | 380610-27-5 | No Structure |
| Peru-15 pCTB | Avant Immunotherapeutics | | No Structure |
| Perzinfotel | American Home Products (Wyeth) | 144912-63-0 |  |
| PET-12 | Renopharm Ltd. | |  |
| PET-2 | Renopharm (Israel) | |  |
| PET-8 | Renopharm Ltd. | |  |
| Petasin | Weber & Weber (Germany) | 26577-85-5 |  |
| Pethidine | Winthrop (Sanofi-Synthelabo) | 57-42-1 |  |
| Pethoxamid | | 106700-29-2 |  |
| Petrosynol | | 111554-19-9 |  |
| PEV-6 | Pevion Biotech Ltd. | | No Structure |
| PEV6A | BioLife Science Forschungs- und Entwicklungsges mbH (Austria) | | No Structure |
| Pexacerfont | Bristol-Myers Squibb (BMS) | 459856-18-9 |  |
| Pexelizumab | Alexion ; Procter & Gamble | 219685-93-5 | No Structure |
| Pexiganan | Magainin (Genaera) | 147664-63-9 |  |
| PF-00356231 | Pfizer | 766536-21-4 (as hydrochloride salt) |  |
| PF-00389027 | Pfizer Inc. (US) | |  |
| PF-00422602 | Upjohn Co (Pfizer) | |  |
| PF-00851623 | Pfizer Inc. (US) | |  |
| PF-02333808 | Upjohn (Pfizer) | 383199-88-0 |  |
| PF-02367982 | Pfizer (GB) | |  |
| PF-03187207 | NicOx ; Pfizer | | No Structure |
| PF-03311945 | Sanofi Aventis | |  |
| PF-03315011 | Pharmacia & Upjohn Co. LLC (Pfizer Inc.) | |  |
| PF-03550096 | Pfizer | |  |
| PF-03716556 | Pfizer | |  |
| PF-03800130 | Pfizer Inc. (US) | |  |
| PF-03900422 | Pfizer Inc. | |  |
| PF-0419789 | Pfizer Inc. (US) | |  |
| PF-04363467 | Pfizer Inc. (US) | |  |
| PF-04449913 | | | No Structure |
| PF-04494700 | TransTech Pharma | | No Structure |
| PF-04577806 | Pfizer Inc. | 1072100-81-2 |  |
| PF-04634817 | | | No Structure |
| PF-04937319 | | | No Structure |
| PF-04958242 | | | No Structure |
| PF-04979064 | Pfizer Inc. | |  |
| PF-04991532 | | | No Structure |
| PF-04995274 | | | No Structure |
| PF-05089771 | | | No Structure |
| PF-05175157 | | | No Structure |
| PF-05190457 | | | No Structure |
| PF-05212372 | | | No Structure |
| PF-05230901 | | | No Structure |
| PF-05230905 | Ablynx NV | | No Structure |
| PF-05236812 | Elan Corporation plc | | No Structure |
| PF-1022A | Meiji Seika | 133413-70-4 |  |
| PF-1022G | Meiji Seika | 203389-23-5 |  |
| PF-1092A | Meiji Seika Kaisha | |  |
| PF-1163A | | |  |
| PF-1237B | Meiji Seika Kaisha | |  |
| PF-1270A | Meiji Seika Kaisha | |  |
| PF-1270B | Meiji Seika Kaisha | |  |
| PF-1270C | Meiji Seika Kaisha | |  |
| PF-184 | Pfizer Inc. (US) | |  |
| PF-184298 | Pfizer | |  |
| PF-217830 | Warner Lambert Co. (Pfizer Inc.) | |  |
| PF-232798 | Pfizer Inc. (US) | |  |
| PF-2391677 | Pfizer | | No Structure |
| PF-2393296 | Pfizer | | No Structure |
| PF-2400013 | Pfizer | | No Structure |
| PF-2413873 | Pfizer Inc. (US) | |  |
| PF-251802 | Pfizer | | No Structure |
| PF-2545920 | Pfizer | |  |
| PF-2575799 | Pfizer | | No Structure |
| PF-275366 | Pfizer | | No Structure |
| PF-277343 | Pfizer Inc. | 332926-04-2 |  |
| PF-3049423 | | | No Structure |
| PF-3052334 | Warner-Lambert (Pfizer) | |  |
| PF-3084014 | Pfizer Inc. (US) | |  |
| PF-3185043 | Pfizer | | No Structure |
| PF-3246799 | Pfizer Inc. | |  |
| PF-3274167 | Pfizer | | No Structure |
| PF-337210 | Pfizer | |  |
| PF-3409409 | Pfizer Inc. | |  |
| PF-3446962 | Amgen Fremont Inc. (US) ; Pfizer Inc. (US) | | No Structure |
| PF-3463275 | Pfizer Inc. (US) | |  |
| PF-3491165 | Pfizer | | No Structure |
| PF-3526299 | | | No Structure |
| PF-3557156 | Pfizer | | No Structure |
| PF-3635659 | | | No Structure |
| PF-3654746 | Pfizer Inc. (US) | 935840-31-6 ; 1039399-17-1 (as TsOH salt) |  |
| PF-3654764 | | | No Structure |
| PF-3715455 | | | No Structure |
| PF-3716539 | | | No Structure |
| PF-371989 | Pfizer Inc. (US) | |  |
| PF-3732010 | Pfizer | | No Structure |
| PF-3758309 | Pfizer Inc. (US) | |  |
| PF-376304 | Warner Lambert Co (Pfizer) | |  |
| PF-3814735 | Pfizer Inc. (US) | |  |
| PF-3823863 | Pfizer Inc. (US) | |  |
| PF-3845 | Pfizer Inc. (US) | |  |
| PF-3864086 | Pfizer | | No Structure |
| PF-3882845 | Pfizer Inc. | |  |
| PF-3893787 | | | No Structure |
| PF-3932295 | Pfizer | | No Structure |
| PF-4064900 | Pfizer | | No Structure |
| PF-4136309 | Incyte | | No Structure |
| PF-4171327 | | | No Structure |
| PF-4181366 | Pfizer Inc. | |  |
| PF-4191834 | Pfizer Inc. | |  |
| PF-4194471 | Pfizer Inc. | | No Structure |
| PF-4217903 | Pfizer Inc. (US) | |  |
| PF-4236921 | | | No Structure |
| PF-4254644 | Pfizer Inc. (US) | |  |
| PF-4287881 | Pfizer Inc. (US) | |  |
| PF-429242 | Pfizer Inc. (US) | |  |
| PF-4308515 | | | No Structure |
| PF-431499 | Pfizer | | No Structure |
| PF-4325667 | Pfizer | | No Structure |
| PF-4382923 | Rinat Neuroscience Corp. (Pfizer Inc.) | | No Structure |
| PF-4418948 | | | No Structure |
| PF-4427429 | | | No Structure |
| PF-4447943 | Pfizer Inc. | |  |
| PF-4455242 | | | No Structure |
| PF-4457845 | | |  |
| PF-446687 | Pfizer | | No Structure |
| PF-4470296 | Pfizer Inc. (US) | |  |
| PF-4480682 | Pfizer | | No Structure |
| PF-4522625 | Pfizer ; PowderMed | | No Structure |
| PF-4531083 | | | No Structure |
| PF-4548043 | Kosan Biosciences (BMS) | | No Structure |
| PF-4554878 | | | No Structure |
| PF-4605412 | Medarex Inc. ; Pfizer | | No Structure |
| PF-4620110 | Pfizer Inc. | |  |
| PF-4629991 | Pfizer | | No Structure |
| PF-4691502 | Pfizer Inc. | |  |
| PF-4764793 | | | No Structure |
| PF-477736 | Agouron (Pfizer) | |  |
| PF-4778574 | Pfizer Inc. | |  |
| PF-4856882 | Pfizer ; CovX | | No Structure |
| PF-4856884 | | | No Structure |
| PF-4878691 | Pfizer | | No Structure |
| PF-489791 | | | No Structure |
| PF-4929113 | | | No Structure |
| PF-4950834 | Pfizer Inc. | |  |
| PF-4967544 | | | No Structure |
| PF-4971729 | | | No Structure |
| PF-5 | Pfizer Inc. | |  |
| PF-514273 | Pfizer | | No Structure |
| PF-5208766 | | | No Structure |
| PF-5212368 | | | No Structure |
| PF-5212371 | Pfizer Inc. | | No Structure |
| PF-5212377 | | | No Structure |
| PF-5212389 | | | No Structure |
| PF-5230894 | | | No Structure |
| PF-5230895 | Trubion Pharmaceuticals Inc. | 1170036-26-6 | No Structure |
| PF-547659 | Pfizer | | No Structure |
| PF-562271 | Pfizer Inc. (US) | |  |
| PF-572778 | Pfizer | | No Structure |
| PF-5901 | USV | 101910-24-1 |  |
| PF-592379 | Pfizer | | No Structure |
| PF-610355 | Pfizer Inc. | |  |
| PF-622 | Pfizer | 898235-65-9 |  |
| PF-670462 | Pfizer Inc. (US) | |  |
| PF-708093 | Pfizer | | No Structure |
| PF-722135 | Pfizer Inc. (US) | |  |
| PF-734629 | Pfizer Inc. (US) | |  |
| PF-738502 | Pfizer | | No Structure |
| PF-750 | Pfizer | |  |
| PF-755616 | Pfizer | | No Structure |
| PF-80 | Pfizer Inc. (US) | |  |
| PF-807925 | Pfizer | | No Structure |
| PF-835231 | Pfizer Inc. (US) | |  |
| PF-885706 | Pfizer | | No Structure |
| PF-904 | Prodesfarma | 141957-35-9 |  |
| PF-904048 | Pfizer | |  |
| PF-915275 | Pfizer | |  |
| PF-941222 | Pfizer | |  |
| PF-956980 | Pfizer | |  |
| PF-987296 | Pharmacia & Upjohn Co (Pfizer) | |  |
| PF-998425 | Pfizer | |  |
| Pfizer-RN-193673-84-6 | Pfizer | 193673-84-6 |  |
| Pfizer-RN-193673-96-0 | Pfizer | 193673-96-0 |  |
| PG-01037 | Government of the USA | |  |
| PG-1014491 | Procter & Gamble Co. (US) | |  |
| PG-11047 | Wisconsin Alumni Res Found (US) | 206991-64-2 ; 308145-19-9 (free base) |  |
| PG-116800 | The Procter & Gamble Co. | 291533-11-4 |  |
| PG-2 | Pharmagenesis Inc. | | No Structure |
| PG-27 | University of Texas (US) | | No Structure |
| PG-301029 | Procter & Gamble ; University of Arizona Foundation | |  |
| PG-36 | Pharmagenesis Inc. | | No Structure |
| PG-49088 | Pharmagenesis | 195883-06-8 |  |
| PG-501 | Progen | |  |
| PG-689 | Pharmagenesis | 458550-73-7 |  |
| PG-694 | Pharmagenesis | 458550-74-8 |  |
| PG-695 | Pharmagenesis | |  |
| PG-700 | Pharmagenesis | 260246-87-5 |  |
| PG-701 | Shanghai Institute of Materia Medica (China) | |  |
| PG-760564 | The Procter & Gamble Co. | | No Structure |
| PG-763 | Pharmagenesis | |  |
| pGA2-JS7 | Emory University (US) ; Secretary of Health and Human Services (US) | | No Structure |
| PGC-GLP-1 | PharmaIN Ltd. (US) | | No Structure |
| PGE-1818689 | Procter & Gamble | |  |
| PGE-3366466 | Procter & Gamble Company | |  |
| PGE-4175997 | Procter & Gamble | 341520-51-2 |  |
| PGE-4924490 | Procter & Gamble | 177325-39-2 |  |
| PGE-6134091 | Procter & Gamble | |  |
| PGE-8335534 | Norwich Eaton (Procter & Gamble) | 129718-09-8 |  |
| PGE-9262932 | Procter & Gamble | 221221-18-7 |  |
| PGE-9509924 | Procter & Gamble | 221221-39-2 |  |
| PGL-135 | Max-Planck-Institut | 26278-83-1 |  |
| PGL-137 | Hoffmann La Roche | 943-04-4 |  |
| PGL-201 | Max-Planck-Institut | |  |
| PGP-4008 | The Penn State Research Foundation | |  |
| PH-027 | University of Kuwait | |  |
| PH-10 | Photogen | |  |
| PH-3 | National Yang Ming University (Taiwan) | 512-04-9 |  |
| PH-794428 | Pfizer | | No Structure |
| PH-797804 | Pharmacia Corp. (Pfizer Inc.) | 586379-66-0 |  |
| PH-797904 | | | No Structure |
| PH-94B | Pherin Pharmaceuticals | | No Structure |
| PHA-384640E | Searle (US) | |  |
| PHA-408 | Pfizer Inc. (US) | |  |
| PHA-529311 | Upjohn (Pfizer) | |  |
| PHA-543613 | Upjohn Co (Pfizer) | |  |
| PHA-665752 | Sugen | |  |
| PHA-666859 | Pharmacia Corp. (Pfizer Inc.) | |  |
| PHA-680632 | Pharmacia Italia (Pfizer) | |  |
| PHA-709829 | Pfizer Inc. (US) | |  |
| PHA-728699 | Upjohn | |  |
| PHA-767491 | Pharmacia (Pfizer) | |  |
| PHA-793887 | Pharmacia Italia SpA (Pfizer Inc.) | |  |
| PHA-794428 | Pharmacia (Pfizer) | | No Structure |
| PHA-848125 | Pfizer Inc. (US) | |  |
| PHA-927-F | Pharmacia | |  |
| Phakellistatin 5 | National Cancer Institute | |  |
| Phanquinone | Ciba (Novartis) | 84-12-8 |  |
| PHCCC | Merck & Co | |  |
| Phellodendrine | Tsumura | 6873-13-8 |  |
| Phenacemide | Abbott | 63-98-9 |  |
| Phenacetin | Monsanto (Pharmacia) | 62-44-2 |  |
| Phenazocine | SmithKline French (GSK) | 127-35-5 |  |
| Phenazone | Ciba-Geigy (Novartis) | 60-80-0 |  |
| Phenazopyridine | Boehringer Ingelheim | 94-78-0 |  |
| Phenbenzamine | Rhone-Poulenc (Aventis) | 961-71-7 |  |
| Phencynonate | Institute of Pharmacology and Toxicology Academy of Military Medical Sciences PLA (China) | 172451-71-7 (HCl salt) |  |
| Phendimetrazine | Boehringer Ingelheim | 634-03-7 |  |
| Phenelzine | Lakeside | 51-71-8 |  |
| Phenethicillin | Beecham (GSK) | 147-55-7 |  |
| Pheneturide | Bayer | 90-49-3 |  |
| Phenformin | USV | 114-86-3 |  |
| Phenglutarimide | Ciba (Novartis) | 1156-05-4 |  |
| Phenindamine | Hoffmann La Roche (Roche) | 82-88-2 |  |
| Phenindione | | 83-12-5 |  |
| Pheniramine | Schering Corp (Merck & Co) | 86-21-5 |  |
| Phenmedipham | Schering AG | 13684-63-4 |  |
| Phenmetrazine | Boehringer Ingelheim | 134-49-6 |  |
| Phenobarbital | Bayer | 50-06-6 |  |
| Phenochalasin A | Kitasato University | 253129-68-9 |  |
| Phenochalasin B | Kitasato University | 253129-70-3 |  |
| Phenolphthalein | Ex Lax | 77-09-8 |  |
| Phenolsulphonphthalein | Thann | 143-74-8 |  |
| Phenoperidine | Eli Lilly | 562-26-5 |  |
| Phenothiazine | | 92-84-2 |  |
| Phenothrin | Sumitomo Chemical | 26002-80-2 |  |
| Phenoxybenzamine | SmithKline Beecham (GSK) | 59-96-1 |  |
| Phenoxyethanol | | 122-99-6 |  |
| Phenoxymethylpenicillin | Hoechst (Sanofi-Aventis) | 87-08-1 |  |
| Phenprobamate | Siegfried | 673-31-4 |  |
| Phenprocoumon | Hoffmann La Roche (Roche) | 435-97-2 |  |
| Phenserine | US Health | 101246-66-6 |  |
| Phensuximide | Parke, Davis (Pfizer) | 86-34-0 |  |
| Phentermine | Merrell (Aventis) | 122-09-8 |  |
| Phenthoate | Montecatini | 2597-03-7 |  |
| Phentolamine | Ciba (Novartis) | 50-60-2 |  |
| Phenylalanine | Pfizer | 673-06-3 |  |
| Phenylbutazone | Geigy (Novartis) | 50-33-9 |  |
| Phenylephrine | | 59-42-7 |  |
| Phenylphenol | Bayer | 90-43-7 |  |
| Phenylpropanol | | 93-54-9 |  |
| Phenylpropanolamine | Nepera | 14838-15-4 |  |
| Phenyltoloxamine | Bristol (BMS) | 92-12-6 |  |
| Phenytoin | Parke, Davis (Pfizer) | 57-41-0 |  |
| PHI-370 | Parker Hughes Inst. | 296235-25-1 |  |
| PHI-380 | Parker Hughes Inst. | 296235-31-9 |  |
| PHI-381 | Parker Hughes Institute | 296235-23-9 |  |
| PHI-P518 | Parker Hughes Institute | 536703-43-2 |  |
| Philinopside A | Chinese Academy of Sciences ; Shanghai Institute of Materia Medica | |  |
| Phlorofucofuroeckol | Pukyong National University (Korea) ; Pusan National University (Korea) | 128129-56-6 |  |
| Phloroglucinol | Lafon (Cephalon) | 108-73-6 |  |
| PHN-021 (Phencynonate) | Institute of Pharmacology and Toxicology Academy of Military Medical Sciences PLA (China) | 172451-71-7 (HCl salt) |  |
| PHN-081 | | | No Structure |
| PHN-121 | | | No Structure |
| PHN-131 | | | No Structure |
| Pholcodine | Dausse | 509-67-1 |  |
| Pholedrine | Knoll (Abbott) | 370-14-9 |  |
| Phomallenic acid C | Merck & Co. | |  |
| Phorate | Bayer | 298-02-2 |  |
| Phosalone | Rhone-Poulenc | 2310-17-0 |  |
| Phosdiphen | Mitsui | 36519-00-3 |  |
| Phosmet | Stauffer | 732-11-6 |  |
| Phosphamidon | Ciba-Geigy (Novartis) | 13171-21-6 |  |
| Phosphatidylcholine | | |  |
| Phosphatidylethanolamine | | |  |
| Phosphatidylserine | | |  |
| Phosphazid | Engelhart Inst. | 124930-59-2 |  |
| Phosphocarb | BASF | 126069-54-3 |  |
| Photofrin | Healux | 87806-31-3 |  |
| Phoxim | Bayer | 14816-18-3 |  |
| PHPS1 | Max Delbrück Centrum für Molekulare Medizin (Germany) | 314291-83-3 (free acid) |  |
| PHT-427 | University of Arizona (US) | |  |
| Phthalascidin | Pharma Mar ; Drug Innovation & Design Inc ; Harvard College | 237756-89-7 |  |
| Phthalide | Bayer | 27355-22-2 |  |
| Phthalylsulfacetamide | | 131-69-1 |  |
| Phthalylsulfathiazole | Sharp & Dohme (Merck & Co.) | 85-73-4 |  |
| Phtharal | Surgikos Inc. | 643-79-8 |  |
| PhXA34 | Pharmacia | 130209-82-4 |  |
| PHY-906 | Yale University | | No Structure |
| Phytic acid | | 83-86-3 |  |
| Phytomenadione | Hoffmann La Roche | 84-80-0 |  |
| PI-1 | Vertex Pharmaceuticals | |  |
| PI-130 | Yamanouchi; Ludwig Institute for Cancer Research; Imperial Cancer Research Technology | 371935-74-9 |  |
| PI-88 | The Australian National University | 185077-23-0 |  |
| Pibaxizine | UCB | 82227-39-2 |  |
| Pibenzimol | Cancer Inst Board ; Melbourne University ; Victoria Anti Cancer Council | 23491-45-4 (trihydrochloride) ; 23491-44-3 |  |
| Piboserod | SmithKline Beecham (GSK) | 152811-62-6 |  |
| Pibrozelesin | Kyowa Hakko | 154889-68-6 |  |
| Pibutidine | Ikeda Mohando | 103922-33-4 |  |
| Piceasin | Novozymes | |  |
| Picenadol | Eli Lilly | 79201-85-7 |  |
| Pichromene | Ontario Cancer Institute (Canada) ; The Hospital for Sick Children (Canada) ; Mount Sinai Hospital ( | |  |
| Picilorex | Hexachimie | 62510-56-9 |  |
| Piclamilast | RPR (Aventis) | 144035-83-6 |  |
| Picloram | DowElanco | 1918-02-1 |  |
| Picloxydine | Aspro-Nicholas | 5636-92-0 |  |
| Piclozotan | Suntory | 182415-09-4 |  |
| Picolamine | Boots (Abbott) | 3731-52-0 |  |
| Picolinafen | Shell | 137641-05-5 |  |
| Picolumi-8220 | Sanko Junyaku | | No Structure |
| Picoperine | Takeda | 21755-66-8 |  |
| Picoplatin | Johnson Matthey | 181630-15-9 |  |
| Picotamide | Societa Italo-Britannica | 32828-81-2 |  |
| Picoxystrobin | BASF | 117428-22-5 |  |
| Picrocrocin | Universidad De Castillala Mancha (Spain) | 138-55-6 |  |
| (-)-Picropodophyllin | University Of Rochester (US) | 477-47-4 |  |
| Picroside I | | 27409-30-9 |  |
| Picroside II | | 39012-20-9 |  |
| Picumast | Boehringer Mannheim (Roche) | 39577-19-0 |  |
| Picumeterol | Glaxo (GSK) | 130641-36-0 |  |
| Pidolic acid | Lafon (Cephalon) | 31377-05-6 |  |
| Pidotimod | Poli | 121808-62-6 |  |
| PIE-12-trimer | University of Utah Research Foundation (US) | | No Structure |
| Pifarnine | Pierrel | 56208-01-6 |  |
| Pifoxime | A. Mieville | 31224-92-7 |  |
| PIK-294 | University of California | 900185-02-6 |  |
| Piketoprofen | Antonio Gallardo | 60576-13-8 |  |
| Pill-Plus | | | No Structure |
| Pilocarpine | | 92-13-7 |  |
| Pilsicainide | Suntory | 88069-67-4 |  |
| Pimagedine | Rockefeller University | 79-17-4 |  |
| Pimavanserin | Acadia Pharmaceuticals | 868855-07-6 ; 706782-28-7 (tartrate salt) |  |
| Pimecrolimus | sandoz (Novartis) | 137071-32-0 |  |
| Pimethixene | Merck & Co. | 314-03-4 |  |
| Pimilprost | Sumitomo Chemical | 139403-31-9 |  |
| Pimobendan | Thomae (Boehringer Ingelheim) | 74150-27-9 |  |
| Pimonidazole | Hoffmann La Roche | 70132-50-2 |  |
| Pimozide | Janssen Pharmaceutica (Johnson & Johnson) | 2062-78-4 |  |
| Pinacidil | Leo Pharmaceutical | 85371-64-8 |  |
| Pinaverium bromide | Societe Berri-Balzac | 53251-94-8 |  |
| Pinazepam | Zambeletti | 52463-83-9 |  |
| Pindobind | Stanford University | 106469-52-7 |  |
| Pindolol | Sandoz (Novartis) | 13523-86-9 |  |
| Pindone | Motomco | 83-26-1 |  |
| Pinosylvin | Arizona Chemical | 22139-77-1 |  |
| Pinoxaden | Syngenta | 243973-20-8 |  |
| Pioglitazone | Takeda | 111025-46-8 |  |
| Pioglitazone & Azilsartan | Takeda | |  |
| Pioglitazone & Metformin | Takeda Chemical Industries Ltd. (Takeda Pharmaceutical Co. Ltd.) | 737811-27-7 ; 111025-46-8 (Pioglitazone) ; 657-24-9 (Metformin) |  |
| PIP-1 | Slovak Technical University | |  |
| PIP-3EA | Friedrich-Alexander-Universität ; Université François-Rabelais ; Universitá degli Studi di Cagliari | |  |
| Pipamazine | Searle (Pharmacia) | 84-04-8 |  |
| Pipamperone | Janssen Pharmaceutica (Johnson & Johnson) | 1893-33-0 |  |
| Pipazetate | Degussa | 2167-85-3 |  |
| Pipecuronium bromide | Gedeon Richter | 52212-02-9 |  |
| Pipemidic acid | Dainippon Pharmaceutical | 51940-44-4 |  |
| Pipendoxifene | American Home Products (Wyeth) | 198480-55-6 |  |
| Pipenzolate bromide | Lakeside | 125-51-9 |  |
| Piperacetazine | Searle (Pharmacia) | 3819-00-9 |  |
| Piperacillin | Toyama | 61477-96-1 |  |
| Piperalin | Elanco | 3478-94-2 |  |
| Piperaquine | Rhone-Poulenc S.A. (France) | 4085-31-8 ; 83764-65-2 |  |
| Piperazine | | 110-85-0 |  |
| Piperidione | Hoffmann La Roche (Roche) | 77-03-2 |  |
| Piperidolate | Lakeside | 82-98-4 |  |
| Piperine | | 94-62-2 |  |
| Piperocaine | Abbott | 136-82-3 |  |
| Piperonyl butoxide | Fairfield American | 51-03-6 |  |
| Piperophos | Ciba-Geigy (Novartis) | 24151-93-7 |  |
| Piperylone | Sandoz (Novartis) | 2531-04-6 |  |
| Pipethanate | Shinyaku | 4546-39-8 |  |
| Pipobroman | Abbott | 54-91-1 |  |
| Pipofezine | A.U.S.R.C.P.I. | 24886-52-0 |  |
| Pipotiazine | Rhone-Poulenc (Aventis) | 39861-99-6 |  |
| Pipoxolan | Rowa-Wagner | 23744-24-3 |  |
| Pipradrol | Merrell (Aventis) | 467-60-7 |  |
| Pipratecol | Servier | 15534-05-1 |  |
| Piprinhydrinate | Promonta | 606-90-6 |  |
| Piproctanyl | Maag | 56717-11-4 |  |
| Piprozolin | Goedecke (Pfizer) | 17243-64-0 |  |
| PIQ-22 | Ishihara | 202200-23-5 |  |
| Piracetam | UCB | 7491-74-9 |  |
| Piragliatin | F. Hoffmann-La Roche | 625114-41-2 |  |
| Pirarubicin | Microbiochemical Research Foundation | 72496-41-4 |  |
| Piraxostat | Yoshitomi Pharmaceutical | 206884-98-2 |  |
| Pirbuterol | Pfizer | 38677-81-5 |  |
| Pirenoxine | Chizu Drug | 1043-21-6 |  |
| Pirenzepine | Thomae (Boehringer Ingelheim) | 28797-61-7 |  |
| Piretanide | Hoechst (Sanofi-Aventis) | 55837-27-9 |  |
| Pirfenidone | Affiliated Medical Research - AMR (Marnac / KDL) | 53179-13-8 |  |
| Piribedil | Servier | 3605-01-4 |  |
| Piridoxilate | Dieckmann | 24340-35-0 |  |
| Pirifibrate | Roussel (Aventis) | 55285-45-5 |  |
| Pirimicarb | ICI (Syngenta) | 23103-98-2 |  |
| Pirimiphos-ethyl | ICI (Syngenta) | 23505-41-1 |  |
| Pirimiphos-methyl | ICI (Syngenta) | 29232-93-7 |  |
| Pirinixic acid | Wyeth | 50892-23-4 |  |
| Pirisudanol | Soc. d'Etudes de Produits Chim. | 33605-94-6 |  |
| Piritramide | Janssen Pharmaceutica (Johnson & Johnson) | 302-41-0 |  |
| Piritrexim | Wellcome (GSK) | 72732-56-0 |  |
| Pirlimycin | Upjohn | 79548-73-5 |  |
| Pirlindole | All Union Scientific Research Chemical Pharmaceutical Inst. | 60762-57-4 |  |
| Pirmagrel | Ciba-Geigy (Novartis) | 85691-74-3 |  |
| Pirmenol | Parke, Davis (Pfizer) | 61477-94-9 |  |
| Piroctone | Hoechst (Sanofi-Aventis) | 50650-76-5 ; 68890-66-4 |  |
| Pirodavir | Janssen Pharmaceutica (Johnson & Johnson) | 124436-59-5 |  |
| Piroheptine | Fujisawa | 16378-21-5 |  |
| Piromidic acid | Dainippon Pharmaceutical | 19562-30-2 |  |
| Piroxantrone | Warner Lambert (Pfizer) | 91441-23-5 |  |
| Piroxicam | Pfizer | 36322-90-4 |  |
| Piroxicam Betadex | Chiesi Farmaceutici | 96684-39-8 |  |
| Piroxicam Cinnamate | Societa Prodotti Antibiotici | 87234-24-0 |  |
| Piroxicam pivalate | Pfizer | 87027-09-6 |  |
| Piroximone | Merrell Dow Pharma | 84490-12-0 |  |
| Pirozadil | Inst. Int. Ter. | 54110-25-7 |  |
| Pirprofen | Ciba (Novartis) | 31793-07-4 |  |
| Piscidin 1 | North Carolina State University | |  |
| Pitofenone | Hoechst (Sanofi-Aventis) | 54063-52-4 |  |
| Pivagabine | Acraf | 69542-93-4 |  |
| Pivaloyloxymethyl butyrate | Bar Ilan University | 122110-53-6 |  |
| Pivmecillinam | Loevens | 32886-97-8 |  |
| Pixantrone | University of Vermont (US) | 150629-26-8 ; 144675-97-8 (dimaleate salt) |  |
| Pizotifen | Sandoz (Novartis) | 15574-96-6 |  |
| PJ-34 | Nixon | 344458-19-1 |  |
| PK-110 | Duke University | 140475-22-5 |  |
| PK-44 | Peakdale Molecular Ltd | |  |
| PKF-217 | Novartis | 359440-17-8 |  |
| PKI-166 | Novartis | |  |
| PKI-402 | Wyeth Corp. (Pfizer Inc.) | |  |
| PKI-587 | Wyeth Corp. (Pfizer Inc.) | |  |
| PL-100 | Pharmacor (Ambrilia Biopharma) | |  |
| PL-1100 (Phosphatidylcholine & Ibuprofen) | The University of Texas System (US) | |  |
| PL-14 | Debiopharm | | No Structure |
| PL-14736 | Sikiric Predrag et al. (Croatia) (Pliva) | 137525-51-0 |  |
| PL-2028 | GSK | |  |
| PL-2100 (Aspirin & Phosphatidylcholine) | Taxas University | |  |
| PL-37 | Pharmaleads SAS (France) | |  |
| PL-3994 | Palatin Technologies | | No Structure |
| PL-69 | Portland State University (US) | |  |
| Plafibride | Investigacion Technica y Aplicada | 63394-05-8 |  |
| Plasminogen (307-319) | Istituto Nazionale Ricerca sul Cancro | |  |
| Platencin | Merck & Co. Inc. (US) ; Merck Sharp & Dohme de España S.A. (Spain) | |  |
| Platensimycin | Merck & Co. ; Merck Sharp & Dohme | |  |
| Plaunotol | Sankyo | 64218-02-6 |  |
| PLD-147 | Pliva Lachema | |  |
| Plecanatide | Synergy Pharmaceuticals, Inc. | 467426-54-6 |  |
| Pleconaril | Sterling Winthrop (Sanofi-Aventis) | 153168-05-9 |  |
| Plerixafor | Anormed | 110078-46-1 |  |
| Plevitrexed | Zeneca (AstraZeneca) ; British Tech Group (BTG) | 153537-73-6 |  |
| Plinabulin | | 714272-27-2 |  |
| Plovamer | Peptimmune | 507277-44-3 ; 1026791-66-1\n(acetate) | No Structure |
| PLUG-X | Università di Milano (Italy) | |  |
| Pluraflavin A | Aventis Pharma | |  |
| PLX-3397 | | | No Structure |
| PLX-4032 | Plexxikon | 918505-61-0 |  |
| PLX-4720 | Plexxikon | 918505-84-7 |  |
| PM-00104 | PharmaMar | |  |
| PM-01183 | PharmaMar SA (Spain) | |  |
| PM-030091 | PharmaMar | |  |
| PM-060184 | | | No Structure |
| PM-103 (Clopidogrel) | Cydex Pharmaceuticals | |  |
| PM-181104 | Nicholas Piramal India Ltd. (India) ; Council of Scientific and Industrial Research (India) | |  |
| PM-20 | US National Cancer Institute ; University of Pittsburgh (USA) | |  |
| PM-62383 | University of Hong Kong | |  |
| PM-62406 | University of Hong Kong | |  |
| PM-92131 | PharmaMar | |  |
| PM-94116 | Pharma Mar | 176019-30-0 |  |
| PMCDG Dipivoxil | LG Chemicals (LG Life Sciences ) | |  |
| PMCG | LG Life Sciences | |  |
| PMCJ-9 | Sanofi Pasteur | | No Structure |
| PMCR-242 | Louisiana State University (US) | |  |
| PMD-3112 | Proteus Molecular Design | |  |
| PMEDAP | Czechoslovak Academy of Science | 113852-41-8 |  |
| PMEG | Ceskoslovenska Akademie Ved ; Rega Inst. | 114088-58-3 |  |
| PMI-001 | University of Texas | | No Structure |
| PMIN | National Research Council of Canada (Canada) | |  |
| PMS-601 | Paris University Diderot ; Centra Energie Atomique | 158978-98-4 |  |
| PMX-205 | University of Queensland | |  |
| PMX-2058 | Pharminox Ltd. | | No Structure |
| PMX-290 | Cancer Research Technology Ltd. | |  |
| PMX-30016 | Polymedix | |  |
| PMX-30063 | PolyMedix Inc. (US) | |  |
| PMX-53 | University of Queensland | |  |
| PMX-622 | | | No Structure |
| PN-0621 | Peptech | | No Structure |
| PN-100 (Naproxen & Lansoprazole) | Pozen | |  |
| PN-200 (Naproxen & Omeprazole) | Pozen | |  |
| PN-2034 | Wellstat Therapeutics Corp. | |  |
| PN-2069 | Wellstat Therapeutics Corp. (US) | |  |
| PN-400 (Naproxen & Esomeprazole) | Pozen Inc. (US) | 22204-53-1 (Naproxen) ; 119141-88-7 (Esomeprazole) |  |
| PN-951 | Wellstat Therapeutics Corp. | | No Structure |
| PNC-28 | State University of New York (US) | |  |
| pneumococcal 13-valent conjugate vaccine | Wyeth Pharmaceuticals (Pfizer) | | No Structure |
| PNGVL3-HICD Vaccine | University of Washington | | No Structure |
| pNGVL4a-Sig-E7(detox)-HSP70 | Johns Hopkins University (US) | | No Structure |
| PNH-192 | Academy of Science Czech Republic | |  |
| PNT-100 | Pronai Therapeutics | | No Structure |
| PNTI | University of Minnesota | 336129-79-4 |  |
| PNU-100480 | Pharmacia & Upjohn (Pharmacia) | 168828-58-8 |  |
| PNU-101017 | Pharmacia & Upjohn (Pharmacia) | 170568-47-5 |  |
| PNU-103017 | Pharmacia | 166335-18-8 |  |
| PNU-103657 | Upjohn (Pharmacia) | 179556-43-5 |  |
| PNU-109291 | Upjohn (Pharmacia) | 187665-60-7 |  |
| PNU-120596 | Upjohn (prfizer) | |  |
| PNU-142633 | Pharmacia | |  |
| PNU-142721 | Upjohn (Pharmacia) | 185220-03-5 |  |
| PNU-142731 | Pharmacia & Upjohn (Pharmacia) | 214212-39-2 |  |
| PNU-144159E | Pharmacia | |  |
| PNU-145185 | Upjohn (Pharmacia) | 228725-44-8 |  |
| PNU-153429 | Farmitalia Carlo Erba (Pharmacia) | 159537-60-7 |  |
| PNU-153833 | Pharmacia & Upjohn | |  |
| PNU-157706 | Pharmacia & Upjohn (Pharmacia) | 188754-67-8 |  |
| PNU-159682 | Pfizer | |  |
| PNU-171990 | Pharmacia & Upjohn (Pfizer) | 26879-67-4 |  |
| PNU-173995 | Upjohn | |  |
| PNU-177553 | Upjohn | |  |
| PNU-177864 | Upjohn (Pfizer) | 250266-51-4 |  |
| PNU-179954 | Pharmacia & Upjohn | 226991-58-8 |  |
| PNU-182171 | Pharmacia & Upjohn (Pfizer) | |  |
| PNU-183792 | Pharmacia & Upjohn (Pfizer) | 282536-25-8 |  |
| PNU-191386 | Pharmacia & Upjohn | |  |
| PNU-193821 | Pharmacia & UPJOHN | |  |
| PNU-200577 | Pharmacia & Upjohn (Pharmacia) | 207679-81-0 |  |
| PNU-282987 | Pharmacia & Upjohn | |  |
| PNU-292137 | Pharmacia & Upjohn ; Upjohn (Pfizer) | |  |
| PNU-92560 | Pharmacia | |  |
| (-)-PNU286607 | Pfizer Inc. (US) | |  |
| Pobilukast | SmithKline Beecham (GSK) | 107023-41-6 |  |
| POBN | | 66893-81-0 |  |
| Pochoxime A | Universite de Strasbourg (France) ; Centre National de la Recherche Scientifique (France) | |  |
| POL-3026 | Polyphor AG (Switzerland) ; Universität Zürich (Switzerland) | |  |
| Polaprezinc | Hamari | 107667-60-7 |  |
| Poldine methylsulfate | Beecham (GSK) | 545-80-2 |  |
| Policresulen | Byk Gulden (Nycomed) | 9011-02-3 |  |
| Polidocanol | | 3055-99-0 |  |
| Poloxamer | Generic | 106392-12-5 (poloxamer) |  |
| Poloxamer-188 | | 106392-12-5 | No Structure |
| Poly-(DL-lactide-co-glycolide) | Southern Research Institute ; Atrix Laboratories, Inc | 26780-50-7 | No Structure |
| poly(vinyl) acetate | Pfizer | 9003-20-7 | No Structure |
| Polyglutamate camptothecin | Cell Therapeutics | |  |
| Polymyxin B | Burroughs Wellcome | 1404-26-8 |  |
| Polyoxin J | Hokko | 22976-89-2 |  |
| Polyphyllin D | CUHK | 50773-41-6 |  |
| Polythiazide | Pfizer | 346-18-9 |  |
| Pomaglumetad methionil | Eli Lilly | 956385-05-0 (monohydrate) ;\n635318-55-7 (anhydrous) |  |
| Pomalidomide | Celgene | 19171-19-8 |  |
| Pomisartan | Thomae (Boehringer Ingelheim) | 144702-17-0 |  |
| Ponalrestat | ICI (AstraZeneca) | 72702-95-5 |  |
| Ponatinib | Ariad Pharmaceuticals Inc. | 943319-70-8 ; 1114544-31-8 (hydrochloride) |  |
| Ponazuril | Bayer | 69004-04-2 |  |
| Ponesimod | Actelion Pharmaceuticals Ltd. (Switzerland) | 854107-55-4 |  |
| Ponezumab | | 1178862-65-1 | No Structure |
| Porfiromycin | American Cyanamid (Wyeth) | 801-52-5 |  |
| Posaconazole | Schering Corp (Merck & Co) | 171228-49-2 |  |
| Posatirelin | Licencia Talalmanyokat | 78664-73-0 |  |
| Posidur (Bupivacaine) | Durect Corp. | 2180-92-9 |  |
| Posizolid | Zeneca (AstraZeneca) | 417702-79-5 |  |
| POT-4 | | | No Structure |
| Potassium ascorbyl tocopheryl phosphate | | 127061-56-7 |  |
| POVPC | Vascular Biogenics Ltd(VBL) | |  |
| Pozanicline | Abbott | 161417-20-5 ; 945405-37-8 (tartrate salt) |  |
| PP-121 | University of California (US) | 1092788-83-4 |  |
| PP-242 | University of California (US) | |  |
| PP-34 | Bharti Vidyapeeth Deemed University (India) ; Panjab University (India) | |  |
| PP-5027 | Pinnacle Pharmaceuticals (US) | |  |
| PP-5073 | Pinnacle Pharmaceuticals (US) | |  |
| PP-55 | Panjab University (India) | |  |
| ppH5HA-I | Fraunhofer USA Inc. (US) | | No Structure |
| PPI-1019 | Praecis Pharmaceuticals | |  |
| PPI-1301 | Presidio Pharmaceuticals Inc. | | No Structure |
| PPI-2458 | Praecis Pharmaceuticals | |  |
| PPI-368 | Pharmaceutical Peptides | 183746-33-0 |  |
| PPI-461 | | | No Structure |
| PPI-4621 | Praecis Pharm Inc. (GlaxoSmithKline plc) | |  |
| PPI-4667 | Praecis Pharm Inc. (GlaxoSmithKline plc) | |  |
| PPI-4691 | Praecis Pharm Inc. (GlaxoSmithKline plc) | |  |
| PPI-4955 | GlaxoSmithKline plc (GB) | |  |
| PPI-802 | Presidio Pharmaceuticals Inc. | | No Structure |
| PPL-100 | Procyon (Ambrilia Biopharma) | |  |
| PPPA | Euro-celtique (Purdue Pharma) | |  |
| PQ-10 | Pfizer | |  |
| PQ-401 | Telik | 196868-63-0 |  |
| PR-047 | Proteolix Inc. (Onyx Pharmaceuticals) | |  |
| PR-104 | University of Auckland | |  |
| PR-957 | Proteolix Inc. (Onyx Pharmaceuticals) | |  |
| PR1 Vaccine | | | No Structure |
| Practolol | ICI (AstraZeneca) | 6673-35-4 |  |
| Pradefovir | Metabasis Therapeutics | 625095-60-5 |  |
| Pradofloxacin | | 195532-12-8 |  |
| Prajmalinum bitartrate | Thomae (Boehringer Ingelheim) | 53862-81-0 |  |
| Pralatrexate | Stanford Research Institute | 146464-95-1 |  |
| Pralidoxime | US Army | 51-15-0 ; 94-63-3 (iodide) |  |
| Prallethrin | Sumitomo Chemical | 23031-36-9 |  |
| Pralmorelin | Polygen ; Univ. of Tulane (US) | 158861-67-7 |  |
| Pralnacasan | Vertex | 192755-52-5 |  |
| Pramiconazole | Janssen Pharmaceutica (Johnson & Johnson) | 219923-85-0 |  |
| Pramipexole | Thomae (Boehringer Ingelheim) | 104632-26-0 |  |
| Pramiracetam | Parke, Davis (Pfizer) | 68497-62-1 |  |
| Pramiverin | E. Merck KGaA | 14334-40-8 |  |
| Pramlintide | Amylin | 151126-32-8 |  |
| Pramocaine | Abbott | 140-65-8 |  |
| Pranazepide | Jouveinal | 150408-73-4 |  |
| Pranidipine | Otsuka pharmaceutical | 99522-79-9 |  |
| Pranlukast | Ono Pharmaceutical | 103177-37-3 |  |
| Pranoprofen | Yoshitomi | 52549-17-4 |  |
| Prasterone | Parke Davis (Pfizer) | 53-43-0 |  |
| Prasugrel | Sankyo (Daiichi Sankyo) ; Ube | 150322-43-3 |  |
| Pratosartan | Kotobuki | 153804-05-8 |  |
| Pravastatin | Sankyo | 81093-37-0 |  |
| Prazepam | Warner Lambert (Pfizer) | 2955-38-6 |  |
| Praziquantel | E. Merck KGaA | 55268-74-1 |  |
| Prazosin | Pfizer | 19216-56-9 |  |
| PrC-210 | Wisconsin Alumni Research Foundation | |  |
| PrC-211 | Wisconsin Alumni Research Foundation | |  |
| PRD-06 | Agency for Science, Technology and Research (Singapore) ; National University of Singapore (Singapor | |  |
| PRD-11 | Agency for Science, Technology and Research (Singapore) ; National University of Singapore (Singapor | |  |
| PRD-23 | Agency for Science, Technology and Research (Singapore) ; National University of Singapore (Singapor | |  |
| PRE-703 | Prescient NeuroPharma | |  |
| Preclamol | Eli Lilly | 75240-91-4 |  |
| Prednicarbate | Hoechst (Sanofi-Aventis) | 73771-04-7 |  |
| Prednimustine | Leo Pharmaceutical | 29069-24-7 |  |
| Prednisolone | Schering Corp (Merck & Co) | 50-24-8 |  |
| Prednisolone 21-(sodium-3-sulfobenzoate) | Roussel Uclaf | 630-67-1 |  |
| Prednisolone Acetate | Schering Corp (Merck & Co) | 52-21-1 |  |
| Prednisolone metasulphobenzoate | Alizyme | 630-67-1 (sodium salt) |  |
| Prednisolone Phosphate | Merck & Co | 302-25-0 |  |
| Prednisolone Succinate | Pfizer | 2920-86-7 |  |
| Prednisolone Tebutate | Merck & Co | 7681-14-3 |  |
| Prednisone | Schering Corp (Merck & Co) | 53-03-2 |  |
| Pregabalin | Northwestern University | 148553-50-8 |  |
| Pregnenolone | | 145-13-1 |  |
| Preladenant | Schering Corp (Merck & Co) | 377727-87-2 |  |
| Premafloxacin | Upjohn (Pharmacia) | 143383-65-7 |  |
| Prenalterol | Ciba-Geigy (Novartis) | 57526-81-5 |  |
| Prenate DHA | Sciele Pharma Inc. (Shionogi Co. Ltd.) | | No Structure |
| Prenate Essential | Sciele Pharma Inc. (Shionogi Co. Ltd.) | | No Structure |
| Prenoxdiazine | Chinoin | 47543-65-7 |  |
| Prenylamine | Hoechst (Sanofi-Aventis) | 390-64-7 |  |
| Prepandrix | GlaxoSmithKline plc (GB) | | No Structure |
| Pretilachlor | Ciba-Geigy (Novartis) | 51218-49-6 |  |
| Pridinol | Hoechst (Sanofi-Aventis) | 511-45-5 |  |
| Pridopidine | Carlsson Research (NeuroSearch) | 346688-38-8 ; 882737-42-0 (HCl) |  |
| Prifinium bromide | Fujisawa | 4630-95-9 |  |
| Prilocaine | Astra (AstraZeneca) | 721-50-6 |  |
| PRIMA-1 | Karolinska Institute (SE) | 5608-24-2 |  |
| Primaquine | Sterling Winthrop (Sanofi-Aventis) | 90-34-6 |  |
| Primidone | ICI (AstraZeneca) | 125-33-7 |  |
| Primisulfuron-Methyl | Ciba-Geigy (Novartis) | 86209-51-0 |  |
| Prinaberel | Wyeth | 524684-52-4 |  |
| Prinomastat | Agouron (Pfizer) | 192329-42-3 |  |
| Priorix-Tetra (TM) | | | No Structure |
| Priralfinamide | Newron | 346670-96-0 |  |
| PRLX-43318 | Prolexys Pharmaceuticals Inc | | No Structure |
| PRLX-8025 | Prolexys Pharmaceuticals Inc | | No Structure |
| PRLX-93936 | | |  |
| PRM-151 | William Marsh Rice University (US) | | No Structure |
| PRO-140 | Progenics | | No Structure |
| PRO-2000 | Procept | 29321-75-3 |  |
| PRO-542 | Progenics | | No Structure |
| Probenazole | Meiji | 27605-76-1 |  |
| Probenecid | Sharp & Dohme (Merck & Co.) | 57-66-9 |  |
| Probucol | Consolidation Coal | 23288-49-5 |  |
| Probuphine (Buprenorphine) | | 52485-79-7 |  |
| Procainamide | Parke, Davis (Pfizer) | 51-06-9 |  |
| Procaine | Hoechst (Sanofi-Aventis) | 59-46-1 |  |
| Procarbazine | Hoffmann La Roche (Roche) | 671-16-9 |  |
| Procaterol | Otsuka | 72332-33-3 |  |
| Prochloraz | Boots (Abbott) | 67747-09-5 |  |
| Prochlorperazine | Rhone-Poulenc (Sanofi-Aventis) | 58-38-8 |  |
| Procodazole | Lafarquim | 23249-97-0 |  |
| Procyanidin B1 | Generic | 20315-25-7 |  |
| Procyanidin B2 | Proteotech | 29106-49-8 |  |
| Procyanidin B3 | Kikkoman Corp. (Japan) | 23567-23-9 |  |
| Procyclidine | Burroughs Wellcome (GSK) | 77-37-2 |  |
| Procymidone | Sumitomo Chemical | 32809-16-8 |  |
| Prodiamine | US Borax & Chemical | 20901-21-2 |  |
| Profenamine | Rhone-Poulenc (Aventis) | 522-00-9 |  |
| Profenofos | Ciba-Geigy (Novartis) | 41198-08-7 |  |
| Proflavine | Casella (Aventis) | 531-73-7 |  |
| Profluazol | DuPont | 190314-43-3 |  |
| Profluthrin | Sumitomo Chemical | 223419-20-3 |  |
| Profoxydim | BASF | 139001-49-3 |  |
| Progabide | Synthelabo (Sanofi-Aventis) | 62666-20-0 |  |
| Progesterone | Schering Corp (Merck & Co) | 57-83-0 |  |
| Proglinazine | Nitrokemia | 68228-20-6 |  |
| Proglumetacin | RottaPharm/Madeus | 57132-53-3 |  |
| Proglumide | RottaPharm/Madeus | 6620-60-6 |  |
| Proguanil | Rhone-Poulenc (Aventis) | 500-92-5 |  |
| Prohexadione | Kumiai | 88805-35-0 |  |
| Prohydrojasmon | Nippon Zeon | 158474-72-7 |  |
| Prolintane | Thomae (Boehringer Ingelheim) | 493-92-5 |  |
| Prolylmeridamycin | Wyeth | |  |
| Promazine | Rhone-Poulenc (Aventis) | 58-40-2 |  |
| Promecarb | Schering AG | 2631-37-0 |  |
| Promegestone | Roussel-Uclaf | 34184-77-5 |  |
| Promestriene | Theramex | 39219-28-8 |  |
| Promethazine | Rhone-Poulenc (Aventis) | 60-87-7 |  |
| Promethazine teoclate | | 17693-51-5 |  |
| Prometon | Geigy (Novartis) | 1610-18-0 |  |
| Prometryn | Geigy (Novartis) | 7287-19-6 |  |
| Propacetamol | Hexachimie | 66532-85-2 |  |
| Propachlor | Monsanto | 1918-16-7 |  |
| Propafenone | Helopharm | 54063-53-5 |  |
| Propagermanium | Sanwa Kagaku | 12758-40-6 |  |
| Propallylonal | Riedel de Haen (Honeywell) | 545-93-7 |  |
| Propamidine | May & Baker (Aventis) | 104-32-5 |  |
| Propamocarb | Schering AG | 24579-73-5 |  |
| Propanidid | Bayer | 1421-14-3 |  |
| Propanil | Bayer | 709-98-8 |  |
| Propanocaine | Clin-Byla | 493-76-5 |  |
| Propantheline Bromide | Searle (Pharmacia) | 50-34-0 |  |
| Propaphos | Nippon Kayaku | 7292-16-2 |  |
| Propaquizafop | Hoffmann La Roche (Roche) ; Novartis | 111479-05-1 |  |
| Propargite | US Rubber | 2312-35-8 |  |
| Propazine | Ciba-Geigy (Novartis) | 139-40-2 |  |
| Propenidazole | Lifepharma | 76448-31-2 |  |
| Propentofylline | Hoechst (Sanofi-Aventis) | 55242-55-2 |  |
| Propetamphos | Sandoz (Syngenta) | 31218-83-4 |  |
| Propham | ICI (Syngenta) | 122-42-9 |  |
| Propicillin | Beecham (GSK) | 551-27-9 |  |
| Propiconazole | Janssen Pharmaceutica (Johnson & Johnson) | 60207-90-1 |  |
| Propineb | Bayer | 12071-83-9 |  |
| Propiomazine | Clin-Byla | 362-29-8 |  |
| Propionylpromazine | Clin-Byla | 3568-24-9 |  |
| Propiram | Bayer | 15686-91-6 |  |
| Propisochlor | American Cyanamid (BASF) | 86763-47-5 |  |
| Propiverine | Apogepha | 60569-19-9 |  |
| Propizepine | UPSA | 10321-12-7 |  |
| Propofol | Ethyl Corp | 2078-54-8 |  |
| Propofol Hemisuccinate | Vyrex | |  |
| Propoxur | Bayer | 114-26-1 |  |
| Propoxycaine | Sterling Drug (Sanofi-Aventis) | 550-83-4 |  |
| Propoxycarbazone | Bayer | 145026-81-9 |  |
| Propoxyphene napsylate & Acetaminophen | | |  |
| Propranolol | ICI (AstraZeneca) | 525-66-6 |  |
| Propylhexedrine | SmithKline French (GSK) | 101-40-6 |  |
| Propyliodone | ICI (AstraZeneca) | 587-61-1 |  |
| Propylthiouracil | | 51-52-5 |  |
| Propyphenazone | Hoffmann La Roche (Roche) | 479-92-5 |  |
| Propyrisulfuron | Sumitomo Chemical ; Takeda Agro | |  |
| Propyromazine bromide | Astra (AstraZeneca) | 145-54-0 |  |
| Propyzamide | Rohm & Haas | 23950-58-5 |  |
| ProQuad | Merck & Co | | No Structure |
| Proquazone | Sandoz (Novartis) | 22760-18-5 |  |
| Proquinazid | DuPont | 189278-12-4 |  |
| Prosavin | Oxford Biomedica | | No Structure |
| Prostalene | Syntex | 54120-61-5 |  |
| Prosulfocarb | ICI (Syngenta) | 52888-80-9 |  |
| Prosulfuron | Ciba-Geigy (Novartis) | 94125-34-5 |  |
| Prosultiamine | Takeda | 59-58-5 |  |
| Prothioconazole | Bayer | 178928-70-6 |  |
| Prothiofos | Bayer | 34643-46-4 |  |
| Prothipendyl | Degussa | 303-69-5 |  |
| Prothoate | Montecatini | 2275-18-5 |  |
| Protiofate | Bioindustria | 58416-00-5 |  |
| Protionamide | Chimie et Atomistique | 14222-60-7 |  |
| Protirelin | Abbott | 24305-27-9 |  |
| Protizinic acid | Rhone-Poulenc (Aventis) | 54323-85-2 |  |
| Protodioscin | Sofarma Ad Bulgaria | 102115-79-7 |  |
| Protokylol | Lakeside | 136-70-9 |  |
| Protopanaxadiol | | 7755-01-3 |  |
| Protrifenbute | FMC | 119544-94-4 |  |
| Protriptyline | Gane's Chemical Works | 438-60-8 |  |
| ProVP-16II | Humboldt Berlin University ;\nTel Aviv University | |  |
| Proxazole | Angelini | 5696-09-3 |  |
| Proxibarbal | Hommel | 2537-29-3 |  |
| Proxinium | University of Zurich | | No Structure |
| Proxofelin (Proxodolol & Clonidine) | | 209919-45-9 |  |
| Proxymetacaine | | 499-67-2 |  |
| Proxyphylline | Ganes | 603-00-9 |  |
| Prozapine | Janssen Pharmaceutica (Johnson & Johnson) | 3426-08-2 |  |
| PRS-050 | Pieris AG (Germany) | | No Structure |
| PRS-211095 | Pharmos | 382137-87-3 |  |
| PRS-211220 | Pharmos | 382138-08-1 |  |
| PRT-060592 | Portola Pharmaceuticals Inc. (US) | |  |
| PRT-4165 | Proteologics Ltd. | |  |
| Prucalopride | Janssen Pharmaceutica (Johnson & Johnson) | 179474-81-8 |  |
| Prulifloxacin | Nippon Shinyaku (Japan) | 123447-62-1 |  |
| Pruvanserin | Merck | 443144-26-1 ; 443144-27-2 (hydrochloride) |  |
| PRX-03140 | Predix Pharmaceuticals | |  |
| PRX-07034 | Predix Pharmaceuticals (EPIX Pharmaceuticals) | |  |
| PRX-08066 | EPIX Pharmaceuticals | | No Structure |
| PRX-102 | Protalix BioTherapeutics Inc. | | No Structure |
| PRX-105 | Yissum Research Development Co. (Israel) | | No Structure |
| PRX-1114 | Proximagen Group plc | | No Structure |
| PRX-1354 | Proximagen Group plc | | No Structure |
| PRX-302 | | | No Structure |
| PRX-321 | US Department of Health | | No Structure |
| PRX-5007 | Proximagen Group plc | | No Structure |
| PS-031291 | Pharmacopeia Inc. (Ligand Pharmaceuticals Inc. ) | | No Structure |
| PS-1145 | Aventis Pharma | |  |
| PS-15 | Jacobus | 152662-90-3 |  |
| PS-166276 | Pharmacopeia Inc. ; Bristol Myers Squibb (BMS) | |  |
| PS-200981 | Pharmacopeia Inc. ; Bristol Myers Squibb (BMS) | |  |
| PS-248288 | | | No Structure |
| PS-26 | Jacobus | 381247-45-6 |  |
| PS-33 | Jacobus | 381247-34-3 |  |
| PS-386113 | Pharmacopeia | | No Structure |
| PS-388023 | Ligand Pharmaceuticals Inc. (US) | |  |
| PS-433540 | Bristol-Myers Squibb (BMS) | |  |
| PS-522501 | Pharmacopeia | | No Structure |
| PS-540446 | Bristol-Myers Squibb Co. | |  |
| PS-680648 | Ligand Pharmaceuticals Inc. (US) | |  |
| PS-8067 | Ligand Pharmaceuticals Inc. (US) | |  |
| PS-873266 | Ligand Pharmaceuticals Inc. | | No Structure |
| PS-939 | | |  |
| PS-948115 | | | No Structure |
| PSA-15143 | Parion Sciences | |  |
| PSA-23609 | Parion Sciences Inc. | |  |
| PSA-23682 | Parion Sciences Inc. | |  |
| PSA-25569 | Parion Sciences | |  |
| PSD-502 (Lidocaine & Prilocaine) | Sciele Pharma Inc. (Shionogi Co. Ltd.) | 101362-25-8 ; 137-58-6 (Lidocaine) ; 721-50-6 (Prilocaine) |  |
| PSD-503 (Phenylephrine) | Medicare Man Consultancy Ltd. (Plethora Solutions Ltd.) | 59-42-7 |  |
| PSD-506 | F. Hoffmann-La Roche AG | | No Structure |
| PSD-508 (Mefenamic acid) | Metris Therapeutics Ltd. | 61-68-7 |  |
| PSD-597 (Lidocaine) | Queen's University at Kingston (Canada) | 137-58-6 |  |
| PSD-958 | Sandoz (Novartis) | 149811-12-1 |  |
| Pseudodeflectusin | Tokyo University | |  |
| Pseudoephedrine | American Cyanamid (Wyeth) | 90-82-4 |  |
| Pseudomycin A' | Eli Lilly | 301533-14-2 |  |
| Pseudomycin B' | Eli Lilly | 301533-15-3 |  |
| PSF-D | Hokuren | 166547-25-7 |  |
| PSI-352938 | Pharmasset Inc. | |  |
| PSI-353661 | Pharmasset Inc. | |  |
| PSI-6130 | Pharmasset | |  |
| PSI-6206 | Roche | |  |
| PSI-697 | Wyeth | |  |
| PSI-7672 | Pharmasset | |  |
| PSI-7851 | Pharmasset Inc. | |  |
| PSI-7976 | Pharmasset | |  |
| PSI-7977 | Pharmasset | |  |
| pSIP-1 | Novo Nordisk AS | |  |
| pSIP-2 | Novo Nordisk AS | |  |
| PSK-3841 | Roussel-Uclaf (Sanofi-Aventis) | 154992-24-2 |  |
| PSMA(441-450) | Kurume University (JP) | |  |
| PSN-119-2 | Prosidion Ltd. (OSI Pharmaceuticals Inc.) | |  |
| PSN-357 | Prosidion Ltd. (GB) | |  |
| PSN-821 | Prosidion | | No Structure |
| PSN-9301 | Prosidion (OSI Pharmaceuticals) | |  |
| PSN-GK1 | Osi Pharmaceuticals Inc. (US) | |  |
| PSNCBAM-1 | Prosidion Ltd. (GB) | |  |
| PT-630 | Point Therapeutics | |  |
| PT-810 | DARA BioSciences Inc. (US) | |  |
| PT-820 | DARA BioSciences Inc. (US) | |  |
| PTC-299 | | 1219951-09-3 | No Structure |
| PTCA | | |  |
| Pterostilbene | | 537-42-8 |  |
| PTI-188 | Albert Einstein College of Medicine of Yeshiva University (US) | | No Structure |
| PTI-202 | | | No Structure |
| PTI-868 | Wyeth Corp. (US) | |  |
| PTK-SMA-01 | Paratek Pharmaceuticals Inc. (US) | |  |
| PTPR | University of Utah | |  |
| PTR-3173 | Peptor | 252845-37-7 |  |
| PTSA1.2-A | Phico Therapeutics Ltd. (GB) | | No Structure |
| PTX-007063 | Pantherix | 494751-41-6 |  |
| PTX-008134 | PanTherix | |  |
| PTX-008218 | PanTherix | |  |
| PTX-008313 | PanTherix | |  |
| PTX-008330 | PanTherix | |  |
| PTX-031553 | Institute of Medical Parazitology and Tropical Medicine ; Pantherix | 136402-17-0 |  |
| PTX-040334 | PanTherix | |  |
| PTX-042695 | PanTherix | |  |
| PTX-110130 | PanTherix | |  |
| PTX-2416 | Naeja | |  |
| PTX3(82-110) | Tecnogen S.p.A. (Italy) | |  |
| PU-24-FCL | Memorial Sloan-Kettering Cancer Center (MSKCC) | |  |
| PU-3 | Memorial Sloan-Kettering Cancer Center \n(MSKCC) | |  |
| PU-H58 | Memorial Sloan-Kettering Cancer Center | |  |
| PU-H71 | Memorial Sloan-Kettering Cancer Center | |  |
| Puerarin | | 3681-99-0 |  |
| PulmoLAR (2-methoxyestradiol) | University of Pittsburgh | 362-07-2 |  |
| Pumafentrine | Byk Gulden (Nycomed) | 207993-12-2 |  |
| Pumosetrag | Mitsubishi (Mitsubishi Tanabe) | 153062-94-3 |  |
| Punicic acid | | 544-72-9 |  |
| Putrescine | Manitoba University | 110-60-1 |  |
| PV-701 | | | No Structure |
| PW-2101 | Penwest Pharmaceuticals | | No Structure |
| PW-3101 | Penwest Pharmaceuticals ; IVAX Corporation (Teva Pharma) | | No Structure |
| PWT-458 | Wyeth | |  |
| PWZ-029 | Wisys Technology Foundation Inc. (US) | |  |
| PX-117735 | Prolifix | |  |
| PX-117794 | MethylGene | |  |
| PX-12 | Prolx Pharmaceuticals (US) | |  |
| PX-316 | University of Georgetown | |  |
| PX-478 | ProIX ; University of Arizona | |  |
| PX-866 | University of Arizona | |  |
| Pycnanthuquinone A | Shaman Pharmaceuticals | 186026-84-6 |  |
| Pycnanthuquinone B | Shaman Pharmaceuticals | 186026-85-7 |  |
| Pymetrozine | Ciba-Geigy (Novartis) | 123312-89-0 |  |
| Pyracarbolide | Hoechst (Sanofi-Aventis) | 24691-76-7 |  |
| Pyraclofos | Takeda | 77458-01-6 |  |
| Pyraclonil | Schering AG | 158353-15-2 |  |
| Pyraclostrobin | BASF | 175013-18-0 |  |
| Pyraflufen ethyl | Nihon Nohyaku | 129630-19-9 |  |
| Pyrafluprole | Nihon Nohyaku | 315208-17-4 |  |
| Pyrametostrobin | Shenyang Research Institute of Chemistry Industry | 915410-70-7 |  |
| Pyrantel | Pfizer | 15686-83-6 |  |
| Pyraoxystrobin | Shenyang Research Institute of Chemistry Industry | 862588-11-2 |  |
| Pyrasulfotole | Aventis CropScience | 365400-11-9 |  |
| Pyratine-6 | | |  |
| Pyrazinamide | E. Merck AG | 98-96-4 |  |
| Pyrazinoylguanidine | Beyer | 60398-24-5 |  |
| Pyrazoloacridine | Warner Lambert (Pfizer) | 99009-20-8 |  |
| Pyrazolynate | Sankyo | 58011-68-0 |  |
| Pyrazophos | Hoechst (Sanofi-Aventis) | 13457-18-6 |  |
| Pyrazosulfuron | Nissan | 98389-04-9 |  |
| Pyrazoxyfen | Ishihara | 71561-11-0 |  |
| Pyribencarb | Kumiai Chemical Industry (JP); Ihara Chemical Industry (JP) | 799247-52-2 |  |
| Pyribenzoxim | Lucky | 168088-61-7 |  |
| Pyributicarb | Toyo Soda | 88678-67-5 |  |
| Pyricarbate | Inoue | 1882-26-4 |  |
| Pyridaben | Nissan | 96489-71-3 |  |
| Pyridafenthion | Mitsui | 119-12-0 |  |
| Pyridafol | Lentia | 40020-01-7 |  |
| Pyridalyl | Sumitomo Chemical | 179101-81-6 |  |
| Pyridate | Chemie Linz (DSM) | 55512-33-9 |  |
| Pyridavone | Tokai Univerity of Tokyo (Japan) | |  |
| Pyridofylline | Debarge | 53403-97-7 |  |
| Pyridostigmine | Hoffmann La Roche (Roche) | 101-26-8 |  |
| Pyridoxal phosphate | Medicure | 54-47-7 |  |
| Pyridoxamine | | 85-87-0 |  |
| Pyridoxine | Gen Aniline & Film | 58-56-0 (HCl) |  |
| Pyrifenox | Hoffmann La Roche (Roche) | 88283-41-4 |  |
| Pyriferone | Biomeasure | 121168-73-8 |  |
| Pyrifluquinazon | Nihon Nohyaku | 337458-27-2 |  |
| Pyriftalid | Dr. R. Maag | 135186-78-6 |  |
| Pyrimethamine | Burroughs Wellcome (GSK) | 58-14-0 |  |
| Pyrimethanil | Pfizer | 53112-28-0 |  |
| Pyrimidifen | Sankyo | 105779-78-0 |  |
| Pyriminobac-methyl | Kumiai | 136191-64-5 |  |
| Pyrimisulfan | Ihara Chemicals; Kumiai Chemical Industry | 221205-90-9 |  |
| Pyriofenone | Ishihara Sangyo Kaisha, Ltd. | 688046-61-9 |  |
| Pyriprole | Nihon Nohyaku | 394730-71-3 |  |
| Pyriproxyfen | Sumitomo Chemical | 95737-68-1 |  |
| Pyrithiobac-Sodium | Kumiai | 123343-16-8 |  |
| Pyrithione | Olin Mathieson | 1121-30-8 |  |
| Pyrithyldione | Hoffmann La Roche (Roche) | 77-04-3 |  |
| Pyritinol | E. Merck KGaA | 1098-97-1 |  |
| Pyronaridine | | 74847-35-1 |  |
| Pyroquilon | Pfizer | 57369-32-1 |  |
| Pyroxamide | Aton ; National Cancer Institute (NCI) | |  |
| Pyroxasulfone | Kumiai Chemical Industry (Japan) | 447399-55-5 |  |
| Pyroxsulam | Dow Agroscience | 422556-08-9 |  |
| Pyrrolnitrin | Fujisawa | 1018-71-9 |  |
| Pyrrophenone | Shionogi | 341973-06-6 |  |
| Pyrvinium chloride | Eastman Kodak | 548-84-5 |  |
| Q-85 | Zeneca (AstraZeneca) ; University of Navarra | 171880-92-5 |  |
| Q-VD-OPh | Institut Pasteur (France) ; Centre National de la Recherche Scientifique (France) ; Institut Nationa | |  |
| QA-241 | Tokyo Tanabe (Mitsubishi) | 108405-58-9 |  |
| QAT-370 | | | No Structure |
| QAX-028 | | | No Structure |
| QAX-576 | Novartis AG ; Novartis Pharma GmbH | 1233953-18-8 | No Structure |
| QAX-935 | Idera Pharmaceuticals | | No Structure |
| QBI-139 | Quintessence Biosciences Inc. (US) | | No Structure |
| QF-0510B | Univ di Bari (IT) ; Univ \nPompeu Fabra (ES) ; Univ Santiago de Compostela (ES) | |  |
| QF-1003B | University of Santiago de Compostela ; University of Pisa | 194608-47-4 |  |
| QF-1004B | University of Santiago de Compostela ; University of Pisa | 320373-87-3 |  |
| QF-2004B | University of Santiago de Compostela | 221332-70-3 |  |
| QM-96521 | Consejo Superior Investigaciones (CSI) | 206662-17-1 |  |
| QM-96639 | Consejo Superior Investigaciones (CSI) | 206662-19-3 |  |
| QMF-149 (Indacaterol & Mometasone Furoate) | Schering-Plough | 312753-06-3 (Indacaterol) ; \n83919-23-7 (Mometasone Furoate) |  |
| QNL-111 | BioAlliance Pharma | |  |
| QPI-1002 | Quark Pharmaceuticals | | No Structure |
| QPT-1 | Pfizer Inc. (US) | |  |
| QR-435 | Quigley | | No Structure |
| QR-449 | | | No Structure |
| QS-21 | Cambridge Biotech | 141256-04-4 |  |
| QT-69 | University Health Network (Canada) | |  |
| QTI-571 (Imatinib) | Novartis AG | |  |
| Quatacaine | Tanabe | 17692-45-4 |  |
| Quazepam | Schering Corp (Merck & Co) | 36735-22-5 |  |
| Quercetin | Rech et Tech Appliques | 117-39-5 |  |
| Quetiapine | ICI (AstraZeneca) | 111974-69-7 |  |
| Quiflapon | Merck & Co. | 136668-42-3 |  |
| Quilostigmine | HMR (Aventis) | 139314-01-5 |  |
| Quinagolide | Sandoz (Novartis) | 87056-78-8 |  |
| Quinaldine Blue | | 2768-90-3 |  |
| Quinaldine Red | E. Busse | 117-92-0 |  |
| Quinalphos | Bayer | 13593-03-8 |  |
| Quinamed (Amonafide) | Laboratorios Made S.A. (Knoll) | 69408-81-7 |  |
| Quinapril | Warner Lambert (Pfizer) | 85441-61-8 |  |
| Quinaprilat | Warner Lambert (Pfizer) | 85441-60-7 |  |
| Quinclorac | BASF | 84087-01-4 |  |
| Quinestrol | Vismara Francesco Spa | 152-43-2 |  |
| Quinethazone | American Cyanamid (Wyeth) | 73-49-4 |  |
| Quinfamide | Sterling Winthrop (Sanofi-Aventis) | 62265-68-3 |  |
| Quinidine | Boehringer Mannheim (Roche) | 56-54-2 |  |
| Quinine | Omnium Chimique | 130-95-0 |  |
| Quinisocaine | SmithKline French (GSK) | 86-80-6 |  |
| Quinmerac | BASF | 90717-03-6 |  |
| Quinocarmycin | | 84573-33-1 |  |
| Quinoclamine | Agro-Kanesho | 2797-51-5 |  |
| Quinophthalone | | 8003-22-3 |  |
| Quinotolast | Fujisawa | 101193-40-2 |  |
| Quinoxyfen | Eli Lilly | 124495-18-4 |  |
| Quinpirole | Eli Lilly | 80373-22-4 |  |
| Quinpramine | Heinrich-Heine Universität Dusseldorf | |  |
| Quintozene | Uniroyal | 82-68-8 |  |
| Quinupramine | Sogeras | 31721-17-2 |  |
| Quinupristin | Rhone-Poulenc (Aventis) | 120138-50-3 |  |
| QuitPak (Mecamylamine & Amfebutamone) | IntelGenx Corp. | 60-40-2 (Mecamylamine) ; 34911-55-2 (Amfebutamone) ; 905818-69-1 (Amfebutamone hydrobromide salt) |  |
| Quizalofop | Nissan | 76578-12-6 |  |
| Quizalofop-P | Uniroyal | 94051-08-8 |  |
| Quizalofop-P-tefuryl | DuPont | 119738-06-6 |  |
| Quizartinib | Ambit Biosciences (US) | 950769-58-1 ; 1132827-21-4 (2HCl) |  |
| QVA-149 (Indacaterol & Glycopyrronium bromide) | Sosei | 312753-06-3 (Indacaterol) ; 596-51-0 (Glycopyrronium bromide) |  |
| QY-998 | Rohm & Haas | 135511-94-3 |  |
| QYL-609 | Wayne State University | 210355-12-7 |  |
| QYL-685 | Wayne State University ; National Inst. of Health (NIH) | 210355-14-9 |  |
| QYL-769 | Wayne | 210355-05-8 |  |
| R-102444 | Sankyo | |  |
| R-113281 | Sankyo | |  |
| R-116010 | Janssen (Johnson & Johnson) | |  |
| R-1206 | F. Hoffmann-La Roche AG (Switzerland) | |  |
| R-121920 | Janssen Pharmaceutica;Neurocrine Biosciences | 195055-01-7 |  |
| R-130823 | Sankyo | |  |
| R-142086 | Daiichi Sankyo Co. Ltd. (Japan) | |  |
| R-1438 | Roche | | No Structure |
| R-1454 | | | No Structure |
| R-146225 | Janssen Pharmaceutica (Johnson & Johnson) | 219979-42-7 |  |
| R-147176 | Daiichi Sankyo Co. Ltd. (Japan) ; Renascience Co. Ltd. (Japan) | |  |
| R-1479 | Roche | |  |
| R-1487 | Hoffmann La Roche | |  |
| R-1503 | Roche | | No Structure |
| R-1511 | Roche | | No Structure |
| R-1530 | Hoffmann-La Roche Ltd. (Switzerland) | |  |
| R-1541 | | | No Structure |
| R-1589 | | | No Structure |
| R-1594 | Genentech | | No Structure |
| R-16 | East China University of Science and Technology (China) ; Shanghai Institute of Materia Medica (Chin | |  |
| R-1646 | | | No Structure |
| R-1647 | Roche | | No Structure |
| R-1663 | Roche | | No Structure |
| R-1664 | | | No Structure |
| R-18893 | Janssen Pharmaceutica (Johnson & Johnson) | 147362-54-7 |  |
| R-189106 | Janssen Pharmaceutica (Johnson & Johnson) | |  |
| R-195 | Nihon Nohyaku | 132457-21-7 |  |
| R-226161 | Janssen Pharmaceutica (Johnson & Johnson) | |  |
| R-228060 | SK BioPharmaceutical | 561069-23-6 |  |
| R-253 | Rigel Pharmaceuticals | |  |
| R-278995 | Taisho Pharmaceutical, | |  |
| R-2HMP | University of Saskatchewan | |  |
| R-343 | Rigel Pharmaceuticals (US) | |  |
| R-4048 | Pharmasset | | No Structure |
| R-406 | Rigel Pharmaceuticals | |  |
| R-428 | Rigel Pharmaceuticals Inc. (US) | |  |
| R-547 | Hoffman La Roche | |  |
| R-59494 | Janssen Pharmaceutica (Johnson & Johnson) | 104588-44-5 |  |
| R-641 | Roche | | No Structure |
| R-7090 | | | No Structure |
| R-7118 | Roche | | No Structure |
| R-7128 | Pharmasset (US) | |  |
| R-71762 | Sankyo ; Ube | 195048-23-8 |  |
| R-7232 | Roche | | No Structure |
| R-755 | Nihon Nohyaku | |  |
| R-82150 | Janssen Pharmaceutica (Johnson & Johnson) | 126320-77-2 |  |
| R-82913 | Janssen Pharmaceutica (Johnson & Johnson) | 126347-69-1 |  |
| R-909794 | Rigel pharmaceuticals | |  |
| R-99224 | Sankyo ; Ube | 204204-74-0 (triflate) |  |
| R-ABS-103 | Desitin Arzneimittel | 155899-34-6 |  |
| R-phenserine | Torreypines Therapeutics Inc, US) | 101246-66-6 |  |
| (R)-Didesmethylsibutramine | Knoll (Abbott) | 229639-56-9 |  |
| (R)-Dixyrazine | UCB | |  |
| (R)-Esprocarb | Celgene | 220280-71-7 |  |
| (R)-FIPCT | Emory University | |  |
| (R)-Fluoxetine | Eli Lilly | 100568-03-4 |  |
| (R)-JG-381 | Seoul National University | 201734-08-9 |  |
| (R)-Ketoprofen | Sepracor | 56105-81-8 |  |
| (R)-LKE-1 | Oklahoma Medical Research Foundation (US) | |  |
| (R)-PID | Yissum Res Dev Co ; Hebrew University | |  |
| (R)-Trolox | Hoffmann La Roche (Roche) | 53101-49-8 |  |
| R15K | University of Texas | |  |
| rAAV-LK68 | Mogam Biotechnology Research Institute | | No Structure |
| rAAV6-beta-ARKct | Thomas Jefferson University (US) | | No Structure |
| RAB-1 | University of Massachusetts (US) | | No Structure |
| Rabeprazole | Janssen Pharmaceutica (Johnson & Johnson) | 117976-89-3 |  |
| Rabeximod | OxyPharma AB (Sweden) | 872178-65-9 |  |
| Racecadotril | Bioprojet Pharma (GSK) | 81110-73-8 |  |
| Racefemine | Clin-Byla | 15686-98-3 |  |
| Rachelmycin | Upjohn (Pfizer) | 69866-21-3 |  |
| Raclopride | Astra (AstraZeneca) | 84225-95-6 |  |
| Ractopamine | Eli Lilly | 97825-25-7 |  |
| rAd-F1co | Ewha University (South Korea) | | No Structure |
| rAd35-L1R | Harvard Medical School (US) ; Crucell Holland BV (Netherland) ; National Institutes of Health (US) | | No Structure |
| Radafaxine | Sepracor ((Dainippon Sumitomo Pharma)) | 192374-14-4 |  |
| Radequinil | Dainippon (Dainippon Sumitomo Pharma) | 219846-31-8 |  |
| Radezolid | Rib-X Pharmaceuticals (US) | 869884-78-6 ; 869884-77-5 (hydrochloride salt) |  |
| Radiprodil | Richter Gedeon Vegyeszet (Hungary) | 496054-87-6 |  |
| Rafabegron | Dainippon Pharmaceutical | 244081-42-3 |  |
| Rafivirumab | Crucell Holland Bv, (Netherland) | 944548-37-2 | No Structure |
| Rafoxanide | Merck & Co. | 22662-39-1 |  |
| Ragaglitazar | Dr Reddy's Laboratories | 222834-30-2 |  |
| Raloxifene | Eli Lilly | 84449-90-1 |  |
| rAls3p-N | Los Angeles Biomedical Research Institute (US) | | No Structure |
| Raltegravir | IRBM P. Angeletti (Merck & Co) | 518048-05-0 ; 871038-72-1 (potassium salt) |  |
| Raltitrexed | ICI (AstraZeneca) | 112887-68-0 |  |
| Raluridine | Akademie der Wissenschaften der DDR | 119644-22-3 |  |
| RAM-150 | Kyorin Pharmaceutical Co. Ltd. (Japan) | |  |
| Ramatroban | Bayer | 116649-85-5 |  |
| RAMBO | The Ohio State University Medical Center (US) | | No Structure |
| Ramelteon | Takeda | 196597-26-9 |  |
| Ramifenazone | Byk Gulden (Nycomed) | 3615-24-5 |  |
| Ramipril | Hoechst (Sanofi-Aventis) | 87333-19-5 |  |
| Ramoplanin | Lepetit (Pfizer) | 76168-83-6 |  |
| Ramorelix | Hoechst (Sanofi-Aventis) | 127932-90-5 |  |
| Ramosetron | Yamanouchi (Astellas) | 132907-72-3 |  |
| Ramucirumab | ImClone Systems | 947687-13-0 | No Structure |
| Ranagengliotucel-T | NovaRx Corporation | | No Structure |
| Ranbezolid | Ranbaxy Pharmaceuticals | |  |
| Ranelic acid | ADIR (Servier) | 135459-90-4 |  |
| Ranibizumab | Genentech | 347396-82-1 | No Structure |
| Ranimustine | Tokyo Tanabe (Mitsubishi) | 58994-96-0 |  |
| Ranirestat | Dainippon Pharmaceutical (Dainippon Sumitomo Pharma) | 147254-64-6 |  |
| Ranitidine | Allen & Hanburys (GSK) | 66357-35-5 |  |
| Ranolazine | Syntex (Roche) | 95635-55-5 |  |
| Ranpirnase | Alfacell | 196488-72-9 | No Structure |
| RAP-031 | Acceleron Pharma Inc. (US) | | No Structure |
| Rapacuronium Bromide | Akzo (Akzo Nobel) | 156137-99-4 |  |
| Rapinyl (Fentanyl) | Diabact AB (Orexo AB, Sweden) | 437-38-7 |  |
| Rasagiline | Teva | 136236-51-6 |  |
| Rasburicase | Sanofi | 134774-45-1 | No Structure |
| Raseglurant | Addex Pharmaceuticals SA (Switzerland) | 757950-09-7 |  |
| RAV-12 | Raven Biotechnologies | | No Structure |
| Ravuconazole | Eisai | 182760-06-1 |  |
| Raxibacumab | | 565451-13-0 | No Structure |
| Raxofelast | Foscama Biomed Chim Farma (Biomedica Foscama) | 128232-14-4 |  |
| Razaxaban | DuPont Pharmaceuticals (BMS) | 405940-76-3 (HCl) |  |
| Razoxane | ICI (AstraZeneca) | 21416-87-5 |  |
| Razupenem | Sumitomo Pharmaceuticals (Dainippon Sumitomo) | 426253-04-5 |  |
| RB-006 & RB-007 | Regado Biosciences | | No Structure |
| RB-101 | INSERM | 135949-60-9 |  |
| RB-2121 | Rhone-Poulenc Rorer | 232585-27-2 |  |
| RB-6145 | Warner Lambert (Pfizer) | 131504-96-6 |  |
| Rb(485-493) | University College Cardiff (Great Britain) | |  |
| rBCG(mbtB)30 | University of California (US) | | No Structure |
| RBx-1000075 | Ranbaxy | |  |
| RBx-10558 | Ranbaxy (India) | | No Structure |
| RBx-7635 | Ranbaxy | |  |
| RBx-9050 | Ranbaxy Laboratories | |  |
| RC-101 | University of California | |  |
| RC-3095 | Tulane University | 138147-78-1 |  |
| RC-529 | Corixa | 216014-46-9 |  |
| RC-552 | Corixa | 253119-91-4 |  |
| RC-8800 | Sandoz | |  |
| rCD154-CLL | University of California | | No Structure |
| RCP-168 | University of Jefferson | | No Structure |
| RD-131 | University of California | |  |
| RD-162 | University of California | |  |
| RD-3 | Crucell Holland BV (Netherlands) | | No Structure |
| RD-37 | University of California | |  |
| RD-65071 | Soyaku Gijutsu Kenkyusho | 16584-54-6 |  |
| RD3-0028 | Rational Drug Design Laboratories | 3886-39-3 |  |
| RD4-2024 | Tosoh | |  |
| RD4-2138 | Tosoh ; Sagami | 76663-53-1 |  |
| RD4-2217 | Soyaku Gijutsu Kenkyusho | |  |
| RD6-Y664 | Fukushima ; Astellas | |  |
| RDEA-119 | Ardea Biosciences Inc. (US) | |  |
| RDEA-806 | Valeant Pharmaceuticals | |  |
| RDS-1643 | University of Cagliari (IT) ; University of Rome (IT) | |  |
| Rebamipide | Otsuka | 90098-04-7 |  |
| Rebimastat | Chiroscience (UCB) | 259188-38-0 |  |
| Reblastatin | Sankyo | 199333-57-8 |  |
| Reboxetine | Farmitalia Carlo Erba (Pharmacia) | 98769-81-4 |  |
| REC-0422 | | | No Structure |
| REC-0436 | Recordati SpA | | No Structure |
| REC-15-3079 | Recordati | 220382-87-6 |  |
| REC-1819 | Recordati SpA | | No Structure |
| Rec-26D-038 | Recordati | |  |
| Rec-26D-073 | Recordati | |  |
| REC-27-0074 | Recordati Industria Chimica e Farmaceutica | |  |
| REC-27-0224 | Recordati | |  |
| REC-27-0262 | Recordati S.p.A. (Italy) | |  |
| Recainam | American Home Products (Wyeth) | 74738-24-2 |  |
| Rectogesic (Nitroglycerin) | Neptune Pharmaceutical Corp. | 55-63-0 |  |
| Regadenoson | CV Therapeutics (Gilead) | 313348-27-5 ; 875148-45-1 (monohydrate) |  |
| Reglitazar | Japan Tobacco | 170861-63-9 |  |
| REGN-668 | Regeneron Pharmaceuticals | | No Structure |
| REGN-727 | Novartis AG (Switzerland) | | No Structure |
| REGN-728 | | | No Structure |
| REGN-846 | | | No Structure |
| REGN-910 | Regeneron Pharmaceuticals Inc. | | No Structure |
| Regorafenib | Bayer | 755037-03-7 |  |
| Regrelor | Inspire Pharmaceuticals | 787548-03-2 |  |
| Relacatib | Smithkline Beecham | 362505-84-8 |  |
| Relaxin-3-INSL5 chimeric peptide | Janssen Pharmaceutica NV (Belgium) | | No Structure |
| Relcovaptan | Sanofi Elf (Sanofi-Aventis) | 150375-75-0 |  |
| Relovair (Vilanterol & Fluticasone furoate) | | 503068-34-6 (Vilanterol) ; 397864-44-7 (Fluticasone furoate) |  |
| Remacemide | Pennwalt | 128298-28-2 |  |
| Rember (Methylthioninium chloride) | TauRx Therapeutics | 61-73-4 |  |
| Remestemcel-L | Osiris Therapeutics | | No Structure |
| Remifentanil | Glaxo (GSK) | 132875-61-7 |  |
| Remimazolam | GlaxoSmithKline | 308242-62-8 |  |
| Remogliflozin | Kissei Pharmaceutical (US) | |  |
| Remogliflozin etabonate | Kissei Pharmaceutical (US) | 442201-24-3 |  |
| Remoxipride | Astra (AstraZeneca) | 80125-14-0 |  |
| ReN-001 | ReNeuron Ltd. | | No Structure |
| REN-1869 | Novo Nordisk | 170149-99-2 |  |
| Renzapride | Beecham (GSK) | 112727-80-7 |  |
| Reovirus | Oncolytics Biotech | | No Structure |
| REP-176021 | Replidyne | |  |
| Repaglinide | Thomae (Boehringer Ingelheim) | 135062-02-1 |  |
| Reparixin | Dompe | 266359-83-5 |  |
| Repel-CV | Life Medical Sciences | | No Structure |
| Repifermin | Human Genome Sciences | 219527-63-6 | No Structure |
| Repinotan | Bayer | 144980-29-0 |  |
| Repirinast | Mitsubishi | 73080-51-0 |  |
| Reproterol | Degussa | 54063-54-6 |  |
| RES-11-79 | Respiratorius AB | |  |
| Resatorvid | Takeda Chemical Industries Ltd. | 243984-11-4 |  |
| Rescinnamine | Pfizer | 24815-24-5 |  |
| Reserpine | Ciba (Novartis) | 50-55-5 |  |
| Resiniferatoxin | Afferon | 57444-62-9 |  |
| Resiquimod | 3M | 144875-48-9 |  |
| Reslizumab | Schering (Merck & Co) | 241473-69-8 | No Structure |
| Resmethrin | National Research Development Corporation (NRDC) | 10453-86-8 |  |
| Resminostat | Altana Pharma AG (Nycomed) | 864814-88-0 |  |
| Resolvin E1 | University of Southern California (US) | |  |
| Resorantel | Hoechst (Sanofi-Aventis) | 20788-07-2 |  |
| RESPIR-4-95 | Respiratorius AB (Sweden) | |  |
| Resveratrol | Osaka Yakuhin Kenkyusho KK | 501-36-0 |  |
| Resveratroloside | | |  |
| Retapamulin | SmithKline Beecham (GSK) | 224452-66-8 |  |
| Retaspimycin | Infinity Pharmaceuticals | 857402-63-2 (hydrochloride salt) ; 857402-23-4 |  |
| Reteplase | Boehringer Mannheim | 133652-38-7 | No Structure |
| Retinol | Bayer | 68-26-8 |  |
| RetinoStat | Oxford BioMedica Ltd. | | No Structure |
| Retosiban | | 820957-38-8 |  |
| Retrocyclin-1 | University of California | |  |
| rEV-131 | Evolutec Group | | No Structure |
| Revamilast | Glenmark pharmaceuticals | 893555-90-3 |  |
| Revaprazan | Yuhan | 199463-33-7 |  |
| Revatropate | Pfizer | 149926-91-0 |  |
| Reversine | Scripps Research Institute (US) | 656820-32-5 |  |
| Reviparin Sodium | | 9041-08-1 |  |
| Revizinone | Janssen Pharmaceutica (Johnson & Johnson) | 133718-29-3 |  |
| Rexin-G | University of Southern California (US) | | No Structure |
| Rezatomidine | Allergan Inc. | 847829-38-3 |  |
| RF-07 | Universidade de Sao Paulo (Brazil) | |  |
| RF-1010 | SuperGen | |  |
| RF-9 | CNRS (FR) ; University of Alberta (CA) | |  |
| RFI-641 | American Cyanamid (Wyeth) | 197366-24-8 |  |
| RG-108 | Dkfz Deutsches Krebsforschungs | |  |
| RG-12525 | Rorer (Aventis) | 120128-20-3 |  |
| RG-13022 | RPR (Aventis) | 149286-90-8 |  |
| RG-13291 | Rorer (Aventis) | 138989-50-1 |  |
| RG-14620 | Rorer (Aventis) | 136831-49-7 |  |
| RG-1578 | | | No Structure |
| RG-4929 | | | No Structure |
| RG-7010 | Roche (Switzerland) | | No Structure |
| RG-7089 | F. Hoffmann-La Roche AG (Switzerland) | | No Structure |
| RG-7103 | F. Hoffmann-La Roche AG (Switzerland) | | No Structure |
| RG-7112 | | | No Structure |
| RG-7160 | Glycart Biotechnology AG (Switzerland) | | No Structure |
| RG-7234 | | | No Structure |
| RG-7256 | | | No Structure |
| RG-7347 | Genentech Inc. (US) | | No Structure |
| RG-7376 | Plexxikon Inc. (US) | | No Structure |
| RG-7414 | Genentech Inc. (US) | | No Structure |
| RG-7416 | Genentech Inc. (US) | | No Structure |
| RG-7417 | Genentech Inc. (US) | | No Structure |
| RG-7418 | BioInvent International AB (Sweden) | | No Structure |
| RG-7419 | | | No Structure |
| RG-7421 | | | No Structure |
| RG-7424 | Hoffmann La Roche (Switzerland) | | No Structure |
| RG-7426 | Bayhill Therapeutics Inc. (US) | | No Structure |
| RG-7440 | Array BioPharma Inc. ; Genentech Inc. | | No Structure |
| RG-7459 | | | No Structure |
| RGB-286147 | Calbiochem-Novabiochem ; GPC Biotech (Agennix) | 784211-09-2 |  |
| RGB-286199 | GPC Biotech (Agennix) | |  |
| RGB-286638 | GPC Biotech (Agennix) | |  |
| RGB-311399 | Axxima Pharmaceuticals (Agennix)(Germany) | |  |
| RGH-237 | Richter Gedeon Vegyeszet | |  |
| RGH-2716 | Gedeon Richter | 134069-68-4 |  |
| RGH-5279 | Gedeon Richter | 192813-81-3 (HCl) |  |
| rh-microplasmin | ThromboGenics (Belgium) | | No Structure |
| Rh-RGD-Hirudin | | | No Structure |
| RH1 | Salford University ; Cancer Research Campaign Technology ; University Technology Corp. | 221635-42-3 |  |
| Rhapontin | | 155-58-8 |  |
| Rhenium 186Re Bivatuzumab | Boehringer Ingelheim | | No Structure |
| rhFGF-21 | Eli Lilly | | No Structure |
| rhITF | The GI Company Inc. (US) ; The General Hospital Corp. (US) | | No Structure |
| Rhizoxin | National Inst. Agro Environment | 90996-54-6 |  |
| Rhodamine B | | 141-84-4 |  |
| Rhodamine-123 | | 62669-70-9 |  |
| RHPS-4 | Cancer Research Ventures Ltd. | |  |
| Rhucin | Pharming Intellectual | | No Structure |
| RI-624 | Rinat Neuroscience | | No Structure |
| Riastap | CSL Ltd. | 9001-32-5 | No Structure |
| Ribavirin | ICN Pharmaceuticals (Valeant) | 36791-04-5 |  |
| Riboflavin | Roche | 83-88-5 |  |
| Ribostamycin | Meiji Seika Kaisha | 25546-65-0 |  |
| Ricasetron | Beecham (GSK) | 117086-68-7 |  |
| Ricobendazole | Syntex (Roche) | 54029-12-8 |  |
| Ridaforolimus | Ariad Gene Therapeutics (Ariad Pharmaceuticals) | 572924-54-0 |  |
| Ridaifen B | Tokyo University of Science (Japan) | 886465-70-9 |  |
| Ridaifen C | Tokyo University of Science (Japan) | |  |
| Ridaifen D | Tokyo University of Science (Japan) | |  |
| Ridogrel | Janssen Pharmaceutica (Johnson & Johnson) | 110140-89-1 |  |
| Rifabutin | Archifar | 72559-06-9 |  |
| Rifai T-22 | Cornell Research Foundation | | No Structure |
| Rifalazil | Kanegafuchi Chemical (Kaneka Corporation) | 129791-92-0 |  |
| Rifametane | Farmitalia Carlo Erba (Pharmacia) | 94168-98-6 |  |
| Rifampicin | Lepetit | 13292-46-1 |  |
| Rifamycin | Lepetit Spa (Italy) | 6998-60-3 ; 15105-92-7 (monosodium salt ) |  |
| Rifamycin O | Lepetit (Italy) | 14487-05-9 |  |
| Rifamycin S | | 13553-79-2 |  |
| Rifapentine | Lepetit | 61379-65-5 |  |
| Rifaximin | Alfa Farmaceutici (Alfa Wassermann) | 80621-81-4 |  |
| RIG-200 | University of St Andrews | 202656-49-3 |  |
| Rilapladib | SmithKline Beecham | 412950-08-4 |  |
| Rilmazafone | Shionogi | 99593-25-6 |  |
| Rilmenidine | Science Union | 54187-04-1 |  |
| Rilonacept | Regeneron Pharmaceuticals | 501081-76-1 | No Structure |
| Rilopirox | Hoechst (Sanofi-Aventis) | 104153-37-9 |  |
| Rilotumumab | Amgen | 872514-65-3 | No Structure |
| Rilpivirine | Janssen Pharmaceutica (Johnson & Johnson) | 500287-72-9 ; 700361-47-3 (hydrochloride) |  |
| Riluzole | RPR (Aventis) | 1744-22-5 |  |
| Rimacalib | Sumitomo Pharmaceutical (Dainippon Sumitomo) | 215174-50-8 |  |
| Rimantadine | DuPont (BMS) | 13392-28-4 |  |
| Rimazolium metilsulfate | Chinoin | 28610-84-6 |  |
| Rimcazole | Burroughs Wellcome (GSK) | 75859-04-0 |  |
| Rimeporide | Merck GMBH | 187870-78-6 |  |
| Rimexolone | Akzo (Akzo Nobel) | 49697-38-3 |  |
| Rimiterol | 3M | 32953-89-2 |  |
| Rimonabant | Sanofi (Sanofi-Aventis) | 158681-13-1 |  |
| Rimoprogin | Spofa | 37750-83-7 |  |
| Rimsulfuron | DuPont | 122931-48-0 |  |
| Rindopepimut | Duke University ; Johns Hopkins University | 1108208-65-6 | No Structure |
| Rinfabate | Insmed | 405341-12-0 |  |
| Rintatolimod | John Hopkins University (US) | 38640-92-5 | No Structure |
| Riociguat | Bayer | 625115-55-1 |  |
| Riodipine | Latvian Inst. Of Organic Synthesis ; Ukranian Inst. Of Organic Synthesis | 71653-63-9 |  |
| Ripisartan | UPSA | 148504-51-2 |  |
| Risarestat | Takeda | 79714-31-1 |  |
| Risedronic acid | Procter & Gamble | 105462-24-6 ; 115436-72-1 (hydrate) |  |
| Rispenzepine | Dompe | 96449-05-7 |  |
| Risperidone | Janssen Pharmaceutica (Johnson & Johnson) | 106266-06-2 |  |
| Rispoval | Smithkline Beckman Animal Health Products | | No Structure |
| Ritanserin | Janssen Pharmaceutica (Johnson & Johnson) | 87051-43-2 |  |
| Ritiometan | | 34914-39-1 |  |
| Ritipenem | Farmitalia Carlo Erba (Pharmacia) | 84845-57-8 |  |
| Ritipenem acoxil | Farmitalia Carlo Erba (Pharmacia) | 87238-52-6 |  |
| Ritobegron | Kissei Pharmaceutical | 255734-04-4 |  |
| Ritodrine | Philips-Duphar | 26652-51-2 |  |
| Ritolukast | American Home Products (Wyeth) | 111974-60-8 |  |
| Ritonavir | Abbott | 155213-67-5 |  |
| Ritterazine-B | University of Tokyo | 160568-10-5 |  |
| Rituximab | | 174722-31-7 | No Structure |
| Rivanicline | Targacept | 675132-86-2 |  |
| Rivaroxaban | Bayer | 366789-02-8 |  |
| Rivastigmine | Yissum Research Development | 123441-03-2 |  |
| RiVax | The University of Texas (US) | | No Structure |
| Rivenprost | Ono Pharmaceutical | 256382-08-8 |  |
| Rivoglitazone | Sankyo | 185428-18-6 |  |
| Rizatriptan | Merck & Co. | 144034-80-0 |  |
| RJ-8 | University Hospital of North Norway, (Norway) | |  |
| RJ-9 | University Hospital of North Norway, (Norway) | |  |
| RJF-01928 | Otsuka Pharmaceuticals | 353477-88-0 |  |
| RJF-01934 | Otsuka Pharmaceuticals | 353477-91-5 |  |
| RK-28 | Kayaku | 93679-10-8 |  |
| RKB-3564S | Inst of Biotechnology Applied | |  |
| RKB-3564SAC | Inst of Biotechnology Applied | |  |
| RKTS-102 | Riken ; Taisho | |  |
| (+)-RKTS-17 | Rikagaku Kenkyusho | |  |
| RKTS-32 | Rikagaku Kenkyusho | |  |
| RKTS-35 | Rikagaku Kenkyusho | |  |
| RKTS-36 | Rikagaku Kenkyusho | |  |
| RKTS-80 | Tokyo University of Science (Japan) | |  |
| RKTS-81 | Tokyo University of Science (Japan) | |  |
| RKTS-82 | Tokyo University of Science (Japan) | |  |
| RL-0013 | US Department of Health & Human Services | 80205-24-9 |  |
| RLJ-NE-299A | Council of Scientific and Industrial Research (India) ; Bharat Biotech International Ltd. (India) | |  |
| RM-4803 | Romark Laboratories | |  |
| RM-4807 | Romark Laboratories | |  |
| RM-4809 | Romark Laboratories | |  |
| RM-4819 | Romark Laboratories | |  |
| RM-6427 | Romark | |  |
| rM. smegmatis | Chongqing Medical University (China) | | No Structure |
| RMS-P3-RR | | | No Structure |
| RN-18 | University of Massachusetts (US) | 431980-38-0 |  |
| RN-316 | Rinat Neuroscience Corp. ; Pfizer Inc. | | No Structure |
| RND-100 | RND Pharmaceuticals (US) | |  |
| RNX-003 | Antigen Biotechnologies Ltd. (Israel) | |  |
| RO-0281501 | Hoffmann La Roche | |  |
| RO-046790 | Hoffmann-La Roche | |  |
| RO-0509727 | F. Hoffmann-La Roche AG | |  |
| RO-0721678-000 | Hoffmann-La Roche | |  |
| RO-09-1227 | Nippon Pharma Dev Inst | 116468-08-7 |  |
| RO-09-2056 | Hoffmann La Roche (Roche) | |  |
| RO-09-3024 | Nippon Roche | 292606-88-3 |  |
| RO-09-4889 | Hoffmann-La Roche | |  |
| RO-091428 | Hoffmann La Roche | 134452-47-4 |  |
| RO-094609 | Basilea Pharmaceutica | |  |
| RO-094879 | Basilea Pharmaceutica | |  |
| RO-098246 | Basilea Pharmaceutica | |  |
| RO-098325 | Nippon Roche | 445510-12-3 |  |
| RO-111464 | Roche | 54123-09-0 |  |
| RO-1130830 | Roche | 193022-04-7 |  |
| Ro-116-6446-008 | Hoffmann La Roche | |  |
| RO-23-9424 | Hoffmann La Roche (Roche) | 115622-58-7 |  |
| RO-24-4383 | Roche | 135312-05-9 |  |
| RO-24-5531 | Roche | 137102-93-3 |  |
| RO-24-6392 | Roche | 131149-63-8 |  |
| RO-25-0236 | Hoffmann La Roche (Roche) | |  |
| RO-25-2016 | Roche | 157026-49-8 |  |
| RO-25-4020 | Hoffmann La Roche (Roche) | 247244-88-8 |  |
| RO-25-4095 | Roche | 157087-73-5 |  |
| RO-25-4835 | Roche | 157026-53-4 |  |
| RO-25-6760 | Roche | |  |
| RO-25-6833 | Hoffmann La Roche (Roche) | 161672-76-0 |  |
| RO-25-6981 | Roche | |  |
| RO-25-9022 | Hoffman-la-Roche | |  |
| RO-27-0574 | Roche | 221046-06-6 |  |
| RO-27-5646 | University of Chicago | |  |
| RO-28-1675 | Hoffmann-La Roche | |  |
| RO-28-2653 | Boehringer Mannheim (Roche) | |  |
| RO-318220 | Hoffmann La Roche (Roche) | 125314-64-9 |  |
| RO-32-7315 | Hoffmann La Roche (Roche) | |  |
| RO-3201195 | Hoffmann-La Roche | |  |
| RO-320432 | Roche | 131848-98-1 |  |
| RO-324397 | Hoffmann La Roche (Roche) | 187589-41-9 |  |
| RO-3244794 | Hoffmann La Roche (Roche) | |  |
| RO-33-4649 | Roche | |  |
| RO-41-0986 | Nippon Roche | |  |
| RO-415253 | Hoffmann La Roche (Roche) | |  |
| RO-435054 | Hoffmann La Roche (Roche) | 138107-95-6 |  |
| RO-438-3582 | Hoffmann-La Roche Inc. | |  |
| RO-4383596 | Hoffmann-La Roche | |  |
| RO-438857 | Roche | 132224-71-6 |  |
| RO-4396686 | Hoffmann-La Roche | |  |
| RO-4545057 | Hoffmann-La Roche AG | |  |
| RO-46-8443 | Hoffmann La Roche | |  |
| RO-48-5695 | Hoffmann La Roche (Roche) | |  |
| RO-481220 | Hoffmann La Roche (Roche) | 180323-80-2 |  |
| RO-481256 | Hoffmann-La Roche | |  |
| RO-486791 | Hoffmann La Roche (Roche) | |  |
| RO-4882224 | F. Hoffmann-La Roche AG | |  |
| RO-4905417 | Hoffmann-La Roche | | No Structure |
| RO-4920506 | F. Hoffmann-La Roche AG | |  |
| RO-4927350 | F. Hoffmann-La Roche AG (Switzerland) | |  |
| RO-4929097 | F. Hoffmann-La Roche AG (Switzerland) | |  |
| RO-4938581 | F. Hoffmann-La Roche AG | |  |
| RO-4998452 | Hoffmann-La Roche | | No Structure |
| RO-5068760 | F. Hoffmann-La Roche AG | |  |
| RO-53-335 | Hoffmann La Roche (Roche) | |  |
| RO-5312776 | F. Hoffmann-La Roche AG | |  |
| RO-60-0175 | Hoffmann La Roche (Roche) | 169675-08-5 |  |
| RO-600332 | Hoffmann-La Roche | |  |
| RO-61-0051-001 | Hoffmann La Roche (Roche) | 179940-42-2 |  |
| RO-618048 | Hoffmann La Roche (Roche) | 199666-03-0 |  |
| RO-62-6091 | Roche | 199476-01-2 |  |
| RO-630563 | Hoffmann-La Roche | |  |
| RO-64-6198 | Hoffmann La Roche (Roche) | 280783-56-4 |  |
| RO-645781 | Roche | 212959-84-7 |  |
| RO-65-2299 | Hoffmann La Roche (Roche) | 241151-12-2 |  |
| RO-657674 | Hoffmann-La Roche | |  |
| RO-67-7447 | Hoffmann-La Roche AG (Switzerland) | |  |
| RO-700004 | Hoffmann La Roche (Roche) | 186386-21-0 |  |
| RO-85 | F. Hoffmann-La Roche AG | |  |
| RO-9187 | F. Hoffmann-La Roche AG (Switzerland) | |  |
| Robalzotan | Astra (AstraZeneca) | 169758-66-1 |  |
| Robatumumab | Schering Corp (Merck & Co) | 934235-44-6 | No Structure |
| Robenacoxib | Novartis | 220991-32-2 |  |
| Robenidine | American Cyanamid (Wyeth) | 25875-51-8 |  |
| Robotnikinin | Broad Institute of Harvard and Massachusetts Institute of Technology (US) ; Harvard University (US) | |  |
| Robustaflavone | Advanced Life Sciences | 49620-13-5 |  |
| Rocepafant | SCRAS (Beaufour-Ipsen) | 132418-36-1 |  |
| Roche-RN-179942-28-0 | Hoffmann La Roche (Roche) | 179942-28-0 |  |
| Rociclovir | Hoechst (Sanofi-Aventis) | 108436-80-2 |  |
| Rociverine | Guidotti | 53716-44-2 |  |
| Rocuronium Bromide | Akzo (Akzo Nobel) | 119302-91-9 |  |
| ROD-185 | CNRS ; University of Bern ; University of Vienna | 314752-82-4 |  |
| (+)-ROD-188 | University of Bern ; CNRS ; University of Vienna | 309267-40-1 |  |
| Rofecoxib | Searle (Pharmacia) | 162011-90-7 |  |
| Rofleponide | AstraZeneca | 144459-70-1 |  |
| Rofleponide palmitate | AstraZeneca | 144653-57-6 |  |
| Roflumilast | Byk Gulden (Nycomed) | 162401-32-3 |  |
| Rogletimide | National Research Development Corporation (NRDC) | 121840-95-7 |  |
| Rohitukine | Hoechst (Sanofi-Aventis) | 71294-60-5 |  |
| Rohm&Haas-RN-135475-57-9 | Rohm & Haas | 135475-57-9 |  |
| Rokitamycin | Toyo Jozo | 74014-51-0 |  |
| Rolafagrel | Farmitalia Carlo Erba (Pharmacia) | 89781-55-5 |  |
| Rolapitant | Schering Corp (Merck & Co) | 552292-08-7 |  |
| Rolipoltide | Immulogic Pharma | 698389-003 |  |
| Rolipram | Schering AG | 61413-54-5 |  |
| Rolitetracycline | Hoechst (Sanofi-Aventis) | 751-97-3 |  |
| Rolofylline | Kyowa Hakko | 136199-02-5 |  |
| Rolziracetam | Warner-Lambert (Pfizer) | 18356-28-0 |  |
| Romazarit | Angelini | 109543-76-2 |  |
| Romidepsin | Fujisawa (Astellas) | 128517-07-7 |  |
| Romifidine | Boehringer Ingelheim | 65896-16-4 |  |
| Romiplostim | Amgen | 267639-76-9 |  |
| Romurtide | Daiichi | 78113-36-7 |  |
| Ronacaleret | SmithKline Beecham | 753449-67-1 ; 702686-96-2 (ronacaleret hydrochloride) |  |
| Ronidazole | Merck & Co. | 7681-76-7 |  |
| Ronifibrate | Yamanouchi (Astellas) | 42597-57-9 |  |
| Rontalizumab | | 948570-30-7 | No Structure |
| Ropidoxuridine | Yale University | 93265-81-7 |  |
| Ropinirole | SmithKline Beecham (GSK) | 91374-20-8 ; 91374-21-9 |  |
| Ropivacaine | Astra (AstraZeneca) ; Apothekernes Laboratorium for Specialpraeparater | 84057-95-4 |  |
| Roquinimex | Leo Pharmaceutical | 84088-42-6 |  |
| Rosabulin | SBR Pharmaceuticals (Synta Pharmaceuticals) | 501948-05-6 |  |
| Rosavin | Kenneth Blum Inc,( US) ; University of Texas, (US) ; Hope Nat Medical Center, (US) | |  |
| Rose Bengal | | 632-68-8 |  |
| ROSE-010 | Eli Lilly & Co. (US) | |  |
| Rosiglitazone | Beecham (GSK) | 122320-73-4 ; 155141-29-0 (maleate) |  |
| Rosonabant | Laboratorios Del Dr. Esteve S.A. | 861151-12-4 |  |
| Rosoxacin | Sterling Drug (Sanofi-Aventis) | 40034-42-2 |  |
| Rostafuroxin | Sigma-Tau | 156722-18-8 |  |
| Rostaporfin | Toledo University | 284041-10-7 |  |
| Rosuvastatin | Shionogi | 147098-20-2 |  |
| Rotarix | GlaxoSmithKline (GSK) | | No Structure |
| RotaTeq | Wistar Institute ; Children's Hospital of Philadelphia | | No Structure |
| Rotigaptide | Zealand Pharmaceuticals | 355151-12-1 |  |
| Rotigotine | Whitby Research (Aderis) | 99755-59-6 |  |
| Rotraxate | Teijin | 92071-51-7 |  |
| Rovelizumab | Icos | 197099-66-4 | No Structure |
| ROX-828 (Ketorolac) | Roxro Pharma | 74103-06-3 |  |
| ROX-888 (Ketorolac) | | 74103-06-3 |  |
| Roxadimate | Amerchol | 58882-17-0 |  |
| Roxarsone | Hoechst (Sanofi-Aventis) | 121-19-7 |  |
| Roxatidine | Teikoku Hormone (Aska Pharmaceuticals) | 78273-80-0 |  |
| Roxifiban | DuPont Merck (BMS) | 176022-59-6 |  |
| Roxindole | E. Merck KGaA | 112192-04-8 |  |
| Roxithromycin | Roussel-Uclaf (Aventis) | 80214-83-1 |  |
| Rozrolimupab | Symphogen | 909402-77-3 | No Structure |
| RP-170 | Pola | 120398-89-2 |  |
| RP-193 | Centre National de la Recherche Scientifique (France) | |  |
| RP-463 | AnorMed ; (Johnson & Johnson) | 244238-18-4 |  |
| RP-517 (Tc99m) | DuPont Merck (BMS) | 206264-05-3 |  |
| RP-52028 | Sanofi-Synthelabo | 85340-56-3 |  |
| RP-527 | Resolution Pharmaceutical (Bracco) | 289057-76-7 |  |
| RP-593 | DuPont (BMS) | 250614-55-2 |  |
| RP-60556A | Aventis (Sanofi-Aventis) | 278795-91-8 |  |
| RP-61969 | May & Baker (Aventis) | 126059-69-5 |  |
| RP-66055 | Rhone-Poulenc (Aventis) | 133783-43-4 |  |
| RP-67580 | Rhone-Poulenc (Aventis) | 135911-02-3 |  |
| RP-67829 | Bellon | 137765-57-2 |  |
| RP-70034 | RPR (Aventis) | 150840-31-6 |  |
| RP-71955 | RPR (Aventis) | |  |
| RPI-1 | NovusPharma | |  |
| RPI-312 | Nippon Mining | 139694-65-8 |  |
| RPI-4610 | Sirna Therapeutics (Merck & Co.) ; Chiron | | No Structure |
| RPI-78M | Phylomed | | No Structure |
| RPI-856 | Takeda | 157381-54-9 |  |
| RPL-554 | Vernalis Ltd. | |  |
| RPL-565 | Vernalis Ltd. | |  |
| RPR-101511A | Rhone-Poulenc Rorer | |  |
| RPR-102341 | Rhone-Poulenc (Aventis) | 149105-53-3 |  |
| RPR-103611 | Rega Institute for Medical Research | 150840-75-8 |  |
| RPR-106145 | RPR (Aventis) | 163957-42-4 |  |
| RPR-106541 | RPR (Aventis) | 159001-35-1 |  |
| RPR-106868 | RPR (Aventis) | |  |
| RPR-107393 | RPR (Aventis) | 190841-57-7 (2HCl) |  |
| RPR-107880 | RPR (Aventis) | 166966-23-0 |  |
| RPR-110993 | RPR (Aventis) | 188827-32-9 |  |
| RPR-112378 | RPR (Aventis) | 267893-26-5 |  |
| RPR-117824 | RPR (Aventis) | 183734-76-1 |  |
| RPR-119990 | RPR (Aventis) | |  |
| RPR-130401 | RPR (Aventis) | 210282-69-2 |  |
| RPR-130673 | RPR (Aventis) | |  |
| RPR-130737 | RPR (Aventis) | 205054-36-0 |  |
| RPR-200765A | RPR (Aventis) | |  |
| RPR-203494 | RPR (Aventis) | |  |
| RPR-208566 | RPR (Aventis) | 219672-61-4 (trifluoroacetate) |  |
| RPR-208707 | RPR (Aventis) | 209285-84-7 |  |
| RPR-208815 | Aventis Pharmaceuticals | |  |
| RPR-209685 | RPR (Aventis) | 234100-28-8 |  |
| RPR-238677 | Rhone Poulenc Rorer | |  |
| RPR-260243 | Aventis | |  |
| RPR-CMV-423 | RPR (Aventis) | 186829-19-6 |  |
| RPR-RN-202577-99-9 | RPR (Aventis) ; Novosibirisk Inst. of Org. Chem. | 202577-89-7 |  |
| RRD-251 | University of South Florida (US) | 72214-67-6 |  |
| RS-0406 | Sankyo | 530112-00-6 |  |
| RS-0466 | Sankyo | 536993-37-0 |  |
| RS-1-59 | The Johns Hopkins University (US) | |  |
| RS-10 | Government of the United States of America (US) | |  |
| RS-100329 | Hoffmann La Roche (Roche) | 232953-52-5 |  |
| RS-112997 | Sankyo (Japan) | |  |
| RS-1154 | Daiichi Sankyo Co. Ltd. | |  |
| RS-1178 | Sankyo | 62052-82-8 |  |
| RS-118641 | Sankyo (Japan) | |  |
| RS-124922 | Sankyo (Japan) | |  |
| RS-1259 | Sankyo | 444667-96-3 |  |
| RS-132943 | Hoffmann La Roche (Roche) | |  |
| RS-1439 | Sankyo | |  |
| RS-17053 | Syntex | 169505-93-5 |  |
| RS-2-19 | The Johns Hopkins University (US) | |  |
| RS-42358 | Synte | 135729-61-2 |  |
| RS-4252 | Sankyo | |  |
| RS-5773 | Sankyo | 129120-56-5 |  |
| RS-86 | Westminster Bank | 3576-73-6 |  |
| rSARS-CoV-dE | Consejo Superior de Investigaciones Científicas (Spain) | | No Structure |
| RSD-921 | University of British Columbia | 114419-77-1 |  |
| RSD-944 | University of British Columbia ; Warner Lambert (Pfizer) | 100067-71-8 |  |
| RSD-992 | Cardiome | 211236-75-8 |  |
| RSD-995 | Nortran Pharmaceuticals | 291776-00-6 (HCl) |  |
| rSeV-hPIV3-HN | St. Jude Children’s Research Hospital (US) | | No Structure |
| rsPSMA Vaccine | | | No Structure |
| RSR-46 | Center for Innovative Technology | 145231-17-0 |  |
| RSV-604 | Arrow Therapeutics | |  |
| RTA-203 | University of Texas | |  |
| RTbtR-NHBn | Lytix Biopharma AS (Norway) | |  |
| RTI-112 | Research Triangle Institute | |  |
| RTI-1176-012 | Research Triangle Institute | |  |
| RTI-336 | Research Triangle Inst. | |  |
| RTI-4229-298 | Research Triangle Inst. | 204068-60-0 |  |
| RTI-5989-29 | Research Triangle Institute | |  |
| RTI-7527-33 | Research Triangle Institute | |  |
| RTL-1000 | Oregon Health & Science University ; Virogenomics (US) | | No Structure |
| RTP-801i-14 | Quark Pharmaceuticals ; Atugen (Silence Therapeutics) | | No Structure |
| rTV | Chinese Center for Disease Control and Prevention Center for AIDS/STD Control and Prevention (China) | | No Structure |
| RU-33965 | Roussel-Uclaf (Aventis) | 122321-05-5 |  |
| RU-34332 | Roussel-Uclaf (Aventis) | 137157-58-5 |  |
| RU-35963 | HMR (Aventis) | 139886-03-6 |  |
| RU-46556 | Roussel Uclaf | |  |
| RU-49041 | HMR (Aventis) | 123828-80-8 |  |
| RU-54115 | Roussel-Uclaf (Aventis) | 137437-16-2 |  |
| RU-58668 | Hoechst Marion Roussel | 151555-47-4 |  |
| RU-59863 | Roussel-Uclaf (Aventis) | 152441-39-9 |  |
| RU-79115 | Aventis | 229307-82-8 |  |
| RU-81843 | Ariad | |  |
| Rubitecan | Research Triangle Inst. | 91421-42-0 |  |
| Ruboxistaurin | Eli Lilly | 169939-94-0 |  |
| Rufinamide | Ciba-Geigy (Novartis) | 106308-44-5 |  |
| Rufloxacin | Mediolanum Farmaceutici | 101363-10-4 |  |
| Rumycin 2 | Recombinogen Ltd. (GB) | |  |
| Rupatadine | Uriach | 158876-82-5 |  |
| Rupintrivir | Agouron (Pfizer) | 223537-30-2 |  |
| Rurioctocog Alfa | Chiron Corp ; Novo Nordisk | | No Structure |
| RUS-350 | Cambridge Laboratories (Ireland) Ltd. (Ireland) | |  |
| Rusalatide | Chrysalis BioTechnology (OrthoLogic) | 121341-81-9 ; 875455-82-6 (acetate) |  |
| Ruscogenin | Kalle | 472-11-7 |  |
| RUTI | Archivel Farma SL (Spain) | | No Structure |
| Ruxolitinib | INCYTE CORPORATION | 1138325-12-8 ; 941678-49-5 ; 1092939-17-7 (H3O4P) |  |
| Ruzadolane | UPSA | 115762-17-9 |  |
| RV 8-2-6-7-VLP | Institut National de la Recherche Agronomique (France) | | No Structure |
| rVIIa-FP | CSL Behring (US) | | No Structure |
| RVX-208 | Resverlogix | 1246400-89-4 | No Structure |
| RWJ-22108 | Ortho McNeil (Johnson & Johnson) | 112769-37-6 |  |
| RWJ-22726 | Ortho McNeil (Johnson & Johnson) | 112769-41-2 |  |
| RWJ-25730 | Ortho McNeil (Johnson & Johnson) | 123547-30-8 |  |
| RWJ-28810 | R.W. Johnson Pharmaceutical Research Inst. (Johnson & Johnson) | 329040-80-4 |  |
| RWJ-314313 | Ortho McNeil (Johnson & Johnson) | 259262-24-3 |  |
| RWJ-333441 | R.W. Johnson Pharmaceutical Research Inst. (Johnson & Johnson) ; Microcide Pharmaceuticals (Essentia | 331780-20-2 |  |
| RWJ-348260 | Ortho McNeil (Johnson & Johnson) | |  |
| RWJ-38063 | Ortho McNeil (Johnson & Johnson) | 216252-56-1 |  |
| RWJ-394674 | Ortho McNeil (Johnson & Johnson) | |  |
| RWJ-413216 | Ortho McNeil (Johnson & Johnson) | |  |
| RWJ-416457 | Ortho McNeil (Johnson & Johnson) | |  |
| RWJ-424716 | Ortho McNeil (Johnson & Johnson) | |  |
| RWJ-442831 | Microcide Pharmaceuticals (Essential Therapeutics) | |  |
| RWJ-445167 | 3-Dimensional (Johnson & Johnson Pharmaceutical) | |  |
| RWJ-50353 | Johnson & Johnson | |  |
| RWJ-52763 | Johnson & Johnson Pharmaceutical | |  |
| RWJ-54428 | Microcide Pharmaceuticals (Essential Therapeutics) | 189448-36-0 (trifluoroacetate) |  |
| RWJ-56110 | Ortho McNeil (Johnson & Johnson); Cor Therapeutics | 252889-88-6 |  |
| RWJ-56423 | Ortho McNeil (Johnson & Johnson) | 608145-22-8 |  |
| RWJ-58259 | Ortho McNeil (Johnson & Johnson) | 315203-31-7 |  |
| RWJ-58643 | Ortho McNeil (Johnson & Johnson) | |  |
| RWJ-60475 | Ortho McNeil (Johnson & Johnson) | 204130-08-5 |  |
| RWJ-63556 | Ortho McNeil (Johnson & Johnson) | 190967-35-2 |  |
| RWJ-671818 | 3-Dimensional Pharmaceuticals Inc. (Johnson & Johnson Inc.) | 858360-15-3 |  |
| RWJ-676070 | Janssen Pharmaceutica (Johnson & Johnson) (Belgium) | |  |
| RWJ-67657 | Ortho McNeil (Johnson & Johnson) | 215303-72-3 |  |
| RWJ-68023 | Ortho McNeil (Johnson & Johnson) | |  |
| RWJ-68354 | Ortho McNeil (Johnson & Johnson) | 215306-39-1 |  |
| Rx-01-423 | Rib-X Pharmaceuticals | |  |
| RX-0201 | Rexahn Pharmaceuticals Inc. (US) | | No Structure |
| RX-10005 | University of Southern California (US) | |  |
| RX-100472 | Trius Therapeutics (US) | |  |
| RX-10100 (Clavulanic acid) | Revaax Pharmaceuticals | |  |
| RX-10100 IR (Clavulanic acid) | Revaax Pharmaceuticals | |  |
| Rx-101005 | | |  |
| RY-024 | University of Wisconsin | |  |
| RY-764 | Merck & Co | |  |
| Ryanodine | | 15662-33-6 |  |
| RZB-014 | Altair Nanomaterials Inc. | 12011-96-0 |  |
| S-(-)-bromofosfamide | | 146452-37-1 |  |
| S-0139 | Shionogi | 193696-54-9 |  |
| S-1 (Tegafur & Gimeracil & Oteracil) | Taiho | 150863-82-4 |  |
| S-101 | Yissum | |  |
| S-12340 | ADIR (Servier) | 144754-35-8 |  |
| S-1255 | Shionogi | |  |
| S-12967 | ADIR (Servier) | 132194-65-1 |  |
| S-12968 | ADIR (Servier) | 132194-66-2 |  |
| S-1319 | Kirin Brewery | 220752-37-4 |  |
| S-1360 | Shionogi | |  |
| S-1389 | Shionogi | 94899-83-9 |  |
| S-14001 | Adir (Servier) | 136071-58-4 |  |
| S-14280 | Servier | 131952-87-9 |  |
| S-14297 | ADIR (Servier) | 157622-55-4 |  |
| S-14506 | ADIR (Servier) | 135722-25-7 |  |
| S-14671 | ADIR (Servier) | 135722-27-9 |  |
| S-15176 | Adir (Servier) | 148089-70-7 |  |
| S-15261 | ADIR (Servier) | 159978-02-6 |  |
| S-15535 | ADIR (Servier) | 146998-34-7 |  |
| S-16020-2 | ADIR (Servier) | 178169-99-8 |  |
| S-16197 | | | No Structure |
| S-16209 | ADIR (Servier) | 151488-80-1 |  |
| S-16317 | ADIR (Servier) | 151489-04-2 |  |
| S-16324 | ADIR (Servier) | 154489-02-0 |  |
| S-16474 | ADIR (Servier) | 149250-10-2 (Na) |  |
| S-1663 | Sibia | 179064-13-2 |  |
| S-16924 | ADIR (Servier) | 169167-86-6 |  |
| S-16961 | ADIR (Servier) | 160555-46-4 |  |
| S-170891 | ADIR (Servier) | 162098-25-1 |  |
| S-17092 | ADIR (Servier) | 176797-26-5 |  |
| S-17625 | Adir | |  |
| S-18127 | Servier | |  |
| S-18204 | ADIR (Servier) | |  |
| S-18326 | ADIR (Servier) | |  |
| S-18327 | ADIR (Servier) | 200398-40-9 |  |
| S-18407 | Aventis Pharma GmbH (Sanofi-Aventis) | |  |
| S-18523 | ADIR (Servier) | 174769-78-9 |  |
| S-18616 | ADIR (Servier) | 162280-52-6 |  |
| S-18841 | ADIR (Servier) | 192565-05-2 |  |
| S-18986 | Adir (Servier) | 175340-20-2 |  |
| S-19014 | ADIR (Servier) | 162098-61-5 |  |
| S-19752 | Boehringer Ingelheim | 188241-50-1 |  |
| S-19812 | ADIR (Servier) | 181308-68-9 |  |
| S-20478 | Adir (Servier) | 140384-34-5 |  |
| S-213571 | ADIR (Servier) | 158591-17-4 (trihydrochloride) |  |
| S-2150 | Shionogi | 149882-23-5 |  |
| S-22153 | ADIR (Servier) | |  |
| S-222611 | | | No Structure |
| S-22687 | ADIR (Servier) | |  |
| S-234462 | | | No Structure |
| S-23521 | Servier | |  |
| S-23757 | Adir | |  |
| S-23906-1 | Servier (Adir) | |  |
| S-24429 | ADIR (Servier) | 219321-20-7 |  |
| S-247 | Searle (Pharmacia) | 280123-03-7 |  |
| S-24718 | ADIR (Servier) | 251562-03-5 |  |
| S-247303 | | | No Structure |
| S-2474 | Shionogi | 158089-95-3 |  |
| S-2512 | Galilaeus | |  |
| S-2513 | Galilaeus | 249929-50-8 |  |
| S-2526 | Galilaeus | |  |
| S-2678 | Shionogi & Co. (Japan) | |  |
| S-26948 | Les Laboratoires Servier (France) ; Centre National de la Recherche Scientifique (France) | |  |
| S-27281 | Sankyo | |  |
| S-27609 | Riker | 151751-58-5 |  |
| S-28687-1 | Servier (Adir) | |  |
| S-288310 | Oncotherapy Science Inc. ; The University of Tokyo (Japan) | | No Structure |
| S-297995 | | | No Structure |
| S-2E | Taiho | 155730-92-0 |  |
| S-30372 | Servier | 211256-31-4 |  |
| S-30972-1 | ADIR (Servier) | |  |
| S-31076 | Kaken Pharmaceutical | 150008-26-7 |  |
| S-312 | Shionogi | 120004-07-1 |  |
| S-31214 | ADIR (Servier) | 196209-64-0 |  |
| S-31354 | ADIR (Servier) | |  |
| S-32006 | Les Laboratoires Servier (France) | |  |
| S-32212 | Servier | |  |
| S-32504 | Adir | |  |
| S-32730 | Kaken Pharmaceutical | 168545-09-3 |  |
| S-33005 | ADIR (Servier) | 242473-60-5 |  |
| S-3304 | Shionogi | 203640-27-1 |  |
| S-33084 | ADIR (Servier) | 273203-30-8 |  |
| S-33113 | Adir (Servier) | |  |
| S-33138 | ADIR (Servier) | 220647-56-3 |  |
| S-3319 | University of Queensland (Australia) | 393569-31-8 |  |
| S-34219 | Adir (servier) | |  |
| S-3422 | Sumitomo Chemical | 65261-98-5 |  |
| S-34324 | ADIR (Servier) | 276235-47-3 |  |
| S-34961 | Servier | |  |
| S-35031 | Adir | |  |
| S-35120 | SERVIER | |  |
| S-3578 | Shionogi | |  |
| S-35898 | Servier | |  |
| S-36496 | Kaken Pharma | |  |
| S-36888 | Servier | |  |
| S-37435 | Kaken Pharmaceutical ; Molecular Research Inst. | |  |
| S-377 | Sumitomo Chemical | 110076-62-5 |  |
| S-38809 | Les Laboratoires Servier (France) | |  |
| S-39625 | Les Laboratoires Servier (France) | |  |
| S-40503 | Kaken Pharmaceutical | |  |
| S-41150 | Servier | | No Structure |
| S-41744 | Les Laboratoires Servier | |  |
| S-421 | Sankyo | 127-90-2 |  |
| S-444823 | | | No Structure |
| S-474474 (Irbesartan & Trichlormethiazide) | | 138402-11-6 (Irbesartan) ; 133-67-5 (Trichlormethiazide) |  |
| S-555739 | | | No Structure |
| S-5751 | Shionogi | 209268-36-0 |  |
| S-661 | Novo Nordisk AS (Denmark) | |  |
| S-707106 | | | No Structure |
| S-71507 | Les Laboratoires Servier (France) | |  |
| S-777469 | Shionogi | | No Structure |
| S-83697 | Sumitomo Chemical | 128306-92-0 |  |
| S-8510 | Shionogi | 151466-23-8 |  |
| S-8921 | Shionogi | 151165-96-7 |  |
| S-90652 (Perindopril) | | |  |
| S-9788 | ADIR (Servier) | 140945-01-3 |  |
| S-9947 | Aventis Pharma | |  |
| S-Amlodipine | Sepracor (Dainippon Sumitomo Pharma) | 103129-82-4 ; 736178-83-9 (Levamlodipine malate) |  |
| S-Bioallethrin | Roussel-Uclaf (Aventis) | 28434-00-6 |  |
| S-Methoprene | Zoecon | 65733-16-6 |  |
| S-Metolachlor | Ciba-Geigy (Novartis) | 87392-12-9 |  |
| S-Nitrosocaptopril | University of of Ohio ; Brigham & Womens Hospital | 122130-63-6 |  |
| S-Tenatoprazole | Tokyo Tanabe (Mitsubishi Pharma) | |  |
| (S,S)-Reboxetine | Upjohn Co (Pfizer) | 98819-76-2 ; 635724-55-9 (succinate salt) |  |
| (S)-4'-(HO)-DADFT-PE | University of Florida | |  |
| (S)-AR-A008055 | Astra (AstraZeneca) | 376629-66-2 |  |
| (S)-Desmethylzopiclone | Sepracor (Dainippon Sumitomo Pharma) | 151776-26-0 |  |
| (S)-Didesmethylsibutramine | Sepracor | 229639-57-0 |  |
| (S)-Doxazosin | Sepracor | |  |
| (-)-(S)-DRF-2655 | Dr. Reddy's Research Foundation | |  |
| (S)-Fluoxetine | Eli Lilly | 100568-02-3 |  |
| (S)-HPMP-5-azaC | Ceskoslovenska Akademie Ved (Czechoslovakia) ; Rega Foundation (Belgium) | |  |
| (S)-LG-120746 | Ligand Pharmaceuticals | 211057-16-8 |  |
| (S)-Nefopam | Arakis Ltd. (Sosei Co. Ltd.) | 110011-82-0 |  |
| (S)-PD-148903 | Warner Lambert (Pfizer) | |  |
| (S)-Rivoglitazone | Daiichi Sankyo Co. Ltd. (Japan) | |  |
| (S)-Trolox | Hoffmann La Roche (Roche) | 135806-59-6 |  |
| S05A-2 | Nymox Corp. (Canada) | |  |
| S05A-7 | Nymox Corp. (Canada) | |  |
| (S188E,A191L)-NAGA | Tokyo Metropolitan Organization for Medical Research (Japan) ; Altif Laboratories Inc. (Japan) | | No Structure |
| S239D-I332E Rituximab | Xencor | | No Structure |
| S5H3 | Genentech Inc. | | No Structure |
| SA-1-204 | Research Corporation Technologies Inc. (US) | |  |
| SA-101B | Salvia Sciences Inc. (US) | |  |
| SA-1042 | Sankyo | 153021-65-9 |  |
| SA-2572 | Santen Pharmaceutical | 112946-90-4 |  |
| SA-40 | Saarland University | |  |
| SA-41 | Saarland University | |  |
| SA-627 | DuPont Merck (BMS) | 169881-96-3 |  |
| SA-7060 | Santen | 179177-51-6 |  |
| SA-862 | DuPont (BMS) | 209730-58-5 |  |
| SA-9000 | Santen | |  |
| SAB-378 | Novartis | |  |
| Sabarubicin | Menarini ; Bristol-Myers Squibb (BMS) | 211100-13-9 |  |
| Sabcomeline | Beecham Group (GSK) | 159912-53-5 |  |
| Sabeluzole | Janssen Pharmaceutica (Johnson & Johnson) | 104383-17-7 |  |
| Sabiporide | CNRS | 324758-66-9 |  |
| Saccharin | | 81-07-2 |  |
| SAD-448 | | | No Structure |
| Safinamide | Farmitalia Carlo Erba (Pfizer) | 133865-89-1 |  |
| Safingol | Pharmacia ; Eli Lilly | 15639-50-6 |  |
| Safironil | Hoechst (Sanofi-Aventis) | 134377-69-8 |  |
| Saflufenacil | BASF | 372137-35-4 |  |
| Sagami-RN-120189-46-0 | Sagami | 120189-46-0 |  |
| Sagopilone | Schering AG | 305841-29-6 |  |
| SAHM-1 | Dana Farber Cancer Institute Inc. (US) ; Harvard College (US) | |  |
| SAL-HIV D | State Research Center Virology and Biotechnology ‘‘Vector’ (Russian Federation) | | No Structure |
| Salbutamol | Allen & Hanburys (GSK) | 18559-94-9 |  |
| Salcaprozic acid | Emisphere Technologies | 183990-46-7 (free acid) ; 203787-91-1 (sodium salt) |  |
| Salicyl-AMS | Sloan Kettering Cancer Institute ; Cornell Research Foundation | |  |
| Salicylamide | | 65-45-2 |  |
| Salicylic acid | | 69-72-7 |  |
| Salinomycin | Kaken Pharmaceutical | 53003-10-4 |  |
| Salirasib | Concordia Pharmaceuticals (US) | 162520-00-5 |  |
| Salmeterol | Glaxo (GSK) | 89365-50-4 |  |
| Salmeterol & Fluticasone | Meda Pharma GmbH & Co. KG (Meda AB) | 89365-50-4 (Salmeterol) ; 80474-14-2 (Fluticasone) |  |
| Salsalate | Boehringer Mannheim (Roche) | 552-94-3 |  |
| Salverine | Montavit | 6376-26-7 |  |
| Salvianolic acid B | Terumo Corp. (Japan) | 115939-25-8 |  |
| Salvicine | Inst. of Materia Medica (Shanghai) | 227753-71-1 |  |
| SAM-1095 | University of Arizona ; University of Nothern Colorado | 288156-58-1 |  |
| SAM-315 | | | No Structure |
| SAM-531 | Wyeth Corp. (Pfizer Inc.) | |  |
| Samalizumab | Alexion Pharmaceuticals Inc. | 1073059-33-2 | No Structure |
| Samarium (153Sm) Lexidronam | Dow | 154427-83-5 |  |
| Sameridine | Astra (AstraZeneca) | 143257-97-0 |  |
| Samixogrel | Thomae (Boehringer Ingelheim) | 133276-80-9 |  |
| Sampatrilat | Pfizer | 129981-36-8 |  |
| Sanazole | Adeka | 104958-90-9 |  |
| Sancuso (Granisetron) | | 109889-09-0 |  |
| Sanfetrinem | Glaxo (GSK) | 156769-21-0 |  |
| Sanfetrinem cilexetil | Glaxo (GSK) | 141646-08-4 |  |
| Sapacitabine | Sankyo | 151823-14-2 |  |
| Saperconazole | Janssen Pharmaceutica (Johnson & Johnson) | 110588-57-3 |  |
| Saposin-C-dioleoylphosphatidylserine | Children's Hospital Medical Center (US) | | No Structure |
| Saprisartan | Glaxo (GSK) | 146623-69-0 |  |
| Sapropterin | Kanegafuchi | 62989-33-7 |  |
| Saptomycin D | Sapporo Breweries | 137714-91-1 |  |
| Saquinavir | Hoffmann La Roche (Roche) | 127779-20-8 |  |
| SAR-100842 | | | No Structure |
| SAR-101099 | | | No Structure |
| SAR-10279 | Sanofi-Aventis | | No Structure |
| SAR-103168 | Sanofi-aventis | |  |
| SAR-104772 | | | No Structure |
| SAR-106881 | Sanofi-aventis | |  |
| SAR-110894 | | | No Structure |
| SAR-113945 | | | No Structure |
| SAR-114137 | | | No Structure |
| SAR-114646 | Sanofi Aventis | | No Structure |
| SAR-150640 | Sanofi-aventis (France) | |  |
| SAR-152954 | | | No Structure |
| SAR-153191 | Regeneron Pharmaceuticals | | No Structure |
| SAR-153192 | Regeneron Pharmaceuticals | | No Structure |
| SAR-164877 | Regeneron Pharmaceuticals | | No Structure |
| SAR-21609 | Sanofi-Aventis ; Coley | | No Structure |
| SAR-260093 | Metabolex Inc. | | No Structure |
| SAR-292833 | Glenmark Pharmaceuticals Ltd. | | No Structure |
| SAR-302532 | | | No Structure |
| SAR-3419 | ImmunoGen | | No Structure |
| SAR-35034 | Sanofi-Aventis | | No Structure |
| SAR-351034 | | | No Structure |
| SAR-377142 | Sanofi-Aventis | | No Structure |
| SAR-407899 | Sanofi-aventis | | No Structure |
| SAR-411298 | | | No Structure |
| SAR-548304 | | | No Structure |
| SAR-566658 | ImmunoGen Inc. (US) | | No Structure |
| SAR-650984 | Sanofi-aventis (France) | | No Structure |
| SAR-707 | Sanofi-aventis | |  |
| SAR-7226 | Sanofi-Aventis | | No Structure |
| SAR-943 | | |  |
| Saracatinib | AstraZeneca | 379231-04-6 ; 893428-72-3 (Difumarate) |  |
| Sarafloxacin | Toyama | 98105-99-8 |  |
| Sarakalim | Syntex | 148430-28-8 |  |
| Saratin | Merck GMBH | |  |
| SarCNU | Suami T | 81965-43-7 |  |
| Sardomozide | Ciba-Geigy (Novartis) | 149400-88-4 |  |
| Saredutant | Sanofi (Sanofi-Aventis) | 142001-63-6 |  |
| Sargramostim | Immunex | 123774-72-1 | No Structure |
| Saripidem | Synthelabo (Sanofi-Aventis) | 103844-86-6 |  |
| Sarizotan | E. Merck KGaA | 177975-08-5 ; 195068-07-6 (hydrochloride) |  |
| Sarpogrelate | Tokyo Tanabe (Mitsubishi) | 125926-17-2 |  |
| Sarsasapogenin | Phytopharm Plc | 126-19-2 |  |
| Satavaptan | Sanofi (Sanofi-Aventis) | 185913-79-5 |  |
| Saterinone | Beiersdorf | 102669-89-6 |  |
| Satigrel | Eisai | 111753-73-2 |  |
| Satraplatin | Johnson Matthey | 129580-63-8 |  |
| Saviprazole | Hoechst (Sanofi-Aventis) | 121617-11-6 |  |
| Savoxepin | Ciba-Geigy (Novartis) | 79262-46-7 |  |
| Saxagliptin | Bristol-Myers Squibb (BMS) | 361442-04-8 ; 945667-22-1 (monohydrate) |  |
| Saxagliptin & Metformin | Bristol-Myers Squibb Co. (US) | 361442-04-8 (Saxagliptin) ; 657-24-9 (Metformin) |  |
| Sazetidine-A | Georgetown University | 820231-95-6 |  |
| SB-101 | Angitia AB (Sweden) ; Celecure AS (Estonia) | | No Structure |
| SB-1518 | S BIO (Singapore) | | No Structure |
| SB-200646A | Beecham (GSK) | 143797-63-1 |  |
| SB-201823A | SmithKline French (GSK) | 141430-36-6 |  |
| SB-202190 | SmithKline Beecham (GSK) | 152121-30-7 |  |
| SB-203105 | Pfizer | 199723-64-3 |  |
| SB-203186 | GlaxoSmithKline (GSK) | |  |
| SB-203208 | GlaxoSmithKline (GSK) | |  |
| SB-203220 | SmithKline Beecham (GSK) | |  |
| SB-203580 | SmithKline Beecham (GSK) | 152121-47-6 |  |
| SB-204070 | SmithKline French (GSK) | 148702-58-3 |  |
| SB-204741 | SmithKline Beecham (GSK) | |  |
| SB-205384 | SmithKline Beecham (GSK) | 160296-13-9 |  |
| SB-205700 | SmithKline Beecham (GSK) | 153353-80-1 |  |
| SB-205800 | GlaxoSmithKline (GSK) | |  |
| SB-205952 | SmithKline Beecham (GSK) | 152366-34-2 |  |
| SB-206343 | SmithKline Beecham (GSK) | |  |
| SB-206553 | GlaxoSmithKline (GSK) | |  |
| SB-208651 | SmithKline French (GSK) | 161169-57-9 |  |
| SB-209670 | SmithKline Beecham (GSK) | 157659-79-5 |  |
| SB-209995 | SmithKline Beecham (GSK) | 146574-41-6 |  |
| SB-213068 | SmithKline Beecham (GSK) | 158062-19-2 |  |
| SB-214111 | SmithKline Beecham (GSK) | |  |
| SB-214751 | UCB | 140623-62-7 |  |
| SB-216763 | SmithKline Beecham (GSK) | 280744-09-4 |  |
| SB-216968 | GlaxoSmithKline (GSK) | 185952-65-2 |  |
| SB-217452 | Glaxo (GSK) | 93301-58-7 |  |
| SB-219383 | GlaxoSmithKline (GSK) | |  |
| SB-219825 | SmithKline Beecham (GSK) | |  |
| SB-219994 | SmithKline Beecham (GSK) | 177785-17-0 |  |
| SB-220646 | SmithKline Beecham | |  |
| SB-221284 | SmithKline Beecham (GSK) | |  |
| SB-221420 | SmithKline Beecham (GSK) | 177091-57-5 |  |
| SB-222200 | SmithKline Beecham (GSK) | 174635-69-9 |  |
| SB-223245 | SmithKline Beecham (GSK) | |  |
| SB-224289 | SmithKline Beecham (GSK) | |  |
| SB-225002 | SmithKline Beecham | 182498-32-4 |  |
| SB-226882 | SmithKline Beecham (GSK) | 180869-16-3 |  |
| SB-228357 | SmithKline Beecham (GSK) | 181629-93-6 |  |
| SB-234551 | SKB (GSK) | |  |
| SB-235375 | SmithKline Beecham (GSK) | 224961-34-6 |  |
| SB-236057 | SmithKline Beecham (GSK) | |  |
| SB-236923 | SmithKline Beecham | |  |
| SB-237376 | SmithKline Beecham (GSK) | 179258-59-4 |  |
| SB-238039 | SmithKline Beecham (GSK) | 186315-03-7 |  |
| SB-239063 | SmithKline Beecham (GSK) | 193551-21-2 |  |
| SB-242084 | SmithKline Beecham (GSK) | 181632-25-7 |  |
| SB-242235 | GlaxoSmithKline (GSK) | |  |
| SB-242784 | SmithKline Beecham (GSK) | 201929-00-2 |  |
| SB-243213 | SmithKline Beecham (GSK) | 200940-22-3 |  |
| SB-247083 | GlaxoSmithKline (GSK) | |  |
| SB-247386 | SmithKline (GSK) | 193535-63-6 |  |
| SB-247464 | SmithKline Beecham (GSK) | 212077-57-1 |  |
| SB-247853 | SmithKline Beecham (GSK) | 200711-10-0 |  |
| SB-249417 | GlaxoSmithKline (GSK) | 339545-61-8 | No Structure |
| SB-249553 | | | No Structure |
| SB-251023 | SmithKline (GSK) | 208842-48-2 |  |
| SB-253149 | GlaxoSmithKline (GSK) ; SYMPHAR | |  |
| SB-253514 | GlaxoSmithKline (GSK) | 292634-13-0 |  |
| SB-258510 | SmithKline Beecham (GSK) | |  |
| SB-258719 | GSK | |  |
| SB-258741 | SmithKline Beecham (GSK) | 201038-58-6 |  |
| SB-263831 | Smithkline Beecham | 220427-70-3 |  |
| SB-264128 | SmithKline Beecham (GSK) | 202585-70-4 |  |
| SB-265123 | SmithKline (GSK) | 206113-21-5 |  |
| SB-265610 | SmithKline Beecham (GSK) | 211096-49-0 |  |
| SB-268091 | SmithKline Beecham (GSK) | 224296-26-8 |  |
| SB-269652 | SmithKline (GSK) | 215802-15-6 |  |
| SB-269970 | GlaxoSmithKline (GSK) | |  |
| SB-269970-A | GSK | |  |
| SB-271046 | SmithKline Beecham (GSK) | |  |
| SB-272183 | SmithKline Beecham (GSK) | 216058-27-4 |  |
| SB-273005 | SmithKline Beecham (GSK) | 205678-31-5 |  |
| SB-277011 | SmithKline Beecham (GSK) | |  |
| SB-331750 | SmithKline Beecham (GSK) | 486442-96-0 |  |
| SB-332235 | Smithkline Beecham (GSK) | 276702-15-9 |  |
| SB-334867 | SmithKline Beecham (GSK) | 249889-64-3 (HCl) |  |
| SB-357114 | SmithKline Beecham (GSK) | 281217-45-6 |  |
| SB-357134 | SmithKline Beecham (GSK) | 219963-52-7 |  |
| SB-362916 | SmithKline Beecham (GSK) | 263896-10-2 |  |
| SB-366791 | GlaxoSmithKline (GSK) | |  |
| SB-380732 | Smithkline Beecham (GSK) | 374088-24-1 |  |
| SB-394725 | GlaxoSmithKline (GSK) | |  |
| SB-399885 | SmithKline Beecham (GSK) | 402713-80-8 |  |
| SB-400238 | GlaxoSmithKline (GSK) | |  |
| SB-414240 | GlaxoSmithKline (GSK) | |  |
| SB-414796 | Smithkline Beecham | |  |
| SB-415286 | SmithKline Beecham (GSK) | 264218-23-7 |  |
| SB-425076 | SmithKline Beecham (GSK) | 433336-82-4 |  |
| SB-431542 | SmithKline Beecham (GSK) | 301836-41-9 |  |
| SB-435495 | SmithKline Beecham (GSK) | 304694-39-1 |  |
| SB-436811 | Smithkline Beecham (GSK) | |  |
| SB-452533 | GlaxoSmithKline (GSK) | |  |
| SB-485232 | GlaxoSmithKline | 479198-61-3 | No Structure |
| SB-505124 | GlaxoSmithKline (GSK) | |  |
| SB-509 | Sangamo Biosciences | | No Structure |
| SB-525334 | Smithkline Beecham | |  |
| SB-590885 | SmithKlineBeecham | |  |
| SB-611812 | Smithkline Beecham | |  |
| SB-612111 | GlaxoSmithKline (GSK) | |  |
| SB-649868 | GlaxoSmithKline plc (GB) | |  |
| SB-649915 | GlaxoSmithKline (GSK) | |  |
| SB-656104A | SmithKline Beecham (GSK) | |  |
| SB-656933 | Smithkline Beecham | |  |
| SB-660618 | Smithkline Beecham (GSK) | |  |
| SB-663042 | GSK | |  |
| SB-674042 | GSK | |  |
| SB-691673 | GSK | |  |
| SB-699551 | GlaxoSmithKline | 791789-61-2 (dihydrochloride) |  |
| SB-705498 | Smithkline Beecham | |  |
| SB-706375 | Smithkline Beecham Corp. | |  |
| SB-710411 | SmithKline Beecham (GSK) | |  |
| SB-711845 | Smithkline Beecham (Glaxo) | |  |
| SB-714786 | Glaxo Group Ltd. | |  |
| SB-737050A | GlaxoSmithKline | |  |
| SB-743921 | Cytokinetics | |  |
| SB-747651-A | GlaxoSmithKline | |  |
| SB-750330 | Smithkline Beecham | |  |
| SB-756050 | | | No Structure |
| SB-756060 | | | No Structure |
| SB-782443 | GlaxoSmithKline plc (GB) | |  |
| SB-9002-1 | Spring Bank | |  |
| SB-9200 | Spring Bank Technologies, Inc. | | No Structure |
| SB-939 | S*Bio Pte Ltd. (Singapore) | 929016-96-6 |  |
| SB-RA-31012 | New York University | 204580-00-7 |  |
| SB-T-1103 | University of New York | |  |
| SB-T-1213 | University of New York | |  |
| SB-T-1214 | University of New York | |  |
| SB-T-1216 | University of New York | |  |
| SB-T-12851-3 | State University of New York (US) | |  |
| SBR-112897 | Shionogi | |  |
| SBR-113702 | Shionogi | |  |
| SC-002 | Taisho | 351032-06-9 |  |
| SC-1 | H3 Pharma (Debiopharm) | | No Structure |
| SC-101c | Scotia | |  |
| SC-113 | Nippon Hai Potsukusu | 135248-67-8 |  |
| SC-144 | University of Southern California (US) | |  |
| SC-2-71 | University of Virgina (US) | |  |
| SC-21 | University of Southern California (US) | |  |
| SC-23 | University of Southern California (US) | |  |
| SC-241 | DuPont Merck (BMS) | |  |
| SC-276 | Searle | |  |
| SC-37111 | Searle (Pharmacia) | 88444-07-9 |  |
| SC-38249 | Searle (Pharmacia) | 84750-41-4 |  |
| SC-409 | Searle & CO (Pfizer) | |  |
| SC-42867 | Searle (Pharmacia) | 102251-91-2 |  |
| SC-435 | Searle (Pharmacia) | |  |
| SC-44914 | Searle (Pharmacia) | 115812-74-3 |  |
| SC-44942A | Searle (Pharmacia) | 114370-67-1 |  |
| SC-45355 | Searle (Pharmacia) | 125793-76-2 |  |
| SC-46749 | Monsanto ; Searle | 123491-58-7 |  |
| SC-46944 | Searle (Pharmacia) | 120729-15-9 |  |
| SC-47643 | Monsanto (Pharmacia) | 126631-86-5 |  |
| SC-49518 | Searle (Pharmacia) | 146388-57-0 |  |
| SC-50605 | Searle (Pharmacia) | 138828-39-4 |  |
| SC-51146 | Searle (Pharmacia) | 141059-52-1 |  |
| SC-51316 | Merck & Co. ; Searle (Pharmacia) | 133690-62-7 |  |
| SC-514 | SmithKline Beecham (GSK) | |  |
| SC-51895 | Searle & Co | 141386-89-2 |  |
| SC-52012A | Searle (Pharmacia) | 145643-15-8 |  |
| SC-53116 | Searle (Pharmacia) | 141196-99-8 |  |
| SC-53606 | Searle | 151898-33-8 |  |
| SC-54750 | Searle | |  |
| SC-55099 | Searle (Pharmacia) | |  |
| SC-56525 | Searle & Co | 159005-44-4 |  |
| SC-56938 | Searle (Pharmacia) | 186901-93-9 |  |
| SC-57461 | Searle (Pharmacia) | 179022-08-3 |  |
| SC-57666 | Searle | |  |
| SC-58125 | Searle (Pharmacia) | 162054-19-5 |  |
| SC-599 | Institut Pasteur (France) ; Institut National de la Santé et de la Recherche Médicale (France) | | No Structure |
| SC-65811 | Searle (Pharmacia) | 188804-88-8 |  |
| SC-68448 | Searle (Pharmacia) | 188804-07-1 |  |
| SC-72115 | Searle | |  |
| SC-744 | Monsanto (Pharmacia) | 263264-10-4 |  |
| SC-795 | Monsanto (Pharmacia) | 315229-16-4 |  |
| SC-84250 | Pharmacia (Pfizer) | |  |
| SCH-00013 | Zenyaku Kogyo | 217963-18-3 |  |
| SCH-039641 | | | No Structure |
| SCH-1359113 | Schering Corp. (Merck & Co. Inc.) ; Pharmacopeia Drug Discovery Inc. (Ligand Pharmaceuticals Inc.) | |  |
| SCH-13929 | Schering Corp (Merck & Co) | 150519-70-3 |  |
| SCH-1473759 | Schering Corp. (Merck & Co. Inc.) | |  |
| SCH-203099 | Schering Corp (Merck & Co) | 245520-70-1 |  |
| SCH-206272 | Schering Corp (Merck & Co) | 226915-43-1 |  |
| SCH-211803 | Schering Corp (Merck & Co) | 331765-50-5 |  |
| SCH-221510 | Schering-Plough Corp. (US) | |  |
| SCH-23390 | Schering Corp (Merck & Co) | 87075-17-0 |  |
| SCH-336 | Schering-Plough (Merck & Co) | |  |
| SCH-350634 | Schering Corp (Merck & Co) | 306293-41-4 (free base) |  |
| SCH-351448 | Schering (Merck & Co) | 267006-37-1 |  |
| SCH-351591 | Darwin Discovery (Celltech) | 266995-28-2 |  |
| SCH-356036 | Schering-Plough (Merck & Co) | |  |
| SCH-37370 | Schering Corp (Merck & Co) | 117796-52-8 |  |
| SCH-388714 | Schering Corp (Merck & Co) | |  |
| SCH-391 | Schering Corp (Merck & Co) | |  |
| SCH-40120 | Schering Corp (Merck & Co) | 110545-79-4 |  |
| SCH-412348 | Schering Corp (Merck & Co) | |  |
| SCH-42495 | Schering Corp (Merck & Co) | 136511-43-8 |  |
| SCH-43478 | Schering Corp (Merck & Co) | 112446-99-8 |  |
| SCH-46642 | Schering Corp (Merck & Co) | 140460-80-6 |  |
| SCH-466457 | Schering (Merck & Co) | 339176-81-7 |  |
| SCH-46792 | Schering Corp (Merck & Co) | |  |
| SCH-47112 | Schering Corp (Merck & Co) | 197503-07-4 |  |
| SCH-47554 | Schering Corp (Merck & Co) | 150050-20-7 |  |
| SCH-486757 | Schering-Plough (Merck & Co.) | |  |
| SCH-48973 | Schering Corp (Merck & Co) | 146949-21-5 |  |
| SCH-49286 | Schering Corp (Merck & Co) | 188202-02-0 |  |
| SCH-50911 | Schering-Plough | |  |
| SCH-51048 | Schering Corp (Merck & Co) | |  |
| SCH-527123 | Schering-Plough (Merck & Co) | |  |
| SCH-58261 | Schering Corp (Merck & Co) | 160098-96-4 |  |
| SCH-58500 | | | No Structure |
| SCH-6 | Schering Corp (Merck & Co) | |  |
| SCH-602539 | Schering-Plough | | No Structure |
| SCH-62373 | Schering Plough | |  |
| SCH-643432 | Schering Plough | | No Structure |
| SCH-655842 | Schering Corp. (Merck & Co. Inc.) | |  |
| SCH-697243 | | | No Structure |
| SCH-697466 | Schering-Plough (Merck & Co) | |  |
| SCH-704742 | Schering-Plough (Merck & Co) | |  |
| SCH-709156 | Schering | |  |
| SCH-726245 | Schering Corp. (Merck & Co.) | |  |
| SCH-72788 | Schering Co | |  |
| SCH-745966 | Schering Corp (Merck & Co) | |  |
| SCH-747123 | Schering-Plough (Merck & Co) | |  |
| SCH-785532 | Schering Corp. (Merck & Co. Inc.) ; Pharmacopeia Drug Discovery Inc. (Ligand Pharmaceuticals Inc.) | |  |
| SCH-79687 | Schering Corp (Merck & Co) | |  |
| SCH-79797 | Schering Corp (Merck & Co) | 245520-69-8 |  |
| SCH-900222 | | | No Structure |
| SCH-900237 | | | No Structure |
| SCH-X | Schering Corp (Merck & Co) | |  |
| Schizandra chinensis extract | | 7432-28-2 ; 223748-53-6 |  |
| Schizandrin | | 7432-28-2 |  |
| Scopinast | Schwabe | 145574-90-9 |  |
| Scopolamine | | 51-34-3 |  |
| SCP-1 | Louisiana State University Medical Center Foundation | |  |
| SCP-123 | Foundation for the LSU Health | |  |
| SCY-635 | Rhone Poulenc Rorer (France) | |  |
| Scyllitol | Ellipsis Neurotherapeutics (Transition Therapeutics) | 488-59-5 |  |
| Scytonemin | University of California | 152075-98-4 |  |
| SCYX-7158 | Anacor Pharmaceuticals Inc. (US) | |  |
| SD-06 | Pharmacia (Pfizer) | |  |
| SD-118 | | | No Structure |
| SD-270 | Du Pont Merck | |  |
| SD-894 | DuPont Merck (BMS) | 183856-26-0 |  |
| SDK-110 | Shinetsu Chemical | 50965-53-2 |  |
| SDS-13 | Gilead Sciences | |  |
| SDX-308 | Salmedix | |  |
| SDZ-208912 | Sandoz (Novartis) | 101000-49-1 |  |
| SDZ-249-665 | Sandoz (Novartis) | 350485-04-0 |  |
| SDZ-267489 | Sandoz | |  |
| SDZ-62434 | Sandoz (Novartis) | 115621-81-3 |  |
| SDZ-64412 | Sandoz (Novartis) | 115621-84-6 |  |
| SDZ-CPI-975 | Sandoz (Novartis) | 157244-53-6 |  |
| SDZ-GLC-756 | Sandoz (Novartis) | 149328-94-9 |  |
| SDZ-LAP-977 | Sandoz (Novartis) | 150779-71-8 |  |
| SDZ-MRL-953 | Sandoz (Novartis) | 123136-61-8 |  |
| SDZ-NVI085 | Sandoz (Novartis) | 104195-17-7 |  |
| SDZ-PRI-053 | Sandoz (Novartis) | 164514-52-7 |  |
| SDZ-SER-082 | ADIR (Servier) | 141474-59-1 |  |
| SDZ-WAG-994 | Sandoz (Novartis) | 130714-47-5 |  |
| SE-063 | DuPont Merck (BMS) | 209804-41-1 |  |
| SEA-0400 | Taisho | 223104-29-8 |  |
| Seboren | SeBo GmbH (Germany) | | No Structure |
| Secalciferol | Teva | 55721-11-4 |  |
| Secbutabarbital | Eli Lilly | 125-40-6 |  |
| Secnidazole | Rhone-Poulenc (Aventis) | 3366-95-8 |  |
| Secobarbital | Eli Lilly | 76-73-3 |  |
| Secretin | Squibb (BMS) | 1393-25-5 |  |
| Secukinumab | Novartis | 875356-43-7 (H chain) ; 875356-44-8 (L chain) | No Structure |
| Securioside A | Kanegafuchi | 343239-53-2 |  |
| Sedanenolide | | 62006-39-7 |  |
| Sedaxane | Syngenta | 874967-67-6 |  |
| SEDI antibody | Amorfix Life Sciences Ltd. (Canada) ; University Health Network (Canada) | | No Structure |
| SEF-19 | Zenyaku Kogyo | 153429-67-5 |  |
| Seganserin | Janssen Pharmaceutica (Johnson & Johnson) | 87729-89-3 |  |
| Seglitide | Merck & Co. | 81377-02-8 |  |
| Selamectin | Pfizer | 165108-07-6 |  |
| Selank | Inst Molekuljarnoj Genetiki ; Nii Farmakologii | |  |
| Selectikine | Merck KGaA (Germany) | | No Structure |
| Selegiline | Chinoin | 14611-51-9 |  |
| Seletracetam | UCB Pharma | 357336-74-4 |  |
| Selexipag | Nippon Shinyaku | 475086-01-2 |  |
| Selfotel | Ciba-Geigy (Novartis) | 110347-85-8 |  |
| Seliciclib | Centre National de la Recherche Scientifique (CNRS, France) ; Institute of Experimental Botany (Czec | 186692-46-6 |  |
| Selodenoson | Discovery Therapeutics (Aderis) | 110299-05-3 |  |
| Selumetinib | Array BioPharma | 865610-79-3 ; 606143-52-6 ; 943332-08-9 (sulfate) |  |
| Semagacestat | Elan ; Eli Lilly | 425386-60-3 |  |
| Semaglutide | | 910463-68-2 |  |
| Semapimod | Picower Institute for Medical Research | 164301-51-3 |  |
| Sematilide | Schering AG | 101526-83-4 |  |
| Semax | Inst Molekuljarnoj Genetiki | 80714-61-0 |  |
| Semaxanib | Sugen | 186610-95-7 |  |
| Semduramicin | Pfizer | 113378-31-7 |  |
| Semotiadil | Santen | 116476-13-2 |  |
| Semparatide | Syntex (Roche) | 154906-40-8 |  |
| Semuloparin | Sanofi-Aventis | 9041-08-1 ; 9005-49-6 | No Structure |
| Semustine | Tokyo Tanabe (Mitsubishi) | 13909-09-6 |  |
| SEN-1269 | Senexis Ltd. (GB) | |  |
| Senazodan | Mitsubishi | 98326-32-0 |  |
| Senicapoc | Icagen | 289656-45-7 |  |
| Senktide | New England Medical Center Hospital | 106128-89-6 |  |
| Senlizumab | | 336128-48-4 | No Structure |
| Seocalcitol | Leo Pharmaceutical | 134404-52-7 |  |
| SEP-118843 | Sepracor | |  |
| SEP-127802 | Sepracor | |  |
| SEP-132433 | Sepracor | |  |
| SEP-132617 | Sepracor | |  |
| SEP-137199 | Sepracor | |  |
| SEP-147960 | Sepracor | |  |
| SEP-155342 | Sepracor | |  |
| SEP-155347 | Sepracor | |  |
| SEP-155409 | Sepracor | |  |
| SEP-156117 | Sepracor | |  |
| SEP-156131 | Sepracor | |  |
| SEP-160394 | Sepracor | |  |
| SEP-164741 | Sepracor | |  |
| SEP-164752 | Sepracor | |  |
| SEP-164759 | Sepracor | |  |
| SEP-164934 | Sepracor | |  |
| SEP-173333 | Sepracor | |  |
| SEP-173352 | Sepracor | |  |
| SEP-173360 | Sepracor | |  |
| SEP-173390 | Sepracor | |  |
| SEP-173391 | Sepracor | |  |
| SEP-173446 | Sepracor | |  |
| SEP-227900 | | | No Structure |
| SEP-228432 | | | No Structure |
| SEP-32196 | Sepracor | 218463-48-0 |  |
| Sepimostat | Torii | 103926-64-3 |  |
| Seprehvir | ARCH Development Corporation (US) | | No Structure |
| Sequifenadine | S. Ordjonikidze All-Union Research Chemical & Pharmaceutical Inst. (VNIChPhI) (USSR) | 57734-69-7 |  |
| SER-120 (Desmopressin) | Serenity Pharmaceuticals Corp. | 16679-58-6 | No Structure |
| [SER12]-HUMANIN | Curagen | |  |
| Seratrodast | Takeda | 112665-43-7 |  |
| Serdemetan | Janssen Pharmaceutica (Johnson & Johnson) (Belgium) | 881202-45-5 |  |
| Sergliflozin | Kissei Pharmaceutical | 408504-26-7 |  |
| Seridopidine | Carlsson Research | | No Structure |
| Serlopitant | Merck & Co., Inc. | 860642-69-9 |  |
| SerMe-ImmH | Industrial Research Ltd. (New Zealand) ; Albert Einstein College of Medicine (US) | |  |
| Sermorelin | Salk Inst. for Biological Studies | 86168-78-7 |  |
| Serofendic acid A | Eisai | 440644-69-9 |  |
| Serofendic acid B | Eisai | 440644-70-2 |  |
| Serrapeptase | | 37312-62-2 | No Structure |
| Sertaconazole | Ferrer | 99592-32-2 |  |
| Sertindole | Lundbeck | 106516-24-9 |  |
| Sertraline | Pfizer | 79617-96-2 |  |
| Sesamex | US Secretary of Agriculture | 51-14-9 |  |
| Sesamin | | 607-80-7 |  |
| Sesin | Union Carbide | 94-83-7 |  |
| Sessiloside | Fancl Corp. (Japan) | |  |
| Setastine | Egyt | 64294-95-7 |  |
| Sethoxydim | Nippon Soda | 74051-80-2 |  |
| Setileuton | Merck Frosst (Canada) | 910656-27-8 |  |
| Setiptiline | Mochida ; Akzo (Akzo Nobel) | 57262-94-9 |  |
| Sevelamer | Geltex Pharma | 52757-95-6 ; 845273-93-0 (carbonate) |  |
| Sevoflurane | Baxter | 28523-86-6 |  |
| SEW-2871 | Maybridge ; University of Arizona (USA) | 256414-75-2 |  |
| Sezolamide | Merck & Co. | 123308-22-5 |  |
| SF-1126 | Semafore Pharmaceuticals (US) | |  |
| SF-2822 | Meiji Seika | 454693-12-0 |  |
| SF-2856 | Meiji Seika Kaisha Ltd. (Japan) | |  |
| SF-303 | DuPont Merck (BMS) | 193003-99-5 |  |
| SFTI-1 | Health And Human Services Department (US) | |  |
| SG-2285 | Spirogen | |  |
| SG-2897 | Spirogen Ltd. (GB) | |  |
| SGI-110 | SuperGen Inc. (US) | |  |
| SGI-1776 | SuperGen Inc. | |  |
| SGN-30 | Seattle Genetics | | No Structure |
| SGN-70 | Seattle Genetics | | No Structure |
| SGS-742 | Ciba Geigy (Novartis) | 123690-78-8 ; 145537-81-1 |  |
| SGX-201 (Beclomethasone dipropionate) | Soligenix Inc. | 5534-09-8 |  |
| SGX-202 (Beclomethasone dipropionate) | Soligenix Inc. | 5534-09-8 |  |
| SGX-203 (Beclomethasone dipropionate) | DOR Biopharma Inc. (Soligenix Inc.) | 5534-09-8 |  |
| SGX-523 | SGX Pharmaceuticals | | No Structure |
| SH-306 | DuPont (BMS) | 257293-29-1 |  |
| SH-646 | DuPont (BMS) | 124669-21-2 |  |
| SH-7 | Chinese Academy of Sciences | |  |
| sh-uPAuPAR | University of Illinois | | No Structure |
| Shepherdin | Isituto Chimico Reconoscimento Molecolare (IT) ; Isituto Nazionale Studio e Cura Tumori (IT) ; Unive | |  |
| SHetA3 | Oklahoma State University ; University of Oklahoma | |  |
| SHetA4 | Oklahoma State University ; University of Oklahoma | |  |
| SHG-00650A | Nihon Schering K.K. | |  |
| SHR-1039 | Shanghai Hengrui Pharmaceutica (China) | |  |
| SHR-1040 | Shanghai Hengrui Pharmaceutica (China) | |  |
| SHU-555C | | | No Structure |
| SI-27 | Banyu | |  |
| SI-34 | Università degli Studi di Siena (Italy) | |  |
| SIB-1553A | Sibia (Merck & Co.) | 191611-76-4 |  |
| SIB-1757 | Sibia | |  |
| SIB-1893 | The Victoria University of Manchester | 7370-21-0 |  |
| Sibenadet | Fisons | 154189-24-9 |  |
| Sibiskoside | Iskra Industry Co. Ltd. (Japan) | |  |
| Sibrafiban | Roche | 172927-65-0 |  |
| Sibrotuzumab | Sloan Kettering Cancer Institute | 216669-97-5 | No Structure |
| Sibutramine | Boots (Abbott) | 106650-56-0 |  |
| SID-17450324 | Burnham Institute for Medical Research (US) ; Human Biomolecular Research Institute (US) | |  |
| Siduron | DuPont | 1982-49-6 |  |
| Sifalimumab | Medarex | 1006877-41-3 | No Structure |
| Sifuvirtide | Tianjin FusoGen Biotech (China) | |  |
| Silafluofen | Mitsui | 105024-66-6 |  |
| Sildenafil | Pfizer | 139755-83-2 |  |
| Sildenafil N-oxide | Solvay Pharmaceuticals BV (Netherlands) | |  |
| Silibinin | | 22888-70-6 |  |
| Silipide | Inverni della Beffa | 134499-06-2 |  |
| Silmitasertib | Cylene Pharmaceuticals Inc. (US) | 1009820-21-6 |  |
| Silodosin | Kissei ; Daiichi | 160970-54-7 |  |
| Silthiopham | Monsanto | 175217-20-6 |  |
| Siltuximab | Centocor | 541502-14-1 | No Structure |
| SIM-01 | CHU Nantes | |  |
| SIM-010603 | Simcere Pharmaceutical Group | | No Structure |
| SIM-0702 | Simcere Pharmaceutical Group | | No Structure |
| SIM-0710 | Simcere Pharmaceutical Group ; Shandong Xiansheng Maidejin Biological Pharmaceutical Co. Ltd. | | No Structure |
| SIM-071201 | Simcere Pharmaceutical Group | | No Structure |
| SIM-6080 | Zambon | 118790-68-4 |  |
| Simazine | Geigy (Novartis) | 122-34-9 |  |
| Simeconazole | Sankyo | 149508-90-7 |  |
| Simenepag | Allergan | 910562-15-1 |  |
| Simenepag isopropyl | Allergan (US) | 910562-13-9 |  |
| Simetride | Kyorin Pharma | 154-82-5 |  |
| Simetryne | Geigy (Novartis) | 1014-70-6 |  |
| Simfibrate | Yoshitomi | 14929-11-4 |  |
| Simotaxel | Florida State University | 791635-59-1 |  |
| Simvastatin | Merck & Co. | 79902-63-9 |  |
| Simvastatin & Niacin | Kos Pharmaceuticals (Abbott) | |  |
| Sinapultide | Scripps Research Institute | 138531-07-4 |  |
| Sincalide | Squibb | 25126-32-3 |  |
| Sinensetin | | 2306-27-6 |  |
| Sinitrodil | Italfarmaco | 143248-63-9 |  |
| Sinofuan (Fluorouracil) | Anhui Zhongren Science & Technology Co. Ltd. | 51-21-8 |  |
| Sintropium bromide | Valeas (Italy) | 79467-19-9 |  |
| Sipatrigine | Wellcome Foundation (GSK) | 130800-90-7 |  |
| Siplizumab | BioTransplant ; University of Louvain | 288392-69-8 | No Structure |
| Sipoglitazar | Takeda Pharmaceutical (Japan) | 342026-92-0 |  |
| Sipuleucel-T | Dendreon | | No Structure |
| Siramesine | Lundbeck | 147817-50-3 |  |
| Sirolimus | Ayerst Mckenna & Harrison (Wyeth) | 53123-88-9 |  |
| Sirolimus (Macusight) | Macusight | 53123-88-9 |  |
| SIRS peptide 1-21 | Research Development Foundation (US) | |  |
| Sisomicin | Schering Corp (Merck & Co) | 32385-11-8 |  |
| Sitafloxacin | Daiichi | 127254-12-0 |  |
| Sitagliptin | Merck & Co. | 486460-32-6 |  |
| Sitamaquine | US Army | 57695-04-2 |  |
| Sitaxsentan | Texas Biotechnology (Encysive Pharmaceuticals) | 184036-34-8 |  |
| Sitimagene ceradenovec | Ark Therapeutics | 898830-54-1 | No Structure |
| SIV239 DNA | Emory University (US) | | No Structure |
| SIV239 MVA | Emory University (US) | | No Structure |
| Sivelestat | Ono Pharmaceutical | 127373-66-4 ; 201677-61-4 (Sivelestat Sodium) |  |
| Sivifene | L. R. Morgan (Dekk-Tec) | 2675-35-6 |  |
| Sizofiran | Taito | 9050-67-3 |  |
| SJ-3366 | Samjin Pharmaceutical | 195720-26-4 |  |
| SJ-8026 | Samjin Pharmaceutical | |  |
| SJ-8029 | Samjin | |  |
| SJA-6017 | Senju Pharmaceutical | 190274-53-4 |  |
| SJA-7019 | Senju | |  |
| SJA-7029 | Senju | |  |
| SJG-136 | Portsmouth University | 232931-57-6 |  |
| SJG-720 | Spirogen Ltd. | |  |
| SJG-738 | Spirogen Ltd. | |  |
| SJL-01 | Japan Science and Technology Agency (Japan) ; Fujifilm Corp. | |  |
| SK-1899 | SK Chemicals | 247081-81-8 |  |
| SK-20 | Council of Scientific and Industrial Research (India) | |  |
| SK-29 | Council of Scientific and Industrial Research (India) | |  |
| SK-549 | DuPont Merck (BMS) | 231300-13-3 |  |
| SK-56 | Council of Scientific and Industrial Research (India) | |  |
| SK-7041 | SK Chemicals ; In2Gen | |  |
| SK-7068 | In2Gen ; SK Chemicals | |  |
| SKF-104078 | GlaxoSmithKline (GSK) | 110857-22-2 |  |
| SKF-104351 | SmithKline Beecham (GSK) | 111908-94-2 |  |
| SKF-104856 | GlaxoSmithKline (GSK) | 138194-10-2 |  |
| SKF-105685 | SmithKline Beecham (GSK) | 124796-27-6 |  |
| SKF-106203 | SmithKline Beecham (GSK) | 130465-17-7 |  |
| SKF-106333 | SmithKline Beecham (GSK) | |  |
| SKF-106760 | SmithKline Beckmann (GSK) | 126053-71-2 |  |
| SKF-107260 | SmithKline Beecham (GSK) | 136620-00-3 |  |
| SKF-108922 | SmithKline French (GSK) | 146794-68-5 |  |
| SKF-38393 | Organon | 67287-49-4 |  |
| SKF-74652 | GlaxoSmithKline (GSK) | 236119-24-7 |  |
| SKF-77434 | Schering Corp (Merck & Co) | 104422-04-0 |  |
| SKF-81297 | Servier | 71636-61-8 |  |
| SKF-82958 | GlaxoSmithKline (GSK) | 80751-65-1 |  |
| SKF-83959 | SmithKline French (GSK) | 80751-85-5 |  |
| SKF-86002 | SmithKline Beecham (GSK) | 72873-74-6 |  |
| SKF-87516 | GlaxoSmithKline (GSK) | 105016-30-6 |  |
| SKF-89626 | SmithKline (GSK) | 79599-96-5 |  |
| SKF-92374 | GlaxoSmithKline (GSK) | |  |
| SKF-94120 | SmithKline French (GSK) | 89541-55-9 |  |
| SKF-94901 | SmithKline French (GSK) | |  |
| SKF-95654 | SmithKline (GSK) | 112127-66-9 |  |
| SKF-96231 | SmithKline French (GSK) | |  |
| SKF-96365 | GlaxoSmithKline (GSK) | 130495-35-1 |  |
| SKF-R-105058 | SmithKline Beecham (GSK) | 130645-66-8 |  |
| SKF-R-106114 | SmithKline Beecham (GSK) | 125375-99-7 (HCl) |  |
| SKF-S-106203 | SmithKline Beecham (GSK) | 129047-98-9 |  |
| SKI-1695 | Sunkyong | |  |
| SKI-2054R | Sunkyong | 146687-25-4 |  |
| SKI-758 | Wyeth | |  |
| SKI-DV2-281 | Sloan Kettering Cancer Institute | |  |
| SKI-DV2-43 | Sloan Kettering Cancer Institute | |  |
| SKI-DV2-M016 | Sloan Kettering Cancer Institute | |  |
| SKP-1041 (Zaleplon) | SkyePharma plc | 151319-34-5 |  |
| SKP-1052 | | | No Structure |
| SKP-450 | Korea Research Inst. of Chemical Technology (KRICT) | 172489-10-0 |  |
| SKS-927 | Wyeth | |  |
| SKY-0402 (Bupivacaine) | DepoTech Corp. (Pacira Pharmaceuticals Inc.) | 2180-92-9 |  |
| SL-017 | | | No Structure |
| SL-11093 | Slil Biomedical | 306292-64-8 |  |
| SL-11144 | SLIL Biomedical | |  |
| SL-251131 | Sanofi-Synthelabo | |  |
| SL-327 | Virginia University | 305350-87-2 |  |
| SL-340026 | Synthelabo (Sanofi-Aventis) | 164523-00-6 |  |
| SL-340829 | Sanofi-Synthelabo | | No Structure |
| SL-591227 | Sanofi (Sanofi-Aventis) | 326488-60-2 |  |
| SL-650102 | Synthelabo (Sanofi-Aventis) | 186348-69-6 |  |
| SL-650477 | Synthelabo (Sanofi-Aventis) | 189439-36-9 |  |
| SL-651136 | Sanofi-Synthelabo | | No Structure |
| SL-651498 | Synthelabo (Sanofi-Aventis) | |  |
| SL-870495 | Synthelabo (Sanofi-Aventis) | 120560-67-3 |  |
| SL-880338 | Sanofi-Synthelabo | |  |
| SL-890591 | Synthelabo (Sanofi-Aventis) | 136605-48-6 |  |
| SLF-Benz-CR | University Leland Stanford Junior | |  |
| SLF-But-CR | University Leland Stanford Junior | |  |
| SLF-Gly-CR | University Leland Stanford Junior | |  |
| SLK-peptide | University of New York | |  |
| SLV-310 | Solvay ; Duphar (Solvay) | |  |
| SLV-313 piperazine N-oxide | Solvay Pharmaceuticals SA (Belgium) | |  |
| SLV-313 pyridine N-oxide | Solvay Pharmaceuticals SA (Belgium) | |  |
| SLV-317 | Solvay Pharmaceuticals GmbH | |  |
| SLV-326 | Solvay | |  |
| SLV-332 | Solvay Pharmaceuticals GmbH | |  |
| SLV-334 | | | No Structure |
| SLV-337 | | | No Structure |
| SLV-338 | | | No Structure |
| SLV-341 | | | No Structure |
| SLV-342 | Solvay Pharmaceuticals (Abbott Laboratories) | | No Structure |
| SLV-352 | Solvay Pharmaceuticals (Abbott Laboratories) | | No Structure |
| SLV-354 | | | No Structure |
| SLV-356 | Solvay Pharmaceuticals (Abbott Laboratories) | | No Structure |
| SLV-357 | Solvay Pharmaceuticals (Abbott Laboratories) | | No Structure |
| SLV-358 | Solvay Pharmaceuticals (Abbott Laboratories) | | No Structure |
| SLV-359 | Solvay Pharmaceuticals (Abbott Laboratories) | | No Structure |
| SLV-360 | Solvay Pharmaceuticals (Abbott Laboratories) | | No Structure |
| SLx-2101 | | |  |
| SLx-2119 | Surface Logix | |  |
| SLx-4090 | Surface Logix | |  |
| SM-10661 | Sumitomo Chemical | 120119-83-9 |  |
| SM-10888 | Sumitomo Chemical | 129297-21-8 |  |
| SM-11044 | Glaxo (GSK) | 142784-65-4 (HBr) |  |
| SM-1235 | University of Michigan (US) | |  |
| SM-1237 | University of Michigan (US) | |  |
| SM-1238 | University of Michigan (US) | |  |
| SM-12502 | Sumitomo Chemical | 119384-34-8 |  |
| SM-130686 | Sumitomo Chemical | 259667-25-9 |  |
| SM-131 | University of Michigan | |  |
| SM-164 | University of Michigan (US) | |  |
| SM-16896 | Sumitomo Chemical | 184224-59-7 |  |
| SM-19712 | Sumitomo Chemical | 194542-56-8 (Na) |  |
| SM-20220 | Sumitomo Chemical | 178052-68-1 |  |
| SM-20550 | Sumitomo Chemical | 178052-69-2 |  |
| SM-324405 | Sumitomo Pharma (Dainippon Sumitomo Pharma) | |  |
| SM-32504 | Sumitomo Chemical | |  |
| SM-337 | University of Michigan (US) | |  |
| SM-360320 | Japan Energy ; Sumitomo | |  |
| SM-406 | University of Michigan (US) | |  |
| SM-735 | Chinese Academy of Sciences ; Shanghai Institute Materia Medica (China) | |  |
| SM-8849 | Sumitomo Chemical | 113759-19-6 |  |
| SM-905 | Shanghai Institute of Materia Medica (China) | |  |
| SM-933 | Shanghai Institute of Materia Medica (China) | |  |
| Sm-p80-pcDNA3 | Texas Tech University Health Sciences Center (US) ; Veterans Affairs Health Care System (US) ; Labor | | No Structure |
| SMA-7 | Fukuoka University (Japan) ; University of Tokyo (Japan) | |  |
| SMA-pirarubicin | Kumamoto University | |  |
| SMA-ZnPP | Maeda Hiroshi (Japan) | | No Structure |
| Smallpox (Vaccinia) Vaccine, Live | Acambis | | No Structure |
| SMC-0001 | SEPS Pharma NV | | No Structure |
| SMC-0002 | SEPS Pharma NV | | No Structure |
| SMC-0003 | SEPS Pharma NV | | No Structure |
| SMC-0004 | SEPS Pharma NV | | No Structure |
| SMC-0005 | SEPS Pharma NV | | No Structure |
| SMC-0006 | SEPS Pharma NV | | No Structure |
| SMC-0101 | SEPS Pharma NV | | No Structure |
| SMC-0102 | SEPS Pharma NV | | No Structure |
| SMC-0103 | SEPS Pharma NV | | No Structure |
| SMC-0104 | SEPS Pharma NV | | No Structure |
| SMC-0105 | SEPS Pharma NV | | No Structure |
| SMC-0201 | SEPS Pharma NV | | No Structure |
| SMC-021 (Calcitonin) | Novartis ; Nordic Bioscience | |  |
| SMC-0301 | SEPS Pharma NV | | No Structure |
| SMC-0302 | SEPS Pharma NV | | No Structure |
| SMC-0303 | SEPS Pharma NV | | No Structure |
| SMC-0401 | SEPS Pharma NV | | No Structure |
| SMD-429 | Chugai Pharmaceutical Co. Ltd. (Japan) | |  |
| SMER-10 | Harvard College, US ; Dana Farber Cancer Institute Inc, US ; Cambridge University (GB) | |  |
| SMER-18 | Harvard College, US ; Dana Farber Cancer Institute Inc, US ; Cambridge University (GB) | |  |
| SMER-28 | Harvard College, US ; Dana Farber Cancer Institute Inc, US ; Cambridge University (GB) | 307538-42-7 |  |
| SMP-028 | Dainippon Sumitomo Pharma | | No Structure |
| SMP-105 | Dainippon Sumitomo Pharma Co. Ltd. (Japan) | | No Structure |
| SMP-300 | Sumitomo Chemical | 194869-85-7 (methanesulfonate) |  |
| SMP-534 | Sumitomo | |  |
| SMP-797 | Dainippon Sumitomo Pharma | 812697-02-2 | No Structure |
| SMP-986 | | | No Structure |
| SMT-14224 | Summit Corp. plc | | No Structure |
| SMT-15000 | Molecular nature Ltd. | |  |
| SMT-19969 | Summit Corp. plc | | No Structure |
| SMT-C2100 | Summit Corp. plc | | No Structure |
| SMT-D-002 | | | No Structure |
| SMT-D001 | Daniolabs Ltd. (Summit Corp. plc) | 4205-90-7 (Clodine) ; 1508-65-2 (Oxybutynin) |  |
| Sn 117M Pentetate | Brookhaven National Laboratory | |  |
| SN-1212 | Koronis Pharmaceuticals | |  |
| SN-27686 | Auckland Unicervices | |  |
| SN-28049 | La Trobe University (Australia) ; Auckland Uniservices Ltd. (New Zealand) | |  |
| SN-29751 | University of Auckland | |  |
| SN-30000 | Auckland Uniservices | |  |
| SN-38 | Yakult Honsha | 86639-52-3 |  |
| SN-429 | Dupont Merck Pharmaceutical | |  |
| SN-6 | Senju Pharma | |  |
| SNAP-37889 | Synaptic Pharmaceutical (Lundeck) | |  |
| SNAP-398299 | Synaptic Pharmaceutical (Lundeck) | |  |
| SNAP-6201 | Synaptic Pharmaceutical (Lundeck) | 252201-38-0 |  |
| SNAP-7915 | Synaptic | 218450-16-9 |  |
| SNAP-7941 | Synaptic Pharmaceutical (Lundeck) | |  |
| SNAP-94847 | Synaptic Pharmaceutical (Lundeck) | |  |
| SNC-162 | Delta Pharmaceuticals (US) | |  |
| SNC-80 | Delta Pharmaceuticals | |  |
| SNC-86 | Delta Pharmaceuticals (US) | |  |
| SNJ-1715 | Senju Pharmaceutical | |  |
| SNJ-1757 | Senju Pharmaceutical | |  |
| SNJ-1945 | Senju Pharmaceutical | |  |
| SNS-01 | Senesco Technologies Inc. (US) | | No Structure |
| SNS-032 | Bristol-Myers Squibb (BMS) | |  |
| SNS-314 | Sunesis Pharmaceuticals | |  |
| SNT-197958 | MyoContract (Santhera Pharmaceuticals) | |  |
| SNT-207707 | Santhera Pharmaceuticals AG (Switzerland) | |  |
| SNT-207858 | Santhera Pharmaceuticals AG (Switzerland) | |  |
| SNX-0723 | Serenex Inc. (Pfizer Inc.) | |  |
| SNX-101959 | Syntaxin Ltd. | | No Structure |
| SNX-185 | Neurex ; Pfizer | 149797-45-5 | No Structure |
| SNX-2112 | Serenex Inc. | |  |
| SNX-482 | Neurex | 203460-30-4 |  |
| SNX-5422 | Serenex Inc. | |  |
| SNX-912 | Elan | |  |
| Sobetirome | Regents of the University of California | 211110-63-3 |  |
| Soblidotin | Teikoku Hormone (Aska Pharmaceuticals) | 149606-27-9 |  |
| Sobrerol | Glidden | 498-71-5 |  |
| Sobuzoxane | Zenyaku Kogyo | 98631-95-9 |  |
| Sodelglitazar | Glaxo Group | 622402-24-8 ; 447406-78-2 |  |
| Sodium ascorbyl monophosphate | Generic | 66170-10-3 |  |
| Sodium aurothiomalate | Rhone-Poulenc (Aventis) | 12244-57-4 |  |
| Sodium borocaptate | Shionogi | 103831-41-0 |  |
| Sodium Copper Chlorophyllin | Arthur William Middleton | 28302-36-5 |  |
| Sodium dibunate | Hoffmann La Roche (Roche) | 14992-59-7 |  |
| Sodium Dichloroacetate | Cypros (Questcor Pharmaceuticals) | 2156-56-1 |  |
| Sodium feredetate | | 15708-41-5 |  |
| Sodium ferric gluconate complex | Cromaceutical Advanced Technologies | 34089-81-1 | No Structure |
| Sodium nitroprusside | | 14402-89-2 (anhydrous ) ; 13755-38-9 (dihydrate) |  |
| Sodium oxybate | L'Equilibre Biologique | 502-85-2 |  |
| Sodium Phenylacetate | | 114-70-5 |  |
| Sodium Phenylbutyrate | Ucyclyd Pharma | 1716-12-7 |  |
| Sodium picosulfate | De Angeli | 10040-45-6 |  |
| Sodium pyruvate | Cellular Sciences (EmphyCorp) | 113-24-6 |  |
| Sodium stibocaptate | Roche | 3064-61-7 |  |
| Sodium tungstate | Bayer | 13472-45-2 |  |
| Sofalcone | Taisho | 64506-49-6 |  |
| Sofigatran | Mitsubishi Chemicals Corp,(US) | 187602-11-5 |  |
| Sofinicline | Abbott Laboratories | 799279-80-4 ; 876170-44-4 (benzenesulfonate salt) |  |
| Sograzepide | Yamanouchi (Astellas) | 155488-25-8 |  |
| SOL-02 | Genfit ; Solvay Pharmaceuticals (Abbott Laboratories) | | No Structure |
| Solabegron | Glaxo Wellcome (GSK) | 451470-34-1 (HCl) |  |
| Solanezumab | University of Washington | 955085-14-0 | No Structure |
| Solifenacin | Yamanouchi (Astellas) | 242478-37-1 |  |
| Solifenacin & Tamsulosin | Astellas Pharma Inc. (Japan) | 242478-37-1 (Solifenacin) ; 106133-20-4 (Tamsulosin) |  |
| Solimastat | British Biotech | 226072-63-5 |  |
| Solithromycin | Optimer Pharmaceuticals Inc. (US) | 760981-83-7 |  |
| Solulin | Schering AG | | No Structure |
| Somatorelin | Theratechnologies | 83930-13-6 |  |
| Somatostatin | Genentech | 38916-34-6 ; 51110-01-1 |  |
| Somatropin | Merck & Co | 12629-01-5 |  |
| Sonedenoson | King Pharmaceuticals | 131865-88-8 |  |
| Sonepiprazole | Upjohn (Pharmacia) | 170858-33-0 |  |
| Soquinolol | Knoll (Abbott) | 61563-18-6 |  |
| Sorafenib | Bayer | 284461-73-0 ; 475207-59-1 (tosylate) |  |
| Soraprazan | Altana (Nycomed) | 261944-46-1 |  |
| Sorbic acid | | 110-44-1 |  |
| Sorbicillactone A | Bayern Freistaat ; University of Johannes Gutenberg | |  |
| Sorbinicate | Guidotti | 6184-06-1 |  |
| Soretolide | Nova Pharm | 130403-08-6 |  |
| SORI-6238 | National Institutes of Health | |  |
| SORI-9409 | Southern Research Inst. | 248273-61-2 |  |
| Sorivudine | Yamasa | 77181-69-2 |  |
| Sotalol | Bristol Myers Squibb (BMS) | 3930-20-9 |  |
| Sotatercept | Acceleron Pharma Inc. (US) | 1001080-50-7 | No Structure |
| Sotirimod | 3M Pharmaceuticals | 227318-75-4 |  |
| Sotrastaurin | Novartis | 425637-18-9 ; 908351-31-5 (acetate salt) |  |
| SOU-001 | Mochida | 77636-92-1 |  |
| Soy isoflavones | Archer Daniels Midland (US) | |  |
| Soybean oil | Nutricia Inc. (US) | 8001-22-7 ; 84776-91-0 | No Structure |
| Sozoiodol | | 554-71-2 |  |
| SP-003 | Georgetown University ; Samaritan Pharmaceuticals | |  |
| SP-004 | Samaritan Pharmaceuticals ; Georgetown University | |  |
| SP-004m | Samaritan Pharmaceuticals ; Georgetown University | |  |
| SP-008 | Samaritan Pharmaceuticals ; Georgetown University | |  |
| SP-01A | Samaritan Pharma | | No Structure |
| SP-10 - China Medical University | China Medical University (Taiwan) | |  |
| SP-10 - Samaritan | Samaritan Pharmaceuticals; Georgetown Univeristy | |  |
| SP-100030 | Signal Pharmaceuticals | |  |
| SP-1093V | Supratek ; McGill University | |  |
| SP-50 | Isis Innovation Ltd. | |  |
| SP-500263 | Signal Pharmaceuticals (Celgene) | |  |
| SP-600125 | Signal Pharmaceuticals (Celgene) | |  |
| SP-727 | Sunesis | |  |
| SP-8-11 | Santen Pharmaceutical | |  |
| SP-CL16(6-28) | Tokyo Tanabe (Mitsubishi) | 170984-50-6 |  |
| SP-III-5Cl | Rega Institute for Medical Research | |  |
| SPA-310 | Sbarro Health Research Organization Inc. (US) | |  |
| SPA-S-843 | SPA (Societa Prodotti Antbiotici) | 202748-83-2 |  |
| Spaglumic acid | Laboratoires Thea | 4910-46-7 |  |
| Sparfloxacin | Dainippon Pharmaceutical | 110871-86-8 |  |
| Sparfosic acid | R. J. Schultz, F. W. Starks | 51321-79-0 |  |
| SPC-2968 | Santaris Pharma | | No Structure |
| SPC-2996 | Santaris Pharma AS (Denmark) | | No Structure |
| SPC-3649 | Santaris (Denmark) | | No Structure |
| SPC-839 | Signal Pharmaceuticals (Celgene) | |  |
| SPC-I | Madurai Medical College ; Rega Institute for Medical Research | |  |
| SPCP | University of Arizona ; Sun Health Research Institute (US) | |  |
| SPD-424 | Hydro Med Sciences (US) | 428438-54-4 | No Structure |
| SPD-465 (Amphetamine & Dexamphetamine) | Shire Pharmaceutical Development | |  |
| SPD-480 (Mesalazine) | Giuliani SPA | 89-57-6 |  |
| SPD-535 | | | No Structure |
| Spectinomycin | Upjohn (Pharmacia) | 1695-77-8 |  |
| SPF-18845-1 | Sumitomo Pharmaceutical | |  |
| SPf-66 | Department of International Development ; Bogota University | 428512-48-5 |  |
| SPH-1286 | Sanochemia | 273930-29-3 |  |
| Sphingosine phosphorylcholine | | 10216-23-6 |  |
| Sphingosine-1-phosphate | The Membrane Institute ; Oncomembrane | 429969-98-2 |  |
| SPI-0023 | Signature Pharmaceuticals LLC (US) | |  |
| SPI-014 | Satori Pharmaceuticals | |  |
| SPI-1620 | Spectrum Pharmaceuticals | 142569-99-1 |  |
| SPI-205 (Leteprinim) | Spectrum Pharmaceuticals Inc. | 138117-50-7 |  |
| SPI-256 | Sequoia Pharmaceuticals Inc. (US) | |  |
| SPI-3005 (Ebselen) | Sound Pharmaceuticals | 60940-34-3 |  |
| SPI-452 | | | No Structure |
| Spiclomazine | Yoshitomi | 24527-27-3 |  |
| SPIKET-P1 | Wayne Hughes Institute (Parker Hughes Institute) | |  |
| Spinetoram | Eli Lilly | 187166-40-1 + 187166-15-0 |  |
| Spinosad | Eli Lilly | 131929-60-7 (A) ; 131929-63-0 (D) |  |
| Spinosulfate A | Aventis Pharma GMBH | |  |
| Spinosulfate B | Aventis Pharma GMBH | |  |
| Spiperone | Janssen Pharmaceutica (Johnson & Johnson) | 749-02-0 |  |
| Spiramycin | Rhone-Poulenc (Aventis) | 8025-81-8 |  |
| Spirapril | Schering Corp (Merck & Co) | 83647-97-6 |  |
| Spiraprilat | Schering Corp (Merck & Co) | 83602-05-5 |  |
| Spirodiclofen | Bayer | 148477-71-8 |  |
| Spiroglumide | RottaPharm/Madeus | 137795-35-8 |  |
| Spiromesifen | Bayer | 283594-90-1 |  |
| Spiromustine | US Government | 56605-16-4 |  |
| Spironolactone | Searle (Pharmacia) | 52-01-7 |  |
| Spirotetramat | Bayer | 203313-25-1 |  |
| Spiroxamine | Bayer | 118134-30-8 |  |
| Spiruchostatin A | Yamanouchi Pharma Co. Ltd. (Astellas Pharma Inc. ) | |  |
| Spisulosine 285 | University of Illinois | 196497-48-0 |  |
| Spizofurone | Takeda | 72492-12-7 |  |
| SPL-7013 | Starpharma | |  |
| SPM-10011 | Schwarz Pharma AG | |  |
| SPM-6868 | Schwarz Pharma AG | |  |
| SPMG | Ocean University of China (China) | |  |
| SPN-538 (Topiramate) | Supernus Pharmaceuticals Inc. | 97240-79-4 |  |
| SPN-802 | | | No Structure |
| SPN-803 | | | No Structure |
| SPN-804 (Oxcarbazepine) | Supernus Pharmaceuticals Inc. | 28721-07-5 |  |
| SPN-805 | | | No Structure |
| SPN-808 | | | No Structure |
| SPN-809 | Supernus Pharmaceuticals Inc. | | No Structure |
| SPN-810 | | | No Structure |
| SPN-811 | | | No Structure |
| SPN-812 | | | No Structure |
| Spongistatin 1 | Arizona State University | 149715-96-8 |  |
| SPP-1148 | | | No Structure |
| SPP-1234 | Speedel Pharmaceuticals (Novartis) | | No Structure |
| SPP-2745 | Speedel Pharmaceuticals (Novartis) | | No Structure |
| SPP-635 | Roche | | No Structure |
| SPP-676 | Speedel Pharma AG | | No Structure |
| SPPARgammaM5 | Merck & Co. Inc. (US) | |  |
| SPR-210 | Sapporo Breweries | 143162-65-6 |  |
| SPRL-123529 | Suntory Pharmaceutical | |  |
| SQ-109 | US Department of Health ; Sequella | |  |
| SQ-28133 | Bioprojet (GSK) | 80970-04-3 |  |
| SQ-28603 | Roussel-Uclaf (Aventis) | 100845-83-8 |  |
| SQ-29548 | Bristol Myers (BMS) | 98299-61-7 |  |
| SQ-31486 | Squibb (BMS) | 107967-38-4 (HCl) |  |
| SQ-33351 | Squibb (BMS) | 133963-43-6 |  |
| SQ-33537 | Squibb (BMS) | 128573-92-2 |  |
| SQ-33600 | Squibb (BMS) | 119901-68-7 |  |
| SQ-33961 | Squibb (BMS) | 139067-88-2 |  |
| SQ-609 | Sequella, Inc. | |  |
| SQ-67454 | | |  |
| SQ-775 | Sequella (USA) | |  |
| SQ-786 | Sequella (USA) | |  |
| SQGem | University of Paris Sud ; CNRS (Centre National de la Recherche Scientifique) | |  |
| SQN-400 | Efamol | |  |
| Squalamine | Magainin (Genaera) | 148717-90-2 |  |
| Squalene | Tadeval | 111-02-4 |  |
| Squalestatin 1 | Glaxo (GSK) | 142561-96-4 |  |
| SR-10204 | Stanford Research Inst. | |  |
| SR-10208 | Stanford Research Inst. | |  |
| SR-121566 | Sanofi (Sanofi-Aventis) | 180144-61-0 |  |
| SR-121787 | Sanofi (Sanofi-Aventis) | |  |
| SR-123781 | Akzo Nobel ; Sanofi-Synthelabo (Sanofi-Aventis) | | No Structure |
| SR-12813 | Symphar | 126411-39-0 |  |
| SR-13676 | SRI International (US) | |  |
| SR-142948 | Sanofi (Sanofi-Aventis) | 184162-64-9 |  |
| SR-144190 | Sanofi (Sanofi-Aventis) | 201152-86-5 |  |
| SR-144528 | Sanofi (Sanofi-Aventis) | 192703-06-3 |  |
| SR-146131 | Sanofi (Sanofi-Aventis) | 221671-61-0 |  |
| SR-16157 | Stanford Research Institute International | |  |
| SR-16388 | SRI International | |  |
| SR-271425 | Winthrop (Sanofi-Aventis) | |  |
| SR-31742 | Sanofi (Sanofi-Aventis) | 139593-05-8 |  |
| SR-31747 | Sanofi (Sanofi-Aventis) | 132173-06-9 |  |
| SR-374 | DuPont | |  |
| SR-3745A | Stanford Research Inst. | |  |
| SR-3784 | Southern Research Inst. | 198267-74-2 |  |
| SR-3785 | Southern Research Inst. | 198267-75-3 |  |
| SR-45023a | Symphar | 126411-13-0 |  |
| SR-46559 | Sanofi (Sanofi-Aventis) | 137733-33-6 |  |
| SR-57227 | Sanofi (Sanofi-Aventis) | 77145-51-8 |  |
| SR-7 | Pittsburgh University | 328005-67-0 |  |
| SRA-444 | | | No Structure |
| Src40-49Tat | The Hospital for Sick Children (Canada) | |  |
| SRD-174 | Serentis Ltd. | | No Structure |
| SRD-285 | Serentis Ltd. | | No Structure |
| SRD-326 | Serentis Ltd. | | No Structure |
| SRD-441 | Surface Therapeutics Ltd. (Serentis Ltd.) | | No Structure |
| SRI-13654 | SRI | |  |
| SRI-20094 | Southern Research Institute | 309270-55-1 |  |
| SRI-21009 | Southern Research Institute (US) | |  |
| SRI-2931 | Southern Research Institute ; UAB Research Foundation | |  |
| SRI-62834 | Sandoz (Novartis) | 113201-37-9 |  |
| SRI-7055 | Southern Research Inst. | |  |
| SRL-172 | | | No Structure |
| SRN-002 (Dihydroergocryptine) | Polichem | 25447-66-9 |  |
| SRP-312t | Stanford Rook Ltd. | |  |
| SRR-SB3 | Rega Institute , Mauritius University | |  |
| SRT-1460 | Sirtris Pharmaceuticals Inc. (GSK) | |  |
| SRT-1720 | Sirtris Pharmaceuticals Inc. (US) | 925434-55-5 |  |
| SRT-2183 | Sirtris Pharmaceuticals Inc. (GSK) | |  |
| SRT-2379 | Sirtris Pharmaceuticals Inc. (GlaxoSmithKline plc) | | No Structure |
| SRT-3025 | | | No Structure |
| SRT-501 (Resveratrol) | Sirtris Pharmaceuticals (GSK) | |  |
| SRX-246 | Azevan Pharmaceuticals | |  |
| SRX-251 | Azevan Pharmaceuticals | |  |
| SS-212 | SS Pharmaceutical | 143540-37-8 |  |
| SS-31 | Cornell Research Foundation | |  |
| SS-750 | SS Pharmaceutical | 229153-17-7 |  |
| SS1P | US Health (NIH) | | No Structure |
| SSA-426 | Wyeth Corp. (US) | |  |
| SSF-109 | Shionogi | 129856-32-9 |  |
| SSI-121 | Shionogi | 108307-07-9 |  |
| SSJ-183 | Hoshi University (Japan) ; Synstar Japan Co. Ltd. ; Schweizerisches Tropeninstitut (Switzerland) | |  |
| SSJ-206 | Japan Science and Technology Agency (Japan) ; Tohoku University (Japan) ; Fujifilm Corp. (Japan) | |  |
| SSR-101010 | Sanofi-Aventis | | No Structure |
| SSR-103800 | Sanofi-Aventis | | No Structure |
| SSR-106462 | | | No Structure |
| SSR-125329A | Sanofi-Synthelabo (Sanofi-Aventis) | 313510-43-9 |  |
| SSR-125543A | Sanofi-Synthelabo (Sanofi-Aventis) | |  |
| SSR-126768A | Sanofi-Synthelabo (Sanofi-Aventis) | |  |
| SSR-128429 | Sanofi-Aventis ; Akzo-Nobel | | No Structure |
| SSR-146977 | Sanofi-Synthelabo (Sanofi-Aventis) | |  |
| SSR-162369 | Sanofi-Synthelabo (Sanofi-Aventis) | | No Structure |
| SSR-180575 | Sanofi-Synthelabo (Sanofi-Aventis) | |  |
| SSR-180711A | Sanofi-Aventis | |  |
| SSR-181507 | Sanofi-Synthelabo (Sanofi-Aventis) | |  |
| SSR-182289 | Sanofi-Synthelabo (Sanofi-Aventis) | |  |
| SSR-240612 | Sanofi-Synthelabo (Sanofi-Aventis) | |  |
| SSR-244738 | Sanofi Aventis | | No Structure |
| SSR-250411 | Sanofi-Synthelabo (Sanofi-Aventis) | | No Structure |
| SSR-411298 | | | No Structure |
| SSR-500400 | Sanofi-aventis (France) | |  |
| SSR-504734 | Sanofi-Synthelabo | |  |
| SSR-97225 | Sanofi-Synthelabo (Sanofi-Aventis) | | No Structure |
| SST-0001 | Sigma-Tau Industrie Farmaceutiche Riunite SpA | | No Structure |
| SSTN82-130 | University of Wisconsin-Madison (US) | | No Structure |
| SSY-726 | SS Pharmaceutical | 136067-87-3 |  |
| ST-1214 | Sigma-Tau | 211236-07-6 |  |
| ST-1420 | Sigma-Tau | |  |
| ST-1469 | Sigma-Tau | |  |
| ST-1535 | Sigma Tau | |  |
| ST-1537 | Sigma Tau | |  |
| ST-1616 | Istituto Nazionale Per Lo Studio E La Cura dei Tumori ; Sigma Tau | |  |
| ST-1702 | Sigma-Tau | |  |
| ST-1859 | Sigma-Tau | |  |
| ST-193 | SIGA Technologies | |  |
| ST-1936 | Sigma-Tau Industrie Farmaceutiche Riunite SpA (Italy) | |  |
| ST-1998 | Sigma Tau | |  |
| ST-2097 | Sigma Tau | |  |
| ST-2143 | Istituto Nazionale Per Lo Studio E La Cura dei Tumori ; Sigma Tau | |  |
| ST-2145 | Sigma Tau | |  |
| ST-2303 | Sigma Tau | |  |
| ST-2370 | Sigma-Tau | |  |
| ST-2449 | Sigma Tau | |  |
| ST-2472 | Sigma Tau | |  |
| ST-2552 | Sigma-Tau | |  |
| ST-2825 | Sigma Tau | |  |
| ST-2837 | Sigma Tau Industrie Farmaceutiche Riunite (Italy) | |  |
| ST-294 | SIGA Technologies | |  |
| ST-2966 | Sigma Tau | |  |
| ST-2969 | Sigma Tau | |  |
| ST-2971 | Sigma Tau | |  |
| ST-2996 | Sigma Tau | |  |
| ST-2998 | Sigma Tau | |  |
| ST-3036 | Sigma Tau | |  |
| ST-3038 | Sigma Tau | |  |
| ST-3040 | Sigma Tau | |  |
| ST-37 | SIGA Technologies | |  |
| ST-3932 | Sigma-Tau Industrie Farmaceutiche Riunite SpA | |  |
| ST-4020 | Sigma-Tau Industrie Farmaceutiche Riunite SpA | |  |
| ST-408306 | Siga Technologies Inc. (US) | |  |
| ST-4206 | Sigma-Tau Industrie Farmaceutiche Riunite SpA | |  |
| ST-570 | Sigma | 140914-56-3 |  |
| ST-6 | Sumitomo Chemical | 148556-91-6 |  |
| ST-600161 | Siga Technologies Inc. (US) | |  |
| ST-602 (Fenretinide) | Sytera (Sirion Therapeutics) | |  |
| ST-681 | Geigy (Novartis) | 74387-73-8 |  |
| ST-743 | Sigma-Tau | 154550-71-7 |  |
| ST-789 | CO Pharma | 104317-64-8 |  |
| ST-9802 | Syntarga | |  |
| ST-9905 | Syntarga | |  |
| STA-21 | US National Cancer Institute | |  |
| STA-9090 | | | No Structure |
| Stacofylline | ADIR (Servier) | 98833-92-2 |  |
| Stalevo (Carbidopa mixture with Entacapone and Levodopa) | Orion Corporation, Finland) | 745835-09-0 |  |
| Stampidine | Parker Hughes Institute | 217178-62-6 |  |
| Stamulumab | Wyeth ; Cambridge Antibody Technology (CAT) | 705287-60-1 | No Structure |
| Stannsoporfin | Rockefeller University | 106344-20-1 |  |
| Stanozolol | Sterling Drug (Sanofi-Aventis) | 10418-03-8 |  |
| StarGen | Oxford BioMedica Ltd. | | No Structure |
| Staurosporine | Bristol-Myers Squibb (BMS) | 62996-74-1 |  |
| Stavudine | Bristol Myers (BMS) ; Yale University | 3056-17-5 |  |
| Stepronin | Mediolanum Farmaceutici | 72324-18-6 |  |
| Sterenin A | Daiichi Sankyo Co. Ltd. (Japan) | |  |
| Sterenin B | Daiichi Sankyo Co. Ltd. (Japan) | |  |
| Sterenin C | Daiichi Sankyo Co. Ltd. (Japan) | |  |
| Sterenin D | Daiichi Sankyo Co. Ltd. (Japan) | |  |
| STF-62247 | Stanford University (US) | |  |
| STG-28 | Ohio State University | |  |
| Stibogluconic acid | The Cleveland Clinic Foundation | 16037-91-5 (Sodium stibogluconate) |  |
| Stiripentol | Unicler | 49763-96-4 |  |
| STP-206 | Sigma-Tau Industrie Farmaceutiche Riunite SpA ; Danisco AS | | No Structure |
| Streptolipin | Council of Scientific and Industrial Research (India) | |  |
| Streptomycin | Rutgers | 57-92-1 |  |
| Streptorix (TM) | GlaxoSmithKline (GSK) | | No Structure |
| Streptozocin | Upjohn (Pharmacia) | 18883-66-4 ; 72521-89-2 |  |
| Stressin1-A | The Salk Institute for Biological Studies (US) | |  |
| Strontium malonate | Osteologix (Denmark) | 183133-72-4 |  |
| Strontium-89 | | | No Structure |
| STX-0119 | Pharma IP General Incorporated Association (Japan) ; Pharma Design Inc. ; Shizuoka Prefecture (Japan | |  |
| STX-100 | | | No Structure |
| STX-1023 | Sterix (Ipsen) | |  |
| STX-1040 | Sterix | |  |
| STX-1375 | Sterix Ltd. (Great Britain) | |  |
| STX-1535 | Sterix Ltd. (Great Britain) | |  |
| STX-1614 | Sterix Ltd. | |  |
| STX-1616 | Sterix Ltd. | |  |
| STX-1623 | Sterix Ltd. | |  |
| STX-1632 | Sterix Ltd. (Great Britain) | |  |
| STX-1854 | Sterix Ltd. (GB) | |  |
| STX-1938 | Sterix Ltd. (GB) | |  |
| STX-1979 | Sterix Ltd. (GB) | |  |
| STX-209 (Arbaclofen) | Seaside Therapeutics | 69308-37-8 |  |
| STX-213 | Sterix | |  |
| STX-237 | Sterix | |  |
| STX-243 | Sterix | |  |
| STX-2484 | Sterix Ltd. (GB) | |  |
| STX-289 | Sterix Ltd. (GB) | |  |
| STX-597 | Sterix | |  |
| STX-640 | Sterix (Ipsen SA) (France) | |  |
| STX-641 | Sterix (Ipsen SA) (France) | |  |
| STX-681 | Sterix | |  |
| Styramate | Armour | 94-35-9 |  |
| SU-014813 | Sugen (Pfizer) | |  |
| SU-0879 | Yissum Research Development | 148741-30-4 |  |
| SU-10944 | Sugen | |  |
| SU-11274 | Pfizer | |  |
| SU-1433 | Sugen | |  |
| SU-1498 | Yissum Research Development | 168835-82-3 |  |
| SU-154 | Digital Biotech | |  |
| SU-20A | University Des Saarlandes | |  |
| SU-4984 | Sugen | 186610-89-9 |  |
| SU-5271 | Zeneca (AstraZeneca) | 153436-54-5 |  |
| SU-5402 | Sugen | 215543-92-3 |  |
| SU-740 | Taisho | 134336-72-4 |  |
| SU-9516 | Sugen | 377090-84-1 |  |
| SU-9518 | Sugen (Pfizer) | |  |
| Subathizone | Schenley | 121-55-1 |  |
| (-)-Subersic acid | Galileo | |  |
| Sublancin 168 | Maryland University | 207410-26-2 | No Structure |
| Succinobucol | AtheroGenics ; Salsbury | 216167-82-7 |  |
| Succinylsulfathiazole | Merck Sharp & Dohme (Merck & Co) | 116-43-8 |  |
| Suclofenide | Geistlich | 30279-49-3 |  |
| Sucralfate | Chugai (Roche) | 54182-58-0 |  |
| Sucralose | Tate & Lyle ; University of London | 56038-13-2 |  |
| Sudismase | Polymun | 110294-55-8 |  |
| Sudoterb | Lupin (India) | |  |
| Sufentanil | Janssen Pharmaceutica (Johnson & Johnson) | 56030-54-7 |  |
| Sufugolix | Takeda | 308831-61-0 |  |
| Sugammadex | Akzo Nobel | 343306-71-8 |  |
| Sulamserod | Syntex (Roche) | 184159-40-8 ; 219757-90-1 |  |
| Sulbactam | Pfizer | 68373-14-8 |  |
| Sulbenicillin | Takeda | 34779-28-7 |  |
| Sulbenox | American Cyanamid (Wyeth) | 58095-31-1 |  |
| Sulbentine | Hermal | 350-12-9 |  |
| Sulbutiamine | Servier | 3286-46-2 |  |
| Sulcofuron | Ciba-Geigy (Novartis) | 24019-05-4 |  |
| Sulconazole | Syntex (Roche) | 61318-90-9 |  |
| Sulcotrione | ICI (Syngenta) | 99105-77-8 |  |
| Sulfabenzamide | Schering AG (Bayer) | 127-71-9 |  |
| Sulfabromomethazine | | 116-45-0 |  |
| Sulfacarbamide | Geigy (Novartis) | 547-44-4 |  |
| Sulfacetamide | Schering Corp (Merck & Co) | 144-80-9 |  |
| Sulfachlorpyridazine | American Cyanamid (Wyeth) | 80-32-0 |  |
| Sulfaclozine | Ciba-Geigy (Novartis) | 27890-59-1 |  |
| Sulfacytine | Parke, Davis (Pfizer) | 17784-12-2 |  |
| Sulfadiazine | Sharp & Dohme (Merck & Co.) | 68-35-9 ; 22199-08-2 (silver) |  |
| Sulfadicramide | Ciba-Geigy (Novartis) | 115-68-4 |  |
| Sulfadimethoxine | Linz | 122-11-2 |  |
| Sulfadimidine | Ward, Blenkinsop | 57-68-1 |  |
| Sulfadoxine | Hoffmann La Roche (Roche) | 2447-57-6 |  |
| Sulfaethidole | American Cyanamid (Wyeth) | 94-19-9 |  |
| Sulfaethoxypyridazine | American Cyanamid (Wyeth) | 963-14-4 |  |
| Sulfafurazole | Hoffmann La Roche (Roche) | 127-69-5 |  |
| Sulfaguanidine | American Cyanamid (Wyeth) | 57-67-0 |  |
| Sulfaguanole | Nordmark | 27031-08-9 |  |
| Sulfalene | Farmitalia Carlo Erba (Pharmacia) | 152-47-6 |  |
| Sulfaloxic acid | | 14376-16-0 |  |
| Sulfamazone | Gentili | 65761-24-2 |  |
| Sulfamerazine | Sharp & Dohme (Merck & Co.) | 127-79-7 |  |
| Sulfamethizole | Lundbeck and Co | 144-82-1 |  |
| Sulfamethoxazole | Shionogi | 723-46-6 |  |
| Sulfamethoxypyridazine | American Cyanamid (Wyeth) | 80-35-3 |  |
| Sulfametoxydiazine | Schering AG | 651-06-9 |  |
| Sulfametrole | Linz | 32909-92-5 |  |
| Sulfamonomethoxine | Daiichi | 1220-83-3 |  |
| Sulfamoxole | Nordmark | 729-99-7 |  |
| Sulfanilamide | Winthrop (Sanofi-Aventis) | 63-74-1 |  |
| Sulfanitran | | 122-16-7 |  |
| Sulfaphenazole | Ciba (Novartis) | 526-08-9 |  |
| Sulfapyrazole | Ciba (Novartis) | 852-19-7 |  |
| Sulfapyridine | May and Baker | 144-83-2 |  |
| Sulfaquinoxaline | Merck & Co. | 59-40-5 |  |
| Sulfasalazine | Pharmacia | 599-79-1 |  |
| Sulfasomizole | May & Baker (Aventis) | 632-00-8 |  |
| Sulfasuccinamide | Fabriques de Produits de Chimie Organique de Laire | 3563-14-2 |  |
| Sulfathiazole | Ciba (Novartis) | 72-14-0 |  |
| Sulfentrazone | FMC | 122836-35-5 |  |
| Sulfinosine | Nucleic Acid Research Inst. | 124508-99-2 |  |
| Sulfinpyrazone | Geigy (Novartis) | 57-96-5 |  |
| Sulfisomidine | Geigy | 515-64-0 |  |
| Sulfluramid | Griffin Corp | 4151-50-2 |  |
| Sulfobromophthalein | | 71-67-0 |  |
| Sulfometuron | DuPont | 74223-56-6 |  |
| Sulfoniazide | Lab. Franc. Chimiother. | 3691-81-4 |  |
| Sulforaphane | Johns Hopkins University | 4478-93-7 |  |
| Sulforidazine | Sandoz (Novartis) | 14759-06-9 |  |
| Sulfosate | Stauffer | 81591-81-3 |  |
| Sulfosulfuron | Takeda | 141776-32-1 |  |
| Sulfotep | Bayer | 3689-24-5 |  |
| sulfoxaflor | Dow AgroScience | 946578-00-3 |  |
| Sulfoxide | Boyce Thompson Inst. for Plant Res. | 120-62-7 |  |
| Sulfur hexafluoride | Bracco International B.V. | 2551-62-4 |  |
| Sulindac | Merck & Co. | 38194-50-2 |  |
| Sulisatin | Andreu | 54935-03-4 |  |
| Sulisobenzone | GAF | 4065-45-6 |  |
| Sulmazole | | 73384-60-8 |  |
| Sulodexide | Opocrin | 57821-29-1 | No Structure |
| Sulofenur | Eli Lilly | 110311-27-8 |  |
| Sulopenem | Pfizer | 120788-07-0 |  |
| Sulopenem etzadroxil | Pfizer | 1000296-70-7 |  |
| Sulotroban | Boehringer Mannheim (Roche) | 72131-33-0 |  |
| Sulphenone | Stauffer | 80-00-2 |  |
| Sulpiride | Delagrange ((Sanofi-Aventis) | 15676-16-1 |  |
| Sulprofos | Bayer | 35400-43-2 |  |
| Sulprostone | Pfizer | 60325-46-4 |  |
| Sultamicillin | Pfizer | 76497-13-7 |  |
| Sulthiame | Bayer | 61-56-3 |  |
| Sultopride | Delagrange ((Sanofi-Aventis) | 53583-79-2 |  |
| Sultosilic acid | Esteve | 57775-26-5 |  |
| Sulukast | Eli Lilly | 98116-53-1 |  |
| Sumacetamol | Sterling Drug (Sanofi-Aventis) | 69217-67-0 |  |
| Sumanirole | Upjohn (Pharmacia) | 179386-43-7 |  |
| Sumatriptan | Glaxo (GSK) | 103628-46-2 |  |
| Sumifiram | University of Firenze | 272786-64-8 |  |
| SUN-1334H | Sun Pharmaceutical Industries Ltd. (India) | |  |
| SUN-13834 | Asubio Pharma Co. Ltd. (Japan) | |  |
| SUN-9221 | Suntory | 136976-16-4 |  |
| SUN-C5174 | Suntory | 191592-35-5 |  |
| SUN-E7001 | Suntory (Daiiche-Sankyo) | |  |
| SUN-N5030 | Suntory | 254432-70-7 (HCl) |  |
| SUN-N5147 | Suntory Ltd. | |  |
| SUN-N8075 | Suntory | |  |
| Sunepitron | Pfizer | 131831-03-3 |  |
| Sunifiram | University of Firenze | 314728-85-3 |  |
| Sunitinib | Sugen (Pfizer) | 557795-19-4 ; 341031-54-7 (malate) |  |
| Suplatast tosilate | Taiho | 94055-76-2 |  |
| Suproclone | Rhone-Poulenc (Aventis) | 76535-71-2 |  |
| Suprofen | Janssen Pharmaceutica (Johnson & Johnson) | 40828-46-4 |  |
| Sur1M2-Montanide Vaccine | Survac APS (Merck KGaA) | | No Structure |
| Suradista | Farmitalia Carlo Erba (Pharmacia) | 154788-16-6 (4K salt) |  |
| Suramin | Rhone Poulenc (Bayer) | 145-63-1 |  |
| Surestem | American Cyanamid (BASF) | 51971-67-6 |  |
| Suriclone | Rhone-Poulenc (Aventis) | 53813-83-5 |  |
| Surinabant | Sanofi-Synthelabo (Sanofi-Aventis) | 288104-79-0 |  |
| Suritozole | Merrell Dow (Aventis) | 110623-33-1 |  |
| Suronacrine | Hoechst (Sanofi-Aventis) | 104675-35-6 |  |
| SUVN-502 | Suven Life Sciences | | No Structure |
| Suxamethonium chloride | Burroughs Wellcome | 71-27-2 |  |
| Suxibuzone | Esteve | 27470-51-5 |  |
| SV-030 | DuPont Pharmaceuticals | |  |
| SV-68-2 | Johns Hopkins University ; Wayne State University | |  |
| SVT-03017 | Salvat | |  |
| SW-13 | University of California (US) | |  |
| SW-14 | University of California (US) | |  |
| SW-30 | University of California (US) | |  |
| SWR-0342SA | Sawai Phermaceutical | 221079-56-7 |  |
| SX-004 | Scios | |  |
| SX-011 | Scios | |  |
| SX-3228 | Dainippon | 156364-04-4 |  |
| SX-4699 | Dainippon Pharmaceutical | 310409-14-4 |  |
| SXN-101000 | Syntaxin Ltd. | | No Structure |
| SXN-323 | | | No Structure |
| SYM-004 | Symphogen AS (Denmark) | | No Structure |
| SYM-2259 | Annovis | |  |
| SYM-2267 | Annovis | |  |
| SYM-2268 | Annovis | |  |
| SYM-2269 | Annovis | |  |
| Symakalim | E. Merck KGaA | 129518-58-7 |  |
| SYN-1020 | SynVax Inc. (US) | |  |
| SYN-1134 | SynPhar | 147135-53-3 |  |
| SYN-118 (Nitisinone) | Syngenta | 104206-65-7 |  |
| SYN-1193 | SynPhar | 168959-30-6 |  |
| SYN-1253 | SynPhar | 168959-31-7 |  |
| SYN-1389 | SynPhar | 169550-40-7 |  |
| SYN-1390 | SynPhar | 217199-33-2 |  |
| SYN-1436 | Syntonix Pharmaceuticals Inc. (US) | |  |
| SYN-2074 | Oxis | 173026-17-0 |  |
| SYN-2190 | SynPhar | 214963-75-4 |  |
| SYN-2869 | SynPhar ; Taiho | 210562-98-4 |  |
| SYN-987 | SynPhar | 168961-75-9 |  |
| Synguanol | University of Michigan ; Wayne State University | 200496-39-5 |  |
| SYR-472 | | | No Structure |
| Syrosingopine | Ciba (Novartis) | 84-36-6 |  |
| Sytrinol | Kgk Synergize (Canada) | | No Structure |
| SYUIQ-5 | Sun Yat-Sen University (China) | |  |
| SZ-042 | DuPont | |  |
| T-0070907 | Sankyo; Tularik | |  |
| T-01132 | Triplex Pharmaceutical | |  |
| T-0128 | Tanabe Seiyaku | |  |
| T-0156 | Tanabe | 324572-93-2 |  |
| T-0509 | Tanabe | 96843-99-1 |  |
| T-0799 | Tanabe | 130211-54-0 |  |
| T-0902395 | Tularik | |  |
| T-0910792 | Tularik Inc. (US) | |  |
| T-0970 | Tanabe | 195313-39-4 (HCl) |  |
| T-1032 | Tanabe | 212500-03-3 |  |
| T-1095 | Tanabe (Mitsubishi Tanabe) | 209746-59-8 |  |
| T-115 | University of Medicine and Dentistry of New Jersey | |  |
| T-157602 | DuPont (BMS) | 2103-99-3 |  |
| T-162559 | Takeda | 339532-12-6 |  |
| T-174 | Tanabe Seiyaku Co. (Japan) | |  |
| T-22 | Seikagaku | |  |
| T-226296 | Takeda | |  |
| T-23207 | Toyama Chemical | |  |
| T-2328 | Mitsubishi Tanabe Pharma Corp. (Japan) | |  |
| T-2384 | Amgen Inc. (US) ; Japan Tobacco Inc. (Japan) | |  |
| T-250 | Toyama Chemical | 179416-05-8 |  |
| T-2513 | Tanabe Seiyaku | |  |
| T-2585 | Tanabe | |  |
| T-26A | Albert Einstein College of Medicine (US) ; New York University US) | |  |
| T-270 | King Pharmaceuticals Inc. | | No Structure |
| T-3 | Centre National de la Recherche Scientifique (CNRS) | |  |
| T-33 | Shanghai Institute of Materia Medica (China) | |  |
| T-4 | Centre National de la Recherche Scientifique (CNRS) | |  |
| T-440 | Tanabe | 155043-84-8 |  |
| T-477 | Tanabe | 136929-56-1 |  |
| T-487 | Tularik (Amgen) | |  |
| T-506 | Toyama | 104884-43-7 |  |
| T-5224 | Toyama Chemical Co. Ltd. | |  |
| T-5575 | Toyama | 168434-93-3 (2Na salt) |  |
| T-5578 | Toyama | 167983-98-4 (Na salt) |  |
| T-588 | Toyama | 142935-03-3 |  |
| T-611 | Tularik (Amgen) | |  |
| T-62 | King pharmaceuticals | |  |
| T-817MA | Toyama Chemical | |  |
| T-82 | SS Pharmaceutical | 38455-99-1 (hemifumarate) |  |
| T-8581 | Toyama | 154950-29-5 |  |
| T-900607 | Tularik (Amgen) | 261944-52-9 |  |
| T-913659 | Tularik | |  |
| T-91485 | Takeda Chemical Industries | |  |
| T-91825 | Takeda | |  |
| T-98475 | Takeda | 192887-28-8 |  |
| T-AraCMP | University of Alabama (USA) ; Southern Research Institute (USA) | |  |
| T-AUCB | University of California (US) | |  |
| T-Pred (Tobramycin & Prednisolone acetate) | ISTA Pharmaceuticals Inc. | 32986-56-4 (Tobramycin) ; 52-21-1 (Prednisolone acetate) |  |
| TA-0201 | Tanabe | 188307-16-6 (Na salt) |  |
| TA-077 | Tanabe | 70189-62-7 |  |
| TA-1095 | | | No Structure |
| TA-1801 | Tanabe | 88352-44-7 |  |
| TA-270 | Dainippon Pharmaceutical | |  |
| TA-383 | Tanabe | 130186-25-3 |  |
| TA-5493 | | | No Structure |
| TA-5538 | | | No Structure |
| TA-606 | Tanabe | |  |
| TA-8995 | Mitsubishi Tanabe Pharma Corp. | | No Structure |
| TA-993 | Tanabe | 122024-98-0 |  |
| TA-NIC | Immulogic Pharmaceutical | | No Structure |
| Taberminogene vadenovec | Eurogene ; Ark Therapeutics | | No Structure |
| Tabimorelin | Novo Nordisk | 193079-69-5 |  |
| TAC-201 | Meiji Dairies Corp. | | No Structure |
| TAC-363 | Fujirebio | 172081-08-2 |  |
| Tacalcitol | Teijin | 57333-96-7 |  |
| Tacapenem | Daiichi | 193811-33-5 |  |
| Tacrine | Madan | 321-64-2 |  |
| Tacrolimus | Fujisawa (Astellas) | 104987-11-3 |  |
| Tadalafil | Glaxo (GSK) ; Icos | 171596-29-5 |  |
| Tadekinig alfa | Yeda R&D (IL) | 220712-29-8 | No Structure |
| Tadocizumab | Maxygen (Codexis) | 339086-80-5 | No Structure |
| TAFA-93 | Isotechnika Inc. | |  |
| Tafamidis | Scripps Research Institute | 594839-88-0 ; 951395-08-7 (meglumine salt) |  |
| Tafenoquine | US Army | 106635-80-7 |  |
| Tafluposide | Pierre Fabre | 179067-42-6 |  |
| Tafluprost | Santen ; Asahi Glass | 209860-87-7 |  |
| Tafoxiparin | Karolinska Innovations AB (Sweden) | 936084-30-9 | No Structure |
| Tagatose | Biospherics (US) | 87-81-0 |  |
| TAJ-955 | Novartis AG (Switzerland) | |  |
| TAK-024 | Takeda | |  |
| TAK-065 | | | No Structure |
| TAK-083 | Takeda Chemical | 21193-77-1 |  |
| TAK-100 | | | No Structure |
| TAK-187 | Takeda | 155432-64-7 |  |
| TAK-218 | Takeda | 156756-06-8 |  |
| TAK-220 | Takeda Chemical | |  |
| TAK-285 | Takeda Pharmaceutical Co. Ltd. | | No Structure |
| TAK-329 | | | No Structure |
| TAK-385 | Takeda Chemical Industries Ltd. (Japan) | |  |
| TAK-438 | Takeda | |  |
| TAK-448 | | | No Structure |
| TAK-456 | Takeda | 181869-54-5 |  |
| TAK-457 | Takeda | 422322-02-9 |  |
| TAK-591 | | | No Structure |
| TAK-593 | | | No Structure |
| TAK-603 | Takeda | 158146-85-1 |  |
| TAK-637 | Takeda | 217185-75-6 |  |
| TAK-661 | Takeda | 175215-34-6 |  |
| TAK-683 | Takeda Pharmaceutical Co. Ltd. | | No Structure |
| TAK-700 | Takeda | |  |
| TAK-715 | Takeda | |  |
| TAK-733 | | | No Structure |
| TAK-751S | Synsorb Biotech | | No Structure |
| TAK-778 | Takeda | 180185-61-9 |  |
| TAK-779 | Takeda | 229005-80-5 |  |
| TAK-783 | Takeda Pharmaceutical Co. Ltd. | | No Structure |
| TAK-802 | Takeda | |  |
| TAK-810 | Takeda | |  |
| TAK-875 | Takeda Pharmaceutical Co. Ltd. | |  |
| TAK-901 | Takeda San Diego Inc. (Takeda Pharmaceutical Co. Ltd.) | |  |
| TAK-937 | | | No Structure |
| TAL-05-00018 | Talecris Therapeutics | | No Structure |
| TAL-6004 | Talecris Biotherapeutics Inc. (US) | | No Structure |
| Talabostat | Point Therapeutics | 149682-77-9 ; 150080-09-4 (mesylate) |  |
| Talactoferrin alfa | Agennix | 308240-58-5 | No Structure |
| Talaglumetad | Eli Lilly | 441765-98-6 |  |
| Talampanel | Cyogyszerkutato Intezet Kft (Teva) | 161832-65-1 |  |
| Talampicillin | Yamanouchi (Astellas) | 47747-56-8 |  |
| Talaporfin | Nippon Petrochemicals | 110230-98-3 |  |
| Talarozole | Janssen (Johnson and Johnson) | 201410-53-9 ; 870093-23-5 |  |
| Talastine | VEB Deutsches Hydrierwerk Rodleben | 16188-61-7 |  |
| Talibegron | ICI (AstraZeneca) | 146376-58-1 |  |
| Taliglucerase alfa | Protalix Ltd. (Israel) | 37228-64-1 | No Structure |
| Talinolol | Arzneimittelwerke VEB | 57460-41-0 |  |
| Talipexole | Thomae (Boehringer Ingelheim) | 101626-70-4 |  |
| Talizumab | Tanox ; Genentech ; Novartis | 380610-22-0 | No Structure |
| Talmapimod | Scios Inc. | 750646-72-1 ; 309913-83-5 |  |
| Talminogene laherparepvec | BioVex | 1187560-31-1 | No Structure |
| Talnetant | SmithKline Beecham (GSK) | 174636-32-9 ; 204519-66-4 (Talnetant Hydrochloride ) |  |
| Talniflumate | Bago | 66898-62-2 |  |
| Talotrexin | Dana Farber Cancer Institute | 113857-87-7 ; 648420-92-2 (Talotrexin Ammonium) |  |
| Talsaclidine | Boehringer Ingelheim | 147025-53-4 |  |
| Taltirelin | Tanabe | 103300-74-9 |  |
| Taltobulin | University of British Columbia | 228266-40-8 |  |
| Tamibarotene | Sumitomo Pharmaceutical ; Yoshitomi Pharmaceutical | 94497-51-5 |  |
| Tamitinol | Merck KGaA | 59429-50-4 |  |
| Tamolarizine | Nippon Chemiphar | 128229-52-7 |  |
| Tamoxifen | ICI (AstraZeneca) | 10540-29-1 |  |
| Tamoxifen methiodide | Pharmos ; Weizmann Inst. | 107256-99-5 |  |
| Tamsulosin | Yamanouchi (Astellas) | 106133-20-4 |  |
| TAN-1057A | Takeda | 128126-44-3 |  |
| TAN-1607A | Takeda | 152920-97-3 |  |
| TAN-67 | Toray | 148545-09-9 |  |
| TAN-821 | Toray Industries | |  |
| TAN-950A | Takeda | 127607-88-9 |  |
| TAN-999 | Takeda | 124843-68-1 |  |
| Tanaproget | Ligand Pharmaceuticals ; Wyeth | 304853-42-7 |  |
| Tandospirone | Sumitomo Chemical | 87760-53-0 |  |
| Tandutinib | Millennium Pharmaceuticals (Takeda) | 387867-13-2 |  |
| Tanespimycin | Kaken Chemical Co. ; Kosan Biosciences (BMS) | 75747-14-7 |  |
| Tanezumab | Rinat Neuroscience Corp. (Pfizer) | 880266-57-9 | No Structure |
| Tangeretin | | 481-53-8 |  |
| Tanogitran | Boehringer Ingelheim | 637328-69-9 |  |
| Tanomastat | Bayer | 179545-77-8 |  |
| Tapentadol | Gruenenthal | 175591-23-8 |  |
| Tapgen | British Biotech | 173940-41-5 | No Structure |
| Taprenepag | Pfizer Inc. | 752187-80-7 |  |
| Taprenepag Isopropyl | Pfizer Inc. | 1005549-94-9 |  |
| Taprizosin | Pfizer | 210538-44-6 |  |
| Taprostene | Gruenenthal | 108945-35-3 |  |
| Tarafenacin | | |  |
| Taranabant | Merck & Co | 701977-09-5 |  |
| Tarasentan | Abbott | |  |
| Tarenflurbil | Syntex (Roche) | 51543-40-9 |  |
| Tariquidar | Xenova (Celtic Pharma) | 206873-63-4 |  |
| TARP-29-37-9V | US Government | | No Structure |
| Tartrazine | Ilford | 1934-21-0 |  |
| TAS-103 | Taiho | 174634-08-3 |  |
| TAS-108 | Stanford Research Institute | 354808-47-2 |  |
| TAS-202 | Taiho Pharmaceutical | |  |
| TAS-3-124 | Taiho | |  |
| TAS-301 | Taiho | 193620-69-8 |  |
| Tasidotin | BASF (Abbott) | 192658-64-3 |  |
| Tasimelteon | Bristol-Myers Squibb (BMS) | 609799-22-6 |  |
| Tasisulam | Eli Lilly | 519055-62-0 ; 519055-63-1 (sodium salt) |  |
| Tasocitinib | Pfizer | 477600-75-2 ; 540737-29-9 (citrate) |  |
| Tasonermin | Genentech Inc. | 94948-59-1 | No Structure |
| Tasosartan | American Home Products (Wyeth) | 145733-36-4 |  |
| Taspoglutide | SCRAS (Ipsen) ; Tulane University, (US) | 275371-94-3 |  |
| Tasquinimod | Active Biotech | 254964-60-8 |  |
| TAT-2A | Università degli Studi di Milano (Italy) | |  |
| TAT-54R-KDEL | Jinan University (China) | | No Structure |
| Tau-Fluvalinate | Zoecon | 102851-06-9 |  |
| Taurolidine | Geistlich | 19388-87-5 |  |
| Tauromustine | Leo Pharmaceutical | 85977-49-7 |  |
| Tazanolast | Wakamoto | 82989-25-1 |  |
| Tazarotene | Allergan | 118292-40-3 |  |
| Tazobactam | Taiho | 89786-04-9 |  |
| Tazofelone | Eli Lilly | 136433-51-7 |  |
| Tazomeline | Ferrosan | 131987-54-7 |  |
| TB-402 | ThromboGenics NV (Belgium) | | No Structure |
| TB-403 | Vlaams ; Thromb-X NV (ThromboGenics) | | No Structure |
| TBA-2,3,6 | Heyden Chemical | 50-31-7 |  |
| TBC-10950 | Immunopharmaceutics (Texas Biotechnology Corporation (Encysive Pharmaceuticals)) | |  |
| TBC-2576 | Texas Biotechnology | 205515-63-5 |  |
| TBC-3214 | Texas Biotechnology | |  |
| TBC-3711 | Texas Biotechnology Corporation (Encysive Pharmaceuticals) | 374680-51-0 |  |
| TBC-3B | | | No Structure |
| tBEU | Imotep | |  |
| TBPCOB | Merck & Co. Inc. | |  |
| TC-1 | Merck & Co. Inc. (US) | |  |
| TC-14003 | University of Louisville ; University of Kagoshima ; Tokyo Medical Dental University | 327610-31-1 |  |
| TC-14005 | University of Louisville ; University of Kagoshima ; Tokyo Medical Dental University | 327610-33-3 |  |
| TC-14012 | Kagoshima University ; Kyoto University ; Tohoku University ; Tokyo Medical and Dental University | |  |
| TC-1698 | Targacept | |  |
| TC-1709 | Targacept | |  |
| TC-2216 | | | No Structure |
| TC-2248 | Targacept | |  |
| TC-2258 | Targacept | |  |
| TC-2559 | Reynolds Tobacco | 326924-19-0 |  |
| TC-5214 | University of South Florida (US) | 107596-30-5 (as HCl salt) |  |
| TC-5619 | Targacept | |  |
| Tc-99m butedronic acid | Hoechst (Sanofi-Aventis) | 51395-42-7 (butedronic acid) |  |
| Tc-99m-RP-128 | CIS Bio International (Schering AG) ; Resolution Pharmaceuticals | |  |
| TCPT | University of Kansas (US) ; University of Kansas Medical Center (US) ; Gsf-Forschungszentrum fur Umw | |  |
| TCRB | Michigan University | |  |
| TCV-309 | Takeda | 131311-25-6 |  |
| TD-1792 | Theravance | |  |
| TD-2749 | Theravance | | No Structure |
| TD-4208 | Theravance | | No Structure |
| Td131-1 | | |  |
| TDP-222669 | 3-Dimensional (Johnson & Johnson Pharmaceutical) | |  |
| TDP-258625 | 3-Dimensional (Johnson & Johnson Pharmaceutical) | |  |
| TDP-521252 | 3-Dimensional (Johnson & Johnson Pharmaceutical) | |  |
| TDP-665759 | 3-Dimensional (Johnson & Johnson Pharmaceutical) | |  |
| TDT-044 | IDEA AG | | No Structure |
| TDT-067 (Terbinafine) | IDEA AG | 91161-71-6 ; 78628-80-5 (hydrochloride) |  |
| TDT-070 (Ketoprofen) | IDEA AG | 22071-15-4 |  |
| TDT-077 | IDEA AG | | No Structure |
| TE-3 | Centre National de la Recherche Scientifique (CNRS) | |  |
| TE-4a | Centre National de la Recherche Scientifique (CNRS) | |  |
| TE-4gt | CNRS | |  |
| TE-802 | Taisho | 153954-82-6 |  |
| TEA-0777 | Taisho | |  |
| TEA-0929 | Taisho | |  |
| TEAM-VP | Theraptosis S.A. (France) | |  |
| Tebanicline | Abbott | 198283-73-7 |  |
| Tebetane | Sertog (France) | | No Structure |
| Tebipenem pivoxil | Lederle (Wyeth Lederle Japan) | 161715-24-8 |  |
| Tebuconazole | Bayer | 107534-96-3 |  |
| Tebufenozide | Rohm & Haas | 112410-23-8 |  |
| Tebufenpyrad | Mitsubishi | 119168-77-3 |  |
| Tebufloquin | Meiji Seika Kaisha, Ltd. | 376645-78-2 |  |
| Tebupirimphos | Bayer | 96182-53-5 |  |
| Tebutam | Farm Protection | 35256-85-0 |  |
| Tebuthiuron | Air Products | 34014-18-1 |  |
| Tecadenoson | CV Therapeutics (Gilead) | 204512-90-3 |  |
| Tecalcet | NPS Pharmaceuticals | 148717-54-8 |  |
| Tecarfarin | Aryx Therapeutics | 867257-26-9 ; 1004551-83-0 (sodium salt) |  |
| Tecastemizole | Sepracor (Dainippon Sumitomo Pharma) | 75970-99-9 |  |
| Teceleukin | Shionogi | 136279-32-8 |  |
| Technetium 99MTc Bicisate | DuPont (BMS) | 121281-41-2 |  |
| Technetium Tc 99M Apcitide | Diatech | |  |
| Technetium Tc 99M Bectumomab | | 158318-63-9 (unlabeled compound) | No Structure |
| Technetium Tc 99M Bivatuzumab | Boehringer Ingelheim | | No Structure |
| Technetium Tc 99M Depreotide | Diatide | |  |
| Technetium Tc 99M Furifosmin | Mallinckrodt | 142481-95-6 |  |
| Technetium Tc 99m Glucarate | Centocor ; The General Hospital Corporation | 131899-29-1 |  |
| Technetium Tc 99m HL-91 | Missouri University | |  |
| Technetium Tc 99M Mebrofenin | Squibb (BMS) | |  |
| Technetium Tc 99m Medronate | | 63347-66-0 (1984-15-2(Medronic acid) |  |
| Technetium Tc 99M Mertiatide | NeoRx | 125224-05-7 |  |
| Technetium Tc 99m Nitridocade | CIS Bio International | 131608-78-1 |  |
| Technetium Tc 99M Sestamibi | Massachusetts Inst. Techn. ; Harvard College | 109581-73-9 |  |
| Technetium Tc 99M teboroxime | Squibb (BMS) | 104716-22-5 |  |
| Technetium Tc 99m Trodat-1 | University of Pennsylvania | |  |
| Technetium Tc99m Exametazime | Amersham (UK) | |  |
| Technetium Tc99m Fanolesomab | Palatin Technologies | 225239-31-6 | No Structure |
| Tecloftalam | Sankyo | 76280-91-6 |  |
| Teclothiazide | | 4267-05-4 |  |
| Teclozan | Sterling Winthrop (Sanofi-Aventis) | 5560-78-1 |  |
| Tecnazene | ICI (Syngenta) | 117-18-0 |  |
| Tecovirimat | ViroPharma | 869572-92-9 ; 816458-31-8 |  |
| Tedalinab | | 916591-01-0 |  |
| Tedisamil | Kali Chemie (Solvay Pharmaceuticals) | 90961-53-8 |  |
| Tedizolid | Dong A Pharmaceutical | 856866-72-3 |  |
| Tedizolid Phosphate | Dong A Pharmaceutical | 856867-55-5 |  |
| Teduglutide | Allelix Biopharmaceuticals (NPS Allelix) | 287714-30-1 |  |
| Teferrol | Hausmann Laboratories Ltd. (Vifor International AG) | 79173-09-4 | No Structure |
| Tefibazumab | Inhibitex | 521079-87-8 | No Structure |
| Teflubenzuron | Celamerck | 83121-18-0 |  |
| Tefluthrin | ICI (Syngenta) | 79538-32-2 |  |
| Tefuryltrione | Aventis Cropscience (Bayer Cropscience) | 473278-76-1 |  |
| Tegafur | Inst. Organitschesk sinteza | 17902-23-7 |  |
| Tegaserod | Sandoz (Novartis) | 145158-71-0 |  |
| Teglarinad chloride | Leo Pharmaceutical | 432037-57-5 |  |
| Teglicar | Sigma-Tau | 250694-07-6 |  |
| Tegobuvir | KU Leuven Research & Development (Belgium) ; Gilead Sciences Inc. | 1000787-75-6 |  |
| TEI-2306 | Teijin | 114627-30-4 |  |
| TEI-3356 | Teijin | 133906-74-8 |  |
| TEI-6363 | Teijin | 325148-08-1 |  |
| TEI-8362 | Teijin | 180154-57-8 |  |
| TEI-9826 | Osaka Bio Science Research | 245732-05-2 |  |
| TEI-9874 | Teijin | 174567-88-5 |  |
| TEI-B00422 | Teijin Ltd. (Japan) ; Microbial Chemistry Research Foundation (Japan) | |  |
| Teicoplanin | Lepetit | 61036-64-4 |  |
| Telaprevir | Eli Lilly | 402957-28-2 |  |
| Telapristone | US Health | 198414-30-1 |  |
| Telapristone acetate | US Health / NICHD | 198414-31-2 |  |
| Telatinib | Bayer | 332012-40-5 |  |
| Telavancin | Theravance Inc. | 372151-71-8 |  |
| Telbermin | | 205887-54-3 | No Structure |
| Telbivudine | Novirio Pharmaceuticals (Idenix Pharmaceuticals) | 3424-98-4 |  |
| Telcagepant | Merck & Co | 781649-09-0 ; 953077-35-5 (USAN) |  |
| Telenzepine | Byk Gulden (Nycomed) | 80880-90-6 |  |
| Teleukin | Philogen SpA (Italy) | | No Structure |
| Telinavir | Monsanto (Pharmacia) | 143224-34-4 |  |
| Telithromycin | Roussel-Uclaf (Sanofi-Aventis) | 173838-31-8 ; 191114-48-4 |  |
| Telmesteine | Yason | 122946-43-4 |  |
| Telmisartan | Thomae (Boehringer Ingelheim) | 144701-48-4 |  |
| Telomestatin | Taiho ; Sosei | |  |
| Telotristat | Lexicon Pharmaceuticals, Inc. | 1033805-28-5 |  |
| Telotristat ethyl | Lexicon Pharmaceuticals Inc. (US) | 1033805-22-9 ; 1137608-69-5 (Telotristat etiprate) |  |
| Teloxantrone | Warner Lambert (Pfizer) | 91441-48-4 |  |
| Temacrazine | US Department of Health & Human Services | 197840-96-3 |  |
| Temafloxacin | Abbott | 108319-06-8 |  |
| Temanogrel | Arena Pharmaceuticals (US) | 887936-68-7 ; 957466-27-2 (hydrochloride) |  |
| Temarotene | Hoffmann La Roche (Roche) | 89410-65-1 |  |
| Temazepam | American Home Products (Wyeth) | 846-50-4 |  |
| Tembotrione | Aventis Cropscience (Bayer Cropscience) | 335104-84-2 |  |
| Temelastine | Searle (Pfizer) | 86181-42-2 |  |
| Temephos | American Cyanamid (BASF) | 3383-96-8 |  |
| Temiverine | Nippon Shinyaku | 173324-94-2 |  |
| Temocapril | Sankyo | 111902-57-9 |  |
| Temocillin | Beecham (GSK) | 66148-78-5 |  |
| Temoporfin | Efamol | 122341-38-2 |  |
| Temozolomide | Cancer Research Campaign Technology | 85622-93-1 |  |
| Tempo | | 2564-83-2 |  |
| Tempol | | 2226-96-2 |  |
| Temsirolimus | American Home Products (Wyeth) | 162635-04-3 |  |
| Tenatoprazole | Tokyo Tanabe (Mitsubishi Pharma) | 113712-98-4 |  |
| Tenatumomab | Sigma Tau | 592557-43-2 (light chain) ; 592557-41-0 (heavy chain) | No Structure |
| Tenecteplase | Genentech | 191588-94-0 | No Structure |
| Teneligliptin | Mitsubishi Pharma (Japan) | 760937-92-6 |  |
| Tenidap | Pfizer | 120210-48-2 |  |
| Tenifatecan | Sonus Pharmaceuticals | 850728-18-6 |  |
| Teniposide | Sandoz (Novartis) | 29767-20-2 |  |
| Tenivastatin | Merck | 121009-77-6 |  |
| Tenofovir | Rega Stichting | 206184-49-8 |  |
| Tenofovir Disoproxil | Academy Of Science of Czech Republic | 201341-05-1 ; 202138-50-9 (Fumarate) |  |
| Tenoic acid | Sanofi (Sanofi-Aventis) | 527-72-0 |  |
| Tenonitrozole | Chantereau | 3810-35-3 |  |
| Tenosal | Medea Research | 95232-68-1 |  |
| Tenovin 1 | University of Dundee (GB) ; University of St. Andrews (GB) | 380315-80-0 |  |
| Tenovin 6 | University of Dundee (GB) ; University of St. Andrews (GB) | 1011557-82-6 |  |
| Tenoxicam | Hoffmann La Roche (Roche) | 59804-37-4 |  |
| Tepirindole | Roussel-Uclaf (Aventis) | 72808-81-2 |  |
| Teplizumab | Tolerance Therapeutics (US) | 876387-05-2 |  |
| Tepoxalin | Ortho McNeil (Johnson & Johnson) | 103475-41-8 |  |
| Tepraloxydim | BASF | 149979-41-9 |  |
| Teprenone | | 6809-52-5 |  |
| Teprotumumab | Genmab A/S | 89957-37-9 | No Structure |
| TER-930180 | Terumo | 172283-12-4 |  |
| Terameprocol | Johns Hopkins University | 24150-24-1 ; 5701-82-6 |  |
| Terazosin | Abbott | 63590-64-7 ; 70024-40-7 (hydrochloride) |  |
| Terbacil | DuPont | 5902-51-2 |  |
| Terbinafine | Sandoz (Novartis) | 91161-71-6 ; 78628-80-5 (hydrochloride) |  |
| Terbogrel | Thomae (Boehringer Ingelheim) | 149979-74-8 |  |
| Terbufos | Hokko | 13071-79-9 |  |
| Terbumeton | Ciba-Geigy (Novartis) | 33693-04-8 |  |
| Terbutaline | Dracco | 23031-25-6 |  |
| Terbuthylazine | Ciba-Geigy (Novartis) | 5915-41-3 |  |
| Terbutryn | Geigy (Novartis) | 886-50-0 |  |
| Terconazole | Janssen Pharmaceutica (Johnson & Johnson) | 67915-31-5 |  |
| Terfenadine | Richardson-Merrell (Aventis) | 50679-08-8 |  |
| Terflavoxate | Recordati | 86433-40-1 |  |
| Terguride | Spofa | 37686-84-3 |  |
| Teriflunomide | Hoechst (Sanofi-Aventis) | 108605-62-5 |  |
| Teriparatide | Armour | 52232-67-4 |  |
| Terizidone | Bracco | 25683-71-0 |  |
| Terlakiren | Pfizer | 119625-78-4 |  |
| Terlipressin | Ceskoslovenska Akademie Ved (Former Czechoslovakia) | 14636-12-5 |  |
| Terodiline | Recip | 15793-40-5 |  |
| tert-Butyl-4-phenyl salicylate | Dow | 87-18-3 |  |
| Tertatolol | Servier | 34784-64-0 |  |
| Tertomotide | Norsk Hydro (Pharmexa) | |  |
| Terutroban | Adir (Servier) | 165538-40-9 |  |
| Tesaglitazar | AstraZeneca | 251565-85-2 |  |
| Tesamorelin | Theratechnologies | 218949-48-5 ; 901758-09-6 (acetate salt) |  |
| Tesetaxel | Daiichi (Daiichi-Sankyo) | 333754-36-2 |  |
| Tesmilifene | University of Manitoba | 98774-23-3 |  |
| Tesofensine | NeuroSearch (Denmark) | 195875-84-4 |  |
| Testolactone | Olin Mathieson | 968-93-4 |  |
| Testosterone | Ciba (Novartis) | 58-22-0 |  |
| Testosterone bucyclate | National Inst. of Health (NIH) | 105165-22-8 |  |
| Testosterone glucoside | Strakan Ltd. (ProStrakan Group plc) | |  |
| Testosterone Propionate | Schering Corp (Merck & Co) | 57-85-2 |  |
| Testosterone undecanoate | Akzona | 5949-44-0 |  |
| Tetcyclacis | BASF | 65245-23-0 |  |
| Tetomilast | Otsuka | 145739-56-6 |  |
| Tetraacetylbrazilin | Seoul National University (South Korea) ; SK Chemicals | 2241-61-4 |  |
| Tetrabenazine | Hoffmann La Roche (Roche) | 58-46-8 |  |
| Tetracaine | Winthrop (Sanofi-Aventis) | 94-24-6 |  |
| Tetrachlorosalicylanilide-3,3',4',5 | Geigy (Novartis) | 1154-59-2 |  |
| Tetrachlorvinphos | Shell | 22248-79-9 |  |
| Tetraconazole | Montedison | 112281-77-3 |  |
| Tetracosactide | Organon (Schering Merck & Co) | 60189-34-6 |  |
| Tetracycline | American Cyanamid (Wyeth) | 60-54-8 |  |
| Tetradecylselenoacetic acid | University of Bergen (Norway) | |  |
| Tetradifon | Philips-Duphar | 116-29-0 |  |
| Tetrafibricin | Hoffmann La Roche (Roche) | 151705-56-5 |  |
| Tetrahydrobiopterin | Biocrates Life Science | |  |
| tetrahydrocannabivarin 9 | | 28172-17-0 |  |
| Tetrahydrocurcumin | Kobe Steel Ltd. | 36062-04-1 |  |
| Tetrahydrohyperforin | Indena SpA | |  |
| Tetrahydrouridine | Halogenetics | 18771-50-1 |  |
| Tetramethrin | Sumitomo Chemical | 7696-12-0 |  |
| Tetramethrin [(1R)-isomers] | Sumitomo Chemical | 1166-46-7 |  |
| Tetramethylfluthrin | Jiangsu Yangnong Chemical Co., Ltd. | 84937-88-2 |  |
| Tetramisole | Janssen Pharmaceutica (Johnson & Johnson) | 5036-02-2 |  |
| Tetrandrine | Knox Van Dyke, US (CBA INT) | 518-34-3 |  |
| Tetrathiomolybdate | University of Michigan | 16330-92-0 |  |
| Tetrazepam | Clin-Byla | 10379-14-3 |  |
| Tetridamine | Polichimica | 17289-49-5 |  |
| Tetrodotoxin | Wex Medical Instrumentation (Wex Pharmaceuticals) ; Nanning Maple Leaf Pharmaceuticals | 4368-28-9 |  |
| Tetrofosmin | Amersham (Nycomed-Amersham) | 127502-06-1 |  |
| Tetroxoprim | Heumann | 53808-87-0 |  |
| Tetryzoline | Sahyun | 84-22-0 |  |
| Teverelix | Kenyon & Kenyon LLP (US) | 151272-78-5 |  |
| Tezacitabine | Merrell Dow (Sanofi-Aventis) | 130306-02-4 |  |
| Tezampanel | Eli Lilly | 154652-83-2 ; 317819-68-4 |  |
| Tezosentan | Hoffmann La Roche (Roche) | 180384-57-0 |  |
| TF-2 | Immunomedics Inc. | | No Structure |
| TFAP | Okayama University (Japan) | |  |
| Tfiba | Japan Government Industrial Research | 164353-12-2 |  |
| TFM | Hoechst (Sanofi-Aventis) | 88-30-2 |  |
| TG-0205221 | TaiGen Biotechnology | |  |
| TG-100-115 | TargeGen | |  |
| TG-100435 | TargeGen Inc. (US) | |  |
| TG-100572 | TargeGen Inc. (US) | |  |
| TG-100598 | TargeGen | |  |
| TG-100801 | TargeGen Inc. (US) | |  |
| TG-100855 | TargeGen Inc. (US) | |  |
| TG-101348 | TargeGen Inc. (US) | |  |
| TG-25 | Wisconin Alumni Research Foundation | |  |
| TG-28 | Ohio State University | |  |
| TG-4010 | | | No Structure |
| tgAAC-09 | Targeted Genetics Corp. (US) ; Children’s Hospital Inc. (US) | | No Structure |
| TGC-0011285 | The Genetics Company Inc. (Switzerland) | |  |
| TGC-0011288 | The Genetics Company Inc. (Switzerland) | |  |
| TGC-0011570 | The Genetics Company Inc. (Switzerland) | |  |
| TGC-0011576 | The Genetics Company Inc. (Switzerland) | |  |
| TGC-0011589 | The Genetics Company Inc. (Switzerland) | |  |
| TGC-0012296 | The Genetics Company Inc. (Switzerland) | |  |
| TGC-0012303 | The Genetics Company Inc. (Switzerland) | |  |
| TGG-II-23A | Bristol-Myers Squibb (BMS) | 153312-20-0 |  |
| TGN-167 (Flovagatran) | Trigen | |  |
| TH-0318 | Theratechnologies | |  |
| TH-1177 | University of Virginia | |  |
| TH-302 | Threshold Pharmaceuticals | 918633-87-1 |  |
| TH-337 | Threshold Pharmaceuticals Inc. | |  |
| TH-482 | Threshold Pharmaceuticals Inc. (US) | |  |
| TH-9402 | University of Montreal (Canada) | 174230-05-8 |  |
| Thaliblastine | Pharmachim | 5373-42-2 |  |
| Thalidomide | Celgene ; Rockefeller University | 50-35-1 |  |
| THE-JL-3 | Therabel | 136772-40-2 |  |
| Theanine | Generic | 3081-61-6 |  |
| Thenalidine | Sandoz (Novartis) | 86-12-4 |  |
| Thenium Closylate | Wellcome Foundation (GSK) | 4304-40-9 |  |
| Thenorphine | Peking University | |  |
| Thenylchlor | Tokuyama | 125034-10-8 |  |
| Thenyldiamine | Monsanto (Pharmacia) | 91-79-2 |  |
| Theodrenaline | Degussa | 13460-98-5 |  |
| Theophylline | | 58-55-9 |  |
| Theta-cypermethrin | Chinoin | 71697-59-1 |  |
| Thiabendazole | Merck & Co. | 148-79-8 |  |
| Thiacloprid | Nihon Tokushu Noyako Seizo | 111988-49-9 |  |
| Thiacymserine | Pfizer; National Inst. of Health (NIH) ; US Government | 145209-51-4 |  |
| Thialbarbital | Abbott | 467-36-7 |  |
| Thiamazole | | 60-56-0 |  |
| Thiamethoxam | Ciba-Geigy (Novartis) | 153719-23-4 |  |
| Thiamine | IG Farben | 59-43-8 |  |
| Thiamphenicol | Sterling Drug (Sanofi-Aventis) | 15318-45-3 |  |
| Thiamylal | Eli Lilly | 337-47-3 |  |
| Thiatolserine | Pfizer ; National Inst. of Health (NIH) ; US Government | 145209-50-3 |  |
| Thiazafluron | Agripat | 25366-23-8 |  |
| Thiazinotrienomycin B | Microbial Chemical Research Foundation | 165337-94-0 |  |
| Thiazinotrienomycin F | Microbial Chemistry Research Foundation (JP) | |  |
| Thiazopyr | Monsanto | 117718-60-2 |  |
| Thiazotropsin A | Strathclyde University | |  |
| Thicyofen | Duphar | 116170-30-0 |  |
| Thidiazimin | Schering AG | 137472-11-8 |  |
| Thidiazuron | Nor-Am | 51707-55-2 |  |
| Thiencarbazone | Bayer AG | |  |
| Thiethylperazine | Sandoz (Novartis) | 1420-55-9 |  |
| Thifensulfuron-methyl | DuPont | 79277-67-1 |  |
| Thifluzamide | Monsanto | 130000-40-7 |  |
| Thioacetazone | Bayer | 104-06-3 |  |
| Thiobencarb | Kumiai | 28249-77-6 |  |
| Thiocolchicoside | UCLAF (Usines Chimiques des Laboratoires Français) | 602-41-5 |  |
| Thioctic acid | DuPont (BMS) | 62-46-4 |  |
| Thiocyclam | Sandoz (Syngenta) | 31895-21-3 |  |
| Thiodicarb | Union Carbide | 59669-26-0 |  |
| Thiofanox | Diamond Shamrock | 39196-18-4 |  |
| Thiomarinol | Sankyo | 146697-04-3 |  |
| Thiomarinol D | Sankyo | 182154-99-0 |  |
| Thiomarinol E | Sankyo | 182155-00-6 |  |
| Thiomarinol F | Sankyo | 182155-01-7 |  |
| Thiomarinol G | Sankyo | 194154-33-1 |  |
| Thiomersal | Eli Lilly | 54-64-8 |  |
| Thiometon | Bayer | 640-15-3 |  |
| Thionazin | American Cyanamid (BASF) | 297-97-2 |  |
| Thiopental | Abbott | 71-73-8 |  |
| Thioperamide | Inst. Nat. Sante Rech. Med. | 106243-16-7 |  |
| Thiophanate | Nippon Soda | 23564-06-9 |  |
| Thiophanate-methyl | Nippon Soda | 23564-05-8 |  |
| Thioplatin | Deutsches Krebsforschungszentrum | 19965-15-2 |  |
| Thioproperazine | Rhone-Poulenc (Aventis) | 316-81-4 |  |
| Thioquinox | Bayer | 93-75-4 |  |
| Thioridazine | Sandoz (Novartis) | 50-52-2 ; 130-61-0 (hydrochloride) |  |
| Thiostrepton | Olin Mathieson | 1393-48-2 |  |
| Thiosultap | Takeda | 52207-48-4 |  |
| Thiotepa | American Cyanamid (Wyeth) | 52-24-4 |  |
| Thioviridamide | Astellas | |  |
| Thiram | Monsanto (Pharmacia) | 137-26-8 |  |
| Thonzonium bromide | Nepera | 553-08-2 |  |
| Thonzylamine | Pyridium Corp | 63-56-9 |  |
| THR-100 | Thromb (ThromboGenics) | | No Structure |
| Thrombin alfa | Ethicon Inc. (US) | 869858-13-9 |  |
| Thrombin-JMI (Bovine thrombin) | King Pharmaceuticals Inc. | 9002-04-4 | No Structure |
| Thrombodipine | Alter | 113658-85-8 |  |
| Thrombomodulin | Asahi Kasei Pharma | 120313-91-9 | No Structure |
| THRX-326151 | Theravance Inc. (US) | |  |
| Thurfyl nicotinate | Ciba (Novartis) | 70-19-9 |  |
| Thymalfasin | SciClone | 62304-98-7 |  |
| Thymectacin | NewBiotics (Celmed BioSciences) | 232925-18-7 |  |
| Thymocartin | Gedeon Richter | 85466-18-8 |  |
| Thymoctonan | Yedares & Dev | 107489-37-2 |  |
| Thymopentin | Sloan Kettering Inst Cancer | 69558-55-0 |  |
| TI-66 | Meiji Seika | 144860-86-6 |  |
| Tiadenol | Eastman Kodak | 6964-20-1 |  |
| Tiadinil | Nihon Nohyaku | 223580-51-6 |  |
| Tiagabine | Novo Nordisk | 115103-54-3 |  |
| Tiamulin | Sandoz (Novartis) | 55297-95-5 |  |
| Tianeptine | Science Union ; Soc Franc. Rech. Med. | 66981-73-5 |  |
| Tiapafant | Alter | 123875-01-4 |  |
| Tiapamil | Ore Pharmaceuticals | 57010-31-8 ; 57010-32-9 (HCl) |  |
| Tiapride | Societe d'Etudes Scientifiques et Industrielles de l'Ile-de-France | 51012-32-9 |  |
| Tiaprofenic acid | Roussel-Uclaf (Aventis) | 33005-95-7 |  |
| Tiaprost | Hoechst (Sanofi-Aventis) | 71116-82-0 |  |
| Tiaramide | Fujisawa | 32527-55-2 |  |
| Tiazofurin | Viratek (Valeant) | 60084-10-8 |  |
| Tiazuril | Pfizer | 35319-70-1 |  |
| Tibezonium iodide | Recordati | 54663-47-7 |  |
| Tibolone | | 5630-53-5 |  |
| Ticagrelor | AstraZeneca | 274693-27-5 |  |
| Ticalopride | Sepracor | 221180-26-3 |  |
| Ticarcillin | Beecham (GSK) | 34787-01-4 |  |
| Ticlopidine | Parcor | 55142-85-3 |  |
| Ticolubant | SmithKline Beecham (GSK) | 154413-61-3 |  |
| Tideglusib | Neuropharma SA (Noscira) | 865854-05-3 |  |
| Tidembersat | SmithKline Beecham (GSK) | 175013-73-7 |  |
| Tidiacic | Crinex | 30097-06-4 |  |
| Tiemonium Iodide | C.E.R.M. | 144-12-7 |  |
| Tienoxolol | Carpibem | 90055-97-3 |  |
| Tifacogin | Monsanto (Pfizer) ; Washington University | 148883-56-1 | No Structure |
| Tifenazoxide | Novo Nordisk | 279215-43-9 |  |
| Tiflorex | Synthelabo (Sanofi-Aventis) | 53993-67-2 |  |
| Tifuvirtide | Trimeris | 251562-00-2 |  |
| Tigapotide | Procyon Biopharma, Inc. (Ambrilia Biopharma, Inc.) | 848084-83-3 ; 848084-84-4 (triflutate) |  |
| Tigatuzumab | | 918127-53-4 | No Structure |
| Tigecycline | Pearl River ; American Cyanamid (Wyeth) | 220620-09-7 |  |
| Tilactase | | 9031-11-2 | No Structure |
| Tilarginine | Glaxo-Wellcome (GSK) | 17035-90-4 |  |
| Tilbroquinol | Beaufour (Beaufour Ipsen) | 7175-09-9 |  |
| Tildipirosin | Zaidan Hojin Biseibutsu | 328898-40-4 |  |
| Tiletamine | Parke, Davis (Pfizer) | 14176-49-9 |  |
| Tilidine | Warner Lambert (Pfizer) | 20380-58-9 |  |
| Tiliquinatine | Wayne State University (US) | 445041-75-8 |  |
| Tiliquinol | Nippon Kayaku | 5541-67-3 |  |
| Tilisolol | Nisshin Flour Milling | 85136-71-6 |  |
| Tilmacoxib | Japan Tobacco | 180200-68-4 |  |
| Tilmicosin | Eli Lilly | 108050-54-0 |  |
| Tilnoprofen arbamel | Yoshitomi | 159098-79-0 |  |
| Tiludronic acid | Sanofi (Sanofi-Aventis) | 89987-06-4 |  |
| TIM-10 | Pharmagap Inc. (Canada) | |  |
| Timcodar | Vertex | 179033-51-3 |  |
| Timepidium bromide | Tanabe | 35035-05-3 |  |
| Timiperone | Daiichi | 57648-21-2 |  |
| Timolol | Merck Frosst (Merck & Co.) | 26839-75-8 |  |
| Timonacic | Sogespar | 444-27-9 |  |
| Tinidazole | Pfizer | 19387-91-8 |  |
| Tinoridine | Yoshitomi | 24237-54-5 |  |
| Tinzaparin sodium | | 9041-08-1 |  |
| Tiocarbazil | Agrimont | 36756-79-3 |  |
| Tiocarlide | Ciba (Novartis) | 910-86-1 |  |
| Tioclomarol | Lipha (E. Merck KGaA) | 22619-35-8 |  |
| Tioclorim | PCUK | 68925-41-7 |  |
| Tioconazole | Pfizer | 65899-73-2 |  |
| Tioguanine | Burroughs Wellcome (GSK) | 154-42-7 |  |
| Tiopronin | Santen | 1953-02-2 |  |
| Tiotixene | Pfizer | 3313-26-6 |  |
| Tiotropium bromide | Boehringer Ingelheim | 136310-93-5 |  |
| Tioxidazole | Schering Corp (Merck & Co) | 61570-90-9 |  |
| Tioxolone | Winthrop (Sanofi-Synthelabo) | 4991-65-5 |  |
| Tipapkinogene sovacivec | | 1052105-48-2 | No Structure |
| Tipelukast | Kyorin | 125961-82-2 |  |
| Tipepidine | Tanabe | 5169-78-8 |  |
| Tipifarnib | Janssen Pharmaceutica (Johnson & Johnson) | 192185-72-1 |  |
| Tiplaxtinin | Wyeth | 393105-53-8 |  |
| Tiplimotide | Neurocrine Biosciences | 178823-49-9 |  |
| TIPP-204 | University of Tokyo (Japan) | |  |
| Tipranavir | Upjohn (Pharmacia) | 174484-41-4 |  |
| Tipredane | Squibb (BMS) | 85197-77-9 |  |
| Tiprolisant | Bioprojet Societe Civile (France) | 362665-56-3 |  |
| Tiqueside | Oregon Medical Res. Found | 99759-19-0 |  |
| Tiquizium bromide | Hokuriku | 71731-58-3 |  |
| Tiracizine | N.I.I FARMA AKAD. MED. USSR | 83275-56-3 |  |
| Tirapazamine | SRI International | 27314-97-2 |  |
| Tiratricol | Glaxo (GSK) | 51-24-1 |  |
| Tirilazad | Upjohn (Pharmacia) | 110101-67-2 |  |
| Tirofiban | Merck & Co. | 142373-60-2 |  |
| Tiropramide | RottaPharm/Madeus | 55837-29-1 |  |
| Tisocalcitate | Schering AG | 156965-06-9 |  |
| Tisopurine | SmithKline Beecham (GSK) | 5334-23-6 |  |
| TISQ | Eli Lilly | |  |
| Titanocene | Ciba-Geigy (Novartis) | 1271-29-0 |  |
| Titanocene X | University College of Dublin (Ireland) | |  |
| Titanocene Y | University College Dublin | |  |
| Tivantinib | ArQule | 905854-02-6 |  |
| Tivirapine | Janssen Pharmaceutica (Johnson & Johnson) | 137332-54-8 |  |
| Tivozanib | Kirin Brewery | 475108-18-0 |  |
| Tixocortol pivalate | Jouvenial (Pfizer France) | 55560-96-8 |  |
| Tizanidine | Wander | 51322-75-9 ; 64461-82-1(hydrochloride) |  |
| TJ-41 | | 389118-03-0 | No Structure |
| TJN-331 | Tsumura & Co. | |  |
| TJN-419 | Tsumura & Co. | |  |
| TKS-1225 | Imperial College Innovations Ltd. | | No Structure |
| TL-1892 | Florida State University (US) | |  |
| TL-310 | University of Florida | |  |
| TLK-16998 | Terrapin Technologies | 210978-64-6 |  |
| TLK-19780 | Telik | 309932-59-0 |  |
| TLK-58747 | Telik Inc. (US) | |  |
| TLK-60357 | Telik Inc. | | No Structure |
| TLK-60404 | Telik Inc. | | No Structure |
| TLK-60596 | Telik Inc. | | No Structure |
| TLN-232 | Biostatin Pharmaceutical | |  |
| TLN-4601 | Ecopia BioSciences (Thallion Pharmaceuticals) | |  |
| TM-208 | Medinox Inc. (US) ; Peking University School of Pharmaceutical Science (China) | |  |
| TM-30339 | 7TM Pharma AS | | No Structure |
| TM-38837 | | | No Structure |
| TM-5007 | JR Tokai Partners Co. Ltd. (Japan) | |  |
| TM-6008 | Tokai University (Japan) | |  |
| TM-6089 | Tokai University (Japan) | |  |
| TMC-120A | Tanabe Seiyaku | |  |
| TMC-120B | Tanabe Seiyaku | |  |
| TMC-120C | Tanabe Seiyaku | |  |
| TMC-135A | Tanabe Seiyaku | |  |
| TMC-353121 | Tibotec Pharmaceuticals Ltd. (Ireland) | |  |
| TMC-435350 | Tibotec Pharmaceuticals Ltd. (Ireland) | |  |
| TMC-66 | Tanabe | 245660-81-5 |  |
| TMC-69 | Tanabe | 337529-09-6 |  |
| TMC-86A | Tanabe | 187877-92-5 |  |
| TMC-86B | Tanabe Seiyaku | |  |
| TMC-95A | Tanabe Seiyaku | 262854-09-1 |  |
| TMC-95B | Tanabe Seiyaku | 262854-07-9 |  |
| TMC-95C | Tanabe Seiyaku | 262854-07-9 |  |
| TMC-95D | Tanabe Seiyaku | 262854-09-1 |  |
| TMC-96 | Tanabe Seiyaku | |  |
| TMC-UREA | Yissum | |  |
| TMI-1 | American Cyanamid Company (Wyeth) | |  |
| TMM | Wisconsin Alumni Research Foundation | |  |
| TMP-153 | Takeda | 128831-46-9 |  |
| TMX-101 (Imiquimod) | University of California (US) ; Telormedix SA | 99011-02-6 |  |
| TMX-202 | | | No Structure |
| TNK-6123 | | 251481-69-3 |  |
| TNX-100 | Chiron | | No Structure |
| TNX-832 | Sunol Molecular Corp. | | No Structure |
| TO-195 | Torii | 151328-90-4 |  |
| Toborinone | Otsuka Pharmaceutical | 143343-83-3 |  |
| Tobramycin | | 32986-56-4 |  |
| TOC-39 | Taiho | 158295-97-7 |  |
| Tocainide | Astra (AstraZeneca) | 41708-72-9 |  |
| Tocamphyl | Chemiewerk Homburg | 5634-42-4 |  |
| Toceranib | Pharmacia Upjohn Co. | 874819-74-6 (phosphate salt) ; 356068-94-5 |  |
| Tocilizumab | Chugai (Roche) | 375823-41-9 | No Structure |
| Tocladesine | Nucleic Acid Research Inst. | 41941-56-4 |  |
| Tocofersolan | Eastman Kodak | 30999-06-5 |  |
| Tocofibrate | Andreu | 50465-39-9 |  |
| Tocopheryl nicotinate | Merck & Co. | 16676-75-8 |  |
| Todralazine | Polfa | 14679-73-3 |  |
| Tofenacin | Brocades-Stheeman ; Pharmacia | 15301-93-6 |  |
| Tofimilast | Pfizer | 185954-27-2 |  |
| Tofisopam | Pharm. Res. Inst. (Egyt) | 22345-47-7 |  |
| Tofogliflozin | Chugai Pharmaceutical Co. Ltd. (Japan) | 903565-83-3 ; 1201913-82-7 (H2O) |  |
| TOK-8801 | Kumiai | 105963-46-0 |  |
| Tolazamide | Upjohn (Pharmacia) | 1156-19-0 |  |
| Tolazoline | Ciba-Geigy (Novartis) | 59-98-3 |  |
| Tolbutamide | Hoechst (Sanofi-Aventis) | 64-77-7 |  |
| Tolcapone | Hoffmann La Roche (Roche) | 134308-13-7 |  |
| Tolciclate | Farmitalia Carlo Erba (Pharmacia) | 50838-36-3 |  |
| Tolclofos-methyl | Sumitomo Chemical | 57018-04-9 |  |
| Tolevamer | GelTex Pharmaceuticals (Genzyme) | 28038-50-8 ; 81998-90-5 (potassium sodium) |  |
| Tolfenamic acid | Gea | 13710-19-5 |  |
| Tolfenpyrad | Mitsubishi Kasei | 129558-76-5 |  |
| Tolindate | USV | 27877-51-6 |  |
| Tolmetin | Ortho McNeil (Johnson & Johnson) | 26171-23-3 |  |
| Tolnaftate | Nippon Soda | 2398-96-1 |  |
| Toloconium metilsulfate | Ciba-Geigy (Novartis) | 552-92-1 |  |
| Tolonidine | Boehringer Ingelheim | 4201-22-3 |  |
| Toloxatone | Delalande | 29218-27-7 |  |
| Tolperisone | Eisai | 728-88-1 |  |
| Tolpropamine | Hoechst (Sanofi-Aventis) | 5632-44-0 |  |
| Tolrestat | Ayerst (Wyeth) | 82964-04-3 |  |
| Tolserine | National Inst. of Health (NIH) | 145209-30-9 |  |
| Tolterodine | Pharmacia & Upjohn (Pharmacia) | 124937-51-5 |  |
| Toltrazuril | Bayer | 69004-03-1 |  |
| Tolvaptan | Otsuka | 150683-30-0 |  |
| Tolycaine | Bayer | 3686-58-6 |  |
| Tolylfluanide | Bayer | 731-27-1 |  |
| Tolylphthalamic acid | US Rubber | 85-72-3 |  |
| Tomatine | Queen Mary and Westfield College (GB) ; St. Bartholomew and the Royal London School of Medicine and | 17406-45-0 |  |
| Tomeglovir | Bayer | 233254-24-5 |  |
| Tomopenem | Sankyo | 222400-20-6 |  |
| Tonabersat | SmithKline Beecham (GSK) | 175013-84-0 |  |
| Tonapofylline | Biogen (Biogen Idec) | 340021-17-2 |  |
| Tonazocine | Sterling Drug (Sanofi-Aventis) | 71461-18-2 |  |
| TOP-008 | Hitachi Chemical | 193285-41-5 |  |
| TOP-53 | Taiho | 148262-19-5 |  |
| Topilutamide | Biophysica | 260980-89-0 |  |
| Topiramate | Ortho McNeil (Johnson & Johnson) | 97240-79-4 |  |
| Topiroxostat | Fuji Yakuhin Co Ltd. (Japan) | 577778-58-6 |  |
| Topixantrone | Boehringer Mannheim (Roche) ; University of Vermont | 156090-18-5 |  |
| Topotecan | SmithKline Beecham (GSK) | 123948-87-7 |  |
| Topovale | Rutgers State University | |  |
| Topramezone | BASF | 210631-68-8 |  |
| Toralizumab | IDEC | 252662-47-8 | No Structure |
| Torasemide | A. Christiaens | 56211-40-6 |  |
| Torcetrapib | Pfizer | 162352-17-0 |  |
| Torcitabine | Novirio (Idenix Pharmaceuticals) | 40093-94-5 |  |
| Toremifene | Farmos ; Orion | 89778-26-7 |  |
| Tosagestin | Akzo (Akzo Nobel) | 110072-15-6 |  |
| Tosedostat | British Biotech Pharmaceuticals (UK) | 238750-77-1 |  |
| Tositumomab-131I | Coulter Pharma (Corixa) ; University of Michigan | 192391-48-3 (free antibody) | No Structure |
| Tosufloxacin | Toyama | 108136-46-1 |  |
| Tosylchloramide sodium | | 127-65-1 |  |
| Totrombopag | Smithkline Beecham (GlaxoSmithKline) | 376592-42-6 |  |
| Tovaxin | Opexa Pharmaceuticals ; Baylor College Medicine | | No Structure |
| TOVNO | Albany Medical College (US) | |  |
| Tozasertib | Vertex Pharmaceuticals | 899827-04-4 (lactate salt) ; 639089-54-6 |  |
| TP-003 | Merck Sharp & Dohme | |  |
| TP-038 | Harvard College (US) | |  |
| TP-10 | Pfizer (US) | |  |
| TP-120 | Tetraphase Pharmaceuticals Inc. | |  |
| TP-2758 | Tetraphase Pharmaceuticals Inc. | | No Structure |
| TP-300 | Chugai | |  |
| TP-38 | Ivax (Teva) | | No Structure |
| TP-434 | Tetraphase Pharmaceuticals Inc. | |  |
| TP-508-Ala | University of Texas | |  |
| TP-508-Ser | University of Texas | |  |
| TP-834 | Tetraphase Pharmaceuticals Inc. | | No Structure |
| TP-9201 | La Jolla Cancer Inst. | 138297-15-1 |  |
| TPA | Rutgers, State University of New Jersey | 165561-29-8 |  |
| TPA-023 | Merck Sharp and Dohme | |  |
| TPCA-1 | Smithkline Beecham (GSK) | |  |
| TPI-1361-17 | University of California (US) | |  |
| TPI-1396-12 | Burnham Institute ; Torrey Pines Institute for Molecular Studies | |  |
| TPI-1396-34 | Burnham Institute ; Torrey Pines Institute for Molecular Studies | |  |
| TPI-1540-14 | Torrey Pines Institute for Molecular Studies | |  |
| TPI-251 | Tapestry Pharmaceuticals | |  |
| TPI-285 | Tapestry Pharmaceuticals | |  |
| TPI-287 | Tapestry Pharmaceuticals | |  |
| TPT-1 | Qufu Normal University (CN) ; Zhejiang University (CN) | |  |
| TR-0960001723 | Lion Bioscience AG | |  |
| TR-14035 | Tanabe | 232271-19-1 |  |
| TR-14531 | Tanabe Seiyaku | |  |
| TR-15170 | Tanabe | |  |
| tRA-98006 | Roswell Park Cancer Institute ; State University of New York | |  |
| Trabectedin | University of Illinois (US) | 114899-77-3 |  |
| Trabedersen | Antisense Pharma (Germany) | 925681-61-4 | No Structure |
| Trafermin | Scios Nov | 131094-16-1 |  |
| Tralkoxydim | ICI (Syngenta) | 87820-88-0 |  |
| Tralokinumab | Cambridge Antibody Technology Limited. | 1044515-88-9 | No Structure |
| Tralomethrin | Roussel-Uclaf (Aventis) | 66841-25-6 |  |
| Tralopyril | American Cyanamid Co. (US) | 122454-29-9 |  |
| Tramadol | Gruenenthal | 27203-92-5 |  |
| Tramadol PM | Circ Pharma Research and Development Ltd. | 27203-92-5 |  |
| Tramazoline | Thomae (Boehringer Ingelheim) | 1082-57-1 |  |
| Tramiprosate | Neurochem | 3687-18-1 |  |
| Trandolapril | Roussel (Sanofi-Aventis) | 87679-37-6 |  |
| Tranexamic acid | Daiichi | 1197-18-8 |  |
| Tranilast | Kissei | 53902-12-8 |  |
| (-)-trans-PAT | University of Florida (US) | |  |
| TRANSDUR Sufentanil | Durect Corp. | 56030-54-7 |  |
| Transfluthrin | Bayer | 118712-89-3 |  |
| Tranylcypromine | SmithKline French (GSK) | 155-09-9 |  |
| TRAP-101 | Università degli Studi di Ferrara (Italy) | 873567-76-1 (HCl salt) |  |
| Trapidil | Rentschler | 15421-84-8 |  |
| Trapoxin A | Shionogi Co. (Japan) | 133155-89-2 |  |
| Trapoxin B | Shionogi Co. (Japan) | 133155-90-5 |  |
| Trastuzumab | Cetus | 180288-69-1 | No Structure |
| Trastuzumab emtansine | Immunogen Inc | 1018448-65-1 | No Structure |
| Travoprost | Alcon | 157283-68-6 |  |
| Traxanox | Yoshitomi | 58712-69-9 |  |
| Traxoprodil | Pfizer | 134234-12-1 |  |
| Trazodone | Angelini | 19794-93-5 |  |
| TRBS-07 | TRION Pharma GmbH | | No Structure |
| TRC-093 | | | No Structure |
| TRC-105 | Health Research Inc. | | No Structure |
| Trecetilide | Pharmacia & Upjohn (Pharmacia) | 180918-68-7 |  |
| Trefentanil | BOC | 120656-74-8 |  |
| Trelanserin | Synthelabo (Sanofi-Aventis) | 189003-92-7 |  |
| TREM-1 CDR2(67-89) | BioXell ; Université Henri Poincaré Nancy 1 | |  |
| TREM-1 CDR3(103-119) | BioXell ; Université Henri Poincaré Nancy 1 | |  |
| Tremelimumab | Abgenix (Amgen) ; Pfizer | 745013-59-6 | No Structure |
| Trenbolone Acetate | Roussel-UCLAF | 10161-34-9 |  |
| Treosulfan | | 299-75-2 |  |
| Trepibutone | Takeda | 41826-92-0 |  |
| Treprostinil | Upjohn (Pharmacia) | 81846-19-7 |  |
| Tresperimus | Fournier | 160677-67-8 |  |
| Tretazicar | Cancer Research Campaign Technology | 21919-05-1 |  |
| Tretinoin | | 302-79-4 |  |
| Tretinoin Tocoferil | Nisshin Flour Milling | 40516-48-1 |  |
| Tretoquinol | | 30418-38-3 |  |
| Treximet (Naproxen & Sumatriptan) | Pozen | |  |
| TRI-1144 | Trimeris | |  |
| TRI-50f | Trigen | |  |
| TRI-999 | Trimeris | |  |
| TRIA-662 (Trigonellinamide Chloride) | Pharmena Sp | 1005-24-9 ; 3106-60-3 (Trigonellinamide) ; 6456-44-6 (Iodide) |  |
| Triacetyluridine | University of California | 4105-38-8 |  |
| Triadimefon | Bayer | 43121-43-3 |  |
| Triadimenol | Bayer | 55219-65-3 |  |
| Triafamone | Bayer CropScience | 874195-61-6 |  |
| Triallate | Monsanto | 2303-17-5 |  |
| Triamcinolone | American Cyanamid (Wyeth) | 124-94-7 |  |
| Triamcinolone acetonide | American Cyanamid (Wyeth) | 76-25-5 |  |
| Triamterene | SmithKline French (GSK) | 396-01-0 |  |
| Triapenthenol | Bayer | 76608-88-3 |  |
| Triapine | Yale University | 143621-35-6 |  |
| Triasulfuron | Ciba-Geigy (Novartis) | 82097-50-5 |  |
| Triazamate | Rohm & Haas ; Shell | 112143-82-5 |  |
| Triazavirine | Russian Academy of Sciences (Russian Federation) ; Russian Academy of Medical Sciences (Russian Fede | |  |
| Triaziflam | Idemetsu Kosan | 131475-57-5 |  |
| Triazofenamide | Kureha | 85830-77-9 |  |
| Triazolam | Upjohn (Pharmacia) | 28911-01-5 |  |
| Triazophos | Hoechst (Sanofi-Aventis) | 24017-47-8 |  |
| Triazoxide | Bayer | 72459-58-6 |  |
| Tribenoside | Ciba (Novartis) | 10310-32-4 |  |
| Tribenuron | DuPont | 106040-48-6 |  |
| Tribromsalan | Unilever | 87-10-5 |  |
| Tribufos | | 78-48-8 |  |
| Tributyrin | Sloan Kettering Cancer Inst. | 60-01-5 |  |
| Tricaine | Sandoz (Novartis) | 582-33-2 |  |
| Trichlamide | Nippon Kayaku | 70193-21-4 |  |
| Trichlorfon | Bayer | 52-68-6 |  |
| Trichlormethiazide | Ciba (Novartis) | 133-67-5 |  |
| Trichlorosalicylanilide | Geigy (Novartis) | 642-84-2 |  |
| Trichostatin A | MethylGene | 58880-19-6 |  |
| Trichostatin D | Kirin Brewery | |  |
| Triciferol | McGill University (Canada) | |  |
| Triciribine | US Department of Health & Human Services | 35943-35-2 |  |
| Triclabendazole | Ciba-Geigy (Novartis) | 68786-66-3 |  |
| Triclocarban | Monsanto | 101-20-2 |  |
| Triclofos | Glaxo (GSK) | 306-52-5 |  |
| Triclopyr | Dow | 55335-06-3 |  |
| Triclosan | Geigy (Novartis) | 3380-34-5 |  |
| Tricyclazole | Elanco | 41814-78-2 |  |
| Tridecactide | Tuzla (Bosnia) | 22006-64-0 |  |
| Tridemorph | BASF | 81412-43-3 |  |
| Tridiphane | Dow | 58138-08-2 |  |
| Tridolgosir | Fujisawa | 72741-87-8 |  |
| Trientine | | 112-24-3 |  |
| Trietazine | Ciba-Geigy (Novartis) | 1912-26-1 |  |
| Triethoxyspinosyn A | DowElanco | 187166-54-7 |  |
| Trifloxystrobin | Ciba-Geigy (Novartis) | 141517-21-7 |  |
| Trifloxysulfuron | Novartis | 145099-21-4 |  |
| Triflumizole | Nippon Soda | 68694-11-1 |  |
| Triflumuron | Bayer | 64628-44-0 |  |
| Trifluoperazine | SmithKline French (GSK) | 117-89-5 |  |
| Trifluperidol | Janssen Pharmaceutica (Johnson & Johnson) | 749-13-3 |  |
| Triflupromazine | SmithKline French (GSK) | 146-54-3 |  |
| Trifluproxim | Bioprojet ; INSERM | |  |
| Trifluralin | Eli Lilly | 1582-09-8 |  |
| Trifluridine | US Department of Health & Human Services | 70-00-8 |  |
| Triflusal | Pennsalt | 322-79-2 |  |
| Triflusulfuron | DuPont | 135990-29-3 |  |
| Triforine | Shell | 26644-46-2 |  |
| Trigonellinamide Chloride | | 1005-24-9 ; 3106-60-3(Trigonellinamide) ; 6456-44-6 (Iodide) |  |
| Trihexyphenidyl | Winthrop (Sanofi-Aventis) | 144-11-6 |  |
| Trilostane | Sterling Drug ; Stegram Pharmaceuticals | 13647-35-3 |  |
| Trimazosin | Pfizer | 35795-16-5 |  |
| Trimebutine | Jouveinal | 39133-31-8 |  |
| Trimecaine | Astra (AstraZeneca) | 616-68-2 |  |
| Trimedoxime | US Army | 56-97-3 |  |
| Trimegestone | Roussel-Uclaf (Sanofi-Aventis) | 74513-62-5 |  |
| Trimetaphan Camsilate | Roche | 68-91-7 |  |
| Trimetazidine | Biofarma | 5011-34-7 |  |
| Trimethacarb | Shell | 2686-99-9 |  |
| Trimethadione | Abbott | 127-48-0 |  |
| Trimethaphan | Roche | 7187-66-8 |  |
| Trimethobenzamide | Hoffmann La Roche (Roche) | 138-56-7 |  |
| Trimethoprim | Burroughs Wellcome (GSK) | 738-70-5 |  |
| Trimethoxybenzene | Lafon (Cephalon) | 621-23-8 |  |
| Trimethyliodosulfonium | Gerda | 2181-42-2 |  |
| Trimetozine | Egyt | 635-41-6 |  |
| Trimetrexate | Parke Davis (Pfizer) | 52128-35-5 |  |
| Trimidox | B. Vant Ried et al. | 95933-74-7 |  |
| Trimipramine | Rhone-Poulenc (Aventis) | 739-71-9 |  |
| TRIN-2750 | TRIN Pharma GmbH | | No Structure |
| TRIN-2755 | TRIN Pharma GmbH | |  |
| TRIN-2758 | TRIN Pharma GmbH | | No Structure |
| Trinexapac-ethyl | Ciba-Geigy (Novartis) | 95266-40-3 |  |
| Trioxysalen | Kalamazoo College | 3902-71-4 |  |
| Tripamide | Eisai | 73803-48-2 |  |
| Tripelennamine | Ciba (Novartis) | 91-81-6 |  |
| Triplatin tetranitrate | Boehringer Mannheim (Roche) | 172903-00-3 |  |
| Triprolidine | Burroughs Wellcome (GSK) | 486-12-4 |  |
| Triptolide | Pharmagenesis | 38748-32-2 |  |
| Triptorelin | Tulane University | 57773-63-4 ; 124508-66-3 (Triptorelin Pamoate) |  |
| Triticonazole | Rhone-Poulenc | 131983-72-7 |  |
| Tritiozine | ISF | 35619-65-9 |  |
| Tritoqualine | Laborec | 14504-73-5 |  |
| Tritosulfuron | BASF | 142469-14-5 |  |
| TRK-091 (Tramadol) | Nippon Shinyaku ; Toray Industries Inc. | |  |
| TRK-530 | Toray | 151425-91-1 |  |
| TRK-710 | Toray | 173903-27-0 |  |
| TRK-850 | Toray Industries Inc. (Japan) | |  |
| TRK-851 | Toray | 189015-24-5 ; 189015-25-6 (monomethanesulfonate) |  |
| TRM-115 | Terumo | 147779-46-2 |  |
| TRO-40303 | Trophos SA (France) | |  |
| Trodulamine | Magainin Pharma (Genaera) | 186139-09-3 |  |
| Trofex | Molecular Insight Pharmaceuticals Inc. | |  |
| Trofosfamide | Asta Medica (Baxter Oncology) | 22089-22-1 |  |
| Troglitazone | Sankyo | 97322-87-7 |  |
| Trolox | Hoffmann La Roche (Roche) | 53188-07-1 |  |
| Tromantadine | Merz | 53783-83-8 |  |
| Trometamol | SmithKline Beecham (GSK) | 77-86-1 |  |
| Tropantiol | University of Pennsylvania | 189950-11-6 |  |
| Tropatepine | Societe Industrielle pour la fabrication des antibiotiques | 27574-24-9 |  |
| Tropenzile | Sandoz (Novartis) | 53834-53-0 |  |
| Tropesin | Spofa | 65189-78-8 |  |
| Tropicamide | Hoffmann La Roche (Roche) | 1508-75-4 |  |
| Tropisetron | Sandoz (Novartis) | 89565-68-4 ; 105826-92-4 (hydrochloride) |  |
| Troplasminogen alfa | Neose Technologies (US) | 931101-84-7 | No Structure |
| Tropoxin | Nauchno Issledovatelsky Inst. | 184350-63-8 |  |
| Trospectomycin | Upjohn (Pharmacia) | 88669-04-9 |  |
| Trospium chloride | Pfleger | 10405-02-4 |  |
| Trovafloxacin | Pfizer | 147059-72-1 |  |
| TroVax | University of Sheffield | 848861-81-4 | No Structure |
| Trovirdine | Medivir | 149488-17-5 |  |
| TROX-1 | Merck & Co. Inc. (US) | |  |
| Troxacitabine | Yale University ; University of Georgia | 145918-75-8 |  |
| Troxerutin | Zyma | 7085-55-4 |  |
| Troxipide | Kyorin | 30751-05-4 |  |
| TRU-015 | GeneCraft (Trubion Pharmaceuticals) | | No Structure |
| TRU-016 | Trubion Pharmaceuticals | | No Structure |
| TRX-385 | Tolerx Inc. | | No Structure |
| TRX-518 | Tolerx Inc. | | No Structure |
| TRX-585 | Tolerx Inc. | | No Structure |
| Trypan Blue | | 72-57-1 |  |
| Trypan Red | | 574-64-1 |  |
| Tryparsamide | Wallau | 554-72-3 |  |
| TS-011 | Taisho Pharmaceutical | |  |
| TS-022 | Taisho Pharmaceutical Co. Ltd. (Japan) | |  |
| TS-032 (PF-4802540) | Taisho | |  |
| TS-071 | Taisho Pharmaceutical Co. Ltd. | |  |
| TS-155-2 | Teijin | 303009-07-6 |  |
| TS-2037 | Meiji Seika | |  |
| TS-734 | The General Hospital Corporation (US) | |  |
| TS-943 | Taisho | |  |
| TS-951 | Taisho | 174486-39-6 |  |
| ts-rSeV-dF-mIFNB-DC | DNAVEC Research Inc. | | No Structure |
| TSD-0014 | AnGes MG Inc. | | No Structure |
| TSL-225 | Tanabe | 211169-95-8 |  |
| TSRI-265 | The Scripps Research Institute | |  |
| TT-138 | Mitsubishi Tanabe Pharma Corp. | | No Structure |
| TT-223 | Waratah Pharmaceuticals (Transition Therapeutics) | | No Structure |
| TT-232 | Biosignal ; Semmelweis University | 147159-51-1 |  |
| TT-235 | University of NorthWestern | |  |
| TT-24 | Kansas State University | |  |
| TT-62 | Teijin | 86976-77-4 |  |
| TTA-A2 | Merck & Co. Inc. (US) | |  |
| TTA-A8 | Merck & Co. Inc. (US) | |  |
| TTA-Q6 | Merck & Co. Inc. | |  |
| TTP-889 | TransTech Pharma | | No Structure |
| TU-2100 | Tamarkin | 207972-39-2 |  |
| Tuaminoheptane | | 123-82-0 |  |
| Tubelactomicin-A | Microbiochemical Research Foundation | 235437-93-1 |  |
| Tubulysin A | GBF | 205304-86-5 |  |
| Tucaresol | Burroughs Wellcome (GSK) | 84290-27-7 |  |
| Tucotuzumab celmoleukin | EMD-Lexigen (E. Merck KGaA) | 339986-90-2 | No Structure |
| Tulathromycin A | Pfizer | 217500-96-4 |  |
| Tulathromycin B | Pfizer | 280755-12-6 |  |
| Tulobuterol | Hokuriku | 41570-61-0 |  |
| Turbostatin 1 | University of Arizona | |  |
| Turbostatin 2 | University of Arizona | |  |
| Turofexorate Isopropyl | Pharmacia & UpJohn Company | 629664-81-9 |  |
| Turosteride | Farmitalia Carlo Erba (Pharmacia) | 137099-09-3 |  |
| Twinrix | Smithkline Beecham Biologicals (GlaxoSmithKline plc) | | No Structure |
| Twynsta (Telmisartan & Amlodipine) | Boehringer Ingelheim | |  |
| TX-1123 | Tokushima University | 157397-06-3 |  |
| TX-1877 | Taiho | 197004-63-0 |  |
| TX-2036 | Tokushima University | |  |
| TX-2060 | Kyoto University ; Tokushima University | |  |
| TX-2152 | The University of Tokushima (Japan) ; Gifu Pharmaceutical University (Japan) ; Research Institute fo | |  |
| TX-380 | Searle (Pharmacia) | 124-85-6 |  |
| TX-525 | Theramex ( Merck KGaA) | 241148-95-8 |  |
| TX-527 | Theramex | 163379-89-3 |  |
| TX-67 | University of Kansas | |  |
| TY-005 | University of Arizona | |  |
| TY-027 | University of Arizona (US) | |  |
| TY-038 | University of Arizona (US) | |  |
| TY-11223 | Sagami ; Toa Eiyo | 140694-43-5 |  |
| TY-11345 | Toa Eiyo | 187589-30-6 |  |
| TY-12283 | Toa Eiyo | |  |
| TY-12533 | Toa Eiyo | 212761-58-5 |  |
| TY-12780 | Toa Eiyo Limited (Japan) | | No Structure |
| TY-51076 | Toa Eiyo | |  |
| TY-51184 | Toa Eiyo | |  |
| TY-51501 | Toa Eiyo Limited (Japan) | | No Structure |
| TYA-1 | NIH ; SC Biosciences ; Kumamoto University ; Kyoto University | |  |
| TYA-2 | NIH ; SC Biosciences ; Kumamoto University ; Kyoto University | |  |
| TYA-3 | NIH ; SC Biosciences ; Kumamoto University ; Kyoto University | |  |
| TYA-4 | NIH ; SC Biosciences ; Kumamoto University ; Kyoto University | |  |
| TYA-5 | NIH ; SC Biosciences ; Kumamoto University ; Kyoto University | |  |
| TYB-1 | NIH ; SC Biosciences ; Kumamoto University ; Kyoto University | |  |
| TYB-2 | NIH ; SC Biosciences ; Kumamoto University ; Kyoto University | |  |
| TYB-5 | NIH ; SC Biosciences ; Kumamoto University ; Kyoto University | |  |
| Tylosin | | 1401-69-0 |  |
| Tyloxapol | | 25301-02-4 |  |
| Tylvalosin | Sanraku Ocean Co. | 63409-12-1 ; 63428-13-7 (tartrate salt) |  |
| Tymazoline | Ciba (Novartis) | 24243-97-8 |  |
| Tyramine | Hexal Pharma | 51-67-2 |  |
| Tyroserleutide | Pepharm | |  |
| Tyroservatide | Pepharm (China) | |  |
| Tyrphostin B46 | Yissum Research Development | 133550-34-2 |  |
| TZB-30878 | ASKA Pharmaceutical Co. Ltd. (Japan) | |  |
| TZDM | Univ of Pennsylvania | |  |
| TZE-5323 | Teikoku Hormone | 150797-71-0 |  |
| TZS-8478 | Teikoku Hormone (Aska Pharmaceuticals) | |  |
| U-0126 | DuPont (BMS) | 109511-58-2 |  |
| U-101958 | Upjohn (Pharmacia) | 179556-82-2 |  |
| U-103017 | Upjohn (Pharmacia) | |  |
| U-50488H | Upjohn (Pharmacia) | 83913-06-8 |  |
| U-54494A | Upjohn (Pharmacia) | 92953-43-0 |  |
| U-73122 | Upjohn (Pharmacia) | 112648-68-7 |  |
| U-74389F | Upjohn (Pharmacia) | 111667-91-5 |  |
| U-74389G | University of Southern California ; Dyke Knox Van | 153190-29-5 |  |
| U-74500 | Pharmacia & Upjohn (Pharmacia) | 111640-85-8 |  |
| U-75302 | Pharmacia & Upjohn (Pharmacia) | 119477-85-9 |  |
| U-75875 | Upjohn (Pharmacia) | 112190-24-6 |  |
| U-78036 | Upjohn (Pharmacia) | 123742-98-3 |  |
| U-78517 | Upjohn (Pharmacia) | 122003-11-6 |  |
| U-81749 | Upjohn (Pharmacia) | 126103-94-4 |  |
| U-83836E | Upjohn (Pharmacia) | 137018-55-4 (2HCl) |  |
| U-87947E | Upjohn (Pharmacia) | 152253-31-1 |  |
| U-88204E | Pharmacia & Upjohn (Pharmacia) | 136816-76-7 |  |
| U-88999E | Upjohn (Pharmacia) | 142223-57-2 |  |
| U-89232 | Squibb (BMS) | 134017-78-0 |  |
| U-89843 | Upjohn (Pharmacia) | 157013-32-6 |  |
| U-91502 | Upjohn (Pharmacia) | 146778-05-4 |  |
| U-92016A | Upjohn (Pharmacia) | 149654-41-1 |  |
| U-92032 | Upjohn (Pharmacia) | 142223-92-5 |  |
| U-96988 | Upjohn (Pharmacia) | 149394-65-0 |  |
| UA-926 | Leuven Univesity , Montpellier University | |  |
| UAMC-00150 | Universiteit Antwerpen (Belgium) | |  |
| UAMC-00251 | Universiteit Antwerpen (Belgium) | |  |
| UB-165 | Univ Bath ; Univ Bristol (GB) | |  |
| Ube-RN-177360-33-7 | Ube ; Sankyo | 177360-33-7 |  |
| Ubenimex | Microbiochemical Research Foundation | 58970-76-6 |  |
| Ubidecarenol | | 56275-39-9 |  |
| Ubidecarenone | | 303-98-0 |  |
| Ubidine | Chosun University | |  |
| UC-10 | Rega Institute for Medical Research | |  |
| UC-16 | Rega Institute for Medical Research | |  |
| UC-38 | Uniroyal Chem | |  |
| UC-42 | Rega Institute for Medical Research | |  |
| UC-68 | Uniroyal Chem | |  |
| UC-70 | Uniroyal | |  |
| UC-781 | Uniroyal | |  |
| UC-81 | Rega Institute for Medical Research | |  |
| UC-82 | Uniroyal | |  |
| UC-84 | Uniroyal | 135812-04-3 |  |
| UC-AA-908 | Unichem Laboratories Ltd. (India) | |  |
| UC-AA-911 | Unichem Laboratories Ltd. (India) | |  |
| UC-AA-915 | Unichem Laboratories Ltd. (India) | |  |
| UCB-101333 | UCB | |  |
| UCB-1277763 | UCB SA (Belgium) | |  |
| UCB-2892 | UCB SA | | No Structure |
| UCB-35440 | UCB | |  |
| UCB-35625 | Banyu Pharma | |  |
| UCB-62106 | UCB | |  |
| UCC-C4243 | Uniroyal | 120890-70-2 |  |
| UCF-116B | Kyowa Hakko | 299436-42-3 |  |
| UCL-1972 | Bioprojet (GSK) | 220728-17-6 |  |
| UCN-01 | Kyowa Hakko | 112953-11-4 |  |
| UCS-1025A | Kyowa Hakko | 209126-31-8 |  |
| UCT-1072M1 | Kyowa Hakko | 193402-64-1 |  |
| UCT-1072M2 | Kyowa Hakko | 193402-65-2 |  |
| Udenafil | Dong-A Pharm. | 268203-93-6 |  |
| UFP-102 | University of Ferrera | |  |
| UFP-512 | Unigene Laboratories Inc. (US) | |  |
| UFP-803 | University of Ferrara | 879497-82-2 |  |
| UH-232 | Carlsson Arvid Emil | 95999-12-5 |  |
| UH-301 | Astra (AstraZeneca) | 127126-21-0 |  |
| UIC-02031 | University of Illinois | |  |
| UIC-1005 | UIC (University of Illinois at Chicago) | |  |
| UIC-94003 | University of Illinois | |  |
| UK-1 | Suntory | 151271-53-3 |  |
| UK-122 | University of Arizona (USA) | |  |
| UK-147535 | Pfizer | |  |
| UK-156406 | Pfizer | 169950-44-1 |  |
| UK-157147 | Pfizer | |  |
| UK-21 | Ube ; Gifu Pharmaceutical University | 134423-92-0 |  |
| UK-224671 | Pfizer | 178309-91-6 |  |
| UK-226471 | Pfizer | | No Structure |
| UK-240455 | Pfizer | | No Structure |
| UK-25 | Ube | 134460-39-2 |  |
| UK-290795 | Pfizer | |  |
| UK-292663 | Pfizer | | No Structure |
| UK-294315 | Pfizer | |  |
| UK-315716 | Pfizer | | No Structure |
| UK-328295 | Pfizer | |  |
| UK-343664 | Pfizer | 215297-27-1 |  |
| UK-356,202 | Pfizer | |  |
| UK-357903 | Pfizer | | No Structure |
| UK-371104 | Pfizer | |  |
| UK-371800 | Pfizer | 247582-13-4 |  |
| UK-371804 | Pfizer | |  |
| UK-373911 | Pfizer | |  |
| UK-396082 | Pfizer | |  |
| UK-396794 | Pfizer | |  |
| UK-421045 | Pfizer | |  |
| UK-432097 | Pfizer | | No Structure |
| UK-484900 | Pfizer Inc. | |  |
| UK-51656 | Alcon | 88150-59-8 |  |
| UK-57562-01 | Pfizer | |  |
| UK-66838 | Pfizer | 111539-44-7 |  |
| Ukrain | Nowicky | 86639-82-9 |  |
| Ularitide | Bissendorf Peptide | 118812-69-4 |  |
| Ulesfia | Summers Laboratories Inc. | 100-51-6 |  |
| Ulifloxacin | Nippon Shinyaku | 112984-60-8 |  |
| Ulimorelin | Tranzyme Pharma (Canada) | 842131-33-3 ; 951326-02-6 (hydrochloride) |  |
| Ulinastatin | Generic | 9010-53-1 | No Structure |
| Ulipristal | Triangle Research Institute | 159811-51-5 |  |
| Ulipristal acetate | Triangle Research Institute | 126784-99-4 |  |
| Ulobetasol | Ciba-Geigy (Novartis) | 66852-54-8 |  |
| UMB-101 | Matsumoto | |  |
| UMB-102 | Matsumoto | |  |
| UMB-103 | Matsumoto | |  |
| UMB-116 | University of Maryland ; University of Mississippi ; University of Oklahoma Health Science Center | |  |
| UMF-078 | Michigan University | 153807-48-8 |  |
| Umifenovir | Vni Khim Farmats (Soviet Union) | 131707-23-8 (HCl) ; \n131707-25-0 |  |
| Umirolimus | Biosensors International | 851536-75-9 |  |
| UMJD-1369 | Univ. degli Studi di Bologna ; Lake Erie College Osteopathic Medicine (US) ; Univ. of Michigan | |  |
| UMN-03 | UMN Pharma Inc. | | No Structure |
| UNBS-1450 | Unibioscreen | |  |
| UNBS-3157 | Unibioscreen | |  |
| UNBS-4209 | Unibioscreen S.A. (Belgium) | |  |
| UNBS-5162 | Unibioscreen SA (Belgium) | |  |
| Uncialamycin | The University of British Columbia (Canada) | |  |
| undecylenic acid | | 112-38-9 |  |
| Uniconazole | Sumitomo Chemical | 83657-22-1 |  |
| Uniconazole-P | Sumitomo Chemical | 83657-17-4 |  |
| Unnarmicin A | Marine Biotechology Institute Co. Ltd. (Japan) | |  |
| Unnarmicin C | Marine Biotechology Institute Co. Ltd. (Japan) | |  |
| Unoprostone | Ueno Seiyaku Oyo Kenkyujo (japan) | 120373-36-6 |  |
| UP-302 | Unigen Pharmaceuticals Inc. (US) | 869743-37-3 |  |
| UP-Bzl | Universiteit Leiden | |  |
| UPF-680 | Children's Hospital Medical Center ; Universita degli Studi di Perugia | |  |
| UPF-874 | University of Maryland School of Medicine (US) ; University of Perugia (Italy) | |  |
| UPF-987 | Intercept Pharmaceuticals Inc. (US) | |  |
| Upidosin | Recordati | 152735-23-4 |  |
| UR-12670 | Uriach | 173604-65-4 |  |
| UR-12715 | Uriach | |  |
| UR-13308 | Uriach | |  |
| UR-14048 | Uriach | |  |
| UR-1505 | Uriach | |  |
| UR-7280 | Uriach | 177848-35-0 |  |
| UR-8308 | Uriach | 158662-54-5 |  |
| UR-8328 | Uriach | 158662-59-0 |  |
| Uracil | Upjohn (Pharmacia) | 66-22-8 |  |
| Uramustine | Upjohn (Pharmacia) | 66-75-1 |  |
| Urapidil | Byk Gulden (Nycomed) | 34661-75-1 |  |
| Urazamide | Synthelabo (Sanofi-Aventis) | 34879-34-0 |  |
| URB-447 | University of California (US) ; Università degli Studi di Urbino ‘‘Carlo Bo” (Italy) ; University of | 1132922-57-6 |  |
| URB-524 | University of California ; University of Urbino ; University of parma | |  |
| URB-532 | University of Bari ; University of California ; University of Napoli ; University of Parma ; Univers | |  |
| URB-597 | University of Bari ; University of California ; University of Napoli ; University of Parma ; Univers | |  |
| URB-937 | University of California | |  |
| Urelumab | Bristol-Myers Squibb Co. (US) | 934823-49-1 | No Structure |
| Uridine | | 58-96-8 |  |
| Uridine triphosphate | University of North Carolina (US) | 63-39-8 |  |
| Urocalun | | | No Structure |
| Urocidin | Bioniche Life Sciences | | No Structure |
| Urocortin 2 | Research Development Foundation (US) | |  |
| Urofollitropin | | 97048-13-0 | No Structure |
| Uroguanylin | IPF Pharmaceuticals | 164252-35-1 |  |
| Urokinase | Leo Pharm | 9039-53-6 | No Structure |
| Ursodeoxycholic acid | Tanabe | 128-13-2 |  |
| Ursolic acid phosphate | Pola Chemical Industries Inc. (Japan) | |  |
| Urtoxazumab | | 502496-16-4 | No Structure |
| Urukthapelstatin A | Marine Biotechnology Institute Co. Ltd. (Japan) | |  |
| Usambarensine | Centre Oscar Lambret | 36150-14-8 |  |
| Ushercell | Dextran Products (Polydex) | 9032-43-3 ; 9005-22-5 (sodium salt) | No Structure |
| UshStat | Oxford BioMedica Ltd. | | No Structure |
| Usistapide | Janssen Pharmaceutica NV (Johnson & Johnson Inc.) | |  |
| USPM-1232 | PharmaMar S.A. (Spain) | |  |
| Ustekinumab | Centocor | 815610-63-0 | No Structure |
| USTILIPID A | HMR (Aventis) | |  |
| UT-15C (Treprostinil) | United Therapeutics Corporation | |  |
| UT-231B | Synergy Pharmaceuticals ; University of Oxford ; Jefferson University | |  |
| UWA-0121 | Atuka Ltd. (Canada) ; Toronto Western Research Institute (Canada) ; Toronto Western Hospital (Canada | |  |
| V-06 | Vertex Pharmaceuticals | |  |
| V-10367 | Vertex | 188614-94-0 |  |
| V-111662 | Euro celtique | |  |
| V-11294A | Euro-Celtique | 162278-09-3 |  |
| V-158411 | Vernalis plc | | No Structure |
| V-158866 | Vernalis plc | | No Structure |
| V-165 | V; V. Tets | |  |
| V-201696 | Cocensys | |  |
| V-212 | Merck & Co. Inc. | | No Structure |
| V-24343 | Vernalis plc | | No Structure |
| V-419 | | | No Structure |
| V-503 | Merck & Co. Inc. | | No Structure |
| V-526 | Merck & Co. Inc. (US) | | No Structure |
| V-5544B | Vita Invest | 168906-58-9 |  |
| V-710 | Intercell | | No Structure |
| V-85546 | British Biotech Pharmaceuticals Ltd. (Vernalis plc) ; Laboratoires Serono SA | |  |
| V-930 | Istituto di Ricerche di Biologia Molecolare P. Angeletti Spa (Merck & Co. Inc.) | | No Structure |
| V-934-V-935 | Geron Corp. | | No Structure |
| V-950 | Merck & Co, Inc. | | No Structure |
| VA-045 | Taisho | 128759-76-2 |  |
| VA-100 | | 174311-57-0 |  |
| VA-101 | | 174311-53-6 |  |
| VA-111913 | Ferring BV | |  |
| VA-118020 | Vantia Ltd. | | No Structure |
| VA-21B7 | Vita Invest | 160599-89-3 |  |
| VA-999260 | Vantia Ltd. | | No Structure |
| Vabicaserin | Wyeth | 620948-34-7 |  |
| Vacc-4x | Bionor Immuno | | No Structure |
| Vadimezan | Cancer Research Campaign Technology (Cancer Research Technology Ltd.) | 117570-53-3 |  |
| VAF-347 | Novartis AG ; Novartis Pharma GmbH | |  |
| VAL-101 | Imperial College Innovations Ltd. | | No Structure |
| VAL-201 | Cancer Research Technology (CRT) | | No Structure |
| Val-Val-Saquinavir | University of Missouri | |  |
| Valaciclovir | Wellcome Foundation (GSK) | 124832-26-4 |  |
| Valategrast | Hoffman-La Roche | 220847-86-9 |  |
| Valdecoxib | Searle (Pfizer) | 181695-72-7 |  |
| Valerenic acid | | 3569-10-6 ; 64130-69-4 |  |
| Valethamate bromide | Kali Chemie | 90-22-2 |  |
| Valganciclovir | Wellcome (GSK) | 175865-60-8 ; 175865-59-5 (hydrochloride) |  |
| Validamycin | Takeda | 37248-47-8 |  |
| Valifenalate | ISAGRO S.p.A. | 283159-90-0 |  |
| Valnemulin | Sandoz | 101312-92-9 |  |
| Valnoctamide | Sanofi (Sanofi-Aventis) | 4171-13-5 |  |
| Valomaciclovir | Medivir | 195156-77-5 |  |
| Valopicitabine | Idenix | 640281-90-9 |  |
| Valproic acid | Chemetron | 99-66-1 ; 1069-66-5 (sodium) |  |
| Valpromide | Labaz | 2430-27-5 |  |
| Valrocemide | Yissum ; Teva | 92262-58-3 |  |
| Valrubicin | Sidney Farber Cancer Inst. | 56124-62-0 |  |
| Valsartan | Ciba-Geigy (Novartis) | 137862-53-4 |  |
| Valsartan & Amlodipine & Hydrochlorothiazide | Novartis AG (Switzerland) | 137862-53-4 (Valsartan) ; 88150-42-9 (Amlodipine) ; 58-93-5 (Hydrochlorothiazide) |  |
| Valspodar | Sandoz (Novartis) | 121584-18-7 |  |
| Valtorcitabine | Idenix Pharmaceuticals | 380886-95-3 |  |
| Vamidothion | Rhone-Poulenc | 2275-23-2 |  |
| VAN-M-02 | Nagoya University (Japan) ; Shionogi & Co. Ltd. | |  |
| Vanadyl(IV)-Allixin | | |  |
| Vancomycin | Eli Lilly | 1404-90-6 |  |
| Vandetanib | AstraZeneca | 338992-00-0 ; 443913-73-3 |  |
| Vaniliprole | Rhone-Poulenc | 145767-97-1 |  |
| Vanillotoxin 3 | University of California | |  |
| Vaniprevir | Merck & Co. Inc. (US) | 923590-37-8 |  |
| Vanoxerine | Gist-Brocades (Royal Gist-Brocades) | 67469-69-6 |  |
| vapaliximab | BioTie ; Boehringer Ingelheim | 336801-86-6 | No Structure |
| Vapitadine | Janssen Pharmaceutica (Johnson & Johnson) | 793655-64-8 ; 279253-83-7 (Dihydrochloride) |  |
| Vapreotide | Tulane University | 103222-11-3 ; 849479-74-9 (acetate) |  |
| VAQKTmV | University of Liverpool (GB) ; University of Manchester (GB) | |  |
| Vardenafil | Bayer | 224785-90-4 |  |
| Varenicline | Pfizer | 249296-44-4 |  |
| Varespladib | Eli Lilly | 172732-68-2 |  |
| Varespladib methyl | Eli Lilly | 172733-08-3 |  |
| Varfollitropin alfa | | 847420-37-5 (alpha subunit) ; \n847420-38-6 (beta subunit) |  |
| Varlitinib | Array BioPharma | 845272-21-1 ; 1146629-86-8 (Tosylate) |  |
| VAS-001 | Vastrata Ltd. | | No Structure |
| VAS-012 | Vastrata Ltd. | | No Structure |
| VAS-021 | Vastrata Ltd. | | No Structure |
| VAS-034 | Vastrata Ltd. | | No Structure |
| VAS-047 | Vastrata Ltd. | | No Structure |
| VAS-048 | Vastrata Ltd. | | No Structure |
| VAS-2870 | Vasopharm Biotech GmbH | |  |
| Vascugel | Pervasis Therapeutics | | No Structure |
| Vasopressin | | 113-79-1 |  |
| Vatalanib | Novartis | 212141-54-3 |  |
| Vatanidipine | Green Cross (Mitsubishi Pharma) | 133743-71-2 (2H2O) |  |
| Vatreptacog alfa (activated) | Novo Nordisk | 897936-89-9 | No Structure |
| VAX-102 | VaxInnate Corp. (US) | | No Structure |
| VAX-125 | VaxInnate Corp. (US) | | No Structure |
| VB-111 | Vascular Biogenics Ltd. | | No Structure |
| VB-19038 | Agouron (Pfizer) | 221045-91-6 |  |
| VB-6845 | Merck | | No Structure |
| VB2-011 | Viventia | | No Structure |
| VB4-845 | | | No Structure |
| VCL-CB01 | Vical Inc. (US) | | No Structure |
| vCP-205 | Sanofi-aventis (France) | | No Structure |
| Vebufloxacin | Otsuka Pharma | 79644-90-9 |  |
| Vecuronium bromide | Akzo (Akzo Nobel) | 50700-72-6 |  |
| Vedaclidine | Novo Nordisk | 141575-50-0 |  |
| Vedaprofen | CERM CENT EUROP RECH MAUVERNAY | 71109-09-6 |  |
| Vedolizumab | Millennium Pharmaceuticals (Takeda) ; Genentech | 943609-66-3 | No Structure |
| Vedotin | Seattle Genetics, Inc. | 474645-27-7 |  |
| VEGF antagonist OSI | | | No Structure |
| VEGF-165 | Ark Therapeutics | 208129-01-5 | No Structure |
| Veglin | USC (University of Southern California) | | No Structure |
| VEL-0230 | Nippon Chemiphar Co. Ltd. (Japan) | |  |
| Velafermin | CuraGen | 697766-75-9 |  |
| Velaglucerase alfa | | 884604-91-5 | No Structure |
| Velaresol | Wellcome (GSK) | 77858-21-0 |  |
| Veliflapon | Bayer | 128253-31-6 |  |
| Velimogene aliplasmid | Vical Incorporated | 296251-72-4 | No Structure |
| Veliparib | Abbott Laboratories | 912444-00-9 |  |
| Velnacrine | Hoechst (Sanofi-Aventis) | 104675-29-8 |  |
| Velneperit | Shionogi | 342577-38-2 |  |
| Veltuzumab | Immunomedics, Inc. | 728917-18-8 | No Structure |
| Velusetrag | Theravance | 866933-46-2 ; 866933-51-9 (hydrochloride salt) |  |
| Vemurafenib | Plexikon | 918504-65-1 |  |
| Venlafaxine | American Home Products (Wyeth) | 93413-69-5 |  |
| Venlafaxine N-oxide | Solvay Pharmaceuticals BV (Netherlands) | |  |
| VER-154403 | Sanofi-aventis (France) ; Vernalis plc (GB) | |  |
| VER-155008 | Vernalis plc | |  |
| VER-156084 | Vernalis Research Ltd. (Vernalis plc) | |  |
| VER-2692 | Vernalis | |  |
| VER-4187 | Vernalis | |  |
| VER-49009 | Vernalis Oxford Ltd. ; Cancer Research Technology ; Institute Of Cancer Research | |  |
| VER-6623 | Vernalis | |  |
| Veralipride | Synthelabo (Sanofi-Aventis) | 66644-81-3 |  |
| Verapamil | Knoll (Abbott) | 52-53-9 |  |
| Verbenone | Glidden Co. | 80-57-9 |  |
| Verbutin | Agro-Chemie (Chinoin) | 185676-84-0 |  |
| Verlukast | Merck Frosst (Merck & Co.) | 120443-16-5 |  |
| Vernakalant | Cardiome Pharma | 605683-48-5 ; 748810-28-8 |  |
| Vernolate | Stauffer | 1929-77-7 |  |
| Verpasep caltespen | Stressgen Biotechnologies (Nventa Biopharmaceuticals) | 295371-00-5 |  |
| Versipelostatin | Toudai | |  |
| Verteporfin | University of British Colombia | 129497-78-5 |  |
| Verubulin | Cytovia (EpiCept) ; Myriad Genetics Inc. (US) | 827031-83-4 ; 917369-31-4 (HCl) |  |
| Verucerfont | Neurocrine Biosciences Inc. (US) | 885220-61-1 |  |
| Vesiculin | Protemix Discovery Ltd | |  |
| Vesnarinone | Otsuka | 81840-15-5 |  |
| Vestipitant | Glaxo(GSK) | 334476-46-9 (mesylate) |  |
| Vetrabutine | Thomae (Boehringer Ingelheim) | 3735-45-3 |  |
| VG-6-1 | Mediolanum Farmaceutici | 173315-47-4 |  |
| VG-III-39 | University of Tennessee (US) ; Ohio State University (US) | |  |
| VGA-1102 | Taisho | |  |
| VGV-1 | Tomson Genetics (Viral Genetics) | | No Structure |
| VGX-1027 | Ganial Immunotherapeutics Inc. | 6501-72-0 |  |
| VGX-3100 | University of Pennsylvania (US) | | No Structure |
| VGX-3200 | VGX Pharmaceuticals | | No Structure |
| VGX-3400 | University of Pennsylvania (US) ; VGX Pharmaceuticals Inc. (Inovio Pharmaceuticals Inc.) | | No Structure |
| VI-0521 (Phentermine & Topiramate) | Vivus Inc. | 960078-81-3 ; 122-09-8 (Phentermine) ; 97240-79-4 (Topiramate) |  |
| VIAject (Insulin) | Biodel Inc. (US) | | No Structure |
| Vialinin B | Tokyo University of Agriculture (Japan) ; Rikagaku Kenkyusho (Japan) | |  |
| VIB-100 | Indena | |  |
| VIB-106 | Indena | |  |
| VIB-173 | Indena | |  |
| VIC-103975 | Upjohn | |  |
| VIC-104203 | Upjohn | |  |
| VIC-104276 | Upjohn | |  |
| VIC-104482 | Upjohn | |  |
| VIC-104766 | Upjohn | |  |
| VIC-104782 | Upjohn | |  |
| VIC-104811 | Upjohn | |  |
| VIC-104819 | Upjohn | |  |
| VIC-104936 | Upjohn | |  |
| VIC-104988 | Pharmacia & Upjohn (Pfizer) | |  |
| VIC-105403 | Vicuron Pharmaceuticals | |  |
| VIC-105404 | Vicuron Pharmaceuticals | |  |
| VIC-105465 | Vicuron Pharmaceuticals | |  |
| VIC-105535 | Warner-Lambert (Pfizer) | |  |
| VIC-105555 | Vicuron Pharmaceuticals | |  |
| VIC-105630 | Vicuron Pharmaceuticals | |  |
| VIC-105759 | Vicuron Pharmaceuticals | |  |
| VIC-106538 | Vicuron | |  |
| VIC-106675 | Pharmacia & Upjohn (Pfizer) | |  |
| VIC-106863 | Pharmacia & Upjohn (Pfizer) | |  |
| VIC-200603 | Biosearch Italia (Vicuron) | |  |
| Vicriviroc | Schering-Plough (Merck & Co) | 306296-47-9 ; 599179-03-0 (maleate) |  |
| Vidarabine | Parke, Davis (Pfizer) | 5536-17-4 |  |
| Vidofludimus | 4SC AG | 717824-30-1 |  |
| Vigabatrin | Merrell Dow (Aventis) | 60643-86-9 |  |
| Vilanterol | GlaxoSmithKline | 503068-34-6 ; 503070-58-4 (trifenatate) |  |
| Vilazodone | E. Merck KGaA | 163521-12-8 ; 163521-08-2 (HCl) |  |
| Vildagliptin | Novartis | 274901-16-5 |  |
| Viloxazine | ICI (AstraZeneca) | 46817-91-8 |  |
| Viminol | Whitefin Holding | 21363-18-8 |  |
| Vinblastine | Can. Pats. Dev. | 865-21-4 |  |
| Vinburnine | Richter Gedeon | 4880-88-0 |  |
| Vincamine | Richter Gedeon | 1617-90-9 ; 10592-03-7 (hydrochloride) ; 64034-84-0 (tartrate) ; 51179-28-3 (teprosilate) |  |
| Vinclozolin | BASF | 50471-44-8 |  |
| Vinconate | Omnichem | 70704-03-9 |  |
| Vincristine | Eli Lilly | 57-22-7 |  |
| Vindeburnol | Roussel Uclaf | 68779-67-9 |  |
| Vindesine | Eli Lilly | 53643-48-4 |  |
| Vinflunine | Pierre Fabre | 162652-95-1 ; 194468-36-5 (ditartrate salt) |  |
| Vinfosiltine | ADIR (Servier) | 123286-00-0 |  |
| Vinorelbine | ANVAR | 71486-22-1 |  |
| Vinpocetine | Richter Gedeon | 42971-09-5 |  |
| Vintoperol | Gedeon Richter | 106498-99-1 |  |
| Vinylamycin | Microbial Chemical Research Foundation | 224427-91-2 |  |
| Vinylbital | BASF (Abbott) | 2430-49-1 |  |
| Violacein | | 548-54-9 |  |
| Viotra | e-Therapeutics plc | | No Structure |
| Vipadenant | Vernalis plc (GB) | 442908-10-3 |  |
| Viqualine | Pharmindustrie | 72714-74-0 |  |
| Viquidacin | Aventis Pharma (Sanofi-Aventis) | 904302-98-3 |  |
| Viquidil | Polaroid | 84-55-9 |  |
| VIR-576 | IPF Pharmaceuticals GmbH (Germany) | |  |
| Viramidine | Nucleic Acid Research Institute | 119567-79-2 ; 40372-00-7 (Hydrochloride) |  |
| Virapt | Vision 7 GmbH ; Chemotherapeutisches Forschunginstitut (Germany) | | No Structure |
| Virulizin | Imutec (Lorus Therapeutics) | 216586-46-8 | No Structure |
| Visilizumab | | 219716-33-3 | No Structure |
| Vismodegib | Genentech Inc ; Curis Inc | 879085-55-9 |  |
| Vitaros (Alprostadil) | NexMed | 745-65-3 |  |
| Vitespen | University of Fordham(US) | 492448-75-6 | No Structure |
| Vitexin | Nippon Mektron KK, Japan | 3681-93-4 (521-33-5) |  |
| Vitilevuamide | University of Utah | 191681-63-7 |  |
| Vitisin C | Meijo University | 180580-73-8 |  |
| Vitreosolve | | | No Structure |
| Vivace (Delapril & Manidipine) | Takeda ; Chiesi Farmaceutici | 187741-48-6 |  |
| Vivit | CBR (Institute for Biomedical Research) | |  |
| VK-28 | Technion ; Yeda | |  |
| VL-0395 | Rotta | |  |
| VLP-H-G | University of Massachusetts (US) | | No Structure |
| VM-202 | ViroMed (South Korea) | | No Structure |
| VMA-99-82 | Volgograd Medical Academy | |  |
| VMD-30283 | | | No Structure |
| VML-530 | Abbott | |  |
| VMP-001 | Walter Read Army Institute of Research (US) | | No Structure |
| vMyxgfp | Robarts Research Institute (Canada) | | No Structure |
| VN-12-1 | University of Maryland | |  |
| VN-124-1 | University of Maryland | |  |
| VN-14-1 | University of Maryland | |  |
| VN-2222 | Vita Invest | |  |
| VN-50A-1 | University of Maryland | |  |
| VN-851 | Maryland University | |  |
| VNA-932 | American Home Products (Wyeth) | 220460-92-4 |  |
| VNLG-60 | University of Maryland | |  |
| VNP-20009 | Sloan Kettering Cancer Inst. ; Vion Pharmaceuticals | | No Structure |
| VNP-489 | Novartis | | No Structure |
| Voclosporin | Isotechnika | 368455-04-3 ; 515814-01-4 |  |
| Vofopitant | Glaxo (GSK) | 168266-90-8 |  |
| Voglibose | Takeda | 83480-29-9 |  |
| Volasertib | Boehringer Ingelheim GmbH (Germany) | 755038-65-4 |  |
| Volinanserin | Merrell Dow (Sanofi-Aventis) | 139290-65-6 |  |
| Volociximab | Protein Design Labs (PDL BioPharma) | 558480-40-3 | No Structure |
| Volpristin | RPR (Aventis) | 21102-49-8 |  |
| Vorapaxar | Schering Corp (Merck & Co) | 618385-01-6 |  |
| Voriconazole | Pfizer | 137234-62-9 |  |
| Vorinostat | Sloan Kettering Cancer Inst. ; Virginia Commonwealth University | 149647-78-9 |  |
| Vorozole | Janssen Pharmaceutica (Johnson & Johnson) | 129731-10-8 |  |
| Vosaroxin | Dainippon | 175414-77-4 |  |
| Votumumab | | 148189-70-2 | No Structure |
| Voxergolide | Roussel-Uclaf (Aventis) | 134377-22-3 |  |
| VP-128 | Universite du Quebec a Trois-Rivieres (Canada) | |  |
| VP-14637 | ViroPharma | 235106-62-4 |  |
| VP-19744 | ViroPharma ; Wyeth | |  |
| VP-32947 | ViroPharma | 212246-37-2 |  |
| VP-343 | Wakamoto | 214143-14-3 |  |
| VP35-VP24-L PMOS | AVI BioPharma | | No Structure |
| VPC-01091 | University of Virginia | |  |
| VPC-01211 | University of Virginia | |  |
| VPC-12249 | University of Virginia | |  |
| VPC-44116 | University of Virginia | |  |
| VPU | Allied Chemicals | 6098-20-0 |  |
| VRC-3783 | Upjohn (Pharmacia) (Pfizer) | |  |
| VRC-3807 | Pharmacia (Pfizer) | |  |
| VRC-3808 | Pharmacia | |  |
| VRC-3909 | Pharmacia | |  |
| VRC-3923 | Pharmacia | |  |
| VRC-3924 | Pharmacia (Pfizer) | |  |
| VRC-4104 | Pharmacia | |  |
| VRC-4219 | Vicuron | |  |
| VRC-4232 | Versicor (Vicuron) | |  |
| VRC-4307 | Versicor (Vicuron) | |  |
| VRC-4530 | Vicuron (Pfizer) | |  |
| VRS-317 | Amunix Inc. | | No Structure |
| VRS-826 | Amunix Inc. | | No Structure |
| VRS-859 | Amunix Inc. | | No Structure |
| VRS-859 (Exenatide) | Amunix Inc. | | No Structure |
| VRT-125853 | Vertex Pharmaceuticals | |  |
| VRT-21493 | Vertex | |  |
| VRX-007 | Saint Louis University | | No Structure |
| VRX-009 | Saint Louis University | | No Structure |
| VRX-011 | Saint Louis University | | No Structure |
| VRX-03011 | Epix Pharmaceuticals Inc. (US) | |  |
| VRX-480773 | Valeant Pharmaceuticals International (US) | |  |
| VRX-806 | | | No Structure |
| VSN-13 | UCL BioMedica | |  |
| VSN-16 | University College London (GB) | |  |
| VSN-29 | UCL BioMedica | |  |
| VSN-32 | UCL BioMedica | |  |
| VSOP-C184 | Silica Gel | | No Structure |
| VSSP-GM3 -E7 Peptide | Centro de Ingenieria Genetica y Biotecnologia | | No Structure |
| VT-111 | Viron Therapeutics | | No Structure |
| VTP-195183 | Vitae Pharmaceuticals | | No Structure |
| VTP-201227 | Vitae Pharmaceuticals | | No Structure |
| VTX-1463 | Array BioPharma Inc. | | No Structure |
| VTX-2337 | Array BioPharma Inc. | |  |
| VTX-744 | VentiRx Pharmaceuticals Inc | | No Structure |
| VTX-763 | Array BioPharma Inc. | | No Structure |
| VU-0255035 | Vanderbilt University Medical Center | 1135243-19-4 |  |
| VU-0357017 | Vanderbilt University (US) | 1135681-23-0 ; 1135242-13-5 (HCl salt) |  |
| VUF-10249 | Vereniging voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek en Patiëntenzorg (Netherland | |  |
| VUF-10321 | Vereniging voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek en Patiëntenzorg (Netherland | |  |
| VUF-10349 | Vereniging voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek en Patiëntenzorg (Netherland | |  |
| VUF-10497 | Vrije Universiteit (Netherlands) | |  |
| VUF-2274 | Berlex | |  |
| VUF-5087 | Kowa | 205875-33-8 |  |
| VUF-5224 | University of Cambridge ; De Novo Pharmaceuticals; Vrije Universiteit | |  |
| VUF-5225 | University of Cambridge ; De Novo Pharmaceuticals; Vrije Universiteit | |  |
| VUF-5228 | University of Cambridge ; De Novo Pharmaceuticals; Vrije Universiteit | |  |
| VUF-5472 | University of Leiden | 331472-39-0 |  |
| VUF-5574 | Schering (Merck & Co) | |  |
| VUF-5642 | University of Cambridge ; De Novo Pharmaceuticals; Vrije Universiteit | |  |
| VUF-5649 | University of Cambridge ; De Novo Pharmaceuticals; Vrije Universiteit | |  |
| VUF-5650 | University of Cambridge ; De Novo Pharmaceuticals; Vrije Universiteit | |  |
| VUF-8504 | University of Amsterdam | |  |
| VUF-K-8788 | Kowa | 219741-10-3 |  |
| VUFB-15496 | Spofa | 104821-37-6 |  |
| VUFB-17724 | Res. Inst. Pharm. Biochem. | 134987-26-1 |  |
| VUFB-18285 | Res. Inst. Pharm. Biochem. | 134987-20-5 |  |
| VUFB-20615 | Leciva | |  |
| VUFB-20623 | Leciva | |  |
| Vx-001 | Institut Gustave Roussy ; INSERM (Institut National de la Sante et de la Recherche Medicale) | |  |
| VX-148 | Vertex | 297730-05-3 |  |
| VX-222 | ViroChem Pharma Inc. (Vertex Pharmaceuticals Inc.) | 1214735-13-3 |  |
| VX-25 | Vaccinex Inc. | | No Structure |
| VX-30 | Vaccinex Inc. | | No Structure |
| VX-35 | Vaccinex Inc. | | No Structure |
| VX-409 | Vertex | | No Structure |
| VX-45 | Vaccinex Inc. | | No Structure |
| VX-5 | Vaccinex Inc. | | No Structure |
| VX-509 | | | No Structure |
| VX-70 | Vaccinex Inc. | | No Structure |
| VX-702 | Vertex | 479543-46-9 |  |
| VX-745 | Vertex | 209410-46-8 |  |
| VX-759 | | | No Structure |
| VX-765 | Vertex | |  |
| VX-809 | Vertex Pharmaceuticals Inc. | 1220975-12-1 |  |
| VX-944 | Vertex | 501345-02-4 |  |
| VX-985 | | | No Structure |
| VX15-2503 | Vaccinex Inc. | | No Structure |
| Vycavert (Hydrocodone & Paracetamol) | Acura Pharmaceuticals Inc. | 125-29-1 (Hydrocodone) ; 103-90-2 (Paracetamol) |  |
| Vytorin (Simvastatin & Ezetimibe) | Schering Corp (Merck & Co) | |  |
| W-140 | Scripps Research Institute | |  |
| W-146 | Scripps Research Institute | |  |
| W-3646 | Wakunaga | |  |
| W-54011 | Mitsubishi Pharma | 405098-33-1 |  |
| Walrycin B | | |  |
| Warfarin | Wisconsin Alumni Research Foundation | 81-81-2 ; 2610-86-8 (potassium) |  |
| WAY-100012 | Wyeth | |  |
| WAY-100135 | Wyeth | 133025-23-7 |  |
| WAY-100289 | Wyeth | 136013-69-9 |  |
| WAY-100635 | Wyeth | 146714-97-8 |  |
| WAY-101 | Wyeth Corp. (US) | |  |
| WAY-103 | | |  |
| WAY-121006 | American Home Products (Wyeth) | 136326-31-3 |  |
| WAY-121520 | American Home Products (Wyeth) | 135872-94-5 |  |
| WAY-121898 | American Home Products (Wyeth) | |  |
| WAY-123223 | American Home Products (Wyeth) | 136727-01-0 |  |
| WAY-123398 | American Home Products (Wyeth) | 138490-53-6 |  |
| WAY-123783 | American Home Products (Wyeth) | 152595-59-0 |  |
| WAY-125971 | American Home Products (Wyeth) | 139047-48-6 |  |
| WAY-127312 | American Home Products (Wyeth) | 143690-42-0 |  |
| WAY-132983 | American Home Products (Wyeth) | |  |
| WAY-133537 | American Home Products (Wyeth) | |  |
| WAY-135433 | American Home Products (Wyeth) | |  |
| WAY-140288 | American Cyanamid (Wyeth) | |  |
| WAY-141608 | American Home Products (Wyeth) | |  |
| WAY-151616 | American Home Products (Wyeth) | |  |
| WAY-151693 | American Cyanamid (Wyeth) | 206551-25-9 (HCl) |  |
| WAY-163909 | American Home Products (Wyeth) | |  |
| WAY-169916 | Wyeth | |  |
| WAY-174231 | | |  |
| WAY-181187 | Wyeth Pharmaceuticals | |  |
| WAY-181484 | Wyeth | |  |
| WAY-204688 | Wyeth | |  |
| WAY-207024 | Pfizer Inc. (US) | |  |
| WAY-208466 | Pfizer Inc. (US) | |  |
| WAY-252623 | Wyeth Corp. (US) | |  |
| WAY-253203 | Wyeth | |  |
| WAY-253752 | Wyeth Corp. (Pfizer Inc.) | |  |
| WAY-254011 | Wyeth Corp. (US) | |  |
| WAY-255348 | Wyeth Corp. (US) | |  |
| WAY-256805 | Wyeth | |  |
| WAY-257651 | Wyeth Corp. | |  |
| WAY-258131 | Wyeth Corp. (US) | |  |
| WAY-259223 | Curis Inc. (US) ; Wyeth Corp. (US) | |  |
| WAY-260022 | Wyeth Corp. (US) | |  |
| WAY-261240 | Pfizer Inc. (US) | |  |
| WAY-262611 | Pfizer Inc. (US) | |  |
| WAY-263216 | Wyeth Corp. | |  |
| WAY-264116 | Wyeth Corp. (Pfizer Inc.) | |  |
| WAY-266175 | Wyeth | |  |
| WAY-281418 | Pfizer Inc. (US) | |  |
| WAY-315193 | Wyeth Corp. (US) | |  |
| WAY-317538 | Siena Biotech SpA (Italy) | |  |
| WAY-855 | Wyeth | |  |
| WB-4101 | | 613-67-2 |  |
| WBI-1001 | Welichem Biotech | |  |
| WBI-2100 | Welichem Biotech Inc. | | No Structure |
| WC-10 | University of North Texas ; Washington University of St. Louis (US) | |  |
| WC-44 | Washington University School of Medicine (US) ; University of North Texas Health Science Center (US) | |  |
| WCK-1152 | Wockhardt Ltd. | |  |
| WCK-1153 | Wockhardt Ltd. | |  |
| WCK-1734 | Wockhardt Ltd. | |  |
| WCK-2349 | Wockhardt Ltd. (India) | |  |
| WCK-2664 | Wockhardt (India) | |  |
| WCK-2832 | Wockhardt (India) | |  |
| WCK-2924 | Wockhardt (India) | |  |
| WCK-3023 | Wockhardt (India) | |  |
| WCK-4086 | Wockhardt Ltd. | | No Structure |
| WCK-4873 | Wockhardt Ltd. | | No Structure |
| WCK-919 | Wockhardt | |  |
| WD-22-RP | National Research Council | |  |
| WD-22-RYP | National Research Council | |  |
| WEB-3 | Biotie Therapies Corp. (Finland) | |  |
| Wellcome-RN-135123-23-8 | University of Birmingham ; Wellcome (GSK) | 135123-23-8 |  |
| WF-10225A | Fujisawa | 195831-12-0 |  |
| WF-3681 | Fujisawa | 105364-56-5 |  |
| WF-536 | Mitsubishi Pharma | |  |
| WHI-05 | Wayne Hughes Inst. | 213982-93-5 |  |
| WHI-07 | Wayne Hughes Inst. | 213982-96-8 |  |
| WHI-P-164 | Hughes Inst. | 256532-03-3 |  |
| WHI-P-180 | Zeneca (AstraZeneca) | 211555-08-7 |  |
| WHI-P97 | Parker Hughes Inst. | 211555-05-4 |  |
| WHIP-131 | Parker Hughes Inst. | 202475-60-3 |  |
| WHIP-154 | Parker Hughes Inst. | 211555-04-3 |  |
| WHIP-273 | Parker Hughes Inst. | 296235-24-0 |  |
| WHIP-371 | Parker Hughes Inst. | 296235-26-2 |  |
| Wilate | Octapharma AG | | No Structure |
| Willardiine | | 21416-43-3 |  |
| WilVent | Pharmagenesis Inc. | | No Structure |
| WIN-17317 | Sanofi-Aventis | |  |
| WIN-33377 | Sterling Winthrop (Sanofi-Aventis) | 146537-07-7 |  |
| WIN-35428 | Organix ; Harvard College | 50370-56-4 |  |
| WIN-49611 | Sterling Drug (Sanofi-Aventis) | |  |
| WIN-54954 | Sterling Drug (Sanofi-Aventis) | 107355-45-3 |  |
| WIN-552122 | Sterling Drug (Sanofi-Aventis) | |  |
| WIN-552123 | Sterling Drug (Sanofi-Aventis) | |  |
| WIN-57273 | Sterling Drug (Sanofi-Aventis) | 123942-04-1 |  |
| WIN-58161 | Sterling Drug (Sanofi-Aventis) | 122033-48-1 |  |
| WIN-63759 | Sterling Winthrop (Sanofi-Aventis) | 142427-32-5 |  |
| WIN-64733 | Sterling Winthrop (Sanofi-Aventis) | 142577-24-0 |  |
| WIN-64821 | Sterling Winthrop (Sanofi-Aventis) | 150881-27-9 |  |
| WK-X-34 | University of Toronto ; University of Bonn | |  |
| WL-108477 | Shell | 94050-50-7 |  |
| WLBU-2 | University of Pittsburgh | |  |
| WM-16 | | |  |
| WM-20 | | |  |
| WM-5 | University of Padova ; Mediolanum, Italy | 304897-80-1 |  |
| WMC-26 | US Department of Health & Human Services | 164672-54-2 |  |
| WMC-79 | National Cancer Institute | 359630-61-8 |  |
| Wortmannin | | 19545-26-7 |  |
| WP-1066 | University of Texas | |  |
| WP-1106 | University of Texas | |  |
| WP-1129 | University of Texas | |  |
| WP-1130 | University of Texas | |  |
| WP-1164 | University of Texas | |  |
| WP-1193 | University of Texas | |  |
| WP-760 | Callisto Pharmaceuticals (US) | |  |
| WP-762 | M.D. Anderson Cancer Center (US) | |  |
| WP-921 | Wakamoto | 134717-73-0 |  |
| WQ-0835 | Wakunaga | 141428-75-3 |  |
| WQ-2128 | Wakunaga | 167073-44-1 |  |
| WQ-2724 | Wakunaga | 189279-56-9 |  |
| WQ-2743 | Wakunaga | 189280-13-5 |  |
| WQ-2756 | Wakunaga | 179740-69-3 |  |
| WQ-2942 | Wakunaga | 208164-87-8 |  |
| WQ-2944 | Wakunaga | |  |
| WQ-3330 | Wakunaga | |  |
| WQ-3335 | Wakunaga Pharma | |  |
| WQ-3810 | Wakunaga Pharmaceutical Co. Ltd. (Japan) | |  |
| WR-151327 | US Bioscience | 82147-31-7 |  |
| WR-225448 | US Army | 80065-55-0 |  |
| WR-227825 | American Home Products | |  |
| WR-268961 | University of Florida ;\nWalter Reed Army Institute | |  |
| WR-3689 | Southern Research Inst. | 20751-90-0 |  |
| WR-85915 | Walter Reed Army Institute | |  |
| WRC-0342 | Discovery Therapeutics (Aderis) | 175097-35-5 |  |
| WRC-0542 | Discovery Therapeutics (Aderis) | 175097-34-4 |  |
| WS-50030 | Solvay Pharmaceuticals BV (Netherlands) | |  |
| WSS-2138 | TAISHO PHARMA | |  |
| WSS-2260 | Taisho Pharma Co Ltd ; Sichuan Antibiotic Ind I Pharm | |  |
| WST-09 | Yeda (Weizmann Institute of Science, Israel) | 274679-00-4 |  |
| WT-4869 | International Institute of Cancer Immunology Inc. (Japan) ; Chugai Pharmaceutical Co. Ltd. ; Dainipp | | No Structure |
| WX-037 | UCB Pharma SA | | No Structure |
| WX-293 | Friedrich-Schiller Jena; Ludwig-Maximilians-Iniversitat; Max-Planck-Gesellschaft; Wilex | |  |
| WX-360 | Wilex | |  |
| WX-508 | Wilex | |  |
| WX-554 | UCB Pharma SA | | No Structure |
| WX-678 | Wilex AG | |  |
| WX-FX4 | Wilex | |  |
| WX-UK1 | Pentapharm | 220355-63-5 |  |
| WXC-340 | Wilex AG (Germany) | |  |
| WY-126227 | American Home Products (Wyeth) | 147972-00-7 |  |
| WY-200 | National University Corporation Gunma University (Japan) ; National University Corporation Nagoya In | |  |
| WY-44655 | Ciba-Geigy (Novartis) | 82714-07-6 |  |
| WY-46135 | American Home Products (Wyeth) | |  |
| WY-48989 | American Home Products (Wyeth) | 136917-40-3 |  |
| WY-49051 | American Home Products (Wyeth) | 113418-56-7 |  |
| WY-50295 | American Home Products (Wyeth) | 123016-21-7 |  |
| WYE-103231 | Wyeth Corp. (Pfizer Inc.) | |  |
| WYE-103914 | Wyeth Corp. (Pfizer Inc.) ; Siena Biotech SpA | |  |
| WYE-125132 | Wyeth Corp. (Pfizer Inc.) | |  |
| WYE-160020 | Pfizer Inc. (US) | |  |
| WYE-354 | Wyeth Corp. (Pfizer Inc.) | 1062169-56-5 |  |
| WYE-672 | Wyeth LLC (Pfizer Inc.) | |  |
| WZ-4002 | Dana Farber Cancer Institute (US) ; Brigham and Women's Hospital (US) ; Northeastern University (US) | 213269-23-8 |  |
| WZ-811 | Emory University (US) | |  |
| Xaliproden | Sanofi (Sanofi-Aventis) | 135354-02-8 |  |
| Xamoterol | ICI (AstraZeneca) | 81801-12-9 |  |
| Xanafide (Amonafide) | Laboratorios Made S.A. (Knoll) | |  |
| Xanomeline | Ferrosan | 131986-45-3 |  |
| Xanthine | Virginia Tech Intellectual Properties | 69-89-6 |  |
| Xanthoepocin | Ajinomoto | |  |
| Xanthohumol | | 569-83-5 ; 6754-58-1 |  |
| Xantinol nicotinate | Wuelfing | 437-74-1 |  |
| XB-513 | DuPont Merck (BMS) | 140941-86-2 |  |
| XBD-173 | Novartis | | No Structure |
| Xemilofiban | Searle ; Monsanto (Pfizer) | 149820-74-6 |  |
| XEN-2174 | Xenome Ltd. | |  |
| XEN-D0101 | | | No Structure |
| XEN-D0103 | Xention Ltd. | | No Structure |
| XEN-D0104 | Xention Ltd. | | No Structure |
| XEN-D0501 | | | No Structure |
| Xenalipin | Wellcome (GSK) | 84392-17-6 |  |
| Xenbucin | Maggioni | 959-10-4 |  |
| XENP-5574 | Xencor Inc. (US) | | No Structure |
| Xenytropium bromide | Licencia Budapest | 511-55-7 |  |
| Xepol | Pharmalink (Sweden) | | No Structure |
| XF-70 | Destiny Pharma Ltd. (GB) ; Solvias AG (Switzerland) | |  |
| XF-73 | Destiny Pharma Ltd. (GB) ; Solvias AG (Switzerland) | |  |
| XH-1 | General Hospital Corporation | |  |
| Xibenolol | Teikoku Hormone (Aska Pharmaceuticals) | 30187-90-7 |  |
| Xibornol | MARPHA | 13741-18-9 |  |
| Xilobam | McNeil (Johnson & Johnson) | 50528-97-7 |  |
| Ximelagatran | Astra (AstraZeneca) | 192939-46-1 |  |
| Ximoprofen | Logeais | 56187-89-4 |  |
| Xipamide | Beiersdorf | 14293-44-8 |  |
| XJ-448 | DuPont Merck (BMS) | 135136-05-9 |  |
| XJ-735 | DuPont Merck (BMS) | 153381-95-4 |  |
| XJB-5-131 | University of Pittsburgh (US) | |  |
| XK-216 | DuPont Merck (BMS) | 152929-04-9 |  |
| XK-469 | | |  |
| XL-019 | | | No Structure |
| XL-139 | Exelixis | | No Structure |
| XL-147 | | | No Structure |
| XL-228 | | | No Structure |
| XL-281 | Exelixis Inc. | | No Structure |
| XL-413 | Exelixis ; BMS | | No Structure |
| XL-418 | Exelixis | |  |
| XL-518 | Exelixis | | No Structure |
| XL-550 | Exelixis Inc. (US) | | No Structure |
| XL-647 | Exelixis | | No Structure |
| XL-652 | Exelixis Inc. (US) | | No Structure |
| XL-765 | Exelixis Inc. | 1123889-87-1 |  |
| XL-784 | Exelixis | | No Structure |
| XL-844 | Exelixis | | No Structure |
| XL-888 | | | No Structure |
| XL-999 | | | No Structure |
| XLi-093 | University of Wisconsin Milwaukee | |  |
| XM-02 | Sicor Biotech UAB (Lithuania) | | No Structure |
| XM-1097 | University of Minnesota | |  |
| XmAb 5485 | Xencor Inc. (US) | | No Structure |
| XmAb-5592 | Xencor Inc. (US) | | No Structure |
| XMC | Hodogaya | 2655-14-3 |  |
| XMP-293 | Xoma | |  |
| XMT-1001 | General Hospital Corporation (US) | |  |
| XMT-1107 | Mersana Therapeutics Inc. (US) | | No Structure |
| XNT | University of Florida (US) | 86456-22-6 |  |
| XO-B422 | Kissei Pharmaceutical Co. Ltd. (Japan) | |  |
| XOB | Amura | 414863-14-2 |  |
| XOMA-3AB | XOMA (US) LLC | | No Structure |
| XOMA-629 | Xoma | |  |
| Xorphanol | Miles Laboratories | 77287-89-9 |  |
| XP-12B (Tranexamic acid) | | |  |
| XP-21B (Diclofenac) | | |  |
| XP-620 | Du Pont Merck Pharma (BMS) | |  |
| XP-828L | Advitech Inc. (Canada) | | No Structure |
| XR-11211 | Xenova | 386212-69-7 |  |
| XR-11576 | Xenova | 346689-77-8 |  |
| XR-12890 | Xenova | |  |
| XR-13097 | Xenova | |  |
| XR-13287 | Xenova | |  |
| XR-299 | DuPont Merck (BMS) | 170229-10-4 |  |
| xr-300 | DuPont Merck (BMS) | 185826-70-4 |  |
| XR-303 | KS Biomedix (Xenova, Celtic Pharma) | | No Structure |
| XR-311 | KS Biomedix (Xenova) | | No Structure |
| XR-5000 | Development Finance Corporation of New Zealand | 89459-25-6 |  |
| XR-510 | Searle | 169181-38-8 |  |
| XR-5118 | Xenova | 174766-49-5 |  |
| XR-5944 | Xenova | 343247-32-5 |  |
| XR-5967 | Xenova | |  |
| XR-774 | Xenova | |  |
| XR-835 | DuPont Merck (BMS) | 167825-84-5 |  |
| XR-9019 | Xenova | 180422-97-3 |  |
| XR-9051 | Xenova | 180422-22-4 (HCl) |  |
| XR-9211 | Xenova | 180598-32-7 |  |
| XRD-563 | Eli Lilly | 124426-49-9. |  |
| XRP-44X | Sanofi-aventis (France) | 729605-21-4 |  |
| XRX-001 | | | No Structure |
| XT-199 | DuPont (BMS) | 211308-14-4 |  |
| XTL-6865 | University of Stanford | | No Structure |
| XU-063 | DuPont Merck (BMS) | 190446-35-6 |  |
| XU-065 | DuPont Merck (BMS) | 169605-80-5 |  |
| XU-817 | DuPont (BMS) | 202123-75-9 |  |
| XV-454 | DuPont Merck (BMS) | 171028-74-3 |  |
| Xylazine | Bayer | 7361-61-7 |  |
| Xylocydine | Seoul National University | |  |
| Xylometazoline | Ciba-Geigy (Novartis) | 526-36-3 |  |
| Xylylcarb | Sumitomo Chemical | 2425-10-7 |  |
| XYZ-033MP | LG Chemical | 331778-84-8 |  |
| Y-128 | Yoshitomi (Mitsubishi pharma) | |  |
| Y-134 | Shanghai Institute of Pharmacology (China) | 849662-80-2 |  |
| Y-20024 | Yoshitomi | 124842-93-9 |  |
| Y-20487 | Yoshitomi | 103969-58-0 |  |
| Y-20811 | Yoshitomi | 107433-19-2 |  |
| Y-22516 | Yoshitomi | 106614-07-7 |  |
| Y-23684 | Yoshitomi (Mitsubishi) | 118288-67-8 |  |
| Y-25510 | Yoshitomi | 145194-32-7 |  |
| Y-26611 | Yoshitomi | 143375-60-4 |  |
| Y-27152 | Yoshitomi | 127408-30-4 |  |
| Y-27632 | Yoshitomi (Mitsubishi) | 129830-38-2 ; 331752-47-7 |  |
| Y-29794 | Yoshitomi (Mitsubishi) | 129184-48-1 |  |
| Y-34867 | Yoshitomi | 214273-16-2 |  |
| Y-39041 | Yoshitomi | 223511-88-4 |  |
| Y-39677 | Welfide | |  |
| Y-39983 | Mitsubishi Pharmaceutical Corp. | |  |
| Y-688 | Yoshitomi | 162685-37-2 |  |
| Y-931 | Yoshitomi (Mitsubishi Pharma) | 221058-54-4 |  |
| Y-ART-3 | Yamanouchi (Astellas) | 179465-88-4 |  |
| YA2-M | Ajinomoto | |  |
| Yatakemycin | Kaken | |  |
| YB-257 | Mitsubishi ; Sanofi-Aventis | |  |
| YC-137 | University of Michigan | |  |
| YH-16 | Yantai Medgenn Ltd. (Simcere Pharmaceutical Group) | 916057-15-3 | No Structure |
| YHI-1 | Nippon Suisan Kaisha | 140893-49-8 |  |
| YHJ-132 | Univesity of Florida | |  |
| YIC-708424 | | |  |
| YIL-781 | Bayer AG (Germany) | |  |
| YIL-870 | Bayer AG (Germany) | |  |
| YJ-AG-168 | Duquesne University | |  |
| YJ-AG-176 | Duquesne University | |  |
| YJ-AG-178 | Duquesne University | |  |
| YJP-40102 | Yungjin Pharmaceutical ; Korea Institute of Science and Technology | |  |
| YK-4-279 | Georgetown University (US) | |  |
| YKP-1358 | SK Bio-Pharmaceuticals (US) | |  |
| YKP-1447 | SK Bio-Pharmaceuticals (US) | |  |
| YKP-3089 | SK BioPharma | | No Structure |
| YKP-581 | | | No Structure |
| YM-022 | Yamanouchi (Astellas) | 145084-28-2 |  |
| YM-116 | Yamanouchi (Astellas) | 183012-13-7 |  |
| YM-126414 | Yamanouchi | 100917-08-6 |  |
| YM-133 | Sanraku | 103360-00-5 |  |
| YM-13650 | Yamanouchi (Astellas) | 87545-58-2 |  |
| YM-154301 | Yamanouchi (Astellas) | 153192-22-4 |  |
| YM-155 | Astellas Pharma | 781661-94-7 |  |
| YM-16151-1 | Yamanouchi (Astellas) | 105617-64-9 |  |
| YM-16638 | Yamanouchi (Astellas) | 104073-72-5 |  |
| YM-169964 | Yamanouchi | |  |
| YM-181741 | Yamanouchi (Astellas) | 320385-54-4 |  |
| YM-187781 | Yamanouchi (Astellas) | 288630-03-5 |  |
| YM-187787 | Yamanouchi (Astellas) | 288630-04-6 |  |
| YM-19020 | Yamanouchi (Astellas) | 115836-13-0 |  |
| YM-198313 | Yamanouchi (Astellas) | |  |
| YM-201627 | Yamanouchi Pharmaceutical (Astellas Pharma) | |  |
| YM-202054 | Yamanouchi | |  |
| YM-202204 | Yamanouchi | 333794-35-7 |  |
| YM-203552 | Yamanouchi | |  |
| YM-203558 | Yamanouchi | |  |
| YM-21170 | Yamanouchi (Astellas) | 125662-80-8 |  |
| YM-215438 | Yamanouchi | |  |
| YM-218 | Yamanouchi Pharmaceutical | |  |
| YM-230888 | Yamanouchi (Astellas Pharma) | |  |
| YM-231146 | Yamanouchi (Astellas Pharma) | |  |
| YM-244769 | Yamanouchi | |  |
| YM-268 | Yamanouchi (Astellas) | 141716-96-3 |  |
| YM-270951 | Yamanouchi (Astellas) | |  |
| YM-271338 | Yamanouchi Pharma (Astellas) | |  |
| YM-281956 | Yamanouchi (Astellas) | |  |
| YM-298198 | Yamanouchi (Astellas) | 748758-45-4 |  |
| YM-341619 | Yamanouchi Pharma (Astellas) | |  |
| YM-344484 | Astellas Pharma Inc. (Japan) ; Toray Industries Inc. (Japan) | |  |
| YM-348 | Yamanouchi | |  |
| YM-355179 | Yamanouchi Pharma ; Toray Industries | |  |
| YM-359445 | Yamanouchi Pharma | |  |
| YM-38336 | Yamanouchi (Astellas) | |  |
| YM-393059 | Astellas Pharma. | |  |
| YM-40220 | Yamanouchi (Astellas) | 162081-75-6 |  |
| YM-43611 | Mitsubishi Chemical | 169451-66-5 |  |
| YM-440 | Yamanouchi (Astellas) | |  |
| YM-461 | Yamanouchi (Astellas) | 118196-11-5 |  |
| YM-46303 | Yamanouchi (Astellas) | 171722-81-9 (HCl) |  |
| YM-46A | Yamanouchi (Astellas) | 142912-85-4 |  |
| YM-471 | Yamanouchi (Astellas) | 168162-57-0 |  |
| YM-511 | Yamanouchi (Astellas) | 148869-05-0 |  |
| YM-534 | Yamanouchi (Astellas) | 95923-66-3 |  |
| YM-53403 | Astellas Pharma | |  |
| YM-543 | Astellas Pharma Inc. ; Kotobuki Pharmaceutical Co. Ltd. | | No Structure |
| YM-553 | Yamanouchi (Astellas) | 157911-98-3 |  |
| YM-57029 | Yamanouchi (Astellas) | |  |
| YM-57158 | Yamanouchi (Astellas) | 179102-65-2 |  |
| YM-580 | Yamanouchi (Astellas) | |  |
| YM-58483 | Yamanouchi (Astellas) | |  |
| YM-58997 | Yamanouchi (Astellas) | |  |
| YM-60828 | Yamanouchi (Astellas) | 179755-65-8 |  |
| YM-737 | Cornell Res Foundation | 97451-46-2 |  |
| YM-75440 | Yamanouchi | |  |
| YM-75466 | Yamanouchi (Astellas) | 209187-02-0 |  |
| YM-758 | Yamanouchi Pharma Co Ltd. (Japan) | |  |
| YM-796 | Yamanouchi (Astellas) | 171252-79-2 |  |
| YM-90709 | Yamanouchi Pharmaceutical | |  |
| YM-90K | Yamanouchi (Astellas) | 154164-30-4 |  |
| YM-92088 | Yamanouchi | |  |
| YM-928 | Yamanouchi | |  |
| YM-934 | Yamanouchi (Astellas) | 135644-11-1 |  |
| YM-954 | Yamanouchi (Astellas) | 132041-85-1 |  |
| YM-976 | Yamanouchi (Astellas) | 191219-80-4 |  |
| YM-F8 | BTG International Ltd. (GB) | |  |
| YNS-15P | Nippon Shinyaku | 198954-06-2 |  |
| Yohimbine | Spiegel Leopold | 146-48-5 |  |
| YP-001 | | | No Structure |
| YP-003 (Carbenoxolone) | Sheffield University (UK) | 5697-56-3 |  |
| YP-004 | York Pharma | | No Structure |
| YP-006 (Abafungin) | York Pharma | |  |
| YR-301 | Ligand Pharmaceuticals Inc. | |  |
| YS-110 | Y's Therapeutics Co. Ltd. | | No Structure |
| YSNSG-Cyclopeptide | Université de Reims Champagne-Ardenne (France) | |  |
| YSPSL | Genetics Institute (US) ; Montreal Heart Institute | 404819-89-2 |  |
| YT-1006 | Yaupon Therapeutics | |  |
| YT-146 | Yamasa Shoyu ; Toa Eiyo | 90596-75-1 |  |
| Yttrium (90Y) tacatuzumab | Immunomedics | 500784-58-7 |  |
| Yttrium 90 clivatuzumab tetraxetan | Immunomedics | 943976-23-6 | No Structure |
| Yttrium Y 90 Labetuzumab | Immunomedics | 501423-27-4 | No Structure |
| Yuehchukene | Kong, Yun Cheung | 96624-37-2 |  |
| (+)-YW-391 | Panorama Research | |  |
| (+)-YW-392 | Panorama Research | |  |
| YW-I-92 | US National Institute of Neurological Disorders and Stroke ; University of Virginia (US) | |  |
| Z-1046 | Zambon | 152212-77-6 |  |
| Z-104657A | Zambon | |  |
| Z-13752A | Zambon | |  |
| Z-15 | University of Virginia | 145554-73-0 |  |
| Z-15370A | Zambon | |  |
| Z-207 | | | No Structure |
| Z-209 | | | No Structure |
| Z-300 | Zeria | 128289-57-6 |  |
| Z-321 | Zeria | 130849-58-0 |  |
| Z-335 | Zeria | 146731-14-8 |  |
| Z-350 | Zeria | 243869-95-6 |  |
| Z-4105 | Zambon | 119737-52-9 |  |
| Z-521 | | | No Structure |
| Z-6568 | SIMES | 174285-75-7 |  |
| Z-7760 | Zambon | 329364-86-5 |  |
| Z-VDVAD-FMK | Lipha (E. Merck KGaA) | 220760-28-1 |  |
| ZAB-003 | Zyentia Ltd. (Great Britain) | | No Structure |
| Zabicipril | Science Union | 83059-56-7 |  |
| Zabofloxacin | Dong Wha | 219680-11-2 |  |
| Zacopride | Delalande | 123441-85-0 |  |
| Zafirlukast | ICI (AstraZeneca) | 107753-78-6 |  |
| Zalcitabine | Hoffmann La Roche (Roche) | 7481-89-2 |  |
| Zaldaride | Ciba-Geigy (Novartis) | 109826-26-8 |  |
| Zaleplon | American Cyanamid (Wyeth) | 151319-34-5 |  |
| Zalospirone | American Home Products (Wyeth) | 114298-18-9 |  |
| Zaltoprofen | Nippon Chemiphar | 89482-00-8 |  |
| Zalutumumab | Medarex (US) | 667901-13-5 | No Structure |
| Zanamivir | Biota | 139110-80-8 |  |
| Zanapezil | Takeda | 142852-51-5 |  |
| Zankiren | Abbott | 138742-43-5 |  |
| Zanolimumab | Genpharm | 652153-01-0 | No Structure |
| Zanoterone | Sterling Drug (Sanofi-Aventis) | 107000-34-0 |  |
| Zardaverine | Byk Gulden (Nycomed) | 101975-10-4 |  |
| Zatebradine | Thomae (Boehringer Ingelheim) | 85175-67-3 |  |
| Zatosetron | Eli Lilly | 123482-22-4 |  |
| Zaurategrast | Celltech (UCB) | 455264-31-0 |  |
| ZC-207 | Spirogen | |  |
| ZC-88 | Beijing Institute of Pharmacology and Toxicology, Academy of Military Medical Sciences (China) | |  |
| ZCR-2060 | Zeria | 150324-42-8 |  |
| ZD-0870 | ICI (AstraZeneca) | 149715-95-7 |  |
| ZD-0892 | ICI (AstraZeneca) | 171964-73-1 |  |
| ZD-0947 | AstraZeneca | 496972-14-6 |  |
| ZD-1611 | Zeneca | |  |
| ZD-200880 | ICI (AstraZeneca) | 105080-50-0 |  |
| ZD-2138 | ICI (AstraZeneca) | 140841-32-3 |  |
| ZD-2315 | | | No Structure |
| ZD-2767P | Zeneca (AstraZeneca) | 156079-88-8 |  |
| ZD-3638 | ICI (AstraZeneca) | 152352-44-8 |  |
| ZD-4190 | Zeneca (AstraZeneca) | 257938-36-6 |  |
| ZD-4407 | Zeneca (AstraZeneca) | 166882-70-8 |  |
| ZD-4927 | AstraZeneca | | No Structure |
| ZD-4974 | AstraZeneca | |  |
| ZD-5522 | ICI (AstraZeneca) | |  |
| ZD-6021 | AstraZeneca | |  |
| ZD-6126 | Angiogene Pharm | 219923-05-4 |  |
| ZD-6169 | ICI (AstraZeneca) | 147696-46-6 |  |
| ZD-6416 | | 346670-92-6 | No Structure |
| ZD-7114 | ICI (AstraZeneca) | 129689-30-1 |  |
| ZD-7155 | ICI (AstraZeneca) | |  |
| ZD-7349 | AstraZeneca | |  |
| ZD-7717 | ICI (AstraZeneca) | 142655-68-3 |  |
| ZD-7944 | Zeneca (AstraZeneca) | |  |
| ZD-8321 | Zeneca (AstraZeneca) | 182073-77-4 |  |
| ZD-9255 | Zeneca (AstraZeneca) | 158747-27-4 |  |
| ZD-9379 | AstraZeneca | 179543-32-9 |  |
| ZD-9583 | ICI (AstraZeneca) | |  |
| Zeaxanthin | BASF | 144-68-3 |  |
| Zebularine | NIH | 3690-10-6 |  |
| Zelandopam | Yamanouchi (Astellas) | 139233-53-7 |  |
| ZEN-012 | Zentaris (Aeterna Zentaris) | |  |
| Zenarestat | Fujisawa | 112733-06-9 |  |
| Zeniplatin | American Cyanamid (Wyeth) | 111490-36-9 |  |
| Zeranol | Commercial Solvents | 26538-44-3 |  |
| Zeta-cypermethrin | National Research Development Corporation (NRDC) | 52315-07-8 (Unstated sterochemistry) |  |
| Zetidoline | Lepetit | 51940-78-4 |  |
| Zibotentan | Zeneca (AstraZeneca) | 186497-07-4 |  |
| Zibrofusidic acid | Leo Pharma | 827603-95-2 |  |
| Ziconotide | Neurex | 107452-89-1 |  |
| Zicronapine | Lundbeck (Denmark) | |  |
| Zidampidine | Parker Hughes Institute | |  |
| Zidometacin | Pierrel | 62851-43-8 |  |
| Zidovudine | Burroughs Wellcome (GSK) | 30516-87-1 |  |
| Zifrosilone | Merrell Dow (Aventis) | 132236-18-1 |  |
| Zilascorb | Norsk Hydro | 122431-96-3 |  |
| Zileuton | Abbott | 111406-87-2 |  |
| Zilpaterol | Roussel Uclaf (France) | 117827-79-9 ; 119520-06-8 (HCl) ; 113827-79-9 |  |
| Zimelidine | Astra | 61129-30-4 |  |
| Zinc Monocysteine | Newsome DA. (US) ; Tate D. (US) | |  |
| Zindotrine | Aventis | 56383-05-2 |  |
| Zineb | Rohm & Haas | 12122-67-7 |  |
| Zingerone | | 122-48-5 |  |
| Zingiber officinalis (ginger) extract | | | No Structure |
| Zinostatin | Yamanouchi (Astellas) | 9014-02-2 |  |
| Zipeprol | Mauvernay | 34758-83-3 |  |
| Ziprasidone | Pfizer | 146939-27-7 |  |
| Zipsor (Diclofenac) | | 15307-86-5 ; 15307-81-0 (Diclofenac potassium) |  |
| Ziram | Sharples Chemicals | 137-30-4 |  |
| ZJ-17 | | |  |
| ZK-110841 | Schering AG | 105595-17-3 |  |
| ZK-112566 | Schering AG | 124824-02-8 |  |
| ZK-118182 | Schering AG | 120962-76-7 |  |
| ZK-119010 | Schering AG | 127451-69-8 |  |
| ZK-137316 | Jenapharm | 198907-45-8 |  |
| ZK-138723 | Schering AG | 134135-12-9 |  |
| ZK-156979 | Schering AG | |  |
| ZK-187638 | Schering AG | |  |
| ZK-191784 | Schering AG | |  |
| ZK-200775 | Schering AG | |  |
| ZK-203278 | Bayer Schering Pharma AG (Germany) | |  |
| ZK-261991 | Bayer Schering Pharma AG (Germany) | |  |
| ZK-281471 | Jenapharm Gmbh | |  |
| ZK-304709 | | |  |
| ZK-4044 | Schering AG | |  |
| ZK-805623 | Berlex | 183299-90-3 |  |
| ZK-813039 | Bayer Schering Pharma AG (Germany) | |  |
| ZK-91296 | Schering AG | 83910-34-3 |  |
| ZK-Epothilone | Schering AG (Bayer-Schering) | |  |
| ZM-172405 | AstraZeneca | |  |
| ZM-214888 | AstraZeneca | |  |
| ZM-224832 | ICI (AstraZeneca) | |  |
| ZM-227189 | ICI (AstraZeneca) | |  |
| ZM-230487 | ICI (AstraZeneca) | 155944-23-3 |  |
| ZM-241385 | ICI (AstraZeneca) | |  |
| ZM-242421 | AstraZeneca | |  |
| ZM-253270 | AstraZeneca | 169340-04-9 |  |
| ZM-260384 | Zeneca (AstraZeneca) | 161229-62-5 |  |
| ZM-374979 | AstraZeneca | |  |
| ZM-447439 | AstraZeneca | |  |
| Zn(sanm)2 | Wakunaga Pharmaceutical | |  |
| ZNC-2381 | Nippon Chemiphar ; Zeria | 249605-64-9 |  |
| Zofenopril | Squibb (BMS) | 81872-10-8 |  |
| Zolazepam | Parke, Davis (Pfizer) | 31352-82-6 |  |
| Zoledronic acid | Ciba-Geigy (Novartis) | 118072-93-8 ; 165800-06-6 (hydrate) |  |
| Zoleprodolol | Vsesoyuznyj Nauchno-issledovatels'kij Khimiko-farmatsevticheskij Institut Im.sergo Ordzhonikidze (US | 158599-53-2 ; 158446-41-4 (HCl) |  |
| Zolimidine | Selvi | 1222-57-7 |  |
| Zolip (Fenofibrate & Simvastatin) | | 49562-28-9 (Fenofibrate) ; 79902-63-9 (Simvastatin) |  |
| Zolmitriptan | Wellcome (GSK) | 139264-17-8 |  |
| Zolpidem | Synthelabo (Sanofi-Aventis) | 82626-48-0 |  |
| Zomepirac | Ortho McNeil (Johnson & Johnson) | 33369-31-2 |  |
| Zonampanel | Yamanouchi (Astellas) | 179010-47-0 ; 210245-80-0 |  |
| Zoniporide | Pfizer | 241800-98-6 |  |
| Zonisamide | Dainippon Pharmaceutical | 68291-97-4 |  |
| Zopfiellin | Nissan Chemical | 155260-94-9 |  |
| Zopiclone | Rhone-Poulenc (Aventis) | 43200-80-2 |  |
| Zopolrestat | Pfizer | 110703-94-1 |  |
| Zoster Vaccine Live | Merck & Co | | No Structure |
| Zosuquidar | Syntex | 167465-36-3 |  |
| Zotarolimus | Abbott Laboratories | 221877-54-9 |  |
| Zotepine | Fujisawa | 26615-21-4 |  |
| Zoxamide | Rohm & Haas | 156052-68-5 |  |
| ZP-120 | Zealand Pharmaceuticals | |  |
| ZP-1846 | Zealand Pharma AS (Denmark) | |  |
| ZP-1848 | Zealand Pharma AS | |  |
| ZP-2307 | Zealand Pharma AS | | No Structure |
| ZP-2653 | Zealand Pharma AS | |  |
| ZP-2663 | Zealand Pharma AS | |  |
| ZP-2929 | Zealand Pharma AS | | No Structure |
| ZR-2002 | McGill University | |  |
| ZSET-1446 | Zenyaku Kogyo | |  |
| ZSET-845 | Zenyaku Kogyo | |  |
| ZSM-I-158 | University of Michigan | |  |
| ZSM-I-89F | University of Michigan | |  |
| ZSTK-474 | Zenyaku Kogyo | |  |
| ZT-031 | National Research Council of Canada | |  |
| Zucapsaicin | Cisco Limited Partnership | 25775-90-0 |  |
| Zuclopenthixol | Kefalas | 53772-83-1 |  |
| Zuplenz (Ondansetron) | MonoSol Rx | 99614-20-5 |  |
| ZYC-22 | University of Washington | |  |
| ZYC-26 | University of Washington | |  |
| ZYC-3 | University of Washington ; University of Florida ; University of North Texas | |  |
| ZYH-7 | Zydus Cadila Healthcare | | No Structure |